3.8-1.2 HLA complex group 26 (non-protein coding) pseudogene 6p21.3 neuropathy, anterior ischemic optic neuropathy, arteritic anterior ischemic optic neuropathy
A1BG alpha-1-B glycoprotein 19q13.43 pancreatic ductal adenocarcinoma
A1CF APOBEC1 complementation factor 10q11.23 amblyopia anisometropia
A2M alpha-2-macroglobulin 12p13.31 alzheimers disease, argyrophilic grain disease, alpha-2-macroglobulin deficiency
A2ML1 alpha-2-macroglobulin-like 1 12p13.31 paraneoplastic pemphigus
A4GALT alpha 1,4-galactosyltransferase 22q13.2 nor polyagglutination syndrome
AA1 Alopecia areata 1 18p11.3-p11.2 alopecia alopecia areata 1
AA2 Alopecia areata 2 16q11-q22 alopecia alopecia areata 2
AAA1 aortic aneurysm, familial abdominal 1 19q13 abdominal aortic aneurysm aneurysm
AAA2 Aortic aneurysm, familial abdominal 2 4q31 aneurysm, aortic aneurysm "aortic aneurysm, familial abdominal 2"
AAA3 Aneurysm, familial abdominal 3 9p21 aneurysm "aneurysm, familial abdominal 3"
AAA4 Aortic aneurysm, familial abdominal, 4 12q13.3 aneurysm, aortic aneurysm "aortic aneurysm, familial abdominal, 4"
AAAS achalasia, adrenocortical insufficiency, alacrimia 12q13.13 abdominal aortic aneurysm, adrenocortical insufficiency, idiopathic achalasia,
AADAC arylacetamide deacetylase 3q25.1 neutral lipid storage disease, lipid storage disease ectropion
AADAT aminoadipate aminotransferase 4q33 huntingtons disease
AAGAB alpha- and gamma-adaptin binding protein 15q23 palmoplantar keratosis, keratoderma "keratoderma, palmoplantar, punctate type ia"
AAMP angio-associated, migratory cell protein 2q35 adenocarcinoma, colon adenocarcinoma coronary restenosis
AANAT aralkylamine N-acetyltransferase 17q25.1 bipolar i disorder, pineocytoma delayed sleep phase syndrome
AARS alanyl-tRNA synthetase 16q22.1 charcot-marie-tooth neuropathy type 2, charcot-marie-tooth disease type 2, mitochondrial cardiomyopathy,
AARS2 alanyl-tRNA synthetase 2, mitochondrial 6p21.1 mitochondrial cardiomyopathy combined oxidative phosphorylation deficiency 8
AASS aminoadipate-semialdehyde synthase 7q31.32 hyperlysinemia, saccharopinuria , breast lymphoma
AASTH1 Allergic/atopic asthma related QTL 1 asthma
AASTH10 Allergic/atopic asthma related QTL 10 asthma
AASTH11 Allergic/atopic asthma related QTL 11 asthma
AASTH12 Allergic/atopic asthma related QTL 12 asthma
AASTH13 Allergic/atopic asthma related QTL 13 asthma
AASTH14 Allergic/atopic asthma related QTL 14 asthma
AASTH15 Allergic/atopic asthma related QTL 15 asthma
AASTH16 Allergic/atopic asthma related QTL 16 asthma
AASTH17 Allergic/atopic asthma related QTL 17 asthma
AASTH18 Allergic/atopic asthma related QTL 18 asthma
AASTH2 Allergic/atopic asthma related QTL 2 asthma
AASTH20 Allergic/atopic asthma related QTL 20 asthma
AASTH21 Allergic/atopic asthma related QTL 21 asthma
AASTH22 Allergic/atopic asthma related QTL 22 asthma
AASTH23 Allergic/atopic asthma related QTL 23 asthma
AASTH24 Allergic/atopic asthma related QTL 24 asthma
AASTH25 Allergic/atopic asthma related QTL 25 asthma
AASTH26 Allergic/atopic asthma related QTL 25 asthma
AASTH27 Allergic/atopic asthma related QTL 27 asthma
AASTH28 Allergic/Atopic asthma related QTL 28 asthma
AASTH29 Allergic/Atopic asthma related QTL 29 asthma
AASTH30 Allergic/atopic asthma related QTL 30 asthma
AASTH32 Allergic/Atopic asthma related QTL 32 asthma
AASTH33 Allergic/atopic asthma related QTL 33 asthma
AASTH34 Allergic/atopic asthma related QTL 34 asthma
AASTH35 Allergic/atopic asthma related QTL 35 asthma
AASTH36 Allergic/atopic asthma related QTL 36 asthma
AASTH37 Allergic/atopic asthma related QTL 37 asthma
AASTH38 Allergic/atopic asthma related QTL 38 asthma
AASTH39 Allergic/atopic asthma related QTL 39 asthma
AASTH4 Allergic/atopic asthma related QTL 4 asthma
AASTH40 Allergic/atopic asthma related QTL 40 asthma
AASTH41 Allergic/Atopic asthma related QTL 41 asthma
AASTH42 Allergic/atopic asthma related QTL 42 asthma
AASTH43 Allergic/atopic asthma related QTL 43 asthma
AASTH44 Allergic/atopic asthma related QTL 44 asthma
AASTH47 Allergic/atopic asthma related QTL 47 asthma
AASTH48 Allergic/atopic asthma related QTL 48 asthma
AASTH49 Allergic/atopic asthma related QTL 49 asthma
AASTH5 Allergic/atopic asthma related QTL 5 asthma
AASTH50 Allergic/atopic asthma related QTL 50 asthma
AASTH51 Allergic/atopic asthma related QTL 51 asthma
AASTH52 Allergic/atopic asthma related QTL 52 asthma
AASTH53 Allergic/atopic asthma related QTL 53 asthma
AASTH54 Allergic/atopic asthma related QTL 54 asthma
AASTH55 Allergic/atopic asthma related QTL 5 asthma
AASTH56 Allergic/Atopic asthma related QTL 56 asthma
AASTH6 Allergic/atopic asthma related QTL 6 asthma
AASTH7 Allergic/atopic asthma related QTL 7 asthma
AASTH8 Allergic/atopic asthma related QTL 8 asthma
AASTH9 Allergic/atopic asthma related QTL 9 asthma
AAT1 Aortic aneurysm, familial thoracic 1 11q23.3-q24 aneurysm "aortic aneurysm, familial thoracic 1"
AAT2 Aortic aneurysm, familial thoracic 2 5q13-q14 aneurysm, aortic aneurysm "aortic aneurysm, familial thoracic 2"
AATK apoptosis-associated tyrosine kinase 17q25.3 neuroblastoma
AAVS1 adeno-associated virus integration site 1 19q13|19q13-qter herpes simplex
ABAT 4-aminobutyrate aminotransferase 16p13.2 schizophrenia, early myoclonic encephalopathy, hypotonia,
ABCA1 ATP-binding cassette, sub-family A (ABC1), member 1 9q31.1 coronary artery disease, scott syndrome, syringomyelia,
ABCA12 ATP-binding cassette, sub-family A (ABC1), member 12 2q35 autosomal recessive congenital ichthyosis, "ichthyosis, congenital, autosomal recessive 2", "ichthyosis, congenital, autosomal recessive 1",
ABCA2 ATP-binding cassette, sub-family A (ABC1), member 2 9q34.3 developmental coordination disorder neuroma
ABCA3 ATP-binding cassette, sub-family A (ABC1), member 3 16p13.3 surfactant dysfunction, "surfactant metabolism dysfunction, pulmonary, 1", pulmonary surfactant metabolism dysfunction,
ABCA4 ATP-binding cassette, sub-family A (ABC1), member 4 1p22.1 leber congenital amaurosis, age related macular degeneration, retinitis pigmentosa,
ABCA5 ATP-binding cassette, sub-family A (ABC1), member 5 17q24.3 gingival fibromatosis with hypertrichosis
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 7q21.12 myeloma, soft tissue sarcoma, breast cancer,
ABCB11 ATP-binding cassette, sub-family B (MDR/TAP), member 11 2q31.1 lung cancer, cholestasis, intrahepatic cholestasis,
ABCB4 ATP-binding cassette, sub-family B (MDR/TAP), member 4 7q21.12 cholangitis, adult syndrome, cholestasis,
ABCB6 ATP-binding cassette, sub-family B (MDR/TAP), member 6 2q35 matthew-wood syndrome, kleptomania, stereotypic movement disorder,
ABCB7 ATP-binding cassette, sub-family B (MDR/TAP), member 7 Xq13.3 myocardial infarction, pearson syndrome, x-linked sideroblastic anemia with ataxia,
ABCC1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1 16p13.11 acute myeloid leukemia, lung cancer, microsporidiosis,
ABCC11 ATP-binding cassette, sub-family C (CFTR/MRP), member 11 16q12.1 dubin-johnson syndrome
ABCC12 ATP-binding cassette, sub-family C (CFTR/MRP), member 12 16q12.1 breast cancer dubin-johnson syndrome
ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 10q24.2 lung cancer, cholangitis, factor vii deficiency,
ABCC3 ATP-binding cassette, sub-family C (CFTR/MRP), member 3 17q21.33 extrahepatic cholestasis, dubin-johnson syndrome, obstructive jaundice
ABCC4 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 13q32.1 lung cancer
ABCC5 ATP-binding cassette, sub-family C (CFTR/MRP), member 5 3q27.1 lymphoblastic leukemia dysembryoplastic neuroepithelial tumor
ABCC6 ATP-binding cassette, sub-family C (CFTR/MRP), member 6 16p13.11 arterial calcification of infancy, dubin-johnson syndrome, angioid streaks,
ABCC8 ATP-binding cassette, sub-family C (CFTR/MRP), member 8 11p15.1 diabetes mellitus, "diabetes mellitus, noninsulin-dependent", hypoglycemia,
ABCC9 ATP-binding cassette, sub-family C (CFTR/MRP), member 9 12p12.1 hypokalemic periodic paralysis, osteochondrodysplasia, choroid plexus papilloma,
ABCD1 ATP-binding cassette, sub-family D (ALD), member 1 Xq28 adrenomyeloneuropathy, peroxisomal disease, spinocerebellar degeneration,
ABCD2 ATP-binding cassette, sub-family D (ALD), member 2 12q12 peroxisomal disease
ABCD3 ATP-binding cassette, sub-family D (ALD), member 3 1p21.3 peroxisomal disease, adrenoleukodystrophy zellweger syndrome
ABCD4 ATP-binding cassette, sub-family D (ALD), member 4 14q24.3 homocystinuria, adrenoleukodystrophy, disorders of intracellular cobalamin metabolism,
ABCF2 ATP-binding cassette, sub-family F (GCN20), member 2 7q36.1 cystic fibrosis
ABCG1 ATP-binding cassette, sub-family G (WHITE), member 1 21q22.3 autosomal recessive nonsyndromic deafness, tangier disease sitosterolemia
ABCG2 ATP-binding cassette, sub-family G (WHITE), member 2 4q22.1 breast cancer, acute myeloid leukemia, choriocarcinoma,
ABCG5 ATP-binding cassette, sub-family G (WHITE), member 5 2p21 familial hypercholesterolemia, aortic atherosclerosis, sitosterolemia,
ABCG8 ATP-binding cassette, sub-family G (WHITE), member 8 2p21 atherosclerosis, gallbladder disease, aortic atherosclerosis,
ABHD11 abhydrolase domain containing 11 7q11.23 williams-beuren syndrome
ABHD12 abhydrolase domain containing 12 20p11.21 polyneuropathy, usher syndrome type 3 "polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract"
ABHD5 abhydrolase domain containing 5 3p21.33 systemic primary carnitine deficiency disease, neutral lipid storage disease lipid storage disease
ABI1 abl-interactor 1 10p12.1 breast cancer, acute myeloid leukemia, colon cancer
ABL1 c-abl oncogene 1, non-receptor tyrosine kinase 9q34.12 lymphoblastic leukemia, leukemia, precursor t-cell acute lymphoblastic leukemia,
ABL2 c-abl oncogene 2, non-receptor tyrosine kinase 1q25.2 leukemia "leukemia, acute myeloid, with eosinophilia"
ABO ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) 9q34.2 malaria blood group incompatibility
ABR active BCR-related 17p13.3 enamel erosion
ABRA actin-binding Rho activating protein 8q23.1 malaria
ABT1 activator of basal transcription 1 6p22.2 spinocerebellar ataxia type 17, roberts syndrome neuronal intranuclear inclusion disease
AC004862.6 uncharacterized LOC101927269 7q21.11 hepatocellular carcinoma
AC007246.3 uncharacterized LOC728730 2p22.1 obesity
AC007743.1 uncharacterized LOC100129434 2p16.1 hiv-1
AC008697.1 uncharacterized LOC285626 5q33.3 psoriasis, multiple sclerosis crohns disease
AC009264.1 uncharacterized LOC349160 7q33 migraine
AC009948.5 uncharacterized LOC101927027 2q31.2 parkinsons disease
AC018647.3 uncharacterized LOC100506725 7p14.2 parkinsons disease
AC019117.1 uncharacterized LOC102659288 7p21.1 cholangiocarcinoma intrahepatic cholangiocarcinoma
AC079586.1 uncharacterized LOC151121 2q21.1 neutropenia
AC091878.1 uncharacterized LOC285696 5p15.1 alzheimers disease bipolar disorder
AC097662.2 uncharacterized LOC654841 2q36.3 keratoconus
ACAA1 acetyl-CoA acyltransferase 1 3p22.2 beta-ketothiolase deficiency, ketothiolase deficiency, rhizomelic chondrodysplasia punctata
ACAA2 acetyl-CoA acyltransferase 2 18q21.1 beta-ketothiolase deficiency, ketothiolase deficiency, akinetic mutism
ACACA acetyl-CoA carboxylase alpha 17q12 multiple carboxylase deficiency, biotin deficiency acetyl-coa carboxylase deficiency
ACACB acetyl-CoA carboxylase beta 12q24.11 biotin deficiency
ACAD11 acyl-CoA dehydrogenase family, member 11 3q22.1 childhood leukemia
ACAD8 acyl-CoA dehydrogenase family, member 8 11q25 mental retardation and microcephaly with pontine and cerebellar hypoplasia isobutyryl-coa dehydrogenase deficiency
ACAD9 acyl-CoA dehydrogenase family, member 9 3q21.3 mitochondrial complex i deficiency , mental retardation and microcephaly with pontine and cerebellar hypoplasia , acad9 deficiency
ACADL acyl-CoA dehydrogenase, long chain 2q34 fatty acid oxidation disorders, hypoglycemia lcad deficiency
ACADM acyl-CoA dehydrogenase, C-4 to C-12 straight chain 1p31.1 sudden infant death syndrome, reye syndrome, multiple carboxylase deficiency,
ACADS acyl-CoA dehydrogenase, C-2 to C-3 short chain 12q24.31 angina pectoris, diverticulitis, sudden infant death syndrome,
ACADSB acyl-CoA dehydrogenase, short/branched chain 10q26.13 isovaleric acidemia 2-methylbutyryl-coa dehydrogenase deficiency
ACADVL acyl-CoA dehydrogenase, very long chain 17p13.1 pericardial effusion, sudden infant death syndrome, fatty acid oxidation disorders,
ACAN aggrecan 15q26.1 multiple epiphyseal dysplasia, spinal stenosis, exotropia,
ACAT1 acetyl-CoA acetyltransferase 1 11q22.3 beta-ketothiolase deficiency, ketothiolase deficiency, the organic acidemias: an,
ACAT2 acetyl-CoA acetyltransferase 2 6q25.3 beta-ketothiolase deficiency, ketothiolase deficiency, acetyl coa acetyltransferase 2 deficiency
ACBD5 acyl-CoA binding domain containing 5 10p12.1 thrombocytopenia
ACCS 1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional) 11p11.2 adenoid cystic carcinoma
ACD adrenocortical dysplasia homolog (mouse) 16q22.1 breast cancer susceptibility
ACE angiotensin I converting enzyme 17q23.3 vascular disease, myocardial infarction, coronary artery disease,
ACE2 angiotensin I converting enzyme 2 Xp22.2 malaria, essential hypertension, posterior urethral valves,
ACER1 alkaline ceramidase 1 19p13.3 lipogranulomatosis farber lipogranulomatosis
ACER2 alkaline ceramidase 2 9p22.1 lipogranulomatosis farber lipogranulomatosis
ACER3 alkaline ceramidase 3 11q13.5 lipogranulomatosis, farber lipogranulomatosis, fetal alcohol syndrome
ACF Asymmetric crying facies (Cayler cardiofacial syndrome) 22q11 velocardiofacial syndrome alzheimers disease
ACHE acetylcholinesterase (Yt blood group) 7q22.1 schizophrenia, hirschsprungs disease, myasthenia gravis,
ACIN1 apoptotic chromatin condensation inducer 1 14q11.2 breast adenomyoepithelioma
ACKR3 atypical chemokine receptor 3 2q37.3 papillary thyroid carcinoma
ACKR4 atypical chemokine receptor 4 3q22.1 pulmonary sarcoidosis
ACLS acrocallosal syndrome 12p13.3-p11.2 acrocallosal syndrome, hydrolethalus syndrome 2 joubert syndrome 12
ACO1 aconitase 1, soluble 9p21.1 x-linked sideroblastic anemia with ataxia, x-linked sideroblastic anemia hyperferritinemia cataract syndrome
ACO2 aconitase 2, mitochondrial 22q13.2 ornithine translocase deficiency infantile cerebellar-retinal degeneration
ACOT11 acyl-CoA thioesterase 11 1p32.3 obesity
ACOT13 acyl-CoA thioesterase 13 6p22.3 cutaneous anthrax larynx verrucous carcinoma
ACOT7 acyl-CoA thioesterase 7 1p36.31 fatty acid oxidation disorders temporal lobe epilepsy
ACOX1 acyl-CoA oxidase 1, palmitoyl 17q25.1 anoxia, rhizomelic chondrodysplasia punctata, adrenoleukodystrophy,
ACOX3 acyl-CoA oxidase 3, pristanoyl 4p16.1 mutism
ACP1 acid phosphatase 1, soluble 2p25.3 malaria, tuberculosis, leopard syndrome,
ACP2 acid phosphatase 2, lysosomal 11p11.2 lysosomal acid phosphatase deficiency
ACP5 acid phosphatase 5, tartrate resistant 19p13.2 giant cell tumor, renal osteodystrophy, hyperparathyroidism,
ACP6 acid phosphatase 6, lysophosphatidic 1q21.2 atrioventricular septal defect
ACPP acid phosphatase, prostate 3q22.1 prostate cancer, prostatic hypertrophy, cloacogenic carcinoma,
ACPT acid phosphatase, testicular 19q13.33 prostate cancer testicular cancer
ACR acrosin 22q13.33 globozoospermia male infertility due to acrosin deficiency
ACRBP acrosin binding protein 12p13.31 arteriolosclerosis
ACRC acidic repeat containing Xq13.1 appendix adenocarcinoma
ACRPS Acropectoral syndrome 7q36 acropectoral syndrome
ACRPV Acropectorovertebral dysplasia (F syndrome) 2q36 acropectorovertebral dysplasia f form
ACRV1 acrosomal vesicle protein 1 11q24.2 hordeolum
ACSF3 acyl-CoA synthetase family member 3 16q24.3 methylmalonic acidemia combined malonic and methylmalonic aciduria
ACSL3 acyl-CoA synthetase long-chain family member 3 2q36.1 saethre-chotzen syndrome
ACSL4 acyl-CoA synthetase long-chain family member 4 Xq23 "mental retardation, x-linked 17/31, microduplication", mental retardation, "mental retardation, x-linked",
ACSL5 acyl-CoA synthetase long-chain family member 5 10q25.2 colorectal cancer
ACSL6 acyl-CoA synthetase long-chain family member 6 5q31.1 myelodysplastic syndromes, rippling muscle disease "acute myeloid leukemia, adult"
ACSM3 acyl-CoA synthetase medium-chain family member 3 16p12.3 essential hypertension hypertension
ACSS3 acyl-CoA synthetase short-chain family member 3 12q21.31 fetal alcohol syndrome
ACT actin-like protein (ACT) gene 2q21.1 "cerebrovascular disease, occlusive" alpha-1-antichymotrypsin deficiency
ACTA1 actin, alpha 1, skeletal muscle 1q42.13 "myopathy, congenital, with fiber-type disproportion 1", congenital fiber-type disproportion, myopathy,
ACTA2 actin, alpha 2, smooth muscle, aorta 10q23.31 moyamoya disease, aneurysm, retinitis pigmentosa 17 ,
ACTB actin, beta 7p22.1 chorea-acanthocytosis, tethered spinal cord syndrome, substernal goiter,
ACTC1 actin, alpha, cardiac muscle 1 15q14 papilloma, scleromyxedema, juvenile nasopharyngeal angiofibroma,
ACTG1 actin, gamma 1 17q25.3 charcot-marie-tooth disease type 2, "deafness, autosomal dominant 4b", usher syndrome type i,
ACTG2 actin, gamma 2, smooth muscle, enteric 2p13.1 legg-calve-perthes disease, visceral myopathy, megacystis microcolon intestinal hypoperistalsis syndrome
ACTL7A actin-like 7A 9q31.3 breast cancer susceptibility, hypertensive nephropathy riley-day syndrome
ACTL7B actin-like 7B 9q31.3 hypertensive nephropathy riley-day syndrome
ACTL9 actin-like 9 19p13.2 breast and colorectal cancer
ACTN1 actinin, alpha 1 14q24.1 "macrothrombocytopenia, autosomal dominant, tubb1-related" "bleeding disorder, platelet-type, 15"
ACTN2 actinin, alpha 2 1q43 endocardial fibroelastosis, "cardiomyopathy, dilated, 1w", infantile onset spinocerebellar ataxia,
ACTN3 actinin, alpha 3 (gene/pseudogene) 11q13.2 dystrophinopathies
ACTN4 actinin, alpha 4 19q13.2 nephrotic syndrome, familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis, glomerulosclerosis,
ACTR2 ARP2 actin-related protein 2 homolog (yeast) 2p14 wiskott-aldrich syndrome
ACTR3BP6 ACTR3B pseudogene 6 22q11.1 hiv-1
ACTR3C ARP3 actin-related protein 3 homolog C (yeast) 7q36.1 lung adenoma
ACVR1 activin A receptor, type I 2q24.1 osteochondroma fibrodysplasia ossificans progressiva
ACVR1B activin A receptor, type IB 12q13.13 pituitary tumors "pancreatic carcinoma, somatic"
ACVR1C activin A receptor, type IC 2q24.1 myositis ossificans
ACVR2A activin A receptor, type IIA 2q22.3 multiple synostoses syndrome
ACVR2B activin A receptor, type IIB 3p22.2 dextrocardia, heterotaxy, "heterotaxy, visceral, 4, autosomal",
ACVRL1 activin A receptor type II-like 1 12q13.13 primary pulmonary hypertension, arteriovenous malformation, klippel-trenaunay syndrome,
ACY1 aminoacylase 1 3p21.2 lung cancer, systolic heart failure, greig cephalopolysyndactyly syndrome
ACY3 aspartoacylase (aminocyclase) 3 11q13.2 hepatitis c, hepatitis c virus hepatitis
AD10 Alzheimer disease-10 7q36 alzheimers disease alzheimer disease-10
AD11 Alzheimer disease-11 9p22.1 alzheimers disease alzheimer disease-11
AD12 Alzheimer disease 12 8p12-q22 alzheimers disease alzheimer disease 12
AD13 Alzheimer disease-13 1q21 alzheimers disease alzheimer disease-13
AD14 Alzheimer disease 14 1q25 alzheimers disease alzheimer disease-14
AD15 Alzheimer disease-15 3q22-q24 alzheimers disease alzheimer disease-15
AD16 Alzheimer disease 16 Xq21.3 alzheimers disease alzheimer disease 16
AD17 Alzheimer disease 17 6p21.2 alzheimers disease alzheimer disease 17
AD5 Alzheimer disease 5 12p11.23-q13.12 alzheimers disease alzheimer disease type 5
AD6 Alzheimer disease 6 10q alzheimers disease alzheimer disease 6
AD7 Alzheimer disease 7 10p13 alzheimers disease alzheimer disease-7
AD8 Alzheimer disease 8 20p alzheimers disease alzheimer disease 8
AD9 Alzheimer disease 9 19p13.2 alzheimers disease "alzheimer disease 9, late onset"
ADA adenosine deaminase 20q13.12 pericardial effusion, gauchers disease, malaria,
ADAL adenosine deaminase-like 15q15.3 epididymitis
ADAM10 ADAM metallopeptidase domain 10 15q21.3 alzheimers disease, degos disease, dowling-degos disease
ADAM11 ADAM metallopeptidase domain 11 17q21.31 breast cancer
ADAM17 ADAM metallopeptidase domain 17 2p25.1 heterotaxy, atrial septal defect 5 "inflammatory skin and bowel disease, neonatal"
ADAM21P1 ADAM metallopeptidase domain 21 pseudogene 1 14q24.2 adult t-cell leukemia
ADAM22 ADAM metallopeptidase domain 22 7q21.12 limbic encephalitis
ADAM33 ADAM metallopeptidase domain 33 20p13 asthma hfe-associated hereditary hemochromatosis
ADAM3A ADAM metallopeptidase domain 3A (pseudogene) 8p11.22 composite lymphoma
ADAM8 ADAM metallopeptidase domain 8 10q26.3 asthma
ADAM9 ADAM metallopeptidase domain 9 8p11.22 myeloma, skin melanoma, cone-rod dystrophy 2,
ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 21q21.3 type 2a von willebrand disease
ADAMTS10 ADAM metallopeptidase with thrombospondin type 1 motif, 10 19p13.2 weill-marchesani syndrome, "weill-marchesani syndrome 1, recessive" adamts10-related weill-marchesani syndrome
ADAMTS13 ADAM metallopeptidase with thrombospondin type 1 motif, 13 9q34.2 disseminated intravascular coagulation, myocardial infarction, malignant hypertension,
ADAMTS17 ADAM metallopeptidase with thrombospondin type 1 motif, 17 15q26.3 weill-marchesani syndrome weill-marchesani-like syndrome
ADAMTS18 ADAM metallopeptidase with thrombospondin type 1 motif, 18 16q23.1 carotid artery occlusion, knobloch syndrome "microcornea, myopic chorioretinal atrophy, and telecanthus"
ADAMTS2 ADAM metallopeptidase with thrombospondin type 1 motif, 2 5q35.3 anosognosia ehlers?àódanlos syndrome dermatosparaxis type
ADAMTS20 ADAM metallopeptidase with thrombospondin type 1 motif, 20 12q12 weill-marchesani syndrome
ADAMTSL1 ADAMTS-like 1 9p22.2 malaria, colonic disease quebec platelet disorder
ADAMTSL2 ADAMTS-like 2 9q34.2 geleophysic dysplasia, weill-marchesani syndrome, tracheal stenosis
ADAMTSL3 ADAMTS-like 3 15q25.2 colorectal cancer
ADAMTSL4 ADAMTS-like 4 1q21.3 weill-marchesani syndrome, adamtsl4-related eye disorders, "ectopia lentis, isolated autosomal recessive",
ADAP2 ArfGAP with dual PH domains 2 17q11.2 gastrointestinal lymphoma
ADAR adenosine deaminase, RNA-specific 1q21.3 lymphocytic choriomeningitis, aicardi-goutieres syndrome, aicardi-goutieres syndrome 7,
ADAT3 adenosine deaminase, tRNA-specific 3 19p13.3 breast and colorectal cancer "mental retardation, autosomal recessive 36"
ADCK2 aarF domain containing kinase 2 7q34 klippel-feil syndrome
ADCK3 aarF domain containing kinase 3 1q42.13 "spinocerebellar ataxia, autosomal recessive, 9", cabc1-related coenzyme q10 deficiency "coenzyme q10 deficiency, primary, 4"
ADCK4 aarF domain containing kinase 4 19q13.2 familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis "nephrotic syndrome, type 9"
ADCY1 adenylate cyclase 1 (brain) 7p12.3 "deafness, autosomal recessive 76", adenoma "deafness, autosomal recessive 44"
ADCY10 adenylate cyclase 10 (soluble) 1q24.2 humoral hypercalcemia of malignancy, cholera, neuroblastoma,
ADCY2 adenylate cyclase 2 (brain) 5p15.31 mccune albright syndrome adenoma
ADCY3 adenylate cyclase 3 2p23.3 adenoma, precocious puberty thyroid adenoma
ADCY4 adenylate cyclase 4 14q12 adenoma
ADCY5 adenylate cyclase 5 3q21.1 adenoma, precocious puberty, myokymia,
ADCY6 adenylate cyclase 6 12q13.12 adenoma, precocious puberty, hypomyelination neuropathy - arthrogryposis
ADCY7 adenylate cyclase 7 16q12.1 adenoma
ADCY8 adenylate cyclase 8 (brain) 8q24.22 adenoma, precocious puberty thyroid adenoma
ADCY9 adenylate cyclase 9 16p13.3 adenoma, precocious puberty, rubinstein-taybi syndrome
ADCYAP1 adenylate cyclase activating polypeptide 1 (pituitary) 18p11.32 schizophrenia, hirschsprungs disease, sudden infant death syndrome,
ADCYAP1R1 adenylate cyclase activating polypeptide 1 (pituitary) receptor type I 7p14.3 post-traumatic stress disorder
ADD1 adducin 1 (alpha) 4p16.3 essential hypertension, gastroschisis, dehydrated hereditary stomatocytosis,
ADD2 adducin 2 (beta) 2p13.3 hypertension, hereditary elliptocytosis, chorea-acanthocytosis,
ADD3 adducin 3 (gamma) 10q25.1 hypertension, hereditary elliptocytosis, dyscalculia,
ADFN albinism-deafness syndrome Xq25-q26|Xq26.3- albinism deafness syndrome
ADH1A alcohol dehydrogenase 1A (class I), alpha polypeptide 4q23 alcohol dependence fetal alcohol syndrome
ADH1B alcohol dehydrogenase 1B (class I), beta polypeptide 4q23 alcohol dependence, pancreatitis, liver cirrhosis,
ADH1C alcohol dehydrogenase 1C (class I), gamma polypeptide 4q23 parkinsons disease, alcohol dependence, alcohol abuse,
ADH4 alcohol dehydrogenase 4 (class II), pi polypeptide 4q23 alcohol dependence, substance abuse, alcoholic liver cirrhosis
ADH5 alcohol dehydrogenase 5 (class III), chi polypeptide 4q23 dermatitis, rhinitis, pharyngitis,
ADH5P4 alcohol dehydrogenase 5 (class III), chi polypeptide, pseudogene 4 6q12 hiv-1
ADH6 alcohol dehydrogenase 6 (class V) 4q23 alcohol dependence fetal alcohol spectrum disorder
ADH7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide 4q23 alcohol dependence, squamous cell carcinoma of the head and neck, gastritis,
ADHD1 Attention deficit-hyperactivity disorder, susceptibility to, 1 16p13 attention deficit hyperactivity disorder
ADHD2 Attention deficit-hyperactivity disorder, susceptibility to, 2 17p11 attention deficit hyperactivity disorder
ADHD3 Attention deficit-hyperactivity disorder, susceptibility to, 2 6q12 attention deficit hyperactivity disorder
ADHD4 Attention deficit-hyperactivity disorder, susceptibility to, 4 5p13 attention deficit hyperactivity disorder
ADIPOQ adiponectin, C1Q and collagen domain containing 3q27.3 pre-eclampsia, carotid intimal medial thickness, coronary artery disease,
ADIPOR1 adiponectin receptor 1 1q32.1 coronary artery disease, insulin resistance, obesity
ADIPOR2 adiponectin receptor 2 12p13.33 insulin resistance, meconium ileus meconium ileus in cystic fibrosis
ADIPQTL2 Circulating adiponectin QTL on chromosome 5 "adiponectin, serum level of, qtl2"
ADIPQTL3 Circulating adiponectin QTL on chromosome 14 "adiponectin, serum level of, qtl3"
ADIPQTL4 Adiponectin, serum level of, QTL4 11q23-q24 systemic lupus erythematosus "adiponectin, serum level of, qtl4"
ADIPQTL5 Adiponectin, serum level of, QTL5 16q23.3 "adiponectin, serum level of, qtl5]"
ADIRF adipogenesis regulatory factor 10q23.2 obesity
ADK adenosine kinase 10q22.2 ischemia, hypermethioninemia, rasmussen encephalitis,
ADM adrenomedullin 11p15.4 diabetic retinopathy, primary pulmonary hypertension, myocardial infarction,
ADNP activity-dependent neuroprotector homeobox 20q13.13 "mental retardation, autosomal dominant, 28"
ADORA1 adenosine A1 receptor 1q32.1 ischemia, brain ischemia, transient cerebral ischemia
ADORA2A adenosine A2a receptor 22q11.23 ischemia, parkinsons disease, schizophrenia,
ADORA2B adenosine A2b receptor 17p12 priapism
ADORA3 adenosine A3 receptor 1p13.2 ischemia brain ischemia
ADPGK ADP-dependent glucokinase 15q24.1 monogenic diabetes type 1 diabetes mellitus
ADPRH ADP-ribosylarginine hydrolase 3q13.33 mucolipidosis ii, tyrosinemia, malaria,
ADRA1A adrenoceptor alpha 1A 8p21.2 attention deficit hyperactivity disorder ureterolithiasis
ADRA1B adrenoceptor alpha 1B 5q33.3 ureterolithiasis
ADRA1D adrenoceptor alpha 1D 20p13 alpha 1-antitrypsin deficiency impotence
ADRA2A adrenoceptor alpha 2A 10q25.2 cholera, schizophrenia, obesity,
ADRA2B adrenoceptor alpha 2B 2q11.1 type 2 diabetes mellitus, essential hypertension, morbid obesity,
ADRA2C adrenoceptor alpha 2C 4p16.3 dyspepsia, orthostatic intolerance , attention deficit hyperactivity disorder,
ADRB1 adrenoceptor beta 1 10q25.3 myocardial infarction, coronary artery disease, chagas disease,
ADRB2 adrenoceptor beta 2, surface 5q32 asthma, myocardial infarction, whim syndrome,
ADRB3 adrenoceptor beta 3 8p11.23 type 2 diabetes mellitus, insulin resistance, essential hypertension,
ADRBK2 adrenergic, beta, receptor kinase 2 22q12.1 whim syndrome
ADSL adenylosuccinate lyase 22q13.1 lesch-nyhan syndrome, histidinemia, adenylosuccinate lyase deficiency,
ADSS adenylosuccinate synthase 1q44 relapsing fever
AEBP1 AE binding protein 1 7p13 gastroschisis
AES amino-terminal enhancer of split 19p13.3 autoimmune polyendocrine syndrome type 2
AFA ankyloblepharon filiforme adnatum reserved imperforate anus
AFA1 Alopecia, androgenetic 3q26 "alopecia, androgenetic, 1"
AFAP1L1 actin filament associated protein 1-like 1 5q32 spindle cell sarcoma
AFD1 acrofacial dysostosis 1, Nager type 9q32 nager acrofacial dysostosis
AFF1 AF4/FMR2 family, member 1 4q21.3 chronic neutrophilic leukemia "leukemia, acute lymphoblastic 3"
AFF2 AF4/FMR2 family, member 2 Xq28 mental retardation, x-linked disease, fragile x syndrome,
AFF3 AF4/FMR2 family, member 3 2q11.2 fibular aplasia
AFF4 AF4/FMR2 family, member 4 5q31.1 lymphoblastic leukemia
AFG3L2 AFG3-like AAA ATPase 2 18p11.21 ataxia, hereditary ataxia, hereditary spastic paraplegia,
AFM afamin 4q13.3 trigonitis squamous papillomatosis
AFP alpha-fetoprotein 4q13.3 hepatocellular carcinoma, polyhydramnios, germ cell cancer,
AGA aspartylglucosaminidase 4q34.3 retinal drusen, aspartylglucosaminuria, lysosomal storage disease,
AGA2 Alopecia, androgenetic, 2 Xq11-q12 "alopecia, androgenetic, 2" alopecia
AGA3 Alopecia, androgenetic, 3 20p11.22 "alopecia, androgenetic, 3"
AGAP2 ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 12q14.1 diphyllobothriasis anisakiasis
AGBL1 ATP/GTP binding protein-like 1 15q25.3 "corneal dystrophy, fuchs endothelial, 8" corneal dystrophy fuchs endothelial 1
AGER advanced glycosylation end product-specific receptor 6p21.32 vascular disease, coronary artery disease, type 2 diabetes mellitus,
AGFG1 ArfGAP with FG repeats 1 2q36.3 choroideremia, hiv-1 griscelli syndrome
AGFG2 ArfGAP with FG repeats 2 7q22.1 xerophthalmia hiv-1
AGGF1 angiogenic factor with G patch and FHA domains 1 5q13.3 klippel-trenaunay syndrome, coats disease proteus syndrome
AGK acylglycerol kinase 7q34 bardet-biedl syndrome 11, mitochondrial dna depletion syndrome, "cataract, autosomal recessive congenital 5",
AGL amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase 1p21.2 glycogen storage disease iii, glycogen storage disease iiib , glycogen storage disease iiia ,
AGMX2 agammaglobulinemia, X-linked 2 (with growth hormone deficiency) Xp22 agammaglobulinemia x-linked type 2
AGPAT2 1-acylglycerol-3-phosphate O-acyltransferase 2 9q34.3 bardet-biedl syndrome 11, insulin resistance, congenital generalized lipodystrophy type 1,
AGPAT9 1-acylglycerol-3-phosphate O-acyltransferase 9 4q21.23 lung cancer
AGPS alkylglycerone phosphate synthase 2q31.2 chondrodysplasia, "rhizomelic chondrodysplasia punctata, type 3", photoallergic dermatitis,
AGR3 anterior gradient 3 7p21.1 breast cancer
AGRN agrin 1p36.33 agrn-related congenital myasthenic syndrome, "myasthenic syndrome, congenital, with pre- and postsynaptic defects", "myasthenia, limb-girdle, familial"
AGRP agouti related protein homolog (mouse) 16q22.1 autism spectrum disorder, "obesity, late-onset", overnutrition,
AGSPX Angio serpiginosum Xp11.3-q12 angio serpiginosum
AGT angiotensinogen (serpin peptidase inhibitor, clade A, member 8) 1q42.2 pre-eclampsia, diabetic retinopathy, myocardial infarction,
AGTR1 angiotensin II receptor, type 1 3q24 mesangial proliferative glomerulonephritis, usual interstitial pneumonia, myocardial infarction,
AGTR2 angiotensin II receptor, type 2 Xq23 coronary artery disease, renal agenesis, "mental retardation, x-linked 17/31, microduplication",
AGXT alanine-glyoxylate aminotransferase 2q37.3 primary hyperoxaluria primary hyperoxaluria type 1
AGXT2 alanine--glyoxylate aminotransferase 2 5p13.2 primary hyperoxaluria
AHCY adenosylhomocysteinase 20q11.22 adenosine deaminase deficiency, hyperhomocysteinemia, hypermethioninemia
AHDC1 AT hook, DNA binding motif, containing 1 1p36.11 xia-gibbs syndrome
AHI1 Abelson helper integration site 1 6q23.3 joubert syndrome 21, joubert syndrome and related disorders, larsen syndrome,
AHNAK2 AHNAK nucleoprotein 2 14q32.33 skeletal muscle regeneration
AHR aryl hydrocarbon receptor 7p21.1 breast cancer, endometriosis, choriocarcinoma,
AHSA1 AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast) 14q24.3 cannabis abuse
AHSG alpha-2-HS-glycoprotein 3q27.3 insulin resistance, aortic valve stenosis, liver cirrhosis,
AHSP alpha hemoglobin stabilizing protein 16p11.2 angina pectoris, myocardial infarction, coronary artery disease,
AIC Aicardi syndrome Xp22 aicardi syndrome
AICDA activation-induced cytidine deaminase 12p13.31 burkitts lymphoma, chondromalacia, x-linked hyper igm syndrome,
AIF1 allograft inflammatory factor 1 6p21.33 traumatic brain injury, demyelinating polyneuropathy, chronic inflammatory demyelinating polyneuropathy
AIFM1 apoptosis-inducing factor, mitochondrion-associated, 1 Xq26.1 rabies, encephalomyopathy, mitochondrial encephalomyopathy,
AIFM2 apoptosis-inducing factor, mitochondrion-associated, 2 10q22.1 colon cancer
AIG1 androgen-induced 1 6q24.2 amebiasis
AIH3 amelogenesis imperfecta 3, hypomaturation or hypoplastic type Xq22-q28 "amelogenesis imperfecta, type ie, x-linked 2"
AIM1 absent in melanoma 1 6q21 oculocutaneous albinism type 4
AIM2 absent in melanoma 2 1q23.2 melanoma
AIMP1 aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 4q24 soft tissue sarcoma, stromal keratitis, prostate adenocarcinoma,
AIP aryl hydrocarbon receptor interacting protein 11q13.2 pituitary adenoma, prolactinoma, acromegaly,
AIPL1 aryl hydrocarbon receptor interacting protein-like 1 17p13.2 leber congenital amaurosis, retinal disease, leber congenital amaurosis 17,
AIR Acute insulin response (2) 1p31 hyperglycemia acute insulin response
AIRE autoimmune regulator 21q22.3 vitiligo, paraneoplastic syndromes, autoimmune hepatitis,
AIS1 autoimmune susceptibility 1 1p31 autoimmune disease 1
AIS2 autoimmune susceptibility 2 7q11.22 "scoliosis, idiopathic 2" autoimmune disease 2
AIS3 autoimmune susceptibility 3 (vitiligo specific) 8 vitiligo autoimmune disease 3
AIS4 autoimmune disease, susceptibility to, 4 4q13-q21 autoimmune disease 4
AITD1 Autoimmune thyroid disease, susceptibility to, 1 6p11 autoimmune thyroid disease 1
AITD2 Autoimmune thyroid disease, susceptibility to, 2 5q31-q33 autoimmune thyroid disease 2
AITD4 Autoimmune thyroid disease, susceptibility to, 4 10q autoimmune thyroid disease 4
AK1 adenylate kinase 1 9q34.11 hemolytic anemia, nail-patella syndrome hemolytic anemia due to adenylate kinase deficiency
AK2 adenylate kinase 2 1p35.1 reticular dysgenesis
AK5 adenylate kinase 5 1p31.1 limbic encephalitis
AK7 adenylate kinase 7 14q32.2 reticular dysgenesis
AKAP10 A kinase (PRKA) anchor protein 10 17p11.2 cardiac conduction defect
AKAP12 A kinase (PRKA) anchor protein 12 6q25.1 osteosarcoma
AKAP13 A kinase (PRKA) anchor protein 13 15q25.3 breast cancer relapsing fever
AKAP17A A kinase (PRKA) anchor protein 17A Xp22.33 chronic tic disorder tic disorder
AKAP5 A kinase (PRKA) anchor protein 5 14q23.3 ureterolithiasis canavan disease
AKAP9 A kinase (PRKA) anchor protein 9 7q21.2 long qt syndrome 1 long qt syndrome 11
AKIP1 A kinase (PRKA) interacting protein 1 11p15.4 breast cancer
AKR1A1 aldo-keto reductase family 1, member A1 (aldehyde reductase) 1p34.1 alcohol dependence, liver cirrhosis, hangover,
AKR1B1 aldo-keto reductase family 1, member B1 (aldose reductase) 7q33 diabetic macular edema, diabetes mellitus, diabetic nephropathy,
AKR1B10 aldo-keto reductase family 1, member B10 (aldose reductase) 7q33 usual interstitial pneumonia
AKR1B1P2 aldo-keto reductase family 1, member B1 pseudogene 2 3p13 pulmonary function
AKR1C2 aldo-keto reductase family 1, member C2 10p15.1 ovarian endometriosis, "obesity, hyperphagia, and developmental delay", "46xy sex reversal 8, modifier of"
AKR1C3 aldo-keto reductase family 1, member C3 10p15.1 asthma
AKR1C4 aldo-keto reductase family 1, member C4 10p15.1 "46xy sex reversal 8, modifier of" 46xy sex reversal 8
AKR1D1 aldo-keto reductase family 1, member D1 7q33 autosomal dominant disease, "bile acid synthesis defect, congenital, 2" congenital bile acid synthesis defect
AKR7A2 aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) 1p36.13 urinary schistosomiasis, intermediate charcot-marie-tooth neuropathy, succinic semialdehyde dehydrogenase deficiency,
AKR7A3 aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) 1p36.13 adult respiratory distress syndrome
AKT1 v-akt murine thymoma viral oncogene homolog 1 14q32.33 "colorectal cancer, somatic", colorectal cancer, breast cancer susceptibility,
AKT2 v-akt murine thymoma viral oncogene homolog 2 19q13.2 type 2 diabetes mellitus, thymoma, insulin resistance,
AKT3 v-akt murine thymoma viral oncogene homolog 3 1q44 corpus callosum agenesis, thymoma, hemimegalencephaly,
AKTIP AKT interacting protein 16q12.2 thymic hyperplasia, balanitis balanitis xerotica obliterans
AL592528.1 uncharacterized LOC100129027 21q22.3 smallpox
ALAD aminolevulinate dehydratase 9q32 amyotrophic lateral sclerosis, tyrosinemia, malaria,
ALAS1 aminolevulinate, delta-, synthase 1 3p21.2 x-linked sideroblastic anemia, acute porphyria acute hepatic porphyria
ALAS2 aminolevulinate, delta-, synthase 2 Xp11.21 congenital erythropoietic porphyria, pearson syndrome, x-linked sideroblastic anemia,
ALB albumin 4q13.3 dysfibrinogenemia, vascular disease, pericardial effusion,
ALDH16A1 aldehyde dehydrogenase 16 family, member A1 19q13.33 mast syndrome
ALDH18A1 aldehyde dehydrogenase 18 family, member A1 10q24.1 pathological gambling, multiple mitochondrial dysfunctions syndrome 1 , aldh18a1-related cutis laxa
ALDH1A1 aldehyde dehydrogenase 1 family, member A1 9q21.13 gallbladder adenocarcinoma erythroplakia
ALDH1A2 aldehyde dehydrogenase 1 family, member A2 15q21.3 spina bifida hangover
ALDH1A3 aldehyde dehydrogenase 1 family, member A3 15q26.3 "microphthalmia, isolated 2", anophthalmia/microphthalmia "microphthalmia, isolated 8"
ALDH1B1 aldehyde dehydrogenase 1 family, member B1 9p13.2 succinic semialdehyde dehydrogenase deficiency
ALDH1L1 aldehyde dehydrogenase 1 family, member L1 3q21.3 methanol poisoning
ALDH2 aldehyde dehydrogenase 2 family (mitochondrial) 12q24.12 alcohol dependence, gout, alcohol abuse,
ALDH3A1 aldehyde dehydrogenase 3 family, member A1 17p11.2 hepatocellular carcinoma, schizophrenia, breast adenocarcinoma
ALDH3A2 aldehyde dehydrogenase 3 family, member A2 17p11.2 quadriplegia, spastic diplegia, genital herpes
ALDH3B1 aldehyde dehydrogenase 3 family, member B1 11q13.2 schizophrenia
ALDH4A1 aldehyde dehydrogenase 4 family, member A1 1p36.13 succinic semialdehyde dehydrogenase deficiency, hyperprolinemia type 2 hyperprolinemia
ALDH5A1 aldehyde dehydrogenase 5 family, member A1 6p22.3 2-hydroxyglutaric aciduria, wagr syndrome, succinic semialdehyde dehydrogenase deficiency,
ALDH6A1 aldehyde dehydrogenase 6 family, member A1 14q24.3 succinic semialdehyde dehydrogenase deficiency methylmalonate semialdehyde dehydrogenase deficiency
ALDH7A1 aldehyde dehydrogenase 7 family, member A1 5q23.2 pyridoxine-dependent epilepsy, combined oxidative phosphorylation deficiency 11 , folinic acid-responsive seizures
ALDH9A1 aldehyde dehydrogenase 9 family, member A1 1q24.1 alcohol dependence, fetal alcohol spectrum disorder hangover
ALDOA aldolase A, fructose-bisphosphate 16p11.2 lung cancer, melanoma-associated retinopathy, glycogen storage disease type 12,
ALDOB aldolase B, fructose-bisphosphate 9q31.1 hepatocellular carcinoma, mycetoma, hereditary fructose intolerance syndrome,
ALDOC aldolase C, fructose-bisphosphate 17q11.2 mycetoma eumycotic mycetoma
ALG1 ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase 16p13.3 congenital disorder of glycosylation, walker-warburg syndrome "congenital disorder of glycosylation, type ik"
ALG10 ALG10, alpha-1,2-glucosyltransferase 12p11.1 long qt syndrome 1 "long qt syndrome, acquired, reduced"
ALG10B ALG10B, alpha-1,2-glucosyltransferase 12q12 drug-induced liver injury due to flucloxacillin
ALG11 ALG11, alpha-1,2-mannosyltransferase 13q14.3 congenital disorder of glycosylation "congenital disorder of glycosylation, type ip"
ALG12 ALG12, alpha-1,6-mannosyltransferase 22q13.33 congenital disorder of glycosylation type 1g
ALG13 ALG13, UDP-N-acetylglucosaminyltransferase subunit Xq23 "mental retardation, x-linked 17/31, microduplication", "mental retardation, autosomal dominant 8" congenital disorder of glycosylation type i
ALG14 ALG14, UDP-N-acetylglucosaminyltransferase subunit 1p21.3 congenital myasthenic syndrome with tubular aggregates 2
ALG2 ALG2, alpha-1,3/1,6-mannosyltransferase 9q22.33 congenital myasthenic syndrome with tubular aggregates 2 congenital disorder of glycosylation type ii
ALG3 ALG3, alpha-1,3- mannosyltransferase 3q27.1 congenital disorder of glycosylation type 1d
ALG6 ALG6, alpha-1,3-glucosyltransferase 1p31.3 protein-losing enteropathy congenital disorder of glycosylation type 1c
ALG8 ALG8, alpha-1,3-glucosyltransferase 11q14.1 congenital disorder of glycosylation type 1h
ALG9 ALG9, alpha-1,2-mannosyltransferase 11q23.1 frontotemporal lobar degeneration with ubiquitin-positive inclusions, bipolar disorder, congenital disorder of glycosylation
ALK anaplastic lymphoma receptor tyrosine kinase 2p23.1 reticulosarcoma, neuroblastoma, primary cutaneous anaplastic large cell lymphoma,
ALKBH3 alkB, alkylation repair homolog 3 (E. coli) 11p11.2 prostate cancer
ALL1 Leukemia, acute lymphocytic, susceptibility to, 1 10q21 "leukemia, acute lymphocytic 1"
ALL2 Leukemia, acute lymphoblastic, susceptibility to, 2 7p12.2 "leukemia, acute lymphoblastic 2"
ALLC allantoicase 2p25.3 lymphogranuloma venereum denture stomatitis
ALMS1 Alstrom syndrome 1 2p13.1 alstrom syndrome
ALMS1P Alstrom syndrome 1 pseudogene 2p13.1 alstrom syndrome
ALOX12 arachidonate 12-lipoxygenase 17p13.1 asthma, prostate cancer, osteoporosis,
ALOX12B arachidonate 12-lipoxygenase, 12R type 17p13.1 meningioma, autosomal recessive congenital ichthyosis, "ichthyosis, congenital, autosomal recessive 2",
ALOX15 arachidonate 15-lipoxygenase 17p13.2 asthma, osteoporosis, atherosclerosis,
ALOX15B arachidonate 15-lipoxygenase, type B 17p13.1 autosomal recessive congenital ichthyosis prostate adenocarcinoma
ALOX5 arachidonate 5-lipoxygenase 10q11.21 asthma, primary pulmonary hypertension, osteoporosis,
ALOX5AP arachidonate 5-lipoxygenase-activating protein 13q12.3 asthma, coronary artery disease, osteoporosis,
ALOXE3 arachidonate lipoxygenase 3 17p13.1 autosomal recessive congenital ichthyosis, "ichthyosis, congenital, autosomal recessive 2", anhidrosis,
ALPI alkaline phosphatase, intestinal 2q37.1 seminoma, hypophosphatasia, gastrointestinal system disease
ALPL alkaline phosphatase, liver/bone/kidney 1p36.12 hypercalcemia, meningioma, choledocholithiasis,
ALPP alkaline phosphatase, placental 2q37.1 prostate cancer, hyperparathyroidism, primary biliary cirrhosis,
ALPPL2 alkaline phosphatase, placental-like 2 2q37.1 germ cell tumors, complete androgen insensitivity syndrome, lipoid adrenal hyperplasia,
ALPQTL2 Alkaline phosphatase, plasma level of, QTL 2 1p36 "alkaline phosphatase, plasma level of, qtl 2"
ALRH Allergic rhinitis asthma, rhinitis allergic rhinitis
ALS2 amyotrophic lateral sclerosis 2 (juvenile) 2q33.1 amyotrophic lateral sclerosis, lateral sclerosis, juvenile primary lateral sclerosis,
ALS2CL ALS2 C-terminal like 3p21.31 blepharitis
ALS2CR11 amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11 2q33.1 amyotrophic lateral sclerosis
ALS2CR12 amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12 2q33.1 amyotrophic lateral sclerosis
ALS3 amyotrophic lateral sclerosis 3 (autosomal dominant) 18q21 amyotrophic lateral sclerosis amyotrophic lateral sclerosis type 3
ALS5 amyotrophic lateral sclerosis 5 15q15.1-q21.1 amyotrophic lateral sclerosis "amyotrophic lateral sclerosis 5, juvenile recessive"
ALS7 amyotrophic lateral sclerosis 7 20p13 amyotrophic lateral sclerosis amyotrophic lateral sclerosis type 7
ALX1 ALX homeobox 1 12q21.31 neural tube defects, cartilage-hair hypoplasia, frontonasal dysplasia
ALX3 ALX homeobox 3 1p13.3 neuroblastoma, frontonasal dysplasia, basal encephalocele,
ALX4 ALX homeobox 4 11p11.2 "craniosynostosis, type 1", craniosynostosis, alopecia,
AMACR alpha-methylacyl-CoA racemase 5p13.2 prostate cancer, adrenomyeloneuropathy, lung cancer,
AMBN ameloblastin (enamel matrix protein) 4q13.3 dentin dysplasia calcifying epithelial odontogenic tumor
AMBP alpha-1-microglobulin/bikunin precursor 9q32 malaria, ovarian cancer, type 1 diabetes mellitus,
AMCN arthrogryposis multiplex congenita, neurogenic 5q35 arthrogryposis multiplex congenita neurogenic type
AMD1 adenosylmethionine decarboxylase 1 6q21 chagas disease, malaria sleeping sickness
AMELX amelogenin, X-linked Xp22.2 "amelogenesis imperfecta, type ia5", amelogenesis imperfecta, dental caries,
AMELY amelogenin, Y-linked Yp11.2 dental pulp necrosis, dental fluorosis turner syndrome
AMER1 APC membrane recruitment protein 1 Xq11.2 wilms tumor osteopathia striata cranial sclerosis
AMER2 APC membrane recruitment protein 2 13q12.13 breast and colorectal cancer
AMFR autocrine motility factor receptor, E3 ubiquitin protein ligase 16q12.2 colorectal cancer
AMH anti-Mullerian hormone 19p13.3 hermaphroditism, cryptorchidism, mixed gonadal dysgenesis,
AMHR2 anti-Mullerian hormone receptor, type II 12q13.13 mixed gonadal dysgenesis, ovarian cancer, "persistent mullerian duct syndrome, type i",
AMIGO2 adhesion molecule with Ig-like domain 2 12q13.11 adenocarcinoma, spondylolisthesis, legg-calve-perthes disease
AMIGO3 adhesion molecule with Ig-like domain 3 3p21.31 ulcerative colitis
AMLCR2 acute myeloid leukemia chromosome region 2 16q22 acute myeloid leukemia
AMMEC Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis Xq22.3 "alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis"
AMMECR1 Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 Xq23 mental retardation, "alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis" alport syndrome - intellectual disability - midface hypoplasia - elliptocytosis
AMN amnion associated transmembrane protein 14q32.32 multiple carboxylase deficiency, megaloblastic anemia, methylmalonic aciduria and homocystinuria type cble,
AMPD1 adenosine monophosphate deaminase 1 1p13.2 coronary artery disease, myopathy, congestive heart failure,
AMPD2 adenosine monophosphate deaminase 2 1p13.3 "pontocerebellar hypoplasia, type 9" spastic paraplegia 63
AMPD3 adenosine monophosphate deaminase 3 11p15.4 penile neoplasm, adenosine monophosphate deaminase deficiency, erythrocyte amp deaminase deficiency
AMPH amphiphysin 7p14.1 breast cancer, transverse myelitis, myelitis,
AMT aminomethyltransferase 3p21.31 glycine encephalopathy, neonatal glycine encephalopathy, infantile glycine encephalopathy,
AMTN amelotin 4q13.3 exotropia dental fluorosis
AMY2A amylase, alpha 2A (pancreatic) 1p21.1 exstrophy of the bladder
AN blood group Ahonen aniridia
ANAPC11 anaphase promoting complex subunit 11 17q25.3 hepatocellular carcinoma
ANBC Aneurysmal bone cysts 16q22 aneurysmal bone cysts
ANC Anal canal carcinoma 11q22-qter anal canal carcinoma
ANCR Angelman syndrome chromosome region 15q11-q12 angelman syndrome prader-willi syndrome
ANG angiogenin, ribonuclease, RNase A family, 5 14q11.2 bladder carcinoma, amyotrophic lateral sclerosis, endometrial carcinoma,
ANGPT1 angiopoietin 1 8q23.1 polycystic liver disease, malaria, malignant peritoneal mesothelioma,
ANGPT2 angiopoietin 2 8p23.1 hepatocellular carcinoma, diabetic retinopathy, breast disease,
ANGPTL2 angiopoietin-like 2 9q33.3 abdominal aortic aneurysm
ANGPTL3 angiopoietin-like 3 1p31.3 "hypobetalipoproteinemia, familial, 2" hypobetalipoproteinemia
ANGPTL4 angiopoietin-like 4 19p13.2 tongue squamous cell carcinoma "plasma triglyceride level qtl, low"
ANGPTL6 angiopoietin-like 6 19p13.2 enterobiasis gnathomiasis
ANIB1 aneurysm, intracranial berry 1 7q11.2 aneurysm "aneurysm, intracranial berry, 1"
ANIB10 Aneurysm, intracranial berry, 10 8q12.1 aneurysm "aneurysm, intracranial berry, 10"
ANIB11 Aneurysm, intracranial berry, 11 8p22 aneurysm "aneurysm, intracranial berry, 11"
ANIB2 aneurysm, intracranial berry 2 19q13 aneurysm "aneurysm, intracranial berry, 2"
ANIB3 aneurysm, intracranial berry 3 1p36.13-p34.3 aneurysm "aneurysm, intracranial berry, 3"
ANIB4 aneurysm, intracranial berry 4 5p15.2-p14.3 aneurysm "aneurysm, intracranial berry, 4"
ANIB5 Aneurysm, intracranial berry, 5 2p15-q14 aneurysm "aneurysm, intracranial berry, 5"
ANIB6 Aneurysm, intracranial berry, 6 9p21 aneurysm "aneurysm, intracranial berry, 6"
ANIB7 Aneurysm, intracranial berry, 7 11q24-q25 aneurysm "aneurysm, intracranial berry, 7"
ANIB8 Aneurysm, intracranial berry, 8 14q23 aneurysm "aneurysm, intracranial berry, 8"
ANIB9 Aneurysm, intracranial berry, 9 2q33.1 aneurysm "aneurysm, intracranial berry, 9"
ANIC Anosmia, isolated congenital 18p11.23-q12.2 congenital anosmia
ANK1 ankyrin 1, erythrocytic 8p11.21 bardet-biedl syndrome 5, hereditary elliptocytosis, "spherocytosis, hereditary, type 5",
ANK2 ankyrin 2, neuronal 4q25 catecholaminergic polymorphic ventricular tachycardia, long qt syndrome 1, long qt syndrome,
ANK3 ankyrin 3, node of Ranvier (ankyrin G) 10q21.2 plexiform neurofibroma "mental retardation, autosomal recessive, 37"
ANKEF1 ankyrin repeat and EF-hand domain containing 1 20p12.2 breast and colorectal cancer
ANKFN1 ankyrin-repeat and fibronectin type III domain containing 1 17q22 cannabis dependence
ANKH ANKH inorganic pyrophosphate transport regulator 5p15.2 ankylosis, pseudogout, craniometaphyseal dysplasia,
ANKHD1 ankyrin repeat and KH domain containing 1 5q31.3 hiv-1
ANKK1 ankyrin repeat and kinase domain containing 1 11q23.2 alcohol dependence, neuroleptic malignant syndrome, traumatic brain injury,
ANKLE2 ankyrin repeat and LEM domain containing 2 12q24.33 pigmented villonodular synovitis, villonodular synovitis scurvy
ANKRD1 ankyrin repeat domain 1 (cardiac muscle) 10q23.31 diastolic heart failure, scimitar syndrome, congenital total pulmonary venous return anomaly
ANKRD11 ankyrin repeat domain 11 16q24.3 intellectual disability, short stature, 16q24.3 microdeletion syndrome,
ANKRD17 ankyrin repeat domain 17 4q13.3 breast cancer "hand, foot and mouth disease"
ANKRD2 ankyrin repeat domain 2 (stretch responsive muscle) 10q24.2 dubin-johnson syndrome
ANKRD26 ankyrin repeat domain 26 10p12.1 thrombocytopenia, thrombocytopenia 2 ankrd26-related thrombocytopenia 2
ANKRD30A ankyrin repeat domain 30A 10p11.21 breast cancer
ANKRD30B ankyrin repeat domain 30B 18p11.21 breast cancer
ANKRD36B ankyrin repeat domain 36B 2q11.2 melanoma acral lentiginous melanoma
ANKRD55 ankyrin repeat domain 55 5q11.2 oligoarticular juvenile arthritis polyarticular onset juvenile idiopathic arthritis
ANKS1A ankyrin repeat and sterile alpha motif domain containing 1A 6p21.31 adjustment disorder
ANKS1B ankyrin repeat and sterile alpha motif domain containing 1B 12q23.1 acute lymphocytic leukemia
ANKS4B ankyrin repeat and sterile alpha motif domain containing 4B 16p12.2 usher syndrome type i
ANKS6 ankyrin repeat and sterile alpha motif domain containing 6 9q22.33 juvenile autosomal recessive medullary cystic kidney disease, infantile autosomal recessive medullary cystic kidney disease nephronophthisis 16
ANMA Anisomastia 16q13-q21 anisomastia
ANO1 anoctamin 1, calcium activated chloride channel 11q13.3 oral cancer small intestinal sarcoma
ANO10 anoctamin 10 3p21.33 "spinocerebellar ataxia, autosomal recessive, 10"
ANO3 anoctamin 3 11p14.2 dystonia 24
ANO5 anoctamin 5 11p14.3 gnathodiaphyseal dysplasia, distal muscular dystrophy, miyoshi muscular dystrophy 1 ,
ANO6 anoctamin 6 12q12 scott syndrome
ANO7 anoctamin 7 2q37.3 prostate cancer
ANON1 Anorexia nervosa, susceptibility to, 1 1p anorexia nervosa anorexia nervosa 1
ANOP1 anophthalmos 1 (with mental retardation, without limb anomalies or dental or urogenital abnormalities) Xq27-q28 microphthalmia syndromic 4
ANP32A acidic (leucine-rich) nuclear phosphoprotein 32 family, member A 15q23 spinocerebellar degeneration
ANPEP alanyl (membrane) aminopeptidase 15q26.1 familial chronic lymphocytic leukemia gastroenteritis
ANTXR1 anthrax toxin receptor 1 2p13.3 colorectal cancer, ataxia telangiectasia, gapo syndrome ,
ANTXR2 anthrax toxin receptor 2 4q21.21 fibromatosis, inhalation anthrax, juvenile hyaline fibromatosis
ANXA2R annexin A2 receptor 5p12 multiple myeloma
ANXA4 annexin A4 2p13.3 gonorrhea, legionnaires disease papillary serous adenocarcinoma
ANXA5 annexin A5 4q27 pancreatic cancer, pregnancy loss, multiple endocrine neoplasia type 2a,
ANXA6 annexin A6 5q33.1 amyotrophic lateral sclerosis, neonatal lupus erythematosus, kwashiorkor
ANXA8 annexin A8 10q11.22 acute promyelocytic leukemia
ANXA8L2 annexin A8-like 2 10q11.22 acute promyelocytic leukemia
AOC1 amine oxidase, copper containing 1 7q36.1 radiation proctitis, cystic fibrosis, diabetic autonomic neuropathy
AOC2 amine oxidase, copper containing 2 (retina-specific) 17q21.31 dissecting aortic aneurysm
AOC3 amine oxidase, copper containing 3 17q21.31 diabetes mellitus coronary artery vasospasm
AOCH Acromegaloid features, overgrowth, cleft palate, and hernia "acromegaloid features, overgrowth, cleft palate and hernia"
AOMS1 Abdominal obesity-metabolic syndrome QTL1 3q27 obesity metabolic syndrome x
AOMS2 abdominal obesity-metabolic syndrome QTL2 17p12 obesity metabolic syndrome x
AOS Adams-Oliver syndrome oliver syndrome
AOX1 aldehyde oxidase 1 2q33.1 amyotrophic lateral sclerosis, lateral sclerosis, end stage renal failure,
AP1B1 adaptor-related protein complex 1, beta 1 subunit 22q12.2 meningioma
AP1G1 adaptor-related protein complex 1, gamma 1 subunit 16q22.2 hypoactive sexual desire disorder
AP1S1 adaptor-related protein complex 1, sigma 1 subunit 7q22.1 erythrokeratodermia variabilis mednik syndrome
AP1S2 adaptor-related protein complex 1, sigma 2 subunit Xp22.2 "mental retardation, x-linked", basal ganglia disease dandy-walker malformation with mental retardation basal ganglia disease and seizures
AP1S3 adaptor-related protein complex 1, sigma 3 subunit 2q36.1 hiv-1, pustulosis palmaris et plantaris, generalized pustular psoriasis
AP2A2 adaptor-related protein complex 2, alpha 2 subunit 11p15.5 wolff-parkinson-white syndrome
AP2S1 adaptor-related protein complex 2, sigma 1 subunit 19q13.32 hypercalcemia, familial hypocalciuric hypercalcemia type 3 familial hypocalciuric hypercalcemia
AP3B1 adaptor-related protein complex 3, beta 1 subunit 5q14.1 platelet storage pool deficiency, hermansky-pudlak syndrome, hermansky-pudlak syndrome 1
AP3B2 adaptor-related protein complex 3, beta 2 subunit 15q25.2 congenital diaphragmatic hernia
AP4B1 adaptor-related protein complex 4, beta 1 subunit 1p13.2 cerebral palsy, "spastic paraplegia 50, autosomal recessive" "spastic paraplegia 47, autosomal recessive"
AP4E1 adaptor-related protein complex 4, epsilon 1 subunit 15q21.2 oligospermia, cerebral palsy, "spastic paraplegia 50, autosomal recessive"
AP4M1 adaptor-related protein complex 4, mu 1 subunit 7q22.1 quadriplegia "spastic paraplegia 50, autosomal recessive"
AP4S1 adaptor-related protein complex 4, sigma 1 subunit 14q12 cerebral palsy, "spastic paraplegia 52, autosomal recessive" "spastic paraplegia 50, autosomal recessive"
AP5M1 adaptor-related protein complex 5, mu 1 subunit 14q22.3 hiv-1
AP5Z1 adaptor-related protein complex 5, zeta 1 subunit 7p22.1 "spastic paraplegia 48, autosomal recessive" spastic paraplegia 48
APAF1 apoptotic peptidase activating factor 1 12q23.1 amyotrophic lateral sclerosis, male germ cell tumor, nonseminomatous germ cell tumor,
APBA1 amyloid beta (A4) precursor protein-binding, family A, member 1 9q21.12 neuronal intranuclear inclusion disease
APBA3 amyloid beta (A4) precursor protein-binding, family A, member 3 19p13.3 melanotic neuroectodermal tumor
APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 11p15.4 alzheimers disease
APBB2 amyloid beta (A4) precursor protein-binding, family B, member 2 4p13 alzheimers disease alzheimer disease type 2
APC adenomatous polyposis coli 5q22.2 "colorectal cancer, somatic", colorectal cancer, fibrous dysplasia,
APCDD1 adenomatosis polyposis coli down-regulated 1 18p11.22 edwards syndrome, hypotrichosis, hypotrichosis simplex,
APCS amyloid P component, serum 1q23.2 oral candidiasis, "amyloidosis, secondary", candida glabrata
APEH acylaminoacyl-peptide hydrolase 3p21.31 renal cell carcinoma, placenta praevia, high pressure neurological syndrome
APEX1 APEX nuclease (multifunctional DNA repair enzyme) 1 14q11.2 amyotrophic lateral sclerosis, breast cancer, cystic fibrosis,
APEX2 APEX nuclease (apurinic/apyrimidinic endonuclease) 2 Xp11.21 mitochondrial disorders
APITD1 apoptosis-inducing, TAF9-like domain 1 1p36.22 neuroblastoma, fanconis anemia gastric antral vascular ectasia
APLF aprataxin and PNKP like factor 2p13.3 degenerative disc disease junctional epidermolysis bullosa
APLN apelin Xq26.1 coronary artery disease, type 2 diabetes mellitus, morbid obesity,
APLNR apelin receptor 11q12.1 hiv-1 aortic valve stenosis
APLP1 amyloid beta (A4) precursor-like protein 1 19q13.12 alzheimers disease
APMR1 Alopecia-mental retardation syndrome 3q26.3-q27.3 alopecia mental retardation syndrome 1
APMR2 Alopecia with mental retardation syndrome 2 3q26.2-q26.31 alopecia mental retardation syndrome 2
APMR3 Alopecia-mental retardation syndrome 3 18q11.2-q12.2 alopecia-mental retardation syndrome 3
APOA1 apolipoprotein A-I 11q23.3 peripheral vascular disease, "amyloidosis, hereditary renal", "amyloidosis, 3 or more types",
APOA2 apolipoprotein A-II 1q23.3 peripheral vascular disease, vascular disease, hereditary amyloidosis,
APOA4 apolipoprotein A-IV 11q23.3 coronary artery disease, schizophrenia, familial hypercholesterolemia,
APOA5 apolipoprotein A-V 11q23.3 coronary artery disease, hypertriglyceridemia, artery disease,
APOB apolipoprotein B 2p24.1 myocardial infarction, coronary artery disease, type 2 diabetes mellitus,
APOBEC1 apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 12p13.31 neurofibromatosis
APOBEC3A apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A 22q13.1 colorectal adenocarcinoma, hepatitis b virus infection human t-cell leukemia virus type 1
APOBEC3B apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B 22q13.1 hepatitis b virus infection human t-cell leukemia virus type 1
APOBEC3F apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F 22q13.1 hiv-1
APOBEC3G apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G 22q13.1 hiv-1 human immunodeficiency virus infectious disease
APOC1 apolipoprotein C-I 19q13.32 coronary artery disease, stomach cancer, alzheimers disease,
APOC1P1 apolipoprotein C-I pseudogene 1 19q13.32 intrahepatic cholangiocarcinoma
APOC2 apolipoprotein C-II 19q13.32 steatorrhea, hypertriglyceridemia, pancreatitis,
APOC3 apolipoprotein C-III 11q23.3 carotid intimal medial thickness, coronary artery disease, type 2 diabetes mellitus,
APOC4 apolipoprotein C-IV 19q13.32 coronary artery disease, breast and colorectal cancer artery disease
APOD apolipoprotein D 3q29 pilocytic astrocytoma, anaplastic astrocytoma, schizophrenia,
APOE apolipoprotein E 19q13.32 myocardial infarction, coronary artery disease, amyotrophic lateral sclerosis,
APOF apolipoprotein F 12q13.3 dacryoadenitis
APOH apolipoprotein H (beta-2-glycoprotein I) 17q24.2 pre-eclampsia, polyarteritis nodosa, antithrombin iii deficiency,
APOL1 apolipoprotein L, 1 22q12.3 schizophrenia, glomerulosclerosis, focal segmental glomerulosclerosis,
APOL2 apolipoprotein L, 2 22q12.3 schizophrenia
APOL4 apolipoprotein L, 4 22q12.3 schizophrenia
APOLD1 apolipoprotein L domain containing 1 12p13.1 diverticulitis, intestinal obstruction, anus cancer,
APOM apolipoprotein M 6p21.33 critical limb ischemia limb ischemia
APP amyloid beta (A4) precursor protein 21q21.3 amyloidosis, amyotrophic lateral sclerosis, alzheimers disease,
APPBP2 amyloid beta precursor protein (cytoplasmic tail) binding protein 2 17q23.2 breast cancer
APPL1 adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 3p14.3 exophthalmos
APPL2 adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 12q23.3 phelan-mcdermid syndrome
APRT adenine phosphoribosyltransferase 16q24.3 lesch-nyhan syndrome, nephrolithiasis, gout,
APTX aprataxin 9p21.1 ataxia, friedreich ataxia, cysticercosis,
AQP1 aquaporin 1 (Colton blood group) 7p14.3 polyhydramnios, oligohydramnios, dysferlinopathy,
AQP12B aquaporin 12B 2q37.3 posterior polar cataract
AQP2 aquaporin 2 (collecting duct) 12q13.12 hydronephrosis, metabolic acidosis, urinary tract obstruction,
AQP3 aquaporin 3 (Gill blood group) 9p13.3 polyhydramnios, oligohydramnios, cystic fibrosis,
AQP4 aquaporin 4 18q11.2 syringomyelia, megalencephalic leukoencephalopathy with subcortical cysts, acute liver failure,
AQP5 aquaporin 5 12q13.12 alzheimers disease, dry eye syndrome, wrinkles,
AQP6 aquaporin 6, kidney specific 12q13.12 menieres disease
AQP7 aquaporin 7 9p13.3 morbid obesity, obesity, menieres disease,
AQP8 aquaporin 8 16p12.1 polyhydramnios oligohydramnios
AQP9 aquaporin 9 15q21.3 polyhydramnios hydrarthrosis
AQPEP laeverin 5q23.1 laryngitis
AR androgen receptor Xq12 prostate cancer, hypospadias, breast cancer,
ARAF v-raf murine sarcoma 3611 viral oncogene homolog Xp11.23 mycobacterium marinum
ARAP2 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 4p14 loiasis urinary schistosomiasis
ARC activity-regulated cytoskeleton-associated protein 8q24.3 "myoclonus, familial cortical" idiopathic generalized epilepsy
ARCI7 Ichthyosis, congenital, autosomal recessive 7 12p11.2-q13.1 "ichthyosis, congenital, autosomal recessive 7"
ARCI9 Ichthyosis, congenital, autosomal recessive 9 "ichthyosis, congenital, autosomal recessive 9"
AREG amphiregulin 4q13.3 prostate cancer, pancreatic cancer, anemia of prematurity,
AREGB amphiregulin B 4q13.3 prostate cancer breast adenocarcinoma
ARF1 ADP-ribosylation factor 1 1q42.13 cholera rheumatic myocarditis
ARF1P1 ADP-ribosylation factor 1 pseudogene 1 7q21.3 hiv-1
ARF3 ADP-ribosylation factor 3 12q13.12 cholera, "distal hereditary motor neuropathy, type ii" platelet storage pool deficiency
ARF4 ADP-ribosylation factor 4 3p14.3 cholera
ARF5 ADP-ribosylation factor 5 7q32.1 cholera
ARF6 ADP-ribosylation factor 6 14q21.3 cholera familial infantile myoclonic epilepsy
ARFGEF2 ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) 20q13.13 exophthalmos, periventricular heterotopia with microcephaly , "periventricular heterotopia, autosomal recessive",
ARFRP1 ADP-ribosylation factor related protein 1 20q13.33 wiskott-aldrich syndrome
ARG1 arginase 1 6q23.2 hepatocellular carcinoma, recessive dystrophic epidermolysis bullosa, hyperargininemia,
ARG2 arginase 2 14q24.1 hyperargininemia
ARHGAP1 Rho GTPase activating protein 1 11p11.2 noma
ARHGAP17 Rho GTPase activating protein 17 16p12.1 syringomyelia
ARHGAP24 Rho GTPase activating protein 24 4q21.23 familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis
ARHGAP26 Rho GTPase activating protein 26 5q31.3 mucopolysaccharidosis vi, juvenile myelomonocytic leukemia alpha thalassemia
ARHGAP31 Rho GTPase activating protein 31 3q13.33 adams-oliver syndrome 1 oliver syndrome
ARHGAP32 Rho GTPase activating protein 32 11q24.3 schizotypal personality disorder
ARHGAP33 Rho GTPase activating protein 33 19q13.12 noma
ARHGAP4 Rho GTPase activating protein 4 Xq28 l1 syndrome
ARHGAP6 Rho GTPase activating protein 6 Xp22.2 microphthalmia with linear skin defects syndrome
ARHGDIA Rho GDP dissociation inhibitor (GDI) alpha 17q25.3 familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis, "nephrotic syndrome, type 8" nephrotic syndrome
ARHGEF1 Rho guanine nucleotide exchange factor (GEF) 1 19q13.2 skin lipoma
ARHGEF10 Rho guanine nucleotide exchange factor (GEF) 10 8p23.3 gastric dilatation "slowed nerve conduction velocity, ad"
ARHGEF12 Rho guanine nucleotide exchange factor (GEF) 12 11q23.3 acute myeloid leukemia, shwachman-diamond syndrome leukemia
ARHGEF16 Rho guanine nucleotide exchange factor (GEF) 16 1p36.32 neuroblastoma
ARHGEF19 Rho guanine nucleotide exchange factor (GEF) 19 1p36.13 blepharitis
ARHGEF28 Rho guanine nucleotide exchange factor (GEF) 28 5q13.2 amyotrophic lateral sclerosis
ARHGEF3 Rho guanine nucleotide exchange factor (GEF) 3 3p14.3 osteoporosis
ARHGEF6 Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 Xq26.3 borjeson-forssman-lehmann syndrome, "mental retardation, x-linked 17/31, microduplication" mental retardation
ARHGEF7 Rho guanine nucleotide exchange factor (GEF) 7 13q34 borjeson-forssman-lehmann syndrome
ARHGEF9 Cdc42 guanine nucleotide exchange factor (GEF) 9 Xq11.2 "epileptic encephalopathy, early infantile, 8", arhgef9-related hyperekplexia hyperekplexia
ARHI1 Age-related hearing impairment 1 8q24.13-q24.22 age-related hearing impairment 1
ARHI2 Age-related hearing impairment 2 3p26.1-p25.1 age-related hearing impairment 2
ARID1A AT rich interactive domain 1A (SWI-like) 1p36.11 coffin-siris syndrome, "mental retardation, autosomal dominant 14", arid1a-related coffin-siris syndrome
ARID1B AT rich interactive domain 1B (SWI1-like) 6q25.3 ladd syndrome , acrocephalosyndactylia, radioulnar synostosis,
ARID3B AT rich interactive domain 3B (BRIGHT-like) 15q24.1 intestinal atresia imperforate anus
ARID4A AT rich interactive domain 4A (RBP1-like) 14q23.1 retinoblastoma
ARID4B AT rich interactive domain 4B (RBP1-like) 1q42.3 breast cancer retinoblastoma
ARID5A AT rich interactive domain 5A (MRF1-like) 2q11.2 alcohol dependence
ARID5B AT rich interactive domain 5B (MRF1-like) 10q21.2 lymphoblastic leukemia
ARL1 ADP-ribosylation factor-like 1 12q23.2 cholera
ARL11 ADP-ribosylation factor-like 11 13q14.2 familial colorectal cancer, dysplastic nevus syndrome, familial breast cancer
ARL13B ADP-ribosylation factor-like 13B 3q11.1 joubert syndrome 8 , arl13b-related joubert syndrome, joubert syndrome 21,
ARL14 ADP-ribosylation factor-like 14 3q25.33 primary biliary cirrhosis
ARL2 ADP-ribosylation factor-like 2 11q13.1 retinitis pigmentosa 2
ARL2BP ADP-ribosylation factor-like 2 binding protein 16q13 retinitis pigmentosa with or without situs inversus , retinitis pigmentosa 66, retinitis pigmentosa 2,
ARL3 ADP-ribosylation factor-like 3 10q24.32 retinitis pigmentosa 2
ARL5A ADP-ribosylation factor-like 5A 2q23.3 prostate carcinoma in situ
ARL6 ADP-ribosylation factor-like 6 3q11.2 leber congenital amaurosis, "bardet-biedl syndrome 1, modifier of", arl6-related retinitis pigmentosa,
ARL6IP1 ADP-ribosylation factor-like 6 interacting protein 1 16p12.3 "spastic paraplegia 61, autosomal recessive"
ARMC10 armadillo repeat containing 10 7q22.1 hepatocellular carcinoma cloacogenic carcinoma
ARMC4 armadillo repeat containing 4 10p12.1 bent bone dysplasia syndrome , "ciliary dyskinesia, primary, 23" "ciliary dyskinesia, primary, 19"
ARMC5 armadillo repeat containing 5 16p11.2 acth-independent macronodular adrenal hyperplasia
ARMC9 armadillo repeat containing 9 2q37.1 mucopolysaccharidosis iii melanoma
ARMS2 age-related maculopathy susceptibility 2 10q26.13 choroiditis, age-related macular degeneration 8, multifocal choroiditis,
ARNT aryl hydrocarbon receptor nuclear translocator 1q21.3 hypoxia acute myeloid leukemia
ARNT2 aryl-hydrocarbon receptor nuclear translocator 2 15q25.1 hypoxia hypothalamic insufficiency-secondary microcephaly-visual impairment-urinary anomalies
ARNTL2 aryl hydrocarbon receptor nuclear translocator-like 2 12p11.23 hypoxia
ARPC5L actin related protein 2/3 complex, subunit 5-like 9q33.3 shigellosis
ARR3 arrestin 3, retinal (X-arrestin) Xq13.1 leber congenital amaurosis, retinal vasculitis rheumatic disease
ARRB1 arrestin, beta 1 11q13.4 whim syndrome
ARRB2 arrestin, beta 2 17p13.2 whim syndrome
ARSA arylsulfatase A 22q13.33 "metachromatic leukodystrophy, juvenile form", cerebral lipidosis, nervous system cancer,
ARSB arylsulfatase B 5q14.1 metachromatic leukodystrophy , mucosulfatidosis, mucopolysaccharidosis vi,
ARSD arylsulfatase D Xp22.33 metachromatic leukodystrophy , mucosulfatidosis, mucopolysaccharidosis vi
ARSE arylsulfatase E (chondrodysplasia punctata 1) Xp22.33 antley-bixler syndrome, metachromatic leukodystrophy , mucosulfatidosis,
ARSH arylsulfatase family, member H Xp22.33 breast fibroadenoma, breast cancer, metachromatic leukodystrophy ,
ARSI arylsulfatase family, member I 5q32 autosomal recessive spastic paraplegia type 66, xerophthalmia relapsing fever
ART1 ADP-ribosyltransferase 1 11p15.4 cholera, pertussis squamous cell carcinoma of the head and neck
ART4 ADP-ribosyltransferase 4 (Dombrock blood group) 12p12.3 acute chest syndrome
ARTN artemin 1p34.1 pancreatic cancer, spinal cord injury, hirschsprungs disease
ARVCF armadillo repeat gene deleted in velocardiofacial syndrome 22q11.21 spinocerebellar ataxia type 10, digeorge syndrome, cleft palate,
ARVD3 arrhythmogenic right ventricular dysplasia 3 14q12-q22 arrhythmogenic right ventricular dysplasia 3
ARVD4 arrhythmogenic right ventricular dysplasia 4 2q32.1-q32.3 arrhythmogenic right ventricular dysplasia 4
ARVD6 arrhythmogenic right ventricular dysplasia 6 10p14-p12 arrhythmogenic right ventricular dysplasia 6
ARX aristaless related homeobox Xp21.3 non-specific x-linked mental retardation, "mental retardation, x-linked 17/31, microduplication", mental retardation,
ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 8p22 lipogranulomatosis, farber lipogranulomatosis spinal muscular atrophy with progressive myoclonic epilepsy
ASAH2 N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 10q11.23 prostate cancer, gauchers disease, obstructive jaundice,
ASAP2 ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 2p25.1 cri-du-chat syndrome
ASB10 ankyrin repeat and SOCS box containing 10 7q36.1 glaucoma, open-angle glaucoma "glaucoma 1, open angle, f"
ASB14 ankyrin repeat and SOCS box containing 14 3p14.3 junctional epidermolysis bullosa cat-scratch disease
ASB16-AS1 ASB16 antisense RNA 1 17q21.31 intrahepatic cholangiocarcinoma
ASB2 ankyrin repeat and SOCS box containing 2 14q32.12 mucopolysaccharidosis vi myeloid leukemia
ASCC1 activating signal cointegrator 1 complex subunit 1 10q22.1 adenocarcinoma, lesch-nyhan syndrome, barretts esophagus
ASCL1 achaete-scute family bHLH transcription factor 1 12q23.2 neuroblastoma, congenital central hypoventilation syndrome, central hypoventilation syndrome,
ASD1 atrial septal defect 1 5p15.31 atrial septal defect 1
ASDP anal sphincter dysplasia anal sphincter dysplasia
ASGR1 asialoglycoprotein receptor 1 17p13.1 hepatitis b hepatitis
ASGR2 asialoglycoprotein receptor 2 17p13.1 hepatitis b, hepatitis liver cirrhosis
ASIC5 acid-sensing (proton-gated) ion channel family member 5 4q32.1 hypoaldosteronism
ASIP agouti signaling protein 20q11.22 autoimmune hepatitis, familial melanoma, obesity
ASL argininosuccinate lyase 7q11.21 hyperargininemia, lysinuric protein intolerance, orotic aciduria,
ASMD anterior segment mesenchymal dysgenesis 4q28-q31 congenital aphakia anterior segment mesenchymal dysgenesis
ASMT acetylserotonin O-methyltransferase Xp22.33 pineoblastoma, pineocytoma insomnia
ASMTL acetylserotonin O-methyltransferase-like Xp22.33 patau syndrome
ASNA1 arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) 19p13.2 breast adenoma
ASNS asparagine synthetase (glutamine-hydrolyzing) 7q21.3 asparagine synthetase deficiency
ASPA aspartoacylase 17p13.2 neurologic diseases, canavan disease, diabetic neuropathy,
ASPG1 Asperger syndrome, susceptibility to, 1 3q25-q27 asperger syndrome susceptibility 1
ASPG2 Asperger syndrome, susceptibility to, 2 17p13 asperger syndrome susceptibility 2
ASPG3 Asperger syndrome, susceptibility to, 3 1q21-q22 asperger syndrome susceptibility 3
ASPG4 Asperger syndrome, susceptibility to, 4 3p24-p21 asperger syndrome susceptibility 4
ASPH aspartate beta-hydroxylase 8q12.3 astigmatism, malignant hyperthermia, catecholaminergic polymorphic ventricular tachycardia,
ASPM asp (abnormal spindle) homolog, microcephaly associated (Drosophila) 1q31.3 microcephaly, primary autosomal recessive microcephalies and seckel syndrome spectrum disorders, primary autosomal recessive microcephaly type 1,
ASPN asporin 9q22.31 osteoarthritis, keloids, degenerative disc disease
ASPSCR1 alveolar soft part sarcoma chromosome region, candidate 1 17q25.3 sarcoma, alveolar soft part sarcoma, renal cell carcinoma,
ASRGL1 asparaginase like 1 11q12.3 central nervous system leukemia
ASRT3 Asthma-related traits, susceptibility to, 3 2p16 asthma asthma-related traits 3
ASRT4 Asthma-related traits, susceptibility to, 4 1p31 asthma asthma-related traits 4
ASRT6 Asthma-related traits, susceptibility to, 6 17q21 asthma asthma-related traits 6
ASRT8 Asthma-related traits, susceptibility to, 8 9q33 asthma asthma-related traits 8
ASS1 argininosuccinate synthase 1 9q34.11 hyperargininemia, lysinuric protein intolerance, isolated acth deficiency,
ASS1P7 argininosuccinate synthetase 1 pseudogene 7 3q26.32 systemic lupus erythematosus
ASS1P8 argininosuccinate synthetase 1 pseudogene 8 4q31.23 fatty liver disease
ASTE1 asteroid homolog 1 (Drosophila) 3q22.1 hailey-hailey disease
ASTN2 astrotactin 2 9q33.1 schizophrenia
ASXL1 additional sex combs like 1 (Drosophila) 20q11.21 lesch-nyhan syndrome, myelodysplastic syndromes, n syndrome,
ASXL3 additional sex combs like 3 (Drosophila) 18q12.1 bainbridge-ropers syndrome
ATAD2 ATPase family, AAA domain containing 2 8q24.13 gonorrhea genital herpes
ATCAY ataxia, cerebellar, Cayman type 19p13.3 ataxia, doid:4019, cerebellar ataxia,
ATD asphixiating thoracic dystrophy (chondroectodermal dysplasia-like syndrome) 15q13 asphyxiating thoracic dystrophy
ATF1 activating transcription factor 1 12q13.12 liposarcoma, fibrous histiocytoma, histiocytoma,
ATF2 activating transcription factor 2 2q31.1 eccrine porocarcinoma
ATF3 activating transcription factor 3 1q32.3 hypospadias
ATF4 activating transcription factor 4 22q13.1 coffin-lowry syndrome
ATF5 activating transcription factor 5 19q13.33 human t-cell leukemia virus type 1
ATF6 activating transcription factor 6 1q23.3 cystic fibrosis wolfram syndrome
ATFB1 Atrial fibrillation, familial 1 10q22-q24 familial atrial fibrillation "atrial fibrillation, familial, 1"
ATFB2 familial atrial fibrillation 2 6q14-q16 familial atrial fibrillation "atrial fibrillation, familial, 2"
ATFB5 Atrial fibrillation, familial, 5 4q25 "atrial fibrillation, familial, 5"
ATFB8 Atrial fibrillation, familial, 8 16q22 "atrial fibrillation, familial, 8"
ATG14 autophagy related 14 14q22.3 human granulocytic anaplasmosis
ATG16L1 autophagy related 16-like 1 (S. cerevisiae) 2q37.1 inflammatory bowel disease, crohns disease, microvascular complications of diabetes 6
ATG4C autophagy related 4C, cysteine peptidase 1p31.3 dependent personality disorder
ATG9B autophagy related 9B 7q36.1 non-hodgkin lymphoma
ATHS atherosclerosis susceptibility (lipoprotein associated) 19p13.3-p13.2 coronary artery disease, hypertriglyceridemia, artery disease,
ATIC 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase 2q35 aica-ribosiduria due to atic deficiency
ATL1 atlastin GTPase 1 14q22.1 paraplegia, hereditary spastic paraplegia, hereditary sensory neuropathy,
ATL2 atlastin GTPase 2 2p22.1 spastic paraplegia 3 spastic paraplegia 3a
ATL3 atlastin GTPase 3 11q13.1 "neuropathy, hereditary sensory, type if", spastic paraplegia 3, spastic paraplegia 3a
ATM ataxia telangiectasia mutated 11q22.3 breast cancer susceptibility, breast cancer, asphyxiating thoracic dystrophy,
ATN1 atrophin 1 12p13.31 schizophrenia, dementia, huntingtons disease,
ATOD1 Dermatitis, atopic 3q21 "dermatitis, atopic 1"
ATOD3 Dermatitis, atopic, 3 20p atopic dermatitis, dermatitis "dermatitis, atopic 3"
ATOD5 Dermatitis, atopic, 5 13q12-q14 atopic dermatitis, dermatitis "dermatitis, atopic 5"
ATOD6 Dermatitis, atopic, 6 5q31-q33 atopic dermatitis, dermatitis "dermatitis, atopic 6"
ATOD7 Dermatitis, atopic, susceptibility to, 7 11q13.5 dermatitis "dermatitis, atopic 7"
ATOH1 atonal homolog 1 (Drosophila) 4q22.2 colon cancer, goblet cell carcinoid, cerebellar liponeurocytoma
ATOH7 atonal homolog 7 (Drosophila) 10q21.3 congenital cataract microcornea with corneal opacity, persistent hyperplastic primary vitreous, open-angle glaucoma
ATP10A ATPase, class V, type 10A 15q12 angelman syndrome
ATP11A ATPase, class VI, type 11A 13q34 idiopathic pulmonary fibrosis
ATP12A ATPase, H+/K+ transporting, nongastric, alpha polypeptide 13q12.12 laryngitis, bile reflux, duodenitis,
ATP13A2 ATPase type 13A2 1p36.13 parkinsons disease, neuronal ceroid-lipofuscinoses, "ceroid lipofuscinosis, neuronal, 12"
ATP13A4 ATPase type 13A4 3q29 benign epilepsy with centrotemporal spikes
ATP1A1 ATPase, Na+/K+ transporting, alpha 1 polypeptide 1p13.1 thyrotoxic periodic paralysis
ATP1A2 ATPase, Na+/K+ transporting, alpha 2 polypeptide 1q23.2 skull base meningioma, hemiplegia, alternating hemiplegia of childhood,
ATP1A3 ATPase, Na+/K+ transporting, alpha 3 polypeptide 19q13.2 dystonia, hemiplegia, alternating hemiplegia of childhood,
ATP1B1 ATPase, Na+/K+ transporting, beta 1 polypeptide 1q24.2 megalencephalic leukoencephalopathy with subcortical cysts thyrotoxic periodic paralysis
ATP1B2 ATPase, Na+/K+ transporting, beta 2 polypeptide 17p13.1 migraine, retinoschisis, hemiplegic migraine,
ATP1B4 ATPase, Na+/K+ transporting, beta 4 polypeptide Xq24 thyrotoxic periodic paralysis
ATP2A1 ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 16p11.2 hypertension, myotonic dystrophy, myotonic dystrophy type 1,
ATP2A2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 12q24.11 keratosis, hypertension, hailey-hailey disease,
ATP2A3 ATPase, Ca++ transporting, ubiquitous 17p13.2 hypertension
ATP2B2 ATPase, Ca++ transporting, plasma membrane 2 3p25.3 "deafness, autosomal recessive 12, modifier of"
ATP2B3 ATPase, Ca++ transporting, plasma membrane 3 Xq28 ataxia, cerebellar ataxia, "spinocerebellar ataxia, x-linked 1"
ATP2C1 ATPase, Ca++ transporting, type 2C, member 1 3q22.1 hailey-hailey disease, pemphigus keratosis follicularis
ATP2C2 ATPase, Ca++ transporting, type 2C, member 2 16q24.1 hailey-hailey disease
ATP4A ATPase, H+/K+ exchanging, alpha polypeptide 19q13.12 laryngitis, bile reflux, duodenitis,
ATP5A1 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle 18q21.1 mitochondrial complex v deficiency, "mitochondrial complex deficiency, nuclear type 4" "mitochondrial complex v deficiency, nuclear type 1"
ATP5E ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit 20q13.32 "mitochondrial complex v deficiency, nuclear type 3", renal oncocytoma, mitochondrial complex v deficiency,
ATP5G1 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) 17q21.32 spindle cell hemangioma
ATP5G2 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) 12q13.13 spindle cell hemangioma
ATP5G2P2 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) pseudogene 2 14q21.3 smallpox
ATP5G3 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) 2q31.1 spindle cell hemangioma
ATP5H ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d 17q25.1 body dysmorphic disorder
ATP5LP5 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit g, pseudogene 5 3q25.2 smallpox
ATP5O ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit 21q22.11 2-hydroxyglutaric aciduria, d-2-hydroxyglutaric aciduria autoimmune polyglandular syndrome type 2
ATP6AP2 ATPase, H+ transporting, lysosomal accessory protein 2 Xp11.4 spasticity, aortic valve stenosis, "parkinsonism with spasticity, x-linked"
ATP6V0A2 ATPase, H+ transporting, lysosomal V0 subunit a2 12q24.31 cutis laxa, osteopetrosis, wrinkly skin syndrome
ATP6V0A4 ATPase, H+ transporting, lysosomal V0 subunit a4 7q34 "renal tubular acidosis, distal", renal tubular acidosis, "renal tubular acidosis, distal, autosomal recessive"
ATP6V0B ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b 1p34.1 cannabis abuse
ATP6V0E2 ATPase, H+ transporting V0 subunit e2 7q36.1 osteopetrosis
ATP6V1A ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A 3q13.2 histoplasmosis
ATP6V1B1 ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 2p13.3 "renal tubular acidosis, distal", renal tubular acidosis, "renal tubular acidosis, distal, autosomal recessive",
ATP6V1B2 ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 8p21.3 pigmented villonodular synovitis villonodular synovitis
ATP6V1E1 ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 22q11.21 cat eye syndrome
ATP6V1G2-DDX39B ATP6V1G2-DDX39B readthrough (NMD candidate) 6p21.33 atopic dermatitis
ATP7A ATPase, Cu++ transporting, alpha polypeptide Xq21.1 wilson disease, muscular atrophy, spinal muscular atrophy,
ATP7B ATPase, Cu++ transporting, beta polypeptide 13q14.3 wilson disease, anterior segment anomalies with or without cataract menkes disease
ATP8A2 ATPase, aminophospholipid transporter, class I, type 8A, member 2 13q12.13 cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, dysequilibrium syndrome, noonan syndrome 4
ATP8A2P3 ATPase, aminophospholipid transporter, class I, type 8A, member 2 pseudogene 3 13q12.13 alzheimers disease
ATP8B1 ATPase, aminophospholipid transporter, class I, type 8B, member 1 18q21.31 cholestasis, intrahepatic cholestasis, benign recurrent intrahepatic cholestasis,
ATPAF1 ATP synthase mitochondrial F1 complex assembly factor 1 1p33 "mitochondrial complex v deficiency, nuclear type 1"
ATPAF2 ATP synthase mitochondrial F1 complex assembly factor 2 17p11.2 mitochondrial complex v deficiency "mitochondrial complex v deficiency, nuclear type 1"
ATPLS antiphospholipid syndrome, familial 6p21.3 antiphospholipid syndrome
ATR ataxia telangiectasia and Rad3 related 3q23 chronic active epstein-barr virus infection, ataxia telangiectasia, ataxia,
ATRIP ATR interacting protein 3p21.31 ataxia telangiectasia, sporadic breast cancer, primary autosomal recessive microcephalies and seckel syndrome spectrum disorders,
ATRN attractin 20p13 radioulnar synostosis obesity
ATRNL1 attractin-like 1 10q25.3 radioulnar synostosis
ATRX alpha thalassemia/mental retardation syndrome X-linked Xq21.1 mental retardation, alpha thalassemia, intellectual disability,
ATXN1 ataxin 1 6p22.3 ataxia, hereditary ataxia, olivopontocerebellar atrophy,
ATXN10 ataxin 10 22q13.31 spinocerebellar ataxia type 10, ataxia, spinocerebellar ataxia
ATXN2 ataxin 2 12q24.12 amyotrophic lateral sclerosis, ophthalmoplegia, ataxia,
ATXN3 ataxin 3 14q32.12 ataxia, hereditary ataxia, spinocerebellar degeneration,
ATXN3L ataxin 3-like Xp22.2 machado-joseph disease
ATXN7 ataxin 7 3p14.1 ataxia, hereditary ataxia, olivopontocerebellar atrophy,
ATXN8 ataxin 8 13q21 infantile onset spinocerebellar ataxia spinocerebellar ataxia type 8
ATXN8OS ATXN8 opposite strand (non-protein coding) 13q21.33 ataxia, friedreich ataxia, infantile onset spinocerebellar ataxia,
AUH AU RNA binding protein/enoyl-CoA hydratase 9q22.31 leigh-like syndrome 3 methylglutaconic aciduria type i
AUNX1 auditory neuropathy, X-linked recessive 1 Xq23-q27.3 auditory neuropathy, "deafness, x-linked 5" x-linked hereditary sensory and autonomic neuropathy with deafness
AURKA aurora kinase A 20q13.2 colorectal cancer, breast cancer, colon cancer,
AURKB aurora kinase B 17p13.1 giant cell glioblastoma, "neuroblastoma, susceptibility" polyploidy
AURKC aurora kinase C 19q13.43 polyploidy, myotonia spermatogenic failure 5
AUTS1 autism susceptibility 1 7q22 autism susceptibility 1
AUTS11 Autism, susceptibility to, 11 1q24.2 autism susceptibility 11
AUTS12 autism, susceptibility to, 12 21p13-q11 autism susceptibility 12
AUTS13 autism, susceptibility to, 13 12q14.2 autism susceptibility 13
AUTS2 autism susceptibility candidate 2 7q11.22 "leukemia, acute lymphoblastic 3" "mental retardation, autosomal dominant 26"
AUTS3 Autism, susceptibility to, 3 13q14.2-q14.1 autism susceptibility 3
AUTS5 Autism, susceptibility to, 5 2q autism susceptibility 5
AUTS6 Autism, susceptibility to, 6 17q21 autism susceptibility 6
AUTS7 Autism, susceptibility to, 7 17q21 autism susceptibility 7
AUTS8 Autism, susceptibility to, 8 3q25-q27 autism susceptibility 8
AVEN apoptosis, caspase activation inhibitor 15q14 alexithymia schizoid personality disorder
AVIL advillin 12q14.1 lennox-gastaut syndrome
AVP arginine vasopressin 20p13 neuroblastoma, septic shock, pituitary apoplexy,
AVPR1A arginine vasopressin receptor 1A 12q14.2 acth-independent macronodular adrenal hyperplasia, adenomyosis, atypical autism,
AVPR1B arginine vasopressin receptor 1B 1q32.1 acth-independent macronodular adrenal hyperplasia, melancholia, asperger syndrome,
AVPR2 arginine vasopressin receptor 2 Xq28 acth-independent macronodular adrenal hyperplasia, l1 syndrome, lung cancer,
AVSD1 atrioventricular septal defect 1 1p31-p21 atrioventricular septal defect atrioventricular septal defect 1
AXIN1 axin 1 16p13.3 hepatocellular carcinoma, caudal duplication, "hepatocellular carcinoma, somatic",
AXIN2 axin 2 17q24.1 "colorectal cancer, somatic", colorectal cancer, "tooth agenesis, selective, 1, with or without orofacial cleft",
AXL AXL receptor tyrosine kinase 19q13.2 critical limb ischemia limb ischemia
AZF1 azoospermia factor 1 Yq11 germ cell tumors, cryptorchidism, oligospermia,
AZGP1 alpha-2-glycoprotein 1, zinc-binding 7q22.1 prostate cancer
AZU1 azurocidin 1 19p13.3 burns, erysipelas cornea cancer
B2M beta-2-microglobulin 15q21.1 amyloidosis, arthropathy, oral candidiasis,
B3GALNT2 beta-1,3-N-acetylgalactosaminyltransferase 2 1q42.3 "muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type a, 11", "muscular dystrophy-dystroglycanopathy , type a, 7", "muscular dystrophy-dystroglycanopathy , type a, 14"
B3GALT2 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 1q31.2 sipple syndrome
B3GALT4 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 6p21.32 uterine corpus cancer
B3GALT6 UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6 1p36.33 mucopolysaccharidoses, morquio syndrome b, sly syndrome,
B3GALTL beta 1,3-galactosyltransferase-like 13q12.3 peters plus syndrome
B3GAT1 beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) 11q25 basaloid squamous cell carcinoma, metanephric adenoma, neurilemmoma,
B3GAT3 beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) 11q12.3 skeletal dysplasias, mucopolysaccharidoses, morquio syndrome b,
B3GNT1 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 11q13.2 "muscular dystrophy-dystroglycanopathy , type a, 7", muscular dystrophy-dystroglycanopathy, "muscular dystrophy-dystroglycanopathy , type a, 13"
B3GNT4 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 12q24.31 mucopolysaccharidoses, morquio syndrome b sly syndrome
B4GALNT1 beta-1,4-N-acetyl-galactosaminyl transferase 1 12q13.3 "spastic paraplegia 26, autosomal recessive" spastic paraplegia 26
B4GALNT2 beta-1,4-N-acetyl-galactosaminyl transferase 2 17q21.32 dermatophytosis tracheitis
B4GALT1 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 9p21.1 blepharophimosis-ptosis-intellectual disability syndrome congenital disorder of glycosylation type 2d
B4GALT5 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5 20q13.13 nasopharynx carcinoma
B4GALT6 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6 18q12.1 prostate carcinoma in situ
B4GALT7 xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 5q35.3 "ehlers-danlos syndrome, progeroid type, 1", johanson-blizzard syndrome reunion islands larsen syndrome
B6QTL1 Vitamin B6 plasma level QTL 1 1p36.12 vitamin b6 plasma level qtl 1
B9D1 B9 protein domain 1 17p11.2 joubert syndrome 21, meckel syndrome 1, b9d1-related meckel syndrome
B9D2 B9 protein domain 2 19q13.2 chronic apical periodontitis, meckel syndrome 1, meckel syndrome 10
bA255A11.4 melanoma antigen pseudogene 9p13.3 melanoma
BAALC brain and acute leukemia, cytoplasmic 8q22.3 acute myeloid leukemia, leukemia, acute leukemia,
BAAT bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) 9q31.1 "hypercholanemia, familial" baat-related familial hypercholanemia
BACE1 beta-site APP-cleaving enzyme 1 11q23.3 alzheimers disease myositis
BACE1-AS BACE1 antisense RNA 11q23.3 alzheimers disease
BACE2 beta-site APP-cleaving enzyme 2 21q22.2 down syndrome
BACH1 BTB and CNC homology 1, basic leucine zipper transcription factor 1 21q21.3 breast cancer, "breast cancer, early-onset" "fanconi anemia, complementation group j"
BAD BCL2-associated agonist of cell death 11q13.1 prostate cancer pancreatic cancer
BAG1 BCL2-associated athanogene 9p13.3 spindle cell hemangioma
BAG2 BCL2-associated athanogene 2 6p11.2 brain cancer spindle cell hemangioma
BAG3 BCL2-associated athanogene 3 10q26.11 axonal neuropathy, "cardiomyopathy, dilated, 1w", giant axonal neuropathy,
BAG4 BCL2-associated athanogene 4 8p11.23 monilethrix
BAG5 BCL2-associated athanogene 5 14q32.33 brain cancer
BAG6 BCL2-associated athanogene 6 6p21.33 coronary artery aneurysm
BAGE B melanoma antigen 21p11.1 hepatocellular carcinoma, bladder carcinoma, b-cell chronic lymphocytic leukemia,
BAHD1 bromo adjacent homology domain containing 1 15q15.1 listeriosis
BAIAP2L1 BAI1-associated protein 2-like 1 7q22.1 insulin resistance
BAK1 BCL2-antagonist/killer 1 6p21.31 colorectal cancer, prostate cancer, pancreatic cancer,
BAMBI BMP and activin membrane-bound inhibitor 10p12.1 megalencephalic leukoencephalopathy with subcortical cysts, pendred syndrome, gnathodiaphyseal dysplasia
BANF1 barrier to autointegration factor 1 11q13.1 collagenous colitis, mandibuloacral dysplasia, familial partial lipodystrophy,
BANK1 B-cell scaffold protein with ankyrin repeats 1 4q24 systemic lupus erythematosus, lupus erythematosus, "systemic lupus erythematosus, association with"
BAP1 BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) 3p21.1 parkinsons disease, breast cancer, malignant mesothelioma,
BARD1 BRCA1 associated RING domain 1 2q35 breast cancer susceptibility, breast cancer, neuroblastoma,
BARX1 BARX homeobox 1 9q22.32 hard palate cancer
BATF2 basic leucine zipper transcription factor, ATF-like 2 11q13.1 acute stress disorder
BAX BCL2-associated X protein 19q13.33 "colorectal cancer, somatic", colorectal cancer, adenocarcinoma,
BAZ1A bromodomain adjacent to zinc finger domain, 1A 14q13.2 williams syndrome
BAZ1B bromodomain adjacent to zinc finger domain, 1B 7q11.23 williams-beuren syndrome williams syndrome
BBC3 BCL2 binding component 3 19q13.32 squamous cell carcinoma of the head and neck
BBIP1 BBSome interacting protein 1 10q25.2 "bardet-biedl syndrome, modifier of"
BBOX1 butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 11p14.2 mulibrey nanism
BBS1 Bardet-Biedl syndrome 1 11q13.2 "bardet-biedl syndrome 1, modifier of", bardet-biedl syndrome 15, bardet-biedl syndrome 3 ,
BBS10 Bardet-Biedl syndrome 10 12q21.2 retinal disease, "bardet-biedl syndrome 1, modifier of", bardet-biedl syndrome 15,
BBS12 Bardet-Biedl syndrome 12 4q27 "bardet-biedl syndrome 1, modifier of", bardet-biedl syndrome 15, bardet-biedl syndrome 3 ,
BBS2 Bardet-Biedl syndrome 2 16q12.2 "bardet-biedl syndrome 1, modifier of", bardet-biedl syndrome 15, bardet-biedl syndrome 3 ,
BBS4 Bardet-Biedl syndrome 4 15q24.1 "bardet-biedl syndrome 1, modifier of", bardet-biedl syndrome 15, bardet-biedl syndrome 3 ,
BBS5 Bardet-Biedl syndrome 5 2q31.1 "bardet-biedl syndrome 1, modifier of", bardet-biedl syndrome 15, bardet-biedl syndrome 3 ,
BBS7 Bardet-Biedl syndrome 7 4q27 "bardet-biedl syndrome 1, modifier of", bardet-biedl syndrome 15, bardet-biedl syndrome 3 ,
BBS9 Bardet-Biedl syndrome 9 7p14.3 "bardet-biedl syndrome 1, modifier of", bardet-biedl syndrome 15, bardet-biedl syndrome 3 ,
BBX bobby sox homolog (Drosophila) 3q13.12 lymphocytic gastritis
BCAM basal cell adhesion molecule (Lutheran blood group) 19q13.32 gonadoblastoma, sickle cell disease testicular gonadoblastoma
BCAP31 B-cell receptor-associated protein 31 Xq28 "deafness, dystonia, and cerebral hypomyelination"
BCAR1 breast cancer anti-estrogen resistance 1 16q23.1 breast cancer differentiating neuroblastoma
BCAR3 breast cancer anti-estrogen resistance 3 1p22.1 breast cancer venezuelan equine encephalitis
BCAR4 breast cancer anti-estrogen resistance 4 (non-protein coding) 16p13.13 breast cancer
BCAS1 breast carcinoma amplified sequence 1 20q13.2 breast cancer
BCAS2 breast carcinoma amplified sequence 2 1p13.2 breast cancer
BCAS3 breast carcinoma amplified sequence 3 17q23.2 breast cancer pharyngitis
BCAS4 breast carcinoma amplified sequence 4 20q13.13 parachordoma choanal atresia
BCAT1 branched chain amino-acid transaminase 1, cytosolic 12p12.1 hyperleucinemia-isoleucinemia or hypervalinemia hyperleucine-isoleucinemia
BCAT2 branched chain amino-acid transaminase 2, mitochondrial 19q13.33 hyperleucine-isoleucinemia hypervalinemia or hyperleucine-isoleucinemia
BCC1 Basal cell carcinoma, susceptibility to, 1 1p36 basal cell carcinoma basal cell carcinoma 1
BCC2 Basal cell carcinoma, susceptibility to, 2 1q42 basal cell carcinoma basal cell carcinoma 2
BCC3 Basal cell carcinoma, susceptibility to, 3 5p15.33 basal cell carcinoma basal cell carcinoma 3
BCC4 Basal cell carcinoma, susceptibility to, 4 12q13 basal cell carcinoma basal cell carcinoma 4
BCC5 Basal cell carcinoma, susceptibility to, 5 9p21 basal cell carcinoma basal cell carcinoma 5
BCC6 Basal cell carcinoma, susceptibility to, 6 7q32 basal cell carcinoma basal cell carcinoma 6
BCDIN3D-AS1 BCDIN3D antisense RNA 1 12q13.12 intrahepatic cholangiocarcinoma
BCHE butyrylcholinesterase 3q26.1 anencephaly, alzheimers disease, dementia,
BCKDHA branched chain keto acid dehydrogenase E1, alpha polypeptide 19q13.2 bacteriuria, pseudogout, maple syrup urine disease,
BCKDHB branched chain keto acid dehydrogenase E1, beta polypeptide 6q14.1 maple syrup urine disease, maple syrup urine disease type 1a, maple syrup urine disease type 1b
BCKDK branched chain ketoacid dehydrogenase kinase 16p11.2 chronic granulomatous disease due to deficiency of ncf-1 branched-chain ketoacid dehydrogenase kinase deficiency
BCL10 B-cell CLL/lymphoma 10 1p22.3 "male germ cell tumor, somatic", edwards syndrome, malt lymphoma,
BCL11A B-cell CLL/lymphoma 11A (zinc finger protein) 2p16.1 leukemia, hypersomnia, beta thalassemia,
BCL2 B-cell CLL/lymphoma 2 18q21.33 seborrheic keratosis, colorectal cancer, adenocarcinoma,
BCL2A1 BCL2-related protein A1 15q25.1 stomach cancer, non-hodgkin lymphoma, cortisol resistance
BCL2L1 BCL2-like 1 20q11.21 myeloma, colorectal cancer, maxillary sinus squamous cell carcinoma,
BCL2L10 BCL2-like 10 (apoptosis facilitator) 15q21.2 acute myeloid leukemia non-hodgkin lymphoma
BCL2L11 BCL2-like 11 (apoptosis facilitator) 2q13 burkitts lymphoma, chronic myeloid leukemia, hematologic cancer,
BCL2L13 BCL2-like 13 (apoptosis facilitator) 22q11.21 cat eye syndrome
BCL2L2 BCL2-like 2 14q11.2 non-hodgkin lymphoma, chronic myeloid leukemia severe acute respiratory syndrome
BCL3 B-cell CLL/lymphoma 3 19q13.32 leukemia, marginal zone b-cell lymphoma, "leukemia/lymphoma, b-cell, 3"
BCL6 B-cell CLL/lymphoma 6 3q27.3 reticulosarcoma, burkitts lymphoma, malt lymphoma,
BCL7A B-cell CLL/lymphoma 7A 12q24.31 burkitts lymphoma, non-hodgkin lymphoma, hodgkins lymphoma
BCL7B B-cell CLL/lymphoma 7B 7q11.23 burkitts lymphoma, williams-beuren syndrome, small intestine adenocarcinoma
BCL7C B-cell CLL/lymphoma 7C 16p11.2 burkitts lymphoma
BCL9 B-cell CLL/lymphoma 9 1q21.2 lymphoblastic leukemia skeletal muscle regeneration
BCL9L B-cell CLL/lymphoma 9-like 11q23.3 colorectal adenoma
BCMO1 beta-carotene 15,15'-monooxygenase 1 16q23.2 "hypercarotenemia and vitamin a deficiency, autosomal dominant" carotid artery occlusion
BCOR BCL6 corepressor Xp11.4 lenz microphthalmia syndrome, bcor-related lenz microphthalmia syndrome oculofaciocardiodental syndrome
BCPR Breast cancer-related regulator of TP53 17p13.3 breast cancer sporadic breast cancer
BCR breakpoint cluster region 22q11.23 myeloproliferative disorder, 8p11 myeloproliferative syndrome, lymphoblastic leukemia,
BCS1L BC1 (ubiquinol-cytochrome c reductase) synthesis-like 2q35 gracile syndrome, "mitochondrial complex iii deficiency, nuclear type 6", mitochondrial complex iii deficiency,
BDA1B Brachydactyly, type A1, locus B 5p13.3-p13.2 brachydactyly type a1
BDET Bleeding disorder, east Texas type 1q23 "bleeding disorder, east texas type"
BDH1 3-hydroxybutyrate dehydrogenase, type 1 3q29 bile duct adenoma
BDKRB1 bradykinin receptor B1 14q32.2 "polycystic kidney disease, type 1", burns, erysipelas
BDKRB2 bradykinin receptor B2 14q32.2 brain edema, essential hypertension, acute mountain sickness,
BDNF brain-derived neurotrophic factor 11p14.1 amyotrophic lateral sclerosis, parkinsons disease, schizophrenia,
BEAN1 brain expressed, associated with NEDD4, 1 16q21 ataxia spinocerebellar ataxia 31
BECN1 beclin 1, autophagy related 17q21.31 nephropathic cystinosis
BED Bornholm eye disease Xq28 bornholm eye disease
BEST1 bestrophin 1 11q12.3 leber congenital amaurosis, vitelliform macular dystrophy, macular dystrophy,
BEST2 bestrophin 2 19p13.2 vitelliform macular dystrophy bestrophinopathy
BEST3 bestrophin 3 12q15 vitelliform macular dystrophy
BEST4 bestrophin 4 1p34.1 vitelliform macular dystrophy
BET1 Bet1 golgi vesicular membrane trafficking protein 7q21.3 neuronitis vestibular neuronitis
BET1L Bet1 golgi vesicular membrane trafficking protein-like 11p15.5 uterine fibroid
BEX2 brain expressed X-linked 2 Xq22.1 breast cancer acute myeloid leukemia
BFIC2 Benign familial infantile convulsions-2 "infantile convulsions and paroxysmal choreoathetosis, familial", benign familial infantile seizures 2 episodic kinesigenic dyskinesia 1
BFIS1 benign familial infantile convulsions 19q "convulsions, benign familial infantile, 1"
BFIS4 Convulsions, benign familial infantile, 4 1p36.12-p35.1 "seizures, benign familial infantile, 4"
BFSP1 beaded filament structural protein 1, filensin 20p12.1 posterior polar cataract, cataract cataract 33
BFSP2 beaded filament structural protein 2, phakinin 3q22.1 epidermolysis bullosa simplex, epidermolysis bullosa, "cataract 12, multiple types"
BGLAP bone gamma-carboxyglutamate (gla) protein 1q22 plagiocephaly, saethre-chotzen syndrome, prostate cancer,
BGN biglycan Xq28 exposure keratitis
BHD Beukes familial hip dysplasia 4q35 "colorectal cancer, somatic", birt-hogg-dube syndrome, primary spontaneous pneumothorax,
BHLHA9 basic helix-loop-helix family, member a9 17p13.3 tibial aplasia - ectrodactyly
BHLHE41 basic helix-loop-helix family, member e41 12p12.1 bipolar i disorder mood disorder
BHMT betaine--homocysteine S-methyltransferase 5q14.1 abdominal aortic aneurysm spina bifida
BHMT2 betaine--homocysteine S-methyltransferase 2 5q14.1 vascular disease, abdominal aortic aneurysm spina bifida
BICC1 BicC family RNA binding protein 1 10q21.1 renal dysplasia "renal dysplasia, cystic"
BICD1 bicaudal D homolog 1 (Drosophila) 12p11.21 lissencephaly
BICD2 bicaudal D homolog 2 (Drosophila) 9q22.31 proximal spinal muscular atrophy "spinal muscular atrophy, lower extremity-predominant, 2, ad"
BID BH3 interacting domain death agonist 22q11.21 cat eye syndrome talipes equinovarus
BIN1 bridging integrator 1 2q14.3 neuroblastoma, centronuclear myopathy, diffuse astrocytoma,
BIN2 bridging integrator 2 12q13.13 breast cancer, epididymo-orchitis orchitis
BIN3 bridging integrator 3 8p21.3 ornithosis
BIRC2 baculoviral IAP repeat containing 2 11q22.2 malt lymphoma
BIRC3 baculoviral IAP repeat containing 3 11q22.2 malt lymphoma, chronic neutrophilic leukemia, marginal zone b-cell lymphoma
BIRC5 baculoviral IAP repeat containing 5 17q25.3 hepatocellular carcinoma, papilloma, prostate cancer,
BIRC7 baculoviral IAP repeat containing 7 20q13.33 melanoma, malignant pleural mesothelioma adenoid cystic carcinoma
BLACE B-cell acute lymphoblastic leukemia expressed 7q36.3 lymphoblastic leukemia
BLID BH3-like motif containing, cell death inducer 11q24.1 breast cancer
BLK B lymphoid tyrosine kinase 8p23.1 sle susceptibility, keratolytic winter erythema, multifocal motor neuropathy,
BLM Bloom syndrome, RecQ helicase-like 15q26.1 werner syndrome, rothmund-thomson syndrome, muscular dystrophy-dystroglycanopathy,
BLMH bleomycin hydrolase 17q11.2 germ cell cancer, alzheimers disease mutagen sensitivity
BLNK B-cell linker 10q24.1 lymphoblastic leukemia, agammaglobulinemia 3 , agammaglobulinemia,
BLOC1S3 biogenesis of lysosomal organelles complex-1, subunit 3 19q13.32 platelet storage pool deficiency, hermansky-pudlak syndrome hermansky-pudlak syndrome 8
BLOC1S6 biogenesis of lysosomal organelles complex-1, subunit 6, pallidin 15q21.1 platelet storage pool deficiency hermansky-pudlak syndrome 9
BLVRA biliverdin reductase A 7p13 spontaneous pneumothorax, pneumothorax, primary spontaneous pneumothorax
BLVRB biliverdin reductase B (flavin reductase (NADPH)) 19q13.2 intestinal atresia, amyotrophic lateral sclerosis, cholera,
BLZF1 basic leucine zipper nuclear factor 1 1q24.2 myocardial infarction, cryptococcosis, primary immunodeficiency disease,
BMI1 BMI1 polycomb ring finger oncogene 10p12.2 embryonal cancer, juvenile nasopharyngeal angiofibroma, myelodysplastic syndromes,
BMIQ10 Obesity, susceptibility to, on chromosome 10q 10q obesity obesity bmiq10
BMIQ16 Chromosome 16p11.2 deletion syndrome, 220kb 16p11.2 16p11.2 deletion syndrome "chromosome 16p11.2 deletion syndrome, 220kb"
BMIQ4 body mass index QTL 4 11q24 obesity bmiq4
BMIQ7 Obesity, susceptibility to, on chromosome 4 4p15-p14 obesity obesity bmiq7
BMIQ8 body mass index quantitative trait locus 8 10p obesity bmiq8
BMND7 bone mineral density quantiative trait locus 7 20p12.3 osteoporosis
BMND8 bone mineral density quantiative trait locus 8 11p12 osteoporosis
BMP1 bone morphogenetic protein 1 8p21.3 gastroschisis, osteogenesis imperfecta type iii, myositis ossificans,
BMP10 bone morphogenetic protein 10 2p13.3 hereditary hemorrhagic telangiectasia ventricular septal defect
BMP15 bone morphogenetic protein 15 Xp11.22 polycystic ovary syndrome, premature ovarian failure, ovarian dysgenesis 1,
BMP2 bone morphogenetic protein 2 20p12.3 osteochondroma, primary pulmonary hypertension, male germ cell tumor,
BMP3 bone morphogenetic protein 3 4q21.21 refractive error
BMP4 bone morphogenetic protein 4 14q22.2 cleft lip, age related macular degeneration, cleft palate,
BMP5 bone morphogenetic protein 5 6p12.1 microtia, meier-gorlin syndrome squamous cell papilloma
BMP6 bone morphogenetic protein 6 6p24.3 colorectal cancer, juvenile nasopharyngeal angiofibroma, diastolic heart failure,
BMP7 bone morphogenetic protein 7 20q13.31 ureteral obstruction, spondylolisthesis, spinal stenosis,
BMP8B bone morphogenetic protein 8b 1p34.2 color blindness blue color blindness
BMPER BMP binding endothelial regulator 7p14.3 spondylocostal dysostosis diaphanospondylodysostosis
BMPR1A bone morphogenetic protein receptor, type IA 10q23.2 juvenile polyposis syndrome, intestinal obstruction, protein-losing enteropathy,
BMPR1B bone morphogenetic protein receptor, type IB 4q22.3 osteochondroma, primary pulmonary hypertension, hypertension,
BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) 2q33.1 primary pulmonary hypertension, hypertension, connective tissue disease,
BMS1 BMS1 ribosome biogenesis factor 10q11.21 tauopathy, circumscribed cutaneous aplasia of the vertex aplasia cutis congenita
BMX BMX non-receptor tyrosine kinase Xp22.2 prostate cancer
BNIP1 BCL2/adenovirus E1B 19kDa interacting protein 1 5q35.1 spindle cell hemangioma
BNIP3 BCL2/adenovirus E1B 19kDa interacting protein 3 10q26.3 pancreatic cancer, malignant glioma hereditary leiomyomatosis and renal cell cancer
BNIP3L BCL2/adenovirus E1B 19kDa interacting protein 3-like 8p21.2 visual epilepsy
BNIPL BCL2/adenovirus E1B 19kD interacting protein like 1q21.3 trigeminal neuralgia
BOK BCL2-related ovarian killer 2q37.3 myelodysplastic syndromes werdnig-hoffmann disease
BOLA3 bolA family member 3 2p13.1 multiple mitochondrial dysfunctions syndrome 2
BOLL boule-like RNA-binding protein 2q33.1 azoospermia actinomycosis
BOP Polymicrogyria, bilateral occipital 6q16.3-q22.1 "polymicrogyria, bilateral occipital"
BOS2 Branchiootic syndrome 2 1q31 branchiootic syndrome branchiootic syndrome 2
BP1 Blood pressure QTL 1 sporadic breast cancer
BP28 Blood pressure QTL 28 adiponectin deficiency
BP51 Blood pressure QTL 51 major depressive disorder major depressive disorder and accelerated response to antidepressant drug treatment
BPGM 2,3-bisphosphoglycerate mutase 7q33 erythrocytosis due to bisphosphoglycerate mutase deficiency
BPI bactericidal/permeability-increasing protein 20q11.23 cystic fibrosis, sepsis, mastitis,
BPIFA1 BPI fold containing family A, member 1 20q11.21 lung cancer patent ductus arteriosus
BPIFA4P BPI fold containing family A, member 4, pseudogene 20q11.21 breast cancer
BPPV vestibulopathy, familial 6q benign paroxysmal positional nystagmus
BPY2 basic charge, Y-linked, 2 Yq11.223 y chromosome infertility, male infertility infertility
BPY2B basic charge, Y-linked, 2B Yq11.23 male infertility infertility
BPY2C basic charge, Y-linked, 2C Yq11.23 male infertility infertility
BRAF v-raf murine sarcoma viral oncogene homolog B 7q34 "colorectal cancer, somatic", colorectal cancer, sarcoma,
BRAT1 BRCA1-associated ATM activator 1 7p22.3 breast cancer, ataxia telangiectasia "rigidity and multifocal seizure syndrome, lethal neonatal"
BRCA1 breast cancer 1, early onset 17q21.31 colorectal cancer, prostate cancer, breast cancer susceptibility,
BRCA2 breast cancer 2, early onset 13q13.1 prostate cancer, breast cancer susceptibility, breast cancer,
BRCA3 breast cancer 3 13q21 breast cancer susceptibility, breast cancer, familial breast cancer,
BRCATA Breast cancer, 11;22 translocation associated 11q23 breast cancer "breast cancer, 11:22 translocation associated"
BRCC3 BRCA1/BRCA2-containing complex, subunit 3 Xq28 t-cell prolymphocytic leukemia moyamoya disease - short stature - facial dysmorphism - hypergonadotropic hypogonadism
BRD2 bromodomain containing 2 6p21.32 photosensitive epilepsy
BRD7 bromodomain containing 7 16q12.1 nasopharynx carcinoma
BRD9 bromodomain containing 9 5p15.33 rhabdomyosarcoma shipyard eye
BREA2 breast cancer estrogen-induced apoptosis 2 8q24.3 breast cancer
BRF2 BRF2, RNA polymerase III transcription initiation factor 50 kDa subunit 8p11.23 lung squamous cell carcinoma
BRI3BP BRI3 binding protein 12q24.31 cervical cancer
BRINP3 bone morphogenetic protein/retinoic acid inducible neural-specific 3 1q31.1 oligoastrocytoma
BRIP1 BRCA1 interacting protein C-terminal helicase 1 17q23.2 breast cancer susceptibility, breast cancer, male breast cancer,
BRKS1 Telopeptide lysyl hydroxylase, bone-specific 17p12 bruck syndrome 1
BRMS1 breast cancer metastasis suppressor 1 11q13.2 breast cancer
BRMS1L breast cancer metastasis-suppressor 1-like 14q13.2 breast cancer
BRS3 bombesin-like receptor 3 Xq26.3 lung cancer hypertension
BRSK2 BR serine/threonine kinase 2 11p15.5 limbic encephalitis
BRV2 Vertigo, benign recurrent, 2 22q12 "vertigo, benign recurrent, 2"
BRWD1 bromodomain and WD repeat domain containing 1 21q22.2 triple-a syndrome coronin-1a deficiency
BRWD3 bromodomain and WD repeat domain containing 3 Xq21.1 mental retardation, b-cell chronic lymphocytic leukemia, "mental retardation, x-linked"
BSCL2 Berardinelli-Seip congenital lipodystrophy 2 (seipin) 11q12.3 insulin resistance, congenital generalized lipodystrophy, lipodystrophy,
BSG basigin (Ok blood group) 19p13.3 brain stem glioma spinal cord astrocytoma
BSND Bartter syndrome, infantile, with sensorineural deafness (Barttin) 1p32.3 polyhydramnios, "deafness, autosomal recessive 76", gitelman syndrome,
BST1 bone marrow stromal cell antigen 1 4p15.32 rheumatoid arthritis arthritis
BST2 bone marrow stromal cell antigen 2 19p13.11 hiv-1, rheumatoid arthritis west nile encephalitis
BSX brain-specific homeobox 11q24.1 jacobsen syndrome
BTBD1 BTB (POZ) domain containing 1 15q25.2 hepatitis c, hepatitis c virus hepatitis
BTBD9 BTB (POZ) domain containing 9 6p21.2 "hydatidiform mole, recurrent" restless legs syndrome
BTC betacellulin 4q13.3 erythropoietic protoporphyria
BTD biotinidase 3p25.1 wells syndrome, coffin-siris syndrome, juvenile myelomonocytic leukemia,
BTG1 B-cell translocation gene 1, anti-proliferative 12q21.33 b-cell chronic lymphocytic leukemia chronic lymphocytic leukemia
BTK Bruton agammaglobulinemia tyrosine kinase Xq22.1 fabry disease, wiskott-aldrich syndrome, isolated growth hormone deficiency,
BTLA B and T lymphocyte associated 3q13.2 rheumatoid arthritis, type 1 diabetes mellitus subacute sclerosing panencephalitis
BTNL2 butyrophilin-like 2 (MHC class II associated) 6p21.32 sarcoidosis, wegeners granulomatosis, human immunodeficiency virus infectious disease,
BTRC beta-transducin repeat containing E3 ubiquitin protein ligase 10q24.32 hiv-1, cerebellar medulloblastoma split-hand/foot malformation 6
BTS1 bladder tumor susceptibility 1 10p11.23 joubert syndrome 10 retinitis pigmentosa 23
BUB1 BUB1 mitotic checkpoint serine/threonine kinase 2q13 colorectal cancer, mosaic variegated aneuploidy syndrome 1 "colorectal cancer with chromosomal instability, somatic"
BUB1B BUB1 mitotic checkpoint serine/threonine kinase B 15q15.1 "colorectal cancer, somatic", colorectal cancer, aicardi-goutieres syndrome,
BUB3 BUB3 mitotic checkpoint protein 10q26.13 mosaic variegated aneuploidy syndrome 1
BULN Bulimia nervosa, susceptibility to 10p bulimia nervosa
BVR1 Burkitt lymphoma variant rearranging region 1 8q24 burkitts lymphoma
BW32 Body weight QTL 32 type 2 diabetes mellitus
BW33 Body weight QTL 33 type 2 diabetes mellitus
BW34 Body weight QTL 34 type 2 diabetes mellitus
BYSL bystin-like 6p21.1 teratocarcinoma
BZW1 basic leucine zipper and W2 domains 1 2q33.1 phlebotomus fever
BZX Bazex syndrome Xq24-q27 bazex-dupre-christol syndrome
C10orf11 chromosome 10 open reading frame 11 10q22.2 oculocutaneous albinism, albinism, tinea unguium
C10orf2 chromosome 10 open reading frame 2 10q24.31 ophthalmoplegia, ataxia, mitochondrial dna depletion syndrome,
C11orf31 chromosome 11 open reading frame 31 11q12.1 staphyloenterotoxemia
C11orf68 chromosome 11 open reading frame 68 11q13.1 leukemia
C11orf74 chromosome 11 open reading frame 74 11p12 severe acute respiratory syndrome
C11orf82 chromosome 11 open reading frame 82 11q14.1 non-small cell lung carcinoma
C11orf95 chromosome 11 open reading frame 95 11q13.1 chondroid lipoma ependymoma
C12orf39 chromosome 12 open reading frame 39 12p12.1 agoraphobia, spondylosis locked-in syndrome
C12orf57 chromosome 12 open reading frame 57 12p13.31 temtamy syndrome
C12orf65 chromosome 12 open reading frame 65 12q24.31 "spastic paraplegia 55, autosomal recessive" combined oxidative phosphorylation deficiency 7
C15orf41 chromosome 15 open reading frame 41 15q14 congenital dyserythropoietic anemia type i, congenital dyserythropoietic anemia "dyserythropoietic anemia, congenital, type ib"
C15orf48 chromosome 15 open reading frame 48 15q21.1 esophageal squamous cell carcinoma
C16DELQ22 Chromosome 16q22 deletion syndrome 16q22 chromosome 16q22 deletion syndrome
C16orf62 chromosome 16 open reading frame 62 16p12.3 esophageal cancer
C17orf70 chromosome 17 open reading frame 70 17q25.3 fanconis anemia "fanconi anemia, complementation group m"
C17orf80 chromosome 17 open reading frame 80 17q25.1 lung cancer
C17orf85 chromosome 17 open reading frame 85 17p13.2 vertebral artery insufficiency
C18orf54 chromosome 18 open reading frame 54 18q21.2 adenoma, lung adenoma inferior myocardial infarction
C18orf8 chromosome 18 open reading frame 8 18q11.2 colon cancer
C19orf12 chromosome 19 open reading frame 12 19q12 neurodegeneration with brain iron accumulation 3 , mitochondrial membrane protein-associated neurodegeneration "spastic paraplegia 43, autosomal recessive"
C19orf26 chromosome 19 open reading frame 26 19p13.3 morgagni cataract
C19orf40 chromosome 19 open reading frame 40 19q13.11 aplastic anemia fanconis anemia
C19orf48 chromosome 19 open reading frame 48 19q13.33 acute myeloid leukemia, acute promyelocytic leukemia, acute leukemia,
C19orf80 chromosome 19 open reading frame 80 19p13.2 hepatocellular carcinoma
C1GALT1 core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 7p22.1 iga glomerulonephritis
C1GALT1C1 C1GALT1-specific chaperone 1 Xq24 iga glomerulonephritis "tn polyagglutination syndrome, somatic"
C1orf192 chromosome 1 open reading frame 192 1q23.3 ulcerative colitis
C1orf35 chromosome 1 open reading frame 35 1q42.13 myeloma multiple myeloma
C1orf43 chromosome 1 open reading frame 43 1q21.3 hepatitis c, hepatitis c virus hepatitis
C1orf64 chromosome 1 open reading frame 64 1p36.13 breast and colorectal cancer
C1QA complement component 1, q subcomponent, A chain 1p36.12 lupus erythematosus, cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus,
C1QB complement component 1, q subcomponent, B chain 1p36.12 "complement component 4, partial deficiency of", duchenne muscular dystrophy, glomerulonephritis,
C1QC complement component 1, q subcomponent, C chain 1p36.12 "complement component 4, partial deficiency of", duchenne muscular dystrophy, glomerulonephritis,
C1QTNF5 C1q and tumor necrosis factor related protein 5 11q23.3 retinal degeneration, taeniasis, late-onset retinal degeneration
C1R complement component 1, r subcomponent 12p13.31 "complement component 4, partial deficiency of", complement deficiency, c1s deficiency
C1RL complement component 1, r subcomponent-like 12p13.31 cll/sll ovary adenocarcinoma
C1S complement component 1, s subcomponent 12p13.31 mitochondrial dna depletion syndrome, "complement component 4, partial deficiency of", complement deficiency,
C2 complement component 2 6p21.33 retinal drusen, age related macular degeneration, "complement component 4, partial deficiency of",
C20orf57 chromosome 20 open reading frame 57 20q11.21 vaccinia
C20orf85 chromosome 20 open reading frame 85 20q13.32 lung cancer
C21orf2 chromosome 21 open reading frame 2 21q22.3 down syndrome
C21orf33 chromosome 21 open reading frame 33 21q22.3 anophthalmia/microphthalmia down syndrome
C21orf59 chromosome 21 open reading frame 59 21q22.11 prostate cancer, "ciliary dyskinesia, primary, 19" "ciliary dyskinesia, primary, 26"
C2orf40 chromosome 2 open reading frame 40 2q12.2 esophageal squamous cell carcinoma esophageal cancer
C2orf43 chromosome 2 open reading frame 43 2p24.1 defective apolipoprotein b-100
C2orf68 chromosome 2 open reading frame 68 2p11.2 colorectal adenocarcinoma
C2orf71 chromosome 2 open reading frame 71 2p23.2 leber congenital amaurosis, retinitis pigmentosa 54 c2orf71-related retinitis pigmentosa
C3 complement component 3 19p13.3 afibrinogenemia, retinal drusen, age related macular degeneration,
C3AR1 complement component 3a receptor 1 12p13.31 lupus nephritis bacterial meningitis
C3orf35 chromosome 3 open reading frame 35 3p22.2 muir-torre syndrome
C3orf58 chromosome 3 open reading frame 58 3q24 hypoxia
C3orf72 chromosome 3 open reading frame 72 3q22.3 keloids
C4A complement component 4A (Rodgers blood group) 6p21.33 autoimmune hepatitis, systemic lupus erythematosus, feltys syndrome,
C4B complement component 4B (Chido blood group) 6p21.33 vitiligo, systemic lupus erythematosus, juvenile rheumatoid arthritis,
C4BPA complement component 4 binding protein, alpha 1q32.2 membranoproliferative glomerulonephritis, gonorrhea, acute poststreptococcal glomerulonephritis,
C4B_2 complement component 4B (Chido blood group), copy 2 HSCHR6_MHC_SSTOp systemic lupus erythematosus, lupus erythematosus, c4b deficiency
C4orf26 chromosome 4 open reading frame 26 4q21.1 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, "amelogenesis imperfecta type, iia4", "amelogenesis imperfecta, type ia5"
C4orf3 chromosome 4 open reading frame 3 4q26 alcohol dependence, hepatitis c, hepatitis c virus
C4orf6 chromosome 4 open reading frame 6 4p16.2 neuroblastoma, differentiating neuroblastoma ellis-van creveld syndrome
C5 complement component 5 9q33.2 rheumatoid arthritis, complement deficiency, acute poststreptococcal glomerulonephritis,
C5AR1 complement component 5a receptor 1 19q13.32 sepsis, systemic lupus erythematosus, multiple sclerosis,
C5AR2 complement component 5a receptor 2 19q13.32 coronary artery disease, sepsis artery disease
C5orf20 chromosome 5 open reading frame 20 5q31.1 major depressive disorder
C5orf42 chromosome 5 open reading frame 42 5p13.2 joubert syndrome 21, joubert syndrome and related disorders, joubert syndrome 22,
C6 complement component 6 5p13.1 monkeypox, complement component 5 deficiency, neisseria meningitidis infection,
C6orf100 chromosome 6 open reading frame 100 6p22.1 systemic lupus erythematosus
C6orf15 chromosome 6 open reading frame 15 6p21.33 follicular lymphoma
C6orf211 chromosome 6 open reading frame 211 6q25.1 breast cancer susceptibility chronic myeloid leukemia
C6orf25 chromosome 6 open reading frame 25 6p21.33 gray platelet syndrome, paraneoplastic pemphigus intestinal disease
C6orf47 chromosome 6 open reading frame 47 6p21.33 human t-cell leukemia virus type 1
C6orf7 chromosome 6 open reading frame 7 6q14 periventricular nodular heterotopia periventricular nodular heterotopia 6
C7 complement component 7 5p13.1 c7 deficiency, sle susceptibility complement component 5 deficiency
C7orf49 chromosome 7 open reading frame 49 7q33 post-traumatic stress disorder
C7orf55 chromosome 7 open reading frame 55 7q34 intrahepatic cholangiocarcinoma
C8A complement component 8, alpha polypeptide 1p32.2 complement component 5 deficiency complement component 8 deficiency type 1
C8B complement component 8, beta polypeptide 1p32.2 complement component 5 deficiency complement component 8 deficiency type 2
C8G complement component 8, gamma polypeptide 9q34.3 oophoritis, complement component 5 deficiency, salpingo-oophoritis,
C8orf12 chromosome 8 open reading frame 12 8p23.1 keratolytic winter erythema
C8orf37 chromosome 8 open reading frame 37 8q22.1 patent foramen ovale, leber congenital amaurosis, cone-rod dystrophy 2,
C8orf4 chromosome 8 open reading frame 4 8p11.21 breast cancer thyroid cancer
C9 complement component 9 5p13.1 complement component 5 deficiency, primary amebic meningoencephalitis, meningoencephalitis,
C9orf3 chromosome 9 open reading frame 3 9q22.32 right bundle branch block newborn respiratory distress syndrome
C9orf72 chromosome 9 open reading frame 72 9p21.2 amyotrophic lateral sclerosis, frontotemporal lobar degeneration with ubiquitin-positive inclusions, "dementia, familial, nonspecific",
C9orf78 chromosome 9 open reading frame 78 9q34.11 hepatocellular carcinoma
C9orf9 chromosome 9 open reading frame 9 9q34.13 transitional cell carcinoma
CA1 carbonic anhydrase I 8q21.2 amnestic disorder subacute thyroiditis
CA10 carbonic anhydrase X 17q22 "hand, foot and mouth disease", retrograde amnesia herpangina
CA12 carbonic anhydrase XII 15q22.2 hypoxia isolated hyperchlorhidrosis
CA13 carbonic anhydrase XIII 8q21.2 suppurative otitis media
CA2 carbonic anhydrase II 8q21.2 hypoxia, renal tubular acidosis, autoimmune pancreatitis,
CA3 carbonic anhydrase III, muscle specific 8q21.2 myocardial infarction, laryngeal disease, auditory agnosia
CA4 carbonic anhydrase IV 17q23.1 leber congenital amaurosis, hypoxia, cystic fibrosis,
CA5A carbonic anhydrase VA, mitochondrial 16q24.2 hyperammonemia due to carbonic anhydrase va deficiency
CA6 carbonic anhydrase VI 1p36.23 "hand, foot and mouth disease", mouth disease, clear cell renal cell carcinoma
CA8 carbonic anhydrase VIII 8q12.1 paraneoplastic cerebellar degeneration, cerebellar degeneration, cerebellar ataxia,
CA9 carbonic anhydrase IX 9p13.3 endometrial carcinoma, hypoxia, sarcomatoid renal cell carcinoma,
CABIN1 calcineurin binding protein 1 22q11.23 invasive aspergillosis, pain disorder, lymphocele
CABP2 calcium binding protein 2 11q13.2 "deafness, autosomal recessive 76", non-hodgkin lymphoma, amebiasis
CABP4 calcium binding protein 4 11q13.2 retinal disease, "night blindness, congenital stationary , 1d, autosomal recessive", blindness,
CABP5 calcium binding protein 5 19q13.33 amebiasis
CACNA1A calcium channel, voltage-dependent, P/Q type, alpha 1A subunit 19p13.2 ataxia, hereditary ataxia, alternating hemiplegia of childhood,
CACNA1B calcium channel, voltage-dependent, N type, alpha 1B subunit 9q34.3 neuroblastoma, essential hypertension, tetanus,
CACNA1C calcium channel, voltage-dependent, L type, alpha 1C subunit 12p13.33 schizotypal personality disorder, hypokalemic periodic paralysis, brugada syndrome 1,
CACNA1D calcium channel, voltage-dependent, L type, alpha 1D subunit 3p21.1 hypokalemic periodic paralysis, "primary aldosteronism, seizures, and neurologic abnormalities" sinoatrial node dysfunction and deafness
CACNA1E calcium channel, voltage-dependent, R type, alpha 1E subunit 1q25.3 migraine
CACNA1F calcium channel, voltage-dependent, L type, alpha 1F subunit Xp11.23 "night blindness, congenital stationary , 1d, autosomal recessive", blindness, congenital stationary night blindness,
CACNA1H calcium channel, voltage-dependent, T type, alpha 1H subunit 16p13.3 "epilepsy, childhood absence, susceptibility to, 2", childhood absence epilepsy, juvenile absence epilepsy,
CACNA1S calcium channel, voltage-dependent, L type, alpha 1S subunit 1q32.1 hypogonadotropic hypogonadism 8 with or without anosmia, malignant hyperthermia susceptibility type 1, malignant hyperthermia susceptibility,
CACNA2D1 calcium channel, voltage-dependent, alpha 2/delta subunit 1 7q21.11 timothy syndrome, short qt syndrome 2 short qt syndrome
CACNA2D2 calcium channel, voltage-dependent, alpha 2/delta subunit 2 3p21.31 infantile epileptic encephalopathy
CACNA2D3 calcium channel, voltage-dependent, alpha 2/delta subunit 3 3p21.1 zimmermann-laband syndrome, laband syndrome hereditary night blindness
CACNA2D4 calcium channel, voltage-dependent, alpha 2/delta subunit 4 12p13.33 "night blindness, congenital stationary , 1d, autosomal recessive", cone-rod dystrophy 2, cone dystrophy 4
CACNB1 calcium channel, voltage-dependent, beta 1 subunit 17q12 malignant hyperthermia susceptibility
CACNB2 calcium channel, voltage-dependent, beta 2 subunit 10p12.33 brugada syndrome 1, lambert-eaton myasthenic syndrome, timothy syndrome,
CACNB3 calcium channel, voltage-dependent, beta 3 subunit 12q13.12 canavan disease
CACNB4 calcium channel, voltage-dependent, beta 4 subunit 2q23.3 idiopathic generalized epilepsy, episodic ataxia, juvenile myoclonic epilepsy,
CACNG1 calcium channel, voltage-dependent, gamma subunit 1 17q24.2 malignant hyperthermia susceptibility
CACNG2 calcium channel, voltage-dependent, gamma subunit 2 22q12.3 schizophrenia "mental retardation, autosomal dominant 10"
CACNG3 calcium channel, voltage-dependent, gamma subunit 3 16p12.1 juvenile absence epilepsy
CACNG5 calcium channel, voltage-dependent, gamma subunit 5 17q24.2 schizophrenia bipolar disorder
CACNG6 calcium channel, voltage-dependent, gamma subunit 6 19q13.42 asthma
CACYBP calcyclin binding protein 1q25.1 neuroblastoma
CADM1 cell adhesion molecule 1 11q23.3 cervical cancer, lung cancer, facial paralysis,
CADPS Ca++-dependent secretion activator 3p14.2 pineoblastoma
CAHM colon adenocarcinoma hypermethylated (non-protein coding) 6q26 adenocarcinoma colon adenocarcinoma
CALB1 calbindin 1, 28kDa 8q21.3 schizophrenia, huntingtons disease, subependymal giant cell astrocytoma,
CALB2 calbindin 2 16q22.2 amyotrophic lateral sclerosis, schizophrenia, adenosarcoma,
CALCA calcitonin-related polypeptide alpha 11p15.2 cherubism, oncogenic osteomalacia, osteomalacia,
CALCB calcitonin-related polypeptide beta 11p15.2 thyroid medullary carcinoma
CALCR calcitonin receptor 7q21.3 osteoporosis, lung cancer "osteoporosis, postmenopausal, susceptibility"
CALCRL calcitonin receptor-like 2q32.1 pulpitis primary angle-closure glaucoma
CALD1 caldesmon 1 7q33 vascular cancer, atypical polypoid adenomyoma, pseudosarcomatous fibromatosis,
CALHM1 calcium homeostasis modulator 1 10q24.33 alzheimers disease temporal lobe epilepsy
CALM1 calmodulin 1 (phosphorylase kinase, delta) 14q32.11 catecholaminergic polymorphic ventricular tachycardia, "ventricular tachycardia, catecholaminergic polymorphic, 2", otomycosis,
CALM2 calmodulin 2 (phosphorylase kinase, delta) 2p21 phencyclidine abuse otomycosis
CALM2P1 calmodulin 2 pseudogene 1 17q24.3 hypokalemic periodic paralysis
CALM3 calmodulin 3 (phosphorylase kinase, delta) 19q13.32 otomycosis
CALML3 calmodulin-like 3 10p15.1 pertussis
CALML4 calmodulin-like 4 15q23 breast cancer
CALML5 calmodulin-like 5 10p15.1 pertussis
CALML6 calmodulin-like 6 1p36.33 pertussis
CALN1 calneuron 1 7q11.22 supravalvular aortic stenosis
CALR calreticulin 19p13.2 pre-eclampsia, malignant hyperthermia, catecholaminergic polymorphic ventricular tachycardia,
CALR3 calreticulin 3 19p13.11 familial hypertrophic cardiomyopathy, hypertrophic cardiomyopathy "cardiomyopathy, familial hypertrophic, 19"
CALY calcyon neuron-specific vesicular protein 10q26.3 schizophrenia
CAMK1G calcium/calmodulin-dependent protein kinase IG 1q32.2 van der woude syndrome
CAMK2B calcium/calmodulin-dependent protein kinase II beta 7p13 phencyclidine abuse
CAMK2G calcium/calmodulin-dependent protein kinase II gamma 10q22.2 ischemia, brain ischemia, transient cerebral ischemia,
CAMK2N2 calcium/calmodulin-dependent protein kinase II inhibitor 2 3q27.1 colorectal adenocarcinoma
CAMK4 calcium/calmodulin-dependent protein kinase IV 5q22.1 allan-herndon-dudley syndrome cerebral hypoxia
CAMKMT calmodulin-lysine N-methyltransferase 2p21 cystinuria, 2p21 microdeletion syndrome, atypical hypotonia - cystinuria syndrome,
CAMP cathelicidin antimicrobial peptide 3p21.31 cardiovascular disease risk factor, mycobacterium marinum, catecholaminergic polymorphic ventricular tachycardia,
CAMPD1 Camptodactyly 1 3q11.2-q13.12 camptodactyly 1
CAMSAP2 calmodulin regulated spectrin-associated protein family, member 2 1q32.1 vohwinkel syndrome
CAMTA1 calmodulin binding transcription activator 1 1p36.31 vascular cancer, epithelioid hemangioendothelioma, histiocytoid hemangioma
CAND1 cullin-associated and neddylation-dissociated 1 12q14.3 glomuvenous malformation
CANDF1 candidiasis, familial 1 2p22.3-p21 "candidiasis, familial, 1, autosomal dominant"
CANDN1 candidiasis, nail 1 (with ICAM1 deficiency) 11p12-q12.1 "candidiasis, familial, 3"
CANT1 calcium activated nucleotidase 1 17q25.3 dwarfism, chagas disease desbuquois syndrome
CANX calnexin 5q35.3 orbital melanoma
CAP1 CAP, adenylate cyclase-associated protein 1 (yeast) 1p34.2 herpes simplex encephalitis 3
CAPN1 calpain 1, (mu/I) large subunit 11q13.1 meningioma meningothelial meningioma
CAPN10 calpain 10 2q37.3 type 2 diabetes mellitus, insulin resistance, 21-hydroxylase deficiency,
CAPN3 calpain 3, (p94) 15q15.1 calpainopathy, dysferlinopathy, familial partial lipodystrophy,
CAPN5 calpain 5 11q13.5 "vitreoretinopathy, neovascular inflammatory"
CAPNS1 calpain, small subunit 1 19q13.12 chronic neutrophilic leukemia
CAPNS2 calpain, small subunit 2 16q12.2 traumatic brain injury
CAPRIN1 cell cycle associated protein 1 11p13 japanese encephalitis
CAPS2 calcyphosine 2 12q21.2 alexithymia
CAPSL calcyphosine-like 5p13.2 primary biliary cirrhosis
CARD11 caspase recruitment domain family, member 11 7p22.2 immunodeficiency 11 persistent polyclonal b-cell lymphocytosis
CARD14 caspase recruitment domain family, member 14 17q25.3 psoriasis, pityriasis rubra pilaris psoriasis susceptibility 2
CARD16 caspase recruitment domain family, member 16 11q22.3 hodgkins lymphoma
CARD17 caspase recruitment domain family, member 17 11q22.3 shigellosis
CARD8 caspase recruitment domain family, member 8 19q13.33 rheumatoid arthritis masters-allen syndrome
CARD9 caspase recruitment domain family, member 9 9q34.3 dermatophytosis, "candidiasis, familial, 2, autosomal recessive", candidiasis,
CARF calcium responsive transcription factor 2q33.2 amyotrophic lateral sclerosis lateral sclerosis
CARS cysteinyl-tRNA synthetase 11p15.4 beckwith-wiedemann syndrome, atypical autism, wilms tumor,
CARTPT CART prepropeptide 5q13.2 hypersomnia, autism spectrum disorder, obesity,
CASC1 cancer susceptibility candidate 1 12p12.1 adenoma lung adenoma
CASC16 cancer susceptibility candidate 16 (non-protein coding) 16q12.2 breast cancer susceptibility
CASC5 cancer susceptibility candidate 5 15q15.1 microcephaly, primary autosomal recessive microcephalies and seckel syndrome spectrum disorders, primary autosomal recessive microcephaly type 1,
CASD1 CAS1 domain containing 1 7q21.3 brachydactyly-syndactyly syndrome
CASK calcium/calmodulin-dependent serine protein kinase (MAGUK family) Xp11.4 mental retardation, "epileptic encephalopathy, early infantile, 17", cerebellar hypoplasia,
CASP1 caspase 1, apoptosis-related cysteine peptidase 11q22.3 myocardial infarction, amyotrophic lateral sclerosis, wells syndrome,
CASP10 caspase 10, apoptosis-related cysteine peptidase 2q33.1 myocardial infarction, "gastric cancer, somatic", non-hodgkin lymphoma,
CASP12 caspase 12 (gene/pseudogene) 11q22.3 myocardial infarction, sepsis prion disease
CASP14 caspase 14, apoptosis-related cysteine peptidase 19p13.12 myocardial infarction plasma cell neoplasm
CASP2 caspase 2, apoptosis-related cysteine peptidase 7q34 saethre-chotzen syndrome, myocardial infarction, primary effusion lymphoma,
CASP3 caspase 3, apoptosis-related cysteine peptidase 4q35.1 myocardial infarction, ischemia, nervous system cancer,
CASP4 caspase 4, apoptosis-related cysteine peptidase 11q22.3 myocardial infarction nephropathic cystinosis
CASP5 caspase 5, apoptosis-related cysteine peptidase 11q22.3 myocardial infarction cowpox
CASP6 caspase 6, apoptosis-related cysteine peptidase 4q25 myocardial infarction, huntingtons disease thoracic cancer
CASP7 caspase 7, apoptosis-related cysteine peptidase 10q25.3 myocardial infarction gastrointestinal lymphoma
CASP8 caspase 8, apoptosis-related cysteine peptidase 2q33.1 hepatocellular carcinoma, myocardial infarction, breast cancer,
CASP9 caspase 9, apoptosis-related cysteine peptidase 1p36.21 myocardial infarction, medulloblastoma, thoracic cancer,
CASQ1 calsequestrin 1 (fast-twitch, skeletal muscle) 1q23.2 malignant hyperthermia susceptibility gas gangrene
CASQ2 calsequestrin 2 (cardiac muscle) 1p13.1 catecholaminergic polymorphic ventricular tachycardia, "ventricular tachycardia, catecholaminergic polymorphic, 2", gas gangrene
CASR calcium-sensing receptor 3q21.1 humoral hypercalcemia of malignancy, renal osteodystrophy, hyperparathyroidism,
CAT catalase 11p13 asthma, vitiligo, systemic lupus erythematosus,
CATMANS Catel-Manzke syndrome catel manzke syndrome
CATSPER1 cation channel, sperm associated 1 11q13.1 male infertility, rhinotracheitis, spermatogenic failure 7 ,
CATSPER2 cation channel, sperm associated 2 15q15.3 male infertility, catsper-related male infertility, deafness-infertility syndrome
CATSPER2P1 cation channel, sperm associated 2 pseudogene 1 15q15.3 deafness and male infertility
CAV1 caveolin 1, caveolae protein, 22kDa 7q31.2 prostate cancer, malignant hyperthermia susceptibility, lung cancer,
CAV3 caveolin 3 3p25.3 limb-girdle muscular dystrophy, sudden infant death syndrome, hepatopulmonary syndrome,
CBFA2T2 core-binding factor, runt domain, alpha subunit 2; translocated to, 2 20q11.21 acute myeloid leukemia myeloid leukemia
CBFA2T3 core-binding factor, runt domain, alpha subunit 2; translocated to, 3 16q24.3 acute myeloid leukemia, myeloid leukemia acute megakaryoblastic leukemia without down syndrome
CBFB core-binding factor, beta subunit 16q22.1 acute myeloid leukemia, imperforate anus, crohns disease,
CBL Cbl proto-oncogene, E3 ubiquitin protein ligase 11q23.3 thanatophoric dysplasia, saethre-chotzen syndrome, juvenile myelomonocytic leukemia,
CBLB Cbl proto-oncogene B, E3 ubiquitin protein ligase 3q13.11 cannabis dependence
CBLN1 cerebellin 1 precursor 16q12.1 benign paroxysmal positional nystagmus
CBLN2 cerebellin 2 precursor 18q22.3 primary pulmonary hypertension heritable pulmonary arterial hypertension
CBLN3 cerebellin 3 precursor 14q12 olivopontocerebellar atrophy spinocerebellar degeneration
CBLN4 cerebellin 4 precursor 20q13.2 colorectal cancer
CBR3 carbonyl reductase 3 21q22.12 lung cancer, lung cancer susceptibility, keloids
CBR3-AS1 CBR3 antisense RNA 1 21q22.12 prostate cancer
CBS cystathionine-beta-synthase 21q22.3 neural tube defects, megakaryocytic leukemia, myelomeningocele,
CBX1 chromobox homolog 1 17q21.32 mandibuloacral dysplasia
CBX2 chromobox homolog 2 17q25.3 46xy sex reversal 6, gonadal dysgenesis 46xy sex reversal 5
CBX4 chromobox homolog 4 17q25.3 brain cancer
CBY1 chibby homolog 1 (Drosophila) 22q13.1 pediatric ependymoma
CC2D1A coiled-coil and C2 domain containing 1A 19p13.12 mental retardation "mental retardation, autosomal recessive 43"
CC2D2A coiled-coil and C2 domain containing 2A 4p15.32 asphyxiating thoracic dystrophy, joubert syndrome and related disorders, congenital hepatic fibrosis,
CC2D2B coiled-coil and C2 domain containing 2B 10q24.1 alcohol dependence
CCA1 cataract, congenital, cerulean type, 1 17q24 "cataract, congenital" cataract 7
CCAL1 chondrocalcinosis 1 (calcium pyrophosphate-deposition disease, early onset osteoarthritis) 8q chondrocalcinosis 1
CCAR2 cell cycle and apoptosis regulator 2 8p21.3 breast cancer
CCAT1 colon cancer associated transcript 1 (non-protein coding) 8q24.21 colon cancer
CCAT2 colon cancer associated transcript 2 (non-protein coding) 8q24.21 colon cancer
CCBE1 collagen and calcium binding EGF domains 1 18q21.32 ovarian cancer, lymphedema, non-immune hydrops fetalis,
CCBL1 cysteine conjugate-beta lyase, cytoplasmic 9q34.11 schizophrenia
CCCSX Cerebral-cerebellar-coloboma syndrome, X-linked "cerebral-cerebellar-coloboma syndrome, x-linked"
CCDC101 coiled-coil domain containing 101 16p11.2 diabetic macular edema
CCDC102A coiled-coil domain containing 102A 16q21 diabetic cataract
CCDC103 coiled-coil domain containing 103 17q21.31 "ciliary dyskinesia, primary, 19", "ciliary dyskinesia, primary, 17" primary ciliary dyskinesia17: ccdc103-related primary ciliary dyskinesia
CCDC11 coiled-coil domain containing 11 18q21.1 situs inversus, heterotaxy, dextrocardia with situs inversus
CCDC114 coiled-coil domain containing 114 19q13.33 "ciliary dyskinesia, primary, 19", hypermethioninemia "ciliary dyskinesia, primary, 20"
CCDC130 coiled-coil domain containing 130 19p13.2 phlebotomus fever trench fever
CCDC170 coiled-coil domain containing 170 6q25.1 breast cancer
CCDC18 coiled-coil domain containing 18 1p22.1 sarcoma
CCDC19 coiled-coil domain containing 19 1q23.2 nasopharynx carcinoma
CCDC22 coiled-coil domain containing 22 Xp11.23 intellectual disability
CCDC28B coiled-coil domain containing 28B 1p35.1 retinal disease, "bardet-biedl syndrome, modifier of" congenital nystagmus
CCDC34 coiled-coil domain containing 34 11p14.1 spinal stenosis
CCDC37 coiled-coil domain containing 37 3q21.3 facial paralysis
CCDC39 coiled-coil domain containing 39 3q26.33 "ciliary dyskinesia, primary, 19", "ciliary dyskinesia, primary, 14" primary ciliary dyskinesia14: ccdc39-related primary ciliary dyskinesia
CCDC40 coiled-coil domain containing 40 17q25.3 "ciliary dyskinesia, primary, 19", "ciliary dyskinesia, primary, 15" primary ciliary dyskinesia15: ccdc40-related primary ciliary dyskinesia
CCDC50 coiled-coil domain containing 50 3q28 "deafness, autosomal dominant 4b", dfna44 nonsyndromic hearing loss and deafness "deafness, autosomal dominant 44"
CCDC6 coiled-coil domain containing 6 10q21.2 follicular thyroid carcinoma, papillary thyroid carcinoma thyroid cancer
CCDC65 coiled-coil domain containing 65 12q13.12 "ciliary dyskinesia, primary, 19", clear cell sarcoma "ciliary dyskinesia, primary, 27"
CCDC78 coiled-coil domain containing 78 16p13.3 centronuclear myopathy 4
CCDC8 coiled-coil domain containing 8 19q13.32 3-m syndrome, "3-m syndrome, ccdc8-related" 3-m syndrome 3
CCDC85B coiled-coil domain containing 85B 11q13.1 relapsing fever hepatitis
CCDC88C coiled-coil domain containing 88C 14q32.11 hydrocephalus, congenital non-communicating hydrocephalus "nonsyndromic hydrocephalus, ccdc88c-related"
CCK cholecystokinin 3p22.1 schizophrenia, pancreatic cancer, dyspepsia,
CCKAR cholecystokinin A receptor 4p15.2 schizophrenia, pancreatic cancer, dyspepsia,
CCKBR cholecystokinin B receptor 11p15.4 gastric ulcer, pancreatic cancer, colon cancer,
CCL1 chemokine (C-C motif) ligand 1 17q12 kaposis sarcoma
CCL11 chemokine (C-C motif) ligand 11 17q12 asthma, folliculitis, coronary stenosis,
CCL13 chemokine (C-C motif) ligand 13 17q12 allergic rhinitis, bullous pemphigoid, far eastern spotted fever
CCL15 chemokine (C-C motif) ligand 15 17q12 pertussis osteosarcoma
CCL17 chemokine (C-C motif) ligand 17 16q21 asthma, cystic fibrosis, peripheral t-cell lymphoma,
CCL18 chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) 17q12 atopic dermatitis, pulmonary fibrosis, idiopathic pulmonary fibrosis
CCL19 chemokine (C-C motif) ligand 19 9p13.3 polyradiculoneuropathy chronic inflammatory demyelinating polyradiculoneuropathy
CCL2 chemokine (C-C motif) ligand 2 17q12 mesangial proliferative glomerulonephritis, nonspecific interstitial pneumonia, usual interstitial pneumonia,
CCL20 chemokine (C-C motif) ligand 20 2q36.3 hepatocellular carcinoma, pancreatic cancer, stromal keratitis,
CCL21 chemokine (C-C motif) ligand 21 9p13.3 b-cell chronic lymphocytic leukemia, wegeners granulomatosis, polyradiculoneuropathy,
CCL22 chemokine (C-C motif) ligand 22 16q13 abdominal aortic aneurysm, atopy, atopic dermatitis,
CCL23 chemokine (C-C motif) ligand 23 17q12 sialadenitis
CCL24 chemokine (C-C motif) ligand 24 7q11.23 acute promyelocytic leukemia, allergic rhinitis, allergic asthma,
CCL25 chemokine (C-C motif) ligand 25 19p13.2 obstructive jaundice allergic asthma
CCL26 chemokine (C-C motif) ligand 26 7q11.23 churg-strauss syndrome, hemimegalencephaly, tuberous sclerosis complex,
CCL27 chemokine (C-C motif) ligand 27 9p13.3 primary biliary cirrhosis, hypophosphatasia, atopic dermatitis,
CCL3 chemokine (C-C motif) ligand 3 17q12 malaria, behcets disease, tuberculosis,
CCL3L1 chemokine (C-C motif) ligand 3-like 1 17q12 hiv-1, acquired immunodeficiency syndrome, trypanosomiasis
CCL4 chemokine (C-C motif) ligand 4 17q12 retinal vasculitis, malaria, tuberculosis,
CCL5 chemokine (C-C motif) ligand 5 17q12 asthma, folliculitis, hiv-1,
CCL7 chemokine (C-C motif) ligand 7 17q12 usual interstitial pneumonia, allergic rhinitis, nephrogenic systemic fibrosis,
CCL8 chemokine (C-C motif) ligand 8 17q12 cholera, primary biliary cirrhosis diffuse gastric cancer
CCM2 cerebral cavernous malformation 2 7p13 klippel-trenaunay syndrome, acrocallosal syndrome, cerebral cavernous malformations-1 ,
CCM2L cerebral cavernous malformation 2-like 20q11.21 cavernous malformation cerebral cavernous malformation
CCNA1 cyclin A1 13q13.3 male germ cell tumor acute myeloid leukemia
CCNA2 cyclin A2 4q27 giant cell tumor, male germ cell tumor, breast cancer,
CCNB1 cyclin B1 5q13.2 cervical cancer, thyroid lymphoma, cholangiocarcinoma,
CCNB2 cyclin B2 15q22.2 cartilage-hair hypoplasia
CCND1 cyclin D1 11q13.3 myeloma, colorectal cancer, adenocarcinoma,
CCND2 cyclin D2 12p13.32 male germ cell tumor, breast cancer, mantle cell lymphoma,
CCND3 cyclin D3 6p21.1 myeloma bladder carcinoma in situ
CCNDBP1 cyclin D-type binding-protein 1 15q15.2 congenital dyserythropoietic anemia type i optic disk drusen
CCNE1 cyclin E1 19q12 breast cancer, malignant peritoneal mesothelioma, primary mediastinal large b-cell lymphoma,
CCNF cyclin F 16p13.3 necrotizing fasciitis
CCNG1 cyclin G1 5q34 mantle cell lymphoma
CCNG2 cyclin G2 4q21.1 thyroid lymphoma
CCNK cyclin K 14q32.2 kaposis sarcoma pthirus pubis infestation
CCNL2 cyclin L2 1p36.33 star syndrome
CCNO cyclin O 5q11.2 "ciliary dyskinesia, primary, 19" "ciliary diskinesia, primary, 29"
CCNT1 cyclin T1 12q13.12 hiv-1
CCNT2 cyclin T2 2q21.3 hiv-1
CCR1 chemokine (C-C motif) receptor 1 3p21.31 mesangial proliferative glomerulonephritis, stomatitis, proliferative glomerulonephritis,
CCR10 chemokine (C-C motif) receptor 10 17q21.2 cutaneous malignant melanoma pthirus pubis infestation
CCR2 chemokine (C-C motif) receptor 2 3p21.31 age related macular degeneration, rheumatoid arthritis, uveitis,
CCR3 chemokine (C-C motif) receptor 3 3p21.31 hiv-1, malaria, atopy,
CCR4 chemokine (C-C motif) receptor 4 3p22.3 nonspecific interstitial pneumonia, primary cutaneous anaplastic large cell lymphoma, rheumatoid arthritis,
CCR5 chemokine (C-C motif) receptor 5 (gene/pseudogene) 3p21.31 mesangial proliferative glomerulonephritis, hiv-1, chagas disease,
CCR6 chemokine (C-C motif) receptor 6 6q27 squamous cell carcinoma of the head and neck, stromal keratitis, diffuse scleroderma,
CCR7 chemokine (C-C motif) receptor 7 17q21.2 squamous cell carcinoma of the head and neck, mycosis fungoides, polymyositis,
CCR8 chemokine (C-C motif) receptor 8 3p22.2 kaposis sarcoma allergic rhinitis
CCR9 chemokine (C-C motif) receptor 9 3p21.31 celiac disease
CCS copper chaperone for superoxide dismutase 11q13.2 amyotrophic lateral sclerosis
CCT cataract, congenital, total X "cataract, congenital" proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome
CCT4 chaperonin containing TCP1, subunit 4 (delta) 2p15 sensory peripheral neuropathy
CCT5 chaperonin containing TCP1, subunit 5 (epsilon) 5p15.2 "neuropathy, hereditary sensory, with spastic paraplegia" autosomal recessive sensory neuropathy with spastic paraplegia
CCT6A chaperonin containing TCP1, subunit 6A (zeta 1) 7p11.2 morphine dependence
CCT7 chaperonin containing TCP1, subunit 7 (eta) 2p13.2 hiv-1 babesiosis
CCV cataract, congenital, Volkmann type 1p36 "cataract, congenital" "cataract 8, multiple types"
CD109 CD109 molecule 6q13 fetal and neonatal alloimmune thrombocytopenia
CD14 CD14 molecule 5q31.3 myocardial infarction, coronary artery disease, appendicitis,
CD151 CD151 molecule (Raph blood group) 11p15.5 skin squamous cell carcinoma, nephropathy with pretibial epidermolysis bullosa and deafness salivary gland cancer
CD160 CD160 molecule 1q21.1 folliculitis, neurotrophic keratopathy allergic asthma
CD163 CD163 molecule 12p13.31 pulpitis, spondylarthropathy, necrobiosis lipoidica,
CD164 CD164 molecule, sialomucin 6q21 bruton-type agammaglobulinemia
CD177 CD177 molecule 19q13.31 myeloproliferative disorder, myelofibrosis, thrombocytosis,
CD180 CD180 molecule 5q12.3 primary biliary cirrhosis
CD19 CD19 molecule 16p11.2 myeloma, b-cell chronic lymphocytic leukemia, hypersensitivity reaction type ii disease,
CD1A CD1a molecule 1q23.1 histiocytosis, mycosis fungoides, multifocal motor neuropathy,
CD1B CD1b molecule 1q23.1 mycobacterium malmoense
CD1C CD1c molecule 1q23.1 mycobacterium malmoense
CD1D CD1d molecule 1q23.1 relapsing polychondritis mycobacterium malmoense
CD1E CD1e molecule 1q23.1 multifocal motor neuropathy mycobacterium malmoense
CD2 CD2 molecule 1p13.1 squamous cell carcinoma of the head and neck, thymoma, malaria,
CD200R1L CD200 receptor 1-like 3q13.2 sleeping sickness
CD207 CD207 molecule, langerin 2p13.3 histiocytosis, allergic conjunctivitis, malignant ependymoma,
CD209 CD209 molecule 19p13.2 hiv-1, tuberculosis, severe acute respiratory syndrome,
CD22 CD22 molecule 19q13.12 eaf lymphosarcoma
CD226 CD226 molecule 18q22.2 refractory celiac disease autoimmune polyendocrinopathy type 2
CD244 CD244 molecule, natural killer cell receptor 2B4 1q23.3 infectious mononucleosis rheumatoid arthritis
CD247 CD247 molecule 1q24.2 oligoarticular juvenile arthritis, polyarticular onset juvenile idiopathic arthritis, immunodeficiency due to defect in cd3-zeta
CD27 CD27 molecule 12p13.31 transverse myelitis, myelitis, common variable immunodeficiency,
CD274 CD274 molecule 9p24.1 lupus nephritis, autoimmune myocarditis, primary mediastinal large b-cell lymphoma,
CD28 CD28 molecule 2q33.2 wegeners granulomatosis sialadenitis
CD2AP CD2-associated protein 6p12.3 nephrotic syndrome, familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis, glomerulosclerosis,
CD2BP2 CD2 (cytoplasmic tail) binding protein 2 16p11.2 lobular neoplasia contagious pustular dermatitis
CD300E CD300e molecule 17q25.1 lice infestation, tungiasis scabies
CD320 CD320 molecule 19p13.2 multiple carboxylase deficiency, methylmalonic aciduria and homocystinuria type cble, methylmalonic aciduria and homocystinuria type cblg,
CD33 CD33 molecule 19q13.41 acute myeloid leukemia, acute promyelocytic leukemia, myelodysplastic syndromes,
CD34 CD34 molecule 1q32.2 giant cell glioblastoma, kaposis sarcoma, mesenchymal cell neoplasm,
CD36 CD36 molecule (thrombospondin receptor) 7q21.11 "osteogenesis imperfecta, type ii", burn scar, osteoporosis,
CD38 CD38 molecule 4p15.32 b-cell chronic lymphocytic leukemia, chronic lymphocytic leukemia, plasmablastic lymphoma,
CD3D CD3d molecule, delta (CD3-TCR complex) 11q23.3 aplastic anemia, viral pneumonia, "severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive",
CD3E CD3e molecule, epsilon (CD3-TCR complex) 11q23.3 hemometra, "severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive", cd3epsilon deficiency,
CD3EAP CD3e molecule, epsilon associated protein 19q13.32 multiple myeloma, lung cancer lung cancer susceptibility
CD3G CD3g molecule, gamma (CD3-TCR complex) 11q23.3 enteropathy-associated t-cell lymphoma, immunodeficiency due to defect in cd3-gamma, "immunodeficiency 17, cd3 gamma deficient"
CD4 CD4 molecule 12p13.31 infectious mononucleosis, hiv-1, cryptococcosis,
CD40 CD40 molecule, TNF receptor superfamily member 5 20q13.12 graves disease, alzheimers disease, critical limb ischemia,
CD40LG CD40 ligand Xq26.3 polyarteritis nodosa, infectious mononucleosis, q fever,
CD44 CD44 molecule (Indian blood group) 11p13 myeloma, thymic epithelial neoplasm, gliomatosis cerebri,
CD46 CD46 molecule, complement regulatory protein 1q32.2 colorectal cancer, afibrinogenemia, gonorrhea,
CD47 CD47 molecule 3q13.12 neonatal meningitis
CD5 CD5 molecule 11q12.2 b-cell chronic lymphocytic leukemia, thymoma, hypersensitivity reaction type ii disease,
CD52 CD52 molecule 1p36.11 b-cell chronic lymphocytic leukemia, chronic lymphocytic leukemia, aplastic anemia,
CD53 CD53 molecule 1p13.3 intestinal tuberculosis
CD55 CD55 molecule, decay accelerating factor for complement (Cromer blood group) 1q32.2 malaria, acute hemorrhagic conjunctivitis, hemoglobinuria,
CD58 CD58 molecule 1p13.1 hepatitis b, hemoglobinuria, hemorrhagic fever with renal syndrome,
CD59 CD59 molecule, complement regulatory protein 11p13 malaria, hemoglobinuria, autoimmune hemolytic anemia,
CD5L CD5 molecule-like 1q23.1 wolman disease
CD6 CD6 molecule 11q12.2 multiple sclerosis oropharynx cancer
CD63 CD63 molecule 12q13.2 melanoma platelet storage pool deficiency
CD68 CD68 molecule 17p13.1 malignant histiocytosis, dendritic cell sarcoma, histiocytic sarcoma,
CD69 CD69 molecule 12p13.31 stromal keratitis, coccidioidomycosis intermediate uveitis
CD7 CD7 molecule 17q25.3 acute myeloid leukemia, leukemia, acute promyelocytic leukemia,
CD70 CD70 molecule 19p13.3 subacute cutaneous lupus erythematosus, mantle cell lymphoma, acute myocarditis
CD74 CD74 molecule, major histocompatibility complex, class II invariant chain 5q32 thymic epithelial neoplasm
CD79A CD79a molecule, immunoglobulin-associated alpha 19q13.2 mesangial proliferative glomerulonephritis, trachoma, infectious mononucleosis,
CD79B CD79b molecule, immunoglobulin-associated beta 17q23.3 chronic lymphocytic leukemia, familial chronic lymphocytic leukemia, agammaglobulinemia 3 ,
CD80 CD80 molecule 3q13.33 lymphocytic choriomeningitis, wegeners granulomatosis sialadenitis
CD81 CD81 molecule 11p15.5 malaria, cerebral creatine deficiency syndrome, "immunodeficiency, common variable, 6"
CD82 CD82 molecule 11p11.2 cervical cancer, prostate cancer, breast cancer,
CD84 CD84 molecule 1q23.3 dysgammaglobulinemia
CD86 CD86 molecule 3q13.33 lymphocytic choriomeningitis, wegeners granulomatosis, allergic encephalomyelitis,
CD8A CD8a molecule 2p11.2 vitiligo, epidermal nevus, breast cyst,
CD9 CD9 molecule 12p13.31 kaposis sarcoma, oral candidiasis, acquired immunodeficiency syndrome
CD93 CD93 molecule 20p11.21 familial hypercholesterolemia, c1 inhibitor deficiency splenic abscess
CD96 CD96 molecule 3q13.13 cat eye syndrome
CD99 CD99 molecule Xp22.33 malignant teratoma, osteosarcoma, spindle cell lipoma,
CDA cytidine deaminase 1p36.12 "xeroderma pigmentosum, group d"
CDAGS Craniosynostosis, anal anomalies, and porokeratosis syndrome 22q12-q13 imperforate anus, "craniosynostosis, anal anomalies, and porokeratosis" porokeratosis
CDAN1 codanin 1 15q15.2 congenital dyserythropoietic anemia type i, congenital dyserythropoietic anemia, "dyserythropoietic anemia, congenital, type ia",
CDAN3 congenital dyserythropoietic anemia, type III 15q21-q25 congenital dyserythropoietic anemia type 3
CDB2 corneal dystrophy of Bowman layer type II (Thiel-Behnke) 10q23-q24 chancroid corneal dystrophy thiel behnke type
CDC14A cell division cycle 14A 1p21.2 cartilage-hair hypoplasia
CDC25C cell division cycle 25C 5q31.2 malaria, hyperapobetalipoproteinemia plague
CDC26 cell division cycle 26 9q32 brain cancer
CDC42 cell division cycle 42 1p36.12 aarskog-scott syndrome, scott syndrome, noma
CDC42BPA CDC42 binding protein kinase alpha (DMPK-like) 1q42.13 myotonic dystrophy
CDC42BPB CDC42 binding protein kinase beta (DMPK-like) 14q32.32 myotonic dystrophy
CDC42BPG CDC42 binding protein kinase gamma (DMPK-like) 11q13.1 myotonic dystrophy
CDC42EP5 CDC42 effector protein (Rho GTPase binding) 5 19q13.42 quadriplegia
CDC42SE1 CDC42 small effector 1 1q21.3 scarlet fever
CDC45 cell division cycle 45 22q11.21 rothmund-thomson syndrome
CDC5L cell division cycle 5-like 6p21.1 tinea capitis, cystoisosporiasis poikiloderma with neutropenia
CDC6 cell division cycle 6 17q21.2 pleural empyema, cervical intraepithelial neoplasia, meier-gorlin syndrome 1,
CDC73 cell division cycle 73 1q31.2 hyperparathyroidism, primary hyperparathyroidism, gonorrhea,
CDCA2 cell division cycle associated 2 8p21.2 dermatophytosis
CDCA3 cell division cycle associated 3 12p13.31 clonorchiasis
CDCA4 cell division cycle associated 4 14q32.33 herpes simplex
CDCA5 cell division cycle associated 5 11q13.1 roberts syndrome
CDCA7 cell division cycle associated 7 2q31.1 mucinous cystadenocarcinoma
CDCA8 cell division cycle associated 8 1p34.3 diphyllobothriasis
CDH1 cadherin 1, type 1, E-cadherin (epithelial) 16q22.1 colorectal cancer, adenocarcinoma, juvenile nasopharyngeal angiofibroma,
CDH11 cadherin 11, type 2, OB-cadherin (osteoblast) 16q21 aneurysmal bone cysts malignant peritoneal mesothelioma
CDH12 cadherin 12, type 2 (N-cadherin 2) 5p14.3 meconium aspiration syndrome
CDH13 cadherin 13 16q23.3 atherosclerosis
CDH15 cadherin 15, type 1, M-cadherin (myotubule) 16q24.3 "mental retardation, autosomal dominant 10" 16q24.3 microdeletion syndrome
CDH16 cadherin 16, KSP-cadherin 16q22.1 mucinous tubular and spindle cell carcinoma, tubulocystic carcinoma, oxyphilic adenoma,
CDH19 cadherin 19, type 2 18q22.1 van maldergem syndrome 1
CDH2 cadherin 2, type 1, N-cadherin (neuronal) 18q12.1 malignant mesothelioma, pseudomyxoma peritonei hypoplastic left heart syndrome
CDH23 cadherin-related 23 10q22.1 breast cancer, "deafness, autosomal recessive 76", dfnb12 nonsyndromic hearing loss and deafness,
CDH3 cadherin 3, type 1, P-cadherin (placental) 16q22.1 radiation proctitis, prostate cancer, breast cancer,
CDH5 cadherin 5, type 2 (vascular endothelium) 16q21 myocardial infarction, prostate cancer, perineurioma,
CDH7 cadherin 7, type 2 18q22.1 charge syndrome
CDH8 cadherin 8, type 2 16q21 learning disability
CDH9 cadherin 9, type 2 (T1-cadherin) 5p14.1 benign epilepsy with centrotemporal spikes
CDHR1 cadherin-related family member 1 10q23.1 leber congenital amaurosis, retinitis pigmentosa 65 , cone-rod dystrophy 15
CDIPT CDP-diacylglycerol--inositol 3-phosphatidyltransferase 16p11.2 alpha 1-antitrypsin deficiency fibromuscular dysplasia
CDK1 cyclin-dependent kinase 1 10q21.2 male germ cell tumor thyroid lymphoma
CDK10 cyclin-dependent kinase 10 16q24.3 star syndrome
CDK11A cyclin-dependent kinase 11A 1p36.33 neuroblastoma
CDK11B cyclin-dependent kinase 11B 1p36.33 neuroblastoma, endodermal sinus tumor childhood endodermal sinus tumor
CDK15 cyclin-dependent kinase 15 2q33.1 amyotrophic lateral sclerosis lateral sclerosis
CDK2 cyclin-dependent kinase 2 12q13.2 male germ cell tumor tetraploidy
CDK20 cyclin-dependent kinase 20 9q22.1 mantle cell lymphoma
CDK2AP1 cyclin-dependent kinase 2 associated protein 1 12q24.31 oral cancer
CDK2AP2 cyclin-dependent kinase 2 associated protein 2 11q13.2 oral cancer hormone producing pituitary cancer
CDK4 cyclin-dependent kinase 4 12q14.1 gliosarcoma, pilocytic astrocytoma, retinoblastoma,
CDK5 cyclin-dependent kinase 5 7q36.1 amyotrophic lateral sclerosis, neuroblastoma, alzheimers disease
CDK5R1 cyclin-dependent kinase 5, regulatory subunit 1 (p35) 17q11.2 tauopathy
CDK5RAP1 CDK5 regulatory subunit associated protein 1 20q11.21 mikulicz disease
CDK5RAP2 CDK5 regulatory subunit associated protein 2 9q33.2 microcephaly, primary autosomal recessive microcephalies and seckel syndrome spectrum disorders, primary autosomal recessive microcephaly type 1,
CDK6 cyclin-dependent kinase 6 7q21.2 glioblastoma multiforme, familial melanoma, primary autosomal recessive microcephalies and seckel syndrome spectrum disorders,
CDK7 cyclin-dependent kinase 7 5q13.2 photosensitive trichothiodystrophy
CDK9 cyclin-dependent kinase 9 9q34.11 hiv-1
CDKAL1 CDK5 regulatory subunit associated protein 1-like 1 6p22.3 "diabetes mellitus, noninsulin-dependent"
CDKL3 cyclin-dependent kinase-like 3 5q31.1 chromosome 5q deletion
CDKL5 cyclin-dependent kinase-like 5 Xp22.13 west syndrome, "epileptic encephalopathy, early infantile, 5", "epileptic encephalopathy, early infantile, 17",
CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1) 6p21.2 papilloma, adenocarcinoma, maxillary sinus squamous cell carcinoma,
CDKN1B cyclin-dependent kinase inhibitor 1B (p27, Kip1) 12p13.1 hepatocellular carcinoma, papilloma, colorectal cancer,
CDKN1C cyclin-dependent kinase inhibitor 1C (p57, Kip2) 11p15.4 hepatocellular carcinoma, partial hydatidiform mole, gestational trophoblastic neoplasm,
CDKN2A cyclin-dependent kinase inhibitor 2A 9p21.3 papilloma, colorectal cancer, adenocarcinoma,
CDKN2B cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) 9p21.3 anaplastic astrocytoma, acute myeloid leukemia, myelodysplastic syndromes,
CDKN2B-AS1 CDKN2B antisense RNA 1 9p21.3 prostate cancer, endometriosis, periodontitis,
CDKN2C cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) 1p32.3 myelodysplastic syndromes, familial melanoma, pancreatic endocrine tumors,
CDKN2D cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) 19p13.2 osteosarcoma "melanoma, malignant, somatic"
CDKN3 cyclin-dependent kinase inhibitor 3 14q22.2 hepatocellular carcinoma, breast cancer, "hepatocellular carcinoma, somatic",
CDL1 Cornelia de Lange syndrome 1 3q26.3 cornelia de lange syndrome 1
CDL2 Cornelia de Lange syndrome 2 reserved cornelia de lange syndrome 2
CDO1 cysteine dioxygenase type 1 5q22.3 hepatoblastoma
CDON cell adhesion associated, oncogene regulated 11q24.2 septopreoptic holoprosencephaly, midline interhemispheric variant of holoprosencephaly, lobar holoprosencephaly,
CDR1 cerebellar degeneration-related protein 1, 34kDa Xq27.1 paraneoplastic cerebellar degeneration, cerebellar degeneration paraneoplastic neurologic disorders
CDR2 cerebellar degeneration-related protein 2, 62kDa 16p12.2 gait apraxia paraneoplastic neurologic disorders
CDR3 Cerebellar degeneration-related autoantigen-3 17q25 paraneoplastic neurologic disorders
CDS1 CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 4q21.23 colorectal cancer, breast cancer, breast and colorectal cancer,
CDSN corneodesmosin 6p21.33 guttate psoriasis, hypotrichosis 2, peeling skin syndrome ,
CDT1 chromatin licensing and DNA replication factor 1 16q24.3 lymphoblastic lymphoma, meier-gorlin syndrome 4 , meier-gorlin syndrome 1
CDX1 caudal type homeobox 1 5q32 colon adenocarcinoma, colon cancer, adult acute lymphocytic leukemia,
CDX2 caudal type homeobox 2 13q12.2 moebius syndrome, colorectal cancer, colorectal adenocarcinoma,
CDX4 caudal type homeobox 4 Xq13.2 acute myeloid leukemia, adult acute lymphocytic leukemia acute lymphocytic leukemia
CDY1 chromodomain protein, Y-linked, 1 Yq11.23 y chromosome infertility
CDY2A chromodomain protein, Y-linked, 2A Yq11.222 y chromosome infertility
CDYL chromodomain protein, Y-like 6p25.1 gingival recession
CDYL2 chromodomain protein, Y-like 2 16q23.2 prostate cancer
CEACAM1 carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) 19q13.2 endometrial carcinoma, adenomatoid tumor gonorrhea
CEACAM16 carcinoembryonic antigen-related cell adhesion molecule 16 19q13.32 "deafness, autosomal dominant 4b"
CEACAM3 carcinoembryonic antigen-related cell adhesion molecule 3 19q13.2 pericardial effusion, pancreatic cancer, colon cancer,
CEACAM4 carcinoembryonic antigen-related cell adhesion molecule 4 19q13.2 endometrial carcinoma papillary thyroid carcinoma
CEACAM5 carcinoembryonic antigen-related cell adhesion molecule 5 19q13.2 colorectal cancer, adenocarcinoma, breast cancer,
CEACAM6 carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) 19q13.2 cholangiocarcinoma
CEACAM7 carcinoembryonic antigen-related cell adhesion molecule 7 19q13.2 colorectal adenocarcinoma, adenocarcinoma, colon cancer,
CEACAM8 carcinoembryonic antigen-related cell adhesion molecule 8 19q13.2 chronic myeloid leukemia
CEBPA CCAAT/enhancer binding protein (C/EBP), alpha 19q13.11 acute myeloid leukemia, acute promyelocytic leukemia, skin squamous cell carcinoma,
CEBPB CCAAT/enhancer binding protein (C/EBP), beta 20q13.13 acute promyelocytic leukemia
CEBPE CCAAT/enhancer binding protein (C/EBP), epsilon 14q11.2 severe congenital neutropenia neutrophil-specific granule deficiency
CEBPZ CCAAT/enhancer binding protein (C/EBP), zeta 2p22.2 normal pressure hydrocephalus
CECR cat eye syndrome chromosome region 22pter-q11 cat eye syndrome
CECR1 cat eye syndrome chromosome region, candidate 1 22q11.1 polyarteritis nodosa, sneddon syndrome, cat eye syndrome,
CECR2 cat eye syndrome chromosome region, candidate 2 22q11.1 cat eye syndrome
CECR3 cat eye syndrome chromosome region, candidate 3 (non-protein coding) 22q11.1 cat eye syndrome
CECR5 cat eye syndrome chromosome region, candidate 5 22q11.1 cat eye syndrome
CECR5-AS1 CECR5 antisense RNA 1 22q11.1 cat eye syndrome
CECR6 cat eye syndrome chromosome region, candidate 6 22q11.1 cat eye syndrome
CECR7 cat eye syndrome chromosome region, candidate 7 (non-protein coding) 22q11.1 cat eye syndrome
CECR9 cat eye syndrome chromosome region, candidate 9 (non-protein coding) 22q11.1 cat eye syndrome
CEL carboxyl ester lipase 9q34.2 retinitis pigmentosa 2, monogenic diabetes, atherosclerosis,
CELA1 chymotrypsin-like elastase family, member 1 12q13.13 hepatopulmonary syndrome, steatorrhea, exocrine pancreatic insufficiency
CELA3B chymotrypsin-like elastase family, member 3B 1p36.12 rift valley fever, steatorrhea, exocrine pancreatic insufficiency,
CELF1 CUGBP, Elav-like family member 1 11p11.2 myotonic dystrophy
CELF2 CUGBP, Elav-like family member 2 10p14 neuroblastoma
CELF4 CUGBP, Elav-like family member 4 18q12.2 seizure disorder
CELIAC10 Celiac disease, susceptibility to, 10 3q25-q26 celiac disease celiac disease 10
CELIAC11 Celiac disease, susceptibility to, 11 3q28 celiac disease celiac disease 11
CELIAC12 Celiac disease, susceptibility to, 12 6q25.3 celiac disease celiac disease 12
CELIAC13 Celiac disease, susceptibility to, 13 12q24 celiac disease celiac disease 13
CELIAC2 celiac disease 2 5q31-q33 celiac disease celiac disease 2
CELIAC5 Celiac disease, susceptibility to, 5 15q11-q13 celiac disease celiac disease 5
CELIAC6 Celiac disease, susceptibility to, 6 4q27 celiac disease, celiac disease 6 autoimmune disease 5
CELIAC7 Celiac disease, susceptibility to, 7 1q31 celiac disease celiac disease 7
CELIAC8 Celiac disease, susceptibility to, 8 2q11-q12 celiac disease celiac disease 8
CELIAC9 Celiac disease, susceptibility to, 9 3p21 celiac disease celiac disease 9
CELSR1 cadherin, EGF LAG seven-pass G-type receptor 1 22q13.31 neural tube defects, spina bifida craniorachischisis
CEMIP cell migration inducing protein, hyaluronan binding 15q25.1 colon cancer
CEMP1 cementum protein 1 16p13.3 cryptosporidiosis
CEND1 cell cycle exit and neuronal differentiation 1 11p15.5 neuroblastoma
CENPB centromere protein B, 80kDa 20p13 primary biliary cirrhosis, limited scleroderma, telangiectasis
CENPC centromere protein C 4q13.2 limited scleroderma
CENPCP1 centromere protein C pseudogene 1 12q21.33 primary biliary cirrhosis
CENPJ centromere protein J 13q12.12 orotic aciduria, microcephaly, primary autosomal recessive microcephalies and seckel syndrome spectrum disorders,
CENPK centromere protein K 5q12.3 chancroid
CENPV centromere protein V 17p11.2 intracranial primitive neuroectodermal tumor
CEP135 centrosomal protein 135kDa 4q12 diabetic macular edema, microcephaly, primary autosomal recessive microcephalies and seckel syndrome spectrum disorders,
CEP152 centrosomal protein 152kDa 15q21.1 microcephaly, primary autosomal recessive microcephalies and seckel syndrome spectrum disorders, primary autosomal recessive microcephaly type 1,
CEP164 centrosomal protein 164kDa 11q23.3 nephronophthisis, senior-loken syndrome 1 nephronophthisis 15
CEP19 centrosomal protein 19kDa 3q29 morbid obesity morbid obesity and spermatogenic failure
CEP290 centrosomal protein 290kDa 12q21.32 prostate cancer, leber congenital amaurosis, joubert syndrome and related disorders,
CEP41 centrosomal protein 41kDa 7q32.2 joubert syndrome 21, joubert syndrome and related disorders, mandibuloacral dysplasia,
CEP55 centrosomal protein 55kDa 10q23.33 colon cancer
CEP57 centrosomal protein 57kDa 11q21 mosaic variegated aneuploidy syndrome, mosaic variegated aneuploidy syndrome 2 mosaic variegated aneuploidy syndrome 1
CEP63 centrosomal protein 63kDa 3q22.2 primary autosomal recessive microcephalies and seckel syndrome spectrum disorders, primary autosomal recessive microcephaly type 1 seckel syndrome type 6
CEP76 centrosomal protein 76kDa 18p11.21 jawad syndrome nail disease
CEP83 centrosomal protein 83kDa 12q22 infantile autosomal recessive medullary cystic kidney disease nephronophthisis 18
CEP85L centrosomal protein 85kDa-like 6q22.31 breast cancer
CEP89 centrosomal protein 89kDa 19q13.11 retinitis pigmentosa 2 cytochrome-c oxidase deficiency disease
CER1 cerberus 1, DAN family BMP antagonist 9p22.3 lung cancer susceptibility, norrie disease osteoporotic fracture
CERKL ceramide kinase-like 2q31.3 leber congenital amaurosis, retinitis, retinitis pigmentosa,
CERS3 ceramide synthase 3 15q26.3 "ichthyosis, congenital, autosomal recessive 9", weill-marchesani-like syndrome, autosomal recessive congenital ichthyosis
CES1 carboxylesterase 1 16q12.2 reye syndrome carboxylesterase 1 deficiency
CES2 carboxylesterase 2 16q22.1 north american indian childhood cirrhosis
CES3 carboxylesterase 3 16q22.1 dental pulp necrosis
CETN2 centrin, EF-hand protein, 2 Xq28 "xeroderma pigmentosum, group c" xeroderma pigmentosum
CETP cholesteryl ester transfer protein, plasma 16q13 carotid intimal medial thickness, vascular disease, coronary stenosis,
CFB complement factor B 6p21.33 choroiditis, multifocal choroiditis, retinal drusen,
CFC1 cripto, FRL-1, cryptic family 1 2q21.1 phenylketonuria, biliary atresia, heterotaxy,
CFD complement factor D (adipsin) 19p13.3 anorexia nervosa, obesity, meningococcal infection
CFH complement factor H 1q31.3 choroiditis, multifocal choroiditis, retinal drusen,
CFHR1 complement factor H-related 1 1q31.3 age related macular degeneration, takayasus arteritis, lyme disease,
CFHR2 complement factor H-related 2 1q31.3 dense deposit disease
CFHR3 complement factor H-related 3 1q31.3 age related macular degeneration, hemolytic-uremic syndrome, atypical hemolytic-uremic syndrome,
CFHR4 complement factor H-related 4 1q31.3 atypical hemolytic-uremic syndrome kuhnt-junius degeneration
CFHR5 complement factor H-related 5 1q31.3 membranoproliferative glomerulonephritis, glomerulonephritis, atypical hemolytic-uremic syndrome,
CFI complement factor I 4q25 congenital afibrinogenemia, afibrinogenemia, glomerulonephritis,
CFL1 cofilin 1 (non-muscle) 11q13.1 corticobasal degeneration
CFL2 cofilin 2 (muscle) 14q13.1 myopathy, typical nemaline myopathy, cfl2-related nemaline myopathy
CFLAR CASP8 and FADD-like apoptosis regulator 2q33.1 cadasil, cholangiocarcinoma, cervical intraepithelial neoplasia
CFLAR-AS1 CFLAR antisense RNA 1 2q33.1 amyotrophic lateral sclerosis
CFM1 cystic fibrosis modifier 1 19q13.2-q13.4 cystic fibrosis, meconium ileus meconium ileus in cystic fibrosis
CFM2 cystic fibrosis modifier 2 reserved cystic fibrosis
CFP complement factor properdin Xp11.23 afibrinogenemia, septic shock, malaria,
CFSS craniofacioskeletal syndrome Xq26-q27 craniofacioskeletal syndrome
CFTDX Myopathy, congenital, with fiber-type disproportion, X-linked Xq13.1-q22.1 "myopathy, congenital, with fiber-type disproportion, x-linked"
CFTR cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) 7q31.2 parkinsons disease, mammary pagets disease, oligospermia,
CFTRP1 cystic fibrosis transmembrane conductance regulator pseudogene 1 20p11.1 cystic fibrosis
CGA glycoprotein hormones, alpha polypeptide 6q14.3 androgen insensitivity syndrome, complete androgen insensitivity syndrome, germ cell cancer,
CGB chorionic gonadotropin, beta polypeptide 19q13.33 germ cell tumors, bladder transitional cell carcinoma, transitional cell carcinoma,
CGB5 chorionic gonadotropin, beta polypeptide 5 19q13.33 kaposis sarcoma, male germ cell tumor, cryptococcosis,
CGB7 chorionic gonadotropin, beta polypeptide 7 19q13.33 bladder carcinoma, cryptococcosis, gestational choriocarcinoma,
CGB8 chorionic gonadotropin, beta polypeptide 8 19q13.33 cryptococcosis
CGNL1 cingulin-like 1 15q21.3 estrogen excess aromatase excess syndrome
CH25H cholesterol 25-hydroxylase 10q23.31 alzheimers disease
CHAT choline O-acetyltransferase 10q11.23 amyotrophic lateral sclerosis, alzheimers disease, rett syndrome,
CHCHD10 coiled-coil-helix-coiled-coil-helix domain containing 10 22q11.23 amyotrophic lateral sclerosis with frontotemporal dementia
CHD2 chromodomain helicase DNA binding protein 2 15q26.1 dravet syndrome, choanal atresia, lennox-gastaut syndrome,
CHD3 chromodomain helicase DNA binding protein 3 17p13.1 dermatomyositis
CHD4 chromodomain helicase DNA binding protein 4 12p13.31 right bundle branch block
CHD5 chromodomain helicase DNA binding protein 5 1p36.31 neuroblastoma
CHD6 chromodomain helicase DNA binding protein 6 20q12 influenza, developmental coordination disorder pitt-hopkins syndrome
CHD7 chromodomain helicase DNA binding protein 7 8q12.1 hypogonadotropic hypogonadism 8 with or without anosmia, hypogonadotropic hypogonadism 17 with or without anosmia, lymphocytic choriomeningitis,
CHD8 chromodomain helicase DNA binding protein 8 14q11.2 charge syndrome autism 18
CHDM Chordoma 7q33 chordoma
CHDS1 Coronary heart disease, susceptibility to, 1 16pter-p13 coronary artery disease
CHDS2 Coronary heart disease, susceptibility to, 2 2q21.1-q22 coronary heart disease 2
CHDS3 Coronary heart disease, susceptibility to, 3 Xq23-q26 autism spectrum disorder coronary heart disease 3
CHDS4 Coronary heart disease, susceptibility to, 4 14q32 coronary heart disease 4
CHDS8 Coronary heart disease, susceptibility to, 8 9p21 coronary heart disease 8
CHDS9 Coronary heart disease, suscpetibility to, 9 8p22 coronary heart disease 9
CHDT3 Congenital heart defects, multiple types, 3 9q31.1 "congenital heart defects, multiple types, 3"
CHED1 corneal endothelial dystrophy 1 (autosomal dominant) 20p11.2-q11.2 posterior polymorphous corneal dystrophy "corneal endothelial dystrophy 1, autosomal dominant"
CHEK1 checkpoint kinase 1 11q24.2 hypoxia
CHEK2 checkpoint kinase 2 22q12.1 colorectal cancer, prostate cancer, breast cancer susceptibility,
CHERP calcium homeostasis endoplasmic reticulum protein 19p13.11 hereditary ataxia, huntingtons disease, spinocerebellar degeneration,
CHGA chromogranin A (parathyroid secretory protein 1) 14q32.12 prostate cancer, neuroblastoma, pituitary adenoma,
CHGB chromogranin B (secretogranin 1) 20p12.3 schizophrenia, prolactinoma, collagenous colitis,
CHI3L1 chitinase 3-like 1 (cartilage glycoprotein-39) 1q32.1 breast cancer, schizophrenia, spondylitis,
CHIA chitinase, acidic 1p13.2 asthma neuromyelitis optica
CHIC2 cysteine-rich hydrophobic domain 2 4q12 acute myeloid leukemia, leukemia myeloid leukemia
CHIT1 chitinase 1 (chitotriosidase) 1q32.1 fabry disease, krabbe disease, gauchers disease,
CHKA choline kinase alpha 11q13.2 myocardial infarction, neuroleptic malignant syndrome, compartment syndrome,
CHKB choline kinase beta 22q13.33 pericardial effusion, polyarteritis nodosa, angina pectoris,
CHL1 cell adhesion molecule L1-like 3p26.3 distal monosomy 3p
CHM choroideremia (Rab escort protein 1) Xq21.2 choroideremia, x-linked disease, charcot-marie-tooth disease type 3,
CHML choroideremia-like (Rab escort protein 2) 1q43 choroideremia, intrahepatic cholangiocarcinoma usher syndrome type ii
CHMP1A charged multivesicular body protein 1A 16q24.3 "pontocerebellar hypoplasia, type 8"
CHMP2A charged multivesicular body protein 2A 19q13.43 adenocarcinoma, breast adenocarcinoma fibrosarcomatous osteosarcoma
CHMP2B charged multivesicular body protein 2B 3p11.2 amyotrophic lateral sclerosis, progressive muscular atrophy, frontotemporal lobar degeneration with ubiquitin-positive inclusions,
CHMP3 charged multivesicular body protein 3 2p11.2 non-small cell lung carcinoma
CHMP4B charged multivesicular body protein 4B 20q11.22 hiv-1, posterior polar cataract, "cataract 6, multiple types"
CHN1 chimerin 1 2q31.1 duane retraction syndrome duane syndrome type 2
CHN2 chimerin 2 7p14.3 schizophrenia
CHNG3 Hypothyroidism, congenital, nongoitrous, 3 15q25.3-q26.1 "hypothyroidism, congenital, nongoitrous, 3"
CHORDC1 cysteine and histidine-rich domain (CHORD) containing 1 11q14.3 inclusion conjunctivitis
CHP2 calcineurin-like EF-hand protein 2 16p12.2 hepatocellular carcinoma
CHPF2 chondroitin polymerizing factor 2 7q36.1 mucopolysaccharidoses, morquio syndrome b sly syndrome
CHPT1 choline phosphotransferase 1 12q23.2 newborn respiratory distress syndrome
CHRDL1 chordin-like 1 Xq23 hypoxia, hodgkins lymphoma, "megalocornea 1, x-linked",
CHRFAM7A CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion 15q13.2 schizophrenia, autosomal dominant nocturnal frontal lobe epilepsy frontal lobe epilepsy
CHRM1 cholinergic receptor, muscarinic 1 11q12.3 schizophrenia, congenital heart block, progressive supranuclear palsy,
CHRM2 cholinergic receptor, muscarinic 2 7q33 chagas disease, tendinosis, neurogenic bladder
CHRM3 cholinergic receptor, muscarinic 3 1q43 bladder disease, urinary tract obstruction, cholinergic urticaria,
CHRM5 cholinergic receptor, muscarinic 5 15q14 schizophrenia cannabis dependence
CHRNA1 cholinergic receptor, nicotinic, alpha 1 (muscle) 2q31.1 myasthenia gravis, "myasthenic syndrome, congenital, with pre- and postsynaptic defects", pterygium,
CHRNA2 cholinergic receptor, nicotinic, alpha 2 (neuronal) 8p21.2 bipolar i disorder, nicotine dependence, lymphoproliferative syndrome 1,
CHRNA3 cholinergic receptor, nicotinic, alpha 3 (neuronal) 15q25.1 lung cancer, lung cancer susceptibility, nicotine dependence,
CHRNA4 cholinergic receptor, nicotinic, alpha 4 (neuronal) 20q13.33 schizophrenia, attention deficit hyperactivity disorder, childhood absence epilepsy,
CHRNA5 cholinergic receptor, nicotinic, alpha 5 (neuronal) 15q25.1 lung cancer, lung cancer susceptibility, nicotine dependence,
CHRNA6 cholinergic receptor, nicotinic, alpha 6 (neuronal) 8p11.21 alcohol dependence, autosomal dominant nocturnal frontal lobe epilepsy frontal lobe epilepsy
CHRNA7 cholinergic receptor, nicotinic, alpha 7 (neuronal) 15q13.3 schizophrenia, intermittent explosive disorder, juvenile myoclonic epilepsy,
CHRNA9 cholinergic receptor, nicotinic, alpha 9 (neuronal) 4p14 nicotine addiction
CHRNB1 cholinergic receptor, nicotinic, beta 1 (muscle) 17p13.1 "myasthenic syndrome, congenital, with pre- and postsynaptic defects", nicotine dependence, pterygium,
CHRNB2 cholinergic receptor, nicotinic, beta 2 (neuronal) 1q21.3 schizophrenia, early onset absence epilepsy, nicotine dependence,
CHRNB3 cholinergic receptor, nicotinic, beta 3 (neuronal) 8p11.21 nicotine dependence, juvenile absence epilepsy, epilepsy with generalized tonic-clonic seizures,
CHRNB4 cholinergic receptor, nicotinic, beta 4 (neuronal) 15q25.1 lung cancer, nicotine dependence nicotine addiction
CHRND cholinergic receptor, nicotinic, delta (muscle) 2q37.1 cerebellar medulloblastoma, medulloblastoma, "myasthenic syndrome, congenital, with pre- and postsynaptic defects",
CHRNE cholinergic receptor, nicotinic, epsilon (muscle) 17p13.2 "myasthenic syndrome, congenital, with pre- and postsynaptic defects", ectropion, congenital myasthenic syndrome associated with acetylcholine receptor deficiency,
CHRNG cholinergic receptor, nicotinic, gamma (muscle) 2q37.1 alveolar rhabdomyosarcoma, myasthenia gravis, refractive error,
CHST1 carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 11p11.2 macular corneal dystrophy
CHST11 carbohydrate (chondroitin 4) sulfotransferase 11 12q23.3 b-cell chronic lymphocytic leukemia, chronic lymphocytic leukemia cannabis dependence
CHST14 carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14 15q15.1 mucopolysaccharidoses, morquio syndrome b, sly syndrome,
CHST3 carbohydrate (chondroitin 6) sulfotransferase 3 10q22.1 larsen syndrome, enophthalmos, spinocerebellar ataxia 29,
CHST5 carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 16q23.1 mucopolysaccharidoses, morquio syndrome b, sly syndrome
CHST6 carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 16q23.1 astigmatism, corneal dystrophy, corneal disease,
CHST8 carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 19q13.11 peeling skin syndrome peeling skin syndrome type a
CHSY1 chondroitin sulfate synthase 1 15q26.3 colorectal cancer, brachydactyly temtamy preaxial brachydactyly syndrome
CHTF8 CTF8, chromosome transmission fidelity factor 8 homolog (S. cerevisiae) 16q22.1 prostate cancer
CHUK conserved helix-loop-helix ubiquitous kinase 10q24.31 skin papilloma cocoon syndrome
CIB1 calcium and integrin binding 1 (calmyrin) 15q26.1 papillary thyroid carcinoma
CIB2 calcium and integrin binding family member 2 15q25.1 "deafness, autosomal recessive 76", usher syndrome type 1g, usher syndrome type i,
CIC capicua transcriptional repressor 19q13.2 pityriasis versicolor oligoastrocytoma
CIDEA cell death-inducing DFFA-like effector a 18p11.21 obesity
CIDEC cell death-inducing DFFA-like effector c 3p25.3 "lipodystrophy, familial partial, type 5"
CIHL hearing loss, cisplatin-induced, susceptibility to 6p22.3 "hearing loss, cisplatin-induced"
CIITA class II, major histocompatibility complex, transactivator 16p13.13 myocardial infarction, mhc class ii deficiency, stromal keratitis,
CILD2 ciliary dyskinesia, primary 2 19q13.3-qter "ciliary dyskinesia, primary, 2"
CILD4 Ciliary dyskinesia, primary, 4 15q13.1-q15.1 primary ciliary dyskinesia 4
CILD8 Ciliary dyskinesia, primary, 8 15q24-q25 primary ciliary dyskinesia 8
CILP cartilage intermediate layer protein, nucleotide pyrophosphohydrolase 15q22.31 lumbar disc disease lymphangitis
CIMT Carotid intimal medial thickness 12q24 carotid intimal medial thickness
CINP cyclin-dependent kinase 2 interacting protein 14q32.31 dysthymic disorder
CIRH1A cirrhosis, autosomal recessive 1A (cirhin) 16q22.1 north american indian childhood cirrhosis, cholestasis, intrahepatic cholestasis
CISD1 CDGSH iron sulfur domain 1 10q21.1 wolfram syndrome 2
CISD2 CDGSH iron sulfur domain 2 4q24 wolfram syndrome, waterhouse-friderichsen syndrome wolfram syndrome 2
CISH cytokine inducible SH2-containing protein 3p21.2 insulin resistance, malaria, tuberculosis,
CIT citron (rho-interacting, serine/threonine kinase 21) 12q24.23 schizophrenia bipolar disorder
CITED2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 6q24.1 patent foramen ovale, hypoxia, tetralogy of fallot ,
CIZ1 CDKN1A interacting zinc finger protein 1 9q34.11 cervical dystonia
CKAP2 cytoskeleton associated protein 2 13q14.3 inclusion conjunctivitis
CKAP4 cytoskeleton-associated protein 4 12q23.3 steroid-induced glaucoma split foot
CKB creatine kinase, brain 14q32.32 myocardial infarction, brain ischemia prostate rhabdomyosarcoma
CKLF chemokine-like factor 16q21 ovarian cystadenoma
CKM creatine kinase, muscle 19q13.32 myocardial infarction, hemophilia b, neuroacanthocytosis
CKMT1A creatine kinase, mitochondrial 1A 15q15.3 prostate rhabdomyosarcoma
CKMT1B creatine kinase, mitochondrial 1B 15q15.3 prostate rhabdomyosarcoma
CKMT2 creatine kinase, mitochondrial 2 (sarcomeric) 5q14.1 prostate rhabdomyosarcoma
CKS1B CDC28 protein kinase regulatory subunit 1B 1q21.3 mantle cell lymphoma
CKS1BP2 CDC28 protein kinase regulatory subunit 1B pseudogene 2 10p11.23 fatty liver disease
CLA3 cerebellar ataxia 3 (cerebellar parenchyma disorder 1) 20q11-q13 spinocerebellar ataxia autosomal recessive 6
CLAM cerebellar atrophy with progressive microcephaly 7q11-q21 pontocerebellar hypoplasia pontocerebellar hypoplasia type 3
CLC Charcot-Leyden crystal galectin 19q13.2 cold-induced sweating syndrome 1
CLCA1 chloride channel accessory 1 1p22.3 cystic fibrosis, ileus, meconium ileus
CLCA2 chloride channel accessory 2 1p22.3 breast cancer, cystic fibrosis bestrophinopathy
CLCA4 chloride channel accessory 4 1p22.3 cystic fibrosis bestrophinopathy
CLCF1 cardiotrophin-like cytokine factor 1 11q13.2 cold-induced sweating syndrome including crisponi syndrome, cold-induced sweating syndrome, crisponi syndrome,
CLCN1 chloride channel, voltage-sensitive 1 7q34 kennedys disease, hypokalemic periodic paralysis, myotonic dystrophy,
CLCN2 chloride channel, voltage-sensitive 2 3q27.1 idiopathic generalized epilepsy, cystic fibrosis, megalencephalic leukoencephalopathy with subcortical cysts,
CLCN4 chloride channel, voltage-sensitive 4 Xp22.2 microphthalmia with linear skin defects syndrome ocular albinism
CLCN5 chloride channel, voltage-sensitive 5 Xp11.23 x-linked hypophosphatemia, nephrocalcinosis, nephrolithiasis,
CLCN7 chloride channel, voltage-sensitive 7 16p13.3 osteopetrosis, osteopetrosis autosomal recessive 1, osteopetrosis autosomal recessive 6,
CLCNKA chloride channel, voltage-sensitive Ka 1p36.13 renal glycosuria, bartter disease, diabetes insipidus,
CLCNKB chloride channel, voltage-sensitive Kb 1p36.13 polyhydramnios, gitelman syndrome, nephrocalcinosis,
CLDN1 claudin 1 3q28 cholangitis, perineurioma, follicular dendritic cell sarcoma,
CLDN10 claudin 10 13q32.1 hepatocellular carcinoma follicular thyroid carcinoma
CLDN11 claudin 11 3q26.2 microcystic adenoma
CLDN14 claudin 14 21q22.13 "deafness, autosomal recessive 76", "deafness, autosomal recessive 29" dfnb29 nonsyndromic hearing loss and deafness
CLDN15 claudin 15 7q22.1 malignant peritoneal mesothelioma
CLDN16 claudin 16 3q28 nephrocalcinosis, botulism, intestinal botulism,
CLDN18 claudin 18 3q22.3 ulcerative colitis
CLDN19 claudin 19 1p34.2 nephrocalcinosis, chorioretinal scar, myopia,
CLDN3 claudin 3 7q11.23 endometrial carcinoma, ovarian cystadenoma, ovarian cancer,
CLDN4 claudin 4 7q11.23 pancreatic cancer, ovarian cystadenoma, williams-beuren syndrome,
CLDN5 claudin 5 22q11.21 usual interstitial pneumonia, gray platelet syndrome, glioblastoma multiforme,
CLDN6 claudin 6 16p13.3 hepatitis c, hepatitis c virus, hepatitis,
CLDN7 claudin 7 17p13.1 prostate cancer, breast cancer, non-small cell lung carcinoma,
CLDN8 claudin 8 21q22.11 renal cell carcinoma, oxyphilic adenoma chromophobe renal cell carcinoma
CLDN9 claudin 9 16p13.3 hepatitis c, hepatitis c virus, hepatitis,
CLEC11A C-type lectin domain family 11, member A 19q13.33 acute promyelocytic leukemia, chronic granulomatous disease piebaldism
CLEC16A C-type lectin domain family 16, member A 16p13.13 multiple sclerosis rheumatoid arthritis
CLEC1B C-type lectin domain family 1, member B 12p13.2 thrombocytopenia due to platelet alloimmunization
CLEC2A C-type lectin domain family 2, member A 12p13.31 acanthoma, pilomatrixoma, hidradenoma,
CLEC3A C-type lectin domain family 3, member A 16q23.1 methylmalonic acidemia
CLEC3B C-type lectin domain family 3, member B 3p21.31 ovarian cancer type 1 diabetes mellitus
CLEC4A C-type lectin domain family 4, member A 12p13.31 coronary artery disease pneumonic plague
CLEC4E C-type lectin domain family 4, member E 12p13.31 chromoblastomycosis
CLEC4G C-type lectin domain family 4, member G 19p13.2 lassa fever
CLEC4M C-type lectin domain family 4, member M 19p13.2 severe acute respiratory syndrome, intrauterine infections "sars infection, protection against"
CLEC5A C-type lectin domain family 5, member A 7q34 dengue disease
CLEC7A C-type lectin domain family 7, member A 12p13.2 "candidiasis, familial, 2, autosomal recessive", candidiasis, coccidioidomycosis,
CLGN calmegin 4q31.1 infertility
CLIC2 chloride intracellular channel 2 Xq28 "mental retardation, x-linked, syndromic 32"
CLIC4 chloride intracellular channel 4 1p36.11 pancreatic cancer
CLIC5 chloride intracellular channel 5 6p21.1 "deafness, autosomal recessive 76"
CLINT1 clathrin interactor 1 5q33.3 schizophrenia
CLIP1 CAP-GLY domain containing linker protein 1 12q24.31 "distal hereditary motor neuropathy, type ii", "mental retardation, autosomal recessive 43" extratemporal epilepsy
CLIP2 CAP-GLY domain containing linker protein 2 7q11.23 williams-beuren syndrome williams syndrome
CLK1 CDC-like kinase 1 2q33.1 3mc syndrome 2
CLLS1 Leukemia, chronic lymphocytic, susceptibility to, 1 11q13.3 "leukemia, chronic lymphocytic 1"
CLLS2 Disrupted in B-cell neoplasia 13q14 "leukemia, chronic lymphocytic 2"
CLLS3 Leukemia, chronic lymphocytic, susceptibility to, 3 9q34.1 "leukemia, chronic lymphocytic 3"
CLLS4 Leukemia, chronic lymphocytic susceptibility to, 4 6p25 "leukemia, chronic lymphocytic 4"
CLLS5 Leukemia, chronic lymphocytic susceptiblity to, 5 11q24.1 follicular lymphoma "leukemia, chronic lymphocytic 5"
CLLU1 chronic lymphocytic leukemia up-regulated 1 12q22 chronic lymphocytic leukemia mature b-cell neoplasm
CLLU1OS chronic lymphocytic leukemia up-regulated 1 opposite strand 12q22 chronic lymphocytic leukemia
CLMP CXADR-like membrane protein 11q24.1 "intestinal pseudoobstruction, neuronal", intestinal pseudo-obstruction short bowel syndrome
CLN3 ceroid-lipofuscinosis, neuronal 3 16p11.2 neuronal ceroid-lipofuscinoses, lafora disease, late-infantile neuronal ceroid lipofuscinosis,
CLN5 ceroid-lipofuscinosis, neuronal 5 13q22.3 neuronal ceroid-lipofuscinoses, myoclonus epilepsy, late-infantile neuronal ceroid lipofuscinosis,
CLN6 ceroid-lipofuscinosis, neuronal 6, late infantile, variant 15q23 neuronal ceroid-lipofuscinoses, late-infantile neuronal ceroid lipofuscinosis, neuronal ceroid lipofuscinosis,
CLN8 ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) 8p23.3 mental retardation, neuronal ceroid-lipofuscinoses, late-infantile neuronal ceroid lipofuscinosis,
CLNK cytokine-dependent hematopoietic cell linker 4p16.1 croup gingival recession
CLOCK clock circadian regulator 4q12 obesity, seasonal affective disorder, narcolepsy
CLP1 cleavage and polyadenylation factor I subunit 1 11q12.1 "pontocerebellar hypoplasia, type 10"
CLPB ClpB caseinolytic peptidase B homolog (E. coli) 11q13.4 tularemia
CLPP caseinolytic mitochondrial matrix peptidase proteolytic subunit 19p13.3 legionnaires disease, perrault syndrome, perrault syndrome 3
CLPS colipase, pancreatic 6p21.31 steatorrhea, acute pancreatitis, personality disorder,
CLPTM1 cleft lip and palate associated transmembrane protein 1 19q13.32 cleft lip
CLPTM1L CLPTM1-like 5p15.33 cleft lip lung cancer
CLRN1 clarin 1 3q25.1 leber congenital amaurosis, usher syndrome type ii, usher syndrome,
CLRN1-AS1 CLRN1 antisense RNA 1 3q25.1 usher syndrome type 3
CLTC clathrin, heavy chain (Hc) 17q23.1 "renal cell carcinoma, papillary, 1", ophthalmia neonatorum inflammatory myofibroblastic tumor
CLTCL1 clathrin, heavy chain-like 1 22q11.21 digeorge syndrome, meningioma atrioventricular septal defect
CLU clusterin 8p21.1 giant cell tumor, prostate cancer, ovarian cystadenoma,
CLUL1 clusterin-like 1 (retinal) 18p11.32 myopia-2
CLVS1 clavesin 1 8q12.2 duane retraction syndrome
CMA1 chymase 1, mast cell 14q12 urticaria, abdominal aortic aneurysm, atopy,
CMAHP cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene 6p22.3 charge syndrome
CMAL Capillary malformations, hereditary 5q13-q22 "capillary malformations, hereditary"
CMAS cytidine monophosphate N-acetylneuraminic acid synthetase 12p12.1 kidney sarcoma
CMC1 C-x(9)-C motif containing 1 3p24.1 telangiectasis, "capillary malformations, congenital, 1, somatic, mosaic" "sturge-weber syndrome, somatic, mosaic"
CMC4 C-x(9)-C motif containing 4 Xq28 "medulloblastoma, desmoplastic"
CMD1B cardiomyopathy, dilated 1B (autosomal dominant) 9q13-q22 "cardiomyopathy, dilated 1b"
CMD1C cardiomyopathy, dilated 1C (autosomal dominant) 10q21-q23 "myopathy, myofibrillar, 4", "left ventricular noncompaction 3, with or without dilated cardiomyopathy" "cardiomyopathy, dilated 1c"
CMD1F cardiomyopathy, dilated 1F (autosomal dominant) 6q23 "cardiomyopathy, dilated, 1f and limb-girdle muscular dystrophy type 1d"
CMD1H cardiomyopathy, dilated 1H (autosomal dominant) 2q14-q22 "cardiomyopathy, dilated, 1h"
CMD1K cardiomyopathy, dilated 1K (autosomal dominant) 6q12-q16 "cardiomyopathy, dilated, 1k"
CMD1Q cardiomyopathy, dilated 1Q (autosomal dominant) 7q22.3-q31.1 "cardiomyopathy, dilated, 1q"
CMDR Craniometaphyseal dysplasia, autosomal recessive 6q21-q22 atrioventricular septal defect 3 , oculodentodigital dysplasia, "oculodentodigital dysplasia, autosomal recessive",
CMH21 Cardiomyopathy, familial hypertrophic, 21 7p12.1-q21 "cardiomyopathy, familial hypertrophic, 21"
CMM cutaneous malignant melanoma/dysplastic nevus 1p36 melanoma, familial melanoma, cutaneous malignant melanoma
CMM4 Melanoma, cutaneous malignant, 4 1p22 "melanoma, cutaneous malignant, 4"
CMM7 Melanoma, cutaneous malignant, susceptibility to, 7 20q11.2 "melanoma, cutaneous malignant, 7"
CMS1A1 myasthenia gravis, familial infantile, 1 17p13 "myasthenia, familial infantile, 1"
CMT1A Charcot-Marie-Tooth neuropathy 1A (greatly reduced nerve conduction velocity, hereditary motor sensory neuropathy Ia) 17p13.1-q12 neuropathy, charcot-marie-tooth disease type 3, charcot-marie-tooth neuropathy type 1 ,
CMT2B Charcot-Marie-Tooth neuropathy 2B 3q13-q22 charcot-marie-tooth disease type 2b
CMT2G Charcot-Marie-Tooth disease, axonal, type 2G 12q12-q13.3 charcot-marie-tooth disease type 2g
CMTDIA Charcot-Marie-Tooth disease, dominant intermediate 2 10q24.1-q25.1 "charcot-marie-tooth disease, dominant intermediate a"
CMTM5 CKLF-like MARVEL transmembrane domain containing 5 14q11.2 ovarian cystadenoma
CMTX2 Charcot-Marie-Tooth neuropathy, X-linked 2 (recessive) Xp22 "charcot-marie-tooth neuropathy, x-linked recessive, 2"
CMTX3 Charcot-Marie-Tooth neuropathy, X-linked 3 (dominant) X x-linked charcot-marie-tooth disease "charcot-marie-tooth neuropathy, x-linked recessive, 3"
CNBP CCHC-type zinc finger, nucleic acid binding protein 3q21.3 myotonic dystrophy, myotonic dystrophy type 2, nondystrophic myotonia,
CNC2 Carney complex type 2, multiple neoplasia and lentiginosis 2p16 primary pigmented nodular adrenocortical disease, familial isolated pituitary adenoma, cowden disease,
CND Corneal dermoids Xq24-qter dermoids of cornea
CNDP1 carnosine dipeptidase 1 (metallopeptidase M20 family) 18q22.3 diabetic nephropathy homocarnosinosis
CNDP2 CNDP dipeptidase 2 (metallopeptidase M20 family) 18q22.3 edwards syndrome
CNGA1 cyclic nucleotide gated channel alpha 1 4p12 leber congenital amaurosis, retinitis pigmentosa, retinitis pigmentosa 49 ,
CNGA2 cyclic nucleotide gated channel alpha 2 Xq28 neuroblastoma
CNGA3 cyclic nucleotide gated channel alpha 3 2q11.2 congenital nystagmus, blue cone monochromacy , color blindness,
CNGB1 cyclic nucleotide gated channel beta 1 16q21 leber congenital amaurosis, achromatopsia, cngb1-related retinitis pigmentosa
CNGB3 cyclic nucleotide gated channel beta 3 8q21.3 congenital nystagmus, stargardt macular degeneration, blue cone monochromacy ,
CNNM1 cyclin M1 10q24.2 urofacial syndrome
CNNM2 cyclin M2 10q24.32 renal hypomagnesemia 4, "hypomagnesemia 6, renal" hypomagnesemia 6
CNNM4 cyclin M4 2q11.2 cone-rod dystrophy amelogenesis imperfecta
CNOT3 CCR4-NOT transcription complex, subunit 3 19q13.42 precursor t-cell acute lymphoblastic leukemia
CNOT8 CCR4-NOT transcription complex, subunit 8 5q33.2 microsporidiosis
CNP 2',3'-cyclic nucleotide 3' phosphodiesterase 17q21.2 schizophrenia, hair disease beta-mannosidosis
CNPY3 canopy FGF signaling regulator 3 6p21.1 swayback
CNR1 cannabinoid receptor 1 (brain) 6q15 paroxysmal dyskinesia, pertussis, schizophrenia,
CNR2 cannabinoid receptor 2 (macrophage) 1p36.11 pertussis chronic pain
CNSN Carnosinemia (carnosinase) 18q21.3 diabetic nephropathy carnosinemia
CNTF ciliary neurotrophic factor 11q12.1 learning disability, amyotrophic lateral sclerosis, schizophrenia,
CNTFR ciliary neurotrophic factor receptor 9p13.3 amyotrophic lateral sclerosis, choroid cancer cold-induced sweating syndrome
CNTN1 contactin 1 12q12 compton-north congenital myopathy
CNTN2 contactin 2 (axonal) 1q32.1 van der woude syndrome, polymyositis, multifocal motor neuropathy,
CNTN4 contactin 4 3p26.3 combined cellular and humoral immune defects with granulomas , distal monosomy 3p 3p deletion syndrome
CNTNAP1 contactin associated protein 1 17q21.2 hypomyelination neuropathy - arthrogryposis
CNTNAP2 contactin associated protein-like 2 7q35 schizophrenia, gilles de la tourette syndrome, mutism,
CNTRL centriolin 9q33.2 8p11 myeloproliferative syndrome duane retraction syndrome
COA5 cytochrome c oxidase assembly factor 5 2q11.2 cytochrome-c oxidase deficiency disease, leigh syndrome with cardiomyopathy mitochondrial cardiomyopathy
COASY CoA synthase 17q21.2 neurodegeneration with brain iron accumulation 6
COCH cochlin 14q12 "deafness, autosomal dominant 4b", menieres disease, primary open angle glaucoma,
COD2 cone dystrophy 2 (X-linked) Xq27 congenital disorder of glycosylation type iil, "cone dystrophy, progressive x-linked, 2" shaheen syndrome
CODA Cavitary optic disc anomalies 12q cavitary optic disc anomalies
COG1 component of oligomeric golgi complex 1 17q25.1 congenital disorder of glycosylation type ii, congenital disorder of glycosylation type 2g cerebrocostomandibular-like syndrome
COG2 component of oligomeric golgi complex 2 1q42.2 vascular disease, coronary artery disease, type 2 diabetes mellitus,
COG4 component of oligomeric golgi complex 4 16q22.1 congenital disorder of glycosylation, "congenital disorder of glycosylation, type iij" oculocerebrorenal syndrome
COG5 component of oligomeric golgi complex 5 7q22.3 "congenital disorder of glycosylation, type iii"
COG6 component of oligomeric golgi complex 6 13q14.11 diabetic cataract, hypohidrosis, congenital disorder of glycosylation type iil,
COG7 component of oligomeric golgi complex 7 16p12.2 congenital disorder of glycosylation type 2e
COG8 component of oligomeric golgi complex 8 16q22.1 nephronophthisis-like nephropathy 1 "congenital disorder of glycosylation, type iih"
COHEN1 Cohen syndrome QTL 1 cohen syndrome
COHEN2 Cohen syndrome QTL 2 cohen syndrome
COIL coilin 17q22 neuroblastoma, differentiating neuroblastoma ischemic neuropathy
COL10A1 collagen, type X, alpha 1 6q22.1 skeletal dysplasias, chondrodysplasia, metaphyseal dysplasia,
COL11A1 collagen, type XI, alpha 1 1p21.1 colorectal cancer, multiple epiphyseal dysplasia, spinal stenosis,
COL11A2 collagen, type XI, alpha 2 6p21.32 "deafness, autosomal recessive 76", "deafness, autosomal dominant 4b", multiple epiphyseal dysplasia,
COL12A1 collagen, type XII, alpha 1 6q14.1 exostosis, ullrich congenital muscular dystrophy, chondromyxoid fibroma
COL14A1 collagen, type XIV, alpha 1 8q24.12 collagenous colitis, odontogenic myxoma "keratoderma, palmoplantar, punctate type ia"
COL17A1 collagen, type XVII, alpha 1 10q25.1 herpes gestationis, mucous membrane pemphigoid, linear iga disease,
COL18A1 collagen, type XVIII, alpha 1 21q22.3 "diabetes, type 2", funisitis, pyridoxine deficiency,
COL1A1 collagen, type I, alpha 1 17q21.33 beare-stevenson cutis gyrata syndrome, "osteogenesis imperfecta, type ii", usual interstitial pneumonia,
COL1A2 collagen, type I, alpha 2 7q21.3 beare-stevenson cutis gyrata syndrome, "osteogenesis imperfecta, type ii", osteoporosis,
COL25A1 collagen, type XXV, alpha 1 4q25 alzheimers disease antisocial personality disorder
COL26A1 collagen, type XXVI, alpha 1 7q22.1 asthma
COL2A1 collagen, type II, alpha 1 12q13.11 collagen disease, chondrodysplasia, achondrogenesis,
COL3A1 collagen, type III, alpha 1 2q32.2 usual interstitial pneumonia, abdominal aortic aneurysm, hypermobility syndrome,
COL4A1 collagen, type IV, alpha 1 13q34 hydranencephaly, arachnoid cysts, thin basement membrane nephropathy,
COL4A2 collagen, type IV, alpha 2 13q34 thin basement membrane nephropathy, porencephaly, ariboflavinosis,
COL4A3 collagen, type IV, alpha 3 (Goodpasture antigen) 2q36.3 focal segmental glomerulosclerosis, posterior polymorphous corneal dystrophy, goodpasture syndrome,
COL4A3BP collagen, type IV, alpha 3 (Goodpasture antigen) binding protein 5q13.3 goodpasture syndrome autosomal recessive alport syndrome
COL4A4 collagen, type IV, alpha 4 2q36.3 thin basement membrane nephropathy, nail-patella syndrome, finnish type amyloidosis,
COL4A5 collagen, type IV, alpha 5 Xq22.3 nephritis, pendred syndrome, exostosis,
COL4A6 collagen, type IV, alpha 6 Xq22.3 secretory meningioma, retinitis pigmentosa 27 , alport syndrome,
COL5A1 collagen, type V, alpha 1 9q34.3 nail-patella syndrome, tendinopathy, ehlers-danlos syndrome,
COL5A2 collagen, type V, alpha 2 2q32.2 nail-patella syndrome, stickler syndrome, ehlers-danlos syndrome,
COL5A3 collagen, type V, alpha 3 19p13.2 pulmonary valve stenosis arterial tortuosity syndrome
COL6A1 collagen, type VI, alpha 1 21q22.3 quadriplegia, spinal cord disease, radiculopathy,
COL6A2 collagen, type VI, alpha 2 21q22.3 myopathy, ullrich congenital muscular dystrophy, "myosclerosis, congenital",
COL6A3 collagen, type VI, alpha 3 2q37.3 giant cell tumor, myopathy, ullrich congenital muscular dystrophy,
COL6A5 collagen, type VI, alpha 5 3q22.1 ullrich congenital muscular dystrophy bethlem myopathy
COL7A1 collagen, type VII, alpha 1 3p21.31 recessive dystrophic epidermolysis bullosa, epidermolysis bullosa acquisita, peeling skin syndrome ,
COL8A1 collagen, type VIII, alpha 1 3q12.1 posterior polymorphous corneal dystrophy fuchs endothelial dystrophy
COL8A2 collagen, type VIII, alpha 2 1p34.3 corneal dystrophy fuchs endothelial 1, corneal dystrophy, posterior polymorphous corneal dystrophy,
COL9A1 collagen, type IX, alpha 1 6q13 osteoarthritis, talipes equinovarus, multiple epiphyseal dysplasia,
COL9A2 collagen, type IX, alpha 2 1p34.2 pseudoachondroplasia, multiple epiphyseal dysplasia, spinal stenosis,
COL9A3 collagen, type IX, alpha 3 20q13.33 pseudoachondroplasia, multiple epiphyseal dysplasia, spinal stenosis,
COLCA1 colorectal cancer associated 1 11q23.1 colorectal cancer
COLCA2 colorectal cancer associated 2 11q23.1 colorectal cancer
COLEC11 collectin sub-family member 11 2p25.3 3mc syndrome 1 3mc syndrome 2
COLQ collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase 3p25.1 nasopharynx carcinoma, endplate acetylcholinesterase deficiency colq-related congenital myasthenic syndrome
COMA Cogan-type congential oculomotor apraxia 2q13 "oculomotor apraxia, congenital, cogan-type"
COMMD1 copper metabolism (Murr1) domain containing 1 2p15 wilson disease
COMMD5 COMM domain containing 5 8q24.3 type 2 diabetes mellitus hypertension
COMP cartilage oligomeric matrix protein 19p13.11 thanatophoric dysplasia, arthropathy, diastrophic dysplasia,
COMT catechol-O-methyltransferase 22q11.21 asthma, parkinsons disease, breast cancer,
COPD Pulmonary disease, chronic obstructive, severe early-onset 2q "pulmonary disease, chronic obstructive" "pulmonary disease, chronic obstructive, severe early-onset"
COPD27 Chronic obstructive pulmonary disease QTL 27 pulmonary function
COPD28 Chronic obstructive pulmonary disease QTL 28 pulmonary function
COPD29 Chronic obstructive pulmonary disease QTL 29 pulmonary function
COPS2 COP9 signalosome subunit 2 15q21.1 apraxia, tactile agnosia, dysgraphia,
COPS5 COP9 signalosome subunit 5 8q13.1 thyroid medullary carcinoma
COPS6 COP9 signalosome subunit 6 7q22.1 hiv-1
COQ10A coenzyme Q10 homolog A (S. cerevisiae) 12q13.3 familial hypercholesterolemia
COQ2 coenzyme Q2 4-hydroxybenzoate polyprenyltransferase 4q21.23 tyrosinemia, multiple system atrophy, tyrosinemia type i,
COQ6 coenzyme Q6 monooxygenase 14q24.3 nephrotic syndrome, steroid-resistant nephrotic syndrome "coenzyme q10 deficiency, primary, 6"
COQ9 coenzyme Q9 16q21 "coenzyme q10 deficiency, primary, 5" coq9-related coenzyme q10 deficiency
CORD1 cone rod dystrophy 1 (autosomal dominant) 18q21.1-q21.3 cone-rod retinal dystrophy-1
CORD17 cone rod dystrophy 17 (autosomal dominant) 10q26 cone-rod dystrophy 17
CORD8 cone rod dystrophy 8 1q12-q24 cone-rod dystrophy 8
CORIN corin, serine peptidase 4p12 eclampsia, scimitar syndrome, cone-rod dystrophy 18
CORO1A coronin, actin binding protein, 1A 16p11.2 chronic granulomatous disease, primary effusion lymphoma, immunodeficiency 8
CORO1B coronin, actin binding protein, 1B 11q13.2 coronin-1a deficiency
CORO1C coronin, actin binding protein, 1C 12q24.11 coronin-1a deficiency
CORT cortistatin 1p36.22 intestinal disease
COTL1P1 COTL1 pseudogene 1 17p11.2 smith magenis syndrome
COX10 cytochrome c oxidase assembly homolog 10 (yeast) 17p12 leigh syndrome with leukodystrophy, leigh disease, cytochrome-c oxidase deficiency disease,
COX11 cytochrome c oxidase assembly homolog 11 (yeast) 17q22 breast cancer susceptibility leigh disease
COX14 cytochrome c oxidase assembly homolog 14 (S. cerevisiae) 12q13.12 cytochrome-c oxidase deficiency disease
COX15 cytochrome c oxidase assembly homolog 15 (yeast) 10q24.2 leigh disease, mitochondrial dna deletion syndromes, cytochrome-c oxidase deficiency disease,
COX16 COX16 cytochrome c oxidase assembly homolog (S. cerevisiae) 14q24.2 intrahepatic cholangiocarcinoma
COX17 COX17 cytochrome c oxidase copper chaperone 3q13.33 leigh disease
COX20 COX20 cytochrome C oxidase assembly factor 1q44 cytochrome-c oxidase deficiency disease
COX4I1 cytochrome c oxidase subunit IV isoform 1 16q24.1 exocrine pancreatic insufficiency calvarial hyperostosis
COX4I2 cytochrome c oxidase subunit IV isoform 2 (lung) 20q11.21 hyperostosis, exocrine pancreatic insufficiency, calvarial hyperostosis
COX5A cytochrome c oxidase subunit Va 15q24.2 colon cancer, swayback, chronic progressive external ophthalmoplegia,
COX6A1 cytochrome c oxidase subunit VIa polypeptide 1 12q24.31 goldenhar syndrome
COX6B1 cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) 19q13.12 cytochrome-c oxidase deficiency disease, leigh syndrome with cardiomyopathy encephalomyopathy
COX6C cytochrome c oxidase subunit VIc 8q22.2 prostate cancer
COX7A2 cytochrome c oxidase subunit VIIa polypeptide 2 (liver) 6q14.1 barretts adenocarcinoma
COX7A2L cytochrome c oxidase subunit VIIa polypeptide 2 like 2p21 breast cancer leigh disease
COX7B cytochrome c oxidase subunit VIIb Xq21.1 "aplasia cutis congenita, reticulolinear, with mmicrocephaly, facial dysmorphism and other congenital anomalies"
COX8C cytochrome c oxidase subunit VIIIC 14q32.12 fatty liver disease
CP ceruloplasmin (ferroxidase) 3q25.1 wilson disease, swayback, malaria,
CP20 Lymphocyte cytosolic protein, molecular weight 20kD 6p21.3-p21.2 alzheimers disease
CPA1 carboxypeptidase A1 (pancreatic) 7q32.2 "pancreatitis, chronic" tracheal stenosis
CPA4 carboxypeptidase A4 7q32.2 prostate cancer, silver-russell syndrome richters syndrome
CPA6 carboxypeptidase A6 8q13.2 febrile seizures, duane retraction syndrome, "epilepsy, familial temporal lobe, 5"
CPAT1 cerebral palsy, ataxic 1 9p12-q12 ataxic cerebral palsy
CPB1 carboxypeptidase B1 (tissue) 3q24 tricuspid valve insufficiency, pancreatitis trachea leiomyoma
CPB2 carboxypeptidase B2 (plasma) 13q14.13 angina pectoris, hemophilia b, hemophilia
CPBHM Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia "chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia"
CPD carboxypeptidase D 17q11.2 hepatitis b hepatitis
CPE carboxypeptidase E 4q32.3 obesity, neuroendocrine tumor pulmonary neuroendocrine tumor
CPLX1 complexin 1 4p16.3 wernicke encephalopathy
CPLX2 complexin 2 5q35.2 schizophrenia
CPLX3 complexin 3 15q24.1 intestinal atresia, imperforate anus hypoplastic left heart syndrome
CPN1 carboxypeptidase N, polypeptide 1 10q24.2 urticaria, angioedema, pyelonephritis
CPO carboxypeptidase O 2q33.3 acute hepatic porphyria harderoporphyria
CPOX coproporphyrinogen oxidase 3q12.1 congenital erythropoietic porphyria, portal hypertension, erythropoietic protoporphyria,
CPQ carboxypeptidase Q 8q22.1 granulocytopenia
CPS1 carbamoyl-phosphate synthase 1, mitochondrial 2q34 ornithine carbamoyltransferase deficiency, carbamoyl phosphate synthetase i deficiency disease, hypertension,
CPSF2 cleavage and polyadenylation specific factor 2, 100kDa 14q32.12 rift valley fever
CPSF3L cleavage and polyadenylation specific factor 3-like 1p36.33 factor viii deficiency, anal fistula meningococcal meningitis
CPSF4 cleavage and polyadenylation specific factor 4, 30kDa 7q22.1 influenza
CPT1A carnitine palmitoyltransferase 1A (liver) 11q13.3 fatty acid oxidation disorders, carnitine-acylcarnitine translocase deficiency, peroxisomal disease,
CPT1B carnitine palmitoyltransferase 1B (muscle) 22q13.33 hypersomnia, visceral steatosis carnitine palmitoyltransferase ii deficiency
CPT2 carnitine palmitoyltransferase 2 1p32.3 neuroleptic malignant syndrome, malignant hyperthermia, fatty acid oxidation disorders,
CPVT3 Ventricular tachycardia, catecholaminergic polymorphic, 3 7p22-p14 "ventricular tachycardia, catecholaminergic polymorphic, 3"
CPXCR1 CPX chromosome region, candidate 1 Xq21.31 cleft palate
CPZ carboxypeptidase Z 4p16.1 sleeping sickness yaws
CR1 complement component (3b/4b) receptor 1 (Knops blood group) 1q32.2 afibrinogenemia, systemic lupus erythematosus, sarcoidosis,
CR2 complement component (3d/Epstein Barr virus) receptor 2 1q32.2 infectious mononucleosis, systemic lupus erythematosus, lupus erythematosus,
CRABP1 cellular retinoic acid binding protein 1 15q25.1 colorectal cancer, acute promyelocytic leukemia papillary thyroid carcinoma
CRABP2 cellular retinoic acid binding protein 2 1q23.1 acute promyelocytic leukemia
CRAC1 colorectal adenoma and carcinoma 1 15q13-q21 colorectal cancer, adenoma, hereditary mixed polyposis syndrome 1
CRADD CASP2 and RIPK1 domain containing adaptor with death domain 12q22 "mental retardation, autosomal recessive 43" "mental retardation, autosomal recessive 34"
CRAT carnitine O-acetyltransferase 9q34.11 overnutrition, thyroid medullary carcinoma, thyroid hormone resistance syndrome,
CRB1 crumbs family member 1, photoreceptor morphogenesis associated 1q31.3 leber congenital amaurosis, leber congenital amaurosis 17, retinitis pigmentosa,
CRB3 crumbs family member 3 19p13.3 leber congenital amaurosis
CRBN cereblon 3p26.2 mental retardation, "mental retardation, autosomal recessive 43", distal monosomy 3p
CRCL Creatinine clearance QTL 3p creatinine clearance qtl
CRCS10 Colorectal cancer, susceptibility to, 10 colorectal cancer, "mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome" colorectal cancer 10
CRCS11 Colorectal cancer, susceptibility to, 11 20p12.3 colorectal cancer colorectal cancer 11
CRCS2 Colorectal cancer, susceptibility to, 2 8q24 colorectal cancer colorectal cancer 2
CRCS5 Colorectal cancer, susceptibility to, 5 10p14 colorectal cancer colorectal cancer 5
CRCS6 colorectal cancer, susceptibility to, 6 8q23 colorectal cancer colorectal cancer 6
CRCS7 colorectal cancer, susceptibility to, 7 11q23 colorectal cancer colorectal cancer 7
CRCS8 Colorectal cancer, susceptibility to, 8 14q22.2 colorectal cancer colorectal cancer 8
CRCS9 colorectal cancer, susceptibility to, 9 16q22.1 colorectal cancer colorectal cancer 9
CREB1 cAMP responsive element binding protein 1 2q33.3 age related macular degeneration, neuroblastoma, hemimegalencephaly,
CREB3 cAMP responsive element binding protein 3 9p13.3 herpes simplex human t-cell leukemia virus type 1
CREB3L1 cAMP responsive element binding protein 3-like 1 11p11.2 osteogenesis imperfecta type iii, myxofibrosarcoma, small cell osteogenic sarcoma
CREB3L2 cAMP responsive element binding protein 3-like 2 7q33 myxofibrosarcoma
CREB3L3 cAMP responsive element binding protein 3-like 3 19p13.3 hepatocellular carcinoma hyperlipoproteinemia type v
CREBBP CREB binding protein 16p13.3 epidermal nevus, acute myeloid leukemia, alpha-thalassemia/mental retardation syndrome,
CRELD1 cysteine-rich with EGF-like domains 1 3p25.3 atrioventricular septal defect, heterotaxy, complete atrioventricular canal - ventricle hypoplasia,
CRELD2 cysteine-rich with EGF-like domains 2 22q13.33 multiple epiphyseal dysplasia, metaphyseal dysplasia cannabis dependence
CRH corticotropin releasing hormone 8q13.1 withdrawal disorder, alzheimers disease, isolated acth deficiency,
CRHBP corticotropin releasing hormone binding protein 5q13.3 acth-secreting pituitary adenoma
CRHR1 corticotropin releasing hormone receptor 1 17q21.31 obesity generalized anxiety disorder
CRIPT cysteine-rich PDZ-binding protein 2p21 short stature with microcephaly and distinctive facies
CRISP2 cysteine-rich secretory protein 2 6p12.3 orchitis epididymitis
CRK v-crk avian sarcoma virus CT10 oncogene homolog 17p13.3 miller-dieker syndrome
CRKL v-crk avian sarcoma virus CT10 oncogene homolog-like 22q11.21 chronic myeloid leukemia distal 22q11.2 microdeletion syndrome
CRLF1 cytokine receptor-like factor 1 19p13.11 idiopathic pulmonary fibrosis, trigeminal neuralgia, stomach carcinoma in situ,
CRLF2 cytokine receptor-like factor 2 Xp22.33 eczema herpeticum
CRLF3 cytokine receptor-like factor 3 17q11.2 neurofibromatosis
CRLS1 cardiolipin synthase 1 20p12.3 catastrophic antiphospholipid syndrome
CRNN cornulin 1q21.3 esophageal squamous cell carcinoma, oral squamous cell carcinoma polyclonal hypergammaglobulinemia
CROCC ciliary rootlet coiled-coil, rootletin 1p36.13 medulloblastoma
CRP C-reactive protein, pentraxin-related 1q23.2 carotid intimal medial thickness, vascular disease, polyarteritis nodosa,
CRSA Craniosynostosis, Adelaide type 4p16 muenke syndrome
CRTAC1 cartilage acidic protein 1 10q24.2 neurofibromatosis, glomus tumor botulism
CRTAP cartilage associated protein 3p22.3 "osteogenesis imperfecta, type ii", dentinogenesis imperfecta, osteogenesis imperfecta,
CRTC1 CREB regulated transcription coactivator 1 19p13.11 hidradenoma, cervical adenosquamous carcinoma, warthin tumor,
CRTC2 CREB regulated transcription coactivator 2 1q21.3 human t-cell leukemia virus type 1
CRTC3 CREB regulated transcription coactivator 3 15q26.1 warthin tumor
CRX cone-rod homeobox 19q13.33 leber congenital amaurosis, leber congenital amaurosis 17, cone-rod dystrophy 2,
CRYAA crystallin, alpha A 21q22.3 sympathetic ophthalmia, hyperlipoproteinemia type iii, "cataract 4, multiple types",
CRYAB crystallin, alpha B 11q23.1 amyotrophic lateral sclerosis, myopathy, multiple system atrophy,
CRYBA1 crystallin, beta A1 17q11.2 autosomal dominant disease, posterior polar cataract, cataract,
CRYBA2 crystallin, beta A2 2q35 uterine fibroid
CRYBA4 crystallin, beta A4 22q12.1 "cataract 1, multiple types", microphthalmia with cataract 2 cataract 23
CRYBB1 crystallin, beta B1 22q12.1 "cataract 4, multiple types", "cataract 1, multiple types", "cataracts, autosomal dominant",
CRYBB2 crystallin, beta B2 22q11.23 cerulean cataract, "cataract 4, multiple types", "cataract 1, multiple types",
CRYBB2P1 crystallin, beta B2 pseudogene 1 22q11.23 cerulean cataract
CRYBB3 crystallin, beta B3 22q11.23 "cataract 22, autosomal recessive", "cataract, congenital", cerulean cataract,
CRYGB crystallin, gamma B 2q34 cerulean cataract, skin atrophy, cataract,
CRYGC crystallin, gamma C 2q33.3 "cataract 1, multiple types", "cataract 3, multiple types", cataract,
CRYGD crystallin, gamma D 2q33.3 cerulean cataract, "cataract 4, multiple types", "cataract 1, multiple types",
CRYGS crystallin, gamma S 3q27.3 birt-hogg-dube syndrome, cataract, "cataract 20, multiple types"
CRYM crystallin, mu 16p12.2 "deafness, autosomal dominant 4b" "deafness, autosomal dominant 40"
CS citrate synthase 12q13.3 kennedys disease, leber hereditary optic neuropathy, insulin resistance,
CSAD cysteine sulfinic acid decarboxylase 12q13.13 stiff-person syndrome, amblyopia disuse amblyopia
CSAG1 chondrosarcoma associated gene 1 Xq28 chondrosarcoma
CSAG2 CSAG family, member 2 Xq28 chondrosarcoma, esophageal cancer lung adenocarcinoma
CSAG3 CSAG family, member 3 Xq28 chondrosarcoma, esophageal cancer lung adenocarcinoma
CSE choreoathetosis/spasticity, episodic (paroxysmal choreoathetosis/spasticity) 1p31 spasticity, paroxysmal choreoathetosis "choreoathetosis/spasticity, episodic"
CSF1 colony stimulating factor 1 (macrophage) 1p13.3 cherubism, giant cell tumor, malignant histiocytosis,
CSF1R colony stimulating factor 1 receptor 5q32 sarcoma, acute myeloid leukemia, megakaryocytic leukemia,
CSF2 colony stimulating factor 2 (granulocyte-macrophage) 5q31.1 acute myeloid leukemia, anemia of prematurity, juvenile myelomonocytic leukemia,
CSF2RA colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) Xp22.33 aplastic anemia, acute basophilic leukemia, "surfactant metabolism dysfunction, pulmonary, 4",
CSF2RB colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) 22q12.3 megakaryocytic leukemia, "surfactant metabolism dysfunction, pulmonary, 1" "surfactant metabolism dysfunction, pulmonary, 5"
CSF3 colony stimulating factor 3 (granulocyte) 17q21.1 breast cancer, acute myeloid leukemia, acute promyelocytic leukemia,
CSF3R colony stimulating factor 3 receptor (granulocyte) 1p34.3 acute myeloid leukemia, myelodysplastic syndromes, chronic neutrophilic leukemia,
CSH1 chorionic somatomammotropin hormone 1 (placental lactogen) 17q23.3 epithelioid trophoblastic tumor, gestational trophoblastic neoplasm, trophoblastic neoplasm,
CSH2 chorionic somatomammotropin hormone 2 17q23.3 epithelioid trophoblastic tumor, gestational trophoblastic neoplasm trophoblastic neoplasm
CSHL1 chorionic somatomammotropin hormone-like 1 17q23.3 trophoblastic neoplasm isolated growth hormone deficiency
CSMD2 CUB and Sushi multiple domains 2 1p34.3 intermediate charcot-marie-tooth neuropathy
CSMD3 CUB and Sushi multiple domains 3 8q23.3 colorectal cancer
CSN1S1 casein alpha s1 4q13.3 lactose intolerance, dental caries, pellagra,
CSN2 casein beta 4q13.3 type 1 diabetes mellitus
CSN3 casein kappa 4q13.3 mammary pagets disease dentin sensitivity
CSNK1A1 casein kinase 1, alpha 1 5q32 lung cancer
CSNK1A1L casein kinase 1, alpha 1-like 13q13.3 angina pectoris, sleep disorder brain disease
CSNK1D casein kinase 1, delta 17q25.3 advanced sleep phase syndrome, "advanced sleep-phase syndrome, familial, 2" familial advanced sleep phase syndrome 1
CSNK1E casein kinase 1, epsilon 22q13.1 advanced sleep phase syndrome
CSNK2A1 casein kinase 2, alpha 1 polypeptide 20p13 globozoospermia
CSNK2A2 casein kinase 2, alpha prime polypeptide 16q21 pandas, globozoospermia theileriasis
CSNK2A3 casein kinase 2, alpha 3 polypeptide 11p15.3 lung cancer
CSNK2B casein kinase 2, beta polypeptide 6p21.33 egg allergy
CSPG4 chondroitin sulfate proteoglycan 4 15q24.2 melanoma acral lentiginous melanoma
CSPG5 chondroitin sulfate proteoglycan 5 (neuroglycan C) 3p21.31 dengue disease spontaneous ocular nystagmus
CSPP1 centrosome and spindle pole associated protein 1 8q13.1 joubert syndrome 21, asphyxiating thoracic dystrophy joubert syndrome with jeune asphyxiating thoracic dystrophy
CSRNP3 cysteine-serine-rich nuclear protein 3 2q24.3 leopard syndrome
CSRP1 cysteine and glycine-rich protein 1 1q32.1 endocardial fibroelastosis pontiac fever
CSRP3 cysteine and glycine-rich protein 3 (cardiac LIM protein) 11p15.1 hypertrophic cardiomyopathy, endocardial fibroelastosis, "cardiomyopathy, dilated, 1w",
CST1 cystatin SN 20p11.21 stomatitis denture stomatitis
CST2 cystatin SA 20p11.21 autoimmune polyendocrine syndrome type 1
CST3 cystatin C 20p11.21 vascular disease, amyloidosis, myocardial infarction,
CST4 cystatin S 20p11.21 blepharitis
CST6 cystatin E/M 11q13.1 breast cancer papillary thyroid carcinoma
CST9 cystatin 9 (testatin) 20p11.21 breast adenocarcinoma
CSTA cystatin A (stefin A) 3q21.1 squamous cell carcinoma of the head and neck, inverted papilloma, angioimmunoblastic t-cell lymphoma
CSTB cystatin B (stefin B) 21q22.3 squamous cell carcinoma of the head and neck, myoclonus, myoclonus epilepsy,
CSTF2 cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa Xq22.1 cytomegalovirus infection
CT45A1 cancer/testis antigen family 45, member A1 Xq26.3 b-cell lymphomas
CT83 cancer/testis antigen 83 Xq23 lung cancer
CTAA1 cataract, anterior polar 1 14q24-qter "cataract 32, multiple types"
CTAA2 cataract, anterior polar 2 17p13 "cataract 24, anterior polar"
CTAG1A cancer/testis antigen 1A Xq28 non-small cell lung carcinoma esophageal squamous cell carcinoma
CTAG1B cancer/testis antigen 1B Xq28 hepatocellular carcinoma, soft tissue sarcoma, pancreatic cancer,
CTAG2 cancer/testis antigen 2 Xq28 germ cell tumors, prostate cancer, breast cancer,
CTAGE1 cutaneous T-cell lymphoma-associated antigen 1 18q11.2 cutaneous t cell lymphoma
CTAGE12P CTAGE family, member 12, pseudogene 9p21.2 alzheimers disease
CTAGE5 CTAGE family, member 5 14q21.1 meningioma familial idiopathic basal ganglia calcification
CTAGE7P CTAGE family, member 7, pseudogene 10q26.3 meningioma
CTBP1-AS CTBP1 antisense RNA 4p16.3 prostate cancer
CTC1 CTS telomere maintenance complex component 1 17p13.1 coats disease "dyskeratosis congenita, autosomal recessive 4"
CTCF CCCTC-binding factor (zinc finger protein) 16q22.1 north american indian childhood cirrhosis, "mental retardation, autosomal dominant 21", mesoblastic nephroma
CTD Coats disease reserved coats disease telangiectasis
CTDP1 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 18q23 "congenital cataracts, facial dysmorphism, and neuropathy"
CTDSP2 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 12q14.1 adenosarcoma osteosarcoma
CTEPH1 Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to 6p21.3 hypertension "pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis"
CTF1 cardiotrophin 1 16p11.2 myocardial infarction, neonatal stroke, motor neuron disease
CTGF connective tissue growth factor 6q23.2 trachoma, diabetic retinopathy, paraneoplastic syndromes,
CTH cystathionase (cystathionine gamma-lyase) 1p31.1 mitochondrial dna depletion syndrome, hyperhomocysteinemia, gamma-cystathionase deficiency,
CTHM cono-truncal heart malformation 22q11 digeorge syndrome, velocardiofacial syndrome, conotruncal heart malformations,
CTHRC1 collagen triple helix repeat containing 1 8q22.3 adenocarcinoma, barretts esophagus barrett esophagus/esophageal adenocarcinoma
CTLA4 cytotoxic T-lymphocyte-associated protein 4 2q33.2 vitiligo, graves disease, collagen disease,
CTNNA1 catenin (cadherin-associated protein), alpha 1, 102kDa 5q31.2 lobular neoplasia, barretts esophagus, diffuse gastric cancer,
CTNNA2 catenin (cadherin-associated protein), alpha 2 2p12 benign schwannoma
CTNNA3 catenin (cadherin-associated protein), alpha 3 10q21.3 "familial isolated arrhythmogenic ventricular dysplasia, biventricular form", "familial isolated arrhythmogenic ventricular dysplasia, right dominant form", "familial isolated arrhythmogenic ventricular dysplasia, left dominant form",
CTNNB1 catenin (cadherin-associated protein), beta 1, 88kDa 3p22.1 hepatocellular carcinoma, "colorectal cancer, somatic", colorectal cancer,
CTNNBL1 catenin, beta like 1 20q11.23 obesity
CTNND1 catenin (cadherin-associated protein), delta 1 11q12.1 lobular neoplasia sarcomatoid renal cell carcinoma
CTNND2 catenin (cadherin-associated protein), delta 2 5p15.2 cri-du-chat syndrome
CTNS cystinosin, lysosomal cystine transporter 17p13.2 nephropathic cystinosis, cystinosis, fanconi syndrome,
CTPP Cataract, posterior polar 1pter-p36.1 posterior polar cataract
CTPP5 Cataract, posterior polar, 5 "cataract 32, multiple types" "cataract, posterior polar, 5"
CTPS1 CTP synthase 1 1p34.2 immunodeficiency 24
CTRB1 chymotrypsinogen B1 16q23.1 methylmalonic aciduria and homocystinuria type cble, methylmalonic aciduria and homocystinuria type cblg, methylmalonic aciduria and homocystinuria type cblc,
CTRC chymotrypsin C (caldecrin) 1p36.21 primary hyperparathyroidism, appendicitis, tropical calcific pancreatitis,
CTRCT25 Cataract, central pouch-like, with sutural opacities 15q21-q22 cataract 25
CTRCT27 Cataract, congenital, nuclear progressive 2p12 "cataract, congenital" "cataract 27, nuclear progressive"
CTRCT28 Cataract 28 6p12-q12 "cataract 28, age-related cortical"
CTRCT29 Cataract 29, coralliform 2pter-p24 "cataract 29, coralliform"
CTRCT34 Cataract, autosomal recessive congenital 3 1p34.3-p32.2 "cataract 34, multiple types"
CTRCT35 cataract, congenital nuclear, autosomal recessive 19q13 "cataract 35, congenital nuclear" "cataract, congenital"
CTRCT37 Cataract, congenital cerulean type, 5 12q24.2-q24.3 "cataract, congenital", "cataract 37, autosomal dominant" cerulean cataract
CTRL chymotrypsin-like 16q22.1 hepatitis a, severe acute respiratory syndrome, netherton syndrome,
CTSA cathepsin A 20q13.12 rheumatoid arthritis, osteoarthritis, ovarian mucinous adenocarcinoma,
CTSB cathepsin B 8p23.1 adenocarcinoma, mucolipidosis ii, alzheimers disease,
CTSC cathepsin C 11q14.2 keratosis, gestational trophoblastic neoplasm, trophoblastic neoplasm,
CTSD cathepsin D 11p15.5 breast cancer, breast disease, male breast cancer,
CTSE cathepsin E 1q32.1 pancreatic cancer
CTSF cathepsin F 11q13.2 neuronal ceroid-lipofuscinoses, clonorchiasis "ceroid lipofuscinosis, neuronal, 13, kufs type"
CTSG cathepsin G 14q12 pulmonary emphysema, cholangitis, chediak-higashi syndrome,
CTSH cathepsin H 15q25.1 colorectal cancer, thyroid crisis, narcolepsy 1,
CTSK cathepsin K 1q21.3 osteoporosis, breast adenocarcinoma, rheumatoid arthritis,
CTSL cathepsin L 9q21.33 ischemia, metachromatic leukodystrophy , rheumatoid arthritis,
CTSS cathepsin S 1q21.3 abdominal aortic aneurysm cercarial dermatitis
CTSV cathepsin V 9q22.33 rheumatoid arthritis, osteoarthritis atherosclerosis
CTSW cathepsin W 11q13.1 autoimmune atrophic gastritis
CTTN cortactin 11q13.3 breast cancer, ethmoid sinus adenocarcinoma ampulla of vater adenocarcinoma
CTTNBP2 cortactin binding protein 2 7q31.31 weaver syndrome
CTU2 cytosolic thiouridylase subunit 2 homolog (S. pombe) 16q24.3 exotropia
CTXN1 cortexin 1 19p13.2 corneal edema
CTXN2 cortexin 2 15q21.1 cystoid macular edema
CUBN cubilin (intrinsic factor-cobalamin receptor) 10p13 nephropathic cystinosis, megaloblastic anemia, "megaloblastic anemia-1, finnish type",
CUL1 cullin 1 7q36.1 glomuvenous malformation
CUL2 cullin 2 10p11.21 glomuvenous malformation
CUL3 cullin 3 2q36.2 pseudohypoaldosteronism type ii, glomuvenous malformation, pseudohypoaldosteronism
CUL4A cullin 4A 13q34 glomuvenous malformation
CUL4B cullin 4B Xq24 conjunctivochalasis, "mental retardation, x-linked, syndromic 15" "mental retardation, x-linked, with short stature, small testes, muscle wasting, and tremor"
CUL5 cullin 5 11q22.3 glomuvenous malformation
CUL7 cullin 7 6p21.1 3-m syndrome, dubowitz syndrome "3-m syndrome, cul7-related"
CUL9 cullin 9 6p21.1 peyronies disease
CUP2Q35 Syndactyly, type I 2q34-q36 craniosynostosis philadelphia type syndactyly type 1
CUX1 cut-like homeobox 1 7q22.1 norrie disease hereditary persistence of fetal hemoglobin
CVMRF cubitus valgus with mental retardation and unusual facies cubitus valgus with mental retardation and unusual facies
CWC15 CWC15 spliceosome-associated protein homolog (S. cerevisiae) 11q21 laryngotracheitis
CWC22 CWC22 spliceosome-associated protein homolog (S. cerevisiae) 2q31.3 malaria
CWC27 CWC27 spliceosome-associated protein homolog (S. cerevisiae) 5q12.3 colon cancer
CX3CL1 chemokine (C-X3-C motif) ligand 1 16q21 rheumatoid vasculitis, chorioretinitis pityriasis rosea
CX3CR1 chemokine (C-X3-C motif) receptor 1 3p22.2 coronary artery disease, retinal vasculitis, age related macular degeneration,
CXADR coxsackie virus and adenovirus receptor 21q21.1 "hypocalcemia, autosomal dominant", malignant glioma familial hypocalciuric hypercalcemia
CXCL1 chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) 4q13.3 kaposis sarcoma melanoma
CXCL10 chemokine (C-X-C motif) ligand 10 4q21.1 corneal neovascularization, hepatitis b, encephalitis,
CXCL11 chemokine (C-X-C motif) ligand 11 4q21.1 malaria, inclusion body myositis, cerebral malaria,
CXCL12 chemokine (C-X-C motif) ligand 12 10q11.21 usual interstitial pneumonia, diabetic retinopathy, breast cancer,
CXCL13 chemokine (C-X-C motif) ligand 13 4q21.1 malt lymphoma, follicular dendritic cell sarcoma, dendritic cell sarcoma
CXCL14 chemokine (C-X-C motif) ligand 14 5q31.1 papillary thyroid carcinoma penile neoplasm
CXCL16 chemokine (C-X-C motif) ligand 16 17p13.2 cholecystitis xanthogranulomatous cholecystitis
CXCL17 chemokine (C-X-C motif) ligand 17 19q13.2 idiopathic pulmonary fibrosis
CXCL2 chemokine (C-X-C motif) ligand 2 4q13.3 sepsis, arthus reaction, nephrogenic systemic fibrosis,
CXCL3 chemokine (C-X-C motif) ligand 3 4q13.3 familial hypercholesterolemia legionellosis
CXCL5 chemokine (C-X-C motif) ligand 5 4q13.3 nonspecific interstitial pneumonia, sarcoidosis, reactive arthritis,
CXCL6 chemokine (C-X-C motif) ligand 6 4q13.3 wegeners granulomatosis periodontal disease
CXCL9 chemokine (C-X-C motif) ligand 9 4q21.1 malaria, acrodermatitis, tuberculosis,
CXCR1 chemokine (C-X-C motif) receptor 1 2q35 adenomyosis, lung cancer, leishmaniasis,
CXCR2 chemokine (C-X-C motif) receptor 2 2q35 kaposis sarcoma, pancreatic cancer, behcets disease,
CXCR3 chemokine (C-X-C motif) receptor 3 Xq13.1 nonspecific interstitial pneumonia, nephritis, malt lymphoma,
CXCR4 chemokine (C-X-C motif) receptor 4 2q22.1 usual interstitial pneumonia, breast cancer, whim syndrome,
CXCR5 chemokine (C-X-C motif) receptor 5 11q23.3 b-cell chronic lymphocytic leukemia, burkitts lymphoma, malt lymphoma
CXorf40A chromosome X open reading frame 40A Xq28 intrahepatic cholangiocarcinoma
CYAT1 immunoglobulin lambda light chain-like hiv-1
CYB5A cytochrome b5 type A (microsomal) 18q22.3 antley-bixler syndrome, methemoglobinemia, 46xy sex reversal 8,
CYB5R1 cytochrome b5 reductase 1 1q32.1 methemoglobinemia
CYB5R2 cytochrome b5 reductase 2 11p15.4 methemoglobinemia
CYB5R3 cytochrome b5 reductase 3 22q13.2 monkeypox, methemoglobinemia, congenital methemoglobinemia,
CYB5R4 cytochrome b5 reductase 4 6q14.2 methemoglobinemia
CYB5RL cytochrome b5 reductase-like 1p32.3 methemoglobinemia
CYBA cytochrome b-245, alpha polypeptide 16q24.3 coronary artery disease, essential hypertension, artery disease,
CYBB cytochrome b-245, beta polypeptide Xp11.4 diastolic heart failure, chronic granulomatous disease, low renin hypertension,
CYC1 cytochrome c-1 8q24.3 "mitochondrial complex iii deficiency, nuclear type 6" mitochondrial complex iii deficiency
CYCS cytochrome c, somatic 7p15.3 antley-bixler syndrome, tyrosinemia, amelanotic melanoma,
CYCSP12 cytochrome c, somatic pseudogene 12 3p25.2 alcohol dependence
CYFIP1 cytoplasmic FMR1 interacting protein 1 15q11.2 angelman syndrome
CYGB cytoglobin 17q25.1 anoxia, nonepidermolytic palmoplantar keratoderma hereditary neuralgic amyotrophy
CYLD cylindromatosis (turban tumor syndrome) 16q12.1 multiple familial trichoepithelioma, brooke-spiegler syndrome, spiradenoma,
CYMD cystoid macular dystrophy 7p21-p15 cystoid macular dystrophy
CYP11A1 cytochrome P450, family 11, subfamily A, polypeptide 1 15q24.1 lipoid adrenal hyperplasia, dosage-sensitive sex reversal, histidinemia,
CYP11B1 cytochrome P450, family 11, subfamily B, polypeptide 1 8q24.3 hyperaldosteronism, familial hyperaldosteronism, iridocyclitis,
CYP11B2 cytochrome P450, family 11, subfamily B, polypeptide 2 8q24.3 focal segmental glomerulosclerosis, essential hypertension, hyperaldosteronism,
CYP17A1 cytochrome P450, family 17, subfamily A, polypeptide 1 10q24.32 antley-bixler syndrome, prostate cancer, breast cancer susceptibility,
CYP19A1 cytochrome P450, family 19, subfamily A, polypeptide 1 15q21.2 antley-bixler syndrome, breast fibroadenoma, breast cancer,
CYP1A1 cytochrome P450, family 1, subfamily A, polypeptide 1 15q24.1 colorectal cancer, prostate cancer, barretts esophagus,
CYP1A2 cytochrome P450, family 1, subfamily A, polypeptide 2 15q24.1 antley-bixler syndrome, cytochrome p450 oxidoreductase deficiency, schizophrenia,
CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1 2p22.2 prostate cancer, breast cancer susceptibility, breast cancer,
CYP20A1 cytochrome P450, family 20, subfamily A, polypeptide 1 2q33.2 scabies
CYP21A1P cytochrome P450, family 21, subfamily A, polypeptide 1 pseudogene 6p21.33 juvenile rheumatoid arthritis c4b deficiency
CYP21A2 cytochrome P450, family 21, subfamily A, polypeptide 2 6p21.33 acanthosis nigricans, antley-bixler syndrome, cytochrome p450 oxidoreductase deficiency,
CYP24A1 cytochrome P450, family 24, subfamily A, polypeptide 1 20q13.2 prostate cancer, osteomalacia, hypercalcemia,
CYP26A1 cytochrome P450, family 26, subfamily A, polypeptide 1 10q23.33 imperforate anus, acute promyelocytic leukemia, refractive error,
CYP26B1 cytochrome P450, family 26, subfamily B, polypeptide 1 2p13.2 craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies
CYP26C1 cytochrome P450, family 26, subfamily C, polypeptide 1 10q23.33 hyperostosis, focal facial dermal dysplasia, diffuse idiopathic skeletal hyperostosis
CYP27A1 cytochrome P450, family 27, subfamily A, polypeptide 1 2q35 lipid storage disease, xanthomatosis, sitosterolemia,
CYP27B1 cytochrome P450, family 27, subfamily B, polypeptide 1 12q14.1 graves disease, prostate cancer, hypophosphatemia,
CYP2A cytochrome P450, family 2, subfamily A 19q13.2 lung cancer, fatty liver disease, coumarin resistance
CYP2A6 cytochrome P450, family 2, subfamily A, polypeptide 6 19q13.2 lung cancer, liver cirrhosis, nicotine addiction,
CYP2B6 cytochrome P450, family 2, subfamily B, polypeptide 6 19q13.2 sinusitis, hiv/aids, acute frontal sinusitis,
CYP2C19 cytochrome P450, family 2, subfamily C, polypeptide 19 10q23.33 gastric ulcer, drug-induced hepatitis, multiple chemical sensitivity,
CYP2C8 cytochrome P450, family 2, subfamily C, polypeptide 8 10q23.33 osteonecrosis of the jaw, osteonecrosis "rhabdomyolysis, cerivastatin-induced"
CYP2C9 cytochrome P450, family 2, subfamily C, polypeptide 9 10q23.33 drug-induced hepatitis, multiple chemical sensitivity, warfarin resistance,
CYP2D6 cytochrome P450, family 2, subfamily D, polypeptide 6 22q13.2 colorectal cancer, parkinsons disease, breast cancer,
CYP2E1 cytochrome P450, family 2, subfamily E, polypeptide 1 10q26.3 beta thalassemia, lung cancer, erythropoietic protoporphyria,
CYP2J2 cytochrome P450, family 2, subfamily J, polypeptide 2 1p32.1 coronary artery disease
CYP2R1 cytochrome P450, family 2, subfamily R, polypeptide 1 11p15.2 gestational diabetes, vitamin d-dependent rickets type i rickets due to defect in vitamin d 25-hydroxylation
CYP2U1 cytochrome P450, family 2, subfamily U, polypeptide 1 4q25 "spastic paraplegia 56, autosomal recessive"
CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4 7q22.1 serotonin syndrome, beta thalassemia, xanthomatosis
CYP3A5 cytochrome P450, family 3, subfamily A, polypeptide 5 7q22.1 multiple chemical sensitivity, engraftment syndrome, warfarin sensitivity
CYP46A1 cytochrome P450, family 46, subfamily A, polypeptide 1 14q32.2 alzheimers disease
CYP4F2 cytochrome P450, family 4, subfamily F, polypeptide 2 19p13.12 warfarin sensitivity
CYP4F22 cytochrome P450, family 4, subfamily F, polypeptide 22 19p13.12 scrub typhus, typhus, autosomal recessive congenital ichthyosis,
CYP4F3 cytochrome P450, family 4, subfamily F, polypeptide 3 19p13.12 ascariasis trichuriasis
CYP4V2 cytochrome P450, family 4, subfamily V, polypeptide 2 4q35.2 corneal dystrophy, bietti crystalline corneoretinal dystrophy choroidal sclerosis
CYP51A1 cytochrome P450, family 51, subfamily A, polypeptide 1 7q21.2 antley-bixler syndrome chagas disease
CYP7A1 cytochrome P450, family 7, subfamily A, polypeptide 1 8q12.1 extrahepatic cholestasis, hyperthyroidism, familial hypercholesterolemia,
CYP7B1 cytochrome P450, family 7, subfamily B, polypeptide 1 8q12.3 atherosclerosis, "breast-ovarian cancer, familial, 1", "bile acid synthesis defect, congenital, 3",
CYR61 cysteine-rich, angiogenic inducer, 61 1p22.3 breast cancer, epispadias, leiomyoma
CYS1 cystin 1 2p25.1 bile duct adenoma, yellow nail syndrome, ureterocele
CYSLTR1 cysteinyl leukotriene receptor 1 Xq21.1 asthma, atopy, churg-strauss syndrome
CYSLTR2 cysteinyl leukotriene receptor 2 13q14.2 asthma, kaposis sarcoma, atopy,
D2HGDH D-2-hydroxyglutarate dehydrogenase 2q37.3 hypotonia, 2-hydroxyglutaric aciduria, d-2-hydroxyglutaric aciduria,
DAB1 Dab, reelin signal transducer, homolog 1 (Drosophila) 1p32.1 lissencephaly with cerebellar hypoplasia "ciliary dyskinesia, primary, 2"
DACH1 dachshund family transcription factor 1 13q21.33 anophthalmia/microphthalmia, postaxial polydactyly type a "postaxial polydactyly, type a2"
DACH2 dachshund family transcription factor 2 Xq21.2 allan-herndon-dudley syndrome
DACT1 dishevelled-binding antagonist of beta-catenin 1 14q23.1 hepatocellular carcinoma, neural tube defects, spina bifida,
DACT3 dishevelled-binding antagonist of beta-catenin 3 19q13.32 placenta praevia
DAG1 dystroglycan 1 (dystrophin-associated glycoprotein 1) 3p21.31 lymphocytic choriomeningitis, duchenne muscular dystrophy, muscular dystrophy-dystroglycanopathy,
DAGLA diacylglycerol lipase, alpha 11q12.2 spinocerebellar ataxia type 20
DAND5 DAN domain family member 5, BMP antagonist 19p13.2 norrie disease , syringoma malignant syringoma
DAO D-amino-acid oxidase 12q24.11 amyotrophic lateral sclerosis, schizophrenia, bipolar disorder
DAOA D-amino acid oxidase activator 13q33.2 schizophrenia, bipolar disorder childhood-onset schizophrenia
DAPK1 death-associated protein kinase 1 9q21.33 choroid plexus papilloma, cervical squamous cell carcinoma, pediatric lymphoma
DAPK3 death-associated protein kinase 3 19p13.3 recessive dystrophic epidermolysis bullosa
DARC Duffy blood group, atypical chemokine receptor 1q23.2 herpes simplex, malaria, hereditary elliptocytosis,
DARS aspartyl-tRNA synthetase 2q21.3 spasticity hypomyelination with brainstem and spinal cord involvement and leg spasticity
DARS2 aspartyl-tRNA synthetase 2, mitochondrial 1q25.1 alpers syndrome, chronic polyneuropathy leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation
DAZ1 deleted in azoospermia 1 Yq11.223 cryptorchidism, oligospermia, y chromosome infertility,
DAZ2 deleted in azoospermia 2 Yq11.223 oligospermia, y chromosome infertility, "spermatogenic failure, y-linked, 2",
DAZ3 deleted in azoospermia 3 Yq11.23 y chromosome infertility, "spermatogenic failure, y-linked, 2", azoospermia
DAZ4 deleted in azoospermia 4 Yq11.23 oligospermia, mixed gonadal dysgenesis, "spermatogenic failure, y-linked, 2",
DAZAP1 DAZ associated protein 1 19p13.3 azoospermia
DAZAP2 DAZ associated protein 2 12q13.13 myeloma, multiple myeloma azoospermia
DAZL deleted in azoospermia-like 3p24.3 paraneoplastic syndromes, seminoma, spermatogenic failure,
DBA2 Diamond-Blackfan anemia 2 8p23.3-p22 diamond-blackfan anemia 2
DBH dopamine beta-hydroxylase (dopamine beta-monooxygenase) 9q34.2 parkinsons disease, schizophrenia, hyperprolactinemia,
DBI diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) 2q14.2 withdrawal disorder alcoholic pancreatitis
DBN1 drebrin 1 5q35.3 schizophrenia
DBP D site of albumin promoter (albumin D-box) binding protein 19q13.33 graves disease, type 2 diabetes mellitus, hemophilia b
DBT dihydrolipoamide branched chain transacylase E2 1p21.2 barth syndrome, maple syrup urine disease, maple syrup urine disease type 1a,
DCAF17 DDB1 and CUL4 associated factor 17 2q31.1 sakati syndrome, neurodegeneration with brain iron accumulation disorders "hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome"
DCAF5 DDB1 and CUL4 associated factor 5 14q24.1 leiomyoma
DCAF8 DDB1 and CUL4 associated factor 8 1q23.2 "giant axonal neuropathy 2, autosomal dominant"
DCC deleted in colorectal carcinoma 18q21.2 "colorectal cancer, somatic", colorectal cancer, mirror movements 1
DCD dermcidin 12q13.2 spinal stenosis, burns root caries
DCDC2 doublecortin domain containing 2 6p22.3 lattice corneal dystrophy, dyslexia writing disorder
DCE desmosterol-to-cholesterol enzyme 20 pyruvate dehydrogenase e2 deficiency
DCHS1 dachsous cadherin-related 1 11p15.4 van maldergem syndrome 1
DCK deoxycytidine kinase 4q13.3 acute myeloid leukemia, pancreatic cancer, neurofibrosarcoma
DCLRE1B DNA cross-link repair 1B 1p13.2 cone-rod dystrophy 12
DCLRE1C DNA cross-link repair 1C 10p13 severe combined immunodeficiency, omenn syndrome, nijmegen breakage syndrome,
DCN decorin 12q21.33 crouzon syndrome, burn scar, keratopathy,
DCR Down syndrome chromosome region 21q22.3 down syndrome
DCT dopachrome tautomerase 13q32.1 chediak-higashi syndrome, amelanotic melanoma, degenerative disc disease
DCTN1 dynactin 1 2p13.1 amyotrophic lateral sclerosis, muscular atrophy, agnathia-otocephaly complex,
DCTN4 dynactin 4 (p62) 5q33.1 cystic fibrosis
DCX doublecortin Xq23 pilocytic astrocytoma, periventricular nodular heterotopia, neuronal migration disorders,
DCXR dicarbonyl/L-xylulose reductase 17q25.3 dacryocystitis, ureteral obstruction, prostate adenocarcinoma,
DDB1 damage-specific DNA binding protein 1, 127kDa 11q12.2 vitelliform macular dystrophy, photosensitive trichothiodystrophy xeroderma pigmentosum
DDB2 damage-specific DNA binding protein 2, 48kDa 11p11.2 "xeroderma pigmentosum, group c", xeroderma pigmentosum, atrophy of testis,
DDC dopa decarboxylase (aromatic L-amino acid decarboxylase) 7p12.1 parkinsons disease, schizophrenia, supratentorial primitive neuroectodermal tumor,
DDD3 Dowling-Degos disease 3 17q21.3-q22 degos disease, dowling-degos disease dowling-degos disease 3
DDH2 Developmental dysplasia of the hip 2 3p22.2 "obesity, hyperphagia, and developmental delay", 46xy sex reversal 8 developmental dysplasia of the hip 2
DDHD1 DDHD domain containing 1 14q22.1 myopathy with deficiency of iscu "spastic paraplegia 28, autosomal recessive"
DDHD2 DDHD domain containing 2 8p11.23 "spastic paraplegia 54, autosomal recessive"
DDIT3 DNA-damage-inducible transcript 3 12q13.3 colon cancer myxoid liposarcoma
DDIT4L DNA-damage-inducible transcript 4-like 4q24 mature teratoma
DDOST dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic) 1p36.12 hyperglycemia "congenital disorder of glycosylation, type ir"
DDR2 discoidin domain receptor tyrosine kinase 2 1q23.3 spondylometaepiphyseal dysplasia short limb-hand type spondyloepimetaphyseal dysplasia
DDT D-dopachrome tautomerase 22q11.23 non-small cell lung carcinoma
DDX1 DEAD (Asp-Glu-Ala-Asp) box helicase 1 2p24.3 retinoblastoma heavy chain disease
DDX11 DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 12p11.21 roberts syndrome, baller-gerold syndrome warsaw breakage syndrome
DDX11L8 DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 like 8 12p13.33 roberts syndrome baller-gerold syndrome
DDX20 DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 1p13.2 muscular atrophy spinal muscular atrophy
DDX21 DEAD (Asp-Glu-Ala-Asp) box helicase 21 10q22.1 stomach disease
DDX23 DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 12q13.12 "distal hereditary motor neuropathy, type ii"
DDX39B DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B 6p21.33 rheumatoid arthritis
DDX3X DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked Xp11.4 precursor t-cell acute lymphoblastic leukemia, hepatitis c, hepatitis c virus
DDX3Y DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked Yq11.21 y chromosome infertility, male infertility, infertility,
DDX43 DEAD (Asp-Glu-Ala-Asp) box polypeptide 43 6q13 chronic myeloid leukemia
DDX53 DEAD (Asp-Glu-Ala-Asp) box polypeptide 53 Xp22.11 autism spectrum disorder
DDX58 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 9p21.1 influenza, parainfluenza virus type 3, west nile virus
DDX59 DEAD (Asp-Glu-Ala-Asp) box polypeptide 59 1q32.1 orofaciodigital syndrome, orofaciodigital syndrome type 14 orofaciodigital syndrome 5
DDX6P2 DEAD (Asp-Glu-Ala-Asp) box helicase 6 pseudogene 2 13q31.1 alzheimers disease
DEAF1 DEAF1 transcription factor 11p15.5 "mental retardation, autosomal dominant 24"
DEC1 deleted in esophageal cancer 1 9q33.1 esophageal squamous cell carcinoma esophageal cancer
DECR1 2,4-dienoyl CoA reductase 1, mitochondrial 8q21.3 glucosephosphate dehydrogenase deficiency, decr deficiency "2,4-dienoyl-coa reductase deficiency"
DEDD death effector domain containing 1q23.3 dental fluorosis
DEFA1 defensin, alpha 1 8p23.1 microsporidiosis, multidrug-resistant tuberculosis, tuberculosis
DEFA1A3 defensin, alpha 1 and alpha 3, variable copy number locus 8p23.1 systemic lupus erythematosus crohns disease
DEFA3 defensin, alpha 3, neutrophil-specific 8p23.1 multidrug-resistant tuberculosis, idiopathic pulmonary fibrosis, bells palsy
DEFA4 defensin, alpha 4, corticostatin 8p23.1 idiopathic pulmonary fibrosis childhood leukemia
DEFA5 defensin, alpha 5, Paneth cell-specific 8p23.1 microsporidiosis, urethritis vulvovaginal candidiasis
DEFA6 defensin, alpha 6, Paneth cell-specific 8p23.1 childhood leukemia
DEFB1 defensin, beta 1 8p23.1 cystic fibrosis, oral candidiasis, periodontitis,
DEFB103A defensin, beta 103A 8p23.1 squamous cell carcinoma of the head and neck oral squamous cell carcinoma
DEFB103B defensin, beta 103B 8p23.1 squamous cell carcinoma of the head and neck, cystic fibrosis, oral candidiasis,
DEFB104A defensin, beta 104A 8p23.1 ulcerative colitis
DEFB118 defensin, beta 118 20q11.21 childhood leukemia
DEFB119 defensin, beta 119 20q11.21 childhood leukemia
DEFB126 defensin, beta 126 20p13 childhood leukemia
DEFB127 defensin, beta 127 20p13 childhood leukemia
DEFB4A defensin, beta 4A 8p23.1 folliculitis, cystic fibrosis, sinusitis,
DEGS1 delta(4)-desaturase, sphingolipid 1 1q42.11 mantle cell lymphoma
DEK DEK oncogene 6p22.3 iridocyclitis "leukemia, acute nonlymphocytic"
DEL10Q26 Chromosome 10q deletion syndrome 10q chromosome 10q deletion chromosome 10q26 deletion syndrome
DEL11P13 Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome 11p13 wagr syndrome
DEL11P15P14 Chromosome 11p15-p14 deletion syndrome 11p15-p14 chromosome 11p15-p14 deletion syndrome 11p15-p14 deletion syndrome
DEL13Q14 Chromosome 13q14 deletion syndrome 13q14 chromosome 13q14 deletion syndrome
DEL14Q11Q22 Chromosome 14q11-q22 deletion syndrome 14q11-q22 chromosome 14q11-q22 deletion syndrome
DEL15Q11.2 Chromosome 15q11.2 deletion syndrome 15q11.2 microdeletion 15q11.2
DEL15Q13.3 Chromosome 15q13.3 microdeletion syndrome 15q13.3 15q13.3 microdeletion
DEL15Q15.3 Deafness and male infertility 15q15.3 male infertility, infertility deafness and male infertility
DEL15Q24 Chromosome 15q24 deletion syndrome 15q24 chromosome 15q24 deletion syndrome
DEL15Q25 Chromosome 15q25 deletion syndrome 15q25 chromosome 15q25 deletion syndrome
DEL15Q26QTER Chromosome 15q26-qter deletion syndrome 15q26-qter chromosome 15q26-qter deletion syndrome
DEL16P11.2 autism, susceptibility to, 14 16p11.2 autism susceptibility 14a "chromosome 16p11.2 deletion syndrome, 593kb"
DEL16P12.1P11.2 Chromosome 16p12.2-p11.2 deletion syndrome 16q12.2-p11.2 chromosome 16p12.2-p11.2 deletion syndrome
DEL16P13.3 Chromosome 16p13.3 deletion syndrome 16p13.3 chromosome 16p13.3 deletion syndrome
DEL17P13.1 Chromosome 17p13.1 deletion syndrome 17p13.1 chromosome 17p13.1 deletion syndrome
DEL17Q11.2 chromosome 17q11.2 deletion syndrome 17q11.2 "chromosome 17q11.2 deletion syndrome, 1.4mb"
DEL17Q12 Chromosome 17q12 deletion syndrome 17q12 chromosome 17q12 deletion syndrome
DEL17Q23.1Q23.2 Chromosome 17q23.1-q23.2 deletion syndrome 17q23.1-q23.2 17q23.1q23.2 microdeletion syndrome
DEL18P Chromosome 18p deletion syndrome 18p 18p deletion syndrome chromosome 18p deletion syndrome
DEL18Q Chromosome 18q deletion syndrome 18q 18q deletion syndrome
DEL19P13.13 Chromosome 19p13.13 deletion syndrome 19p13.13 chromosome 19p13.13 deletion syndrome chromosome 19p13.13 duplication syndrome
DEL19Q13.11 Chromosome 19q13.11 deletion syndrome 19q13.11 chromosome 19q13.11 deletion syndrome
DEL1P32P31 Chromosome 1p32-p31 deletion syndrome 1p32-p31 chromosome 1p32-p31 deletion syndrome
DEL1P36 Chromosome 1p36 deletion syndrome 1p36 1p36 deletion syndrome chromosome 1p36 deletion syndrome
DEL1Q21 Chromosome 1q21.1 deletion syndrome 1q21.1 thrombocytopenia-absent radius syndrome 1q21.1 deletion
DEL1Q41Q42 Chromosome 1q41-q42 deletion syndrome 1q41-q42 chromosome 1q41-q42 deletion syndrome
DEL1Q43Q44 Chromosome 1q42-q44 deletion syndrome 1q42-q44 chromosome 1q43-q44 deletion syndrome
DEL22Q11.2 Chromosome 22q11.2 deletion syndrome, distal 22q11.2 schizophrenia "chromosome 22q11.2 deletion syndrome, distal"
DEL2P12P11.2 Chromosome 2p12-p11.2 deletion syndrome 2p12-p11.2 chromosome 2p12-p11.2 deletion syndrome
DEL2P16.1-P15 Chromosome 2p16.1-p15 deletion syndrome 2p16.1-p15 chromosome 2p16.1-p15 deletion syndrome 2p16.1-p15 deletion syndrome
DEL2P21 Hypotonia-cystinuria syndrome 2p21 cystinuria hypotonia-cystinuria syndrome
DEL2Q31 Chromosome 2q31.2 deletion syndrome 2q31.2 chromosome 2q31.2 deletion syndrome
DEL3PTERP25 3p- syndrome 3pter-p25 3p deletion syndrome
DEL3Q13.31 Chromosome 3q13.31 deletion syndrome 3q13.31 chromosome 3q13.31 deletion syndrome
DEL3Q29 Chromosome 3q29 microdeletion syndrome 3q29 chromosome 3q29 microdeletion syndrome
DEL4Q21 Chromosome 4q21 deletion syndrome 4q21 chromosome 4q21 deletion syndrome
DEL5Q12 Chromosome 5q12 deletion sydrome 5q12 chromosome 5q12 deletion sydrome
DEL6PTER Chromosome 6pter deletion syndrome 6pter-p24 chromosome 6pter-p24 deletion syndrome
DEL6Q11Q14 Chromosome 6q11-q14 deletion syndrome 6q11-q14 chromosome 6q11-q14 deletion syndrome
DEL6Q24Q25 Chromosome 6q25-q25 deletion syndrome 6q24-q25 chromosome 6q25-q25 deletion syndrome
DEL7Q11.23 Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb 7q11.23 "chromosome 7q11.23 deletion syndrome, distal, 1.2mb"
DEL8Q12Q21 Bor-Duane hydrocephalus contiguous gene syndrome 8q12.2-q21.2 bor-duane hydrocephalus contiguous gene syndrome
DEL8Q13 Mesomelia-synostoses syndrome 8q13 mesomelia-synostoses syndrome mesomelia
DEL8Q21.11 Chromosome 8q21.11 deletion syndrome 8q21.11 chromosome 8q21.11 deletion syndrome
DEL9P Chromosome 9p deletion syndrome 9p chromosome 9p deletion
DELXP11.3 Chromosome Xp11.3 deletion syndrome Xp11.3 xp11.3 deletion syndrome chromosome xp11.3 deletion syndrome
DELXP21 Chromosome Xp21 deletion syndrome Xp21 chromosome xp21 deletion syndrome
DELXP22.11 Autism, X-linked, susceptibility to, 4 Xp22.11 "autism susceptibility, x-linked 4"
DELXQ21 Choroideremia, deafness, and mental retardation Xq21 choroideremia "choroideremia, deafness, and mental retardation"
DELYQ11 Sertoli cell-only syndrome, Y-linked Yq11 "spermatogenic failure, y-linked, 1"
DENR density-regulated protein 12q24.31 pleomorphic adenoma
DEPDC1B DEP domain containing 1B 5q12.1 breast cancer
DEPDC5 DEP domain containing 5 22q12.2 hepatocellular carcinoma, hepatitis c, hepatitis c virus,
DER22T11-22 Emanuel syndrome 22q11.2 emanuel syndrome
DER22T8-22 Supernumerary der(22)t(8-22) syndrome 22q11.2 supernumerary der t syndrome
DERA deoxyribose-phosphate aldolase (putative) 12p12.3 tick infestation phlebotomus fever
DERL1 derlin 1 8q24.13 cavernous hemangioma cystic fibrosis
DES desmin 2q35 epulis, cavernous hemangioma, giant cell tumor,
DFCTRPS Deafness, cataract, retinitis pigmentosa, and sperm abnormalities "deafness, cataract, retinitis pigmentosa, and sperm abnormalities"
DFFB DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) 1p36.32 huntingtons disease
DFN5 deafness, X-linked 5 reserved "deafness, x-linked 5"
DFN8 deafness, X-linked 8 reserved auditory neuropathy
DFNA16 deafness, autosomal dominant 16 2q24 "deafness, autosomal dominant 16"
DFNA18 deafness, autosomal dominant 18 3q22 "deafness, autosomal dominant 18"
DFNA21 deafness, autosomal dominant 21 6p24.1-p22.3 "deafness, autosomal dominant 21"
DFNA24 deafness, autosomal dominant 24 4q35-qter "deafness, autosomal dominant 24"
DFNA27 deafness, autosomal dominant 27 4q12-q13.1 "deafness, autosomal dominant 27"
DFNA30 deafness, autosomal dominant 30 15q25-q26 "deafness, autosomal dominant 30"
DFNA31 deafness, autosomal dominant 31 6p21 "deafness, autosomal dominant 31"
DFNA33 deafness, autosomal dominant 33 13q34-qter "deafness, autosomal dominant 33"
DFNA40 deafness, autosomal dominant 40 16p12 "deafness, autosomal dominant 40"
DFNA41 deafness, autosomal dominant 41 12q24.1-q24.3 "deafness, autosomal dominant 41"
DFNA42 deafness, autosomal dominant 42 5q31.1-q32 "deafness, autosomal dominant 52"
DFNA43 deafness, autosomal dominant 43 2p12-p11.1 "deafness, autosomal dominant 43"
DFNA47 deafness, autosomal dominant 47 9p22-p21 "deafness, autosomal dominant 47"
DFNA49 deafness, autosomal dominant 49 1q21-q23 "deafness, autosomal dominant 49"
DFNA5 deafness, autosomal dominant 5 7p15.3 "deafness, autosomal dominant 4b", dfna 5 nonsyndromic hearing loss and deafness "deafness, autosomal dominant 5"
DFNA52 deafness, autosomal dominant 52 5q31.1-q32 "deafness, autosomal dominant 52"
DFNA53 deafness, autosomal dominant 53 14q11-q12 "deafness, autosomal dominant 53"
DFNA54 deafness, autosomal dominant 54 5q31 "deafness, autosomal dominant 54"
DFNA55 deafness, autosomal dominant 55 9p13.3.-p13.2 auditory neuropathy
DFNA58 deafness, autosomal dominant 58 2p21-p12 "deafness, autosomal dominant 58"
DFNA59 deafness, autosomal dominant 59 11p14.2-q12.3 "deafness, autosomal dominant 59"
DFNA7 deafness, autosomal dominant 7 1q21-q23 "deafness, autosomal dominant 7"
DFNB13 deafness, autosomal recessive 13 7q34-q36 "deafness, autosomal recessive 13"
DFNB14 deafness, autosomal recessive 14 7q31 "deafness, autosomal recessive 14"
DFNB17 deafness, autosomal recessive 17 7q31 "deafness, autosomal recessive 17"
DFNB20 deafness, autosomal recessive 20 11q25-qter "deafness, autosomal recessive 20"
DFNB26 deafness, autosomal recessive 26 4q31 "deafness, autosomal recessive 26"
DFNB27 deafness, autosomal recessive 27 2q24 "deafness, autosomal recessive 27"
DFNB31 deafness, autosomal recessive 31 9q32 "deafness, autosomal recessive 76", usher syndrome type ii, usher syndrome type 2a,
DFNB32 deafness, autosomal recessive 32 1p22.1-p13.3 "deafness, autosomal recessive 32"
DFNB33 deafness, autosomal recessive 33 10p11.23-q21.1 dfnb1 "deafness, autosomal recessive 33"
DFNB38 deafness, autosomal recessive 38 6q25.3-q27 "deafness, autosomal recessive 38"
DFNB40 deafness, autosomal recessive 40 22q11.21-q12.1 "deafness, autosomal recessive 40"
DFNB44 deafness, autosomal recessive 44 7p14.1-q11.22 "deafness, autosomal recessive 44"
DFNB45 deafness, autosomal recessive 45 1q43-q44 "deafness, autosomal recessive 45"
DFNB46 deafness, autosomal recessive 46 18p11.32-p11.31 autosomal recessive nonsyndromic deafness "deafness, autosomal recessive 46"
DFNB47 deafness, autosomal recessive 47 2p25.1-p24.3 "deafness, neurosensory, autosomal recessive 47"
DFNB5 deafness, autosomal recessive 5 14q12 "deafness, autosomal recessive 5"
DFNB51 deafness, autosomal recessive 51 11p13-p12 "deafness, autosomal recessive 51"
DFNB55 deafness, autosomal recessive 55 4q12-q13.2 "deafness, autosomal recessive 55"
DFNB59 deafness, autosomal recessive 59 2q31.2 "deafness, autosomal recessive 76", auditory neuropathy, deafness and hereditary hearing loss,
DFNB62 deafness, autosomal recessive 62 12p13.2-p11.23 "deafness, autosomal recessive 62"
DFNB65 deafness, autosomal recessive 65 20q13.2-q13.32 "deafness, autosomal recessive 65"
DFNB66 deafness, autosomal recessive 66 6p22.3-p21.2 "deafness, autosomal recessive 66"
DFNB68 deafness, autosomal recessive 68 19p13.2 "deafness, autosomal recessive 68"
DFNB71 deafness, autosomal recessive 71 8p22-p21.3 "deafness, autosomal recessive 71"
DFNB74 deafness, autosomal recessive 74 12q14.1-q15 "deafness, autosomal recessive 74"
DFNB81 deafness, autosomal recessive 81 19p13 "deafness, autosomal recessive 81"
DFNB83 deafness, autosomal recessive 83 9p23-p21.2 "deafness, autosomal recessive 83" "deafness, autosomal dominant 47"
DFNB85 deafness, autosomal recessive 85 17p12-q11.2 "deafness, autosomal recessive 85"
DFNB93 deafness, autosomal recessive 93 11q12.2-q13.4 "deafness, autosomal recessive 93"
DFNB96 deafness, autosomal recessive 96 1p36.31-p36.13 "deafness, autosomal recessive 96"
DFNM1 deafness (recessive, nonsyndromic) modifier 1 1q24 "deafness, nonsyndromic, modifier 1"
DFNX3 deafness, X-linked 3 Xp21.2 "deafness, x-linked 3" "deafness, x-linked 4"
DFNY1 deafness, Y-linked 1 Y "deafness, y-linked 1"
DGAT1 diacylglycerol O-acyltransferase 1 8q24.3 obesity diarrhea 7
DGAT2L6 diacylglycerol O-acyltransferase 2-like 6 Xq13.1 tropical sprue
DGCR DiGeorge syndrome chromosome region 22q11.21-q11.23 digeorge syndrome, velocardiofacial syndrome tetralogy of fallot
DGCR10 DiGeorge syndrome critical region gene 10 (non-protein coding) 22q11.21 digeorge syndrome
DGCR11 DiGeorge syndrome critical region gene 11 (non-protein coding) 22q11.21 digeorge syndrome
DGCR14 DiGeorge syndrome critical region gene 14 22q11.21 digeorge syndrome velocardiofacial syndrome
DGCR2 DiGeorge syndrome critical region gene 2 22q11.21 digeorge syndrome, velocardiofacial syndrome digeorge syndrome/velocardiofacial syndrome complex-2
DGCR6 DiGeorge syndrome critical region gene 6 22q11.21 digeorge syndrome schizophrenia
DGCR6L DiGeorge syndrome critical region gene 6-like 22q11.21 digeorge syndrome
DGCR8 DGCR8 microprocessor complex subunit 22q11.21 digeorge syndrome
DGKE diacylglycerol kinase, epsilon 64kDa 17q22 atypical hemolytic-uremic syndrome "nephrotic syndrome, type 7"
DGKG diacylglycerol kinase, gamma 90kDa 3q27.3 dominant optic atrophy
DGKQ diacylglycerol kinase, theta 110kDa 4p16.3 dominant optic atrophy
DGS2 DiGeorge syndrome/velocardiofacial syndrome complex 2 10p14-p13 digeorge syndrome digeorge syndrome/velocardiofacial syndrome complex-2
DGUOK deoxyguanosine kinase 2p13.1 mitochondrial dna depletion syndrome, t lymphocyte deficiency, muscle glycogenosis,
DHCR24 24-dehydrocholesterol reductase 1p32.3 spasticity, alzheimers disease desmosterolosis
DHCR7 7-dehydrocholesterol reductase 11q13.4 bardet-biedl syndrome 10, atrioventricular septal defect, holoprosencephaly,
DHDDS dehydrodolichyl diphosphate synthase 1p36.11 leber congenital amaurosis, retinitis pigmentosa dhdds-related retinitis pigmentosa
DHDH dihydrodiol dehydrogenase (dimeric) 19q13.33 lung cancer
DHFR dihydrofolate reductase 5q14.1 cerebral folate deficiency, tetrahydrobiopterin deficiency, chagas disease,
DHFRL1 dihydrofolate reductase-like 1 3q11.1 methylmalonic aciduria and homocystinuria type cble, methylmalonic aciduria and homocystinuria type cblg, methylmalonic aciduria and homocystinuria type cblc,
DHFRP2 dihydrofolate reductase pseudogene 2 6p21.33 systemic lupus erythematosus ankylosing spondylitis
DHH desert hedgehog 12q13.12 b-cell chronic lymphocytic leukemia, bardet-biedl syndrome 9, mixed gonadal dysgenesis,
DHODH dihydroorotate dehydrogenase (quinone) 16q22.2 chagas disease, malaria miller syndrome
DHPS deoxyhypusine synthase 19p13.2 malaria, pneumocystosis, whipple disease
DHS dehydrated hereditary stomatocytosis 16q23-q24 dehydrated hereditary stomatocytosis dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema
DHTKD1 dehydrogenase E1 and transketolase domain containing 1 10p14 charcot-marie-tooth disease type 2, reye syndrome, charcot-marie-tooth disease,
DHX34 DEAH (Asp-Glu-Ala-His) box polypeptide 34 19q13.32 asthma, atopic dermatitis dermatitis
DHX40 DEAH (Asp-Glu-Ala-His) box polypeptide 40 17q23.1 norum disease
DHX8 DEAH (Asp-Glu-Ala-His) box polypeptide 8 17q21.31 asthma, atopic dermatitis, dermatitis
DHX9 DEAH (Asp-Glu-Ala-His) box helicase 9 1q25.3 pseudopterygium
DIABLO diablo, IAP-binding mitochondrial protein 12q24.31 colon cancer, nonsyndromic deafness, lung cancer,
DIANPH diabetic nephropathy 18q22.3-q23 diabetic nephropathy
DIAPH1 diaphanous-related formin 1 5q31.3 "deafness, autosomal dominant 4b", "deafness, autosomal dominant 1" dfna 1 nonsyndromic hearing loss and deafness
DIAPH2 diaphanous-related formin 2 Xq21.33 premature ovarian failure premature ovarian failure 2a
DIAPH3 diaphanous-related formin 3 13q21.2 neuropathy, auditory neuropathy, "deafness, autosomal dominant 4b",
DICER1 dicer 1, ribonuclease type III 14q32.13 blastoma, goiter, pelizaeus-merzbacher disease,
DIH1 diaphragmatic hernia 1 15q26.1-q26.2 "hernia, congenital diaphragmatic 1"
DIH2 Hernia, congenital diaphragmatic 2 8p23.1 "hernia, congenital diaphragmatic 2"
DIO1 deiodinase, iodothyronine, type I 1p32.3 euthyroid sick syndrome, familial partial lipodystrophy keshan disease
DIO2 deiodinase, iodothyronine, type II 14q31.1 graves disease, type 2 diabetes mellitus, thyrotoxicosis,
DIO3 deiodinase, iodothyronine, type III 14q32.31 hepatocellular carcinoma, septic shock, papillary thyroid carcinoma
DIP2B DIP2 disco-interacting protein 2 homolog B (Drosophila) 12q13.12 "mental retardation, fra12a type"
DIRAS1 DIRAS family, GTP-binding RAS-like 1 19p13.3 esophageal squamous cell carcinoma
DIRC1 disrupted in renal carcinoma 1 2q32.2 familial renal cell carcinoma
DIRC2 disrupted in renal carcinoma 2 3q21.1 renal cell carcinoma, kidney cancer, familial renal cell carcinoma,
DIRC3 disrupted in renal carcinoma 3 2q35 follicular thyroid carcinoma familial renal cell carcinoma
DIS3L2 DIS3 like 3'-5' exoribonuclease 2 2q37.1 "wilms tumor, type 1" renal hamartomas nephroblastomatosis and fetal gigantism
DISC1 disrupted in schizophrenia 1 1q42.2 schizophrenia, endogenous depression schizoaffective disorder
DISC2 disrupted in schizophrenia 2 (non-protein coding) 1q42.1 schizophrenia
DISP1 dispatched homolog 1 (Drosophila) 1q41 septopreoptic holoprosencephaly, midline interhemispheric variant of holoprosencephaly, lobar holoprosencephaly,
DKBI Dyskeratosis, hereditary benign intraepithelial 4q35 hereditary benign intraepithelial dyskeratosis
DKC1 dyskeratosis congenita 1, dyskerin Xq28 aplastic anemia, "dyskeratosis congenita, autosomal recessive 4", intrauterine infections,
DKK1 dickkopf WNT signaling pathway inhibitor 1 10q21.1 myeloma, osteoporosis, colon cancer,
DKK4 dickkopf WNT signaling pathway inhibitor 4 8p11.21 idiopathic pulmonary fibrosis
DLAT dihydrolipoamide S-acetyltransferase 11q23.1 primary biliary cirrhosis, vaginitis, pyruvate decarboxylase deficiency,
DLC1 deleted in liver cancer 1 8p22 "colorectal cancer, somatic", lung cancer esophageal cancer
DLD dihydrolipoamide dehydrogenase 7q31.1 leigh disease, maple syrup urine disease, alpha-ketoglutarate dehydrogenase deficiency ,
DLEC1 deleted in lung and esophageal cancer 1 3p22.2 lung cancer, brown-vialetto-van laere syndrome esophageal cancer
DLEC1P1 deleted in lung and esophageal cancer 1 pseudogene 1 3p22.2 esophageal cancer
DLEU1 deleted in lymphocytic leukemia 1 (non-protein coding) 13q14.2 b-cell chronic lymphocytic leukemia, leukemia chronic lymphocytic leukemia
DLEU2 deleted in lymphocytic leukemia 2 (non-protein coding) 13q14.2 b-cell chronic lymphocytic leukemia
DLEU2L deleted in lymphocytic leukemia 2-like 1p31.3 b-cell chronic lymphocytic leukemia chronic lymphocytic leukemia
DLG1 discs, large homolog 1 (Drosophila) 3q29 mayer-rokitansky-kuster-hauser syndrome
DLG2 discs, large homolog 2 (Drosophila) 11q14.1 bilateral retinoblastoma
DLG3 discs, large homolog 3 (Drosophila) Xq13.1 non-specific x-linked mental retardation, borjeson-forssman-lehmann syndrome, "mental retardation, x-linked 17/31, microduplication",
DLG4 discs, large homolog 4 (Drosophila) 17p13.1 schizophrenia
DLGAP1 discs, large (Drosophila) homolog-associated protein 1 18p11.31 myopia-2
DLGAP3 discs, large (Drosophila) homolog-associated protein 3 1p34.3 trichotillomania gilles de la tourette syndrome
DLK1 delta-like 1 homolog (Drosophila) 14q32.2 obesity, "maternal uniparental disomy, chromosome 14", "uniparental disomy, paternal, chromosome 14"
DLL1 delta-like 1 (Drosophila) 6q27 septopreoptic holoprosencephaly, midline interhemispheric variant of holoprosencephaly, lobar holoprosencephaly,
DLL3 delta-like 3 (Drosophila) 19q13.2 spondylocostal dysostosis, dysostosis, "dll3-related spondylocostal dysostosis, autosomal recessive",
DLST dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) 14q24.3 wernicke-korsakoff syndrome alpha-ketoglutarate dehydrogenase deficiency
DLX1 distal-less homeobox 1 2q31.1 autism spectrum disorder
DLX2 distal-less homeobox 2 2q31.1 axenfeld-rieger syndrome, ankylosis dyslexia 2
DLX3 distal-less homeobox 3 17q21.33 amelogenesis imperfecta, ovarian serous cystadenocarcinoma, dental enamel hypoplasia,
DLX4 distal-less homeobox 4 17q21.33 acute promyelocytic leukemia x-linked charcot-marie-tooth disease
DLX5 distal-less homeobox 5 7q21.3 split foot, split hand, rett syndrome,
DLX6 distal-less homeobox 6 7q21.3 split foot, split hand, rett syndrome
DMAP1 DNA methyltransferase 1 associated protein 1 1p34.1 male germ cell tumor
DMBT1 deleted in malignant brain tumors 1 10q26.13 anaplastic astrocytoma, appendicitis, medulloblastoma,
DMD dystrophin Xp21.1 "mental retardation, x-linked 17/31, microduplication", spinal cord injury, centronuclear myopathy,
DMGDH dimethylglycine dehydrogenase 5q14.1 sarcosinemia dimethylglycine dehydrogenase deficiency
DMP1 dentin matrix acidic phosphoprotein 1 4q22.1 oncogenic osteomalacia, hypophosphatemia, osteomalacia,
DMPK dystrophia myotonica-protein kinase 19q13.32 myotonic dystrophy, myotonic dystrophy type 2, congenital myotonic dystrophy,
DMRT1 doublesex and mab-3 related transcription factor 1 9p24.3 chromosome 9p deletion, 46xy sex reversal 6 hypogonadotropic hypogonadism 16 with or without anosmia
DMRT2 doublesex and mab-3 related transcription factor 2 9p24.3 46xy sex reversal 6
DMRTC1 DMRT-like family C1 Xq13.2 intrahepatic cholangiocarcinoma
DMTF1 cyclin D binding myb-like transcription factor 1 7q21.12 lung cancer dental fluorosis
DNA2 DNA replication helicase/nuclease 2 10q21.3 seckel syndrome type 8 "progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 6"
DNAAF1 dynein, axonemal, assembly factor 1 16q23.3 "ciliary dyskinesia, primary, 19", leukostasis, "ciliary dyskinesia, primary, 13"
DNAAF2 dynein, axonemal, assembly factor 2 14q21.3 "ciliary dyskinesia, primary, 19" primary ciliary dyskinesia10: dnaaf2-related primary ciliary dyskinesia
DNAAF3 dynein, axonemal, assembly factor 3 19q13.42 "ciliary dyskinesia, primary, 19", succinic semialdehyde dehydrogenase deficiency, primary ciliary dyskinesia,
DNAH11 dynein, axonemal, heavy chain 11 7p15.3 situs inversus, "ciliary dyskinesia, primary, 19", primary ciliary dyskinesia,
DNAH17 dynein, axonemal, heavy chain 17 17q25.3 nonepidermolytic palmoplantar keratoderma brachial plexus neuropathy
DNAH5 dynein, axonemal, heavy chain 5 5p15.2 astigmatism, situs inversus, "ciliary dyskinesia, primary, 19",
DNAH8 dynein, axonemal, heavy chain 8 6p21.2 malignant hypertension, diabetic angiopathy, torsion dystonia,
DNAI1 dynein, axonemal, intermediate chain 1 9p13.3 situs inversus, "ciliary dyskinesia, primary, 19", primary ciliary dyskinesia,
DNAI2 dynein, axonemal, intermediate chain 2 17q25.1 situs inversus, "ciliary dyskinesia, primary, 19", primary ciliary dyskinesia,
DNAJA1 DnaJ (Hsp40) homolog, subfamily A, member 1 9p21.1 oculopharyngeal muscular dystrophy
DNAJA2 DnaJ (Hsp40) homolog, subfamily A, member 2 16q12.1 adult syndrome
DNAJA3 DnaJ (Hsp40) homolog, subfamily A, member 3 16p13.3 hepatocellular carcinoma
DNAJB1 DnaJ (Hsp40) homolog, subfamily B, member 1 19p13.12 sleeping sickness hepatocellular fibrolamellar carcinoma
DNAJB12 DnaJ (Hsp40) homolog, subfamily B, member 12 10q22.1 choroideremia
DNAJB2 DnaJ (Hsp40) homolog, subfamily B, member 2 2q35 "spinal muscular atrophy, distal, autosomal recessive, 5"
DNAJB4 DnaJ (Hsp40) homolog, subfamily B, member 4 1p31.1 oculopharyngeal muscular dystrophy
DNAJB6 DnaJ (Hsp40) homolog, subfamily B, member 6 7q36.3 walker-warburg syndrome, myofibrillar myopathy, dnajb6-related myofibrillar myopathy
DNAJB8 DnaJ (Hsp40) homolog, subfamily B, member 8 3q21.3 renal cell carcinoma
DNAJC12 DnaJ (Hsp40) homolog, subfamily C, member 12 10q21.3 polycystic liver disease
DNAJC13 DnaJ (Hsp40) homolog, subfamily C, member 13 3q22.1 parkinson disease 1, chronic tic disorder tic disorder
DNAJC14 DnaJ (Hsp40) homolog, subfamily C, member 14 12q13.2 schizophrenia bipolar disorder
DNAJC15 DnaJ (Hsp40) homolog, subfamily C, member 15 13q14.11 cicatricial entropion entropion
DNAJC19 DnaJ (Hsp40) homolog, subfamily C, member 19 3q26.33 dilated cardiomyopathy, barth syndrome, dilated cardiomyopathy with ataxia syndrome
DNAJC28 DnaJ (Hsp40) homolog, subfamily C, member 28 21q22.11 chickenpox
DNAJC30 DnaJ (Hsp40) homolog, subfamily C, member 30 7q11.23 williams-beuren syndrome
DNAJC4 DnaJ (Hsp40) homolog, subfamily C, member 4 11q13.1 wermer syndrome
DNAJC5 DnaJ (Hsp40) homolog, subfamily C, member 5 20q13.33 cystic fibrosis, malaria, neuronal ceroid-lipofuscinoses,
DNAJC6 DnaJ (Hsp40) homolog, subfamily C, member 6 1p31.3 "parkinson disease 19, juvenile-onset"
DNAL1 dynein, axonemal, light chain 1 14q24.3 "ciliary dyskinesia, primary, 19", craniofacial anomalies and anterior segment dysgenesis syndrome , "ciliary dyskinesia, primary, 16"
DNASE1 deoxyribonuclease I 16p13.3 myocardial infarction, cystic fibrosis, systemic lupus erythematosus,
DNASE1L1 deoxyribonuclease I-like 1 Xq28 xerophthalmia, keratomalacia, barth syndrome
DNASE1L3 deoxyribonuclease I-like 3 3p14.3 systemic lupus erythematosus, lupus erythematosus, lymphadenitis,
DND1 DND microRNA-mediated repression inhibitor 1 5q31.3 germ cell tumors, testicular germ cell tumor tongue squamous cell carcinoma
DNM1 dynamin 1 9q34.11 neuronal intranuclear inclusion disease
DNM1L dynamin 1-like 12p11.21 lethal encephalopathy due to defective mitochondrial peroxisomal fission "encephalopahty, lethal, due to defective mitochondrial peroxisomal fission"
DNM2 dynamin 2 19p13.2 centronuclear myopathy, intermediate charcot-marie-tooth neuropathy, larsen syndrome,
DNM3 dynamin 3 1q24.3 dominant optic atrophy
DNMT1 DNA (cytosine-5-)-methyltransferase 1 19p13.2 breast cancer, myelodysplastic syndromes, lymphosarcoma,
DNMT3A DNA (cytosine-5-)-methyltransferase 3 alpha 2p23.3 acute myeloid leukemia, juvenile myelomonocytic leukemia, lymphosarcoma,
DNMT3B DNA (cytosine-5-)-methyltransferase 3 beta 20q11.21 lung cancer, early-onset schizophrenia, mutagen sensitivity,
DNMT3L DNA (cytosine-5-)-methyltransferase 3-like 21q22.3 ovarian endometriosis, seminoma testis seminoma
DNTT DNA nucleotidylexotransferase 10q24.1 acute myeloid leukemia, myelodysplastic syndromes, acute leukemia,
DOCK3 dedicator of cytokinesis 3 3p21.2 wiskott-aldrich syndrome attention deficit hyperactivity disorder
DOCK6 dedicator of cytokinesis 6 19p13.2 adams-oliver syndrome 1 , oliver syndrome, pilomyxoid astrocytoma
DOCK7 dedicator of cytokinesis 7 1p31.3 "epileptic encephalopathy, early infantile, 23"
DOCK8 dedicator of cytokinesis 8 9p24.3 primary immunodeficiency disease, "mental retardation, autosomal dominant 10", lagophthalmos,
DOHH deoxyhypusine hydroxylase/monooxygenase 19p13.3 actinomycosis
DOK7 docking protein 7 4p16.3 "myasthenic syndrome, congenital, with pre- and postsynaptic defects", "myasthenia, limb-girdle, familial", fetal akinesia deformation sequence ,
DOLK dolichol kinase 9q34.11 "cardiomyopathy, dilated, 1w", protein-deficiency anemia "congenital disorder of glycosylation, type im"
DPAGT1 dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) 11q23.3 congenital disorder of glycosylation, exotropia, acute intermittent porphyria,
DPCR1 diffuse panbronchiolitis critical region 1 6p21.33 diffuse panbronchiolitis
DPEP1 dipeptidase 1 (renal) 16q24.3 acute hemorrhagic conjunctivitis blau syndrome
DPF2 D4, zinc and double PHD fingers family 2 11q13.1 pituitary tumors
DPH1 diphthamide biosynthesis 1 17p13.3 ovarian cancer
DPH2 DPH2 homolog (S. cerevisiae) 1p34.1 spindle cell hemangioma
DPH3 diphthamide biosynthesis 3 3p25.1 diphtheria
DPM1 dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit 20q13.13 recurrent respiratory papillomatosis congenital disorder of glycosylation type 1e
DPM2 dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit 9q34.11 muscular dystrophy-dystroglycanopathy, congenital disorder of glycosylation type i "congenital disorder of glycosylation, type iu"
DPM3 dolichyl-phosphate mannosyltransferase polypeptide 3 1q22 "congenital disorder of glycosylation, type io"
DPP10 dipeptidyl-peptidase 10 (non-functional) 2q14.1 asthma hfe-associated hereditary hemochromatosis
DPP4 dipeptidyl-peptidase 4 2q24.2 type 2 diabetes mellitus, nasopharyngitis, hepatosplenic t-cell lymphoma,
DPP6 dipeptidyl-peptidase 6 7q36.2 amyotrophic lateral sclerosis, autosomal dominant microcephaly, "ventricular fibrillation, paroxysmal familial, 2"
DPP9 dipeptidyl-peptidase 9 19p13.3 obesity idiopathic pulmonary fibrosis
DPPA3 developmental pluripotency associated 3 12p13.31 germ cell tumors
DPT dermatopontin 1q24.2 amblyopia, anisometropia, cycloplegia
DPY19L2 dpy-19-like 2 (C. elegans) 12q14.2 spermatogenic failure, globozoospermia, spermatogenic failure 9
DPYD dihydropyrimidine dehydrogenase 1p21.3 colon cancer, gallbladder cancer, orotic aciduria,
DPYS dihydropyrimidinase 8q22.3 beriberi, testicular gonadoblastoma, dihydropyrimidine dehydrogenase deficiency,
DPYSL2 dihydropyrimidinase-like 2 8p21.2 schizophrenia
DPYSL5 dihydropyrimidinase-like 5 2p23.3 visual pathway disease
DR1 down-regulator of transcription 1, TBP-binding (negative cofactor 2) 1p22.1 stargardt disease
DRC1 dynein regulatory complex subunit 1 homolog (Chlamydomonas) 2p23.3 "ciliary dyskinesia, primary, 19", muscular dystrophy-dystroglycanopathy "ciliary dyskinesia, primary, 21"
DRD1 dopamine receptor D1 5q35.2 parkinsons disease, cholera, schizophrenia,
DRD2 dopamine receptor D2 11q23.2 parkinsons disease, alcohol dependence, schizophrenia,
DRD3 dopamine receptor D3 3q13.31 parkinsons disease, alcohol dependence, schizophrenia,
DRD4 dopamine receptor D4 11p15.5 parkinsons disease, schizophrenia, hyperprolactinemia,
DRD5 dopamine receptor D5 4p16.1 alcohol dependence, schizophrenia, bipolar disorder,
DSC1 desmocollin 1 18q12.1 atrophic lichen planus, subcorneal pustular dermatosis astroblastoma
DSC2 desmocollin 2 18q12.1 "familial isolated arrhythmogenic ventricular dysplasia, biventricular form", "familial isolated arrhythmogenic ventricular dysplasia, right dominant form", "familial isolated arrhythmogenic ventricular dysplasia, left dominant form",
DSC3 desmocollin 3 18q12.1 subcorneal pustular dermatosis, pemphigus, pemphigus vulgaris,
DSCAM Down syndrome cell adhesion molecule 21q22.2 down syndrome cystic lymphangioma
DSCAML1 Down syndrome cell adhesion molecule like 1 11q23.3 down syndrome
DSCR10 Down syndrome critical region gene 10 (non-protein coding) 21q22.13 down syndrome
DSCR3 Down syndrome critical region gene 3 21q22.13 down syndrome
DSCR4 Down syndrome critical region gene 4 21q22.13 gestational choriocarcinoma down syndrome
DSE dermatan sulfate epimerase 6q22.1 esophagus squamous cell carcinoma, amblyopia, anisometropia,
DSG1 desmoglein 1 18q12.1 seborrheic keratosis, keratosis, herpes gestationis,
DSG2 desmoglein 2 18q12.1 "familial isolated arrhythmogenic ventricular dysplasia, biventricular form", "familial isolated arrhythmogenic ventricular dysplasia, right dominant form", "familial isolated arrhythmogenic ventricular dysplasia, left dominant form",
DSG3 desmoglein 3 18q12.1 follicular dendritic cell sarcoma, dendritic cell sarcoma, impetigo,
DSG4 desmoglein 4 18q12.1 hypotrichosis, wermer syndrome, impetigo,
DSP desmoplakin 6p24.3 keratosis, "familial isolated arrhythmogenic ventricular dysplasia, biventricular form", "familial isolated arrhythmogenic ventricular dysplasia, right dominant form",
DSPP dentin sialophosphoprotein 4q22.1 dentin sensitivity, pulpitis, dental caries,
DST dystonin 6p12.1 herpes gestationis, ocular cicatricial pemphigoid, scabies,
DSTYK dual serine/threonine and tyrosine protein kinase 1q32.1 unilateral renal agenesis congenital anomalies of kidney and urinary tract
DTNA dystrobrevin, alpha 18q12.1 dystrophinopathies, barth syndrome, left ventricular noncompaction,
DTNBP1 dystrobrevin binding protein 1 6p22.3 schizophrenia, schizoaffective disorder, hermansky-pudlak syndrome
DUH1 Dyschromatosis universalis hereditaria 6q24.2-q25.2 dyschromatosis universalis hereditaria dyschromatosis universalis hereditaria 1
DUH2 Dyschromatosis universalis hereditaria 2 12q21-q23 dyschromatosis universalis hereditaria dyschromatosis universalis hereditaria 2
DUOX1 dual oxidase 1 15q21.1 follicular thyroid carcinoma
DUOX2 dual oxidase 2 15q21.1 follicular thyroid carcinoma, pendred syndrome, hepatopulmonary syndrome,
DUOXA1 dual oxidase maturation factor 1 15q21.1 dyshormonogenic goiter
DUOXA2 dual oxidase maturation factor 2 15q21.1 rapsn-related congenital myasthenic syndrome, bile reflux thyroid dyshormonogenesis 5
DUP16P11.2 Chromosome 16p11.2 duplication syndrome 16p11.2 autism 14b chromosome 16p11.2 duplication syndrome
DUP16P13.3 Chromosome 16p13.3 duplication syndrome 16p13.3 chromosome 16p13.3 duplication
DUP17P13.3 Chromosome 17p13.3 duplication syndrome 17p13.3 chromosome 17p13.3 duplication syndrome
DUP17Q12 Chromosome 17q12 duplication syndrome 17q12 chromosome 17q12 duplication syndrome
DUP17Q21.31 Chromosome 17q21.31 duplication syndrome 17q21.31 chromosome 17q21.31 duplication syndrome
DUP17Q23.1Q23.2 Chromosome 17q23.1-q23.2 duplication syndrome 17q23.1-q23.2 chromosome 17q23.1-q23.2 duplication syndrome
DUP18PDEL18Q Chromosome 18 pericentric inversion 18q22 chromosome 18 pericentric inversion
DUP1Q21 Chromosome 1q21.1 duplication syndrome 1q21.1 chromosome 1q21.1 duplication syndrome
DUP22Q11.2 Chromosome 22q11.2 microduplication syndrome 22q11.2 22q11.2 duplication
DUP22Q13 Chromosome 22q13 duplication syndrome 22q13 chromosome 22q13 duplication syndrome
DUP2Q31.1 Chromosome 2q31.1 duplication syndrome 2q31.1 chromosome 2q31.1 duplication syndrome
DUP3Q29 chromosome 3q29 microduplication syndrome 3q29 chromosome 3q29 microduplication syndrome
DUP5P13 Chromosome 5p13 duplication syndrome 5p13 chromosome 5p13 duplication syndrome
DUP7Q11.23 Chromosome 7q11.23 duplication syndrome 7q11.23 7q11.23 duplication syndrome
DUPC1 Dupuytren contracture 1 16q11.1-q22 dupuytren contracture 1
DUPXP11.23P11.22 Chromosome Xp11.23-p11.22 duplication syndrome Xp11.23-p11.22 chromosome xp11.23-p11.22 duplication syndrome
DUPXQ27.3Q28 Chromosome Xq27.3-q28 duplication syndrome Xq27.3-q28 chromosome xq27.3-q28 duplication syndrome
DUPXQ28 Chromosome Xq28 duplication syndrome Xq28 chromosome xq28 duplication syndrome
DURS1 Duane retraction syndrome 1 8q13 duane retraction syndrome duane syndrome type 1
DUS2 dihydrouridine synthase 2 16q22.1 lung cancer
DUSP1 dual specificity phosphatase 1 5q35.1 vaccinia
DUSP13 dual specificity phosphatase 13 10q22.2 endometrial carcinoma, juvenile polyposis syndrome, bannayan-riley-ruvalcaba syndrome,
DUSP15 dual specificity phosphatase 15 20q11.21 vaccinia
DUSP19 dual specificity phosphatase 19 2q32.1 osteochondroma, amyotrophic lateral sclerosis cowden disease
DUSP2 dual specificity phosphatase 2 2q11.2 type 2 diabetes mellitus
DUSP21 dual specificity phosphatase 21 Xp11.3 breast and colorectal cancer
DUSP22 dual specificity phosphatase 22 6p25.3 duane retraction syndrome alk-negative anaplastic large cell lymphoma
DUSP23 dual specificity phosphatase 23 1q23.2 interstitial lung disease dental enamel hypoplasia
DUSP26 dual specificity phosphatase 26 (putative) 8p12 embryonal cancer
DUSP3 dual specificity phosphatase 3 17q21.31 breast cancer, ovarian cancer, vaccinia
DUSP5 dual specificity phosphatase 5 10q25.2 malt lymphoma
DUSP6 dual specificity phosphatase 6 12q21.33 hypogonadotropic hypogonadism 8 with or without anosmia, hypogonadotropic hypogonadism 17 with or without anosmia, inclusion body myositis,
DUSP8 dual specificity phosphatase 8 11p15.5 vaccinia
DUT deoxyuridine triphosphatase 15q21.1 cysticercosis
DUX4 double homeobox 4 4q35.2 embryonal rhabdomyosarcoma facioscapulohumeral muscular dystrophy
DUX4L9 double homeobox 4 like 9 4q35.2 opioid abuse
DVL1 dishevelled segment polarity protein 1 1p36.33 charcot-marie-tooth disease type 2, familial adenomatous polyposis, charcot-marie-tooth disease type 2a
DVL2 dishevelled segment polarity protein 2 17p13.1 double outlet right ventricle alk-positive anaplastic large cell lymphoma
DVL3 dishevelled segment polarity protein 3 3q27.1 alk-positive anaplastic large cell lymphoma
DWS dandy-walker syndrome 3q22-q24 dandy-walker syndrome
DYM dymeclin 18q21.1 osteochondrodysplasia, spondyloepimetaphyseal dysplasia, smith mccort dysplasia
DYNC1H1 dynein, cytoplasmic 1, heavy chain 1 14q32.31 charcot-marie-tooth neuropathy type 2, spinal muscular atrophy, "mental retardation, autosomal dominant 10",
DYNC1I2 dynein, cytoplasmic 1, intermediate chain 2 2q31.1 leukorrhea
DYNC2H1 dynein, cytoplasmic 2, heavy chain 1 11q22.3 asphyxiating thoracic dystrophy, polydactyly, sensenbrenner syndrome,
DYNLT3 dynein, light chain, Tctex-type 3 Xp11.4 ornithine carbamoyltransferase deficiency
DYRK1A dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A 21q22.13 "mental retardation, autosomal dominant 10", down syndrome "mental retardation, autosomal dominant 7"
DYRK1B dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B 19q13.2 abdominal obesity-metabolic syndrome 3
DYSF dysferlin 2p13.2 myopathy, limb-girdle muscular dystrophy, dysferlinopathy,
DYT10 dystonia 10 16p11.2-q12.1 diabetic macular edema, paroxysmal dyskinesia, diabetic angiopathy,
DYT13 dystonia 13, torsion 1p36 torsion dystonia, dystonia 13 "primary dystonia, dyt13 type"
DYT15 dystonia 15, myoclonic 18p11 myoclonus-dystonia, "dystonia-11, myoclonic" "dystonia 15, myoclonic"
DYT17 dystonia 17 20p11.2-q13.12 torsion dystonia, "dystonia-17, primary torsion", "primary dystonia, dyt17 type"
DYT2 dystonia 2, torsion (autosomal recessive) reserved torsion dystonia "primary dystonia, dyt2 type"
DYT21 dystonia 21, torsion (autosomal dominant) 2q14.3-q21.3 torsion dystonia, "primary dystonia, dyt21 type" dystonia 21
DYT7 dystonia 7, torsion (autosomal dominant) 18p torsion dystonia, cervical dystonia, dystonia 7,
DYX1 dyslexia susceptibility 1 15 dyslexia, dyslexia 1 "ciliary dyskinesia, primary, 25"
DYX1C1 dyslexia susceptibility 1 candidate 1 15q21.3 "ciliary dyskinesia, primary, 19", dyslexia, articulation disorder,
DYX1C1-CCPG1 DYX1C1-CCPG1 readthrough (NMD candidate) 15q21.3 dyslexia
DYX2 dyslexia susceptibility 2 6 dyslexia dyslexia 2
DYX3 dyslexia susceptibility 3 2p16-p15 dyslexia 3
DYX5 dyslexia susceptibility 5 3p12-q13 dyslexia dyslexia 5
DYX6 dyslexia susceptibility 6 18p11.2 dyslexia 6
DYX8 dyslexia susceptibility 8 1p36-p34 dyslexia 8
DYX9 dyslexia susceptibility 9 Xq27.3 dyslexia 9
E2F1 E2F transcription factor 1 20q11.22 osteochondroma, retinoblastoma, colon cancer,
E2F3 E2F transcription factor 3 6p22.3 retinoblastoma
E2F8 E2F transcription factor 8 11p15.1 erythema infectiosum
E4F1 E4F transcription factor 1 16p13.3 "polycystic kidney disease, type 1" "tuberous sclerosis, type 2"
EA3 Episodic ataxia, type 3 1q42 "episodic ataxia, type 3"
EA7 Episodic ataxia, type 7 19q13 "episodic ataxia, type 7"
EAF1 ELL associated factor 1 3p25.1 childhood leukemia
EAF1-AS1 EAF1 antisense RNA 1 3p25.1 eaf
EARS2 glutamyl-tRNA synthetase 2, mitochondrial 16p12.2 primary cutaneous amyloidosis, anisometropia combined oxidative phosphorylation deficiency 12
EBAG9 estrogen receptor binding site associated, antigen, 9 8q23.2 cervical cancer, pre-eclampsia, pancreatic cancer,
EBF3 early B-cell factor 3 10q26.3 glioblastoma multiforme thyroid lymphoma
EBF4 early B-cell factor 4 20p13 gestational choriocarcinoma choriocarcinoma
EBI3 Epstein-Barr virus induced 3 19p13.3 sialadenitis
EBNA1BP2 EBNA1 binding protein 2 1p34.2 intracranial hypotension
EBP emopamil binding protein (sterol isomerase) Xp11.23 chondrodysplasia, esotropia, anaplastic large cell lymphoma,
ECA1 epilepsy, childhood absence 1 8q24 "epilepsy, childhood absence, 1"
ECE1 endothelin converting enzyme 1 1p36.12 autonomic dysfunction, hirschsprungs disease, essential hypertension,
ECEL1 endothelin converting enzyme-like 1 2q37.1 "arthrogryposis, distal, type 5d" distal arthrogryposis
ECH1 enoyl CoA hydratase 1, peroxisomal 19q13.2 myotonic dystrophy type 2
ECHS1 enoyl CoA hydratase, short chain, 1, mitochondrial 10q26.3 sudden infant death syndrome human monocytic ehrlichiosis
ECI2 enoyl-CoA delta isomerase 2 6p25.2 hepatocellular carcinoma aplastic anemia
ECM1 extracellular matrix protein 1 1q21.3 generalized dystonia, lichen sclerosus, peripheral retinal degeneration,
ECRP ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) pseudogene 14q11.2 biliary dyskinesia
ECSIT ECSIT signalling integrator 19p13.2 pulpitis
ECT centralopathic epilepsy 11p13 centrotemporal epilepsy
ECTD5 Ectodermal dysplasia 5, hair/nail type 10q24.32-q25.1 "ectodermal dysplasia 5, hair/nail type"
ECTD6 Ectodermal dysplasia 6, hair/nail type 17p12-q21.2 "ectodermal dysplasia 6, hair/nail type"
ECTD7 Ectodermal dysplasia 7, hair/nail type 12p11.1-q21.1 "ectodermal dysplasia 7, hair/nail type"
ECTD8 Ectodermal dysplasia 8, hair/tooth/nail type 18q22.1-q22.3 "ectodermal dysplasia 8, hair/tooth/nail type"
EDA ectodysplasin A Xq13.1 "tooth agenesis, selective, 1, with or without orofacial cleft", hypohidrotic ectodermal dysplasia, tooth agenesis,
EDA2R ectodysplasin A2 receptor Xq12 hypohidrotic ectodermal dysplasia, ectodermal dysplasia "ectodermal dysplasia 1, hypohidrotic, x-linked"
EDAR ectodysplasin A receptor 2q12.3 "ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant", hypohidrotic ectodermal dysplasia, hypohidrosis,
EDARADD EDAR-associated death domain 1q42.3 "tooth agenesis, selective, 1, with or without orofacial cleft", "ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant", hypohidrotic ectodermal dysplasia,
EDC3 enhancer of mRNA decapping 3 15q24.1 actinomycosis
EDC4 enhancer of mRNA decapping 4 16q22.1 ulnar neuropathy thoracic outlet syndrome
EDN1 endothelin 1 6p24.1 polyhydramnios, mesangial proliferative glomerulonephritis, primary pulmonary hypertension,
EDN2 endothelin 2 1p34.2 primary biliary cirrhosis, essential hypertension, hypertension,
EDN3 endothelin 3 20q13.32 hirschsprungs disease, congenital central hypoventilation syndrome, central hypoventilation syndrome,
EDNRA endothelin receptor type A 4q31.22 colorectal cancer, radiation proctitis, toxic shock syndrome,
EDNRB endothelin receptor type B 13q22.3 hirschsprungs disease, congenital central hypoventilation syndrome, central hypoventilation syndrome,
EDS8 Ehlers-Danlos syndrome, type VIII 12p13 "ehlers-danlos syndrome, type viii"
EDSS2 Ectodermal dysplasia-syndactyly syndrome 2 7p21.2-p14.3 ectodermal dysplasia-syndactyly syndrome 2
EEC1 ectrodactyly, ectodermal dysplasia and cleft lip/palate syndrome 1 7q11.2-q21.3 eec syndrome-1 eec syndrome
EED embryonic ectoderm development 11q14.2 hiv-1
EEF1A1 eukaryotic translation elongation factor 1 alpha 1 6q13 cervical cancer, feltys syndrome tinea nigra
EEF1A1P14 eukaryotic translation elongation factor 1 alpha 1 pseudogene 14 1q31.3 alzheimers disease
EEF1A1P24 eukaryotic translation elongation factor 1 alpha 1 pseudogene 24 3p22.1 multiple myeloma
EEF1A1P5 eukaryotic translation elongation factor 1 alpha 1 pseudogene 5 9q34.13 multiple myeloma
EEF1A1P6 eukaryotic translation elongation factor 1 alpha 1 pseudogene 6 7p15.3 tinea nigra
EEF1A1P9 eukaryotic translation elongation factor 1 alpha 1 pseudogene 9 4q24 multiple myeloma
EEF1A2 eukaryotic translation elongation factor 1 alpha 2 20q13.33 ovarian cancer legionellosis
EEF1D eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) 8q24.3 hiv-1 cystic echinococcosis
EEF2 eukaryotic translation elongation factor 2 19p13.3 spinocerebellar ataxia 26
EFEMP1 EGF containing fibulin-like extracellular matrix protein 1 2p16.1 age related macular degeneration, wolfram syndrome doyne honeycomb retinal dystrophy
EFEMP2 EGF containing fibulin-like extracellular matrix protein 2 11q13.1 cutis laxa, lethal arteriopathy syndrome due to fibulin-4 deficiency, efemp2-related cutis laxa,
EFHC1 EF-hand domain (C-terminal) containing 1 6p12.2 juvenile myoclonic epilepsy, "epilepsy, juvenile myoclonic 8", sapho syndrome,
EFHC2 EF-hand domain (C-terminal) containing 2 Xp11.3 turner syndrome
EFNA1 ephrin-A1 1q22 adenoid cystic carcinoma
EFNA2 ephrin-A2 19p13.3 craniofrontonasal syndrome
EFNA3 ephrin-A3 1q22 androgenic alopecia
EFNB1 ephrin-B1 Xq13.1 craniofrontonasal syndrome, congenital diaphragmatic hernia hyperlipoproteinemia type v
EFNB2 ephrin-B2 13q33.3 craniofrontonasal syndrome
EFS embryonal Fyn-associated substrate 14q11.2 kidney cancer
EFTUD1 elongation factor Tu GTP binding domain containing 1 15q25.2 shwachman-diamond syndrome
EFTUD2 elongation factor Tu GTP binding domain containing 2 17q21.31 microcephaly, choanal atresia, dysostosis
EGF epidermal growth factor 4q25 adenocarcinoma, embryonal cancer, folliculitis,
EGFL6 EGF-like-domain, multiple 6 Xp22.2 meningioma, detrusor sphincter dyssynergia fibrous meningioma
EGFR epidermal growth factor receptor 7p11.2 gliosarcoma, giant cell glioblastoma, adenocarcinoma,
EGI epilepsy, generalized, idiopathic 8q24 idiopathic generalized epilepsy juvenile myoclonic epilepsy
EGID-100124696 transient erythroblastopenia of childhood 19q13.2 transient erythroblastopenia of childhood
EGID-100505381 Miyoshi muscular dystrophy 2 10p miyoshi muscular dystrophy 2 distal muscular dystrophy
EGID-7795 Methylation modifier for class I HLA 1p36.1-p35 alcohol dependence, sporadic breast cancer conduct disorder
EGLN1 egl-9 family hypoxia-inducible factor 1 1q42.2 hypoxia, familial erythrocytosis 3, familial erythrocytosis 4
EGLN1P1 egl-9 family hypoxia-inducible factor 1 pseudogene 1 15q25.2 hypoxia
EGLN2 egl-9 family hypoxia-inducible factor 2 19q13.2 pre-eclampsia, hypoxia, renal oncocytoma,
EGLN3 egl-9 family hypoxia-inducible factor 3 14q13.1 pre-eclampsia hypoxia
EGOT eosinophil granule ontogeny transcript (non-protein coding) 3p26.1 fetishism
EGR1 early growth response 1 5q31.2 familial tumoral calcinosis, aortic valve disease, normophosphatemic familial tumoral calcinosis
EGR2 early growth response 2 10q21.3 charcot-marie-tooth neuropathy type 4, charcot-marie-tooth disease type 4, charcot-marie-tooth neuropathy type 1d,
EGR3 early growth response 3 8p21.3 bipolar i disorder, chondromalacia, chondromalacia patellae,
EHBP1 EH domain binding protein 1 2p15 prostate cancer "prostate cancer, hereditary, 12"
EHD1 EH-domain containing 1 11q13.1 bardet-biedl syndrome 1 subvalvular aortic stenosis
EHD2 EH-domain containing 2 19q13.33 pathological gambling
EHD4 EH-domain containing 4 15q15.1 hepatocellular carcinoma
EHF ets homologous factor 11p13 ebola hemorrhagic fever, vertebrobasilar insufficiency allergic urticaria
EHHADH enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase 3q27.2 fanconi renotubular syndrome 2 , neonatal adrenoleukodystrophy, d-bifunctional protein deficiency,
EHMT1 euchromatic histone-lysine N-methyltransferase 1 9q34.3 kleefstra syndrome due to 9q34 microdeletion, kleefstra syndrome due to a point mutation kleefstra syndrome
EIF2AK2 eukaryotic translation initiation factor 2-alpha kinase 2 2p22.2 herpes simplex, rift valley fever, hepatitis d,
EIF2AK3 eukaryotic translation initiation factor 2-alpha kinase 3 2p11.2 brain ischemia epiphyseal dysplasia multiple with early-onset diabetes mellitus
EIF2AK4 eukaryotic translation initiation factor 2 alpha kinase 4 15q15.1 yellow fever, pulmonary venoocclusive disease pulmonary venoocclusive disease 2
EIF2B1 eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa 12q24.31 retrograde amnesia, mast cell neoplasm, leukoencephaly with vanishing white matter,
EIF2B2 eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa 14q24.3 mast cell neoplasm, eif2b2-related childhood ataxia with central nervous system hypomyelination/vanishing white matter, leukoencephaly with vanishing white matter,
EIF2B3 eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa 1p34.1 leukodystrophy, hepatitis c, hepatitis c virus,
EIF2B4 eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa 2p23.3 mast cell neoplasm, leukoencephaly with vanishing white matter, ovarioleukodystrophy ,
EIF2B5 eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa 3q27.1 mast cell neoplasm, leukoencephaly with vanishing white matter, ovarioleukodystrophy ,
EIF2D eukaryotic translation initiation factor 2D 1q32.1 hepatocellular carcinoma
EIF3FP3 eukaryotic translation initiation factor 3, subunit F pseudogene 3 2p16.1 cannabis dependence uterine fibroid
EIF3H eukaryotic translation initiation factor 3, subunit H 8q24.11 trichorhinophalangeal syndrome type i
EIF3I eukaryotic translation initiation factor 3, subunit I 1p35.1 clonorchiasis
EIF3M eukaryotic translation initiation factor 3, subunit M 11p13 cystic lymphangioma
EIF4A1 eukaryotic translation initiation factor 4A1 17p13.1 skin atrophy
EIF4A1P1 eukaryotic translation initiation factor 4A1 pseudogene 1 21q21.3 major depressive disorder
EIF4A3 eukaryotic translation initiation factor 4A3 17q25.3 vaginal cancer richieri costa pereira syndrome
EIF4E eukaryotic translation initiation factor 4E 4q23 mouth disease, laryngeal squamous cell carcinoma, laryngeal carcinoma,
EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 8p11.23 tuberous sclerosis
EIF4EBP3 eukaryotic translation initiation factor 4E binding protein 3 5q31.3 lung adenocarcinoma
EIF4G1 eukaryotic translation initiation factor 4 gamma, 1 3q27.1 parkinsons disease, mouth disease, lewy body dementia,
EIF4G2 eukaryotic translation initiation factor 4 gamma, 2 11p15.3 amnestic disorder
EIF4H eukaryotic translation initiation factor 4H 7q11.23 williams-beuren syndrome iridocyclitis
EIF5A eukaryotic translation initiation factor 5A 17p13.1 malaria
EIF5AP2 eukaryotic translation initiation factor 5A pseudogene 2 17q25.3 hiv-1
EIF5AP3 eukaryotic translation initiation factor 5A pseudogene 3 19q13.32 hiv-1
EIF6 eukaryotic translation initiation factor 6 20q11.22 exophthalmos, shwachman-diamond syndrome, mucous membrane pemphigoid
EIG2 Epilepsy, idiopathic generalized, susceptibility to 2 14q23 "epilepsy, idiopathic generalized 2"
EIG3 Epilepsy, idiopathic generalized, susceptibility to 3 9q32-q33 "epilepsy, idiopathic generalized 3"
EIG4 Epilepsy, idiopathic generalized, susceptibility to 4 10q25-q26 "epilepsy, idiopathic generalized 4"
EIG5 Epilepsy, idiopathic generalized, susceptibility to, 5 10p11.22 "epilepsy, idiopathic generalized 5"
EIM Infantile myoclonic epilepsy myoclonic epilepsy of infancy
EJM2 epilepsy, juvenile myoclonic 2 15q14 juvenile myoclonic epilepsy "epilepsy, idiopathic generalized 7"
EJM3 Epilepsy, juvenile myoclonic 3 6p21 "epilepsy, juvenile myoclonic 3"
EJM4 Myoclonic epilepsy, juvenile, 4 5q12-q14 "myoclonic epilepsy, juvenile, 4"
EJM9 Epilepsy, juvenile myoclonic, susceptiblity to, 9 2q33-q36 "epilepsy, juvenile myoclonic, susceptiblity to, 9"
EKD2 Episodic kinesigenic dyskinesia 2 16q13-q22.1 dystonia 19
EKV3 erythrokeratodermia variabilis 3 (Kamouraska type) 7q22 erythrokeratodermia variabilis
ELAC2 elaC ribonuclease Z 2 17p12 prostate cancer, familial prostate cancer, "prostate cancer, progression and metastasis of",
ELANE elastase, neutrophil expressed 19p13.3 bronchopulmonary dysplasia, disseminated intravascular coagulation, pulmonary emphysema,
ELAVL2 ELAV like neuron-specific RNA binding protein 2 9p21.3 contagious pustular dermatitis
ELAVL3 ELAV like neuron-specific RNA binding protein 3 19p13.2 encephalitis, limbic encephalitis encephalomyelitis
ELAVL4 ELAV like neuron-specific RNA binding protein 4 1p33 paraneoplastic neurologic disorders, encephalomyelitis "neuropathy, paraneoplastic sensory"
ELF3 E74-like factor 3 (ets domain transcription factor, epithelial-specific ) 1q32.1 retroperitoneal sarcoma
ELF4 E74-like factor 4 (ets domain transcription factor) Xq26.1 agammaglobulinemia and isolated hormone deficiency
ELK3 ELK3, ETS-domain protein (SRF accessory protein 2) 12q23.1 relapsing fever tick-borne relapsing fever
ELL elongation factor RNA polymerase II 19p13.11 leukemia
ELMO1 engulfment and cell motility 1 7p14.1 diabetic nephropathy diaphanospondylodysostosis
ELMOD2 ELMO/CED-12 domain containing 2 4q31.1 pulmonary fibrosis idiopathic pulmonary fibrosis
ELMOD3 ELMO/CED-12 domain containing 3 2p11.2 "deafness, autosomal recessive 76" "deafness, autosomal recessive 88"
ELN elastin 7q11.23 pulmonary emphysema, periventricular nodular heterotopia, adenomatoid tumor,
ELOF1 elongation factor 1 homolog (S. cerevisiae) 19p13.2 stomatitis
ELOVL1 ELOVL fatty acid elongase 1 1p34.2 peroxisomal disease
ELOVL2 ELOVL fatty acid elongase 2 6p24.2 gastric antral vascular ectasia
ELOVL4 ELOVL fatty acid elongase 4 6q14.1 quadriplegia, spastic quadriplegia, benign concentric annular macular dystrophy,
ELOVL5 ELOVL fatty acid elongase 5 6p12.1 low tension glaucoma
ELOVL6 ELOVL fatty acid elongase 6 4q25 choledocholithiasis cholecystolithiasis
ELP2 elongator acetyltransferase complex subunit 2 18q12.2 eastern equine encephalitis
ELP3 elongator acetyltransferase complex subunit 3 8p21.1 riley-day syndrome
ELP4 elongator acetyltransferase complex subunit 4 11p13 benign epilepsy with centrotemporal spikes, landau-kleffner syndrome, aniridia,
EMCN endomucin 4q24 angiolipoma
EMD emerin Xq28 neuromuscular disease, familial partial lipodystrophy, rigid spine syndrome,
EMG1 EMG1 N1-specific pseudouridine methyltransferase 12p13.31 sporadic breast cancer, hyperprolinemia bowen-conradi syndrome
EMILIN2 elastin microfibril interfacer 2 18p11.32 porokeratosis, myopia-2 porokeratosis of mibelli
EML1 echinoderm microtubule associated protein like 1 14q32.2 usher syndrome type i
EML4 echinoderm microtubule associated protein like 4 2p21 congenital pulmonary airway malformation
EMP2 epithelial membrane protein 2 16p13.13 charcot-marie-tooth disease type 1, familial idiopathic steroid-resistant nephrotic syndrome with minimal changes, charcot-marie-tooth disease type 1c,
EMWX episodic muscle weakness, X-linked Xp22.3 "episodic muscle weakness, x-linked"
EMX2 empty spiracles homeobox 2 10q26.11 periventricular nodular heterotopia, neuronal migration disorders, focal epilepsy,
EN1 engrailed homeobox 1 2q14.2 tyrosinemia, congenital central hypoventilation syndrome, central hypoventilation syndrome,
EN2 engrailed homeobox 2 7q36.3 autistic disorder autism spectrum disorder
ENAM enamelin 4q13.3 amelogenesis imperfecta, craniopharyngioma, dentinogenesis imperfecta,
ENDO1 Endometriosis, susceptibility to, 1 10q26 endometriosis endometriosis 1
ENDOG endonuclease G 9q34.11 osteosarcoma mitochondrial disorders
ENDOU endonuclease, polyU-specific 12q13.11 mucinous cystadenocarcinoma
ENFL2 Epilepsy, nocturnal frontal lobe, type 2 15q24 "epilepsy, nocturnal frontal lobe, type 2"
ENG endoglin 9q34.11 juvenile nasopharyngeal angiofibroma, trachoma, arteriovenous malformation,
ENGASE endo-beta-N-acetylglucosaminidase 17q25.3 fucosidosis sparganosis
ENO1 enolase 1, (alpha) 1p36.23 autoimmune retinopathy, giardiasis, lymphocytic hypophysitis,
ENO2 enolase 2 (gamma, neuronal) 12p13.31 epulis, nervous system cancer, central nervous system cancer,
ENO3 enolase 3 (beta, muscle) 17p13.2 glycogen storage disease, discoid lupus erythematosus, coenzyme q10 deficiency disease,
ENOSF1 enolase superfamily member 1 18p11.32 rothmund-thomson syndrome
ENPEP glutamyl aminopeptidase (aminopeptidase A) 4q25 gestational choriocarcinoma, choriocarcinoma neurogenic hypertension
ENPP1 ectonucleotide pyrophosphatase/phosphodiesterase 1 6q23.2 type 2 diabetes mellitus, calcinosis, arterial calcification of infancy,
ENPP3 ectonucleotide pyrophosphatase/phosphodiesterase 3 6q23.2 bile duct disease sm-ahnmd
ENSG00000112474 HSCHR6_MHC_QBLp2 colorectal cancer breast and colorectal cancer
ENSG00000137197 HSCHR6_MHC_COXp2 hypotrichosis simplex skin disease
ENSG00000137397 HSCHR6_MHC_QBLp2 gastric adenocarcinoma
ENSG00000183214 HSCHR6_MHC_QBLp2 psoriatic arthritis
ENSG00000184494 HSCHR6_MHC_QBLp2 galactosialidosis
ENSG00000200150 14q32.31 angelman syndrome
ENSG00000204364 HSCHR6_MHC_MANNp rothmund-thomson syndrome
ENSG00000204692 HSCHR6_MHC_MCFp2 colorectal cancer breast and colorectal cancer
ENSG00000206235 HSCHR6_MHC_MANNp sjogrens syndrome
ENSG00000206282 HSCHR6_MHC_QBLp2 familial tumoral calcinosis normophosphatemic familial tumoral calcinosis
ENSG00000206290 HSCHR6_MHC_QBLp2 fibrochondrogenesis, otospondylomegaepiphyseal dysplasia stickler syndrome
ENSG00000206298 HSCHR6_MHC_QBLp2 chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature
ENSG00000206331 HSCHR6_MHC_QBLp2 breast and colorectal cancer
ENSG00000206340 HSCHR6_MHC_QBLp2 sle susceptibility c4a deficiency
ENSG00000206353 HSCHR6_MHC_QBLp2 diarrhea syndromic diarrhea
ENSG00000206372 HSCHR6_MHC_QBLp2 rothmund-thomson syndrome
ENSG00000206378 HSCHR6_MHC_QBLp2 colorectal cancer breast and colorectal cancer
ENSG00000206468 HSCHR6_MHC_MCFp2 diabetic nephropathy
ENSG00000206478 HSCHR6_MHC_QBLp2 pancreatic ductal adenocarcinoma
ENSG00000206510 HSCHR6_MHC_QBLp2 frasier syndrome
ENSG00000215641 HSCHR6_MHC_QBLp2 germ cell tumors papillary thyroid carcinoma
ENSG00000223493 HSCHR6_MHC_DBBp2 diarrhea syndromic diarrhea
ENSG00000223531 HSCHR6_MHC_MCFp2 gastric adenocarcinoma
ENSG00000223852 HSCHR6_MHC_DBBp2 frasier syndrome
ENSG00000223858 HSCHR6_MHC_MCFp2 frasier syndrome
ENSG00000223957 HSCHR6_MHC_MANNp galactosialidosis
ENSG00000224168 HSCHR6_MHC_SSTOp gastric adenocarcinoma
ENSG00000224487 HSCHR6_MHC_MANNp colorectal cancer breast and colorectal cancer
ENSG00000224841 HSCHR6_MHC_COXp2 familial tumoral calcinosis normophosphatemic familial tumoral calcinosis
ENSG00000225130 HSCHR6_MHC_MANNp gastric adenocarcinoma
ENSG00000225141 HSCHR6_MHC_DBBp2 breast and colorectal cancer
ENSG00000225312 HSCHR6_MHC_DBBp2 colorectal cancer breast and colorectal cancer
ENSG00000225737 HSCHR6_MHC_COXp2 diarrhea syndromic diarrhea
ENSG00000226201 HSCHR6_MHC_MCFp2 chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature
ENSG00000226560 HSCHR6_MHC_MCFp2 rothmund-thomson syndrome
ENSG00000226858 HSCHR6_MHC_COXp2 frasier syndrome
ENSG00000227122 HSCHR6_MHC_MCFp2 breast and colorectal cancer
ENSG00000227129 HSCHR6_MHC_MCFp2 galactosialidosis
ENSG00000227231 HSCHR6_MHC_DBBp2 pancreatic ductal adenocarcinoma
ENSG00000227315 HSCHR6_MHC_COXp2 galactosialidosis
ENSG00000227720 HSCHR6_MHC_DBBp2 hemochromatosis
ENSG00000227746 HSCHR6_MHC_MCFp2 sle susceptibility c4a deficiency
ENSG00000227801 HSCHR6_MHC_COXp2 fibrochondrogenesis, otospondylomegaepiphyseal dysplasia stickler syndrome
ENSG00000228263 HSCHR6_MHC_DBBp2 colorectal cancer breast and colorectal cancer
ENSG00000228267 HSCHR6_MHC_COXp2 c4b deficiency sle susceptibility
ENSG00000228357 HSCHR6_MHC_MANNp colorectal cancer breast and colorectal cancer
ENSG00000228454 HSCHR6_MHC_SSTOp c4b deficiency sle susceptibility
ENSG00000228691 HSCHR6_MHC_APDp2 galactosialidosis
ENSG00000228712 HSCHR6_MHC_COXp2 colorectal cancer breast and colorectal cancer
ENSG00000228736 HSCHR6_MHC_MCFp2 familial tumoral calcinosis normophosphatemic familial tumoral calcinosis
ENSG00000228896 HSCHR6_MHC_SSTOp syndromic diarrhea
ENSG00000228913 HSCHR6_MHC_COXp2 diabetic nephropathy
ENSG00000229006 HSCHR6_MHC_SSTOp germ cell tumors papillary thyroid carcinoma
ENSG00000229071 HSCHR6_MHC_COXp2 breast and colorectal cancer
ENSG00000229077 HSCHR6_MHC_MCFp2 colorectal cancer breast and colorectal cancer
ENSG00000229488 HSCHR6_MHC_MANNp breast and colorectal cancer
ENSG00000230034 HSCHR6_MHC_DBBp2 chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature
ENSG00000230128 HSCHR6_MHC_MANNp pancreatic ductal adenocarcinoma
ENSG00000230279 HSCHR6_MHC_SSTOp psoriatic arthritis
ENSG00000230669 HSCHR6_MHC_APDp2 chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature
ENSG00000230930 HSCHR6_MHC_DBBp2 fibrochondrogenesis, otospondylomegaepiphyseal dysplasia stickler syndrome
ENSG00000231408 HSCHR6_MHC_MANNp psoriatic arthritis
ENSG00000231479 HSCHR6_MHC_COXp2 colorectal cancer breast and colorectal cancer
ENSG00000231543 HSCHR6_MHC_DBBp2 rothmund-thomson syndrome
ENSG00000231631 HSCHR6_MHC_SSTOp chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature
ENSG00000231968 HSCHR6_MHC_DBBp2 diabetic nephropathy
ENSG00000232099 HSCHR6_MHC_MANNp frasier syndrome
ENSG00000232180 HSCHR6_MHC_SSTOp colorectal cancer breast and colorectal cancer
ENSG00000232357 HSCHR6_MHC_MCFp2 breast and colorectal cancer
ENSG00000232616 HSCHR6_MHC_MCFp2 syndromic diarrhea
ENSG00000233314 HSCHR6_MHC_APDp2 hemochromatosis
ENSG00000233573 HSCHR6_MHC_DBBp2 gastric adenocarcinoma
ENSG00000234058 HSCHR6_MHC_COXp2 hemochromatosis
ENSG00000234343 HSCHR6_MHC_DBBp2 galactosialidosis
ENSG00000234495 HSCHR6_MHC_APDp2 germ cell tumors papillary thyroid carcinoma
ENSG00000234669 HSCHR6_MHC_SSTOp frasier syndrome
ENSG00000234846 HSCHR6_MHC_SSTOp galactosialidosis
ENSG00000235017 HSCHR6_MHC_COXp2 rothmund-thomson syndrome
ENSG00000235030 HSCHR6_MHC_SSTOp pancreatic ductal adenocarcinoma
ENSG00000235336 HSCHR6_MHC_APDp2 colorectal cancer breast and colorectal cancer
ENSG00000235696 HSCHR6_MHC_SSTOp rothmund-thomson syndrome
ENSG00000235708 HSCHR6_MHC_MCFp2 fibrochondrogenesis, otospondylomegaepiphyseal dysplasia stickler syndrome
ENSG00000235715 HSCHR6_MHC_COXp2 chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature
ENSG00000235956 HSCHR6_MHC_SSTOp breast and colorectal cancer
ENSG00000236443 HSCHR6_MHC_MANNp chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature
ENSG00000236625 HSCHR6_MHC_DBBp2 c4b deficiency sle susceptibility
ENSG00000237071 HSCHR6_MHC_COXp2 germ cell tumors papillary thyroid carcinoma
ENSG00000237114 HSCHR6_MHC_MANNp hypotrichosis simplex skin disease
ENSG00000237123 HSCHR6_MHC_DBBp2 hypotrichosis simplex skin disease
ENSG00000237155 HSCHR6_MHC_COXp2 pancreatic ductal adenocarcinoma
ENSG00000237165 HSCHR6_MHC_MCFp2 hypotrichosis simplex skin disease
ENSG00000237825 HSCHR6_MHC_DBBp2 familial tumoral calcinosis normophosphatemic familial tumoral calcinosis
ENSG00000238056 HSCHR6_MHC_APDp2 breast and colorectal cancer
ENSG00000242022 HSCHR6_MHC_DBBp2 colorectal cancer breast and colorectal cancer
ENTPD1 ectonucleoside triphosphate diphosphohydrolase 1 10q24.1 radiation proctitis, proctitis spastic paraplegia 64
ENTPD2 ectonucleoside triphosphate diphosphohydrolase 2 9q34.3 cholera dentin sensitivity
ENTPD3 ectonucleoside triphosphate diphosphohydrolase 3 3p22.1 mucocutaneous leishmaniasis
ENTPD8 ectonucleoside triphosphate diphosphohydrolase 8 9q34.3 mucocutaneous leishmaniasis
EOE1 Esophagitis, eosinophilic 17q11.2 esophagitis "esophagitis, eosinophilic, 1"
EOE2 Esophagitis, eosinophilic, 2 5q22 esophagitis "esophagitis, eosinophilic, 2"
EOGT EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase 3p14.1 adams-oliver syndrome 1 , oliver syndrome, adams-oliver syndrome 3
EOMES eomesodermin 3p24.1 corpus callosum agenesis microcephaly - polymicrogyria - corpus callosum agenesis
EOS eosinophilia, familial 5q31-q33 familial eosinophilia
EP300 E1A binding protein p300 22q13.2 "colorectal cancer, somatic", colorectal cancer, breast cancer,
EP400 E1A binding protein p400 12q24.33 ossifying fibromyxoid tumor
EPAS1 endothelial PAS domain protein 1 2p21 hypoxia, pheochromocytoma, familial erythrocytosis 4,
EPB41 erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) 1p35.3 hereditary elliptocytosis, neuroacanthocytosis, corneal ulcer
EPB41L1 erythrocyte membrane protein band 4.1-like 1 20q11.23 "mental retardation, autosomal dominant 10" "mental retardation, autosomal dominant 11"
EPB41L2 erythrocyte membrane protein band 4.1-like 2 6q23.2 malignant ependymoma
EPB41L3 erythrocyte membrane protein band 4.1-like 3 18p11.31 adenocarcinoma, meningioma benign meningioma
EPB41L5 erythrocyte membrane protein band 4.1 like 5 2q14.2 intussusception
EPB42 erythrocyte membrane protein band 4.2 15q15.2 platelet storage pool deficiency, congenital dyserythropoietic anemia type i, congenital dyserythropoietic anemia,
EPC1 enhancer of polycomb homolog 1 (Drosophila) 10p11.22 t-cell leukemia adult t-cell leukemia
EPC2 enhancer of polycomb homolog 2 (Drosophila) 2q23.1 lymph node tuberculosis
EPCAM epithelial cell adhesion molecule 2p21 colorectal cancer, adenocarcinoma, diarrhea,
EPDR1 ependymin related 1 7p14.1 colorectal cancer
EPG5 ectopic P-granules autophagy protein 5 homolog (C. elegans) 18q21.1 vici syndrome
EPGN epithelial mitogen 4q13.3 fascioliasis, clonorchiasis, opisthorchiasis,
EPHA10 EPH receptor A10 1p34.3 duodenum cancer
EPHA2 EPH receptor A2 1p36.13 brain stem glioma, "cataract 6, multiple types", cataract,
EPHA3 EPH receptor A3 3p11.1 colorectal cancer pleomorphic rhabdomyosarcoma
EPHA4 EPH receptor A4 2q36.1 staphyloenterotoxemia
EPHA5 EPH receptor A5 4q13.1 drug psychosis
EPHA7 EPH receptor A7 6q16.1 brachydactyly-syndactyly syndrome gallbladder adenocarcinoma
EPHB2 EPH receptor B2 1p36.12 colorectal cancer, prostate cancer, familial prostate cancer,
EPHB3 EPH receptor B3 3q27.1 spinal cord ependymoma
EPHB4 EPH receptor B4 7q22.1 prostate cancer
EPHB6 EPH receptor B6 7q34 gliosarcoma, colorectal cancer familial colorectal cancer
EPHX1 epoxide hydrolase 1, microsomal (xenobiotic) 1q42.12 pre-eclampsia, diabetic macular edema, lung cancer,
EPHX2 epoxide hydrolase 2, cytoplasmic 8p21.2 familial hypercholesterolemia, hypercholesterolemia, "hypercholesterolemia, familial, due to ldlr defect, modifier of"
EPM2A epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) 6q24.3 myoclonus, myoclonus epilepsy, lafora disease,
EPO erythropoietin 7q22.1 myelofibrosis, diabetic macular edema, anemia of prematurity,
EPOR erythropoietin receptor 19p13.2 thrombocytosis, non-small cell lung carcinoma, neuroblastoma,
EPPIN epididymal peptidase inhibitor 20q13.12 male infertility infertility
EPPK1 epiplakin 1 8q24.3 vacterl association
EPPS Epilepsy, partial, with pericentral spikes 4p15 "epilepsy, partial, with pericentral spikes"
EPRPDC Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp 16p12-p11.2 "epilepsy, rolandic with paroxysmal exercise-induced dystonia and writers cramp"
EPRS glutamyl-prolyl-tRNA synthetase 1q41 hemorrhagic cystitis
EPS15 epidermal growth factor receptor pathway substrate 15 1p32.3 troyer syndrome
EPS8 epidermal growth factor receptor pathway substrate 8 12p12.3 "deafness, autosomal recessive 76"
EPS8L3 EPS8-like 3 1p13.3 pagets disease of bone hypotrichosis 4
EPT1 ethanolaminephosphotransferase 1 (CDP-ethanolamine-specific) 2p23.3 exocrine pancreatic insufficiency staphyloenterotoxemia
EPX eosinophil peroxidase 17q22 asthma, urinary schistosomiasis, atopy,
EPYC epiphycan 12q21.33 posterior amorphous corneal dystrophy
ERAP1 endoplasmic reticulum aminopeptidase 1 5q15 endometrial carcinoma, psoriatic arthritis, ankylosing spondylitis
ERAS ES cell expressed Ras Xp11.23 hypoplastic left heart syndrome acquired immunodeficiency syndrome
ERBB2 v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 17q12 adenocarcinoma, thymic epithelial neoplasm, transitional cell carcinoma,
ERBB3 v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 12q13.2 breast cancer, pancreatic cancer, gestational trophoblastic tumor,
ERBB4 v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 2q34 colorectal cancer, amyotrophic lateral sclerosis, breast cancer,
ERC1 ELKS/RAB6-interacting/CAST family member 1 12p13.33 follicular thyroid carcinoma, papillary carcinoma, legg-calve-perthes disease,
ERC2 ELKS/RAB6-interacting/CAST family member 2 3p14.3 blastomycosis
ERCC1 excision repair cross-complementation group 1 19q13.32 squamous cell carcinoma of the head and neck, lung cancer, ovarian cancer,
ERCC2 excision repair cross-complementation group 2 19q13.32 bladder cancer susceptibility, microtia, breast cancer,
ERCC3 excision repair cross-complementation group 3 2q14.3 cutaneous fibrous histiocytoma, photosensitive trichothiodystrophy, "xeroderma pigmentosum, group c",
ERCC4 excision repair cross-complementation group 4 16p13.12 "fanconi anemia, complementation group c", photosensitive trichothiodystrophy, "xeroderma pigmentosum, group f",
ERCC5 excision repair cross-complementation group 5 13q33.1 xanthogranulomatous pyelonephritis, photosensitive trichothiodystrophy, "xeroderma pigmentosum, group c",
ERCC6 excision repair cross-complementation group 6 10q11.23 age related macular degeneration, lung cancer, meningioma,
ERCC6L2 excision repair cross-complementation group 6-like 2 9q22.32 bone marrow failure syndrome 2
ERCC8 excision repair cross-complementation group 8 5q12.1 "xeroderma pigmentosum, group c", keratosis follicularis, cockayne syndrome,
EREG epiregulin 4q13.3 colorectal cancer, pancreatic cancer, erythropoietic protoporphyria
ERF Ets2 repressor factor 19q13.2 craniosynostosis 4, "craniosynostosis, type 1", crouzon syndrome,
ERG v-ets avian erythroblastosis virus E26 oncogene homolog 21q22.2 prostate cancer, acute myeloid leukemia, peripheral primitive neuroectodermal tumor,
ERGIC3 ERGIC and golgi 3 20q11.22 breast cancer
ERLIN1 ER lipid raft associated 1 10q24.31 autosomal recessive spastic paraplegia type 62
ERLIN2 ER lipid raft associated 2 8p11.23 intellectual disability, recessive intellectual disability - motor dysfunction - multiple joint contractures, "spastic paraplegia 18, autosomal recessive"
ERMARD ER membrane-associated RNA degradation 6q27 periventricular nodular heterotopia, periventricular heterotopia, 6q terminal deletion syndrome
ERV3-1 endogenous retrovirus group 3, member 1 7q11.21 choriocarcinoma
ERVE-4 endogenous retrovirus group E, member 4 6q15 kidney cancer
ERVK-6 endogenous retrovirus group K, member 6 7p22.1 hiv-1 ovarian germ cell tumor
ERVW-1 endogenous retrovirus group W, member 1 7q21.2 schizophrenia choriocarcinoma
ESCO1 establishment of sister chromatid cohesion N-acetyltransferase 1 18q11.2 roberts syndrome nail disease
ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 8p21.1 sc phocomelia syndrome, roberts syndrome, phocomelia
ESD esterase D 13q14.2 retinoblastoma, bilateral retinoblastoma patau syndrome
ESPN espin 1p36.31 "deafness, autosomal recessive 76", dfnb36 nonsyndromic hearing loss and deafness, "deafness, autosomal recessive 36"
ESR1 estrogen receptor 1 6q25.1 adenocarcinoma, juvenile nasopharyngeal angiofibroma, myocardial infarction,
ESR2 estrogen receptor 2 (ER beta) 14q23.3 lobular neoplasia, prostate cancer, breast cancer,
ESRRA estrogen-related receptor alpha 11q13.1 endometrial carcinoma
ESRRB estrogen-related receptor beta 14q24.3 dosage-sensitive sex reversal, "deafness, autosomal recessive 76", chondrosarcoma,
ESRRG estrogen-related receptor gamma 1q41 breast cancer vaginal cancer
ESX1 ESX homeobox 1 Xq22.2 germ cell tumors, allan-herndon-dudley syndrome testicular germ cell tumor
ETFA electron-transfer-flavoprotein, alpha polypeptide 15q24.3 riboflavin deficiency , glutaric acidemia iia, glutaric acidemia iib,
ETFB electron-transfer-flavoprotein, beta polypeptide 19q13.41 systemic primary carnitine deficiency disease, neutral lipid storage disease, lipid storage disease,
ETFDH electron-transferring-flavoprotein dehydrogenase 4q32.1 riboflavin deficiency , systemic primary carnitine deficiency disease, neutral lipid storage disease,
ETHE1 ethylmalonic encephalopathy 1 19q13.31 ethylmalonic encephalopathy
ETL2 epilepsy, familial temporal lobe 12q22-q23.3 "epilepsy, familial temporal lobe, 2"
ETL4 epilepsy, occipitotemporal lobe, and migraine with aura 9q21-q22 "epilepsy, familial temporal lobe, 4"
ETM1 essential tremor 1 3q13 schizophrenia essential tremor
ETM2 essential tremor 2 2p25-p22 "tremor hereditary essential, 2"
ETM3 Tremor, hereditary essential, 3 6p23 "tremor, hereditary essential, 3"
ETS1 v-ets avian erythroblastosis virus E26 oncogene homolog 1 11q24.3 meningioma jacobsen syndrome
ETS2 v-ets avian erythroblastosis virus E26 oncogene homolog 2 21q22.2 frey syndrome
ETV1 ets variant 1 7p21.2 prostate cancer, gastrointestinal stromal tumor peripheral primitive neuroectodermal tumor
ETV3 ets variant 3 1q23.1 brain cancer
ETV4 ets variant 4 17q21.31 extraosseous ewings sarcoma peripheral primitive neuroectodermal tumor
ETV6 ets variant 6 12p13.2 lymphoblastic leukemia, chronic myeloid leukemia, mesoblastic nephroma,
ETV7 ets variant 7 6p21.31 prostate cancer
EVC Ellis van Creveld syndrome 4p16.2 asphyxiating thoracic dystrophy, ellis-van creveld syndrome, weyers acrofacial dysostosis,
EVC2 Ellis van Creveld syndrome 2 4p16.2 ellis-van creveld syndrome, evc2-related ellis-van creveld syndrome, weyers acrofacial dysostosis,
EVI5 ecotropic viral integration site 5 1p22.1 neuroblastoma
EVL Enah/Vasp-like 14q32.2 hypersplenism esophageal varix
EVPL envoplakin 17q25.1 thymoma, follicular dendritic cell sarcoma, dendritic cell sarcoma,
EVR3 exudative vitreoretinopathy 3 11p13-p12 exudative vitreoretinopathy exudative vitreoretinopathy-3
EWSR1 EWS RNA-binding protein 1 22q12.2 sarcoma, desmoplastic small round cell tumor, chondrosarcoma,
EXO1 exonuclease 1 1q43 colorectal cancer, chilblain lupus aicardi-goutieres syndrome
EXOC3L2 exocyst complex component 3-like 2 19q13.32 hepatitis b
EXOC7 exocyst complex component 7 17q25.1 eastern equine encephalitis
EXOSC10 exosome component 10 1p36.22 scleroderma polymyositis
EXOSC3 exosome component 3 9p13.2 pontocerebellar hypoplasia "pontocerebellar hypoplasia, type 1b"
EXOSC5 exosome component 5 19q13.2 cat-scratch disease
EXOSC9 exosome component 9 4q27 scleroderma polymyositis
EXPH5 exophilin 5 11q22.3 "epidermolysis bullosa, nonspecific, autosomal recessive"
EXT1 exostosin glycosyltransferase 1 8q24.11 osteochondroma, metatropic dysplasia , hereditary multiple exostoses,
EXT2 exostosin glycosyltransferase 2 11p11.2 osteochondroma, hereditary multiple exostoses, exostosis,
EXT3 exostoses (multiple) 3 19p hereditary multiple exostoses "exostoses, multiple, type 3"
EXTL1 exostosin-like glycosyltransferase 1 1p36.11 hereditary multiple exostoses exostosis
EXTL2 exostosin-like glycosyltransferase 2 1p21.2 hereditary multiple exostoses exostosis
EXTL3 exostosin-like glycosyltransferase 3 8p21.1 hereditary multiple exostoses, exostosis, gonorrhea,
EYA1 eyes absent homolog 1 (Drosophila) 8q13.3 microtia, branchiootorenal syndrome, townes-brocks syndrome,
EYA4 eyes absent homolog 4 (Drosophila) 6q23.2 "deafness, autosomal dominant 4b", dilated cardiomyopathy, eya4-related dilated cardiomyopathy,
EYS eyes shut homolog (Drosophila) 6q12 leber congenital amaurosis, retinitis, retinitis pigmentosa,
EZH1 enhancer of zeste homolog 1 (Drosophila) 17q21.2 weaver syndrome
EZH2 enhancer of zeste homolog 2 (Drosophila) 7q36.1 prostate cancer, weaver syndrome, chronic myelomonocytic leukemia
EZR ezrin 6q25.3 prostate cancer, pediatric osteosarcoma, osteosarcoma,
F10 coagulation factor X 13q34 afibrinogenemia, dysfibrinogenemia, antithrombin iii deficiency,
F11 coagulation factor XI 4q35.2 afibrinogenemia, factor viii deficiency, factor xi deficiency,
F12 coagulation factor XII (Hageman factor) 5q35.3 patent foramen ovale, factor xi deficiency, angioedema,
F13A1 coagulation factor XIII, A1 polypeptide 6p25.1 dysfibrinogenemia, scleromyxedema, kaposis sarcoma,
F13B coagulation factor XIII, B polypeptide 1q31.3 varicose veins, factor xiii deficiency, hemarthrosis,
F2 coagulation factor II (thrombin) 11p11.2 hepatocellular carcinoma, congenital afibrinogenemia, afibrinogenemia,
F2R coagulation factor II (thrombin) receptor 5q13.3 bernard-soulier syndrome, 5q- syndrome glanzmanns thrombasthenia
F2RL1 coagulation factor II (thrombin) receptor-like 1 5q13.3 papillary adenocarcinoma, neuroleptic malignant syndrome pulmonary vein stenosis
F2RL2 coagulation factor II (thrombin) receptor-like 2 5q13.3 schizophrenia
F3 coagulation factor III (thromboplastin, tissue factor) 1p21.3 congenital afibrinogenemia, afibrinogenemia, peripheral vascular disease,
F5 coagulation factor V (proaccelerin, labile factor) 1q24.2 pre-eclampsia, afibrinogenemia, dysfibrinogenemia,
F7 coagulation factor VII (serum prothrombin conversion accelerator) 13q34 carotid intimal medial thickness, myocardial infarction, coronary artery disease,
F8 coagulation factor VIII, procoagulant component Xq28 afibrinogenemia, bernard-soulier syndrome, sneddon syndrome,
F8A1 coagulation factor VIII-associated 1 Xq28 severe hemophilia a acquired hemophilia
F8A2 coagulation factor VIII-associated 2 Xq28 severe hemophilia a
F8A3 coagulation factor VIII-associated 3 Xq28 severe hemophilia a
F9 coagulation factor IX Xq27.1 bernard-soulier syndrome, sneddon syndrome, arthropathy,
FA2H fatty acid 2-hydroxylase 16q23.1 leukodystrophy, schnitzler syndrome, spastic paraparesis,
FAAH fatty acid amide hydrolase 1p33 schizophrenia, somatoform disorder, autoimmune encephalitis,
FABP1 fatty acid binding protein 1, liver 2p11.2 hepatocellular adenoma, thin basement membrane nephropathy, proteinuria
FABP12 fatty acid binding protein 12 8q21.13 myocardial infarction, schizophrenia, obesity,
FABP2 fatty acid binding protein 2, intestinal 4q26 intestinal atresia, insulin resistance, morbid obesity,
FABP3 fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) 1p35.2 chronic thromboembolic pulmonary hypertension, pulmonary embolism, myocardial infarction,
FABP4 fatty acid binding protein 4, adipocyte 8q21.13 insulin resistance, obesity, cerebellar liponeurocytoma,
FABP5 fatty acid binding protein 5 (psoriasis-associated) 8q21.13 psoriasis bladder squamous cell carcinoma
FABP6 fatty acid binding protein 6, ileal 5q33.3 colorectal adenocarcinoma
FABP7 fatty acid binding protein 7, brain 6q22.31 subependymal giant cell astrocytoma, optic nerve glioma, malignant glioma,
FABP9 fatty acid binding protein 9, testis 8q21.13 sporadic breast cancer
FADD Fas (TNFRSF6)-associated via death domain 11q13.3 oculootodental syndrome, oral leukoplakia, autoimmune lymphoproliferative syndrome,
FADS1 fatty acid desaturase 1 11q12.2 vitelliform macular dystrophy
FADS2 fatty acid desaturase 2 11q12.2 vitelliform macular dystrophy paranoid schizophrenia
FAF2 Fas associated factor family member 2 5q35.2 atopic dermatitis, dermatitis enophthalmos
FAH fumarylacetoacetate hydrolase (fumarylacetoacetase) 15q25.1 tyrosinemia, tyrosinemia type ii, tyrosinemia type i
FAM107A family with sequence similarity 107, member A 3p14.2 renal cell carcinoma
FAM111A family with sequence similarity 111, member A 11q12.1 kenny-caffey syndrome type 2 gracile bone dysplasia
FAM111B family with sequence similarity 111, member B 11q12.1 "poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis"
FAM117B family with sequence similarity 117, member B 2q33.2 amyotrophic lateral sclerosis lateral sclerosis
FAM120A family with sequence similarity 120A 9q22.31 achondrogenesis myiasis
FAM120C family with sequence similarity 120C Xp11.22 intellectual disability
FAM126A family with sequence similarity 126, member A 7p15.3 hypomyelination and congenital cataract
FAM129A family with sequence similarity 129, member A 1q25.3 pineoblastoma
FAM134B family with sequence similarity 134, member B 5p15.1 spasticity, neuropathy, dementia,
FAM13A family with sequence similarity 13, member A 4q22.1 idiopathic pulmonary fibrosis
FAM155B family with sequence similarity 155, member B Xq13.1 enterobiasis
FAM161A family with sequence similarity 161, member A 2p15 leber congenital amaurosis, retinitis, retinitis pigmentosa,
FAM161B family with sequence similarity 161, member B 14q24.3 retinitis pigmentosa 28
FAM163A family with sequence similarity 163, member A 1q25.2 neuroblastoma
FAM167A family with sequence similarity 167, member A 8p23.1 keratolytic winter erythema
FAM168A family with sequence similarity 168, member A 11q13.4 tongue cancer
FAM172A family with sequence similarity 172, member A 5q15 diabetic angiopathy
FAM174A family with sequence similarity 174, member A 5q21.1 hepatitis c, hepatitis c virus hepatitis
FAM178A family with sequence similarity 178, member A 10q24.31 infantile onset spinocerebellar ataxia
FAM208A family with sequence similarity 208, member A 3p14.3 retinoblastoma
FAM20A family with sequence similarity 20, member A 17q24.2 amelogenesis imperfecta and gingival hyperplasia syndrome, amelogenesis imperfecta and gingival fibromatosis syndrome , "amelogenesis imperfecta, type ig"
FAM20B family with sequence similarity 20, member B 1q25.2 exostosis
FAM20C family with sequence similarity 20, member C 7p22.3 raine syndrome
FAM215A family with sequence similarity 215, member A (non-protein coding) 17q21.31 prostate cancer, primary biliary cirrhosis, b-cell chronic lymphocytic leukemia,
FAM21B family with sequence similarity 21, member B 10q11.22 brain cancer
FAM21C family with sequence similarity 21, member C 10q11.22 vaccinia
FAM221B family with sequence similarity 221, member B 9p13.3 cartilage-hair hypoplasia
FAM27L family with sequence similarity 27-like 17p11.2 chronic myeloid leukemia
FAM3C family with sequence similarity 3, member C 7q31.31 intestinal atresia, coffin-siris syndrome, pancreatic cancer
FAM46C family with sequence similarity 46, member C 1p12 yellow fever chromosome 1p deletion
FAM46D family with sequence similarity 46, member D Xq21.1 recurrent corneal erosion
FAM57A family with sequence similarity 57, member A 17p13.3 adenocarcinoma lung adenocarcinoma
FAM58A family with sequence similarity 58, member A Xq28 star syndrome syndactyly
FAM83H family with sequence similarity 83, member H 8q24.3 "amelogenesis imperfecta, type iii" adult medulloblastoma
FAM84B family with sequence similarity 84, member B 8q24.21 breast cancer susceptibility, breast cancer gastroesophageal junction adenocarcinoma
FAM86A family with sequence similarity 86, member A 16p13.3 hereditary myopathy with early respiratory failure
FAM8A6P family with sequence similarity 8, member A6 pseudogene 6q23.2 fatty liver disease pulmonary function
FAM9A family with sequence similarity 9, member A Xp22.31 uterine fibroid
FAME3 Epilepsy, familial adult myoclonic, 3 5p15.31-p15.1 "epilepsy, myoclonic, familial adult, 3"
FAME4 Epilepsy, familial adult myoclonic, 4 3q26.32-q28 "epilepsy, familial adult myoclonic, 4"
FAN1 FANCD2/FANCI-associated nuclease 1 15q13.2 nephritis, interstitial nephritis, chronic kidney failure
FANCA Fanconi anemia, complementation group A 16q24.3 breast cancer, "fanconi anemia, complementation group a", "fanconi anemia, complementation group c",
FANCB Fanconi anemia, complementation group B Xp22.2 breast cancer susceptibility, "fanconi anemia, complementation group c", fanconis anemia,
FANCC Fanconi anemia, complementation group C 9q22.32 breast cancer, "fanconi anemia, complementation group c", fanconis anemia,
FANCD2 Fanconi anemia, complementation group D2 3p25.3 breast cancer, "fanconi anemia, complementation group c", fanconis anemia,
FANCD2P1 Fanconi anemia, complementation group D2 pseudogene 1 3p25.3 "fanconi anemia, complementation group d2"
FANCD2P2 Fanconi anemia, complementation group D2 pseudogene 2 3p25.2 "fanconi anemia, complementation group d2"
FANCE Fanconi anemia, complementation group E 6p21.31 breast cancer, "fanconi anemia, complementation group c", fanconis anemia,
FANCF Fanconi anemia, complementation group F 11p14.3 breast cancer susceptibility, breast cancer, ovarian cancer,
FANCG Fanconi anemia, complementation group G 9p13.3 breast cancer, pancreatic cancer, "fanconi anemia, complementation group a",
FANCI Fanconi anemia, complementation group I 15q26.1 "fanconi anemia, complementation group c", fanconis anemia, fanci-related fanconi anemia
FANCL Fanconi anemia, complementation group L 2p16.1 "fanconi anemia, complementation group c", fanconis anemia, mutism,
FANCM Fanconi anemia, complementation group M 14q21.2 "fanconi anemia, complementation group c", fanconis anemia, "fanconi anemia, complementation group m"
FAP fibroblast activation protein, alpha 2q24.2 pharyngitis infiltrative basal cell carcinoma
FARS2 phenylalanyl-tRNA synthetase 2, mitochondrial 6p25.1 alpers syndrome combined oxidative phosphorylation deficiency 14
FARSA phenylalanyl-tRNA synthetase, alpha subunit 19p13.2 impetigo
FAS Fas cell surface death receptor 10q23.31 burn scar, sarcomatoid renal cell carcinoma, posterior uveitis,
FASLG Fas ligand (TNF superfamily, member 6) 1q24.3 systemic lupus erythematosus, posterior uveitis, lung cancer,
FASN fatty acid synthase 17q25.3 trophoblastic neoplasm
FASTK Fas-activated serine/threonine kinase 7q36.1 autism spectrum disorder
FASTKD2 FAST kinase domains 2 2q33.3 cytochrome-c oxidase deficiency disease fastkd2-related infantile mitochondrial encephalomyopathy
FAT1 FAT atypical cadherin 1 4q35.2 dentin caries
FAT2 FAT atypical cadherin 2 5q33.1 skin squamous cell carcinoma
FAT4 FAT atypical cadherin 4 4q28.1 van maldergem syndrome 1, cystic kidney van maldergem syndrome 2
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 11q13.1 sarcoma
FBF1 Fas (TNFRSF6) binding factor 1 17q25.1 hypermobility syndrome nocardiosis
FBL fibrillarin 19q13.2 diffuse scleroderma scleroderma
FBLIM1 filamin binding LIM protein 1 1p36.21 kindler syndrome skin atrophy
FBLN1 fibulin 1 22q13.31 megalencephalic leukoencephalopathy with subcortical cysts, osteochondritis dissecans, vitreoretinal dystrophy,
FBLN2 fibulin 2 3p25.1 osteochondritis dissecans familial osteochondritis dissecans
FBLN5 fibulin 5 14q32.12 age related macular degeneration, cutis laxa, costello syndrome,
FBN1 fibrillin 1 15q21.1 craniosynostosis, recessive dystrophic epidermolysis bullosa, geleophysic dysplasia,
FBN2 fibrillin 2 5q23.3 geleophysic dysplasia, weill-marchesani syndrome, congenital contractural arachnodactyly,
FBN3 fibrillin 3 19p13.2 weill-marchesani syndrome
FBP1 fructose-1,6-bisphosphatase 1 9q22.32 metabolic acidosis, hypoglycemia, acute pyelonephritis
FBP2 fructose-1,6-bisphosphatase 2 9q22.32 glycogen storage disease type 1a "fructose-1,6-bisphosphatase deficiency"
FBXL19 F-box and leucine-rich repeat protein 19 16p11.2 psoriasis
FBXL3 F-box and leucine-rich repeat protein 3 13q22.3 estrogen-receptor positive breast cancer
FBXL4 F-box and leucine-rich repeat protein 4 6q16.1 mitochondrial dna depletion syndrome mitochondrial dna depletion syndrome 13
FBXO11 F-box protein 11 2p16.3 vitiligo fetal hydantoin syndrome
FBXO2 F-box protein 2 1p36.22 herpes simplex, benign paroxysmal positional nystagmus menieres disease
FBXO21 F-box protein 21 12q24.22 mast cell neoplasm
FBXO27 F-box protein 27 19q13.2 chronic myeloid leukemia
FBXO31 F-box protein 31 16q24.2 breast cancer mast cell neoplasm
FBXO32 F-box protein 32 8q24.13 myopathy of critical illness
FBXO33 F-box protein 33 14q21.1 osteoporosis
FBXO38 F-box protein 38 5q32 "neuronopathy, distal hereditary motor, type iid"
FBXO47 F-box protein 47 17q12 papillary renal cell carcinoma
FBXO5 F-box protein 5 6q25.2 tetraploidy
FBXO7 F-box protein 7 22q12.3 astigmatism, parkinsons disease, corneal edema,
FBXW2 F-box and WD repeat domain containing 2 9q33.2 benign paroxysmal positional nystagmus, botulism, egg allergy,
FBXW4 F-box and WD repeat domain containing 4 10q24.32 split foot, split hand, syndactyly,
FBXW4P1 F-box and WD repeat domain containing 4 pseudogene 1 22q11.23 split hand
FBXW7 F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase 4q31.3 colorectal cancer, breast cancer glomuvenous malformation
FBXW8 F-box and WD repeat domain containing 8 12q24.22 3-m syndrome
FBXW9 F-box and WD repeat domain containing 9 19p13.2 mucoepidermoid carcinoma
FCAR Fc fragment of IgA, receptor for 19q13.42 spondylitis, oral lichen planus aggressive periodontitis
FCER1A Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide 1q23.2 urticaria, allergic rhinitis, allergic asthma,
FCER1G Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide 1q23.3 aplastic anemia
FCER2 Fc fragment of IgE, low affinity II, receptor for (CD23) 19p13.2 asthma, b-cell chronic lymphocytic leukemia, chronic lymphocytic leukemia,
FCGR1A Fc fragment of IgG, high affinity Ia, receptor (CD64) 1q21.2 sepsis, peritonitis pharyngitis
FCGR2A Fc fragment of IgG, low affinity IIa, receptor (CD32) 1q23.3 myasthenia gravis, cryptococcosis, cystic fibrosis,
FCGR2B Fc fragment of IgG, low affinity IIb, receptor (CD32) 1q23.3 cardiovascular disease risk factor, systemic lupus erythematosus, malaria,
FCGR2C Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) 1q23.3 autoimmune thrombocytopenic purpura purpura
FCGR3A Fc fragment of IgG, low affinity IIIa, receptor (CD16a) 1q23.3 folliculitis, cryptococcosis, systemic lupus erythematosus,
FCGR3B Fc fragment of IgG, low affinity IIIb, receptor (CD16b) 1q23.3 cryptococcosis, malaria, vasculitis,
FCGRT Fc fragment of IgG, receptor, transporter, alpha 19q13.33 epidermolysis bullosa acquisita, "hypoproteinemia, hypercatabolic" persistent fetal circulation syndrome
FCMTE3 familial cortical myoclonic tremor with epilepsy 3 5p15.31-p15 "epilepsy, myoclonic, familial adult, 3"
FCN1 ficolin (collagen/fibrinogen domain containing) 1 9q34.3 mannose-binding lectin deficiency
FCN2 ficolin (collagen/fibrinogen domain containing lectin) 2 9q34.3 rheumatic heart disease, cutaneous leishmaniasis rheumatic fever
FCN3 ficolin (collagen/fibrinogen domain containing) 3 1p36.11 autistic disorder, systemic lupus erythematosus, rheumatic heart disease,
FCP1 F-cell production 1 Xp22.2 "congenital cataracts, facial dysmorphism, and neuropathy", hereditary persistence of fetal hemoglobin fetal hemoglobin quantitative trait locus 3
FCRL2 Fc receptor-like 2 1q23.1 chronic lymphocytic leukemia
FCRL3 Fc receptor-like 3 1q23.1 autoimmune hepatitis, primary biliary cirrhosis, systemic lupus erythematosus,
FCRL4 Fc receptor-like 4 1q23.1 myeloma, multiple myeloma, non-hodgkin lymphoma
FCRL6 Fc receptor-like 6 1q23.2 viral pneumonia
FDFT1 farnesyl-diphosphate farnesyltransferase 1 8p23.1 keratolytic winter erythema, smith-lemli-opitz syndrome sitosterolemia
FDPS farnesyl diphosphate synthase 1q22 osteonecrosis of the jaw
FDX1 ferredoxin 1 11q22.3 lipoid adrenal hyperplasia, cerebrotendinous xanthomatosis, congenital adrenal insufficiency
FDXR ferredoxin reductase 17q25.1 prostate cancer, lipoid adrenal hyperplasia, locked-in syndrome
FEB1 febrile convulsions 1 8q13-q21 "febrile seizures, familial, 1"
FEB10 Febrile convulsions, familial, 10 3q26.2-q26.33 "febrile seizures, familial, 10"
FEB2 febrile convulsions 2 19p13.3 "febrile seizures, familial, 2"
FEB4 febrile convulsions 4 5q14-q15 "usher syndrome, type 2c, gpr98/pdzd7 digenic", "febrile seizures, familial, 4" "usher syndrome, type 2c"
FEB5 febrile convulsions 5 6q22-q24 "febrile seizures, familial, 5"
FEB6 febrile convulsions 6 18p11.2 "febrile seizures, familial, 6"
FEB7 febrile convulsions 7 21q22 "febrile seizures, familial, 7"
FEB9 Febrile convulsions, familial, 9 3p24.2-p23 "febrile seizures, familial, 9"
FECD2 corneal dystrophy, Fuchs endothelial 2 13pter-q12.13 corneal dystrophy fuchs endothelial 2
FECD3 Corneal dystrophy, Fuchs endothelial, 3 18q21.2-q21.3 "corneal dystrophy, fuchs endothelial, 3"
FECD5 Corneal dystrophy, Fuchs endothelial, 5 5q33.1-q35.2 "corneal dystrophy, fuchs endothelial, 5"
FECD7 Corneal dystrophy, Fuchs endothelial, 7 9p24.1-p22.1 "corneal dystrophy, fuchs endothelial, 7"
FECH ferrochelatase 18q21.31 congenital erythropoietic porphyria, erythropoietic protoporphyria, hypochromic anemia,
FECHP1 ferrochelatase pseudogene 1 3p22.3 alzheimers disease
FEN1 flap structure-specific endonuclease 1 11q12.2 werner syndrome, vitelliform macular dystrophy macular dystrophy
FEOM3 fibrosis of extraocular muscles, congenital, 3 16q24.2-q24.3 congenital fibrosis of the extraocular muscles
FER fer (fps/fes related) tyrosine kinase 5q21.3 sarcoma encephalitis
FERD3L Fer3-like bHLH transcription factor 7p21.1 acrocephalosyndactylia breast and colorectal cancer
FERMT1 fermitin family member 1 20p12.3 kindler syndrome, skin atrophy "hereditary acrokeratotic poikiloderma, weary type"
FERMT2 fermitin family member 2 14q22.1 kindler syndrome
FERMT3 fermitin family member 3 11q13.1 leukocyte adhesion deficiency, low renin hypertension, kindler syndrome
FES feline sarcoma oncogene 15q26.1 sarcoma acute promyelocytic leukemia
FETUB fetuin B 3q27.3 hantavirus pulmonary syndrome
FEV FEV (ETS oncogene family) 2q35 eating disorder adenosquamous carcinoma
FEZ1 fasciculation and elongation protein zeta 1 (zygin I) 11q24.2 schizophrenia esophageal squamous cell carcinoma
FEZF1 FEZ family zinc finger 1 7q31.32 uterine inversion, lymph node tuberculosis breast metaplastic carcinoma
FEZF2 FEZ family zinc finger 2 3p14.2 uterine inversion, lymph node tuberculosis breast metaplastic carcinoma
FFAR3 free fatty acid receptor 3 19q13.12 pertussis
FFAR4 free fatty acid receptor 4 10q23.33 obesity
FGA fibrinogen alpha chain 4q31.3 congenital afibrinogenemia, afibrinogenemia, dysfibrinogenemia,
FGB fibrinogen beta chain 4q31.3 congenital afibrinogenemia, "dysfibrinogenemia, beta type", fgb-related congenital afibrinogenemia,
FGD1 FYVE, RhoGEF and PH domain containing 1 Xp11.22 aarskog-scott syndrome, scott syndrome, fgd1-related x-linked mental retardation,
FGD2 FYVE, RhoGEF and PH domain containing 2 6p21.2 glucocorticoid deficiency 2
FGD3 FYVE, RhoGEF and PH domain containing 3 9q22.31 glucocorticoid deficiency 3, aarskog-scott syndrome scott syndrome
FGD4 FYVE, RhoGEF and PH domain containing 4 12p11.21 charcot-marie-tooth neuropathy type 4h, sensory peripheral neuropathy, charcot-marie-tooth neuropathy type 4
FGD5 FYVE, RhoGEF and PH domain containing 5 3p25.1 aarskog-scott syndrome, scott syndrome gastroduodenitis
FGF1 fibroblast growth factor 1 (acidic) 5q31.3 breast fibroadenoma, barretts esophagus ischemia
FGF10 fibroblast growth factor 10 5p12 aplasia of lacrimal and salivary glands , fgf10-related lacrimo-auriculo-dento-digital syndrome, ladd syndrome ,
FGF13 fibroblast growth factor 13 Xq27.1 borjeson-forssman-lehmann syndrome
FGF14 fibroblast growth factor 14 13q33.1 ladd syndrome , spinocerebellar ataxia type27, spinocerebellar ataxia 27
FGF16 fibroblast growth factor 16 Xq21.1 metacarpals 4 and 5 fusion
FGF17 fibroblast growth factor 17 8p21.3 hypogonadotropic hypogonadism 8 with or without anosmia, hypogonadotropic hypogonadism 17 with or without anosmia hypogonadotropic hypogonadism 20 with or without anosmia
FGF19 fibroblast growth factor 19 11q13.3 reticulosarcoma, extrahepatic cholestasis, diarrhea
FGF2 fibroblast growth factor 2 (basic) 4q27 osteochondroma, thanatophoric dysplasia, hypochondroplasia,
FGF20 fibroblast growth factor 20 8p22 ladd syndrome , renal hypodysplasia/aplasia 2, renal agenesis,
FGF21 fibroblast growth factor 21 19q13.33 type 2 diabetes mellitus
FGF23 fibroblast growth factor 23 12p13.32 epidermal nevus, calcinosis, enthesopathy,
FGF3 fibroblast growth factor 3 11q13.3 thanatophoric dysplasia, achondroplasia, hypochondroplasia,
FGF4 fibroblast growth factor 4 11q13.3 sarcoma, kaposis sarcoma, gallbladder squamous cell carcinoma,
FGF5 fibroblast growth factor 5 4q21.21 kaposis sarcoma
FGF6 fibroblast growth factor 6 12p13.32 signet ring cell adenocarcinoma
FGF7 fibroblast growth factor 7 15q21.2 oncogenic osteomalacia, clear cell acanthoma acanthoma
FGF8 fibroblast growth factor 8 (androgen-induced) 10q24.32 hypogonadotropic hypogonadism 8 with or without anosmia, hypogonadotropic hypogonadism 17 with or without anosmia, kallmann syndrome,
FGF9 fibroblast growth factor 9 13q12.11 multiple synostoses syndrome 3 , synovial chondromatosis, multiple synostosis syndrome 1,
FGFBP1 fibroblast growth factor binding protein 1 4p15.32 colorectal adenocarcinoma adenocarcinoma
FGFBP2 fibroblast growth factor binding protein 2 4p15.32 asthma
FGFR1 fibroblast growth factor receptor 1 8p11.22 osteochondroma, myeloproliferative disorder, 8p11 myeloproliferative syndrome,
FGFR1OP FGFR1 oncogene partner 6q27 myeloproliferative disorder, steroid-induced glaucoma, 8p11 myeloproliferative syndrome,
FGFR1OP2 FGFR1 oncogene partner 2 12p11.23 8p11 myeloproliferative syndrome
FGFR2 fibroblast growth factor receptor 2 10q26.13 thanatophoric dysplasia, ladd syndrome , achondroplasia,
FGFR3 fibroblast growth factor receptor 3 4p16.3 osteochondroma, thanatophoric dysplasia, ladd syndrome ,
FGFR4 fibroblast growth factor receptor 4 5q35.2 achondroplasia, gliomatosis cerebri, cancer progression/metastasis,
FGFRL1 fibroblast growth factor receptor-like 1 4p16.3 radioulnar synostosis wolf-hirschhorn syndrome
FGG fibrinogen gamma chain 4q31.3 congenital afibrinogenemia, "thrombophilia, dysfibrinogenemic", afibrinogenemia,
FGGY FGGY carbohydrate kinase domain containing 1p32.1 amyotrophic lateral sclerosis
FGL1 fibrinogen-like 1 8p22 hepatocellular carcinoma
FGR feline Gardner-Rasheed sarcoma viral oncogene homolog 1p36.11 sarcoma pre-eclampsia
FGS2 FG syndrome 2 Xq11-q28 fg syndrome 2
FGS3 FG syndrome 3 Xp22.3 fg syndrome 3
FGS5 FG syndrome 5 Xq22.3 fg syndrome 5
FH fumarate hydratase 1q43 polyhydramnios, familial hypercholesterolemia, leiomyosarcoma,
FHASD Foveal hypoplasia and anterior segment dysgenesis 16q23.2-q24.2 foveal hypoplasia foveal hypoplasia and anterior segment dysgenesis
FHII Hyperaldosteronism, familial, type II 7p22 familial hyperaldosteronism, low renin hypertension familial hyperaldosteronism type 2
FHIT fragile histidine triad 3p14.2 cervical cancer, breast cancer, lung cancer,
FHL1 four and a half LIM domains 1 Xq26.3 talipes equinovarus, rigid spine syndrome, myofibrillar myopathy,
FHL2 four and a half LIM domains 2 2q12.2 rhabdomyosarcoma, "cardiomyopathy, dilated, 1w" hemophagocytic lymphohistiocytosis
FHL3 four and a half LIM domains 3 1p34.3 "hemophagocytic lymphohistiocytosis, familial, 3"
FHL5 four and a half LIM domains 5 6q16.1 familial hemophagocytic lymphohistiocytosis 5
FIG4 FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae) 6q21 charcot-marie-tooth neuropathy type 4, amyotrophic lateral sclerosis, lateral sclerosis,
FIGF c-fos induced growth factor (vascular endothelial growth factor D) Xp22.2 breast cancer, glioblastoma multiforme, papillary thyroid carcinoma
FIGLA folliculogenesis specific basic helix-loop-helix 2p13.3 premature ovarian failure premature ovarian failure 6
FIGNL1 fidgetin-like 1 7p12.1 autism spectrum disorder
FILIP1 filamin A interacting protein 1 6q14.1 status asthmaticus
FILIP1L filamin A interacting protein 1-like 3q12.1 ovarian cancer
FIM1 Friend-murine leukemia virus integration site 1 homolog 6p23-p22.3 "myasthenia, familial infantile, 1"
FIP1L1 factor interacting with PAPOLA and CPSF1 4q12 acute promyelocytic leukemia, endomyocardial fibrosis, hypereosinophilic syndrome,
FIS1 fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) 7q22.1 dental fluorosis
FKBP10 FK506 binding protein 10, 65 kDa 17q21.2 dentinogenesis imperfecta, bruck syndrome 2 , osteogenesis imperfecta type 5,
FKBP14 FK506 binding protein 14, 22 kDa 7p14.3 ullrich congenital muscular dystrophy "ehlers-danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss"
FKBP1B FK506 binding protein 1B, 12.6 kDa 2p23.3 catecholaminergic polymorphic ventricular tachycardia
FKBP4 FK506 binding protein 4, 59kDa 12p13.33 in situ carcinoma facial paralysis
FKBP5 FK506 binding protein 5 6p21.31 myelofibrosis, post-traumatic stress disorder, major depressive disorder,
FKBP6 FK506 binding protein 6, 36kDa 7q11.23 williams-beuren syndrome, williams syndrome, male infertility
FKRP fukutin related protein 19q13.32 neuromuscular disease, "muscular dystrophy-dystroglycanopathy , type a, 7", "muscular dystrophy-dystroglycanopathy , type a, 14",
FKTN fukutin 9q31.2 "cardiomyopathy, dilated, 1w", dilated cardiomyopathy, "muscular dystrophy-dystroglycanopathy , type a, 7",
FL1 Follicular lymphoma, susceptibility to, 1 6p21.33 follicular lymphoma follicular lymphoma 1
FLAD1 flavin adenine dinucleotide synthetase 1 1q21.3 agnosia, riboflavin deficiency , cholinergic urticaria,
FLCN folliculin 17p11.2 "colorectal cancer, somatic", colorectal cancer, tuberous sclerosis complex,
FLG filaggrin 1q21.3 recessive dystrophic epidermolysis bullosa, hermaphroditism, x-linked ichthyosis,
FLG2 filaggrin family member 2 1q21.3 psoriasis, ichthyosis vulgaris eczema herpeticum
FLI1 Fli-1 proto-oncogene, ETS transcription factor 11q24.3 sarcoma, lymphoblastic leukemia, leukemia,
FLII flightless I homolog (Drosophila) 17p11.2 smith magenis syndrome
FLJ90680 FLJ90680 protein 22q12.3 hiv-1 childhood leukemia
FLNA filamin A, alpha Xq28 fg syndrome 2, schizotypal personality disorder, periventricular nodular heterotopia,
FLNB filamin B, beta 3p14.3 synostosis, periventricular heterotopia, luteoma,
FLNC filamin C, gamma 7q32.1 lipoid adrenal hyperplasia, cardiac rupture, cerebrotendinous xanthomatosis,
FLOT1 flotillin 1 6p21.33 mycobacterium marinum
FLOT2 flotillin 2 17q11.2 megacolon toxic megacolon
FLRT1 fibronectin leucine rich transmembrane protein 1 11q13.1 autosomal recessive spastic paraplegia type 68
FLRT3 fibronectin leucine rich transmembrane protein 3 20p12.1 hypogonadotropic hypogonadism 8 with or without anosmia, kabuki syndrome hypogonadotropic hypogonadism 21 with anosmia
FLT1 fms-related tyrosine kinase 1 13q12.3 pre-eclampsia, breast cancer, astrocytoma,
FLT3 fms-related tyrosine kinase 3 13q12.2 8p11 myeloproliferative syndrome, acute myeloid leukemia, lymphoblastic leukemia,
FLT3LG fms-related tyrosine kinase 3 ligand 19q13.33 glioblastoma multiforme, myelodysplastic syndromes, aplastic anemia
FLT4 fms-related tyrosine kinase 4 5q35.3 kaposis sarcoma, hemangioma, hydrocele,
FLVCR1 feline leukemia virus subgroup C cellular receptor 1 1q32.3 ataxia, retinitis, retinitis pigmentosa,
FLVCR2 feline leukemia virus subgroup C cellular receptor family, member 2 14q24.3 hydranencephaly, leukemia, dissociative disorder,
FMN1 formin 1 15q13.3 renal hypoplasia
FMO1 flavin containing monooxygenase 1 1q24.3 trimethylaminuria
FMO2 flavin containing monooxygenase 2 (non-functional) 1q24.3 trimethylaminuria
FMO3 flavin containing monooxygenase 3 1q24.3 lymphocytic choriomeningitis, familial adenomatous polyposis trimethylaminuria
FMO4 flavin containing monooxygenase 4 1q24.3 plasma cell neoplasm trimethylaminuria
FMO5 flavin containing monooxygenase 5 1q21.1 trimethylaminuria
FMOD fibromodulin 1q32.1 b-cell chronic lymphocytic leukemia myopia
FMR1 fragile X mental retardation 1 Xq27.3 essential tremor, tremor, multiple system atrophy,
FMR1NB fragile X mental retardation 1 neighbor Xq27.3 sarcoma
FMR3 fragile X mental retardation associated 3 Xq28 fragile xe syndrome
FMTLE Epilepsy, familial mesial temporal lobe 4q13.2-q21.3 "epilepsy, familial mesial temporal lobe"
FN1 fibronectin 1 2q35 myeloma, colorectal cancer, secretory meningioma,
FN3K fructosamine 3 kinase 17q25.3 hyperglycemia
FNBP4 formin binding protein 4 11p11.2 anophthalmos with limb anomalies
FNDC1 fibronectin type III domain containing 1 6q25.3 prostate leiomyosarcoma
FOLH1 folate hydrolase (prostate-specific membrane antigen) 1 11p11.12 colorectal cancer, amyotrophic lateral sclerosis, prostate cancer,
FOLR1 folate receptor 1 (adult) 11q13.4 anencephaly, cerebral folate deficiency, ovarian cancer,
FOLR2 folate receptor 2 (fetal) 11q13.4 neural tube defects rheumatoid arthritis
FOS FBJ murine osteosarcoma viral oncogene homolog 14q24.3 breast cancer, withdrawal disorder, congenital generalized lipodystrophy,
FOSB FBJ murine osteosarcoma viral oncogene homolog B 19q13.32 osteosarcoma
FOSL1 FOS-like antigen 1 11q13.1 breast cancer, glioblastoma multiforme human t-cell leukemia virus type 1
FOXA1 forkhead box A1 14q21.1 mirror-image polydactyly
FOXA2 forkhead box A2 20p11.21 meckels diverticulum maturity-onset diabetes of the young
FOXB1 forkhead box B1 15q22.2 wernicke-korsakoff syndrome
FOXC1 forkhead box C1 6p25.3 intestinal atresia, developmental disabilities, primary congenital glaucoma,
FOXC2 forkhead box C2 (MFH-1, mesenchyme forkhead 1) 16q24.1 cleft palate, insulin resistance, varicose veins,
FOXD2 forkhead box D2 1p33 croup
FOXD3 forkhead box D3 1p31.3 chronic myeloid leukemia, autoimmune disease 1, entropion
FOXD4 forkhead box D4 9p24.3 dilated cardiomyopathy
FOXE1 forkhead box E1 (thyroid transcription factor 2) 9q22.33 cleft lip, cleft palate, follicular thyroid carcinoma,
FOXE3 forkhead box E3 1p33 aniridia, congenital aphakia, "foxe3-related cataracts, autosomal dominant",
FOXF1 forkhead box F1 16q24.1 nonspecific interstitial pneumonia, vacterl association, alveolar capillary dysplasia,
FOXF2 forkhead box F2 6p25.3 blepharophimosis duane retraction syndrome
FOXG1 forkhead box G1 14q12 west syndrome, rett syndrome, "epileptic encephalopathy, early infantile, 2",
FOXH1 forkhead box H1 8q24.3 septopreoptic holoprosencephaly, midline interhemispheric variant of holoprosencephaly, lobar holoprosencephaly,
FOXI1 forkhead box I1 5q35.1 pendred syndrome, pendred syndrome/dfnb4, enlarged vestibular aqueduct
FOXJ1 forkhead box J1 17q25.1 systemic lupus erythematosus, rhinitis allergic rhinitis
FOXL1 forkhead box L1 16q24.1 hypoplastic left heart syndrome, hereditary lymphedema lymphedema-distichiasis syndrome
FOXL2 forkhead box L2 3q22.3 developmental disabilities, mixed gonadal dysgenesis, autosomal dominant disease,
FOXM1 forkhead box M1 12p13.33 central pontine myelinolysis
FOXN1 forkhead box N1 17q11.2 thymic epithelial neoplasm, anencephaly, alopecia,
FOXN2 forkhead box N2 2p16.3 leukemia t-cell leukemia
FOXN3 forkhead box N3 14q32.11 auditory neuropathy
FOXO1 forkhead box O1 13q14.11 rhabdomyosarcoma "rhabdomyosarcoma 2, alveolar"
FOXO3 forkhead box O3 6q21 neuroblastoma, acute leukemia rhabdomyosarcoma
FOXO4 forkhead box O4 Xq13.1 leukemia, cutaneous fibrous histiocytoma, malignant fibroxanthoma
FOXP1 forkhead box P1 3p13 malt lymphoma, hypertonia, thyroid lymphoma,
FOXP2 forkhead box P2 7q31.1 pervasive developmental disorder, hypertonia, axenfeld-rieger syndrome,
FOXP3 forkhead box P3 Xp11.23 trachoma, leishmaniasis, pancreas adenocarcinoma,
FOXQ1 forkhead box Q1 6p25.3 duane retraction syndrome
FOXRED1 FAD-dependent oxidoreductase domain containing 1 11q24.2 mitochondrial complex i deficiency , mitochondrial dna deletion syndromes, mitochondrial dna-associated leigh syndrome and narp,
FPGS folylpolyglutamate synthase 9q34.11 soft tissue sarcoma
FPR1 formyl peptide receptor 1 19q13.41 amyloidosis, shwachman-diamond syndrome, periodontitis,
FPR2 formyl peptide receptor 2 19q13.41 amyloidosis, bacterial meningitis prion disease
FRA16A fragile site, folic acid type, rare, fra(16)(p13.11) 16p13.11 obesity
FRAS1 Fraser syndrome 1 4q21.21 cryptophthalmos, fraser syndrome, unilateral renal agenesis
FRAT1 frequently rearranged in advanced T-cell lymphomas 10q24.1 esophageal squamous cell carcinoma
FRAXA fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation) Xq27.3 pervasive developmental disorder, fragile x syndrome, fragile x-associated primary ovarian insufficiency
FRAXD fragile site, aphidicolin type, common, fra(X)(q27.2) D Xq27.2 fraxd
FRAXE fragile site, folic acid type, rare, fra(X)(q28) E Xq28 pervasive developmental disorder, x-linked disease fragile xe syndrome
FRAXF fragile site, folic acid type, rare, fra(X)(q28) F Xq28 pervasive developmental disorder
FRDA2 Friedreich ataxia 2 9p23-p11 friedreich ataxia 2
FREM1 FRAS1 related extracellular matrix 1 9p22.3 trigonocephaly 1 , diaphragmatic hernia 3, fraser syndrome,
FREM2 FRAS1 related extracellular matrix protein 2 13q13.3 fraser syndrome, macrostomia, unilateral renal agenesis
FREM3 FRAS1 related extracellular matrix 3 4q31.21 fraser syndrome
FRG1 FSHD region gene 1 4q35.2 muscular dystrophy, suppurative lymphadenitis, facioscapulohumeral muscular dystrophy
FRG2 FSHD region gene 2 4q35.2 facioscapulohumeral muscular dystrophy facioscapulohumeral muscular dystrophy 2
FRMD3 FERM domain containing 3 9q21.32 diabetic nephropathy
FRMD7 FERM domain containing 7 Xq26.2 congenital nystagmus, spontaneous ocular nystagmus, "nystagmus, infantile periodic alternating, x-linked",
FRRS1 ferric-chelate reductase 1 1p21.2 multidrug-resistant tuberculosis
FRS2 fibroblast growth factor receptor substrate 2 12q15 opioid abuse
FRTS1 Fanconi renotubular syndrome 15q15.3 fanconi renotubular syndrome fanconi renotubular syndrome 1
FRZB frizzled-related protein 2q32.1 osteoarthritis dihydropyrimidine dehydrogenase deficiency
FSCN1 fascin actin-bundling protein 1 7p22.1 juvenile xanthogranuloma, follicular dendritic cell sarcoma, dendritic cell sarcoma,
FSCN2 fascin actin-bundling protein 2, retinal 17q25.3 leber congenital amaurosis, retinitis pigmentosa, dendritic cell sarcoma,
FSCN3 fascin actin-bundling protein 3, testicular 7q32.1 dendritic cell sarcoma
FSHB follicle stimulating hormone, beta polypeptide 11p14.1 ovarian hyperstimulation syndrome, pituitary tumors, galactosemia,
FSHMD1A facioscapulohumeral muscular dystrophy 1A 4q35 embryonal rhabdomyosarcoma, muscular dystrophy facioscapulohumeral muscular dystrophy
FSHMD1B facioscapulohumeral muscular dystrophy 1B reserved facioscapulohumeral muscular dystrophy
FSHR follicle stimulating hormone receptor 2p16.3 coronary thrombosis, estrogen excess, ovarian disease,
FST follistatin 5q11.2 prostate cancer, endometriosis polycystic ovary syndrome
FSTL1 follistatin-like 1 3q13.33 rheumatoid arthritis
FTCD formimidoyltransferase cyclodeaminase 21q22.3 glutamate formiminotransferase deficiency
FTH1 ferritin, heavy polypeptide 1 11q12.3 hemosiderosis, siderosis, exanthem,
FTHL17 ferritin, heavy polypeptide-like 17 Xp21.2 klinefelters syndrome
FTL ferritin, light polypeptide 19q13.33 schizotypal personality disorder, basal ganglia disease, generalized dystonia,
FTLP4 ferritin, light polypeptide pseudogene 4 9p21.1 alzheimers disease
FTMT ferritin mitochondrial 5q23.1 myelodysplastic syndromes, friedreich ataxia, spontaneous pneumothorax,
FTO fat mass and obesity associated 16q12.2 overnutrition, obesity "growth retardation, developmental delay, coarse facies, and early death"
FTOP1 fat mass and obesity associated pseudogene 1 2p21 obesity
FTSJ1 FtsJ RNA methyltransferase homolog 1 (E. coli) Xp11.23 "mental retardation, x-linked 17/31, microduplication", mental retardation "mental retardation, x-linked"
FTSJ2 FtsJ RNA methyltransferase homolog 2 (E. coli) 7p22.3 multidrug-resistant tuberculosis
FUBP1 far upstream element (FUSE) binding protein 1 1p31.1 oligoastrocytoma
FUCA1 fucosidase, alpha-L- 1, tissue 1p36.11 fabry disease, lysosomal storage disease, angiokeratoma,
FUCA1P1 fucosidase, alpha-L- 1, tissue pseudogene 1 2q31.1 fucosidosis
FUCA2 fucosidase, alpha-L- 2, plasma 6q24.2 quadriplegia, spastic quadriplegia, fucosidosis
FUNDC2 FUN14 domain containing 2 Xq28 cervical cancer, hepatitis c, hepatitis c virus
FURIN furin (paired basic amino acid cleaving enzyme) 15q26.1 hypohidrotic ectodermal dysplasia, plague, influenza,
FUS fused in sarcoma 16p11.2 amyotrophic lateral sclerosis, lateral sclerosis, factor viii deficiency,
FUT2 fucosyltransferase 2 (secretor status included) 19q13.33 mastitis, primary sclerosing cholangitis, atrophic gastritis,
FUT3 fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) 19p13.3 inflammatory breast carcinoma, atrophic gastritis hypertropia
FUT4 fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) 11q21 colon adenocarcinoma, acute promyelocytic leukemia, benign mesothelioma,
FUT6 fucosyltransferase 6 (alpha (1,3) fucosyltransferase) 19p13.3 fucosyltransferase 6 deficiency
FUT7 fucosyltransferase 7 (alpha (1,3) fucosyltransferase) 9q34.3 human granulocytic anaplasmosis human t-cell leukemia virus type 1
FUT8 fucosyltransferase 8 (alpha (1,6) fucosyltransferase) 14q23.3 leukocyte adhesion deficiency pancreatic acinar cell adenocarcinoma
FUT9 fucosyltransferase 9 (alpha (1,3) fucosyltransferase) 6q16.1 malaria
FUZ fuzzy planar cell polarity protein 19q13.33 neural tube defects, spina bifida, caudal regression syndrome,
FWS Forsythe-Wakeling syndrome 1p33-p31.1 forsythe-wakeling syndrome
FXN frataxin 9q21.11 ataxia, friedreich ataxia with retained reflexes , friedreich ataxia,
FXR2 fragile X mental retardation, autosomal homolog 2 17p13.1 mental retardation
FXYD1 FXYD domain containing ion transport regulator 1 19q13.12 spinal cord injury
FXYD2 FXYD domain containing ion transport regulator 2 11q23.3 "hypomagnesemia 2, renal"
FXYD5 FXYD domain containing ion transport regulator 5 19q13.12 intracranial hypotension
FYCO1 FYVE and coiled-coil domain containing 1 3p21.31 "cataract 4, multiple types", cataract, "cataract, autosomal recessive congenital 2"
FYN FYN oncogene related to SRC, FGR, YES 6q21 estrogen-receptor negative breast cancer
FZD1 frizzled class receptor 1 7q21.13 exudative vitreoretinopathy
FZD10 frizzled class receptor 10 12q24.33 cervical cancer colon cancer
FZD3 frizzled class receptor 3 8p21.1 schizophrenia substance-induced psychosis
FZD4 frizzled class receptor 4 11q14.2 coats disease, osteoporosis-pseudoglioma syndrome, persistent hyperplastic primary vitreous,
FZD5 frizzled class receptor 5 2q33.3 exudative vitreoretinopathy
FZD6 frizzled class receptor 6 8q22.3 exudative vitreoretinopathy, pachyonychia congenita, osteoblastoma
FZD7 frizzled class receptor 7 2q33.1 hepatocellular carcinoma exudative vitreoretinopathy
FZD8 frizzled class receptor 8 10p11.21 exudative vitreoretinopathy
FZD9 frizzled class receptor 9 7q11.23 williams-beuren syndrome, exudative vitreoretinopathy williams syndrome
G0S2 G0/G1switch 2 1q32.2 van der woude syndrome
G3BP2 GTPase activating protein (SH3 domain) binding protein 2 4q21.1 nodular malignant melanoma
G6PC glucose-6-phosphatase, catalytic subunit 17q21.31 sudden infant death syndrome, portal hypertension, glycogen storage disease,
G6PC2 glucose-6-phosphatase, catalytic, 2 2q31.1 type 1 diabetes mellitus
G6PC3 glucose 6 phosphatase, catalytic, 3 17q21.31 neutropenia, severe congenital neutropenia, myotonia,
G6PD glucose-6-phosphate dehydrogenase Xq28 alpha thalassemia, acute chest syndrome, lysinuric protein intolerance,
GAA glucosidase, alpha; acid 17q25.3 krabbe disease, glycogen storage disease, respiratory failure,
GAB1 GRB2-associated binding protein 1 4q31.21 leopard syndrome
GABARAP GABA(A) receptor-associated protein 17p13.1 stiff-person syndrome
GABARAPL1 GABA(A) receptor-associated protein like 1 12p13.2 spastic hemiplegia
GABBR1 gamma-aminobutyric acid (GABA) B receptor, 1 6p22.1 schizophrenia, spasticity, withdrawal disorder,
GABBR2 gamma-aminobutyric acid (GABA) B receptor, 2 9q22.33 "nicotine dependence, protection against", nicotine dependence, hereditary sensory neuropathy type 1
GABPA GA binding protein transcription factor, alpha subunit 60kDa 21q21.3 down syndrome
GABPB1 GA binding protein transcription factor, beta subunit 1 15q21.2 adenylosuccinate lyase deficiency
GABRA1 gamma-aminobutyric acid (GABA) A receptor, alpha 1 5q34 early myoclonic encephalopathy, "epilepsy, childhood absence, susceptibility to, 2", juvenile myoclonic epilepsy,
GABRA2 gamma-aminobutyric acid (GABA) A receptor, alpha 2 4p12 alcohol dependence cannabis dependence
GABRA3 gamma-aminobutyric acid (GABA) A receptor, alpha 3 Xq28 color blindness thyrotoxic periodic paralysis 1
GABRA5 gamma-aminobutyric acid (GABA) A receptor, alpha 5 15q12 angelman syndrome
GABRA6 gamma-aminobutyric acid (GABA) A receptor, alpha 6 5q34 alcohol dependence, antisocial personality disorder, asperger syndrome
GABRB1 gamma-aminobutyric acid (GABA) A receptor, beta 1 4p12 schizophrenia
GABRB2 gamma-aminobutyric acid (GABA) A receptor, beta 2 5q34 antisocial personality disorder
GABRB3 gamma-aminobutyric acid (GABA) A receptor, beta 3 15q12 pervasive developmental disorder, atypical autism, angelman syndrome,
GABRD gamma-aminobutyric acid (GABA) A receptor, delta 1p36.33 idiopathic generalized epilepsy, juvenile myoclonic epilepsy, "epilepsy, juvenile myoclonic 8",
GABRG2 gamma-aminobutyric acid (GABA) A receptor, gamma 2 5q34 hyperekplexia, "epilepsy, childhood absence, susceptibility to, 2", childhood absence epilepsy,
GAD1 glutamate decarboxylase 1 (brain, 67kDa) 2q31.1 diabetic retinopathy, schizophrenia, encephalitis,
GAD2 glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) 10p12.1 schizophrenia, rubella, obesity,
GADD45A growth arrest and DNA-damage-inducible, alpha 1p31.3 breast cancer, schizophrenia, pancreatic cancer
GAEC1 gene amplified in esophageal cancer 1 7q22.1 esophageal squamous cell carcinoma esophageal cancer
GAGE1 G antigen 1 Xp11.23 stomach cancer glioblastoma multiforme
GAGE12I G antigen 12I Xp11.23 glioblastoma multiforme
GAL galanin/GMAP prepropeptide 11q13.3 hyperprolactinemia, acromegaly, anorexia nervosa,
GAL3ST1 galactose-3-O-sulfotransferase 1 22q12.2 metachromatic leukodystrophy renal cell carcinoma
GALC galactosylceramidase 14q31.3 metachromatic leukodystrophy , krabbe disease, leukodystrophy,
GALE UDP-galactose-4-epimerase 1p36.11 galactosemia, typhoid fever, epimerase deficiency galactosemia,
GALK1 galactokinase 1 17q25.1 burkitts lymphoma, galactosemia, citrin deficiency,
GALK2 galactokinase 2 15q21.1 galactokinase deficiency
GALNS galactosamine (N-acetyl)-6-sulfate sulfatase 16q24.3 mucopolysaccharidosis vi, mucopolysaccharidosis, beta-ketothiolase deficiency,
GALNT11 :polypeptide N-acetylgalactosaminyltransferase 11 7q36.1 heterotaxy
GALNT12 polypeptide N-acetylgalactosaminyltransferase 12 9q22.33 colorectal cancer colorectal cancer 1
GALNT13 polypeptide N-acetylgalactosaminyltransferase 13 2q23.3 tricuspid valve insufficiency osteochondrosis
GALNT15 polypeptide N-acetylgalactosaminyltransferase 15 3p25.1 hypertension
GALNT3 polypeptide N-acetylgalactosaminyltransferase 3 2q24.3 calcinosis, hyperphosphatemic familial tumoral calcinosis, hyperphosphatemia,
GALNT5 polypeptide N-acetylgalactosaminyltransferase 5 2q24.1 hereditary multiple exostoses exostosis
GALT galactose-1-phosphate uridylyltransferase 9p13.3 galactosemia, galactokinase deficiency, lens subluxation,
GAMT guanidinoacetate N-methyltransferase 19p13.3 hypotonia, creatine deficiency syndromes, creatine transporter deficiency,
GAN gigaxonin 16q23.2 neuropathy, axonal neuropathy, endometriosis of uterus,
GANAB glucosidase, alpha; neutral AB 11q12.3 polycystic liver disease glycogen storage disease ii
GANC glucosidase, alpha; neutral C 15q15.1 congenital dyserythropoietic anemia type i glycogen storage disease ii
GAP43 growth associated protein 43 3q13.31 amyotrophic lateral sclerosis, schizophrenia, appendicitis,
GAPDH glyceraldehyde-3-phosphate dehydrogenase 12p13.31 pituitary adenoma, obesity, turcot syndrome,
GAR1 GAR1 ribonucleoprotein 4q25 aplastic anemia
GARS glycyl-tRNA synthetase 7p14.3 hyperekplexia, charcot-marie-tooth neuropathy type 2, spinal muscular atrophy,
GART phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase 21q22.11 amyotrophic lateral sclerosis benign mesothelioma
GAS1 growth arrest-specific 1 9q21.33 septopreoptic holoprosencephaly, midline interhemispheric variant of holoprosencephaly, lobar holoprosencephaly,
GAS2 growth arrest-specific 2 11p14.3 gnathodiaphyseal dysplasia
GAS6 growth arrest-specific 6 13q34 ovarian endometriosis, critical limb ischemia, limb ischemia,
GAS7 growth arrest-specific 7 17p13.1 spastic hemiplegia
GAST gastrin 17q21.2 gastroduodenitis, pancreatic cancer, colon cancer,
GATA1 GATA binding protein 1 (globin transcription factor 1) Xp11.23 myeloproliferative disorder, myelofibrosis, acute myeloid leukemia,
GATA2 GATA binding protein 2 3q21.3 acute myeloid leukemia, myelodysplastic syndromes, bannayan-riley-ruvalcaba syndrome,
GATA3 GATA binding protein 3 10p14 sarcomatoid renal cell carcinoma, nephritis, "leukemia, acute lymphoblastic 3",
GATA4 GATA binding protein 4 8p23.1 patent foramen ovale, tetralogy of fallot , atrioventricular septal defect,
GATA5 GATA binding protein 5 20q13.33 aortic valve disease, tetralogy of fallot , "atrial fibrillation, familial, 9",
GATA6 GATA binding protein 6 18q11.2 patent foramen ovale, velocardiofacial syndrome, conotruncal heart malformations,
GATAD1 GATA zinc finger domain containing 1 7q21.2 "cardiomyopathy, dilated, 1w", dilated cardiomyopathy "cardiomyopathy, dilated, 2b"
GATAD2B GATA zinc finger domain containing 2B 1q21.3 "mental retardation, autosomal dominant 18"
GATM glycine amidinotransferase (L-arginine:glycine amidinotransferase) 15q21.1 acute pancreatitis, creatine deficiency syndromes, creatine transporter deficiency,
GBA glucosidase, beta, acid 1q22 parkinsons disease, fabry disease, gauchers disease,
GBA2 glucosidase, beta (bile acid) 2 9p13.3 spasticity, splenic sequestration, "spastic paraplegia 46, autosomal recessive"
GBA3 glucosidase, beta, acid 3 (gene/pseudogene) 4p15.2 gauchers disease
GBD2 gallbladder disease 2 1p36.21 gallbladder disease gallbladder disease 2
GBD3 gallbladder disease 3 1p34.3 gallbladder disease gallbladder disease 3
GBE1 glucan (1,4-alpha-), branching enzyme 1 3p12.2 glycogen storage disease, glycogen storage disease iv, adult polyglucosan body disease,
GBP1 guanylate binding protein 1, interferon-inducible 1p22.2 chronic active epstein-barr virus infection, aneurysmal bone cysts pseudopseudohypoparathyroidism
GBP3 guanylate binding protein 3 1p22.2 hypoglycemic coma
GBP5 guanylate binding protein 5 1p22.2 chronic active epstein-barr virus infection
GBX2 gastrulation brain homeobox 2 2q37.2 prostate cancer
GC group-specific component (vitamin D binding protein) 4q13.3 graves disease, osteoporosis, acute liver failure,
GC06M011196 non-small cell lung carcinoma
GC07P072301 shwachman-diamond syndrome
GCC1 GRIP and coiled-coil domain containing 1 7q32.1 secretory diarrhea
GCC2 GRIP and coiled-coil domain containing 2 2q12.3 secretory diarrhea
GCCD2 Glucocorticoid deficiency 2 glucocorticoid deficiency 3, glucocorticoid deficiency 2 familial glucocorticoid deficiency
GCCD3 glucocorticoid deficiency 3 8q11.2-q13.2 glucocorticoid deficiency 3 familial glucocorticoid deficiency
GCDH glutaryl-CoA dehydrogenase 19p13.2 l-2-hydroxyglutaric aciduria, 2-hydroxyglutaric aciduria, generalized dystonia,
GCG glucagon 2q24.2 type 2 diabetes mellitus, obesity, steatorrhea,
GCGR glucagon receptor 17q25.3 diabetes mellitus, essential hypertension, hyperglycemia,
GCH1 GTP cyclohydrolase 1 14q22.2 vitiligo, parkinsons disease, tetrahydrobiopterin deficiency,
GCK glucokinase (hexokinase 4) 7p13 type 2 diabetes mellitus, diabetes mellitus, hyperglycemia,
GCKR glucokinase (hexokinase 4) regulator 2p23.3 cardiovascular disease risk factor maturity-onset diabetes of the young
GCLC glutamate-cysteine ligase, catalytic subunit 6p12.1 myocardial infarction, hemolytic anemia hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency
GCLM glutamate-cysteine ligase, modifier subunit 1p22.1 myocardial infarction
GCM2 glial cells missing homolog 2 (Drosophila) 6p24.2 primary hyperparathyroidism, gcm2-related familial isolated hypoparathyroidism, familial isolated hypoparathyroidism due to agenesis of parathyroid gland,
GCNT1 glucosaminyl (N-acetyl) transferase 1, core 2 9q21.13 mast cell neoplasm
GCNT2 glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) 6p24.3 "cataract, congenital", mast cell neoplasm, cataract 13 with adult i phenotype ,
GCNT4 glucosaminyl (N-acetyl) transferase 4, core 2 5q13.3 mast cell neoplasm
GCSAM germinal center-associated, signaling and motility 3q13.2 diffuse large b-cell lymphoma
GCSH glycine cleavage system protein H (aminomethyl carrier) 16q23.2 glycine encephalopathy, neonatal glycine encephalopathy, gcsh-related glycine encephalopathy,
GDAP1 ganglioside induced differentiation associated protein 1 8q21.11 charcot-marie-tooth neuropathy type 4, charcot-marie-tooth disease type 4, charcot-marie-tooth neuropathy type 2,
GDAP1L1 ganglioside induced differentiation associated protein 1-like 1 20q13.12 neuroblastoma
GDF1 growth differentiation factor 1 19p13.11 velocardiofacial syndrome, conotruncal heart malformations, persistent truncus arteriosus,
GDF10 growth differentiation factor 10 10q11.22 osteosarcoma
GDF15 growth differentiation factor 15 19p13.11 prostate cancer, colon cancer, congenital dyserythropoietic anemia type i,
GDF2 growth differentiation factor 2 10q11.22 hepatopulmonary syndrome, hereditary hemorrhagic telangiectasia "telangiectasia, hereditary hemorrhagic, type 5"
GDF3 growth differentiation factor 3 12p13.31 matthew-wood syndrome, mixed germ cell tumor, "microphthalmia, isolated 2",
GDF5 growth differentiation factor 5 20q11.22 multiple synostosis syndrome 1, multiple synostoses syndrome, "acromesomelic dysplasia, hunter-thompson type",
GDF6 growth differentiation factor 6 8q22.1 matthew-wood syndrome, leber congenital amaurosis, leber congenital amaurosis 17,
GDF7 growth differentiation factor 7 2p24.1 ankylosis
GDF9 growth differentiation factor 9 5q31.1 kidney cancer, polycystic ovary syndrome premature ovarian failure
GDI1 GDP dissociation inhibitor 1 Xq28 "mental retardation, x-linked 17/31, microduplication", mental retardation tumor of exocrine pancreas
GDNF glial cell derived neurotrophic factor 5p13.2 amyotrophic lateral sclerosis, ischemia, renal agenesis,
GEFSP4 Epilepsy, generalized, with febrile seizures plus, type 4 2p24 "epilepsy, generalized, with febrile seizures plus, type 4"
GEFSP6 Generalized epilepsy with febrile seizures plus, type 6 8p23-p21 generalized epilepsy with febrile seizures plus "epilepsy, generalized, with febrile seizures plus, type 6"
GEFSP8 Generalized epilepsy with febrile seizures plus, type 8 6q16.3-q22.31 "epilespy, generalized, with febrile seizures plus, type 8" generalized epilepsy with febrile seizures plus
GEMIN2 gem (nuclear organelle) associated protein 2 14q21.1 mowat-wilson syndrome benign hereditary chorea
GER Gastroesophageal reflux 13q14 gastroesophageal reflux disease
GET4 golgi to ER traffic protein 4 homolog (S. cerevisiae) 7p22.3 erysipeloid louping ill
GFAP glial fibrillary acidic protein 17q21.31 gliosarcoma, giant cell glioblastoma, pilocytic astrocytoma,
GFER growth factor, augmenter of liver regeneration 16p13.3 nodular regenerative hyperplasia, kidney disease, polycystic kidney disease
GFI1 growth factor independent 1 transcription repressor 1p22.1 myeloproliferative disorder, neutropenia, tetraploidy,
GFI1B growth factor independent 1B transcription repressor 9q34.13 gray platelet syndrome, megakaryocytic leukemia, aplastic anemia,
GFM1 G elongation factor, mitochondrial 1 3q25.32 pearson syndrome, factor vii deficiency, heart aneurysm
GFND1 Glomerulopathy with fibronectin deposits 1 1q32 glomerulopathy with fibronectin deposits 1
GFPT1 glutamine--fructose-6-phosphate transaminase 1 2p13.3 congenital myasthenic syndrome with tubular aggregates 2, gfpt1-related congenital myasthenic syndrome, "myasthenia, congenital, with tubular aggregates 1"
GFRA1 GDNF family receptor alpha 1 10q25.3 hirschsprungs disease, congenital central hypoventilation syndrome, central hypoventilation syndrome
GFRA2 GDNF family receptor alpha 2 8p21.3 hirschsprungs disease
GGCX gamma-glutamyl carboxylase 2p11.2 herpes simplex, hemorrhagic disease, vitamin k deficiency hemorrhagic disease,
GGH gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) 8q12.3 acromegaly, herpes simplex, neuroendocrine tumor,
GGT1 gamma-glutamyltransferase 1 22q11.23 recessive dystrophic epidermolysis bullosa, extrahepatic cholestasis, primary biliary cirrhosis,
GGT3P gamma-glutamyltransferase 3 pseudogene 22q11.21 hyperthyroxinemia, stickler syndrome benign recurrent intrahepatic cholestasis
GGT6 gamma-glutamyltransferase 6 17p13.2 glutathionuria
GGTA1P glycoprotein, alpha-galactosyltransferase 1 pseudogene 9q33.2 germ cell tumors
GH1 growth hormone 1 17q23.3 septo-optic dysplasia, mccune albright syndrome, fibrous dysplasia,
GH2 growth hormone 2 17q23.3 choriocarcinoma, trophoblastic neoplasm, pituitary tumors
GHR growth hormone receptor 5p13.1 osteoporosis, papilledema, pituitary adenoma,
GHRH growth hormone releasing hormone 20q11.23 dwarfism, recessive dystrophic epidermolysis bullosa, serotonin syndrome,
GHRHR growth hormone releasing hormone receptor 7p14.3 dwarfism, prostate cancer, prolactinoma,
GHRL ghrelin/obestatin prepropeptide 3p25.3 type 2 diabetes mellitus, anovulation, seizure disorder,
GHS Goldenhar syndrome goldenhar syndrome
GHSR growth hormone secretagogue receptor 3q26.31 acromegaly, isolated growth hormone deficiency, anorexia nervosa,
GIF gastric intrinsic factor (vitamin B synthesis) 11q12.1 galactosemia, diphyllobothriasis, megaloblastic anemia,
GIGYF2 GRB10 interacting GYF protein 2 2q37.1 parkinsons disease, parkinson disease 1 parkinson disease 11
GIMAP1 GTPase, IMAP family member 1 7q36.1 breast and colorectal cancer
GIMAP4 GTPase, IMAP family member 4 7q36.1 acute lymphocytic leukemia
GIMAP5 GTPase, IMAP family member 5 7q36.1 systemic lupus erythematosus
GIMAP6 GTPase, IMAP family member 6 7q36.1 lung cancer
GIN1 gypsy retrotransposon integrase 1 5q21.1 parametritis
GINGF2 gingival fibromatosis, hereditary, 2 5q13-q22 "gingival fibromatosis, 2"
GINGF3 Fibromatosis, gingival, 3 2p23.3-p22.3 "fibromatosis, gingival" "gingival fibromatosis, 3"
GINGF4 gingival fibromatosis, hereditary, 4 11p15 "gingival fibromatosis, 4"
GIP gastric inhibitory polypeptide 17q21.32 type 2 diabetes mellitus, insulin resistance, obesity,
GIPC3 GIPC PDZ domain containing family, member 3 19p13.3 "deafness, autosomal recessive 76", nonsyndromic deafness, autosomal recessive nonsyndromic deafness,
GIPR gastric inhibitory polypeptide receptor 19q13.32 insulinoma, cushings syndrome adrenal adenoma
GJA1 gap junction protein, alpha 1, 43kDa 6q22.31 gliosarcoma, "deafness, autosomal recessive 76", axenfeld-rieger syndrome,
GJA3 gap junction protein, alpha 3, 46kDa 13q12.11 peripheral neuropathy, posterior polar cataract, "cataract 14, multiple types",
GJA4 gap junction protein, alpha 4, 37kDa 1p34.3 myocardial infarction, coronary artery disease, peripheral neuropathy,
GJA5 gap junction protein, alpha 5, 40kDa 1q21.2 rheumatic heart disease, peripheral neuropathy, tetralogy of fallot ,
GJA8 gap junction protein, alpha 8, 50kDa 1q21.2 peripheral neuropathy, "cataract 1, multiple types", cataract,
GJB1 gap junction protein, beta 1, 32kDa Xq13.1 charcot-marie-tooth neuropathy type 2, charcot-marie-tooth disease type 2, neuropathy,
GJB2 gap junction protein, beta 2, 26kDa 13q12.11 "deafness, autosomal recessive 76", nonsyndromic hearing loss and deafness, pendred syndrome,
GJB3 gap junction protein, beta 3, 31kDa 1p34.3 "deafness, autosomal recessive 76", nonsyndromic deafness, autosomal recessive nonsyndromic deafness,
GJB4 gap junction protein, beta 4, 30.3kDa 1p34.3 peripheral neuropathy, skin disease, clouston syndrome,
GJB5 gap junction protein, beta 5, 31.1kDa 1p34.3 lung cancer erythrokeratodermia variabilis
GJB6 gap junction protein, beta 6, 30kDa 13q12.11 "deafness, autosomal recessive 76", nonsyndromic hearing loss and deafness, auditory neuropathy,
GJC1 gap junction protein, gamma 1, 45kDa 17q21.31 cystic fibrosis
GJC2 gap junction protein, gamma 2, 47kDa 1q42.13 peripheral neuropathy, pelizaeus-merzbacher disease, torsion dystonia,
GJC3 gap junction protein, gamma 3, 30.2kDa 7q22.1 peripheral neuropathy
GJD2 gap junction protein, delta 2, 36kDa 15q14 peripheral neuropathy, essential tremor, tremor,
GJE1 gap junction protein, epsilon 1, 23kDa 6q24.1 peripheral neuropathy
GK glycerol kinase Xp21.2 acute liver failure, duchenne muscular dystrophy, dystrophinopathies,
GK2 glycerol kinase 2 4q21.21 complex glycerol kinase deficiency x-linked adrenal hypoplasia congenita
GLA galactosidase, alpha Xq22.1 gangliosidosis gm1, fabry disease, tay-sachs disease,
GLB1 galactosidase, beta 1 3p22.3 gangliosidosis gm1, krabbe disease, lactose intolerance,
GLB1L galactosidase, beta 1-like 2q35 mucopolysaccharidoses, morquio syndrome b sly syndrome
GLC1B glaucoma 1, open angle, B (adult-onset) 2cen-q13 glaucoma "glaucoma 1b, primary open angle, adult onset"
GLC1C glaucoma 1, open angle, C 3q21-q24 glaucoma "glaucoma 1c, primary open angle"
GLC1D glaucoma 1, open angle, D (adult-onset) 8q23 "glaucoma 1d, primary open angle"
GLC1F glaucoma 1, open angle, F (adult-onset) 7q35-q36 "glaucoma 1, open angle, f"
GLC1H glaucoma 1, open angle, H (adult-onset) 2p16.3-p15 glaucoma "glaucoma 1, open angle, h"
GLC1I glaucoma 1, open angle, I 15q11-q13 "glaucoma 1, open angle, i"
GLC1J glaucoma 1, open angle, J (juvenile-onset) 9q22 glaucoma
GLC1K glaucoma 1, open angle, K (juvenile-onset) 20p12 glaucoma "glaucoma 1k, primary open angle, juvenile-onset"
GLC1L glaucoma 1, open angle, L (adult-onset) 3p22-p21 glaucoma
GLC1M glaucoma 1, open angle, M (juvenile-onset) 5q glaucoma "glaucoma 1, open angle, m"
GLC1N glaucoma 1, open angle, N (juvenile-onset) 15q22-q24 glaucoma "glaucoma 1, open angle, n"
GLC1P glaucoma 1, open angle, P 12q14 "glaucoma 1, open angle, p"
GLC1Q glaucoma 1, open angle, Q 4q35.1-q35.2 glaucoma
GLC3B glaucoma 3, primary infantile, B 1p36 primary congenital glaucoma, glaucoma, glaucoma 3 primary infantile b
GLC3C glaucoma 3, primary congenital, C 14q24.3-q31.1 primary congenital glaucoma "glaucoma 3, primary congenital, c"
GLCCI1 glucocorticoid induced transcript 1 7p21.3 "glucocorticoid therapy, response to"
GLDC glycine dehydrogenase (decarboxylating) 9p24.1 early myoclonic encephalopathy, glycine encephalopathy, neonatal glycine encephalopathy,
GLE1 GLE1 RNA export mediator 9q34.11 congenital contractures, lethal congenital contracture syndrome 1 , lethal arthrogryposis with anterior horn cell disease
GLG1 golgi glycoprotein 1 16q23.1 amyotrophic lateral sclerosis
GLI1 GLI family zinc finger 1 12q13.3 colorectal cancer, pancreatic cancer, neuroblastoma,
GLI2 GLI family zinc finger 2 2q14.2 septo-optic dysplasia, septopreoptic holoprosencephaly, midline interhemispheric variant of holoprosencephaly,
GLI3 GLI family zinc finger 3 7p14.1 synovial chondromatosis, imperforate anus, hypothalamic hamartomas,
GLIPR1 GLI pathogenesis-related 1 12q21.2 prostate cancer glioblastoma multiforme
GLIS2 GLIS family zinc finger 2 16p13.3 juvenile autosomal recessive medullary cystic kidney disease, nephronophthisis 7 , acute megakaryoblastic leukemia without down syndrome
GLIS3 GLIS family zinc finger 3 9p24.2 hypothyroidism, congenital hypothyroidism "diabetes mellitus, neonatal, with congenital hypothyroidism"
GLM4 Glioma, familial, 1 15q23-q26.3 glioma susceptibility 4
GLM5 Glioma susceptibility 5 9p21.3 glioma susceptibility 5
GLM6 Glioma susceptibility 6 20q13.33 glioma susceptibility 6
GLM7 Glioma susceptibility 7 8q24.21 glioma susceptibility 7
GLM8 Glioma susceptibility 8 5p15.33 glioma susceptibility 8
GLMN glomulin, FKBP associated protein 1p22.1 klippel-trenaunay syndrome, coats disease, glomus tumor,
GLP1R glucagon-like peptide 1 receptor 6p21.2 type 2 diabetes mellitus fasting hypoglycemia
GLRA1 glycine receptor, alpha 1 5q33.1 hyperekplexia, "hyperekplexia, hereditary 1, autosomal dominant or recessive", aspiration pneumonia,
GLRA2 glycine receptor, alpha 2 Xp22.2 hyperekplexia dyscalculia
GLRA3 glycine receptor, alpha 3 4q34.1 hyperekplexia
GLRA4 glycine receptor, alpha 4 Xq22.2 hyperekplexia
GLRB glycine receptor, beta 4q32.1 hyperekplexia, "hyperekplexia, hereditary 1, autosomal dominant or recessive", glycine encephalopathy,
GLRX glutaredoxin (thioltransferase) 5q15 pancreatic cancer, pancreatic cystadenocarcinoma transitional meningioma
GLRX3 glutaredoxin 3 10q26.3 lymphocytic choriomeningitis
GLRX5 glutaredoxin 5 14q32.13 pearson syndrome, aspartylglucosaminuria, pyridoxine-refractory autosomal recessive sideroblastic anemia,
GLS glutaminase 2q32.2 amyotrophic lateral sclerosis, schizophrenia, hepatic encephalopathy
GLS2 glutaminase 2 (liver, mitochondrial) 12q13.3 schizophrenia, l-2-hydroxyglutaric aciduria, 2-hydroxyglutaric aciduria
GLTSCR2 glioma tumor suppressor candidate region gene 2 19q13.33 seborrheic keratosis
GLUD1 glutamate dehydrogenase 1 10q23.2 amyotrophic lateral sclerosis, schizophrenia, malaria,
GLUD1P5 glutamate dehydrogenase 1 pseudogene 5 10p11.2 hyperinsulinism-hyperammonemia syndrome
GLUL glutamate-ammonia ligase 1q25.3 amyotrophic lateral sclerosis, schizophrenia, reye syndrome,
GLYAT glycine-N-acyltransferase 11q12.1 osteogenesis imperfecta type i, substance-induced psychosis bullous pemphigoid
GLYATL1 glycine-N-acyltransferase-like 1 11q12.1 body dysmorphic disorder, bacterial conjunctivitis acute conjunctivitis
GLYATL1P2 glycine-N-acyltransferase-like 1 pseudogene 2 11q12.1 pulmonary function
GLYCAM1 glycosylation dependent cell adhesion molecule 1 (pseudogene) 12q13.2 macular corneal dystrophy
GLYCTK glycerate kinase 3p21.1 d-glyceric aciduria
GLYR1 glyoxylate reductase 1 homolog (Arabidopsis) 16p13.3 band keratopathy
GLYS1 glycosuria 1, renal 6p21.3 renal glycosuria
GM2A GM2 ganglioside activator 5q33.1 sandhoff disease, tay-sachs disease, gangliosidosis,
GMDS GDP-mannose 4,6-dehydratase 6p25.3 leukocyte adhesion deficiency
GMNN geminin, DNA replication inhibitor 6p22.3 breast cancer melanoacanthoma
GMPPA GDP-mannose pyrophosphorylase A 2q35 achalasia "alacrima, achalasia, and mental retardation syndrome"
GMPPB GDP-mannose pyrophosphorylase B 3p21.31 "muscular dystrophy-dystroglycanopathy , type a, 14", muscular dystrophy-dystroglycanopathy, short rib-polydactyly syndrome,
GMPS guanine monphosphate synthase 3q25.31 acute myeloid leukemia, "acute myeloid leukemia, adult" nephronophthisis 13
GNA11 guanine nucleotide binding protein (G protein), alpha 11 (Gq class) 19p13.3 hypercalcemia, foramen magnum meningioma, "hypocalcemia, autosomal dominant",
GNA12 guanine nucleotide binding protein (G protein) alpha 12 7p22.2 familial hyperaldosteronism
GNA14 guanine nucleotide binding protein (G protein), alpha 14 9q21.2 pertussis chorea-acanthocytosis
GNAI1 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 7q21.11 pertussis
GNAI2 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 3p21.31 olivopontocerebellar atrophy, acth-secreting pituitary adenoma, hemiplegic migraine,
GNAI3 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 1p13.3 auriculocondylar syndrome 1
GNAL guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type 18p11.21 schizophrenia, bipolar disorder, dystonia,
GNAO1 guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O 16q12.2 "epileptic encephalopathy, early infantile, 17"
GNAQ guanine nucleotide binding protein (G protein), q polypeptide 9q21.2 chorea-acanthocytosis, weber syndrome, sturge-weber syndrome,
GNAS GNAS complex locus 20q13.32 cherubism, mccune albright syndrome, fibrous dysplasia,
GNAS-AS1 GNAS antisense RNA 1 20q13.32 pseudohypoparathyroidism
GNAT1 guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1 3p21.31 retinal disease, "night blindness, congenital stationary , 1d, autosomal recessive", blindness,
GNAT2 guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 1p13.3 congenital nystagmus, stargardt disease, achromatopsia,
GNAZ guanine nucleotide binding protein (G protein), alpha z polypeptide 22q11.22 pertussis, autosomal dominant congenital stationary night blindness achromatopsia
GNB1 guanine nucleotide binding protein (G protein), beta polypeptide 1 1p36.33 hemiplegic migraine familial hemiplegic migraine
GNB1L guanine nucleotide binding protein (G protein), beta polypeptide 1-like 22q11.21 digeorge syndrome hypopharynx cancer
GNB2L1 guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 5q35.3 wells syndrome lung cancer
GNB3 guanine nucleotide binding protein (G protein), beta polypeptide 3 12p13.31 schizophrenia, essential hypertension, aortic coarctation,
GNB4 guanine nucleotide binding protein (G protein), beta polypeptide 4 3q26.33 "myopathy, myofibrillar, 3" "charcot-marie-tooth disease, dominant intermediate f"
GNE glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase 9p13.3 myopathy, inclusion body myositis, pagets disease of bone,
GNG2 guanine nucleotide binding protein (G protein), gamma 2 14q22.1 hemiplegic migraine familial hemiplegic migraine
GNG8 guanine nucleotide binding protein (G protein), gamma 8 19q13.32 pertussis
GNGT2 guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 17q21.32 cll/sll
GNLY granulysin 2p11.2 folliculitis, primary biliary cirrhosis, tuberculosis
GNMT glycine N-methyltransferase 6p21.1 hepatocellular carcinoma, hypermethioninemia glycine n-methyltransferase deficiency
GNPAT glyceronephosphate O-acyltransferase 1q42.2 chondrodysplasia, rhizomelic chondrodysplasia punctata, rhizomelic chondrodysplasia punctata type 2,
GNPATP glyceronephosphate O-acyltransferase pseudogene 16q21 pulmonary function
GNPDA2 glucosamine-6-phosphate deaminase 2 4p12 obesity
GNPTAB N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits 12q23.2 mucolipidosis ii, mucolipidosis, speech disorder,
GNPTG N-acetylglucosamine-1-phosphate transferase, gamma subunit 16p13.3 mucolipidosis ii, mucolipidosis, speech disorder,
GNRH1 gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) 8p21.2 hypogonadotropic hypogonadism 17 with or without anosmia, prostate cancer, mccune albright syndrome,
GNRH2 gonadotropin-releasing hormone 2 20p13 medulloblastoma ovarian cancer
GNRHR gonadotropin-releasing hormone receptor 4q13.2 hypogonadotropic hypogonadism 17 with or without anosmia, oligospermia, hypogonadism,
GNS glucosamine (N-acetyl)-6-sulfatase 12q14.3 mucopolysaccharidosis mucopolysaccharidosis type iiid
GOLGA2 golgin A2 9q34.11 mucopolysaccharidosis iii
GOLGA5 golgin A5 14q32.12 follicular thyroid carcinoma, papillary thyroid carcinoma chorea-acanthocytosis
GOLGA6A golgin A6 family, member A 15q24.1 phobic disorder, fibrosarcoma congenital fibrosarcoma
GOLGA6B golgin A6 family, member B 15q24.1 phobic disorder, fibrosarcoma congenital fibrosarcoma
GOLGA6L2 golgin A6 family-like 2 15q11.2 speech disorder
GOLIM4 golgi integral membrane protein 4 3q26.2 nasopharynx carcinoma
GOLM1 golgi membrane protein 1 9q21.33 dyggve-melchior-clausen syndrome
GOLPH3 golgi phosphoprotein 3 (coat-protein) 5p13.3 specific phobia focal dermal hypoplasia
GOPC golgi-associated PDZ and coiled-coil motif containing 6q22.1 cystic fibrosis, globozoospermia parkinson disease 17
GORAB golgin, RAB6-interacting 1q24.2 hypercementosis geroderma osteodysplastica
GORASP2 golgi reassembly stacking protein 2, 55kDa 2q31.1 exudative vitreoretinopathy
GOSR2 golgi SNAP receptor complex member 2 17q21.32 essential hypertension, hypertension, myoclonus epilepsy,
GOT1 glutamic-oxaloacetic transaminase 1, soluble 10q24.2 reye syndrome, exanthem, gallbladder disease,
GOT1L1 glutamic-oxaloacetic transaminase 1-like 1 8p11.23 euthyroid sick syndrome
GOT2 glutamic-oxaloacetic transaminase 2, mitochondrial 16q21 reye syndrome, fascioliasis, exanthem
GP1BA glycoprotein Ib (platelet), alpha polypeptide 17p13.2 bernard-soulier syndrome, thrombocytosis, coronary thrombosis,
GP1BB glycoprotein Ib (platelet), beta polypeptide 22q11.21 bernard-soulier syndrome, digeorge syndrome, velocardiofacial syndrome,
GP2 glycoprotein 2 (zymogen granule membrane) 16p12.3 lymphocytic choriomeningitis, hemorrhagic fever, ebola hemorrhagic fever,
GP5 glycoprotein V (platelet) 3q29 bernard-soulier syndrome, gray platelet syndrome cervix uteri carcinoma in situ
GP6 glycoprotein VI (platelet) 19q13.42 coronary thrombosis, gray platelet syndrome, cervix uteri carcinoma in situ
GP9 glycoprotein IX (platelet) 3q21.3 bernard-soulier syndrome, gray platelet syndrome, "bernard-soulier syndrome, type a2",
GPBAR1 G protein-coupled bile acid receptor 1 2q35 primary sclerosing cholangitis, ocular albinism, sclerosing cholangitis
GPBP1 GC-rich promoter binding protein 1 5q11.2 atherosclerosis
GPC1 glypican 1 2q37.3 biliary atresia
GPC2 glypican 2 7q22.1 mucopolysaccharidoses, morquio syndrome b sly syndrome
GPC3 glypican 3 Xq26.2 hepatocellular carcinoma, extragonadal germ cell tumor, placental site trophoblastic tumor,
GPC4 glypican 4 Xq26.2 anoxia, postaxial polydactyly type a, simpson-golabi-behmel syndrome,
GPC6 glypican 6 13q31.3 body dysmorphic disorder omodysplasia 1
GPD1 glycerol-3-phosphate dehydrogenase 1 (soluble) 12q13.12 hypertriglyceridemia "hypertriglyceridemia, transient infantile"
GPD1L glycerol-3-phosphate dehydrogenase 1-like 3p22.3 brugada syndrome 1, sudden infant death syndrome, craniometaphyseal dysplasia,
GPD2 glycerol-3-phosphate dehydrogenase 2 (mitochondrial) 2q24.1 type 2 diabetes mellitus, "diabetes, type 2" methylmalonic acidemia
GPDS1 glaucoma-related pigment dispersion syndrome 1 7q35-q36 pigment-dispersion syndrome
GPER1 G protein-coupled estrogen receptor 1 7p22.3 breast cancer pain disorder
GPHA2 glycoprotein hormone alpha 2 11q13.1 norrie disease
GPHN gephyrin 14q23.3 hyperekplexia, "hyperekplexia, hereditary 1, autosomal dominant or recessive", herpes zoster,
GPI glucose-6-phosphate isomerase 19q13.11 primary hyperoxaluria, hemolytic anemia, root caries,
GPIHBP1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 8q24.3 type 2 diabetes mellitus, hyperlipoproteinemia type v, familial lipoprotein lipase deficiency
GPM6B glycoprotein M6B Xp22.2 pelizaeus-merzbacher disease
GPNMB glycoprotein (transmembrane) nmb 7p15.3 iris disease
GPR112 G protein-coupled receptor 112 Xq26.3 neuroendocrine carcinoma
GPR125 G protein-coupled receptor 125 4p15.2 schizophrenia bipolar disorder
GPR143 G protein-coupled receptor 143 Xp22.2 strabismus, albinism, congenital nystagmus,
GPR148 G protein-coupled receptor 148 2q21.1 cicatricial entropion entropion
GPR15 G protein-coupled receptor 15 3q11.2 osteosarcoma
GPR152 G protein-coupled receptor 152 11q13.2 estrogen-receptor positive breast cancer
GPR17 G protein-coupled receptor 17 2q14.3 spinal cord injury, amblyopia suppression amblyopia
GPR171 G protein-coupled receptor 171 3q25.1 usher syndrome type 3
GPR179 G protein-coupled receptor 179 17q12 "night blindness, congenital stationary , 1d, autosomal recessive", blindness, night blindness,
GPR182 G protein-coupled receptor 182 12q13.3 oligohydramnios sepsis
GPR35 G protein-coupled receptor 35 2q37.3 primary sclerosing cholangitis
GPR37 G protein-coupled receptor 37 (endothelin receptor type B-like) 7q31.33 parkinsons disease
GPR45 G protein-coupled receptor 45 2q12.1 breast and colorectal cancer
GPR50 G protein-coupled receptor 50 Xq28 autism spectrum disorder mood disorder
GPR56 G protein-coupled receptor 56 16q21 periventricular nodular heterotopia, neuronal migration disorders, lennox-gastaut syndrome,
GPR68 G protein-coupled receptor 68 14q32.11 ovarian cancer
GPR75 G protein-coupled receptor 75 2p16.2 age related macular degeneration
GPR78 G protein-coupled receptor 78 4p16.1 schizophrenia
GPR83 G protein-coupled receptor 83 11q21 dissecting aortic aneurysm
GPR84 G protein-coupled receptor 84 12q13.13 pertussis
GPR87 G protein-coupled receptor 87 3q25.1 breast and colorectal cancer, oral squamous cell carcinoma lung squamous cell carcinoma
GPR98 G protein-coupled receptor 98 5q14.3 febrile seizures, usher syndrome type ii, "usher syndrome, type 2c, gpr98/pdzd7 digenic",
GPRASP2 G protein-coupled receptor associated sorting protein 2 Xq22.1 autism spectrum disorder
GPSM2 G-protein signaling modulator 2 1p13.3 "deafness, autosomal recessive 76", nonsyndromic deafness, autosomal recessive nonsyndromic deafness,
GPT glutamic-pyruvate transaminase (alanine aminotransferase) 8q24.3 hepatocellular carcinoma, polyarteritis nodosa, extrahepatic cholestasis,
GPX1 glutathione peroxidase 1 3p21.31 coronary artery disease, breast cancer, malaria,
GPX1P2 glutathione peroxidase pseudogene 2 21q21.3 major depressive disorder
GPX3 glutathione peroxidase 3 (plasma) 5q33.1 keshan disease
GPX4 glutathione peroxidase 4 19p13.3 keshan disease, toxic encephalopathy spondylometaphyseal dysplasia sedaghatian type
GPX5 glutathione peroxidase 5 (epididymal androgen-related protein) 6p22.1 keshan disease
GPX6 glutathione peroxidase 6 (olfactory) 6p22.1 keshan disease
GPX7 glutathione peroxidase 7 1p32.3 goldenhar syndrome
GPX8 glutathione peroxidase 8 (putative) 5q11.2 keshan disease
GRAMD3 GRAM domain containing 3 5q23.2 hepatitis c hepatitis c virus
GRB10 growth factor receptor-bound protein 10 7p12.1 silver-russell syndrome albrights hereditary osteodystrophy
GRB2 growth factor receptor-bound protein 2 17q25.1 hydrocele
GRD1 Graves disease, susceptiblity to, 1 14q31 graves disease graves disease 1
GRD2 Graves disease, susceptibility to, 2 20q13.11 graves disease graves disease 2
GRDX Graves disease, susceptibility to, X-linked Xp11 graves disease graves disease x-linked
GREB1 growth regulation by estrogen in breast cancer 1 2p25.1 breast cancer
GREB1L growth regulation by estrogen in breast cancer-like 18q11.1 breast cancer
GREM1 gremlin 1, DAN family BMP antagonist 15q13.3 asphyxiating thoracic dystrophy, proliferative vitreoretinopathy, adenoma,
GREM2 gremlin 2, DAN family BMP antagonist 1q43 esotropia, norrie disease accommodative esotropia
GRHL2 grainyhead-like 2 (Drosophila) 8q22.3 "deafness, autosomal dominant 4b", "deafness, autosomal dominant 28" dfna28 nonsyndromic hearing loss and deafness
GRHL3 grainyhead-like 3 (Drosophila) 1p36.11 van der woude syndrome van der woude syndrome 2
GRHPR glyoxylate reductase/hydroxypyruvate reductase 9p13.2 primary hyperoxaluria primary hyperoxaluria type 2
GRIA1 glutamate receptor, ionotropic, AMPA 1 5q33.2 limbic encephalitis
GRIA2 glutamate receptor, ionotropic, AMPA 2 4q32.1 amyotrophic lateral sclerosis, schizophrenia, lateral sclerosis,
GRIA3 glutamate receptor, ionotropic, AMPA 3 Xq25 auditory neuropathy, rasmussen encephalitis, canavan disease
GRIA4 glutamate receptor, ionotropic, AMPA 4 11q22.3 schizophrenia
GRID2 glutamate receptor, ionotropic, delta 2 4q22.1 autosomal recessive congenital cerebellar ataxia due to grid2 deficiency
GRIK1 glutamate receptor, ionotropic, kainate 1 21q21.3 juvenile absence epilepsy, amnestic disorder, monosomy 21
GRIK2 glutamate receptor, ionotropic, kainate 2 6q16.3 "mental retardation, autosomal recessive 43", hemimegalencephaly juvenile absence epilepsy
GRIK3 glutamate receptor, ionotropic, kainate 3 1p34.3 schizophrenia
GRIK5 glutamate receptor, ionotropic, kainate 5 19q13.2 schizophrenia
GRIN1 glutamate receptor, ionotropic, N-methyl D-aspartate 1 9q34.3 schizophrenia, neuroblastoma, bipolar disorder,
GRIN2A glutamate receptor, ionotropic, N-methyl D-aspartate 2A 16p13.2 "epilepsy, focal, with speech disorder and with or without mental retardation", epilepsy with neurodevelopmental defects, speech disorder,
GRIN2B glutamate receptor, ionotropic, N-methyl D-aspartate 2B 12p13.1 "epileptic encephalopathy, early infantile, 5", myoclonic astatic epilepsy, "mental retardation, autosomal dominant 10",
GRIN2C glutamate receptor, ionotropic, N-methyl D-aspartate 2C 17q25.1 schizophrenia toxic encephalopathy
GRIN3B glutamate receptor, ionotropic, N-methyl-D-aspartate 3B 19p13.3 opioid abuse
GRIP1 glutamate receptor interacting protein 1 12q14.3 grip1-related fraser syndrome, cryptophthalmos fraser syndrome
GRK1 G protein-coupled receptor kinase 1 13q34 "night blindness, congenital stationary , 1d, autosomal recessive", blindness, fundus albipunctatus ,
GRK4 G protein-coupled receptor kinase 4 4p16.3 essential hypertension, aortic coarctation hypertension
GRK6 G protein-coupled receptor kinase 6 5q35.3 whim syndrome
GRM1 glutamate receptor, metabotropic 1 6q24.3 breast cancer, schizophrenia, bipolar disorder,
GRM2 glutamate receptor, metabotropic 2 3p21.2 schizophrenia
GRM3 glutamate receptor, metabotropic 3 7q21.11 schizophrenia
GRM5 glutamate receptor, metabotropic 5 11q14.3 fragile x syndrome
GRM6 glutamate receptor, metabotropic 6 5q35.3 "night blindness, congenital stationary , 1d, autosomal recessive", optic nerve disease, amblyopia,
GRN granulin 17q21.31 amyotrophic lateral sclerosis, frontotemporal lobar degeneration with ubiquitin-positive inclusions, "dementia, familial, nonspecific",
GRP gastrin-releasing peptide 18q21.32 prostate cancer, pancreatic cancer, colon cancer,
GRPR gastrin-releasing peptide receptor Xp22.2 prostate cancer, colon cancer, lung cancer,
GRXCR1 glutaredoxin, cysteine rich 1 4p13 "deafness, autosomal recessive 76" "deafness, autosomal recessive 25"
GRXCR2 glutaredoxin, cysteine rich 2 5q32 "deafness, autosomal recessive 76" "deafness, autosomal recessive 101"
GS1-204I12.1 uncharacterized LOC101929093 1q25.3 prostate cancer
GS1-251I9.4 uncharacterized LOC100506365 8q21.3 migraine
GS1-279B7.1 microtubule-associated protein 1 light chain 3 beta pseudogene 1q25.3 prostate cancer
GSAP gamma-secretase activating protein 7q11.23 alzheimers disease
GSC goosecoid homeobox 14q32.13 microtia, auditory neuropathy, cornelia de lange syndrome
GSC2 goosecoid homeobox 2 22q11.21 digeorge syndrome
GSDMB gasdermin B 17q12 primary biliary cirrhosis
GSDMC gasdermin C 8q24.21 melanoma
GSG2 germ cell associated 2 (haspin) 17p13.2 rhinotracheitis
GSK3A glycogen synthase kinase 3 alpha 19q13.2 schizophrenia
GSK3B glycogen synthase kinase 3 beta 3q13.33 parkinsons disease, alzheimers disease, aneurysmal bone cysts,
GSM1 geniospasm 1 9q13-q21 geniospasm
GSN gelsolin 9q33.2 colorectal cancer, hereditary amyloidosis, amyloidosis,
GSR glutathione reductase 8p12 amyotrophic lateral sclerosis, chagas disease, encephalitis,
GSS glutathione synthetase 20q11.22 anoxia, metabolic acidosis, glutathione synthetase deficiency,
GSTA1 glutathione S-transferase alpha 1 6p12.2 toxic encephalopathy
GSTA2 glutathione S-transferase alpha 2 6p12.2 periventricular nodular heterotopia, malignant pleural mesothelioma toxic encephalopathy
GSTA3 glutathione S-transferase alpha 3 6p12.2 juvenile myoclonic epilepsy toxic encephalopathy
GSTA4 glutathione S-transferase alpha 4 6p12.2 atherosclerosis malignant pleural mesothelioma
GSTM1 glutathione S-transferase mu 1 1p13.3 colorectal cancer, breast cancer, beta thalassemia,
GSTM3 glutathione S-transferase mu 3 (brain) 1p13.3 bronchogenic carcinoma, lung cancer, non-hodgkin lymphoma,
GSTM4 glutathione S-transferase mu 4 1p13.3 breast cancer susceptibility tinea pedis
GSTM5 glutathione S-transferase mu 5 1p13.3 breast cancer susceptibility
GSTO1 glutathione S-transferase omega 1 10q25.1 parkinsons disease, vascular dementia barretts adenocarcinoma
GSTO2 glutathione S-transferase omega 2 10q25.1 parkinsons disease barretts adenocarcinoma
GSTP1 glutathione S-transferase pi 1 11q13.2 bladder cancer susceptibility, pre-eclampsia, maxillary sinus squamous cell carcinoma,
GSTT1 glutathione S-transferase theta 1 22q11.23 coronary artery disease, prostate cancer, breast cancer,
GSTT2 glutathione S-transferase theta 2 22q11.23 malignant pleural mesothelioma barretts adenocarcinoma
GSTZ1 glutathione S-transferase zeta 1 14q24.3 phenylketonuria, tyrosinemia, "tyrosinemia, type ib",
GSX1 GS homeobox 1 13q12.2 moebius syndrome
GTF2E1 general transcription factor IIE, polypeptide 1, alpha 56kDa 3q13.33 richters syndrome
GTF2H1 general transcription factor IIH, polypeptide 1, 62kDa 11p15.1 rift valley fever "xeroderma pigmentosum, group c"
GTF2H2 general transcription factor IIH, polypeptide 2, 44kDa 5q13.2 muscular atrophy, seminoma, idiopathic pulmonary fibrosis
GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa 6p21.33 photosensitive trichothiodystrophy nonphotosensitive trichothiodystrophy
GTF2H5 general transcription factor IIH, polypeptide 5 6q25.3 cutaneous fibrous histiocytoma, photosensitive trichothiodystrophy "trichothiodystrophy, complementation group a"
GTF2I general transcription factor IIi 7q11.23 williams-beuren syndrome
GTF2IP1 general transcription factor IIi, pseudogene 1 7q11.23 williams-beuren syndrome
GTF2IRD1 GTF2I repeat domain containing 1 7q11.23 williams-beuren syndrome, neurilemmoma williams syndrome
GTF2IRD2 GTF2I repeat domain containing 2 7q11.23 williams-beuren syndrome
GTF2IRD2B GTF2I repeat domain containing 2B 7q11.23 williams-beuren syndrome
GTF2IRD2P1 GTF2I repeat domain containing 2 pseudogene 1 7q11.23 williams-beuren syndrome
GTF3A general transcription factor IIIA 13q12.2 prostate carcinoma in situ endocarditis
GTS Gilles de la Tourette syndrome 11q23 gilles de la tourette syndrome
GUCA1A guanylate cyclase activator 1A (retina) 6p21.1 cone-rod dystrophy 2, partial central choroid dystrophy, cone dystrophy,
GUCA1B guanylate cyclase activator 1B (retina) 6p21.1 leber congenital amaurosis, retinitis pigmentosa, retinitis pigmentosa 48
GUCA2A guanylate cyclase activator 2A (guanylin) 1p34.2 cholera cystic fibrosis
GUCA2B guanylate cyclase activator 2B (uroguanylin) 1p34.2 pertussis, cystic fibrosis ovarian mucinous neoplasm
GUCY1A2 guanylate cyclase 1, soluble, alpha 2 11q22.3 colorectal cancer
GUCY1A3 guanylate cyclase 1, soluble, alpha 3 4q32.1 moyamoya 6 with achalasia
GUCY2C guanylate cyclase 2C (heat stable enterotoxin receptor) 12p12.3 diarrhea, ileus, meconium ileus,
GUCY2D guanylate cyclase 2D, membrane (retina-specific) 17p13.1 leber congenital amaurosis, leber congenital amaurosis 17, keratoconus,
GUK1 guanylate kinase 1 1q42.13 ankylosis
GULOP gulonolactone (L-) oxidase, pseudogene 8p21.1 scurvy
GUSB glucuronidase, beta 7q11.21 infectious mononucleosis, fabry disease, mucopolysaccharidosis,
GUST Gustavson mental retardation syndrome (with microcephaly, optic Xq26 x-linked mental retardation gustavson type
GYG1 glycogenin 1 3q24 lymphogranuloma venereum, ornithosis glycogen storage disease xv
GYG2 glycogenin 2 Xp22.33 glycogen storage disease type 0
GYLTL1B glycosyltransferase-like 1B 11p11.2 dyscalculia ureteral benign neoplasm
GYPA glycophorin A (MNS blood group) 4q31.21 malaria, werner syndrome, cerebral malaria
GYPB glycophorin B (MNS blood group) 4q31.21 malaria cerebral malaria
GYPC glycophorin C (Gerbich blood group) 2q14.3 malaria, hereditary elliptocytosis herpes zoster
GYPE glycophorin E (MNS blood group) 4q31.21 congenital dyserythropoietic anemia type i, malaria sickle cell disease
GYS1 glycogen synthase 1 (muscle) 19q13.33 insulin resistance, glucose intolerance, coumarin resistance
GYS2 glycogen synthase 2 (liver) 12p12.1 glycogen storage disease type 0, hypoglycemia fasting hypoglycemia
GZMA granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) 5q11.2 chediak-higashi syndrome
GZMB granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) 14q12 myocardial infarction, subcutaneous panniculitis-like t-cell lymphoma, peripheral t-cell lymphoma,
GZMK granzyme K (granzyme 3; tryptase II) 5q11.2 allergic asthma, arts syndrome t-cell large granular lymphocyte leukemia
H19 H19, imprinted maternally expressed transcript (non-protein coding) 11p15.5 bladder carcinoma, juvenile nasopharyngeal angiofibroma, beckwith-wiedemann syndrome,
H2AFX H2A histone family, member X 11q23.3 vulvar intraepithelial neoplasia
H2AFY H2A histone family, member Y 5q31.1 medulloblastoma
H2BFS H2B histone family, member S (pseudogene) 21q22.3 acute myeloid leukemia
H2BFWT H2B histone family, member W, testis-specific Xq22.2 male infertility infertility
H3F3C H3 histone, family 3C 12p11.21 lattice corneal dystrophy corneal granular dystrophy
H6PD hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) 1p36.22 parotitis, cortisone reductase deficiency 1 cortisone reductase deficiency
HAAO 3-hydroxyanthranilate 3,4-dioxygenase 2p21 pellagra olivopontocerebellar atrophy
HABP2 hyaluronan binding protein 2 10q25.3 venous thromboembolism, follicular mucinosis, thromboembolism,
HACE1 HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 6q16.3 neuroblastoma
HACL1 2-hydroxyacyl-CoA lyase 1 3p25.1 rhizomelic chondrodysplasia punctata beriberi
HADH hydroxyacyl-CoA dehydrogenase 4q25 hypoglycemia, familial hyperinsulinism , hyperinsulinemic hypoglycemia,
HADHA hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit 2p23.3 retinal artery occlusion, fatty acid oxidation disorders, hellp syndrome,
HADHB hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit 2p23.3 rhizomelic chondrodysplasia punctata, peroxisomal disease, d-bifunctional protein deficiency,
HAL histidine ammonia-lyase 12q23.1 histidinemia
HAMP hepcidin antimicrobial peptide 19q13.12 congenital dyserythropoietic anemia type i, juvenile hereditary hemochromatosis, hemochromatosis,
HAND1 heart and neural crest derivatives expressed 1 5q33.2 tetralogy of fallot , congenital heart disease ventricular septal defect
HAND2 heart and neural crest derivatives expressed 2 4q34.1 saethre-chotzen syndrome, split hand congenital heart disease
HAND2-AS1 HAND2 antisense RNA 1 (head to head) 4q34.1 neuroblastoma
HAO1 hydroxyacid oxidase (glycolate oxidase) 1 20p12.3 primary hyperoxaluria
HAO2 hydroxyacid oxidase 2 (long chain) 1p12 primary hyperoxaluria
HAP1 huntingtin-associated protein 1 17q21.2 huntingtons disease
HARS histidyl-tRNA synthetase 5q31.3 polymyositis, antisynthetase syndrome, dermatomyositis,
HARS2 histidyl-tRNA synthetase 2, mitochondrial 5q31.3 sensorineural hearing loss, perrault syndrome, perrault syndrome 1
HAS1 hyaluronan synthase 1 19q13.41 rheumatoid arthritis, malignant peritoneal mesothelioma, macroglobulinemia,
HAS2 hyaluronan synthase 2 8q24.13 rheumatoid arthritis, osteosarcoma lipoblastoma
HAS3 hyaluronan synthase 3 16q22.1 nodular basal cell carcinoma, skin atrophy juvenile hyaline fibromatosis
HAUS2 HAUS augmin-like complex, subunit 2 15q15.2 congenital dyserythropoietic anemia type i
HAVCR1 hepatitis A virus cellular receptor 1 5q33.3 asthma, malaria, hepatitis,
HAVCR2 hepatitis A virus cellular receptor 2 5q33.3 malaria, hepatitis, epithelial malignant thymoma,
HAX1 HCLS1 associated protein X-1 1q21.3 neutropenia, kidney disease, idiopathic neutropenia,
HBA1 hemoglobin, alpha 1 16p13.3 alpha thalassemia, beta thalassemia, vascular cancer,
HBA2 hemoglobin, alpha 2 16p13.3 alpha thalassemia, beta thalassemia, malaria,
HBB hemoglobin, beta 11p15.4 trachoma, alpha thalassemia, acute chest syndrome,
HBBP1 hemoglobin, beta pseudogene 1 11p15.4 beta thalassemia, hereditary persistence of fetal hemoglobin delta-beta thalassemia
HBD hemoglobin, delta 11p15.4 hereditary persistence of fetal hemoglobin, thalassemia, sickle cell disease,
HBE1 hemoglobin, epsilon 1 11p15.4 malaria, hepatitis d, cerebral malaria,
HBEGF heparin-binding EGF-like growth factor 5q31.3 pancreatic cancer, bladder disease, perinatal necrotizing enterocolitis,
HBFQTL2 hereditary persistence of fetal hemoglobin, heterocellular 6q22.3-q23.1 hereditary persistence of fetal hemoglobin fetal hemoglobin quantitative trait locus 2
HBFQTL4 Fetal hemoglobin QTL on chromosome 8 8q fetal hemoglobin quantitative trait locus 4
HBG1 hemoglobin, gamma A 11p15.4 juvenile myelomonocytic leukemia, beta thalassemia, hereditary persistence of fetal hemoglobin,
HBG2 hemoglobin, gamma G 11p15.4 cavernous hemangioma, alpha thalassemia, malaria,
HBHR alpha-thalassemia/mental retardation syndrome, type 1 16pter-p13.3 alpha-thalassemia/mental retardation syndrome "alpha-thalassemia/mental retardation syndrome, type 1"
HBP1 HMG-box transcription factor 1 7q22.3 ureter cancer
HBQ1 hemoglobin, theta 1 16p13.3 alpha thalassemia
HBS1L HBS1-like (S. cerevisiae) 6q23.3 thalassemia, sickle cell disease hemoglobinopathy
HBZ hemoglobin, zeta 16p13.3 alpha thalassemia spinal cord disease
HCA1 Hypercalciuria, absorptive, 1 4q33-qter "hypercalciuria, absorptive"
HCAR3 hydroxycarboxylic acid receptor 3 12q24.31 "distal hereditary motor neuropathy, type ii"
HCCAT3 hepatocellular carcinoma associated transcript 3 (non-protein coding) 19q13.41 hepatocellular carcinoma
HCCAT4 hepatocellular carcinoma associated transcript 4 (non-protein coding) 9q34.3 hepatocellular carcinoma
HCCAT5 hepatocellular carcinoma associated transcript 5 (non-protein coding) 16q22.3 hepatocellular carcinoma
HCCS holocytochrome c synthase Xp22.2 microphthalmia with linear skin defects syndrome, microphthalmia, congenital diaphragmatic hernia,
HCFC1 host cell factor C1 (VP16-accessory protein) Xq28 "mental retardation, x-linked 17/31, microduplication", "mental retardation, x-linked", herpes simplex
HCFC2 host cell factor C2 12q23.3 herpes simplex botulism
HCG22 HLA complex group 22 6p21.33 follicular lymphoma
HCHOLA4 hypercholesterolemia, autosomal dominant 4 16q22.1 hypercholesterolemia
HCK hemopoietic cell kinase 20q11.21 parkinsons disease, cervical adenosquamous carcinoma adenosquamous carcinoma
HCL3 hair color 3 (brown) 15q oculocutaneous albinism type 2 "albinism, brown oculocutaneous"
HCN1 hyperpolarization activated cyclic nucleotide-gated potassium channel 1 5p12 sick sinus syndrome "epileptic encephalopathy, early infantile, 24"
HCN2 hyperpolarization activated cyclic nucleotide-gated potassium channel 2 19p13.3 thyrotoxicosis sick sinus syndrome
HCN3 hyperpolarization activated cyclic nucleotide-gated potassium channel 3 1q22 sick sinus syndrome pallister-hall syndrome
HCN4 hyperpolarization activated cyclic nucleotide-gated potassium channel 4 15q24.1 brugada syndrome 1, sick sinus syndrome, spondyloepimetaphyseal dysplasia,
HCP5 HLA complex P5 (non-protein coding) 6p21.33 toxic epidermal necrolysis, stevens-johnson syndrome, drug-induced liver injury due to flucloxacillin
HCRP1 hepatocellular carcinoma-related HCRP1 6p21.1 hepatocellular carcinoma "spastic paraplegia 53, autosomal recessive"
HCRT hypocretin (orexin) neuropeptide precursor 17q21.2 alobar holoprosencephaly, parkinsons disease, schizophrenia,
HCRTR1 hypocretin (orexin) receptor 1 1p35.2 pertussis, neuroblastoma, eating disorder,
HCRTR2 hypocretin (orexin) receptor 2 6p12.1 sleep disorder, narcolepsy, cluster headache
HDAC1 histone deacetylase 1 1p35.1 retinoblastoma, atrichia with papular lesions chromosome 1p deletion
HDAC4 histone deacetylase 4 2q37.3 brachydactyly, albrights hereditary osteodystrophy, cohen syndrome,
HDAC5 histone deacetylase 5 17q21.31 colon cancer
HDAC6 histone deacetylase 6 Xp11.23 alexander disease, cohen syndrome "chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia"
HDAC8 histone deacetylase 8 Xq13.1 obesity, cornelia de lange syndrome 1 , cornelia de lange syndrome,
HDAC9 histone deacetylase 9 7p21.1 hiv-1, gastrointestinal neuroendocrine tumor, peters plus syndrome
HDC histidine decarboxylase 15q21.2 colorectal cancer, duodenal ulcer, gilles de la tourette syndrome,
HDDC2 HD domain containing 2 6q22.31 hepatitis c, hepatitis c virus hepatitis
HDGF hepatoma-derived growth factor 1q23.1 hepatocellular carcinoma
HDHD1 haloacid dehalogenase-like hydrolase domain containing 1 Xp22.31 x-linked ichthyosis
HDL3 Huntington-like neurodegenerative disorder 2 4p15.3 huntington disease-like 3
HDLBP high density lipoprotein binding protein 2q37.3 familial hdl deficiency
HDLC3 High density lipoprotein cholesterol, low serum, 3 16q24.1 "high density lipoprotein cholesterol, low serum, 3"
HDLCQ14 Hypoalphalipoproteinemia, primary 11q23.3 hypoalphalipoproteinemia high density lipoprotein cholesterol level qtl14
HDPA Hodgkin disease, susceptibility, pseudoautosomal Xpter-p22.32 "hodgkin disease susceptibility, pseudoautosomal"
HEATR2 HEAT repeat containing 2 7p22.3 "ciliary dyskinesia, primary, 19", primary ciliary dyskinesia18: heatr2-related primary ciliary dyskinesia "ciliary dyskinesia, primary, 18"
HEATR6 HEAT repeat containing 6 17q23.1 breast cancer
HEBP1 heme binding protein 1 12p13.1 ankylosis dental enamel hypoplasia
HECA headcase homolog (Drosophila) 6q24.1 lichen nitidus
HEIH hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA 5q35.3 hepatocellular carcinoma
HELLS helicase, lymphoid-specific 10q23.33 autosomal dominant progressive external ophthalmoplegia rothmund-thomson syndrome
HELZ helicase with zinc finger 17q24.2 nonepidermolytic palmoplantar keratoderma
HEMK1 HemK methyltransferase family member 1 3p21.2 acrocephalosyndactylia
HEPACAM hepatic and glial cell adhesion molecule 11q24.2 bladder transitional cell carcinoma, transitional cell carcinoma, megalencephalic leukoencephalopathy with subcortical cysts,
HEPH hephaestin Xq12 age related macular degeneration, aceruloplasminemia, congenital disorder of glycosylation type i
HEPN1 hepatocellular carcinoma, down-regulated 1 11q24.2 hepatocellular carcinoma
HERC2 HECT and RLD domain containing E3 ubiquitin protein ligase 2 15q13.1 "mental retardation, autosomal recessive 38"
HERC2P1 hect domain and RLD 2 pseudogene 1 15q13 angelman syndrome
HERC2P5 hect domain and RLD 2 pseudogene 5 16p11.2 angelman syndrome
HERC2P6 hect domain and RLD 2 pseudogene 6 15q11.2 angelman syndrome
HERC2P8 hect domain and RLD 2 pseudogene 8 16p11.2 angelman syndrome
HERC5 HECT and RLD domain containing E3 ubiquitin protein ligase 5 4q22.1 liddle syndrome
HES1 hes family bHLH transcription factor 1 3q29 dominant optic atrophy
HES6 hes family bHLH transcription factor 6 2q37.3 alveolar rhabdomyosarcoma, autism spectrum disorder mood disorder
HES7 hes family bHLH transcription factor 7 17p13.1 dextrocardia, spondylocostal dysostosis, dextrocardia with situs inversus,
HESX1 HESX homeobox 1 3p14.3 hypogonadotropic hypogonadism 8 with or without anosmia, kallmann syndrome, septo-optic dysplasia,
HEXA hexosaminidase A (alpha polypeptide) 15q23 sensory peripheral neuropathy, amyotrophic lateral sclerosis, gangliosidosis gm1,
HEXB hexosaminidase B (beta polypeptide) 5q13.3 cervical cancer, sandhoff disease, tay-sachs disease,
HEXDC hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing 17q25.3 sandhoff disease tay-sachs disease
HEY hairy ears, Y-linked Yq "hairy ears, y-linked"
HEY1 hes-related family bHLH transcription factor with YRPW motif 1 8q21.13 mesenchymal chondrosarcoma
HEY2 hes-related family bHLH transcription factor with YRPW motif 2 6q22.31 abdominal aortic aneurysm, tetralogy of fallot , tricuspid atresia
HFE hemochromatosis 6p22.2 hepatocellular carcinoma, wilson disease, arthropathy,
HFE2 hemochromatosis type 2 (juvenile) 1q21.1 periventricular nodular heterotopia, juvenile hereditary hemochromatosis, hemochromatosis,
HFM Hemifacial microsomia 14q32 goldenhar syndrome
HFM1 HFM1, ATP-dependent DNA helicase homolog (S. cerevisiae) 1p22.2 epicondylitis, spastic hemiplegia premature ovarian failure 9
HGC6.3 uncharacterized LOC100128124 6q27 ovarian cancer
HGD homogentisate 1,2-dioxygenase 3q13.33 alkaptonuria, ochronosis lumbar disc herniation
HGF hepatocyte growth factor (hepapoietin A; scatter factor) 7q21.11 hepatocellular carcinoma, gastric ulcer, kaposis sarcoma,
HGFAC HGF activator 4p16.3 hepatocellular carcinoma, pancreatic cancer idiopathic pulmonary fibrosis
HGS hepatocyte growth factor-regulated tyrosine kinase substrate 17q25.3 hypertonia, neurofibromatosis pelger-huet anomaly
HGSNAT heparan-alpha-glucosaminide N-acetyltransferase 8p11.21 mucopolysaccharidosis iii, lysosomal storage disease mucopolysaccharidosis type iiic
HHAT hedgehog acyltransferase 1q32.2 melanoma chondrodysplasia - disorder of sex development
HHATL hedgehog acyltransferase-like 3p22.1 skin squamous cell carcinoma
HHC3 hypocalciuric hypercalcemia 3 (Oklahoma type) 19q13 familial hypocalciuric hypercalcemia type 3
HHCM Mahlavu hepatocellular carcinoma 8q24.3 hepatocellular carcinoma
HHEX hematopoietically expressed homeobox 10q23.33 type 2 diabetes mellitus gestational diabetes
HHLA1 HERV-H LTR-associating 1 8q24.22 oligohydramnios benign paroxysmal positional nystagmus
HHPP Hyperhidrosis palmaris et plantaris 14q11.2-q13 hyperhidrosis palmaris et plantaris
HHT3 Osler-Rendu-Weber syndrome 3 5q31.3-q32 hereditary hemorrhagic telangiectasia type 3 weber syndrome
HHT4 Telangiectasia, hereditary hemorrhagic, type 4 7p14 hereditary hemorrhagic telangiectasia type 4
HHV8S Human herpesvirus 8, susceptibility to 3p22 classic kaposi sarcoma
HIBADH 3-hydroxyisobutyrate dehydrogenase 7p15.2 3-hydroxyisobutyric aciduria
HIBCH 3-hydroxyisobutyryl-CoA hydrolase 2q32.2 fukuyama congenital muscular dystrophy 3-hydroxyisobutryl-coa hydrolase deficiency
HIC1 hypermethylated in cancer 1 17p13.3 hepatocellular carcinoma, male germ cell tumor, breast cancer,
HIF1A hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) 14q23.2 cervical cancer, pericardial effusion, diabetic retinopathy,
HIF1AN hypoxia inducible factor 1, alpha subunit inhibitor 10q24.31 pre-eclampsia, hypoxia pancreatic endocrine tumors
HIF3A hypoxia inducible factor 3, alpha subunit 19q13.32 hypoxia extratemporal epilepsy
HIGD1A HIG1 hypoxia inducible domain family, member 1A 3p22.1 hypoxia
HIGD1B HIG1 hypoxia inducible domain family, member 1B 17q21.31 hypoxia
HIGD2B HIG1 hypoxia inducible domain family, member 2B 15q24.1 hypoxia
HILPDA hypoxia inducible lipid droplet-associated 7q32.1 hypoxia, end stage renal failure mantle cell lymphoma
HINT1 histidine triad nucleotide binding protein 1 5q23.3 schizophrenia, axonal neuropathy "neuromyotonia and axonal neuropathy, autosomal recessive"
HIP1 huntingtin interacting protein 1 7q11.23 prostate cancer, huntingtons disease "prostate cancer, progression of"
HIRA histone cell cycle regulator 22q11.21 digeorge syndrome cystic lymphangioma
HIST1H1A histone cluster 1, H1a 6p22.2 paratyphoid fever
HIST1H1B histone cluster 1, H1b 6p22.1 neuroendocrine tumor human t-cell leukemia virus type 1
HIST1H1D histone cluster 1, H1d 6p22.2 paratyphoid fever
HIST1H2AA histone cluster 1, H2aa 6p22.2 riddle syndrome
HIST1H2AD histone cluster 1, H2ad 6p22.2 riddle syndrome
HIST1H2AE histone cluster 1, H2ae 6p22.2 riddle syndrome
HIST1H2AH histone cluster 1, H2ah 6p22.1 riddle syndrome
HIST4H4 histone cluster 4, H4 12p12.3 colorectal cancer
HIVEP3 human immunodeficiency virus type I enhancer binding protein 3 1p34.2 presbyopia
HJURP Holliday junction recognition protein 2q37.1 lung cancer
HK1 hexokinase 1 10q22.1 hemolytic anemia, hemolytic anemia due to hexokinase deficiency "neuropathy, hereditary motor and sensory, russe type"
HK2 hexokinase 2 2p12 pancreatic cancer chondroblastoma
HKDC1 hexokinase domain containing 1 10q22.1 amebiasis
HLA-A major histocompatibility complex, class I, A 6p22.1 cervical cancer, malaria, histoplasmosis,
HLA-B major histocompatibility complex, class I, B 6p21.33 trachoma, behcets disease, takayasus arteritis,
HLA-C major histocompatibility complex, class I, C 6p21.33 hiv-1, psoriasis, guttate psoriasis,
HLA-DMA major histocompatibility complex, class II, DM alpha 6p21.32 cardiac sarcoidosis measles
HLA-DPA1 major histocompatibility complex, class II, DP alpha 1 6p21.32 pre-eclampsia, acute disseminated encephalomyelitis berylliosis
HLA-DPB1 major histocompatibility complex, class II, DP beta 1 6p21.32 chronic thromboembolic pulmonary hypertension, neonatal lupus erythematosus, rubella,
HLA-DPB2 major histocompatibility complex, class II, DP beta 2 (pseudogene) 6p21.32 treacher collins syndrome, fibrochondrogenesis, otospondylomegaepiphyseal dysplasia
HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 6p21.32 pre-eclampsia, celiac disease, sympathetic ophthalmia,
HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 6p21.32 trachoma, acute chest syndrome, myasthenia gravis,
HLA-DQB3 major histocompatibility complex, class II, DQ beta 3 6p21.32 hypersensitivity reaction type ii disease
HLA-DRA major histocompatibility complex, class II, DR alpha 6p21.32 mhc class ii deficiency, allergic encephalomyelitis, diffuse panbronchiolitis
HLA-DRB1 major histocompatibility complex, class II, DR beta 1 6p21.32 trachoma, polyarteritis nodosa, acute chest syndrome,
HLA-DRB2 major histocompatibility complex, class II, DR beta 2 (pseudogene) 6p21.3 gestational diabetes
HLA-DRB3 major histocompatibility complex, class II, DR beta 3 HSCHR6_MHC_APDp2 pityriasis rosea
HLA-DRB4 major histocompatibility complex, class II, DR beta 4 HSCHR6_MHC_MCFp2 autoimmune hepatitis, primary biliary cirrhosis, hypersensitivity reaction type ii disease,
HLA-DRB5 major histocompatibility complex, class II, DR beta 5 6p21.32 malaria, alveolar echinococcosis, hemorrhagic fever with renal syndrome,
HLA-DRB6 major histocompatibility complex, class II, DR beta 6 (pseudogene) 6p21.32 gestational diabetes
HLA-DRB9 major histocompatibility complex, class II, DR beta 9 (pseudogene) 6p21.32 ulcerative colitis
HLA-G major histocompatibility complex, class I, G 6p22.1 asthma, pre-eclampsia, soft tissue sarcoma,
HLA-H major histocompatibility complex, class I, H (pseudogene) 6p22.1 alzheimers disease, hemochromatosis, variegate porphyria,
HLA-K major histocompatibility complex, class I, K (pseudogene) 6p22.1 systemic lupus erythematosus
HLA-N major histocompatibility complex, class I, N (pseudogene) 6p22.1 systemic lupus erythematosus
HLA-S major histocompatibility complex, class I, S (pseudogene) 6p21.33 cervical cancer, pulmonary tuberculosis, t-cell prolymphocytic leukemia,
HLA-T major histocompatibility complex, class I, T (pseudogene) 6p22.1 microscopic colitis
HLA-W major histocompatibility complex, class I, W (pseudogene) 6p22.1 hiv-1
HLCS holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) 21q22.13 multiple carboxylase deficiency, propionic acidemia, biotin deficiency,
HLF hepatic leukemia factor 17q22 "leukemia, acute lymphoblastic 3"
HLP hyperkeratosis lenticularis perstans hyperkeratosis lenticularis perstans
HLX H2.0-like homeobox 1q41 congenital diaphragmatic hernia
HM13 histocompatibility (minor) 13 20q11.21 malaria, hepatitis c, hepatitis c virus,
HMBS hydroxymethylbilane synthase 11q23.3 schizophrenia, congenital erythropoietic porphyria, erythropoietic protoporphyria,
HMCN1 hemicentin 1 1q25.3 age related macular degeneration, age-related macular degeneration 1 "macular degeneration, age-related, reduced risk of"
HMGA1 high mobility group AT-hook 1 6p21.31 ring chromosome 1, "diabetes mellitus, noninsulin-dependent", atypical lipomatous tumor,
HMGA2 high mobility group AT-hook 2 12q14.3 ring chromosome 1, obesity, chondroma,
HMGB1 high mobility group box 1 13q12.3 recessive dystrophic epidermolysis bullosa, malaria, malignant peritoneal mesothelioma,
HMGB2 high mobility group box 2 4q34.1 juvenile rheumatoid arthritis
HMGB3 high mobility group box 3 Xq28 "microphthalmia, syndromic 13" terminal osseous dysplasia
HMGCL 3-hydroxymethyl-3-methylglutaryl-CoA lyase 1p36.11 beta-ketothiolase deficiency, ketothiolase deficiency, ornithine carbamoyltransferase deficiency,
HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase 5q13.3 myocardial infarction, coronary artery disease, familial hypercholesterolemia,
HMGCS2 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) 1p12 3-hydroxy-3-methylglutaryl-coa synthase 2 deficiency hmg-coa synthase-2 deficiency
HMHB1 histocompatibility (minor) HB-1 5q31.3 lymphoblastic leukemia
HMMR hyaluronan-mediated motility receptor (RHAMM) 5q34 breast cancer susceptibility, breast cancer, acute myeloid leukemia,
HMN7A Motor neuronopathy, distal hereditary, type VIIA "neuronopathy, distal hereditary motor, type viia"
HMNJ Distal hereditary motor neuropathy, Jerash type 9p21.1-p12 "neuropathy, distal hereditary motor, jerash type"
HMOX1 heme oxygenase (decycling) 1 22q12.3 ischemia, acute chest syndrome, arteriovenous malformation,
HMOX2 heme oxygenase (decycling) 2 16p13.3 hirschsprungs disease, adenomyosis, pyloric stenosis,
HMSD histocompatibility (minor) serpin domain containing 18q22.1 hematopoietic stem cell transplantation
HMSN5 Hereditary motor and sensory neuropathy V 4q34.3-q35.2 "charcot-marie-tooth disease with pyramidal features, autosomal dominant"
HMSNO Neuropathy, hereditary motor and sensory, Okinawa type "neuropathy, hereditary motor and sensory, okinawa type"
HMX1 H6 family homeobox 1 4p16.1 oculoauricular syndrome
HMX2 H6 family homeobox 2 10q26.13 split foot split hand
HMX3 H6 family homeobox 3 10q26.13 stickler syndrome
HN1 hematological and neurological expressed 1 17q25.1 testicular leukemia
HN1L hematological and neurological expressed 1-like 16p13.3 bronchioalveolar carcinoma
HNB1 hereditary neuroblastoma 1 16p13-p12 neuroblastoma neuroblastoma 1
HNF1A HNF1 homeobox A 12q24.31 colorectal cancer, type 2 diabetes mellitus, aminoaciduria,
HNF1B HNF1 homeobox B 17q12 type 2 diabetes mellitus, prostate cancer, endometriosis,
HNF4A hepatocyte nuclear factor 4, alpha 20q13.12 type 2 diabetes mellitus, insulin resistance, diabetes mellitus,
HNFJ3 Hyperuricemic nephropathy, familial juvenile, 3 2p22.1-p21 "hyperuricemic nephropathy, familial juvenile, 3"
HNMT histamine N-methyltransferase 2q22.1 asthma, urticaria, intestinal disease,
HNP1 Hypertensive nephropathy 9q31-q32 hypertensive nephropathy
HNRNPA1 heterogeneous nuclear ribonucleoprotein A1 12q13.13 amyotrophic lateral sclerosis, spinal cord disease, frontotemporal dementia,
HNRNPA1P1 heterogeneous nuclear ribonucleoprotein A1 pseudogene 1 6p22.1 systemic lupus erythematosus
HNRNPA1P2 heterogeneous nuclear ribonucleoprotein A1 pseudogene 2 6p21.32 systemic lupus erythematosus
HNRNPA2B1 heterogeneous nuclear ribonucleoprotein A2/B1 7p15.2 frontotemporal dementia, inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2, inclusion body myopathy with early-onset paget disease and frontotemporal dementia 1
HNRNPA3 heterogeneous nuclear ribonucleoprotein A3 2q31.2 sipple syndrome
HNRNPAB heterogeneous nuclear ribonucleoprotein A/B 5q35.3 wells syndrome
HNRNPC heterogeneous nuclear ribonucleoprotein C (C1/C2) 14q11.2 oculopharyngeal muscular dystrophy
HNRNPCL1 heterogeneous nuclear ribonucleoprotein C-like 1 1p36.21 pancreatic endocrine carcinoma
HNRNPDL heterogeneous nuclear ribonucleoprotein D-like 4q21.22 connective tissue disease
HNRNPH1 heterogeneous nuclear ribonucleoprotein H1 (H) 5q35.3 precursor t-cell acute lymphoblastic leukemia hereditary lymphedema
HNRNPLL heterogeneous nuclear ribonucleoprotein L-like 2p22.1 t cell deficiency
HNRNPU heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) 1q44 diffuse gastric cancer
HNRNPUL2-BSCL2 HNRNPUL2-BSCL2 readthrough 11q12.3 berardinelli-seip congenital lipodystrophy
HOGA1 4-hydroxy-2-oxoglutarate aldolase 1 10q24.2 alzheimers disease, primary hyperoxaluria primary hyperoxaluria type 3
HOPX HOP homeobox 4q12 choriocarcinoma lung cancer
HOXA1 homeobox A1 7p15.2 teratocarcinoma, autistic disorder, autism spectrum disorder,
HOXA10 homeobox A10 7p15.2 endometrial carcinoma, acute myeloid leukemia, cryptorchidism,
HOXA11 homeobox A11 7p15.2 synostosis, radioulnar synostosis, ectopic pregnancy,
HOXA13 homeobox A13 7p15.2 hypospadias, split hand, esophageal squamous cell carcinoma,
HOXA2 homeobox A2 7p15.2 microtia, cleft palate, bamforth-lazarus syndrome ,
HOXA3 homeobox A3 7p15.2 vacterl association
HOXA4 homeobox A4 7p15.2 acute myeloid leukemia, abdominal aortic aneurysm chronic myeloid leukemia
HOXA5 homeobox A5 7p15.2 acute myeloid leukemia, esophageal squamous cell carcinoma, oral squamous cell carcinoma,
HOXA7 homeobox A7 7p15.2 acute promyelocytic leukemia, acute leukemia esophageal squamous cell carcinoma
HOXA9 homeobox A9 7p15.2 acute myeloid leukemia, myelodysplastic syndromes, acute leukemia
HOXA@ homeobox A cluster 7p15.2 chronic myeloid leukemia
HOXB1 homeobox B1 17q21.32 autistic disorder, autism spectrum disorder, facial paralysis
HOXB13 homeobox B13 17q21.32 prostate cancer, familial prostate cancer, ependymoma,
HOXB2 homeobox B2 17q21.32 acute myeloid leukemia, pancreatic cancer bamforth-lazarus syndrome
HOXB3 homeobox B3 17q21.32 acute myeloid leukemia, myeloid leukemia vacterl association
HOXB5 homeobox B5 17q21.32 acute myeloid leukemia, gastroschisis, oral squamous cell carcinoma
HOXB6 homeobox B6 17q21.32 colorectal cancer, acute myeloid leukemia myeloid leukemia
HOXB7 homeobox B7 17q21.32 cytomegalovirus infection
HOXB8 homeobox B8 17q21.32 colorectal cancer trichotillomania
HOXB9 homeobox B9 17q21.32 prostate cancer, lung cancer papillary thyroid carcinoma
HOXB@ homeobox B cluster 17q21.32 autism spectrum disorder
HOXC13 homeobox C13 12q13.13 "ectodermal dysplasia 4, hair/nail type", skin pilomatrix carcinoma "ectodermal dysplasia 9, hair/nail type"
HOXC4 homeobox C4 12q13.13 vacterl association
HOXC5 homeobox C5 12q13.13 b-cell lymphomas
HOXC6 homeobox C6 12q13.13 esophageal squamous cell carcinoma, b-cell lymphomas cytomegalovirus infection
HOXD10 homeobox D10 2q31.1 talipes equinovarus, wilms tumor, charcot-marie-tooth disease,
HOXD11 homeobox D11 2q31.1 acute myeloid leukemia brachydactyly-syndactyly syndrome
HOXD12 homeobox D12 2q31.1 talipes equinovarus brachydactyly-syndactyly syndrome
HOXD13 homeobox D13 2q31.1 hypospadias, split hand, acute myeloid leukemia,
HOXD3 homeobox D3 2q31.1 vacterl association duane retraction syndrome
HOXD4 homeobox D4 2q31.1 clubfoot
HOXD9 homeobox D9 2q31.1 brachydactyly-syndactyly syndrome
HOXD@ homeobox D cluster 2q31.1 autism spectrum disorder
HP haptoglobin 16q22.2 trachoma, coronary artery disease, malaria,
HPBP phosphate binding apolipoprotein hiv-1
HPC1 hereditary prostate cancer 1 1q24-q25 prostate cancer prostate cancer 1
HPC10 Prostate cancer, hereditary, 10 8q24 prostate cancer "prostate cancer, hereditary, 10"
HPC14 Prostate cancer, hereditary, 14 11q13 prostate cancer "prostate cancer, hereditary, 14"
HPC15 Prostate cancer, hereditary, 15 19q13.4 prostate cancer "prostate cancer, hereditary, 15"
HPC3 Prostate cancer, hereditary, 3 20q13 prostate cancer prostate cancer 3
HPC4 Prostate cancer, hereditary, 4 7p11-q21 prostate cancer prostate cancer 4
HPC5 prostate cancer, hereditary, 5 3p26 prostate cancer "prostate cancer, hereditary, 5"
HPC6 Prostate cancer, susceptibility to 22q12.3 prostate cancer
HPC7 Prostate cancer, hereditary, 7 15q12 prostate cancer "prostate cancer, hereditary, 7"
HPC9 Prostate cancer, hereditary, 9 17q21-q22 prostate cancer "prostate cancer, hereditary, 9"
HPCA hippocalcin 1p35.1 ascending cholangitis
HPCQTL19 Prostate cancer aggressiveness quantitative trait locus on chromosome 19 19q prostate cancer
HPCX hereditary prostate cancer, X-linked Xq27-q28 prostate cancer
HPCX2 Prostate cancer, hereditary, X-linked 2 Xp11.22 prostate cancer "prostate cancer, hereditary, x-linked 2"
HPD 4-hydroxyphenylpyruvate dioxygenase 12q24.31 tyrosinemia, tyrosinemia type iii, tyrosinemia type i,
HPE1 holoprosencephaly 1, alobar 21q22.3 holoprosencephaly-1
HPE6 holoprosencephaly 6 2q37.1 holoprosencephaly-6 exencephaly
HPE8 holoprosencephaly 8 14q13 holoprosencephaly-8
HPFH2 hereditary persistence of fetal hemoglobin, heterocellular, Indian type 7q36 hereditary persistence of fetal hemoglobin
HPGD hydroxyprostaglandin dehydrogenase 15-(NAD) 4q34.1 primary hypertrophic osteoarthropathy, cranio osteoarthropathy, chorioamnionitis,
HPLH1 hemophagocytic lymphohistiocytosis 1 9q21.3-q22 hemophagocytic lymphohistiocytosis
HPN hepsin 19q13.12 prostate cancer
HPPD Hypertelorism, preauricular sinus, punctal pits, and deafness 14q31 "hypertelorism, preauricular sinus, punctal pits, and deafness" preauricular sinus
HPR haptoglobin-related protein 16q22.2 endometrial carcinoma, breast cancer, sleeping sickness,
HPRHP Hypophosphatemic rickets and hyperparathyroidism 13q13.1 hyperparathyroidism hypophosphatemic rickets and hyperparathyroidism
HPRT1 hypoxanthine phosphoribosyltransferase 1 Xq26.2 lesch-nyhan syndrome, colon cancer, tetrahydrobiopterin deficiency,
HPS1 Hermansky-Pudlak syndrome 1 10q24.2 platelet storage pool deficiency, chediak-higashi syndrome, oculocutaneous albinism type 1,
HPS3 Hermansky-Pudlak syndrome 3 3q24 platelet storage pool deficiency, oculocutaneous albinism type 1, hermansky-pudlak syndrome 6 ,
HPS4 Hermansky-Pudlak syndrome 4 22q12.1 platelet storage pool deficiency, albinism, intestinal disease,
HPS5 Hermansky-Pudlak syndrome 5 11p15.1 platelet storage pool deficiency, hermansky-pudlak syndrome 6 , hermansky-pudlak syndrome,
HPS6 Hermansky-Pudlak syndrome 6 10q24.32 platelet storage pool deficiency, hermansky-pudlak syndrome 6 , hermansky-pudlak syndrome,
HPSE heparanase 4q21.23 colon adenocarcinoma, gallbladder cancer, periapical granuloma,
HPSE2 heparanase 2 10q24.2 urofacial syndrome, urofacial syndrome 1 hpse2-related urofacial syndrome
HPT hypoparathyroidism Xq27 hypoparathyroidism x-linked
HPV18I1 human papilloma virus (type 18) integration site 1 8q24 papilloma
HPX hemopexin 11p15.4 blackwater fever
HR hair growth associated 8p21.3 alopecia, atrichia with papular lesions , hypotrichosis 4,
HRAS Harvey rat sarcoma viral oncogene homolog 11p15.5 "nevus sebaceous, somatic", "bladder cancer, somatic", sarcoma,
HRC histidine rich calcium binding protein 19q13.33 mixed glioma
HRES1 HTLV-1 related endogenous sequence 1q42 systemic lupus erythematosus
HRG histidine-rich glycoprotein 3q27.3 corneal neovascularization, myocardial infarction, thrombophilia,
HRH1 histamine receptor H1 3p25.3 asthma, malaria, cholinergic urticaria,
HRH2 histamine receptor H2 5q35.2 laryngitis, gastric ulcer, schizophrenia,
HRH3 histamine receptor H3 20q13.33 schizophrenia, attention deficit hyperactivity disorder, hepatic coma
HRH4 histamine receptor H4 18q11.2 paraneoplastic cerebellar degeneration cerebellar degeneration
HRPT3 Hyperparathyroidism 3 2p14-p13.3 hyperparathyroidism hyperparathyroidism 3
HRX Hyperreflexia 7q "leukemia, myeloid/lymphoid or mixed-lineage" wiedemann-steiner syndrome
HS1BP3 HCLS1 binding protein 3 2p24.1 essential tremor, tremor bells palsy
HS3ST3B1 heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 17p12 papillon-lefevre disease
HS3ST4 heparan sulfate (glucosamine) 3-O-sulfotransferase 4 16p12.1 herpes simplex
HS3ST5 heparan sulfate (glucosamine) 3-O-sulfotransferase 5 6q22.1 mucopolysaccharidoses
HS3ST6 heparan sulfate (glucosamine) 3-O-sulfotransferase 6 16p13.3 mucopolysaccharidoses morquio syndrome b
HS6ST1 heparan sulfate 6-O-sulfotransferase 1 2q14.3 hypogonadotropic hypogonadism 8 with or without anosmia, hypogonadotropic hypogonadism 17 with or without anosmia hypogonadotropic hypogonadism 15 with or without anosmia
HSCB HscB mitochondrial iron-sulfur cluster co-chaperone 22q12.1 x-linked sideroblastic anemia with ataxia x-linked sideroblastic anemia
HSCR5 Hirschsprung disease, susceptibility to, 5 9q31 hirschsprungs disease, megacolon, hirschsprung disease 5
HSCR6 Hirschsprung disease, short-segment, 2 3p21 hirschsprungs disease hirschsprung disease 6
HSCR7 Hirschsprung disease, short-segment, 3 19q12 hirschsprungs disease hirschsprung disease 7
HSCR8 Hirschsprung disease modifier 2 9q31 hirschsprungs disease hirschsprung disease 8
HSCR9 Hirschsprung disease, susceptibility to, 9 4q31.3-q32.3 hirschsprungs disease hirschsprung disease 9
HSD11B1 hydroxysteroid (11-beta) dehydrogenase 1 1q32.2 insulin resistance, acth deficiency, obesity,
HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 16q22.1 north american indian childhood cirrhosis, essential hypertension, hypertension,
HSD17B1 hydroxysteroid (17-beta) dehydrogenase 1 17q21.2 prostate cancer, ovarian endometriosis, endometriosis,
HSD17B10 hydroxysteroid (17-beta) dehydrogenase 10 Xp11.22 "mental retardation, x-linked 17/31, microduplication", beta-ketothiolase deficiency, ketothiolase deficiency,
HSD17B13 hydroxysteroid (17-beta) dehydrogenase 13 4q22.1 endometrial carcinoma, breast cancer, mucopolysaccharidosis iii
HSD17B14 hydroxysteroid (17-beta) dehydrogenase 14 19q13.33 estrogen-receptor positive breast cancer
HSD17B1P1 hydroxysteroid (17-beta) dehydrogenase 1 pseudogene 1 17q21.2 mixed gonadal dysgenesis
HSD17B2 hydroxysteroid (17-beta) dehydrogenase 2 16q23.3 progesterone resistance hereditary breast ovarian cancer
HSD17B3 hydroxysteroid (17-beta) dehydrogenase 3 9q22.32 pseudohermaphroditism, gynecomastia, hamamy syndrome ,
HSD17B4 hydroxysteroid (17-beta) dehydrogenase 4 5q23.1 polyhydramnios, rhizomelic chondrodysplasia punctata, fatty acid oxidation disorders,
HSD17B6 hydroxysteroid (17-beta) dehydrogenase 6 12q13.3 apparent mineralocorticoid excess syndrome
HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 1p12 prostate cancer, patent ductus arteriosus, familial prostate cancer
HSD3B2 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 1p12 prostate cancer, familial prostate cancer, adrenocortical insufficiency,
HSD3B7 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 16p11.2 cholestasis, liver disease, congenital bile acid synthesis defect
HSD3BP4 hydroxy-delta-5-steroid dehydrogenase, 3 beta, pseudogene 4 1p12 3-beta-hydroxysteroid dehydrogenase deficiency late-onset congenital adrenal hyperplasia
HSF1 heat shock transcription factor 1 8q24.3 amyotrophic lateral sclerosis spinocerebellar ataxia type 6
HSF4 heat shock transcription factor 4 16q22.1 spinal cord disease, parotitis, intracranial hypotension,
HSF5 heat shock transcription factor family member 5 17q22 prediabetes syndrome
HSFY1 heat shock transcription factor, Y-linked 1 Yq11.222 y chromosome infertility azoospermia
HSFY1P1 heat shock transcription factor, Y-linked 1 pseudogene 1 22q11.1 cat eye syndrome
HSN1B Hereditary sensory neuropathy, type IB 3p24-p22 "neuropathy, hereditary sensory, type ib"
HSP90AA1 heat shock protein 90kDa alpha (cytosolic), class A member 1 14q32.31 lobular neoplasia, primary hyperoxaluria, gastrointestinal stromal tumor,
HSP90B1 heat shock protein 90kDa beta (Grp94), member 1 12q23.3 globozoospermia
HSPA12B heat shock 70kD protein 12B 20p13 atherosclerosis
HSPA14 heat shock 70kDa protein 14 10p13 malaria tetralogy of fallot
HSPA1A heat shock 70kDa protein 1A 6p21.33 ischemia, acute mountain sickness, sleep apnea,
HSPA1B heat shock 70kDa protein 1B 6p21.33 mulibrey nanism acute mountain sickness
HSPA1L heat shock 70kDa protein 1-like 6p21.33 visceral leishmaniasis, pulmonary edema, diabetic foot ulcers,
HSPA4 heat shock 70kDa protein 4 5q31.1 ischemia, leishmaniasis, scrub typhus,
HSPA4L heat shock 70kDa protein 4-like 4q28.1 endolymphatic hydrops
HSPA5 heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) 9q33.3 spinocerebellar ataxia type 17, borna disease wolfram syndrome
HSPA8 heat shock 70kDa protein 8 11q24.1 ischemia, malaria, primary hyperoxaluria,
HSPA9 heat shock 70kDa protein 9 (mortalin) 5q31.2 myotonic dystrophy type 2
HSPB1 heat shock 27kDa protein 1 7q11.23 amyotrophic lateral sclerosis, charcot-marie-tooth neuropathy type 2, charcot-marie-tooth disease type 2,
HSPB2 heat shock 27kDa protein 2 11q23.1 amyotrophic lateral sclerosis, prostate cancer, glioblastoma multiforme
HSPB3 heat shock 27kDa protein 3 5q11.2 distal hereditary motor neuropathy, "neuronopathy, distal hereditary motor, type iid" "distal hereditary motor neuronopathy, type iic"
HSPB6 heat shock protein, alpha-crystallin-related, B6 19q13.12 hereditary cerebral hemorrhage with amyloidosis, keloids cerebral amyloid angiopathy
HSPB8 heat shock 22kDa protein 8 12q24.23 breast cancer, "distal hereditary motor neuropathy, type ii", charcot-marie-tooth neuropathy type 2,
HSPBAP1 HSPB (heat shock 27kDa) associated protein 1 3q21.1 familial renal cell carcinoma
HSPD1 heat shock 60kDa protein 1 (chaperonin) 2q33.1 trachoma, behcets disease, urethritis,
HSPD1P9 heat shock 60kDa protein 1 (chaperonin) pseudogene 9 13q13.3 pulmonary function
HSPG2 heparan sulfate proteoglycan 2 1p36.12 nonspecific interstitial pneumonia, empty sella syndrome, keratoconjunctivitis sicca,
HSPH1 heat shock 105kDa/110kDa protein 1 13q12.3 hepatitis d
HT Hashimoto thyroiditis 8q23-q24 thyroiditis autoimmune thyroiditis
HTATIP2 HIV-1 Tat interactive protein 2, 30kDa 11p15.1 hiv-1 gnathodiaphyseal dysplasia
HTATSF1 HIV-1 Tat specific factor 1 Xq26.3 hiv-1
HTATSF1P1 HIV-1 Tat specific factor 1 pseudogene 1 6p21 hiv-1
HTATSF1P2 HIV-1 Tat specific factor 1 pseudogene 2 6p25.2 hiv-1
HTC1 hypertrichosis 1 (universalis, congenital) 8 ambras syndrome
HTC2 hypertrichosis 2 (generalized, congenital) Xq27.1 "hypertrichosis, congenital generalized"
HTGH Hypertrichosis terminalis, generalized, with or without gingival hyperplasia 17q24.2-q24.3 "hypertrichosis terminalis, generalized, with or without gingival hyperplasia"
HTGS Hypertriglyceridemia, familial 15q11.2-q13.1 hypertriglyceridemia
HTLVR human T-cell leukemia virus (I and II) receptor 17q graves disease, primary biliary cirrhosis, t-cell leukemia,
HTN1 histatin 1 4q13.3 atypical autism candida glabrata
HTN3 histatin 3 4q13.3 oral candidiasis, candidiasis candida glabrata
HTNB hypertension with brachydactyly 12p12.2-p11.2 hypertension brachydactyly with hypertension
HTR1A 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled 5q12.3 metachromatic leukodystrophy , schizophrenia, neuroleptic malignant syndrome,
HTR1B 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled 6q14.1 alcohol dependence, schizophrenia, intermittent explosive disorder,
HTR1D 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled 1p36.12 schizophrenia
HTR1E 5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled 6q14.3 skin papilloma
HTR2A 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled 13q14.2 peripheral vascular disease, intermittent claudication, alcohol dependence,
HTR2B 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled 2q37.1 hepatopulmonary syndrome, ocular hypotension heart valve disease
HTR2C 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled Xq23 schizophrenia, generalized anxiety disorder, attention deficit hyperactivity disorder,
HTR3A 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic 11q23.2 schizophrenia, neuroleptic malignant syndrome, serotonin syndrome,
HTR3B 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic 11q23.2 gilles de la tourette syndrome fibromyalgia
HTR3C 5-hydroxytryptamine (serotonin) receptor 3C, ionotropic 3q27.1 sleep apnea obstructive sleep apnea
HTR3D 5-hydroxytryptamine (serotonin) receptor 3D, ionotropic 3q27.1 migraine
HTR3E 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic 3q27.1 irritable bowel syndrome obstructive sleep apnea
HTR4 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled 5q32 colonic disease, hereditary diffuse leukoencephalopathy with spheroids functional colonic disease
HTR5A 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled 7q36.2 autistic disorder
HTR6 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled 1p36.13 schizophrenia
HTR7 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled 10q23.31 autistic disorder
HTRA1 HtrA serine peptidase 1 10q26.13 choroiditis, multifocal choroiditis, age related macular degeneration,
HTRA2 HtrA serine peptidase 2 2p13.1 parkinsons disease, parkinson disease 1, htra2-related parkinson disease,
HTRA3 HtrA serine peptidase 3 4p16.1 "vitreoretinopathy, neovascular inflammatory"
HTRA4 HtrA serine peptidase 4 8p11.22 pre-eclampsia
HTT huntingtin 4p16.3 spasticity, huntingtons disease, ataxia with oculomotor apraxia type 1,
HTX2 heterotaxy 2 (autosomal dominant) heterotaxy, double outlet right ventricle, "transposition of the great arteries, dextro-looped 2",
HTX3 Heterotaxy, visceral, 3 6q21 heterotaxy "heterotaxy, visceral, 3, autosomal"
HULC hepatocellular carcinoma up-regulated long non-coding RNA 6p24.3 hepatocellular carcinoma
HUWE1 HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase Xp11.22 "mental retardation, x-linked, syndromic, turner type" angelman syndrome
HV1S herpes simplex virus type 1 sensitivity 3 or 11p11-qter herpes simplex
HVBS7 hepatitis B virus integration site 7 18q11.1-q11.2 hepatitis b
HVBS8 hepatitis B virus integration site 8 17p12-p11.2 hepatitis b
HWE1 Epilepsy, hot water, 1 10q21.3-q22.3 "epilepsy, hot water, 1"
HWE2 Epilepsy, hot water, 2 4q24-q28 "epilepsy, hot water, 2"
HYAL1 hyaluronoglucosaminidase 1 3p21.31 type 1 diabetes mellitus, mucopolysaccharidosis ix mucolipidoses
HYAL2 hyaluronoglucosaminidase 2 3p21.31 mucopolysaccharidosis ix
HYAL3 hyaluronoglucosaminidase 3 3p21.31 nodular basal cell carcinoma, lung squamous cell carcinoma mucopolysaccharidosis ix
HYAL4 hyaluronoglucosaminidase 4 7q31.32 oxyphilic adenoma
HYD2 hypodontia 2 (autosomal recessive) 16q12.1 "tooth agenesis, selective, 2"
HYDIN HYDIN, axonemal central pair apparatus protein 16q22.2 "ciliary dyskinesia, primary, 19", primary ciliary dyskinesia, primary ciliary dyskinesia 5: hydin-related primary ciliary dyskinesia,
HYDIN2 HYDIN2, axonemal central pair apparatus protein (pseudogene) 1q21.1 hydrocephalus
HYI hydroxypyruvate isomerase (putative) 1p34.2 hypertrophic scars
HYKK hydroxylysine kinase 15q25.1 lung cancer
HYLS1 hydrolethalus syndrome 1 11q24.2 hydrolethalus syndrome hydrolethalus syndrome 1
HYMAI hydatidiform mole associated and imprinted (non-protein coding) 6q24.2 diabetes mellitus, transient neonatal diabetes mellitus, paternal uniparental disomy of chromosome 6
HYOU1 hypoxia up-regulated 1 11q23.3 myocardial infarction hypoxia
HYP10 Hypotrichosis 10 7p22.3-p21.3 hypotrichosis 10
HYPLIP2 hyperlipidemia, combined, 2 11p "hyperlipidemia, combined, 2"
HYPT9 Hypotrichosis 9 10q11.23-q22.3 hypotrichosis 9
HYSP3 Hypospadias 3, autosomal 7q32.2-q36.1 "hypospadias 3, autosomal"
HYSP4 Hypospadias 4, X-linked, susceptibilty to Xp11.22 "hypospadias 4, x-linked, susceptibilty to"
HYT1 Hypertension, essential, susceptibility to, 1 17q hypertension "hypertension, essential 1"
HYT2 Hypertension, essential, susceptibility to, 2 15q hypertension "hypertension, essential 2"
HYT3 Hypertension, essential, susceptibility to, 3 2p25-p24 hypertension "hypertension, essential 3"
HYT4 Hypertension, essential, susceptibility to, 4 12p12.2-p12.1 hypertension "hypertension, essential 4"
HYT5 Hypertension, essential, susceptibility to, 5 20q11-q13 hypertension "hypertension, essential 5"
HYT6 Hypertension, essential, susceptibility to, 6 5p13-q12 hypertension "hypertension, essential 6"
HYT7 Hypertension, essential, susceptibility to, 7 3p14.1-q12.3 hypertension "hypertension, essential 7"
HYT8 hypertension, essential, susceptibility to, 8 18q21.2 hypertension "hypertension, essential 8"
IAPP islet amyloid polypeptide 12p12.1 type 2 diabetes mellitus, pancreatic cancer, insulin resistance,
IARS isoleucyl-tRNA synthetase 9q22.31 turcot syndrome, polymyositis dermatomyositis
IBA57 IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae) 1q42.13 multiple mitochondrial dysfunctions syndrome 3
IBD11 Inflammatory bowel disease 11 7q22 inflammatory bowel disease inflammatory bowel disease 11
IBD12 Inflammatory bowel disease 12 3p21.3 inflammatory bowel disease inflammatory bowel disease 12
IBD15 Inflammatory bowel disease-15 10q21 inflammatory bowel disease, crohns disease inflammatory bowel disease 15
IBD16 Inflammatory bowel disease-16 9q32 inflammatory bowel disease inflammatory bowel disease 16
IBD18 Inflammatory bowel disease-18 5p13.1 inflammatory bowel disease, crohns disease inflammatory bowel disease 18
IBD19 Inflammatory bowel disease 19 inflammatory bowel disease, "mycobacterium tuberculosis, protection against" inflammatory bowel disease 19
IBD2 inflammatory bowel disease 2 12p13.2-q24.1 inflammatory bowel disease, crohns disease, ulcerative colitis
IBD20 Inflammatory bowel disease-20 10q24 inflammatory bowel disease inflammatory bowel disease 20
IBD21 Inflammatory bowel disease-21 18p11 inflammatory bowel disease inflammatory bowel disease 21
IBD22 Inflammatory bowel disease-22 17q21.2 inflammatory bowel disease inflammatory bowel disease 22
IBD23 Inflammatory bowel disease-23 1q32 inflammatory bowel disease, crohns disease, ulcerative colitis
IBD24 Inflammatory bowel disease-24 20q13 inflammatory bowel disease inflammatory bowel disease 24
IBD25 Inflammatory bowel disease-25 inflammatory bowel disease "inflammatory bowel disease 25, early onset, autosomal recessive"
IBD26 Inflammatory bowel disease-26 12q15 inflammatory bowel disease inflammatory bowel disease 26
IBD27 Inflammatory bowel disease-27 13q13.3 inflammatory bowel disease inflammatory bowel disease 27
IBD3 inflammatory bowel disease 3 6p inflammatory bowel disease inflammatory bowel disease 3
IBD4 inflammatory bowel disease 4 14q11-q12 inflammatory bowel disease, crohns disease inflammatory bowel disease 4
IBD5 inflammatory bowel disease 5 5q31-q33 inflammatory bowel disease, crohns disease inflammatory bowel disease 5
IBD6 inflammatory bowel disease 6 19p13 inflammatory bowel disease, crohns disease inflammatory bowel disease 6
IBD7 inflammatory bowel disease 7 1p36 inflammatory bowel disease, crohns disease, ulcerative colitis
IBD8 inflammatory bowel disease 8 16p inflammatory bowel disease inflammatory bowel disease 8
IBD9 inflammatory bowel disease 9 3p26 inflammatory bowel disease inflammatory bowel disease 9
IBGC1 idiopathic basal ganglia calcification 1 14q familial idiopathic basal ganglia calcification "basal ganglia cancification, idiopathic, 1"
IBGC2 Basal ganglia calcification, idiopathic, 2 2q37 "basal ganglia calcification, idiopathic, 2"
IBSP integrin-binding sialoprotein 4q22.1 prostate cancer, fibrous dysplasia, breast cancer,
ICA1 islet cell autoantigen 1, 69kDa 7p21.3 diabetes mellitus
ICA1L islet cell autoantigen 1,69kDa-like 2q33.2 amyotrophic lateral sclerosis lateral sclerosis
ICAM1 intercellular adhesion molecule 1 19p13.2 carotid intimal medial thickness, diabetic macular edema, diabetic retinopathy,
ICAM2 intercellular adhesion molecule 2 17q23.3 polyarteritis nodosa idiopathic pulmonary fibrosis
ICAM3 intercellular adhesion molecule 3 19p13.2 multiple sclerosis
ICAM4 intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) 19p13.2 childhood leukemia
ICCA infantile convulsions and paroxysmal choreoathetosis 16p12-q12 paroxysmal dyskinesia, paroxysmal choreoathetosis, "infantile convulsions and paroxysmal choreoathetosis, familial",
ICK intestinal cell (MAK-like) kinase 6p12.1 endocrine-cerebroosteodysplasia
ICOS inducible T-cell co-stimulator 2q33.2 b-cell chronic lymphocytic leukemia, primary sclerosing cholangitis, paracoccidioidomycosis,
ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 20q11.21 prostate cancer
ID2 inhibitor of DNA binding 2, dominant negative helix-loop-helix protein 2p25.1 congenital hydronephrosis
ID4 inhibitor of DNA binding 4, dominant negative helix-loop-helix protein 6p22.3 prostate cancer, acute leukemia, chronic myeloid leukemia
IDDM10 insulin-dependent diabetes mellitus 10 10p11-q11 diabetes mellitus, interleukin 2 receptor alpha chain deficiency "diabetes, mellitus, insulin-dependent 10"
IDDM11 insulin-dependent diabetes mellitus 11 14q24.3-q31 diabetes mellitus "diabetes mellitus, insulin-dependent, 11"
IDDM13 insulin-dependent diabetes mellitus 13 2q34 diabetes mellitus "diabetes mellitus, insulin-dependent, 13"
IDDM15 insulin-dependent diabetes mellitus 15 6q21 "diabetes mellitus, insulin-dependent, 15"
IDDM17 insulin-dependent diabetes mellitus 17 10q25 "diabetes mellitus, insulin-dependent, 17"
IDDM18 insulin-dependent diabetes mellitus 18 5q31.1-q33.1 "diabetes mellitus, insulin-dependent, 18"
IDDM2 insulin-dependent diabetes mellitus 2 11p15.5 diabetes mellitus, type 1 diabetes mellitus, permanent neonatal diabetes mellitus,
IDDM23 Diabetes mellitus, insulin-dependent, 23 4q27 diabetes mellitus "diabetes mellitus, insulin-dependent, 23"
IDDM24 Diabetes mellitus, insulin-dependent, 24 10q23.31 diabetes mellitus "diabetes mellitus, insulin-dependent, 24"
IDDM3 insulin-dependent diabetes mellitus 3 15q26 diabetes mellitus "diabetes mellitus, insulin-dependent, 3"
IDDM4 insulin-dependent diabetes mellitus 4 11q13 diabetes mellitus "diabetes mellitus, insulin-dependent, 4"
IDDM6 insulin-dependent diabetes mellitus 6 18q21 "diabetes mellitus, insulin-dependent, 6"
IDDM7 insulin-dependent diabetes mellitus 7 2q31 diabetes mellitus "diabetes mellitus, insulin-dependent, 7"
IDDM8 insulin-dependent diabetes mellitus 8 6q27 "diabetes mellitus, insulin-dependent, 8"
IDDMX Diabetes mellitus, insulin-dependent, X-linked, susceptibility to Xp11 diabetes mellitus "diabetes mellitus, insulin-dependent, x-linked"
IDE insulin-degrading enzyme 10q23.33 type 2 diabetes mellitus alzheimers disease
IDH1 isocitrate dehydrogenase 1 (NADP+), soluble 2q34 gliosarcoma, giant cell glioblastoma, pilocytic astrocytoma,
IDH2 isocitrate dehydrogenase 2 (NADP+), mitochondrial 15q26.1 gliosarcoma, acute myeloid leukemia, 2-hydroxyglutaric aciduria,
IDH3B isocitrate dehydrogenase 3 (NAD+) beta 20p13 leber congenital amaurosis, retinitis pigmentosa 46 idh3b-related retinitis pigmentosa
IDH3G isocitrate dehydrogenase 3 (NAD+) gamma Xq28 periventricular heterotopia
IDI1 isopentenyl-diphosphate delta isomerase 1 10p15.3 neonatal adrenoleukodystrophy
IDO1 indoleamine 2,3-dioxygenase 1 8p11.21 trachoma, bladder disease, malaria,
IDS iduronate 2-sulfatase Xq28 mucopolysaccharidosis, sudden infant death syndrome, x-linked disease,
IDUA iduronidase, alpha-L- 4p16.3 metachromatic leukodystrophy , mucopolysaccharidosis, autosomal recessive disease,
IER3 immediate early response 3 6p21.33 juvenile hyaline fibromatosis
IER3IP1 immediate early response 3 interacting protein 1 18q21.1 microcephaly "microcephaly, epilepsy, and diabetes syndrome"
IER5 immediate early response 5 1q25.3 acute myeloid leukemia
IFI27 interferon, alpha-inducible protein 27 14q32.12 maxillary sinus squamous cell carcinoma, transitional cell carcinoma, endometrial carcinoma,
IFI30 interferon, gamma-inducible protein 30 19p13.11 endometritis neuromyelitis optica
IFI44 interferon-induced protein 44 1p31.1 hepatitis c
IFIH1 interferon induced with helicase C domain 1 2q24.2 melanoma, aicardi-goutieres syndrome 7, sle susceptibility,
IFIT2 interferon-induced protein with tetratricopeptide repeats 2 10q23.31 ebola hemorrhagic fever
IFIT3 interferon-induced protein with tetratricopeptide repeats 3 10q23.31 acute promyelocytic leukemia adult dermatomyositis
IFITM1 interferon induced transmembrane protein 1 11p15.5 rift valley fever
IFITM2 interferon induced transmembrane protein 2 11p15.5 rift valley fever, west nile virus, anisometropia
IFITM3 interferon induced transmembrane protein 3 11p15.5 rift valley fever, influenza, west nile virus
IFITM5 interferon induced transmembrane protein 5 11p15.5 osteogenesis imperfecta, osteogenesis imperfecta type 5 ifitm5-related osteogenesis imperfecta
IFLTD1 intermediate filament tail domain containing 1 12p12.1 lung adenoma
IFN1@ interferon, type 1, cluster 9p22 retinal vasculitis, hepatitis b, non-hodgkin lymphoma,
IFNA1 interferon, alpha 1 9p21.3 hepatocellular carcinoma, polyarteritis nodosa, kaposis sarcoma,
IFNA10 interferon, alpha 10 9p21.3 hiv-1, dengue hemorrhagic fever, cutaneous malignant melanoma,
IFNA13 interferon, alpha 13 9p21.3 hiv-1, dengue hemorrhagic fever hiv/aids
IFNA14 interferon, alpha 14 9p21.3 hiv-1
IFNA16 interferon, alpha 16 9p21.3 hiv-1, dengue hemorrhagic fever hiv/aids
IFNA17 interferon, alpha 17 9p21.3 hiv-1, dengue hemorrhagic fever, cutaneous malignant melanoma,
IFNA2 interferon, alpha 2 9p21.3 myeloproliferative disorder, colorectal cancer, polyarteritis nodosa,
IFNA21 interferon, alpha 21 9p21.3 hiv-1 hiv/aids
IFNA4 interferon, alpha 4 9p21.3 hiv-1
IFNA5 interferon, alpha 5 9p21.3 hiv-1
IFNA6 interferon, alpha 6 9p21.3 hiv-1
IFNA7 interferon, alpha 7 9p21.3 hiv-1 acute hemorrhagic conjunctivitis
IFNA8 interferon, alpha 8 9p21.3 hiv-1 st. louis encephalitis
IFNAR1 interferon (alpha, beta and omega) receptor 1 21q22.11 malaria cerebral amyloid angiopathy
IFNAR2 interferon (alpha, beta and omega) receptor 2 21q22.11 hepatocellular carcinoma, measles mumps
IFNB1 interferon, beta 1, fibroblast 9p21.3 retinal vasculitis, multiple sclerosis, herpes simplex,
IFNE interferon, epsilon 9p21.3 dengue hemorrhagic fever cutaneous malignant melanoma
IFNG interferon, gamma 12q15 folliculitis, nonspecific interstitial pneumonia, usual interstitial pneumonia,
IFNG-AS1 IFNG antisense RNA 1 12q15 encephalomyelitis
IFNGR1 interferon gamma receptor 1 6q23.3 malaria, leprosy, leishmaniasis,
IFNGR2 interferon gamma receptor 2 (interferon gamma transducer 1) 21q22.11 estrogen resistance, lepromatous leprosy, lipomatosis,
IFNK interferon, kappa 9p21.2 dengue hemorrhagic fever cutaneous malignant melanoma
IFNL3 interferon, lambda 3 19q13.2 hepatitis c, hepatitis c virus, hepatitis b virus infection
IFNW1 interferon, omega 1 9p21.3 dengue hemorrhagic fever cutaneous malignant melanoma
IFRD1 interferon-related developmental regulator 1 7q31.1 cystic fibrosis, pheochromocytoma, skeletal muscle regeneration
IFT122 intraflagellar transport 122 homolog (Chlamydomonas) 3q21.3 pelizaeus-merzbacher disease, sensenbrenner syndrome, cranioectodermal dysplasia 1
IFT140 intraflagellar transport 140 homolog (Chlamydomonas) 16p13.3 asphyxiating thoracic dystrophy, short-rib thoracic dysplasia 2 with or without polydactyly, short-rib thoracic dysplasia 9 with or without polydactyly ,
IFT172 intraflagellar transport 172 homolog (Chlamydomonas) 2p23.3 vacterl association, short-rib thoracic dysplasia 2 with or without polydactyly short-rib thoracic dysplasia 10 with or without polydactyly
IFT27 intraflagellar transport 27 homolog (Chlamydomonas) 22q12.3 "bardet-biedl syndrome, modifier of" bardet-biedl syndrome 19
IFT43 intraflagellar transport 43 homolog (Chlamydomonas) 14q24.3 sensenbrenner syndrome, cranioectodermal dysplasia 1 cranioectodermal dysplasia 3
IFT80 intraflagellar transport 80 homolog (Chlamydomonas) 3q25.33 asphyxiating thoracic dystrophy, alzheimers disease, sensenbrenner syndrome,
IFT88 intraflagellar transport 88 homolog (Chlamydomonas) 13q12.11 kidney disease, orofaciodigital syndrome, polycystic kidney disease,
IGAD1 immunoglobulin A (IgA) deficiency susceptibility 1 6p21.3 selective iga deficiency disease
IGAN1 IgA nephropathy 6q22-q23 iga nephropathy 1
IGAN2 IgA nephropathy, susceptibility to, 2 2q36 iga nephropathy 2
IGAT Immune response to synthetic polypeptide--IRGAT 6p21.3 "muscular dystrophy-dystroglycanopathy , type a, 13"
IGBP1 immunoglobulin (CD79A) binding protein 1 Xq13.1 coloboma, cavernous malformation, cerebral cavernous malformation,
IGES immunoglobulin E concentration, serum 5q31.1 asthma, graves disease, polyarteritis nodosa,
IGF1 insulin-like growth factor 1 (somatomedin C) 12q23.2 hypochondroplasia, diabetic retinopathy, amyotrophic lateral sclerosis,
IGF1R insulin-like growth factor 1 receptor 15q26.3 colorectal cancer, breast cancer, insulin resistance,
IGF2 insulin-like growth factor 2 (somatomedin A) 11p15.5 hepatocellular carcinoma, colorectal cancer, juvenile nasopharyngeal angiofibroma,
IGF2-AS IGF2 antisense RNA 11p15.5 lung cancer, lung cancer susceptibility wilms tumor
IGF2BP2 insulin-like growth factor 2 mRNA binding protein 2 3q27.2 hepatocellular carcinoma "diabetes mellitus, noninsulin-dependent"
IGF2BP3 insulin-like growth factor 2 mRNA binding protein 3 7p15.3 pilomyxoid astrocytoma
IGF2R insulin-like growth factor 2 receptor 6q25.3 hepatocellular carcinoma, insulin resistance, lung cancer,
IGFALS insulin-like growth factor binding protein, acid labile subunit 16p13.3 acid-labile subunit deficiency short stature due to primary acid-labile subunit deficiency
IGFBP1 insulin-like growth factor binding protein 1 7p12.3 pre-eclampsia, diabetic retinopathy, myocardial infarction,
IGFBP2 insulin-like growth factor binding protein 2, 36kDa 2q35 amyotrophic lateral sclerosis, prostate cancer, lung cancer,
IGFBP3 insulin-like growth factor binding protein 3 7p12.3 colorectal cancer, recessive dystrophic epidermolysis bullosa, prostate cancer,
IGFBP4 insulin-like growth factor binding protein 4 17q21.2 follicular thyroid carcinoma ovarian cancer
IGFBP5 insulin-like growth factor binding protein 5 2q35 neuroblastoma 3-m syndrome
IGFBP6 insulin-like growth factor binding protein 6 12q13.13 pheochromocytoma
IGFBP7 insulin-like growth factor binding protein 7 4q12 diabetic angiopathy, cerebral aneurysms, pulmonic stenosis
IGFL3 IGF-like family member 3 19q13.32 type 2 diabetes mellitus testicular disease
IGH immunoglobulin heavy locus 14q32.33 myeloma, b-cell chronic lymphocytic leukemia, chronic lymphocytic leukemia,
IGHA1 immunoglobulin heavy constant alpha 1 14q32.33 breast adenocarcinoma hepatitis a
IGHD immunoglobulin heavy constant delta 14q32.33 b-cell chronic lymphocytic leukemia chronic lymphocytic leukemia
IGHE immunoglobulin heavy constant epsilon 14q32.33 asthma, urinary schistosomiasis, hydrocele,
IGHG1 immunoglobulin heavy constant gamma 1 (G1m marker) 14q32.33 b-cell chronic lymphocytic leukemia congenital hypogammaglobulinemia
IGHG2 immunoglobulin heavy constant gamma 2 (G2m marker) 14q32.33 congenital hypogammaglobulinemia, recurrent infections associated with rare immunoglobulin isotypes deficiency, sarcomatosis
IGHG3 immunoglobulin heavy constant gamma 3 (G3m marker) 14q32.33 heavy chain disease, hepatitis a, relapsing-remitting multiple sclerosis,
IGHM immunoglobulin heavy constant mu 14q32.33 myeloma, b-cell chronic lymphocytic leukemia, burkitts lymphoma,
IGHMBP2 immunoglobulin mu binding protein 2 11q13.3 respiratory failure, progressive multifocal leukoencephalopathy, spinal muscular atrophy with respiratory distress 1
IGHV1-2 immunoglobulin heavy variable 1-2 14q32.33 gastrointestinal lymphoma, heavy chain disease, small intestine lymphoma,
IGHV1OR21-1 immunoglobulin heavy variable 1/OR21-1 (non-functional) 21p11.2 hiv-1
IGHV3-21 immunoglobulin heavy variable 3-21 14q32.33 b-cell chronic lymphocytic leukemia chronic lymphocytic leukemia
IGHV4-31 immunoglobulin heavy variable 4-31 14q32.33 acute myeloid leukemia
IGHV4-34 immunoglobulin heavy variable 4-34 14q32.33 hairy cell leukemia hcl-v
IGK immunoglobulin kappa locus 2p12 multiple myeloma, non-hodgkin lymphoma b-cell lymphomas
IGKC immunoglobulin kappa constant 2p11.2 extramedullary plasmacytoma, recurrent infections associated with rare immunoglobulin isotypes deficiency light chain deposition disease
IGKV1-5 immunoglobulin kappa variable 1-5 2p11.2 multiple myeloma, follicular lymphoma light chain deposition disease
IGKV2D-23 immunoglobulin kappa variable 2D-23 (pseudogene) 2p11.2 fatty liver disease
IGL immunoglobulin lambda locus 22q11.2 multiple myeloma, mantle cell lymphoma hodgkins lymphoma
IGLL1 immunoglobulin lambda-like polypeptide 1 22q11.23 autosomal recessive disease, agammaglobulinemia 3 , agammaglobulinemia,
IGLL5 immunoglobulin lambda-like polypeptide 5 22q11.22 carotid artery dissection
IGLV1-40 immunoglobulin lambda variable 1-40 22q11.22 papilledema
IGLV1-44 immunoglobulin lambda variable 1-44 22q11.22 papilledema
IGLV1-51 immunoglobulin lambda variable 1-51 22q11.22 aspartylglucosaminuria
IGLV9-49 immunoglobulin lambda variable 9-49 22q11.22 chronic maxillary sinusitis acute maxillary sinusitis
IGSF1 immunoglobulin superfamily, member 1 Xq26.2 central hypothyroidism and testicular enlargement, hypothyroidism subacute sclerosing panencephalitis
IGSF6 immunoglobulin superfamily, member 6 16p12.2 inflammatory bowel disease inflammatory bowel disease 1
IGSF6-DREV1 region containing immunoglobulin superfamily, member 6 and DREV1 inflammatory bowel disease inflammatory bowel disease 1
IH Hemihypertrophy 11p15 hemihypertrophy
IHG1 iris hypoplasia with glaucoma 1 X iris hypoplasia
IHH indian hedgehog 2q35 acrocallosal syndrome, brachydactyly type a1, brachydactyly
IHPS2 Pyloric stenosis, infantile hypertrophic, 2 16p13-p12 "pyloric stenosis, infantile hypertrophic, 2"
IHPS3 Pyloric stenosis, infantile hypertrophic, 3 11q14-q22 "pyloric stenosis, infantile hypertrophic, 3"
IHPS4 Pyloric stenosis, infantile hypertrophic, 4 Xq23 "pyloric stenosis, infantile hypertrophic, 4"
IHPS5 Pyloric stenosis, infantile hypertrophic, 5 16q24.3 "pyloric stenosis, infantile hypertrophic, 5"
IK IK cytokine, down-regulator of HLA II 5q31.3 central sleep apnea
IKBKAP inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein 9q31.3 differentiating neuroblastoma, autonomic neuropathy, dysautonomia,
IKBKB inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 8p11.21 insulin resistance immunodeficiency 15
IKBKE inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon 1q32.1 breast cancer sle susceptibility
IKBKG inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma Xq28 hypohidrotic ectodermal dysplasia, coats disease, exudative vitreoretinopathy,
IKZF1 IKAROS family zinc finger 1 (Ikaros) 7p12.2 lymphoblastic leukemia, acute lymphocytic leukemia, "leukemia, acute lymphoblastic 3",
IKZF3 IKAROS family zinc finger 3 (Aiolos) 17q12 oophoritis
IL10 interleukin 10 1q32.1 trachoma, choroiditis, multifocal choroiditis,
IL10RA interleukin 10 receptor, alpha 11q23.3 post-transplant lymphoproliferative disease, inflammatory bowel disease, visceral leishmaniasis,
IL10RB interleukin 10 receptor, beta 21q22.11 inflammatory bowel disease, "immunodeficiency, common variable, 11" "inflammatory bowel disease 25, autosomal recessive"
IL11 interleukin 11 19q13.42 osteoporosis, endometriosis, dengue disease,
IL11RA interleukin 11 receptor, alpha 9p13.3 colorectal adenocarcinoma, megakaryocytic leukemia, cartilage-hair hypoplasia,
IL12A interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) 3q25.33 stomatitis, primary biliary cirrhosis, malaria,
IL12B interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) 5q33.3 asthma, sarcoidosis, multiple sclerosis,
IL12RB1 interleukin 12 receptor, beta 1 19p13.11 primary biliary cirrhosis, sarcoidosis, malaria,
IL12RB2 interleukin 12 receptor, beta 2 1p31.3 behcets disease leprosy
IL13 interleukin 13 5q31.1 asthma, nonspecific interstitial pneumonia, usual interstitial pneumonia,
IL13RA1 interleukin 13 receptor, alpha 1 Xq24 atopy malignant glioma
IL13RA2 interleukin 13 receptor, alpha 2 Xq23 kaposis sarcoma, burkitts lymphoma, glioblastoma multiforme,
IL15 interleukin 15 4q31.21 celiac disease, lung cancer, cardiac sarcoidosis,
IL15RA interleukin 15 receptor, alpha 10p15.1 t-cell large granular lymphocyte leukemia
IL16 interleukin 16 15q25.1 vasomotor rhinitis, viral meningitis, whiplash
IL17A interleukin 17A 6p12.2 trachoma, psoriasis, autoimmune encephalitis,
IL17C interleukin 17C 16q24.3 childhood leukemia, hyper ige syndrome enthesitis-related arthritis
IL17F interleukin 17F 6p12.2 "candidiasis, familial, 2, autosomal recessive", candidiasis, spinal stenosis,
IL17RA interleukin 17 receptor A 22q11.1 "candidiasis, familial, 2, autosomal recessive", stromal keratitis, rheumatoid arthritis,
IL17RD interleukin 17 receptor D 3p14.3 hypogonadotropic hypogonadism 8 with or without anosmia, polyploidy hypogonadotropic hypogonadism 18 with or without anosmia
IL18 interleukin 18 (interferon-gamma-inducing factor) 11q23.1 nonspecific interstitial pneumonia, rosacea, nephritis,
IL18BP interleukin 18 binding protein 11q13.4 wegeners granulomatosis, smallpox acute graft versus host disease
IL18R1 interleukin 18 receptor 1 2q12.1 collagen disease, malaria, acute basophilic leukemia,
IL18RAP interleukin 18 receptor accessory protein 2q12.1 celiac disease, leprosy inflammatory bowel disease
IL19 interleukin 19 1q32.1 melanoma richters syndrome
IL1A interleukin 1, alpha 2q13 laryngitis, pulpitis, somatoform disorder,
IL1B interleukin 1, beta 2q13 laryngitis, wells syndrome, shigellosis,
IL1R1 interleukin 1 receptor, type I 2q11.2 wells syndrome, shigellosis, papilledema,
IL1R2 interleukin 1 receptor, type II 2q11.2 aseptic meningitis
IL1RAP interleukin 1 receptor accessory protein 3q28 stromal keratitis
IL1RAPL1 interleukin 1 receptor accessory protein-like 1 Xp21.3 "mental retardation, x-linked 17/31, microduplication", mental retardation, "mental retardation, x-linked",
IL1RAPL2 interleukin 1 receptor accessory protein-like 2 Xq22.3 wells syndrome, osteoporosis, sepsis,
IL1RL1 interleukin 1 receptor-like 1 2q12.1 yellow fever allergic conjunctivitis
IL1RN interleukin 1 receptor antagonist 2q13 bronchopulmonary dysplasia, osteoporosis, west syndrome,
IL2 interleukin 2 4q27 chronic active epstein-barr virus infection, burning mouth syndrome, capillary leak syndrome,
IL20 interleukin 20 1q32.1 psoriasis spondyloarthropathy
IL20RA interleukin 20 receptor, alpha 6q23.3 psoriasis
IL21 interleukin 21 4q27 psoriasis, visceral leishmaniasis, reactive arthritis,
IL21R interleukin 21 receptor 16p12.1 chronic cholangitis "immunodeficiency, primary, autosomal recessive, il21r-related"
IL22 interleukin 22 12q15 interstitial lung disease, acute generalized exanthematous pustulosis, alcoholic hepatitis
IL23R interleukin 23 receptor 1p31.3 behcets disease, psoriatic arthritis, inflammatory bowel disease,
IL24 interleukin 24 1q32.1 prostate cancer, pancreatic cancer melanoma
IL25 interleukin 25 14q11.2 allergic asthma
IL27 interleukin 27 16p11.2 posterior uveitis eosinophilic granulomatosis with polyangiitis
IL2RA interleukin 2 receptor, alpha 10p15.1 folliculitis, soft tissue sarcoma, stromal keratitis,
IL2RB interleukin 2 receptor, beta 22q12.3 infectious mononucleosis, orchitis, posterior uveitis,
IL2RG interleukin 2 receptor, gamma Xq13.1 lymphopenia, severe combined immunodeficiency, omenn syndrome,
IL3 interleukin 3 (colony-stimulating factor, multiple) 5q31.1 asthma, myelofibrosis, wells syndrome,
IL31 interleukin 31 12q24.31 asthma, atopic dermatitis, primary cutaneous amyloidosis,
IL31RA interleukin 31 receptor A 5q11.2 amyloidosis, mycobacterium avium complex disease, primary cutaneous amyloidosis,
IL32 interleukin 32 16p13.3 pancreatic cancer, food allergy, venezuelan equine encephalitis
IL33 interleukin 33 9p24.1 allergic conjunctivitis
IL36G interleukin 36, gamma 2q13 herpes simplex
IL36RN interleukin 36 receptor antagonist 2q13 acrodermatitis, pustulosis palmaris et plantaris, alopecia areata,
IL37 interleukin 37 2q13 morbid obesity
IL3RA interleukin 3 receptor, alpha (low affinity) Xp22.33 acute myeloid leukemia, acute leukemia, burns,
IL4 interleukin 4 5q31.1 asthma, folliculitis, trachoma,
IL4I1 interleukin 4 induced 1 19q13.33 primary mediastinal large b-cell lymphoma perinephritis
IL4R interleukin 4 receptor 16p12.1 asthma, malaria, atopy,
IL5 interleukin 5 (colony-stimulating factor, eosinophil) 5q31.1 asthma, folliculitis, urinary schistosomiasis,
IL5RA interleukin 5 receptor, alpha 3p26.2 atopy
IL6 interleukin 6 (interferon, beta 2) 7p15.3 monoclonal gammopathy of uncertain significance, myeloma, carotid intimal medial thickness,
IL6R interleukin 6 receptor 1q21.3 myeloma, kaposis sarcoma, prostate cancer,
IL6ST interleukin 6 signal transducer (gp130, oncostatin M receptor) 5q11.2 kaposis sarcoma, rheumatoid arthritis, malaria,
IL7 interleukin 7 8q21.12 lymphoblastic leukemia, lymphocytic choriomeningitis, malaria,
IL7R interleukin 7 receptor 5p13.2 thyroid lymphoma, "severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive", lymphopenia,
IL8 interleukin 8 4q13.3 bronchopulmonary dysplasia, nonspecific interstitial pneumonia, polyarteritis nodosa,
IL9 interleukin 9 5q31.1 asthma, cystic fibrosis, sarcoidosis,
IL9R interleukin 9 receptor Xq28 asthma, cystic fibrosis, adult t-cell leukemia,
ILDR1 immunoglobulin-like domain containing receptor 1 3q13.33 "deafness, autosomal recessive 76" "deafness, autosomal recessive 42"
ILF2 interleukin enhancer binding factor 2 1q21.3 hepatitis b hepatitis
ILK integrin-linked kinase 11p15.4 scar contracture
IMMP2L IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae) 7q31.1 atypical autism
IMMT inner membrane protein, mitochondrial 2p11.2 gracile syndrome, melanoma-associated retinopathy, amish lethal microcephaly
IMMTP1 inner membrane protein, mitochondrial (mitofilin) pseudogene 1 21q22.3 "fanconi anemia, complementation group a"
IMPA1 inositol(myo)-1(or 4)-monophosphatase 1 8q21.13 chronic intestinal vascular insufficiency bipolar disorder
IMPA2 inositol(myo)-1(or 4)-monophosphatase 2 18p11.21 schizophrenia bipolar disorder
IMPACT impact RWD domain protein 18q11.2 learning disability
IMPAD1 inositol monophosphatase domain containing 1 8q12.1 chondrodysplasia, "chondrodysplasia with joint dislocations, gpapp type", "chondrodysplasia with joint dislocations, grapp type"
IMPDH1 IMP (inosine 5'-monophosphate) dehydrogenase 1 7q32.1 leber congenital amaurosis, leber congenital amaurosis 11 , impdh1-related retinitis pigmentosa,
IMPG1 interphotoreceptor matrix proteoglycan 1 6q14.1 retinal drusen, progressive bifocal chorioretinal atrophy, benign concentric annular macular dystrophy,
IMPG2 interphotoreceptor matrix proteoglycan 2 3q12.3 leber congenital amaurosis, "maculopathy, impg2-related", impg2-related retinitis pigmentosa
INA internexin neuronal intermediate filament protein, alpha 10q24.33 gliomatosis cerebri, hypothalamic hamartomas, wernicke encephalopathy,
INCENP inner centromere protein antigens 135/155kDa 11q12.3 roberts syndrome graham little-piccardi-lassueur syndrome
INDX Immunoneurologic syndrome X-linked, of Wood, Black, and Norbury Xq26-qter wood neuroimmunologic syndrome
INF2 inverted formin, FH2 and WH2 domain containing 14q32.33 familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis, megalencephalic leukoencephalopathy with subcortical cysts, glomerulosclerosis,
ING1 inhibitor of growth family, member 1 13q34 squamous cell carcinoma of the head and neck "squamous cell carcinoma, head and neck, somatic"
ING2 inhibitor of growth family, member 2 4q35.1 non-small cell lung carcinoma
ING3 inhibitor of growth family, member 3 7q31.31 squamous cell carcinoma of the head and neck "squamous cell carcinoma, head and neck, somatic"
INHA inhibin, alpha 2q35 endometrial carcinoma, ovarian endometriosis, adenofibroma,
INHBA inhibin, beta A 7p14.1 ovary adenocarcinoma preterm premature rupture of the membranes
INHBB inhibin, beta B 2q14.2 ectopic pregnancy varicocele
INHBC inhibin, beta C 12q13.3 endometrial adenocarcinoma gastric diffuse adenocarcinoma
INHBE inhibin, beta E 12q13.3 germ cell tumors, testicular germ cell tumor endometrial adenocarcinoma
INPP5E inositol polyphosphate-5-phosphatase, 72 kDa 9q34.3 joubert syndrome 21, joubert syndrome and related disorders, doid:4019,
INPP5K inositol polyphosphate-5-phosphatase K 17p13.3 miller-dieker syndrome oculocerebrorenal syndrome
INPPL1 inositol polyphosphate phosphatase-like 1 11q13.4 opsismodysplasia, breast cancer oculocerebrorenal syndrome
INS insulin 11p15.5 acanthosis nigricans, carotid intimal medial thickness, diabetic macular edema,
INSC inscuteable homolog (Drosophila) 11p15.2 optic disk drusen
INSIG2 insulin induced gene 2 2q14.2 morbid obesity obesity
INSL3 insulin-like 3 (Leydig cell) 19p13.11 cryptorchidism, anorchia, testicular cancer,
INSL4 insulin-like 4 (placenta) 9p24.1 placenta accreta
INSM1 insulinoma-associated 1 20p11.23 insulinoma
INSR insulin receptor 19p13.2 acanthosis nigricans, type 2 diabetes mellitus, congenital fiber-type disproportion,
INSRL insulin receptor-like 7p13-q22 alzheimers disease
INSRR insulin receptor-related receptor 1q23.1 neurofibrosarcoma
INTLQ1 Intelligence QTL1 4p16-q34 intelligence qtl1
INTLQ2 Intelligence QTL3 2q24.1-q31.1 intelligence qtl3
INTLQ3 Intelligence QTL3 6p25.3-p22.3 intelligence qtl3
INTS10 integrator complex subunit 10 8p21.3 neonatal ovarian cyst
INTS8 integrator complex subunit 8 8q22.1 dysembryoplastic neuroepithelial tumor familial lipoprotein lipase deficiency
INTS9 integrator complex subunit 9 8p21.1 opisthorchiasis
INVS inversin 9q31.1 situs inversus, asphyxiating thoracic dystrophy, nephronophthisis,
IPO11 importin 11 5q12.1 triple-a syndrome
IPOX Intestinal pseudoobstruction, neuronal, primary idiopathic "intestinal pseudoobstruction, neuronal"
IPP intracisternal A particle-promoted polypeptide 1p34.1 cardiac tamponade peyronies disease
IPPK inositol 1,3,4,5,6-pentakisphosphate 2-kinase 9q22.31 heart septal defect atrial heart septal defect
IPW imprinted in Prader-Willi syndrome (non-protein coding) 15q11.2 prader-willi syndrome
IQCB1 IQ motif containing B1 3q13.33 leber congenital amaurosis, leber congenital amaurosis 17, senior-loken syndrome,
IQGAP1 IQ motif containing GTPase activating protein 1 15q26.1 skin disease bullous skin disease
IQSEC2 IQ motif and Sec7 domain 2 Xp11.22 "mental retardation, x-linked 17/31, microduplication", mental retardation, pigmented villonodular synovitis,
IRAK1 interleukin-1 receptor-associated kinase 1 Xq28 systemic lupus erythematosus pediatric systemic lupus erythematosus
IRAK3 interleukin-1 receptor-associated kinase 3 12q14.3 asthma, asthma susceptibility 5 melioidosis
IRAK4 interleukin-1 receptor-associated kinase 4 12q12 pneumococcal meningitis, isovaleric acidemia, baraitser-winter syndrome,
IREB2 iron-responsive element binding protein 2 15q25.1 erythropoietic protoporphyria
IRF1 interferon regulatory factor 1 5q31.1 "gastric cancer, somatic", acute myeloid leukemia, lung cancer,
IRF2 interferon regulatory factor 2 4q35.1 eczema herpeticum mumps
IRF2BP1 interferon regulatory factor 2 binding protein 1 19q13.32 brain cancer
IRF2BP2 interferon regulatory factor 2 binding protein 2 1q42.3 mesenchymal chondrosarcoma
IRF3 interferon regulatory factor 3 19q13.33 lymphocytic choriomeningitis herpes simplex
IRF4 interferon regulatory factor 4 6p25.3 myeloma, primary cutaneous anaplastic large cell lymphoma, malt lymphoma,
IRF5 interferon regulatory factor 5 7q32.1 primary biliary cirrhosis, systemic lupus erythematosus, cutaneous lupus erythematosus,
IRF6 interferon regulatory factor 6 1q32.2 "tooth agenesis, selective, 1, with or without orofacial cleft", cleft lip, cleft palate,
IRF7 interferon regulatory factor 7 11p15.5 stomatitis central nervous system lymphoma
IRF8 interferon regulatory factor 8 16q24.1 fetal alcohol syndrome, baraitser-winter syndrome, baraitser-winter syndrome 1,
IRF9 interferon regulatory factor 9 14q12 lymphocytic choriomeningitis ebola hemorrhagic fever
IRGM immunity-related GTPase family, M 5q33.1 pulmonary tuberculosis, crohns disease, tuberculosis,
IRS1 insulin receptor substrate 1 2q36.3 coronary artery disease, type 2 diabetes mellitus, insulin resistance,
IRS2 insulin receptor substrate 2 13q34 insulin resistance "diabetes mellitus, noninsulin-dependent"
IRS4 insulin receptor substrate 4 Xq22.3 exostosis, boutonneuse fever cribriform carcinoma
IRX2 iroquois homeobox 2 5p15.33 soft tissue sarcoma squamous cell carcinoma of the head and neck
IRX5 iroquois homeobox 5 16q12.2 hamamy syndrome
IS1 Adolescent idiopathic scoliosis 19p13.3 "scoliosis, idiopathic 1"
IS2 Scoliosis, idiopathic 2 17p11.2 "scoliosis, idiopathic 2"
IS4 Scoliosis, idiopathic, susceptibility to, 4 9q31.2-q34.2 "scoliosis, idiopathic 4"
ISCA1P2 iron-sulfur cluster assembly 1 pseudogene 2 1q42.13 pulmonary function
ISCU iron-sulfur cluster assembly enzyme 12q23.3 siderosis, myopathy with deficiency of iron-sulfur cluster assembly enzyme myopathy with deficiency of iscu
ISG15 ISG15 ubiquitin-like modifier 1p36.33 amyotrophic lateral sclerosis, stomatitis, acute promyelocytic leukemia,
ISG20 interferon stimulated exonuclease gene 20kDa 15q26.1 leukemia malignant glioma
ISL1 ISL LIM homeobox 1 5q11.1 gilles de la tourette syndrome, tetralogy of fallot , maturity-onset diabetes of the young
ISL2 ISL LIM homeobox 2 15q24.3 cortical blindness
ISM1 isthmin 1, angiogenesis inhibitor 20p12.1 indolent systemic mastocytosis
ISPD isoprenoid synthase domain containing 7p21.2 "muscular dystrophy-dystroglycanopathy , type a, 7", muscular dystrophy-dystroglycanopathy, walker-warburg syndrome,
IST1 increased sodium tolerance 1 homolog (yeast) 16q22.2 lung cancer
ISYNA1 inositol-3-phosphate synthase 1 19p13.11 fungal meningitis
ITC1 hypertrichosis universalis congenita, Ambras type 8q22 hypertrichosis universalis congenita
ITCH itchy E3 ubiquitin protein ligase 20q11.22 hemiplegic migraine, familial hemiplegic migraine itch e3 ubiquitin ligase deficiency
ITFG1 integrin alpha FG-GAP repeat containing 1 16q12.1 tethered spinal cord syndrome
ITGA1 integrin, alpha 1 5q11.2 phimosis colon carcinoma in situ
ITGA11 integrin, alpha 11 15q23 tick infestation
ITGA2 integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) 5q11.2 bernard-soulier syndrome, gingival overgrowth, fetal and neonatal alloimmune thrombocytopenia,
ITGA2B integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) 17q21.31 bernard-soulier syndrome, myocardial infarction, megakaryocytic leukemia,
ITGA3 integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) 17q21.33 nephrotic syndrome, hydrocele, cheilitis,
ITGA4 integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) 2q31.3 myeloma, multiple sclerosis, chronic venous leg ulcers,
ITGA5 integrin, alpha 5 (fibronectin receptor, alpha polypeptide) 12q13.13 gastric cardia adenocarcinoma
ITGA6 integrin, alpha 6 2q31.1 ocular cicatricial pemphigoid, gastrointestinal stromal tumor, mucous membrane pemphigoid,
ITGA7 integrin, alpha 7 12q13.2 congenital fiber-type disproportion, fukuyama congenital muscular dystrophy, "muscular dystrophy, congenital, due to itga7 deficiency"
ITGA8 integrin, alpha 8 10p13 renal agenesis renal hypodysplasia/aplasia 1
ITGA9 integrin, alpha 9 3p22.2 congenital muscular dystrophy with hyperlaxity
ITGAD integrin, alpha D 16p11.2 chronic monocytic leukemia
ITGAE integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide) 17p13.2 nephropathic cystinosis cystinosis
ITGAL integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) 16p11.2 acute myeloid leukemia, guttate psoriasis, leukocyte adhesion deficiency,
ITGAM integrin, alpha M (complement component 3 receptor 3 subunit) 16p11.2 bronchopulmonary dysplasia, myocardial infarction, acute promyelocytic leukemia,
ITGAV integrin, alpha V 2q32.1 priapism, cerebral hypoxia chorioangioma
ITGAX integrin, alpha X (complement component 3 receptor 4 subunit) 16p11.2 acute promyelocytic leukemia, vasculitis, leukocyte adhesion deficiency,
ITGB1 integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) 10p11.22 frozen shoulder, pustulosis palmaris et plantaris, cerebral hypoxia
ITGB1BP1 integrin beta 1 binding protein 1 2p25.1 cavernous malformation cerebral cavernous malformation
ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 21q22.3 malaria, urticaria, leukocyte adhesion deficiency,
ITGB3 integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) 17q21.32 carotid intimal medial thickness, bernard-soulier syndrome, coronary thrombosis,
ITGB3BP integrin beta 3 binding protein (beta3-endonexin) 1p31.3 breast cancer
ITGB4 integrin, beta 4 17q25.1 in situ carcinoma, ocular cicatricial pemphigoid, mucous membrane pemphigoid,
ITGB6 integrin, beta 6 2q24.2 "amelogenesis imperfecta, type iii" "amelogenesis imperfecta, type ib"
ITGB7 integrin, beta 7 12q13.13 spongiotic dermatitis
ITGBL1 integrin, beta-like 1 (with EGF-like repeat domains) 13q33.1 isolated growth hormone deficiency
ITIH4 inter-alpha-trypsin inhibitor heavy chain family, member 4 3p21.1 hiv-1, aids dementia complex, hypercholesterolemia
ITK IL2-inducible T-cell kinase 5q33.3 peripheral t-cell lymphoma, lymphoproliferative syndrome 1, thyroid medullary carcinoma
ITLN1 intelectin 1 (galactofuranose binding) 1q23.3 type 2 diabetes mellitus, insulin resistance, obesity
ITM2B integral membrane protein 2B 13q14.2 alzheimers disease, dementia, cerebral amyloid angiopathy,
ITPA inosine triphosphatase (nucleoside triphosphate pyrophosphatase) 20p13 adenosine deaminase deficiency, leukopenia, nodular regenerative hyperplasia
ITPKC inositol-trisphosphate 3-kinase C 19q13.2 kawasaki disease coronary artery aneurysm
ITPR1 inositol 1,4,5-trisphosphate receptor, type 1 3p26.1 ataxia, spinocerebellar ataxia, spinocerebellar ataxia 29,
ITPR3 inositol 1,4,5-trisphosphate receptor, type 3 6p21.31 type 1 diabetes mellitus
ITS Insulinoma tumor suppressor gene locus 22q12.1-q12.2 insulinoma
IVD isovaleryl-CoA dehydrogenase 15q15.1 radiculopathy, the organic acidemias: an, organic acidemia,
IVL involucrin 1q21.3 recessive dystrophic epidermolysis bullosa, clear cell acanthoma, acanthoma,
IVNS1ABP influenza virus NS1A binding protein 1q25.3 encephalitis, dengue hemorrhagic fever, influenza
IYD iodotyrosine deiodinase 6q25.1 rapsn-related congenital myasthenic syndrome, hypothyroidism, croup,
JAG1 jagged 1 20p12.2 biliary atresia, pulmonary valve stenosis, tetralogy of fallot ,
JAG2 jagged 2 14q32.33 pain agnosia, agnosia, fibroma,
JAK2 Janus kinase 2 9p24.1 myelofibrosis, thrombocytosis, acute myeloid leukemia,
JAK3 Janus kinase 3 19p13.11 severe combined immunodeficiency, anaplastic large cell lymphoma, jacobsen syndrome,
JAM3 junctional adhesion molecule 3 11q25 torch syndrome, pseudo-torch syndrome "hemorrhagic destruction of the brain, subependymal calcification, and cataracts"
JAZF1 JAZF zinc finger 1 7p15.1 endometrial stromal tumor
JBS Jacobsen syndrome 11q24.1 johanson-blizzard syndrome jacobsen syndrome
JDP2 Jun dimerization protein 2 14q24.3 skeletal muscle neoplasm
JKAMP JNK1/MAPK8-associated membrane protein 14q23.1 medulloblastoma
JMJD6 jumonji domain containing 6 17q25.1 trigeminal neuralgia, chorioretinal scar intramuscular hemangioma
JPD juvenile periodontitis 4 periodontitis, papillon-lefevre disease, "periodontitis 1, juvenile"
JPH2 junctophilin 2 20q13.12 "cardiomyopathy, familial hypertrophic 17"
JPH3 junctophilin 3 16q24.2 chorea-acanthocytosis, huntingtons disease, nephronophthisis 11
JRK Jrk homolog (mouse) 8q24.3 "epilepsy, childhood absence, susceptibility to, 2", childhood absence epilepsy "epilepsy, juvenile myoclonic 8"
JRKL JRK-like 11q21 fatty liver disease
JTB jumping translocation breakpoint 1q21.3 lymph node tuberculosis
JUN jun proto-oncogene 1p32.1 sarcoma, recessive dystrophic epidermolysis bullosa, breast cancer,
JUNB jun B proto-oncogene 19p13.2 fumarate hydratase deficiency
JUND jun D proto-oncogene 19p13.11 wermer syndrome, kidney cancer human t-cell leukemia virus type 1
JUP junction plakoglobin 17q21.2 bladder carcinoma, "familial isolated arrhythmogenic ventricular dysplasia, biventricular form", "familial isolated arrhythmogenic ventricular dysplasia, right dominant form",
KAL1 Kallmann syndrome 1 sequence Xp22.31 hypogonadotropic hypogonadism 8 with or without anosmia, hypogonadotropic hypogonadism 17 with or without anosmia, kallmann syndrome 1,
KALRN kalirin, RhoGEF kinase 3q21.1 coronary heart disease 5
KANK1 KN motif and ankyrin repeat domains 1 9p24.3 renal cell carcinoma, metanephric adenoma, congenital fibrosis of the extraocular muscles,
KANSL1 KAT8 regulatory NSL complex subunit 1 17q21.31 intellectual disability, koolen de vries syndrome, kansl1-related intellectual disability syndrome
KARS lysyl-tRNA synthetase 16q23.1 "deafness, autosomal recessive 76", polymyositis, antisynthetase syndrome,
KAT2A K(lysine) acetyltransferase 2A 17q21.2 dosage-sensitive sex reversal
KAT2B K(lysine) acetyltransferase 2B 3p24.3 enamel erosion holt-oram syndrome
KAT5 K(lysine) acetyltransferase 5 11q13.1 kaposis sarcoma hiv-1
KAT6A K(lysine) acetyltransferase 6A 8p11.21 acute myeloid leukemia, leukemia, neonatal leukemia,
KAT6B K(lysine) acetyltransferase 6B 10q22.2 leukemia, monocytic leukemia, noonan syndrome 1,
KATNAL2 katanin p60 subunit A-like 2 18q21.1 tinea capitis
KAZA1 Kala-azar (visceral leishmaniasis), susceptibility to 22q12 leishmaniasis, visceral leishmaniasis kala-azar 1
KAZA2 Kala-azar, susceptibility to, 2 1p22 kala-azar 2
KAZA3 Kala-azar, susceptibility to, 3 6p27 kala-azar 3
KAZALD1 Kazal-type serine peptidase inhibitor domain 1 10q24.31 malignant peritoneal mesothelioma
KBTBD13 kelch repeat and BTB (POZ) domain containing 13 15q22.31 myopathy, childhood-onset nemaline myopathy, congenital aphakia,
KCNA1 potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) 12p13.32 ataxia, episodic ataxia, spinocerebellar ataxia type 6,
KCNA2 potassium voltage-gated channel, shaker-related subfamily, member 2 1p13.3 benign neonatal seizures
KCNA3 potassium voltage-gated channel, shaker-related subfamily, member 3 1p13.3 breast adenocarcinoma, pancreas adenocarcinoma, type 1 diabetes mellitus
KCNA4 potassium voltage-gated channel, shaker-related subfamily, member 4 11p14.1 pancreas adenocarcinoma episodic ataxia type 1
KCNA5 potassium voltage-gated channel, shaker-related subfamily, member 5 12p13.32 hepatopulmonary syndrome, patent ductus arteriosus, insulinoma,
KCNA6 potassium voltage-gated channel, shaker-related subfamily, member 6 12p13.32 myokymia benign neonatal seizures
KCNAB2 potassium voltage-gated channel, shaker-related subfamily, beta member 2 1p36.31 1p36 deletion syndrome
KCNB1 potassium voltage-gated channel, Shab-related subfamily, member 1 20q13.13 blastomycosis sporotrichosis
KCNC3 potassium voltage-gated channel, Shaw-related subfamily, member 3 19q13.33 localized osteosarcoma, spinocerebellar ataxia type13 spinocerebellar ataxia type 13
KCND3 potassium voltage-gated channel, Shal-related subfamily, member 3 1p13.2 brugada syndrome 1, myokymia spinocerebellar ataxia 19
KCNE1 potassium voltage-gated channel, Isk-related family, member 1 21q22.12 atrioventricular block, "atrial fibrillation, familial, 9", familial atrial fibrillation,
KCNE1L KCNE1-like Xq23 familial atrial fibrillation alport syndrome - intellectual disability - midface hypoplasia - elliptocytosis
KCNE2 potassium voltage-gated channel, Isk-related family, member 2 21q22.11 congenital heart block, atrioventricular block, "atrial fibrillation, familial, 9",
KCNE3 potassium voltage-gated channel, Isk-related family, member 3 11q13.4 hypokalemic periodic paralysis, brugada syndrome 1, familial atrial fibrillation,
KCNH2 potassium voltage-gated channel, subfamily H (eag-related), member 2 7q36.1 sudden infant death syndrome, syncope, atrioventricular block,
KCNH4 potassium voltage-gated channel, subfamily H (eag-related), member 4 17q21.2 campylobacteriosis
KCNJ1 potassium inwardly-rectifying channel, subfamily J, member 1 11q24.3 polyhydramnios, hydranencephaly, pseudohypoaldosteronism type ii,
KCNJ10 potassium inwardly-rectifying channel, subfamily J, member 10 1q23.2 idiopathic generalized epilepsy, pendred syndrome, pendred syndrome/dfnb4,
KCNJ11 potassium inwardly-rectifying channel, subfamily J, member 11 11p15.1 type 2 diabetes mellitus, diabetes mellitus, hypoglycemia,
KCNJ12 potassium inwardly-rectifying channel, subfamily J, member 12 17p11.2 hypokalemic periodic paralysis, bartter disease lens subluxation
KCNJ13 potassium inwardly-rectifying channel, subfamily J, member 13 2q37.1 leber congenital amaurosis, leber congenital amaurosis 17, endolymphatic sac tumor,
KCNJ14 potassium inwardly-rectifying channel, subfamily J, member 14 19q13.33 menieres disease
KCNJ16 potassium inwardly-rectifying channel, subfamily J, member 16 17q24.3 body dysmorphic disorder, thyrotoxic periodic paralysis pierre robin sequence
KCNJ18 potassium inwardly-rectifying channel, subfamily J, member 18 17 hypokalemic periodic paralysis, thyrotoxic periodic paralysis 1, thyrotoxic periodic paralysis
KCNJ2 potassium inwardly-rectifying channel, subfamily J, member 2 17q24.3 hypokalemic periodic paralysis, catecholaminergic polymorphic ventricular tachycardia, refractive error,
KCNJ3 potassium inwardly-rectifying channel, subfamily J, member 3 2q24.1 pancreas adenocarcinoma
KCNJ5 potassium inwardly-rectifying channel, subfamily J, member 5 11q24.3 myocardial infarction, anoxia, hyperaldosteronism,
KCNJ8 potassium inwardly-rectifying channel, subfamily J, member 8 12p12.1 brugada syndrome 1, sudden infant death syndrome, craniometaphyseal dysplasia,
KCNJ9 potassium inwardly-rectifying channel, subfamily J, member 9 1q23.2 idiopathic generalized epilepsy
KCNK10 potassium channel, subfamily K, member 10 14q31.3 dentin sensitivity
KCNK18 potassium channel, subfamily K, member 18 10q25.3 migraine, migraine with aura "migraine, with or without aura 13"
KCNK3 potassium channel, subfamily K, member 3 2p23.3 primary pulmonary hypertension, sleep apnea, central sleep apnea,
KCNK4 potassium channel, subfamily K, member 4 11q13.1 dentin sensitivity
KCNK6 potassium channel, subfamily K, member 6 19q13.2 developmental coordination disorder, brachial plexus lesion, sickle cell anemia
KCNK9 potassium channel, subfamily K, member 9 8q24.3 sleep apnea, fetal alcohol spectrum disorder, central sleep apnea,
KCNMA1 potassium large conductance calcium-activated channel, subfamily M, alpha member 1 10q22.3 paroxysmal dyskinesia, impotence generalized epilepsy and paroxysmal dyskinesia
KCNMB1 potassium large conductance calcium-activated channel, subfamily M, beta member 1 5q35.1 sleep apnea "hypertension, diastolic"
KCNMB3 potassium large conductance calcium-activated channel, subfamily M beta member 3 3q26.32 idiopathic generalized epilepsy
KCNN1 potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1 19p13.11 schizophrenia
KCNN3 potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 1q21.3 schizophrenia bipolar disorder
KCNQ1 potassium voltage-gated channel, KQT-like subfamily, member 1 11p15.5 beckwith-wiedemann syndrome, secretory diarrhea, atrioventricular block,
KCNQ1DN KCNQ1 downstream neighbor (non-protein coding) 11p15.4 wilms tumor
KCNQ1OT1 KCNQ1 opposite strand/antisense transcript 1 (non-protein coding) 11p15.5 beckwith-wiedemann syndrome, hemihypertrophy, adrenal neuroblastoma,
KCNQ2 potassium voltage-gated channel, KQT-like subfamily, member 2 20q13.33 "epileptic encephalopathy, early infantile, 17", neuroblastoma, spermatogenic failure 12,
KCNQ3 potassium voltage-gated channel, KQT-like subfamily, member 3 8q24.22 "epilepsy, juvenile myoclonic 8", speech disorder, benign familial infantile seizures 2,
KCNQ4 potassium voltage-gated channel, KQT-like subfamily, member 4 1p34.2 "deafness, autosomal dominant 4b", dfna2 nonsyndromic hearing loss "deafness, autosomal dominant 2a"
KCNRG potassium channel regulator 13q14.2 autoimmune polyendocrine syndrome type 1
KCNS1 potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 20q13.12 chronic pain
KCNT1 potassium channel, subfamily T, member 1 9q34.3 "epileptic encephalopathy, early infantile, 12", malignant migrating partial seizures of infancy, benign familial infantile epilepsy,
KCNV2 potassium channel, subfamily V, member 2 9p24.2 retinal cone dystrophy 3 , cone dystrophy 3 retinal cone dystrophy 3b
KCTD1 potassium channel tetramerization domain containing 1 18q11.2 scalp ear nipple syndrome
KCTD10 potassium channel tetramerization domain containing 10 12q24.11 methylmalonic acidemia
KCTD5 potassium channel tetramerization domain containing 5 16p13.3 agoraphobia rectal neoplasm
KCTD7 potassium channel tetramerization domain containing 7 7q11.21 neuronal ceroid-lipofuscinoses, birt-hogg-dube syndrome, myoclonus epilepsy,
KDELR1 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 19q13.33 hydranencephaly actinobacillosis
KDM4C lysine (K)-specific demethylase 4C 9p24.1 esophageal squamous cell carcinoma
KDM5A lysine (K)-specific demethylase 5A 12p13.33 retinoblastoma
KDM5B lysine (K)-specific demethylase 5B 1q32.1 retinoblastoma
KDM5C lysine (K)-specific demethylase 5C Xp11.22 mental retardation "x-linked syndromic mental retardation, claes-jensen type"
KDM5D lysine (K)-specific demethylase 5D Yq11.222 y chromosome infertility
KDM6A lysine (K)-specific demethylase 6A Xp11.3 kabuki syndrome, kabuki syndrome 1 , kabuki syndrome 2
KDR kinase insert domain receptor (a type III receptor tyrosine kinase) 4q12 colorectal cancer, kaposis sarcoma, hemangioma,
KDSR 3-ketodihydrosphingosine reductase 18q21.33 follicular lymphoma
KEAP1 kelch-like ECH-associated protein 1 19p13.2 papillary adenocarcinoma, non-small cell lung carcinoma diabetic cataract
KEL Kell blood group, metallo-endopeptidase 7q34 neuroacanthocytosis chronic granulomatous disease
KERA keratocan 12q21.33 cloacogenic carcinoma, mucopolysaccharidoses, morquio syndrome b,
KERSMCR cytokeratin, Smith Magenis syndrome chromosome region 17p11.2 smith magenis syndrome
KFM Klippel-Feil malformation reserved "klippel-feil syndrome 2, autosomal recessive"
KHDC3L KH domain containing 3-like, subcortical maternal complex member 6q13 gestational trophoblastic neoplasm, triploidy "hydatidiform mole, recurrent, 2"
KHDRBS3 KH domain containing, RNA binding, signal transduction associated 3 8q24.23 transvestism, hypophosphatasia extratemporal epilepsy
KHK ketohexokinase (fructokinase) 2p23.3 obstructive jaundice, fructosuria "fructosuria, essential"
KHSRP KH-type splicing regulatory protein 19p13.3 pheochromocytoma spinocerebellar ataxia type 17
KIAA0020 KIAA0020 9p24.2 hepatitis b
KIAA0040 KIAA0040 1q25.1 alcohol dependence
KIAA0100 KIAA0100 17q11.2 breast cancer in situ carcinoma
KIAA0101 KIAA0101 15q22.31 hepatitis c, hepatitis c virus hepatitis
KIAA0196 KIAA0196 8q24.13 spasticity, paraplegia, hereditary spastic paraplegia,
KIAA0226 KIAA0226 3q29 lactose intolerance, autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to kiaa0226 deficiency "spinocerebellar ataxia, autosomal recessive 15"
KIAA0319 KIAA0319 6p22.3 lattice corneal dystrophy, kidney disease, dyslexia,
KIAA0319L KIAA0319-like 1p34.3 limited scleroderma dyslexia
KIAA1033 KIAA1033 12q23.3 "mental retardation, autosomal recessive 43" phimosis
KIAA1109 KIAA1109 4q27 posterior uveitis celiac disease
KIAA1279 KIAA1279 10q22.1 pseudobulbar palsy, goldberg-shprintzen megacolon syndrome megacolon
KIAA1377 KIAA1377 11q22.1 monomelic amyotrophy
KIAA1429 KIAA1429 8q22.1 oxyphilic adenoma
KIAA1462 KIAA1462 10p11.23 coronary artery disease artery disease
KIAA1468 KIAA1468 18q21.33 chronic recurrent multifocal osteomyelitis
KIAA1549 KIAA1549 7q34 pilocytic astrocytoma, astrocytoma dysembryoplastic neuroepithelial tumor
KIAA2022 KIAA2022 Xq13.3 "mental retardation, x-linked 98" kiaa2022-related x-linked mental retardation
KIF11 kinesin family member 11 10q23.33 kidney disease, "xeroderma pigmentosum, group f", lymphedema,
KIF15 kinesin family member 15 3p21.31 breast cancer
KIF16B kinesin family member 16B 20p12.1 congenital fibrosis of the extraocular muscles
KIF18A kinesin family member 18A 11p14.1 asbestosis
KIF1A kinesin family member 1A 2q37.3 neuropathy, "mental retardation, autosomal dominant 10", adrenal neuroblastoma,
KIF1B kinesin family member 1B 1p36.22 neuroblastoma, charcot-marie-tooth neuropathy type 2, charcot-marie-tooth disease type 2,
KIF1C kinesin family member 1C 17p13.2 benign glioma, "spastic ataxia 2, autosomal recessive" cutaneous anthrax
KIF20A kinesin family member 20A 5q31.2 charcot-marie-tooth disease type 4
KIF21A kinesin family member 21A 12q12 congenital fibrosis of the extraocular muscles 2, congenital fibrosis of the extraocular muscles, amblyopia,
KIF21B kinesin family member 21B 1q32.1 multiple sclerosis inflammatory bowel disease
KIF22 kinesin family member 22 16p11.2 hypogonadotropic hypogonadism 10 with or without anosmia , spondyloepimetaphyseal dysplasia "spondyloepimetaphyseal dysplasia with joint laxity, type 2"
KIF23 kinesin family member 23 15q23 congenital dyserythropoietic anemia type 3
KIF26A kinesin family member 26A 14q32.33 megacolon
KIF2A kinesin heavy chain member 2A 5q12.1 "cortical dysplasia, complex, with other brain malformations" "cortical dysplasia, complex, with other brain malformations 3"
KIF2B kinesin family member 2B 17q22 charcot-marie-tooth disease type 4
KIF3A kinesin family member 3A 5q31.1 orofaciodigital syndrome
KIF3C kinesin family member 3C 2p23.3 benign glioma
KIF5A kinesin family member 5A 12q13.3 paraplegia, hereditary spastic paraplegia, louping ill,
KIF5B kinesin family member 5B 10p11.22 blackwater fever
KIF5C kinesin family member 5C 2q23.1 trichohepatoenteric syndrome 2 , "cortical dysplasia, complex, with other brain malformations 2" "cortical dysplasia, complex, with other brain malformations"
KIF7 kinesin family member 7 15q26.1 joubert syndrome and related disorders, "bardet-biedl syndrome 1, modifier of", bardet-biedl syndrome 15,
KIR2DL1 killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 19q13.42 behcets disease, cutaneous t cell lymphoma, leptospirosis,
KIR2DL2 killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 19_GL000209.1 type 1 diabetes mellitus, leptospirosis, acquired immunodeficiency syndrome,
KIR2DL3 killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 19q13.42 adenomyosis, malaria, cutaneous t cell lymphoma,
KIR2DL4 killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 19q13.42 leptospirosis, hematopoietic stem cell transplantation recurrent respiratory papillomatosis
KIR2DL5A killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A 19p13.3 non-hodgkin lymphoma, leptospirosis, hepatitis b virus infection,
KIR2DP1 killer cell immunoglobulin-like receptor, two domains, pseudogene 1 19q13.42 hepatitis b virus infection, ankylosing spondylitis hematopoietic stem cell transplantation
KIR2DS1 killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1 19q13.4 guttate psoriasis, psoriatic arthritis, non-hodgkin lymphoma,
KIR2DS2 killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2 19q13.4 non-hodgkin lymphoma, chronic myeloid leukemia, type 1 diabetes mellitus,
KIR2DS3 killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 19q13.4 acute myeloid leukemia, sjogrens syndrome, non-hodgkin lymphoma,
KIR2DS4 killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4 19q13.42 birdshot chorioretinopathy klippel-feil syndrome
KIR2DS5 killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5 19q13.4 non-hodgkin lymphoma, chronic myeloid leukemia, type 1 diabetes mellitus,
KIR3DL1 killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 19q13.42 behcets disease, hematopoietic stem cell transplantation, "aids, delayed/rapid progression to"
KIR3DP1 killer cell immunoglobulin-like receptor, three domains, pseudogene 1 19q13.42 hematopoietic stem cell transplantation
KIR3DS1 killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1 19_GL000209.1 rheumatic disease, pulmonary tuberculosis, type 1 diabetes mellitus,
KIRREL3 kin of IRRE like 3 (Drosophila) 11q24.2 "mental retardation, autosomal dominant 10"
KISS1 KiSS-1 metastasis-suppressor 1q32.1 hypogonadotropic hypogonadism 17 with or without anosmia, pancreatic cancer, hypothalamic hamartomas,
KISS1R KISS1 receptor 19p13.3 hypogonadotropic hypogonadism 8 with or without anosmia, hypogonadotropic hypogonadism 17 with or without anosmia, kallmann syndrome,
KIT v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog 4q12 germ cell tumors, sarcoma, myelofibrosis,
KITLG KIT ligand 12q21.32 "male germ cell tumor, somatic", aplastic anemia, urticaria,
KIZ kizuna centrosomal protein 20p11.23 leber congenital amaurosis retinitis pigmentosa 69
KL klotho 13q13.1 coronary artery disease, calcinosis, hyperphosphatemic familial tumoral calcinosis,
KLB klotho beta 4p14 diarrhea
KLC1 kinesin light chain 1 14q32.33 medulloblastoma
KLF1 Kruppel-like factor 1 (erythroid) 19p13.2 congenital dyserythropoietic anemia, hereditary persistence of fetal hemoglobin, congenital dyserythropoietic anemia type iv,
KLF10 Kruppel-like factor 10 8q22.3 pancreatic cancer, nephroblastoma, pallister-hall syndrome
KLF11 Kruppel-like factor 11 2p25.1 pancreatic cancer, maturity-onset diabetes of the young, "maturity-onset diabetes of the young, type 1"
KLF4 Kruppel-like factor 4 (gut) 9q31.2 colon cancer, secretory meningioma, malaria,
KLF5 Kruppel-like factor 5 (intestinal) 13q22.1 essential thrombocythemia cerebral aneurysms
KLF6 Kruppel-like factor 6 10p15.1 hepatocellular carcinoma, prostate cancer, "gastric cancer, somatic",
KLF9 Kruppel-like factor 9 9q21.12 endometrial carcinoma kabuki syndrome
KLHDC2 kelch domain containing 2 14q21.3 hepatocellular carcinoma
KLHDC8B kelch domain containing 8B 3p21.31 hodgkins lymphoma
KLHL10 kelch-like family member 10 17q21.2 oligospermia spermatogenic failure 11
KLHL2 kelch-like family member 2 4q32.3 monkeypox
KLHL24 kelch-like family member 24 3q27.1 urethral stricture neurogenic bladder
KLHL3 kelch-like family member 3 5q31.2 hypertension, metabolic acidosis, pseudohypoaldosteronism type iid
KLHL4 kelch-like family member 4 Xq21.31 mullerian aplasia
KLHL40 kelch-like family member 40 3p22.1 myopathy, severe congenital nemaline myopathy "nemaline myopathy 8, autosomal recessive"
KLHL41 kelch-like family member 41 2q31.1 childhood-onset nemaline myopathy, typical nemaline myopathy, intermediate nemaline myopathy,
KLHL7 kelch-like family member 7 7p15.3 leber congenital amaurosis, retinitis, retinitis pigmentosa,
KLHL9 kelch-like family member 9 9p21.3 cutaneous malignant melanoma
KLK1 kallikrein 1 19q13.33 abdominal aortic aneurysm vascular dementia
KLK10 kallikrein-related peptidase 10 19q13.41 prostate cancer, ovarian cancer lung squamous cell carcinoma
KLK11 kallikrein-related peptidase 11 19q13.41 prostate cancer
KLK12 kallikrein-related peptidase 12 19q13.41 eczema herpeticum
KLK13 kallikrein-related peptidase 13 19q13.41 breast cancer ovarian cancer
KLK15 kallikrein-related peptidase 15 19q13.33 peripheral vascular disease, vascular disease, prostate cancer
KLK2 kallikrein-related peptidase 2 19q13.33 prostate cancer
KLK3 kallikrein-related peptidase 3 19q13.33 polyarteritis nodosa, prostate cancer, prostatic hypertrophy,
KLK4 kallikrein-related peptidase 4 19q13.41 colorectal adenocarcinoma, endometrial carcinoma, prostate cancer,
KLK5 kallikrein-related peptidase 5 19q13.41 prostate cancer ovarian cancer
KLK6 kallikrein-related peptidase 6 19q13.41 spinal cord injury ovarian cancer
KLK7 kallikrein-related peptidase 7 19q13.41 atopic dermatitis, dermatitis netherton syndrome
KLK8 kallikrein-related peptidase 8 19q13.41 seborrheic keratosis, spinal cord injury, ovarian cancer
KLK9 kallikrein-related peptidase 9 19q13.41 breast cancer
KLKB1 kallikrein B, plasma (Fletcher factor) 1 4q35.2 essential hypertension, fletcher factor deficiency, prekallikrein deficiency,
KLLN killin, p53-regulated DNA replication inhibitor 10q23.31 cowden syndrome 4 , cowden syndrome 1 "breast-ovarian cancer, familial, 2"
KLRB1 killer cell lectin-like receptor subfamily B, member 1 12p13.31 cytomegalovirus infection
KLRC1 killer cell lectin-like receptor subfamily C, member 1 12p13.2 malaria
KLRC2 killer cell lectin-like receptor subfamily C, member 2 12p13.2 rheumatic disease, paroxysmal nocturnal hemoglobinuria toxic epidermal necrolysis
KLRC3 killer cell lectin-like receptor subfamily C, member 3 12p13.2 monkeypox
KLRC4 killer cell lectin-like receptor subfamily C, member 4 12p13.2 nasopharyngitis
KLRD1 killer cell lectin-like receptor subfamily D, member 1 12p13.2 t-cell large granular lymphocyte leukemia
KLRK1 killer cell lectin-like receptor subfamily K, member 1 12p13.2 primary sclerosing cholangitis, alveolar echinococcosis, tongue cancer,
KMO kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) 1q43 paroxysmal dyskinesia, huntingtons disease, pneumococcal meningitis
KMS Kabuki mental retardation syndrome reserved bardet-biedl syndrome 6, mckusick-kaufman syndrome hypogonadotropic hypogonadism 1 with or without anosmia
KMT2A lysine (K)-specific methyltransferase 2A 11q23.3 acute myeloid leukemia, lymphoblastic leukemia, shwachman-diamond syndrome,
KMT2B lysine (K)-specific methyltransferase 2B 19q13.12 leukemia
KMT2C lysine (K)-specific methyltransferase 2C 7q36.1 leukemia
KMT2D lysine (K)-specific methyltransferase 2D 12q13.12 kabuki syndrome, colorectal cancer 1, kmt2d-related kabuki syndrome
KMT2E lysine (K)-specific methyltransferase 2E 7q22.3 leukemia
KNG1 kininogen 1 3q27.3 pre-eclampsia, neuroblastoma, pulpitis,
KNTC1 kinetochore associated 1 12q24.31 dependent personality disorder, histrionic personality disorder osteitis fibrosa
KONDS Kondoh syndrome 1p36.32-p35.3 kondoh syndrome
KPNA2 karyopherin alpha 2 (RAG cohort 1, importin alpha 1) 17q24.2 malignant germ cell tumor borna disease
KPNA3 karyopherin alpha 3 (importin alpha 4) 13q14.2 opiate dependence
KPNA7 karyopherin alpha 7 (importin alpha 8) 7q22.1 partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome
KPNB1 karyopherin (importin) beta 1 17q21.32 campomelic dysplasia
KPTN kaptin (actin binding protein) 19q13.32 "mental retardation, autosomal recessive 41"
KRAS Kirsten rat sarcoma viral oncogene homolog 12p12.1 "bladder cancer, somatic", colorectal cancer, adenocarcinoma,
KRBOX4 KRAB box domain containing 4 Xp11.3 diffuse mesangial sclerosis transient neonatal diabetes mellitus
KRCC1 lysine-rich coiled-coil 1 2p11.2 hepatitis
KREMEN1 kringle containing transmembrane protein 1 22q12.1 osteoporosis-pseudoglioma syndrome sost-related sclerosing bone dysplasia
KRI1 KRI1 homolog (S. cerevisiae) 19p13.2 dental pulp necrosis
KRIT1 KRIT1, ankyrin repeat containing 7q21.2 cavernous hemangioma, clear cell acanthoma, acanthoma,
KRR1 KRR1, small subunit (SSU) processome component, homolog (yeast) 12q21.2 hiv-1
KRT1 keratin 1 12q13.13 epidermal nevus, keratosis, recessive dystrophic epidermolysis bullosa,
KRT10 keratin 10 17q21.2 epidermal nevus, keratosis, acanthoma,
KRT12 keratin 12 17q21.2 corneal dystrophy, aniridia, limbal stem cell deficiency,
KRT13 keratin 13 17q21.2 papilloma, transitional cell carcinoma, oral cancer,
KRT14 keratin 14 17q21.2 mammary pagets disease, craniopharyngioma, sweat gland carcinoma,
KRT15 keratin 15 17q21.2 pancreatoblastoma, spiradenoma, syringocystadenoma papilliferum
KRT16 keratin 16 17q21.2 acanthoma, gonorrhea, hypertrophic scars,
KRT17 keratin 17 17q21.2 ampulla of vater adenocarcinoma, cervical intraepithelial neoplasia, pleuropneumonia,
KRT18 keratin 18 12q13.13 cavernous hemangioma, mammary pagets disease, placental site trophoblastic tumor,
KRT18P16 keratin 18 pseudogene 16 5q23.2 alzheimers disease
KRT19 keratin 19 17q21.2 hepatocellular carcinoma, cervical cancer, cavernous hemangioma,
KRT2 keratin 2 12q13.13 keloids, hereditary mucosal leukokeratosis, pachyonychia congenita,
KRT20 keratin 20 17q21.2 colorectal cancer, adenocarcinoma, signet ring cell adenocarcinoma,
KRT24 keratin 24 17q21.2 hypohidrosis
KRT3 keratin 3 12q13.13 breast disease, burns, keratoconus,
KRT31 keratin 31 17q21.2 basal cell carcinoma, nodular basal cell carcinoma skin pilomatrix carcinoma
KRT34 keratin 34 17q21.2 esophageal squamous cell carcinoma
KRT38 keratin 38 17q21.2 basal cell carcinoma, nodular basal cell carcinoma ectropion
KRT4 keratin 4 12q13.13 basaloid squamous cell carcinoma, oral lichen planus, epidermodysplasia verruciformis,
KRT5 keratin 5 12q13.13 hemophilia b, vulvar intraepithelial neoplasia, hidradenocarcinoma,
KRT6A keratin 6A 12q13.13 fibroma, ossifying fibroma, glossitis,
KRT6B keratin 6B 12q13.13 glossitis, focal palmoplantar keratoderma, hereditary mucosal leukokeratosis,
KRT6C keratin 6C 12q13.13 autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering, "palmoplantar keratoderma, nonepidermolytic, focal or diffuse" focal palmoplantar keratoderma
KRT7 keratin 7 12q13.13 hepatocellular carcinoma, adenocarcinoma, signet ring cell adenocarcinoma,
KRT71 keratin 71 12q13.13 "woolly hair, autosomal dominant" hypotrichosis 13
KRT72 keratin 72 12q13.13 pachyonychia congenita
KRT74 keratin 74 12q13.13 hypotrichosis 2, hypotrichosis simplex, hypotrichosis 3,
KRT75 keratin 75 12q13.13 pseudofolliculitis barbae loose anagen hair syndrome
KRT8 keratin 8 12q13.13 mammary pagets disease, corneal edema, villous adenoma,
KRT80 keratin 80 12q13.13 cervix uteri carcinoma in situ
KRT81 keratin 81 12q13.13 pilomatrixoma, cholecystitis, pachyonychia congenita,
KRT83 keratin 83 12q13.13 meningioma, monilethrix, parotid gland cancer,
KRT84 keratin 84 12q13.13 meningioma petroclival meningioma
KRT85 keratin 85 12q13.13 "ectodermal dysplasia 4, hair/nail type"
KRT86 keratin 86 12q13.13 x-linked ichthyosis, pachyonychia congenita, epidermolytic hyperkeratosis,
KRT9 keratin 9 17q21.2 palmoplantar keratosis, amebiasis, bile duct carcinoma,
KRTAP1-1 keratin associated protein 1-1 17q21.2 choroid cancer
KRTAP1-3 keratin associated protein 1-3 17q21.2 choroid cancer
KRTAP10-8 keratin associated protein 10-8 21q22.3 breast and colorectal cancer
KRTAP10-9 keratin associated protein 10-9 21q22.3 c1 inhibitor deficiency
KRTAP11-1 keratin associated protein 11-1 21q22.11 hereditary mucosal leukokeratosis, pachyonychia congenita, monilethrix
KRTAP17-1 keratin associated protein 17-1 17q21.2 pachyonychia congenita
KRTAP20-1 keratin associated protein 20-1 21q22.11 breast and colorectal cancer
KRTAP21-1 keratin associated protein 21-1 21q22.11 breast and colorectal cancer
KRTAP5-1 keratin associated protein 5-1 11p15.5 epidermolytic hyperkeratosis
KRTAP9-3 keratin associated protein 9-3 17q21.2 mixed gonadal dysgenesis
KRTCAP3 keratinocyte associated protein 3 2p23.3 intrahepatic cholangiocarcinoma
KSR1 kinase suppressor of ras 1 17q11.1 pharyngitis, scarlet fever bronchopneumonia
KSS Kearns-Sayre syndrome mitochondria kearns-sayre syndrome
KTCN2 Keratoconus 2 16q22.3-q23.1 keratoconus 2
KTCN3 Keratoconus 3 3p14-q13 keratoconus 3
KTCN4 Keratoconus 4 2p24 keratoconus keratoconus 4
KTCN5 Keratoconus 5 5q14.1-q21.3 keratoconus 5
KTCN6 Keratoconus 6 9q34 keratoconus 6
KTCN7 Keratoconus 7 13q32 keratoconus keratoconus 7
KTCN8 Keratoconus 8 14q24.3 keratoconus 8
KTI12 KTI12 homolog, chromatin associated (S. cerevisiae) 1p32.3 ostertagiasis
KTWS Klippel-Trenaunay-Weber syndrome 8q22.3 klippel-trenaunay syndrome weber syndrome
KWE keratolytic winter erythema (Oudtshoorn skin disease) 8p23-p22 keratolytic winter erythema skin disease
KYNU kynureninase 2q22.2 pellagra, hydroxykynureninuria encephalopathy due to hydroxykynureninuria
KYPSC1 Kyphoscoliosis 1 5p13 kyphoscoliosis 1
L1CAM L1 cell adhesion molecule Xq28 corpus callosum agenesis, hirschsprungs disease, l1 syndrome,
L1RE1 LINE1 retrotransposable element 1 22q11.1-q11.2 tetralogy of fallot
L2HGDH L-2-hydroxyglutarate dehydrogenase 14q21.3 l-2-hydroxyglutaric aciduria, 2-hydroxyglutaric aciduria d-2-hydroxyglutaric aciduria
L3MBTL3 l(3)mbt-like 3 (Drosophila) 6q23.1 gastric dilatation intestinal volvulus
LACRT lacritin 12q13.2 blepharitis
LACTB lactamase, beta 15q22.2 cystic fibrosis, gonorrhea, sinusitis,
LAD1 ladinin 1 1q32.1 linear iga disease, epidermolysis bullosa acquisita, junctional epidermolysis bullosa
LAG5 Leukocyte antigen group 5 "neutropenia, alloimmune neonatal"
LAGE3 L antigen family, member 3 Xq28 shipyard eye
LAIR1 leukocyte-associated immunoglobulin-like receptor 1 19q13.42 chronic active epstein-barr virus infection cytomegalovirus infection
LALBA lactalbumin, alpha- 12q13.11 mammary pagets disease, celiac disease, atopy
LALL Lymphomatous acute lymphoblastic leukemia 9p22-p21 lymphoblastic leukemia acute lymphocytic leukemia
LAMA2 laminin, alpha 2 6q22.33 cartilage-hair hypoplasia, pontocerebellar hypoplasia, walker-warburg syndrome,
LAMA3 laminin, alpha 3 18q11.2 epidermolysis bullosa acquisita, epidermolysis bullosa, junctional epidermolysis bullosa,
LAMA4 laminin, alpha 4 6q21 "cardiomyopathy, dilated, 1w" "cardiomyopathy, dilated, 1jj"
LAMA5 laminin, alpha 5 20q13.33 pontocerebellar hypoplasia
LAMB1 laminin, beta 1 7q31.1 secretory meningioma, diffuse mesangial sclerosis, junctional epidermolysis bullosa,
LAMB2 laminin, beta 2 (laminin S) 3p21.31 nephrotic syndrome, diffuse mesangial sclerosis, nephrosis,
LAMB3 laminin, beta 3 1q32.2 mucous membrane pemphigoid, "amelogenesis imperfecta, type ib", epidermolysis bullosa,
LAMC1 laminin, gamma 1 (formerly LAMB2) 1q25.3 diffuse mesangial sclerosis, mayer-rokitansky-kuster-hauser syndrome, junctional epidermolysis bullosa
LAMC2 laminin, gamma 2 1q25.3 ovarian mucinous neoplasm, mucous membrane pemphigoid, epidermolysis bullosa acquisita,
LAMC3 laminin, gamma 3 9q34.12 fatal familial insomnia "cortical malformations, occipital"
LAMP1 lysosomal-associated membrane protein 1 13q34 chediak-higashi syndrome salla disease
LAMP2 lysosomal-associated membrane protein 2 Xq24 salla disease , danon disease vacuolar myopathy
LAMTOR2 late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 1q22 immunodeficiency due to defect in mapbp-interacting protein
LAMTOR5 late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 1p13.3 non-small cell lung carcinoma, hepatitis b hepatitis
LAMTOR5P1 late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 pseudogene 1 1p31.3 hepatitis b hepatitis
LAP Laryngeal adductor paralysis 6p21.3-p21.2 acute myeloid leukemia, acute t cell leukemia laryngeal adductor paralysis
LAP3 leucine aminopeptidase 3 4p15.32 endometrial carcinoma, trichomoniasis vulvovaginal candidiasis
LAPTM5 lysosomal protein transmembrane 5 1p35.2 pigmented villonodular synovitis villonodular synovitis
LARGE like-glycosyltransferase 22q12.3 "muscular dystrophy-dystroglycanopathy , type a, 7", "muscular dystrophy-dystroglycanopathy , type a, 14", muscular dystrophy-dystroglycanopathy,
LARP7 La ribonucleoprotein domain family, member 7 4q25 "cardiomyopathy, familial hypertrophic 6" alazami syndrome
LARS leucyl-tRNA synthetase 5q32 patellofemoral pain syndrome, "liver failure, infantile, syndromic" conjugate gaze palsy
LARS2 leucyl-tRNA synthetase 2, mitochondrial 3p21.31 nasopharyngitis, perrault syndrome, perrault syndrome 1
LAS1L LAS1-like (S. cerevisiae) Xq12 spinal muscular atrophy with respiratory distress type 2
LASP1 LIM and SH3 protein 1 17q12 colorectal cancer, breast cancer b-cell lymphomas
LAT2 linker for activation of T cells family, member 2 7q11.23 williams-beuren syndrome wolff-parkinson-white syndrome
LATS1 large tumor suppressor kinase 1 6q25.1 mesoblastic nephroma, childhood kidney neoplasm tetraploidy
LATS2 large tumor suppressor kinase 2 13q12.11 intracranial abscess
LAX1 lymphocyte transmembrane adaptor 1 1q32.1 coffin-siris syndrome, chondromalacia, lagophthalmos,
LBP lipopolysaccharide binding protein 20q11.23 sepsis, bacteremia, peritonitis,
LBR lamin B receptor 1q42.12 schizotypal personality disorder, behcets disease, toxic shock syndrome,
LBX1 ladybird homeobox 1 10q24.31 split foot, split hand, osteosarcoma,
LBX2 ladybird homeobox 2 2p13.1 alstrom syndrome
LCA10 lung carcinoma-associated protein 10 Xq28 leber congenital amaurosis, bardet-biedl syndrome 14, senior-loken syndrome,
LCA5 Leber congenital amaurosis 5 6q14.1 leber congenital amaurosis, leber congenital amaurosis 17, leber congenital amaurosis 5,
LCA5L Leber congenital amaurosis 5-like 21q22.2 leber congenital amaurosis leber congenital amaurosis 5
LCA9 Leber congenital amaurosis 9 1p36 leber congenital amaurosis leber congenital amaurosis 9
LCAT lecithin-cholesterol acyltransferase 16q22.1 "amyloidosis, secondary", hypoalphalipoproteinemia, atherosclerosis,
LCE1C late cornified envelope 1C 1q21.3 psoriatic arthritis
LCE2B late cornified envelope 2B 1q21.3 irritant dermatitis
LCE3A late cornified envelope 3A 1q21.3 atopic dermatitis irritant dermatitis
LCE3B late cornified envelope 3B 1q21.3 psoriatic arthritis, allergic contact dermatitis contact dermatitis
LCE3C late cornified envelope 3C 1q21.3 psoriatic arthritis, allergic contact dermatitis contact dermatitis
LCE5A late cornified envelope 5A 1q21.3 irritant dermatitis
LCK lymphocyte-specific protein tyrosine kinase 1p35.1 immunodeficiency 22
LCLAT1 lysocardiolipin acyltransferase 1 2p23.1 barth syndrome
LCMT2 leucine carboxyl methyltransferase 2 15q15.3 multiple chemical sensitivity tracheitis
LCN1 lipocalin 1 9q34.3 pre-eclampsia, stromal keratitis, morbid obesity,
LCN2 lipocalin 2 9q34.11 pancreatic cancer, insulin resistance renovascular hypertension
LCN9 lipocalin 9 9q34.3 tick infestation
LCO liver cancer oncogene 2q14-q21 hepatocellular carcinoma
LCORL ligand dependent nuclear receptor corepressor-like 4p15.31 croup
LCP1 lymphocyte cytosolic protein 1 (L-plastin) 13q14.13 chromosome 13q deletion
LCR-OPSIN opsin locus control region blue cone monochromacy
LCRB locus control region, beta 11p15.5 "thalassemia, hispanic gamma-delta-beta"
LCS1 lymphedema-cholestasis syndrome 1 15q aagenaes syndrome
LCT lactase 2q21.3 lactose intolerance, giardiasis, intestinal disease
LDB1 LIM domain binding 1 10q24.32 nail-patella syndrome
LDB3 LIM domain binding 3 10q23.2 coronary aneurysm, intussusception, "myopathy, myofibrillar, 4",
LDHA lactate dehydrogenase A 11p15.1 malignant germ cell tumor, fanconi bickel syndrome, ovarian serous cystadenocarcinoma,
LDHB lactate dehydrogenase B 12p12.1 lactate dehydrogenase b deficiency
LDLR low density lipoprotein receptor 19p13.2 coronary artery disease, familial hypercholesterolemia, chronic progressive external ophthalmoplegia,
LDLRAP1 low density lipoprotein receptor adaptor protein 1 1p36.11 familial hypercholesterolemia, hypercholesterolemia, dysequilibrium syndrome,
LDOC1 leucine zipper, down-regulated in cancer 1 Xq27.1 breast cancer
LEAP2 liver expressed antimicrobial peptide 2 5q31.1 coccidiosis
LECD Corneal dystrophy, Lisch epithelial Xp22.3 "corneal dystrophy, lisch epithelial"
LECT1 leukocyte cell derived chemotaxin 1 13q14.3 myeloma, multiple myeloma, aortic valve disease
LECT2 leukocyte cell-derived chemotaxin 2 5q31.1 hepatocellular carcinoma rheumatoid arthritis
LEF1 lymphoid enhancer-binding factor 1 4q25 colorectal cancer, prostate cancer, acute myeloid leukemia,
LEFTY1 left-right determination factor 1 1q42.12 ivemark syndrome
LEFTY2 left-right determination factor 2 1q42.12 pregnancy loss, proteus syndrome, infertility,
LELP1 late cornified envelope-like proline-rich 1 1q21.3 esophageal squamous cell carcinoma epidermolytic hyperkeratosis
LEMD3 LEM domain containing 3 12q14.3 melorheostosis, 12q14 microdeletion syndrome, osteopoikilosis,
LEP leptin 7q32.1 pre-eclampsia, type 2 diabetes mellitus, choriocarcinoma,
LEPQTL1 Leptin, serum levels of 2p21 type 2 diabetes mellitus, congenital generalized lipodystrophy, end stage renal failure,
LEPR leptin receptor 1p31.3 pre-eclampsia, obesity, leptin deficiency,
LEPRE1 leucine proline-enriched proteoglycan (leprecan) 1 1p34.2 "osteogenesis imperfecta, type ii", dentinogenesis imperfecta, osteogenesis imperfecta,
LEPREL1 leprecan-like 1 3q28 breast cancer, liposarcoma, myxoid liposarcoma,
LEPREL4 leprecan-like 4 17q21.2 cystitis
LEPROT leptin receptor overlapping transcript 1p31.3 acute promyelocytic leukemia obesity
LETM1 leucine zipper-EF-hand containing transmembrane protein 1 4p16.3 wolf-hirschhorn syndrome
LETMD1 LETM1 domain containing 1 12q13.12 cervical cancer
LFNG LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase 7p22.3 spondylocostal dysostosis, dysostosis, spondylocostal dysostosis 1,
LFS3 Li-Fraumeni syndrome 3 1q23 li-fraumeni syndrome 3
LGALS1 lectin, galactoside-binding, soluble, 1 22q13.1 amyotrophic lateral sclerosis, fucosidosis, osteosarcoma,
LGALS2 lectin, galactoside-binding, soluble, 2 22q13.1 myocardial infarction coronary artery disease
LGALS3 lectin, galactoside-binding, soluble, 3 14q22.3 pilocytic astrocytoma, encephalitis, astrocytoma,
LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 17q25.3 henoch-schoenlein purpura, strongyloidiasis ostertagiasis
LGALS4 lectin, galactoside-binding, soluble, 4 19q13.2 colorectal cancer, colon adenocarcinoma measles
LGALS7 lectin, galactoside-binding, soluble, 7 19q13.2 esophageal squamous cell carcinoma bladder squamous cell carcinoma
LGALS8 lectin, galactoside-binding, soluble, 8 1q43 prostatic hypertrophy cholesteatoma
LGALS9 lectin, galactoside-binding, soluble, 9 17q11.2 pneumococcal meningitis
LGI1 leucine-rich, glioma inactivated 1 10q23.33 benign epilepsy with centrotemporal spikes, limbic encephalitis, temporal lobe epilepsy,
LGMD1D limb girdle muscular dystrophy 1D (autosomal dominant) 7q "cardiomyopathy, dilated, 1f and limb-girdle muscular dystrophy type 1d"
LGMD1G limb girdle muscular dystrophy 1G (autosomal dominant) 4q21 limb-girdle muscular dystrophy type 1g
LGMD1H limb girdle muscular dystrophy 1H (autosomal dominant) 3p25.1-p23 limb-girdle muscular dystrophy type 1h
LGR4 leucine-rich repeat containing G protein-coupled receptor 4 11p14.1 "bone mineral density, low"
LGR6 leucine-rich repeat containing G protein-coupled receptor 6 1q32.1 ovarian cystadenoma myxedema
LGSN lengsin, lens protein with glutamine synthetase domain 6q12 mucopolysaccharidosis iv
LHB luteinizing hormone beta polypeptide 19q13.33 asperger syndrome, frozen shoulder, familial prostate cancer,
LHCGR luteinizing hormone/choriogonadotropin receptor 2p16.3 adenoma, hypogonadism, ovarian epithelial cancer,
LHFP lipoma HMGIC fusion partner 13q14.11 chondroma lipoma
LHFPL5 lipoma HMGIC fusion partner-like 5 6p21.31 "deafness, autosomal recessive 76", lipoma, vitreous detachment,
LHX1 LIM homeobox 1 17q12 nephroblastoma, mayer-rokitansky-kuster-hauser syndrome, classic mayer-rokitansky-k??ster-hauser syndrome,
LHX2 LIM homeobox 2 9q33.3 schizencephaly
LHX3 LIM homeobox 3 9q34.3 septo-optic dysplasia, borjeson-forssman-lehmann syndrome, thyrotoxicosis,
LHX4 LIM homeobox 4 1q25.2 borjeson-forssman-lehmann syndrome, pituitary hypoplasia, isolated growth hormone deficiency,
LHX5 LIM homeobox 5 12q24.13 keratosis follicularis
LHX8 LIM homeobox 8 1p31.1 cleft palate odontoma
LHX9 LIM homeobox 9 1q31.3 frasier syndrome
LI5 Lamellar ichthyosis 5 autosomal recessive congenital ichthyosis
LIAS lipoic acid synthetase 4p14 pyruvate dehydrogenase lipoic acid synthetase deficiency
LIF leukemia inhibitory factor 22q12.2 leukemia, pregnancy loss, malaria,
LIFR leukemia inhibitory factor receptor alpha 5p13.1 leukemia, adenoma, cerebral meningioma,
LIG1 ligase I, DNA, ATP-dependent 19q13.33 bloom syndrome dna ligase i deficiency
LIG3 ligase III, DNA, ATP-dependent 17q12 bloom syndrome
LIG4 ligase IV, DNA, ATP-dependent 13q33.3 breast cancer, multiple myeloma, primary immunodeficiency disease,
LILRA3 leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 19q13.42 ascariasis trichuriasis
LILRA4 leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 19q13.42 blastic plasmacytoid dendritic cell
LILRB1 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 19q13.42 pre-eclampsia cytomegalovirus infection
LIM2 lens intrinsic membrane protein 2, 19kDa 19q13.41 "cataract 1, multiple types", cataract, cataract 19
LIMK1 LIM domain kinase 1 7q11.23 williams-beuren syndrome, intracranial aneurysm williams syndrome
LIMS1 LIM and senescent cell antigen-like domains 1 2q12.3 atrioventricular septal defect ebstein anomaly
LIN28A lin-28 homolog A (C. elegans) 1p36.11 extragonadal germ cell tumor embryonal tumor with multilayered rosettes
LIN28B lin-28 homolog B (C. elegans) 6q16.3 neuroblastoma, central precocious puberty idiopathic central precocious puberty
LIN37 lin-37 homolog (C. elegans) 19q13.12 central pontine myelinolysis hemoglobin e disease
LIN7A lin-7 homolog A (C. elegans) 12q21.31 pulmonary aspergilloma
LIN7C lin-7 homolog C (C. elegans) 11p14.1 mood disorder
LINC00035 long intergenic non-protein coding RNA 35 7q11.23 williams-beuren syndrome
LINC00162 long intergenic non-protein coding RNA 162 21q22.3 narcolepsy
LINC00163 long intergenic non-protein coding RNA 163 21q22.3 narcolepsy
LINC00165 long intergenic non-protein coding RNA 165 21q22.3 narcolepsy
LINC00208 long intergenic non-protein coding RNA 208 8p23.1 keratolytic winter erythema
LINC00261 long intergenic non-protein coding RNA 261 20p11.21 hepatocellular carcinoma
LINC00529 long intergenic non-protein coding RNA 529 8p23.1 keratolytic winter erythema
LINC00543 long intergenic non-protein coding RNA 543 13q12.2 intrahepatic cholangiocarcinoma
LINC00581 long intergenic non-protein coding RNA 581 6p22.3 west syndrome
LINC00663 long intergenic non-protein coding RNA 663 19p13.11 papillary thyroid carcinoma
LINC01090 long intergenic non-protein coding RNA 1090 2q32.1 post-traumatic stress disorder
LINC01114 long intergenic non-protein coding RNA 1114 2q12.1 pancreatic cancer
LINC01122 long intergenic non-protein coding RNA 1122 2p16.1 cannabis dependence
LINC01152 long intergenic non-protein coding RNA 1152 17q24.3 campomelic dysplasia
LINC01194 long intergenic non-protein coding RNA 1194 5p15.2 pineocytoma
LINS lines homolog (Drosophila) 15q26.3 lobular neoplasia, "mental retardation, autosomal recessive 43" theileriasis
LIPA lipase A, lysosomal acid, cholesterol esterase 10q23.31 asphyxiating thoracic dystrophy, blepharitis, lipid storage disease,
LIPC lipase, hepatic 15q21.3 "diabetes mellitus, noninsulin-dependent", hypoalphalipoproteinemia, atherosclerosis,
LIPE lipase, hormone-sensitive 19q13.2 obesity familial combined hyperlipidemia
LIPF lipase, gastric 10q23.31 wolman disease, cholesteryl ester storage disease, cholesterol ester storage disease
LIPG lipase, endothelial 18q21.1 hyperalphalipoproteinemia
LIPH lipase, member H 3q27.2 "diabetes mellitus, noninsulin-dependent", hypotrichosis simplex, monilethrix,
LIPI lipase, member I 21q11.2 hypertriglyceridemia
LIPN lipase, family member N 10q23.31 "ichthyosis, congenital, autosomal recessive 1" "ichthyosis, congenital, autosomal recessive 8"
LIPT1 lipoyltransferase 1 2q11.2 leigh syndrome with leukodystrophy lipoyl transferase 1 deficiency
LITAF lipopolysaccharide-induced TNF factor 16p13.13 orchitis, charcot-marie-tooth neuropathy type 1 , charcot-marie-tooth disease type 1,
LKMCD Leukoencephalopathy with metaphyseal chondrodysplasia Xq25-q27 leukoencephalopathy with metaphyseal chondrodysplasia
LMAN1 lectin, mannose-binding, 1 18q21.32 factor viii deficiency combined factor v and viii deficiency
LMBR1 limb development membrane protein 1 7q36.3 cblf, polydactyly, syndactyly,
LMBRD1 LMBR1 domain containing 1 6q13 hepatitis, megaloblastic anemia, methylmalonic aciduria and homocystinuria type cblf,
LMF1 lipase maturation factor 1 16p13.3 lipase deficiency combined "hyperlipoproteinemia, type ib"
LMLN leishmanolysin-like (metallopeptidase M8 family) 3q29 leishmaniasis, congenital nystagmus esotropia
LMNA lamin A/C 1q22 gauchers disease, ovarian cystadenoma, "familial isolated arrhythmogenic ventricular dysplasia, biventricular form",
LMNB1 lamin B1 5q23.2 leukodystrophy, progressive muscular atrophy, progeria,
LMNB2 lamin B2 19p13.3 lipodystrophy, pelger-huet anomaly, reynolds syndrome
LMO1 LIM domain only 1 (rhombotin 1) 11p15.4 t-cell leukemia, cd3epsilon deficiency, acute t cell leukemia
LMO2 LIM domain only 2 (rhombotin-like 1) 11p13 lymphoblastic leukemia, norrie disease , acute t cell leukemia
LMO4 LIM domain only 4 1p22.3 acute t cell leukemia
LMO7 LIM domain 7 13q22.2 townes-brocks syndrome
LMOD1 leiomodin 1 (smooth muscle) 1q32.1 steroid-induced glaucoma, graves disease, follicular thyroid carcinoma
LMPH1B Lymphedema, hereditary, IB 6q16.2-q22.1 "lymphedema, hereditary, ib"
LMX1A LIM homeobox transcription factor 1, alpha 1q23.3 mucinous cystadenocarcinoma ovarian mucinous cystadenocarcinoma
LMX1B LIM homeobox transcription factor 1, beta 9q33.3 meier-gorlin syndrome, nail-patella syndrome genitopatellar syndrome
LNCR1 Lung cancer 1 6q23-q25 lung cancer lung cancer susceptibility
LNCR3 Lung cancer susceptibility 3 5p15.33 lung cancer, lung cancer susceptibility lung cancer susceptibility 3
LNCR4 Lung cancer susceptibility 4 6p21.33 lung cancer, lung cancer susceptibility lung cancer susceptibility 4
LNCR5 Lung cancer susceptibility 5 3q28 lung cancer, lung cancer susceptibility lung cancer susceptibility 5
LNPEP leucyl/cystinyl aminopeptidase 5q15 epithelioid trophoblastic tumor, pineoblastoma, gestational diabetes
LNX1 ligand of numb-protein X 1, E3 ubiquitin protein ligase 4q12 autoimmune enteropathy "usher syndrome, type 1c"
LNX2 ligand of numb-protein X 2 13q12.2 q fever
LOAS Leber optic atrophy, susceptibility to Xp11 leber hereditary optic neuropathy
LOC100128226 hypothetic protein 11q23.1 alzheimers disease
LOC100128265 uncharacterized LOC100128265 Xq27.3 smallpox
LOC100128356 protein transactivated by hepatitis B virus E antigen 10p15.1 hepatitis b hepatitis b virus infection
LOC100132612 uncharacterized LOC100132612 14q32.2 smallpox
LOC100216355 methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria pseudogene 11p13 cbld
LOC100216356 methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria pseudogene Xq13.3 cbld
LOC100288628 SUMO1/sentrin specific peptidase 6 pseudogene 6p11.2 eosinophilic esophagitis
LOC100288978 myeloma overexpressed 2 pseudogene 14q22.1 myeloma
LOC100291666 serologically defined breast cancer antigen NY-BR-40 breast cancer
LOC100294362 uncharacterized LOC100294362 17q25.3 moyamoya disease
LOC100420551 synovial sarcoma, X breakpoint 5 pseudogene Xp11.23 synovial sarcoma
LOC100421207 Fanconi anemia, complementation group L pseudogene "fanconi anemia, complementation group l"
LOC100421404 retinitis pigmentosa 9 (autosomal dominant) pseudogene retinitis pigmentosa 9
LOC100422637 myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) pseudogene 4p16.1 influenza
LOC100422638 myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) pseudogene 4p16.1 influenza
LOC100422639 myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) pseudogene 4p16.1 influenza
LOC100500719 Hermansky-Pudlak syndrome 1 pseudogene 22q12.3 hermansky-pudlak syndrome 1
LOC100506431 B2 RNA 6p25-p24 non-small cell lung carcinoma
LOC100506634 hepatocellular carcinoma-associated antigen HCA25a 19q13.43 hepatocellular carcinoma
LOC100507346 uncharacterized LOC100507346 pulmonary function
LOC100508227 uncharacterized LOC100508227 3q27.3 drug-induced liver injury due to flucloxacillin
LOC100509457 HLA class II histocompatibility antigen, DQ alpha 1 chain-like systemic lupus erythematosus
LOC100533717 breast cancer anti-estrogen resistance 1 pseudogene 15q11.1 breast cancer
LOC100533718 breast cancer anti-estrogen resistance 1 pseudogene 15q11.2 breast cancer
LOC100533757 Sjogren syndrome antigen B (autoantigen La) pseudogene 12q12 sjogrens syndrome
LOC101060835 HLA class II histocompatibility antigen, DQ beta 1 chain-like systemic lupus erythematosus
LOC102724250 neuroblastoma breakpoint family member 1-like neuroblastoma
LOC152586 glycosyltransferase 54 domain-containing protein 4q31.1 idiopathic pulmonary fibrosis
LOC152845 pleiomorphic adenoma gene-like 2 pseudogene 4q21.23 adenoma
LOC285692 uncharacterized LOC285692 5p15.2 hypersomnia
LOC389465 Sjogren syndrome antigen B pseudogene 7p21.3 sjogrens syndrome
LOC440792 proline dehydrogenase (oxidase) 1 pseudogene 22q11.21 hyperprolinemia
LOC441996 aconitase 2, mitochondrial pseudogene 22q12.3 smallpox
LOC442427 putative UPF0607 protein ENSP00000381418-like 9q21.32 ulcerative colitis
LOC619539 lentiginosis, inherited patterned 4q21.1-q22.3 familial generalized lentiginosis
LOC619540 keratosis palmoplantaris papulosa 15q22-q24 keratosis palmoplantaris papulosa
LOC641589 neuroblastoma breakpoint family, member 19-like 1q21.1 neuroblastoma
LOC643387 TAR DNA binding protein pseudogene 2q37.3 frontotemporal lobar degeneration with ubiquitin-positive inclusions alzheimers disease
LOC644462 amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 2 pseudogene 1p33 amyotrophic lateral sclerosis
LOC644681 synovial sarcoma, X breakpoint 2 interacting protein pseudogene 3q13.11 synovial sarcoma
LOC645266 pre-mRNA processing factor 4B pseudogene 9q32 crohns disease
LOC646506 lysosomal-associated membrane protein 1 pseudogene Xp21.1 alzheimers disease
LOC647132 DEAH (Asp-Glu-Ala-His) box polypeptide 29 pseudogene 1q31.1 smallpox
LOC647275 purine nucleoside phosphorylase pseudogene 2p12 purine nucleoside phosphorylase deficiency
LOC653541 double homeobox, 4-like 4q35.2 facioscapulohumeral muscular dystrophy
LOC653588 Sjogren syndrome antigen B (autoantigen La) pseudogene Xq11.1 sjogrens syndrome
LOC728989 phosphodiesterase 4D interacting protein pseudogene 1q21.1 hiv-1
LOC729968 uncharacterized LOC729968 2q36.3 smallpox
LONP1 lon peptidase 1, mitochondrial 19p13.3 glossopharyngeal neuralgia merrf syndrome
LONRF2 LON peptidase N-terminal domain and ring finger 2 2q11.2 neuroblastoma
LOR loricrin 1q21.3 olmsted syndrome , porokeratosis, ichthyosis vulgaris,
LOX lysyl oxidase 5q23.2 amyotrophic lateral sclerosis, pancreatic cancer, bronchogenic carcinoma,
LOXHD1 lipoxygenase homology domains 1 18q21.1 "deafness, autosomal recessive 76", fuchs endothelial dystrophy, "deafness, autosomal recessive 77"
LOXL1 lysyl oxidase-like 1 15q24.1 primary angle-closure glaucoma, open-angle glaucoma, exfoliation syndrome
LPA lipoprotein, Lp(a) 6q26 myocardial infarction, coronary artery disease, "amyloidosis, secondary",
LPAL2 lipoprotein, Lp(a)-like 2, pseudogene 6q25.3 atherosclerosis
LPAR1 lysophosphatidic acid receptor 1 9q31.3 neuroblastoma
LPAR2 lysophosphatidic acid receptor 2 19p13.11 colon cancer, ovarian cancer secretory diarrhea
LPAR6 lysophosphatidic acid receptor 6 13q14.2 hypotrichosis, hypotrichosis simplex, "woolly hair, autosomal dominant",
LPCAT3 lysophosphatidylcholine acyltransferase 3 12p13.31 brachydactyly-syndactyly syndrome
LPHN1 latrophilin 1 19p13.12 dermatophytosis
LPHN3 latrophilin 3 4q13.1 sialuria
LPIN1 lipin 1 2p25.1 lipodystrophy "myoglobinuria, acute recurrent, autosomal recessive"
LPIN2 lipin 2 18p11.31 insulin resistance, lipodystrophy, hypertriglyceridemia,
LPIN3 lipin 3 20q12 insulin resistance, lipodystrophy hypertriglyceridemia
LPL lipoprotein lipase 8p21.3 carotid intimal medial thickness, coronary artery disease, obesity,
LPO lactoperoxidase 17q22 gingival disease
LPP LIM domain containing preferred translocation partner in lipoma 3q27.3 acute myeloid leukemia, chondroma, lipoma,
LPRS Leprosy, susceptibility to 1 10p13 "leprosy, paucibacillary type"
LPRS6 Leprosy, susceptiblity to, 6 13q14.11 leprosy "leprosy, susceptiblity to, 6"
LPSA Oncogene liposarcoma (DNA segment, single copy, expressed, probes 19p13.2-q13.3 liposarcoma
LPXN leupaxin 11q12.1 familial hypercholesterolemia chronic pyelonephritis
LRAT lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) 4q31.3 leber congenital amaurosis, leber congenital amaurosis 17, "retinal dystrophy, early-onset, severe",
LRBA LPS-responsive vesicle trafficking, beach and anchor containing 4q31.3 "immunodeficiency, common variable, 9", common variable immunodeficiency "immunodeficiency, common variable, 8, with autoimmunity"
LRCH1 leucine-rich repeats and calponin homology (CH) domain containing 1 13q14.13 osteoarthritis
LRG1 leucine-rich alpha-2-glycoprotein 1 19p13.3 normal pressure hydrocephalus
LRIG2 leucine-rich repeats and immunoglobulin-like domains 2 1p13.2 urofacial syndrome, urofacial syndrome 1 , urofacial syndrome 2
LRIT3 leucine-rich repeat, immunoglobulin-like and transmembrane domains 3 4q25 "night blindness, congenital stationary , 1d, autosomal recessive", blindness, night blindness,
LRMP lymphoid-restricted membrane protein 12p12.1 lung adenoma
LRP1 low density lipoprotein receptor-related protein 1 12q13.3 alzheimers disease, compartment syndrome liposarcoma
LRP12 low density lipoprotein receptor-related protein 12 8q22.3 familial cold autoinflammatory syndrome familial cold autoinflammatory syndrome 2
LRP2 low density lipoprotein receptor-related protein 2 2q31.1 nephropathic cystinosis, cystinosis, nephritis,
LRP4 low density lipoprotein receptor-related protein 4 11p11.2 "myasthenic syndrome, congenital, with pre- and postsynaptic defects", sost-related sclerosing bone dysplasia, syndactyly,
LRP5 low density lipoprotein receptor-related protein 5 11q13.2 hyperostosis, osteoporosis, polycystic liver disease,
LRP6 low density lipoprotein receptor-related protein 6 12p13.2 coronary artery disease, artery disease, sost-related sclerosing bone dysplasia
LRP8 low density lipoprotein receptor-related protein 8, apolipoprotein e receptor 1p32.3 myocardial infarction, lissencephaly with cerebellar hypoplasia, lissencephaly,
LRPAP1 low density lipoprotein receptor-related protein associated protein 1 4p16.3 myopia, "myopia, high, with cataract and vitreoretinal degeneration" "myopia 23, autosomal recessive"
LRPPRC leucine-rich pentatricopeptide repeat containing 2p21 "leigh syndrome, french canadian type"
LRRC16A leucine rich repeat containing 16A 6p22.2 acute urate nephropathy
LRRC26 leucine rich repeat containing 26 9q34.3 intrahepatic cholangiocarcinoma
LRRC4C leucine rich repeat containing 4C 11p12 extragonadal seminoma
LRRC6 leucine rich repeat containing 6 8q24.22 "ciliary dyskinesia, primary, 19" primary ciliary dyskinesia19: lrrc6-related primary ciliary dyskinesia
LRRC8A leucine rich repeat containing 8 family, member A 9q34.11 agammaglobulinemia 3 , agammaglobulinemia agammaglobulinemia 5
LRRFIP2 leucine rich repeat (in FLII) interacting protein 2 3p22.2 "colorectal cancer, hereditary nonpolyposis, type 1"
LRRK1 leucine-rich repeat kinase 1 15q26.3 parkinsons disease
LRRK2 leucine-rich repeat kinase 2 12q12 parkinsons disease, rheumatoid arthritis, essential tremor,
LRRN1 leucine rich repeat neuronal 1 3p26.2 atrioventricular septal defect
LRRN3 leucine rich repeat neuronal 3 7q31.1 autism spectrum disorder
LRRTM1 leucine rich repeat transmembrane neuronal 1 2p12 autism spectrum disorder
LRRTM3 leucine rich repeat transmembrane neuronal 3 10q21.3 autism spectrum disorder
LRSAM1 leucine rich repeat and sterile alpha motif containing 1 9q33.3 charcot-marie-tooth neuropathy type 2, malaria, mixed malaria,
LRSL Larsen-like syndrome 6p25 larsen syndrome larsen-like syndrome
LRTOMT leucine rich transmembrane and O-methyltransferase domain containing 11q13.4 "deafness, autosomal recessive 76", nonsyndromic deafness, autosomal recessive nonsyndromic deafness,
LSG1 large 60S subunit nuclear export GTPase 1 3q29 tick infestation
LSM1 LSM1, U6 small nuclear RNA associated 8p11.23 breast cancer lung cancer
LSM2 LSM2 homolog, U6 small nuclear RNA associated (S. cerevisiae) 6p21.33 rheumatic disease connective tissue disease
LSP1 lymphocyte-specific protein 1 11p15.5 breast cancer susceptibility
LSR lipolysis stimulated lipoprotein receptor 19q13.12 prosopagnosia, visual agnosia radiculopathy
LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 21q22.3 dependent personality disorder, candida glabrata, spondylolisthesis
LST1 leukocyte specific transcript 1 6p21.33 "hyperbilirubinemia, rotor type, digenic"
LTA lymphotoxin alpha 6p21.33 monoclonal gammopathy of uncertain significance, myocardial infarction, shigellosis,
LTB4R leukotriene B4 receptor 14q12 pancreatic cancer
LTBP1 latent transforming growth factor beta binding protein 1 2p22.3 geleophysic dysplasia
LTBP2 latent transforming growth factor beta binding protein 2 14q24.3 megalocornea - spherophakia - secondary glaucoma, "weill-marchesani syndrome 3, recessive", "tooth agenesis, selective, 6",
LTBP3 latent transforming growth factor beta binding protein 3 11q13.1 "tooth agenesis, selective, 1, with or without orofacial cleft", megalocornea - spherophakia - secondary glaucoma, "weill-marchesani syndrome 3, recessive",
LTBP4 latent transforming growth factor beta binding protein 4 19q13.2 "cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities", "cutis laxa, autosomal recessive, type ic", duchenne muscular dystrophy
LTC4S leukotriene C4 synthase 5q35.3 asthma, henoch-schoenlein purpura, leukotriene c4 synthase deficiency ,
LTF lactotransferrin 3p21.31 radiation proctitis, polyarteritis nodosa, diarrhea,
LTV1 LTV1 ribosome biogenesis factor 6q24.2 spinal cord disease strongyloidiasis
LUCAT1 lung cancer associated transcript 1 (non-protein coding) 5q14.3 lung cancer
LUM lumican 12q21.33 posterior amorphous corneal dystrophy
LUZP2 leucine zipper protein 2 11p14.3 aniridia
LUZP4 leucine zipper protein 4 Xq23 parapsoriasis
LVNC2 noncompaction of left ventricular myocardium, familial isolated, autosomal dominant 2 11p15 left ventricular noncompaction 2
LVSKS Levy-Shanske syndrome 15q26-qter levy-shanske syndrome
LXN latexin 3q25.32 atypical autism, listeriosis endocervicitis
LY6E lymphocyte antigen 6 complex, locus E 8q24.3 acute promyelocytic leukemia subvalvular aortic stenosis
LY6G6D lymphocyte antigen 6 complex, locus G6D 6p21.33 childhood leukemia
LY75 lymphocyte antigen 75 2q24.2 thymic epithelial neoplasm lipid pneumonia
LY9 lymphocyte antigen 9 1q23.3 dysgammaglobulinemia
LY96 lymphocyte antigen 96 8q21.11 neonatal abstinence syndrome, botulism, wound botulism
LYL1 lymphoblastic leukemia associated hematopoiesis regulator 1 19p13.2 acute myeloid leukemia, lymphoblastic leukemia, leukemia,
LYN v-yes-1 Yamaguchi sarcoma viral related oncogene homolog 8q12.1 sarcoma chorea-acanthocytosis
LYNX1 Ly6/neurotoxin 1 8q24.3 psoriasis
LYPD1 LY6/PLAUR domain containing 1 2q21.2 bannayan-riley-ruvalcaba syndrome, ruvalcaba syndrome cowden disease
LYPD3 LY6/PLAUR domain containing 3 19q13.31 esophageal squamous cell carcinoma
LYPLA2P1 lysophospholipase II pseudogene 1 6p21.32 systemic lupus erythematosus
LYRM4 LYR motif containing 4 6p25.1 combined oxidative phosphorylation deficiency 19
LYRM7 LYR motif containing 7 5q23.3 "mitochondrial complex iii deficiency, nuclear type 6" "mitochondrial complex iii deficiency, nuclear type 8"
LYST lysosomal trafficking regulator 1q42.3 platelet storage pool deficiency, chediak-higashi syndrome, exfoliation syndrome,
LYVE1 lymphatic vessel endothelial hyaluronan receptor 1 11p15.4 kaposis sarcoma, prostate cancer, complete androgen insensitivity syndrome,
LYZ lysozyme 12q15 "amyloidosis, hereditary renal", "amyloidosis, 3 or more types", "amyloidosis, renal",
LZTFL1 leucine zipper transcription factor-like 1 3p21.31 "bardet-biedl syndrome 1, modifier of", bardet-biedl syndrome 15, bardet-biedl syndrome 3 ,
LZTR1 leucine-zipper-like transcription regulator 1 22q11.21 gliosarcoma, giant cell glioblastoma, digeorge syndrome,
LZTS1 leucine zipper, putative tumor suppressor 1 8p21.3 esophageal squamous cell carcinoma, esophageal cancer collecting duct carcinoma
MAA microphthalmia or anophthalmia and associated anomalies X lenz microphthalmia syndrome
MAB21L2 mab-21-like 2 (C. elegans) 4q31.3 "microphthalmia, syndromic 14"
MACC1 metastasis associated in colon cancer 1 7p21.1 colon cancer
MACROD2 MACRO domain containing 2 20p12.1 kabuki syndrome
MACST Macrostomia 1p34-p32 macrostomia
MAD1L1 MAD1 mitotic arrest deficient-like 1 (yeast) 7p22.3 "prostate cancer, somatic" "lymphoma, somatic"
MADCAM1 mucosal vascular addressin cell adhesion molecule 1 19p13.3 cholera, malt lymphoma primary sclerosing cholangitis
MADD MAP-kinase activating death domain 11p11.2 diastolic heart failure, insulinoma, glucagonoma,
MAEA macrophage erythroblast attacher 4p16.3 lung cancer
MAF v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog 16q23.2 adenofibroma, placental choriocarcinoma, cerulean cataract,
MAFA v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A 8q24.3 hyperglycemia, monogenic diabetes fibrosarcoma
MAFB v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B 20q12 monoclonal gammopathy of uncertain significance, posterior polar cataract, fibrosarcoma
MAFD1 major affective disorder 1 18p major affective disorder 1
MAFD2 major affective disorder 2 Xq27-q28 duchenne muscular dystrophy major affective disorder 2
MAFD3 Major affective disorder 3, early onset 21q22.13 "major affective disorder 3, early onset"
MAFD4 Major affective disorder 4 16p12 major affective disorder 4
MAFD5 Major affective disorder 5 2q22-q24 major affective disorder 5
MAFD6 Major affective disorder 6 6q23-q24 major affective disorder 6
MAFD8 Major affective disorder-8, susceptibility to 10q21 major affective disorder-8
MAFD9 Major affective disorder-9, susceptibility to 12p13.3 major affective disorder-9
MAFF v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F 22q13.1 placental choriocarcinoma, fibrosarcoma ulnar neuropathy
MAFG v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G 17q25.3 fibrosarcoma
MAFK v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K 7p22.3 fibrosarcoma
MAG myelin associated glycoprotein 19q13.12 monoclonal gammopathy of uncertain significance, amyotrophic lateral sclerosis, schizophrenia,
MAGEA1 melanoma antigen family A, 1 (directs expression of antigen MZ2-E) Xq28 hepatocellular carcinoma, colorectal cancer, melanoma
MAGEA10 melanoma antigen family A, 10 Xq28 stomach cancer, melanoma intrahepatic cholangiocarcinoma
MAGEA10-MAGEA5 MAGEA10-MAGEA5 readthrough Xq28 melanoma
MAGEA11 melanoma antigen family A, 11 Xq28 melanoma
MAGEA12 melanoma antigen family A, 12 Xq28 oral squamous cell carcinoma
MAGEA2 melanoma antigen family A, 2 Xq28 oral squamous cell carcinoma
MAGEA3 melanoma antigen family A, 3 Xq28 hepatocellular carcinoma, melanoma, lung cancer,
MAGEA4 melanoma antigen family A, 4 Xq28 hepatocellular carcinoma, pancreatic cancer, melanoma,
MAGEA5 melanoma antigen family A, 5 Xq28 melanoma oral squamous cell carcinoma
MAGEA6 melanoma antigen family A, 6 Xq28 melanoma terminal osseous dysplasia
MAGEA9 melanoma antigen family A, 9 Xq28 melanoma, dyskeratosis congenita, terminal osseous dysplasia
MAGEA9B melanoma antigen family A, 9B Xq28 terminal osseous dysplasia enophthalmos
MAGEB1 melanoma antigen family B, 1 Xp21.2 dosage-sensitive sex reversal
MAGEB10 melanoma antigen family B, 10 Xp21.3 melanoma
MAGEB2 melanoma antigen family B, 2 Xp21.2 melanoma dosage-sensitive sex reversal
MAGEB3 melanoma antigen family B, 3 Xp21.2 melanoma
MAGEB4 melanoma antigen family B, 4 Xp21.2 melanoma
MAGEC1 melanoma antigen family C, 1 Xq27.2 melanoma multiple myeloma
MAGEC2 melanoma antigen family C, 2 Xq27.2 hepatocellular carcinoma brain cancer
MAGEC3 melanoma antigen family C, 3 Xq27.2 hepatocellular carcinoma
MAGED1 melanoma antigen family D, 1 Xp11.22 seborrheic keratosis melanoma
MAGED2 melanoma antigen family D, 2 Xp11.21 hepatocellular carcinoma, breast cancer melanoma
MAGED4B melanoma antigen family D, 4B Xp11.22 oral squamous cell carcinoma malignant glioma
MAGEE1 melanoma antigen family E, 1 Xq13.3 hepatocellular carcinoma melanoma
MAGEE2 melanoma antigen family E, 2 Xq13.3 hepatocellular carcinoma melanoma
MAGEH1 melanoma antigen family H, 1 Xp11.21 melanoma
MAGEL2 MAGE-like 2 15q11.2 angelman syndrome, prader-willi syndrome, obesity,
MAGI2 membrane associated guanylate kinase, WW and PDZ domain containing 2 7q21.11 ohtahara syndrome
MAGT1 magnesium transporter 1 Xq21.1 "mental retardation, x-linked 17/31, microduplication", holt-oram syndrome, tbx5-related holt-oram syndrome
MAK male germ cell-associated kinase 6p24.2 leber congenital amaurosis, retinitis pigmentosa 62 mak-related retinitis pigmentosa
MAL mal, T-cell differentiation protein 2q11.1 metachromatic leukodystrophy , megakaryocytic leukemia primary mediastinal large b-cell lymphoma
MALAT1 metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) 11q13.1 adenocarcinoma, embryonal sarcoma, undifferentiated embryonal sarcoma of the liver
MALL mal, T-cell differentiation protein-like 2q13 skin melanoma
MALT1 mucosa associated lymphoid tissue lymphoma translocation gene 1 18q21.32 edwards syndrome, malt lymphoma, gastric lymphoma,
MAML2 mastermind-like 2 (Drosophila) 11q21 hidradenoma, cervical adenosquamous carcinoma, warthin tumor,
MAMLD1 mastermind-like domain containing 1 Xq28 hypospadias, "hypospadias 2, x-linked" x-linked centronuclear myopathy
MAN1B1 mannosidase, alpha, class 1B, member 1 9q34.3 "mental retardation, autosomal recessive 43", intellectual disability, man1b1-cdg
MAN2A1 mannosidase, alpha, class 2A, member 1 5q21.3 systemic lupus erythematosus congenital disorder of glycosylation type ii
MAN2B1 mannosidase, alpha, class 2B, member 1 19p13.2 beta-mannosidosis, alpha-mannosidosis, "alpha-mannosidosis, adult form",
MANBA mannosidase, beta A, lysosomal 4q24 angiokeratoma, beta-mannosidosis alpha-mannosidosis
MANEA mannosidase, endo-alpha 6q16.1 dracunculiasis
MANEAL mannosidase, endo-alpha-like 1p34.3 duodenum cancer
MANF mesencephalic astrocyte-derived neurotrophic factor 3p21.2 squamous cell carcinoma of the head and neck pancreatic cancer
MAOA monoamine oxidase A Xp11.3 pre-eclampsia, lesch-nyhan syndrome, parkinsons disease,
MAOB monoamine oxidase B Xp11.3 amyotrophic lateral sclerosis, parkinsons disease, schizophrenia,
MAP1B microtubule-associated protein 1B 5q13.2 olivopontocerebellar atrophy, tick infestation werdnig-hoffmann disease
MAP1LC3A microtubule-associated protein 1 light chain 3 alpha 20q11.22 nephropathic cystinosis
MAP1LC3B microtubule-associated protein 1 light chain 3 beta 16q24.2 sporadic pheochromocytoma
MAP2 microtubule-associated protein 2 2q34 gliomatosis cerebri, ischemia, striatonigral degeneration,
MAP2K1 mitogen-activated protein kinase kinase 1 15q22.31 leopard syndrome, cardiofaciocutaneous syndrome, map2k1-related cardiofaciocutaneous syndrome,
MAP2K2 mitogen-activated protein kinase kinase 2 19p13.3 costello syndrome, leopard syndrome, cardiofaciocutaneous syndrome,
MAP2K4P1 mitogen-activated protein kinase kinase 4 pseudogene 1 Xq13.2 gastric adenocarcinoma
MAP2K5 mitogen-activated protein kinase kinase 5 15q23 developmental coordination disorder
MAP2K6 mitogen-activated protein kinase kinase 6 17q24.3 pierre robin sequence
MAP3K1 mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase 5q11.2 breast cancer susceptibility, 46xy sex reversal 3, 46xy sex reversal 6
MAP3K10 mitogen-activated protein kinase kinase kinase 10 19q13.2 neuroblastoma differentiating neuroblastoma
MAP3K7 mitogen-activated protein kinase kinase kinase 7 6q15 hypohidrotic ectodermal dysplasia
MAP3K8 mitogen-activated protein kinase kinase kinase 8 10p11.23 lung cancer "lung cancer, somatic"
MAP6 microtubule-associated protein 6 11q13.5 ebstein anomaly
MAPK1 mitogen-activated protein kinase 1 22q11.22 mesangial proliferative glomerulonephritis, trachoma, breast cancer,
MAPK10 mitogen-activated protein kinase 10 4q21.3 coffin-lowry syndrome, opioid abuse, anhidrosis,
MAPK14 mitogen-activated protein kinase 14 6p21.31 alexander disease influenza
MAPK3 mitogen-activated protein kinase 3 16p11.2 breast cancer, corticobasal degeneration, pleomorphic rhabdomyosarcoma
MAPK4 mitogen-activated protein kinase 4 18q21.1 pulmonary immaturity
MAPK8 mitogen-activated protein kinase 8 10q11.22 diastolic heart failure, frozen shoulder restrictive cardiomyopathy
MAPK8IP1 mitogen-activated protein kinase 8 interacting protein 1 11p11.2 type 2 diabetes mellitus, insulin resistance, "diabetes, type 2",
MAPK8IP2 mitogen-activated protein kinase 8 interacting protein 2 22q13.33 ameloblastic carcinoma
MAPKAP1 mitogen-activated protein kinase associated protein 1 9q33.3 nephrogenic systemic fibrosis, coffin-lowry syndrome, bronchiolitis,
MAPRE1 microtubule-associated protein, RP/EB family, member 1 20q11.21 colorectal cancer pediatric ependymoma
MAPRE1P1 MAPRE1 pseudogene 1 8q24.23 fatty liver disease
MAPRE1P2 MAPRE1 pseudogene 2 4p15.1 alzheimers disease
MAPT microtubule-associated protein tau 17q21.31 learning disability, amyotrophic lateral sclerosis, parkinsons disease,
MARCKSL1 MARCKS-like 1 1p35.1 anencephaly, neural tube defects intermediate charcot-marie-tooth neuropathy
MARCO macrophage receptor with collagenous structure 2q14.2 spondylarthropathy
MARS methionyl-tRNA synthetase 12q13.3 voyeurism, autosomal recessive spastic paraplegia type 70, infantile liver failure syndrome 2,
MARS2 methionyl-tRNA synthetase 2, mitochondrial 2q33.1 "spastic ataxia 3, autosomal recessive"
MARVELD2 MARVEL domain containing 2 5q13.2 "deafness, autosomal recessive 76", "deafness, autosomal recessive 49", dfnb49 nonsyndromic hearing loss and deafness
MAS1LP1 MAS1 oncogene-like pseudogene 1 6p22.1 systemic lupus erythematosus
MASP1 mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) 3q27.3 iga glomerulonephritis, michels syndrome 3mc syndrome 1
MASP2 mannan-binding lectin serine peptidase 2 1p36.22 c1 inhibitor deficiency, rheumatic fever, mannose-binding lectin deficiency
MAST4 microtubule associated serine/threonine kinase family member 4 5q12.3 cystic lymphangioma
MASTL microtubule associated serine/threonine kinase-like 10p12.1 gray platelet syndrome, thrombocytopenia, mastl-related thrombocytopenia 2
MAT1A methionine adenosyltransferase I, alpha 10q23.1 hepatocellular carcinoma, beta-ketothiolase deficiency, ketothiolase deficiency,
MAT2A methionine adenosyltransferase II, alpha 2p11.2 hypermethioninemia glycine n-methyltransferase deficiency
MATK megakaryocyte-associated tyrosine kinase 19p13.3 breast cancer, spondylolisthesis preretinal fibrosis
MATN1 matrilin 1, cartilage matrix protein 1p35.2 relapsing polychondritis, epidermolysis bullosa acquisita tufting enteropathy
MATN3 matrilin 3 2p24.1 skeletal dysplasias, pseudoachondroplasia, multiple epiphyseal dysplasia,
MATR3 matrin 3 5q31.2 amyotrophic lateral sclerosis, myopathy, distal muscular dystrophy,
MAVS mitochondrial antiviral signaling protein 20p13 chikungunya
MAX MYC associated factor X 14q23.3 pheochromocytoma, hereditary paraganglioma-pheochromocytoma syndromes, max-related susceptibility to pheochromocytoma,
MB myoglobin 22q12.3 myocardial infarction, adenosarcoma, neuroleptic malignant syndrome,
MBD1 methyl-CpG binding domain protein 1 18q21.1 autistic disorder, cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus
MBD3 methyl-CpG binding domain protein 3 19p13.3 cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus silver-russell syndrome
MBD3L2 methyl-CpG binding domain protein 3-like 2 19p13.2 germ cell tumors
MBD4 methyl-CpG binding domain protein 4 3q21.3 cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus, angelman syndrome,
MBD5 methyl-CpG binding domain protein 5 2q23.1 exposure keratitis, "mental retardation, autosomal dominant 10", 2q23.1 microdeletion syndrome
MBL1P mannose-binding lectin (protein A) 1, pseudogene 10q22.3 hepatitis b virus infection
MBL2 mannose-binding lectin (protein C) 2, soluble 10q21.1 trachoma, q fever, cryptococcosis,
MBL3P mannose-binding lectin family member 3, pseudogene 10q22.3 coccidioidomycosis, invasive aspergillosis, mannose-binding lectin deficiency
MBNL1 muscleblind-like splicing regulator 1 3q25.1 myotonic dystrophy, myotonic dystrophy type 2, congenital myotonic dystrophy
MBNL3 muscleblind-like splicing regulator 3 Xq26.2 c3 deficiency
MBNP ?Membranous nephropathy, susceptibility to 6p21.3 membranous glomerulonephritis
MBOAT1 membrane bound O-acyltransferase domain containing 1 6p22.3 brachydactyly-syndactyly syndrome
MBP myelin basic protein 18q23 krabbe disease, multiple sclerosis, pelizaeus-merzbacher disease,
MBS1 Moebius syndrome 1 13q12.2 moebius syndrome
MBS2 Moebius syndrome 2 3q21-q22 moebius syndrome, hereditary congenital facial paresis "facial paresis, hereditary congenital, 1"
MBS3 Moebius syndrome 3 10q21.3-q22.1 moebius syndrome hereditary congenital facial paresis
MBTPS1 membrane-bound transcription factor peptidase, site 1 16q23.3 hypoplastic left heart syndrome
MBTPS2 membrane-bound transcription factor peptidase, site 2 Xp22.12 keratosis, olmsted syndrome , malignant fibroxanthoma,
MC1R melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) 16q24.3 melanoma, familial melanoma, congenital nystagmus,
MC2R melanocortin 2 receptor (adrenocorticotropic hormone) 18p11.21 somatoform disorder, 21-hydroxylase deficiency, obesity,
MC3R melanocortin 3 receptor 20q13.2 anorexia nervosa, morbid obesity, obesity,
MC4R melanocortin 4 receptor 18q21.32 acth deficiency, "obesity, late-onset", anorexia nervosa,
MC5R melanocortin 5 receptor 18p11.21 morbid obesity obesity
MCAM melanoma cell adhesion molecule 11q23.3 melanoma, placental site trophoblastic tumor epithelioid trophoblastic tumor
MCAT malonyl CoA:ACP acyltransferase (mitochondrial) 22q13.2 neuronitis vestibular neuronitis
MCC mutated in colorectal cancers 5q22.2 "colorectal cancer, somatic"
MCCC1 methylcrotonoyl-CoA carboxylase 1 (alpha) 3q27.1 biotin deficiency, the organic acidemias: an, organic acidemia,
MCCC2 methylcrotonoyl-CoA carboxylase 2 (beta) 5q13.2 the organic acidemias: an, organic acidemia, 3-methylcrotonyl-coa carboxylase deficiency,
MCDR1 macular dystrophy, retinal, 1 (North Carolina type) 6q14-q16.2 north carolina macular dystrophy
MCDR3 macular dystrophy, retinal 3 5p15.33-p13.1 north carolina macular dystrophy "macular dystrophy, retinal, 3"
MCEE methylmalonyl CoA epimerase 2p13.3 methylmalonic acidemia, mcee-related methylmalonic acidemia methylmalonyl-coa epimerase deficiency
MCF2 MCF.2 cell line derived transforming sequence Xq27.1 aarskog-scott syndrome scott syndrome
MCFD2 multiple coagulation factor deficiency 2 2p21 germ cell tumors, factor viii deficiency, paratyphoid fever,
MCHR1 melanin-concentrating hormone receptor 1 22q13.2 vitiligo
MCI2 Myocardial infarction, susceptiblity to, 2 13q12 myocardial infarction myocardial infarction 2
MCKD1 medullary cystic kidney disease 1 (autosomal dominant) 1q21 kidney disease medullary cystic kidney disease type 1
MCKD2 medullary cystic kidney disease 2 (autosomal dominant) 16p12 kidney disease, umod-associated kidney disease, familial juvenile hyperuricaemic nephropathy
MCL1 myeloid cell leukemia 1 1q21.3 myeloma, megalencephalic leukoencephalopathy with subcortical cysts, cholangiocarcinoma,
MCM10 minichromosome maintenance complex component 10 10p13 rothmund-thomson syndrome
MCM2 minichromosome maintenance complex component 2 3q21.3 cervix endometriosis
MCM3 minichromosome maintenance complex component 3 6p12.2 cervical cancer papillary thyroid carcinoma
MCM3AP minichromosome maintenance complex component 3 associated protein 21q22.3 intellectual disability
MCM4 minichromosome maintenance complex component 4 8q11.21 natural killer cell and glucocorticoid deficiency with dna repair defect
MCM5 minichromosome maintenance complex component 5 22q12.3 desmoid tumor melanoacanthoma
MCM6 minichromosome maintenance complex component 6 2q21.3 lactose intolerance, enchondroma, "lactose intolerance, adult type"
MCM8 minichromosome maintenance complex component 8 20p12.3 gingival recession
MCOLN1 mucolipin 1 19p13.2 strabismus, mucolipidosis mucolipidosis iv
MCOP1 microphthalmia, autosomal recessive 14q32 "microphthalmia, isolated 1"
MCOPCB1 Microphthalmia, colobomatous, 1 microphthalmia with coloboma 1
MCOPCB2 Microphthalmia, colobomatous, 2 15q12-q15 microphthalmia with coloboma 2
MCOPCT1 cataract, congenital, with microphthalmia 16p13.3 "cataract, congenital" microphthalmia with cataract 1
MCOPS13 Microphthalmia, syndromic 13 "microphthalmia, syndromic 13"
MCOR microcoria, congenital 13q31-q32 "microcoria, congenital"
MCPH1 microcephalin 1 8p23.1 microcephaly, primary autosomal recessive microcephalies and seckel syndrome spectrum disorders, primary autosomal recessive microcephaly type 1
MCRS1 microspherule protein 1 12q13.12 ampulla of vater carcinoma pigmented basal cell carcinoma
MCS Miles-Carpenter X-linked mental retardation syndrome Xq13-q22 miles-carpenter syndrome miles-carpenter x-linked mental retardation syndrome
MCTP2 multiple C2 domains, transmembrane 2 15q26.2 drug-induced liver injury due to flucloxacillin distal monosomy 15q
MDC1B Muscular dystrophy, congenital, 1B 1q42 "muscular dystrophy, congenital, 1b"
MDCMP muscular dystrophy, congenital, merosin-positive 4p16.3 "muscular dystrophy, congenital, merosin-positive", rigid spine syndrome, ullrich congenital muscular dystrophy
MDD1 Major depressive disorder 12q22-q23.2 major depressive disorder 1 major depressive disorder
MDD2 Major depressive disorder 2 15q25.3-q26.2 major depressive disorder major depressive disorder 2
MDFIC MyoD family inhibitor domain containing 7q31.1 doid:4019
MDGA2 MAM domain containing glycosylphosphatidylinositol anchor 2 14q21.3 benign epilepsy with centrotemporal spikes
MDH1 malate dehydrogenase 1, NAD (soluble) 2p15 schizophrenia
MDH2 malate dehydrogenase 2, NAD (mitochondrial) 7q11.23 l-2-hydroxyglutaric aciduria, 2-hydroxyglutaric aciduria sleeping sickness
MDK midkine (neurite growth-promoting factor 2) 11p11.2 hepatocellular carcinoma, periapical granuloma mesomelic dysplasia kantaputra type
MDM2 MDM2 oncogene, E3 ubiquitin protein ligase 12q15 giant cell glioblastoma, gliomatosis cerebri, soft tissue sarcoma,
MDNS Mammary-digital-nail syndrome 22q12.3-q13.1 mammary-digital-nail syndrome
MDRV muscular dystrophy, with rimmed vacuoles 19p13.3 muscular dystrophy with rimmed vacuoles
MDS2 myelodysplastic syndrome 2 translocation associated 1p36.11 decubitus ulcer
ME1 malic enzyme 1, NADP(+)-dependent, cytosolic 6q14.2 fascioliasis
ME2 malic enzyme 2, NAD(+)-dependent, mitochondrial 18q21.2 idiopathic generalized epilepsy, fascioliasis opiate dependence
MEA1 male-enhanced antigen 1 6p21.1 mucoepidermoid carcinoma
MEAF6 MYST/Esa1-associated factor 6 1p34.3 sarcoma
MECOM MDS1 and EVI1 complex locus 3q26.2 "myelodysplastic syndrome, somatic", pallister-hall syndrome 3q21q26 syndrome
MECP2 methyl CpG binding protein 2 (Rett syndrome) Xq28 learning disability, "mental retardation, x-linked 17/31, microduplication", mental retardation,
MECR mitochondrial trans-2-enoyl-CoA reductase 1p35.3 blepharospasm
MED10 mediator complex subunit 10 5p15.31 seborrheic keratosis, cri-du-chat syndrome junctional epidermolysis bullosa
MED12 mediator complex subunit 12 Xq13.1 "mental retardation, x-linked 17/31, microduplication", schizophrenia, focal segmental glomerulosclerosis,
MED12L mediator complex subunit 12-like 3q25.1 usher syndrome type 3
MED13L mediator complex subunit 13-like 12q24.21 "mental retardation, autosomal recessive 43", transposition of the great arteries, "transposition of the great arteries, dextro-looped 1"
MED15 mediator complex subunit 15 22q11.21 epicondylitis
MED17 mediator complex subunit 17 11q21 cannabis dependence, infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly "microcephaly, postnatal progressive, with seizures and brain atrophy"
MED19 mediator complex subunit 19 11q12.1 lung cancer breast lipoma
MED22 mediator complex subunit 22 9q34.2 atypical autism
MED23 mediator complex subunit 23 6q23.2 "mental retardation, autosomal recessive 43" "mental retardation, autosomal recessive 18"
MED24 mediator complex subunit 24 17q21.1 transposition of the great arteries
MED25 mediator complex subunit 25 19q13.33 charcot-marie-tooth neuropathy type 2, charcot-marie-tooth disease type 2, charcot-marie-tooth disease,
MED28 mediator complex subunit 28 4p15.32 chronic intestinal vascular insufficiency
MEF2A myocyte enhancer factor 2A 15q26.3 myocardial infarction, coronary artery disease, artery disease,
MEF2B myocyte enhancer factor 2B 19p13.11 non-hodgkin lymphoma
MEF2C myocyte enhancer factor 2C 5q14.3 5q14.3 microdeletion syndrome "mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations"
MEF2D myocyte enhancer factor 2D 1q22 parkinsons disease lymphoblastic leukemia
MEFV Mediterranean fever 16p13.3 "osteogenesis imperfecta, type ii", polyarteritis nodosa, stomatitis,
MEG3 maternally expressed 3 (non-protein coding) 14q32.2 "maternal uniparental disomy, chromosome 14" "uniparental disomy, paternal, chromosome 14"
MEGF10 multiple EGF-like-domains 10 5q23.2 schizophrenia, myopathy, dysphagia,
MEGF8 multiple EGF-like-domains 8 19q13.2 dextrocardia, carpenter syndrome carpenter syndrome 2
MEGF9 multiple EGF-like-domains 9 9q33.2 heart septal defect atrial heart septal defect
MEHMO mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly and obesity syndrome Xp22.13-p21.1 obesity "mental retardation, epileptic seizures, hypogonadism and hypogenitalism, microcephaly, and obesity"
MEIS1 Meis homeobox 1 2p14 acute myeloid leukemia collagen type vi-related disorders
MEIS2 Meis homeobox 2 15q14 15q14 microdeletion syndrome
MEMO1 mediator of cell motility 1 2p22.3 hepatitis c, hepatitis c virus hepatitis
MEN1 multiple endocrine neoplasia I 11q13.1 hyperparathyroidism, primary hyperparathyroidism, serotonin syndrome,
MENOQ1 menopause, natural, age at, QTL Xp21.3 "menopause, natural, age at, qtl1"
MENOQ2 Menopause, natural, age at, QTL2 19q13.4 "menopause, natural, age at, qtl2"
MENOQ3 Menopause, natural, age at, QTL3 20p12.3 "menopause, natural, age at, qtl3"
MENOQ4 Menopause, natural, age at, QTL4 5q35.2 "menopause, natural, age at, qtl4"
MEOX1 mesenchyme homeobox 1 17q21.31 mesoblastic nephroma, sost-related sclerosing bone dysplasia, klippel-feil syndrome,
MEOX2 mesenchyme homeobox 2 7p21.2 female stress incontinence, neurogenic bladder, low compliance bladder
MEP1A meprin A, alpha (PABA peptide hydrolase) 6p12.3 juvenile myoclonic epilepsy dentin dysplasia
MEP1B meprin A, beta 18q12.1 dentinogenesis imperfecta dentin dysplasia
MEPE matrix extracellular phosphoglycoprotein 4q22.1 oncogenic osteomalacia, "hypophosphatemic rickets, autosomal dominant", dentinogenesis imperfecta
MERTK c-mer proto-oncogene tyrosine kinase 2q13 leber congenital amaurosis, mertk-related retinitis pigmentosa retinitis pigmentosa 38
MESP1 mesoderm posterior 1 homolog (mouse) 15q26.1 spondylocostal dysostosis
MESP2 mesoderm posterior 2 homolog (mouse) 15q26.1 spondylocostal dysostosis, spondylocostal dysostosis 1, "spondylocostal dysostosis, autosomal recessive",
MEST mesoderm specific transcript 7q32.2 silver-russell syndrome
MET met proto-oncogene 7q31.2 hepatocellular carcinoma, colorectal cancer, alveolar soft part sarcoma,
METAP2 methionyl aminopeptidase 2 12q22 microsporidiosis
METTL13 methyltransferase like 13 1q24.3 exhibitionism
METTL21A methyltransferase like 21A 2q33.3 hepatocellular carcinoma
METTL21B methyltransferase like 21B 12q14.1 hepatocellular carcinoma
METTL23 methyltransferase like 23 17q25.1 "mental retardation, autosomal recessive 43"
METTL9 methyltransferase like 9 16p12.2 inflammatory bowel disease 1
MEX3C mex-3 RNA binding family member C 18q21.2 hypertension
MF4 metacarpal 4-5 fusion metacarpals 4 and 5 fusion
MFF mitochondrial fission factor 2q36.3 hydrocele, elephantiasis, keratitis,
MFGE8 milk fat globule-EGF factor 8 protein 15q26.1 hidrocystoma, carpal tunnel syndrome simultanagnosia
MFHAS1 malignant fibrous histiocytoma amplified sequence 1 8p23.1 malignant fibroxanthoma, fibrous histiocytoma histiocytoma
MFI2 antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 3q29 melanoma, melanotic neuroectodermal tumor clear cell sarcoma
MFN2 mitofusin 2 1p36.22 charcot-marie-tooth neuropathy type 2, charcot-marie-tooth disease type 2, neuropathy,
MFRP membrane frizzled-related protein 11q23.3 microphthalmia, hyperopia, isolated microphthalmia,
MFSD1 major facilitator superfamily domain containing 1 3q25.32 intraductal papilloma
MFSD10 major facilitator superfamily domain containing 10 4p16.3 wolman disease
MFSD8 major facilitator superfamily domain containing 8 4q28.2 neuronal ceroid-lipofuscinoses, late-infantile neuronal ceroid lipofuscinosis, neuronal ceroid lipofuscinosis
MFT2 Trichoepithelioma, multiple familial, 2 9p21 multiple familial trichoepithelioma 2
MGARP mitochondria-localized glutamic acid-rich protein 4q31.1 hypoxia
MGAT1 mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 5q35.3 plague brain disease
MGAT2 mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 14q21.3 congenital disorder of glycosylation type 2a
MGAT3 mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase 22q13.1 hepatoblastoma
MGAT4C mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) 12q21.32 beta-mannosidosis
MGAT5B mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B 17q25.2 walker-warburg syndrome fukuyama congenital muscular dystrophy
MGC39545 uncharacterized LOC403312 11q24.2 breast and colorectal cancer
MGCT male germ cell tumor 12q22 germ cell tumors male germ cell tumor
MGEA5 meningioma expressed antigen 5 (hyaluronidase) 10q24.32 meningioma
MGME1 mitochondrial genome maintenance exonuclease 1 20p11.23 mitochondrial dna depletion syndrome mitochondrial dna depletion syndrome 11
MGMT O-6-methylguanine-DNA methyltransferase 10q26.3 gliosarcoma, giant cell glioblastoma, colorectal cancer,
MGP matrix Gla protein 12p12.3 hyperphosphatemia, varicose veins, hemorrhagic disease,
MGR1 Migraine with aura, susceptibility to 4q24 migraine with or without aura 1
MGR12 Migraine, with or without aura, susceptibility to, 12 10q22-q23 migraine "migraine, with or without aura 12"
MGR2 Migraine, familial typical, susceptibility to Xq migraine "migraine, familial typical 2"
MGR3 Migraine, familial, with or without aura, susceptibility to 6p21.1-p12.2 migraine migraine with or without aura 3
MGR4 Migraine, susceptibility to, 4 14q21.2-q22.3 migraine migraine without aura 4
MGR5 Migraine with or without aura, susceptibility to, 5 19p13 migraine, hemiplegic migraine, familial hemiplegic migraine
MGR6 Migraine, several forms 1q31 hemiplegic migraine, familial hemiplegic migraine migraine without aura
MGR7 Migraine with aura, susceptibility to, 7 15q11.2-q12 migraine migraine with aura 7
MGR8 Migraine, susceptibility to, 8 5q21 migraine migraine 8
MGR9 Migraine with aura, susceptibility to, 9 11q24 migraine migraine with aura 9
MGS Mungen syndrome 8q23-q24 mungan syndrome
MGST1 microsomal glutathione S-transferase 1 12p12.3 megalencephalic leukoencephalopathy with subcortical cysts hereditary pancreatitis
MHAC microhydranencephaly 16p13.3-p12.1 lissencephaly 4 microhydranencephaly
MHB myopathy, hyaline body, autosomal recessive 3p22.2-p21.32 "myopathy, hyaline body"
MHS2 malignant hyperthermia susceptibility 2 17q11.2-q24 malignant hyperthermia susceptibility malignant hyperthermia susceptibility type 2
MHS3 Malignant hyperthermia susceptibility 3 7q21-q22 malignant hyperthermia susceptibility malignant hyperthermia susceptibility type 3
MHS4 malignant hyperthermia susceptibility 4 3q13.1 malignant hyperthermia susceptibility malignant hyperthermia susceptibility type 4
MHS6 malignant hyperthermia susceptibility 6 5p malignant hyperthermia susceptibility malignant hyperthermia susceptibility type 6
MHW1 Mental health wellness 1 4p mental health wellness-1
MHW2 Mental health wellness 2 4q mental health wellness-2
MIA melanoma inhibitory activity 19q13.2 melanoma, oral squamous cell carcinoma skin melanoma
MIAT myocardial infarction associated transcript (non-protein coding) 22q12.1 myocardial infarction
MIB1 mindbomb E3 ubiquitin protein ligase 1 18q11.2 "left ventricular noncompaction 1, with or without congenital heart defects", alkaptonuria left ventricular noncompaction 7
MICA MHC class I polypeptide-related sequence A 6p21.33 myeloma, hiv-1, psoriasis,
MICB MHC class I polypeptide-related sequence B 6p21.33 behcets disease dengue shock syndrome
MICC MHC class I polypeptide-related sequence C (pseudogene) 6p22.1 microcephaly-capillary malformation syndrome
MICD MHC class I polypeptide-related sequence D (pseudogene) 6p22.1 geleophysic dysplasia, stiff skin syndrome , geleophysic dysplasia 2 ,
MICU1 mitochondrial calcium uptake 1 10q22.1 atopy myopathy with extrapyramidal signs
MID1 midline 1 (Opitz/BBB syndrome) Xp22.2 cleft lip, hypospadias, imperforate anus,
MID2 midline 2 Xq22.3 "mental retardation, x-linked 17/31, microduplication"
MIEN1 migration and invasion enhancer 1 17q12 prostate adenocarcinoma brain cancer
MIF macrophage migration inhibitory factor (glycosylation-inhibiting factor) 22q11.23 septic shock, rheumatoid arthritis, juvenile rheumatoid arthritis,
MINOS1-NBL1 MINOS1-NBL1 readthrough 1p36.13 neuroblastoma
MINPP1 multiple inositol-polyphosphate phosphatase 1 10q23.2 follicular thyroid carcinoma, bannayan-riley-ruvalcaba syndrome ruvalcaba syndrome
MIOX myo-inositol oxygenase 22q13.33 type 1 diabetes mellitus
MIP major intrinsic protein of lens fiber 12q13.3 malaria, brain edema, traumatic brain injury,
MIPOL1 mirror-image polydactyly 1 14q13.3 polydactyly, mirror-image polydactyly laurin-sandrow syndrome
MIR100 microRNA 100 11q24.1 acute myeloid leukemia, esophageal squamous cell carcinoma, esophageal cancer
MIR101-1 microRNA 101-1 1p31.3 adult t-cell leukemia
MIR107 microRNA 107 10q23.31 alzheimers disease
MIR10A microRNA 10a 17q21.32 acute myeloid leukemia, neuroblastoma, chronic myeloid leukemia
MIR10B microRNA 10b 2q31.1 neuroblastoma, pancreatic ductal adenocarcinoma esophageal cancer
MIR1208 microRNA 1208 8q24.21 atopic dermatitis
MIR122 microRNA 122 18q21.31 hepatitis c virus borna disease
MIR1224 microRNA 1224 3q27.1 major depressive disorder
MIR124-1 microRNA 124-1 8p23.1 acute myeloid leukemia, oral squamous cell carcinoma esophageal cancer
MIR124-2 microRNA 124-2 8q12.3 oral squamous cell carcinoma
MIR124-3 microRNA 124-3 20q13.33 oral squamous cell carcinoma clear cell renal cell carcinoma
MIR125A microRNA 125a 19q13.41 familial breast cancer verrucous carcinoma
MIR125B1 microRNA 125b-1 11q24.1 acute promyelocytic leukemia, oral squamous cell carcinoma, b-cell lymphomas
MIR126 microRNA 126 9q34.3 non-small cell lung carcinoma
MIR127 microRNA 127 14q32.2 b-cell lymphomas diffuse large b-cell lymphoma
MIR128-1 microRNA 128-1 2q21.3 acute myeloid leukemia, familial breast cancer adult t-cell leukemia
MIR128-2 microRNA 128-2 3p22.3 acute myeloid leukemia familial breast cancer
MIR1297 microRNA 1297 13 lung adenocarcinoma
MIR130B microRNA 130b 22q11.21 multiple myeloma papillary thyroid carcinoma
MIR132 microRNA 132 17p13.3 ductal carcinoma in situ
MIR1322 microRNA 1322 8 esophageal squamous cell carcinoma
MIR133A1 microRNA 133a-1 18q11.2 bladder carcinoma, esophageal squamous cell carcinoma, bladder carcinoma in situ
MIR133A2 microRNA 133a-2 20q13.33 lung squamous cell carcinoma
MIR133B microRNA 133b 6p12.2 esophageal squamous cell carcinoma
MIR135A1 microRNA 135a-1 3p21.1 colorectal cancer
MIR137 microRNA 137 1p21.3 squamous cell carcinoma of the head and neck, oral squamous cell carcinoma 1p21.3 microdeletion syndrome
MIR138-1 microRNA 138-1 3p21.32 tongue squamous cell carcinoma clear cell renal cell carcinoma
MIR139 microRNA 139 11q13.4 bladder carcinoma bladder carcinoma in situ
MIR141 microRNA 141 12p13.31 esophageal squamous cell carcinoma
MIR142 microRNA 142 17q22 bladder carcinoma, acute myeloid leukemia, esophageal squamous cell carcinoma
MIR143 microRNA 143 5q32 esophageal squamous cell carcinoma
MIR144 microRNA 144 17q11.2 type 2 diabetes mellitus pulmonary tuberculosis
MIR145 microRNA 145 5q32 esophageal squamous cell carcinoma, lung adenocarcinoma endometrial adenocarcinoma
MIR1468 microRNA 1468 Xq11.2 systemic lupus erythematosus
MIR146A microRNA 146a 5q33.3 breast cancer, squamous cell carcinoma of the head and neck, acute promyelocytic leukemia,
MIR146B microRNA 146b 10q24.32 papillary thyroid carcinoma sporadic breast cancer
MIR148B microRNA 148b 12q13.13 hodgkins lymphoma
MIR149 microRNA 149 2q37.3 squamous cell carcinoma of the head and neck, lung cancer, lung cancer susceptibility
MIR150 microRNA 150 19q13.33 non-small cell lung carcinoma, chronic myeloid leukemia, esophageal squamous cell carcinoma
MIR155 microRNA 155 21q21.3 borna disease
MIR155HG MIR155 host gene (non-protein coding) 21q21.3 lung cancer, lung cancer susceptibility, b-cell lymphomas
MIR15A microRNA 15a 13q14.2 multiple myeloma b-cell lymphomas
MIR16-1 microRNA 16-1 13q14.2 multiple myeloma, critical limb ischemia, limb ischemia,
MIR16-2 microRNA 16-2 3q25.33 esophageal cancer
MIR17 microRNA 17 13q31.3 familial breast cancer, pediatric systemic lupus erythematosus, chronic myeloid leukemia,
MIR17HG miR-17-92 cluster host gene (non-protein coding) 13q31.3 mantle cell lymphoma, feingold syndrome 2 feingold syndrome
MIR181A1 microRNA 181a-1 1q32.1 acute myeloid leukemia, papillary thyroid carcinoma oral squamous cell carcinoma
MIR181A2 microRNA 181a-2 9q33.3 non-hodgkin lymphoma, oral squamous cell carcinoma hodgkins lymphoma
MIR181B1 microRNA 181b-1 1q32.1 acute myeloid leukemia, pancreatic ductal adenocarcinoma gastric adenocarcinoma
MIR181B2 microRNA 181b-2 9q33.3 acute myeloid leukemia
MIR182 microRNA 182 7q32.2 microphthalmia, gastric adenocarcinoma, posterior uveal melanoma,
MIR183 microRNA 183 7q32.2 lung cancer
MIR184 microRNA 184 15q25.1 edict syndrome
MIR192 microRNA 192 11q13.1 multiple myeloma diabetic nephropathy
MIR193A microRNA 193a 17q11.2 acute myeloid leukemia endometrial adenocarcinoma
MIR193B microRNA 193b 16p13.12 acute myeloid leukemia multiple myeloma
MIR194-1 microRNA 194-1 1q41 multiple myeloma
MIR195 microRNA 195 17p13.1 primary peritoneal carcinoma tongue squamous cell carcinoma
MIR196A1 microRNA 196a-1 17q21.32 pancreatic ductal adenocarcinoma, esophageal squamous cell carcinoma keloids
MIR196A2 microRNA 196a-2 12q13.13 moyamoya disease, squamous cell carcinoma of the head and neck, familial breast cancer,
MIR196B microRNA 196b 7p15.2 acute myeloid leukemia
MIR198 microRNA 198 3q13.33 lung adenocarcinoma
MIR199B microRNA 199b 9q34.11 acute myeloid leukemia chronic myeloid leukemia
MIR200A microRNA 200a 1p36.33 gastric adenocarcinoma, lung adenocarcinoma clear cell renal cell carcinoma
MIR200B microRNA 200b 1p36.33 lung adenocarcinoma endometrial adenocarcinoma
MIR200C microRNA 200c 12p13.31 intrahepatic cholangiocarcinoma
MIR205 microRNA 205 1q32.2 esophageal squamous cell carcinoma
MIR206 microRNA 206 6p12.2 myotonic dystrophy type 1
MIR20A microRNA 20a 13q31.3 colorectal adenocarcinoma, acute myeloid leukemia mantle cell lymphoma
MIR21 microRNA 21 17q23.1 neuroblastoma, papillary thyroid carcinoma, pancreatic ductal adenocarcinoma,
MIR210 microRNA 210 11p15.5 pediatric osteosarcoma, siderosis pulmonary arteriovenous malformation
MIR214 microRNA 214 1q24.3 pediatric osteosarcoma, esophageal squamous cell carcinoma intrahepatic cholangiocarcinoma
MIR215 microRNA 215 1q41 multiple myeloma
MIR217 microRNA 217 2p16.1 pancreatic ductal adenocarcinoma
MIR218-1 microRNA 218-1 4p15.31 lung squamous cell carcinoma
MIR218-2 microRNA 218-2 5q34 lung squamous cell carcinoma
MIR22 microRNA 22 17p13.3 hairy cell leukemia
MIR221 microRNA 221 Xp11.3 papillary thyroid carcinoma, hairy cell leukemia benign metastasizing leiomyoma
MIR222 microRNA 222 Xp11.3 papillary thyroid carcinoma
MIR223 microRNA 223 Xq12 acute myeloid leukemia, b-cell lymphomas diffuse large b-cell lymphoma
MIR224 microRNA 224 Xq28 pancreatic ductal adenocarcinoma
MIR23B microRNA 23b 9q22.32 spinal cord injury
MIR24-1 microRNA 24-1 9q22.32 familial breast cancer, b-cell lymphomas, diffuse large b-cell lymphoma
MIR25 microRNA 25 7q22.1 esophageal squamous cell carcinoma tongue squamous cell carcinoma
MIR26A1 microRNA 26a-1 3p22.2 acute myeloid leukemia, esophageal cancer acth-secreting pituitary adenoma
MIR27A microRNA 27a 19p13.13 familial breast cancer, esophageal squamous cell carcinoma gastric adenocarcinoma
MIR27B microRNA 27b 9q22.32 type 2 diabetes mellitus
MIR296 microRNA 296 20q13.32 esophageal squamous cell carcinoma
MIR29A microRNA 29a 7q32.3 acute myeloid leukemia, b-cell lymphomas, mantle cell lymphoma
MIR29B1 microRNA 29b-1 7q32.3 acute myeloid leukemia multiple myeloma
MIR29B2 microRNA 29b-2 1q32.2 familial breast cancer
MIR29C microRNA 29c 1q32.2 esophageal squamous cell carcinoma
MIR30A microRNA 30a 6q13 chronic myeloid leukemia esophageal cancer
MIR30C1 microRNA 30c-1 1p34.2 breast cancer, familial breast cancer esophageal cancer
MIR30E microRNA 30e 1p34.2 esophageal cancer major depressive disorder
MIR31 microRNA 31 9p21.3 chronic myeloid leukemia lung squamous cell carcinoma
MIR3151 microRNA 3151 8q22.3 acute myeloid leukemia
MIR325 microRNA 325 Xq21.1 dyspepsia
MIR34A microRNA 34a 1p36.22 soft tissue sarcoma, acute myeloid leukemia placenta accreta
MIR34B microRNA 34b 11q23.1 papillary thyroid carcinoma malignant pleural mesothelioma
MIR365A microRNA 365a 16p13.12 multiple myeloma
MIR365B microRNA 365b 17q11.2 multiple myeloma
MIR370 microRNA 370 14q32.2 acute myeloid leukemia
MIR371A microRNA 371a 19q13.42 germ cell tumors testicular germ cell tumor
MIR372 microRNA 372 19q13.42 germ cell tumors, testicular germ cell tumor lung adenocarcinoma
MIR373 microRNA 373 19q13.42 germ cell tumors, testicular germ cell tumor esophageal cancer
MIR375 microRNA 375 2q35 lobular neoplasia, esophageal squamous cell carcinoma esophageal cancer
MIR377 microRNA 377 14q32.31 diabetic nephropathy
MIR378A microRNA 378a 5q32 acute myeloid leukemia non-small cell lung carcinoma
MIR381 microRNA 381 14q32.31 lung adenocarcinoma
MIR3940 microRNA 3940 19p13.3 non-small cell lung carcinoma
MIR3972 microRNA 3972 1p36.13 acute myeloid leukemia
MIR3973 microRNA 3973 11p13 acute myeloid leukemia
MIR3974 microRNA 3974 12 acute myeloid leukemia
MIR3975 microRNA 3975 18 acute myeloid leukemia
MIR3976 microRNA 3976 18p11.31 acute myeloid leukemia
MIR3977 microRNA 3977 5 acute myeloid leukemia
MIR3978 microRNA 3978 Xq23 acute myeloid leukemia
MIR423 microRNA 423 17q11.2 esophageal cancer transposition of the great arteries
MIR424 microRNA 424 Xq26.3 fragile x-associated tremor/ataxia syndrome
MIR4315-1 microRNA 4315-1 17 juvenile xanthogranuloma dandy-walker syndrome
MIR4315-2 microRNA 4315-2 17 juvenile xanthogranuloma dandy-walker syndrome
MIR451A microRNA 451a 17q11.2 chronic myeloid leukemia
MIR486 microRNA 486 8p11.21 pancreatic ductal adenocarcinoma
MIR492 microRNA 492 12q22 esophageal cancer
MIR497 microRNA 497 17p13.1 primary peritoneal carcinoma
MIR499A microRNA 499a 20q11.22 breast cancer susceptibility, squamous cell carcinoma of the head and neck ulcerative colitis
MIR504 microRNA 504 Xq26.3 oral squamous cell carcinoma
MIR506 microRNA 506 Xq27.3 primary biliary cirrhosis
MIR510 microRNA 510 Xq27.3 irritable bowel syndrome
MIR511-1 microRNA 511-1 10p12.33 lung adenocarcinoma
MIR518B microRNA 518b 19q13.42 esophageal squamous cell carcinoma
MIR564 microRNA 564 3p21.31 chronic myeloid leukemia
MIR570 microRNA 570 3q29 gastric adenocarcinoma
MIR574 microRNA 574 4p14 fragile x-associated tremor/ataxia syndrome
MIR584 microRNA 584 5q32 clear cell renal cell carcinoma
MIR588 microRNA 588 6q22.32 ulcerative colitis
MIR590 microRNA 590 7q11.23 alzheimers disease
MIR593 microRNA 593 7q32.1 esophageal cancer
MIR604 microRNA 604 10p11.23 esophageal cancer
MIR605 microRNA 605 10q21.1 lung cancer lung cancer susceptibility
MIR608 microRNA 608 10q24.31 esophageal cancer tendinopathy
MIR625 microRNA 625 14q23.3 malignant pleural mesothelioma
MIR631 microRNA 631 15q24.2 esophageal cancer
MIR663A microRNA 663a 20p11.1 acute myeloid leukemia
MIR7-1 microRNA 7-1 9q21.32 breast cancer susceptibility
MIR708 microRNA 708 11q14.1 lung adenocarcinoma
MIR9-1 microRNA 9-1 1q22 gastric adenocarcinoma clear cell renal cell carcinoma
MIR9-3 microRNA 9-3 15q26.1 clear cell renal cell carcinoma
MIR920 microRNA 920 12p12.1 familial breast cancer
MIR92A1 microRNA 92a-1 13q31.3 malignant pleural mesothelioma hodgkins lymphoma
MIR96 microRNA 96 7q32.2 microphthalmia, "deafness, autosomal dominant 4b", "deafness, autosomal dominant 50",
MIR98 microRNA 98 Xp11.22 esophageal squamous cell carcinoma
MIR99A microRNA 99a 21q21.1 esophageal squamous cell carcinoma
MIRLET7A1 microRNA let-7a-1 9q22.32 esophageal squamous cell carcinoma endometrial adenocarcinoma
MIRLET7I microRNA let-7i 12q14.1 ankylosing spondylitis
MITF microphthalmia-associated transcription factor 3p14.1 pendred syndrome, microphthalmia, mutism,
MIXL1 Mix paired-like homeobox 1q42.12 uterine inversion
MKI67 marker of proliferation Ki-67 10q26.2 papilloma, cavernous hemangioma, soft tissue sarcoma,
MKKS McKusick-Kaufman syndrome 20p12.2 "bardet-biedl syndrome 1, modifier of", bardet-biedl syndrome 15, bardet-biedl syndrome 3 ,
MKL1 megakaryoblastic leukemia (translocation) 1 22q13.2 leukemia, megakaryocytic leukemia acute leukemia
MKL2 MKL/myocardin-like 2 16p13.12 chondroid lipoma
MKRN3 makorin ring finger protein 3 15q11.2 prader-willi syndrome, central precocious puberty, precocious puberty,
MKS1 Meckel syndrome, type 1 17q22 joubert syndrome 21, "bardet-biedl syndrome 1, modifier of", bardet-biedl syndrome 15,
MLANA melan-A 9p24.1 juvenile xanthogranuloma, halo nevi, retroperitoneal sarcoma,
MLC1 megalencephalic leukoencephalopathy with subcortical cysts 1 22q13.33 schizophrenia, megalencephalic leukoencephalopathy with subcortical cysts, mlc1-related megalencephalic leukoencephalopathy with subcortical cysts
MLF1 myeloid leukemia factor 1 3q25.32 acute myeloid leukemia, leukemia, myelodysplastic syndromes
MLF2 myeloid leukemia factor 2 12p13.31 leukemia myeloid leukemia
MLH1 mutL homolog 1 3p22.2 colorectal cancer, endometrial carcinoma, breast cancer,
MLH3 mutL homolog 3 14q24.3 "colorectal cancer, somatic", colorectal cancer, endometrial carcinoma,
MLLT1 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 19p13.3 mitochondrial dna depletion syndrome mitochondrial dna depletion syndrome 8a
MLLT10 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 10p12.31 precursor t-cell acute lymphoblastic leukemia, acute biphenotypic leukemia verrucous papilloma
MLLT11 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11 1q21.3 leukemia, mitochondrial dna depletion syndrome, acute myelomonocytic leukemia
MLLT3 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 9p21.3 leukemia
MLLT4 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 6q27 lymphoblastic leukemia leukemia
MLLT6 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 17q12 leukemia, meier-gorlin syndrome meier-gorlin syndrome 3
MLN motilin 6p21.31 obesity, hyperglycemia, zollinger-ellison syndrome,
MLNR motilin receptor 13q14.2 colonic disease, type 1 diabetes mellitus, diabetic autonomic neuropathy,
MLPH melanophilin 2q37.3 griscelli syndrome, piebaldism, griscelli syndrome type 2,
MLSM7 Myelodysplasia and leukemia syndrome with monosomy 7 7q myelodysplasia and leukemia syndrome with monosomy 7
MLVI4 Moloney leukemia virus integration site 4, mouse, homolog of 8q24 multiple myeloma
MLX MLX, MAX dimerization protein 17q21.2 takayasus arteritis
MLXIPL MLX interacting protein-like 7q11.23 williams-beuren syndrome, hepatocellular adenoma persistent mullerian duct syndrome
MLYCD malonyl-CoA decarboxylase 16q23.3 metabolic acidosis, combined malonic and methylmalonic aciduria malonyl-coa decarboxylase deficiency
MMAA methylmalonic aciduria (cobalamin deficiency) cblA type 4q31.21 methylmalonic acidemia, spondylocostal dysostosis, mmaa-related methylmalonic acidemia
MMAB methylmalonic aciduria (cobalamin deficiency) cblB type 12q24.11 ataxia telangiectasia, methylmalonic acidemia, "methylmalonic aciduria, vitamin b12-responsive, due to defect in synthesis of adenosylcobalamin, cblb complementation type"
MMACHC methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria 1p34.1 multiple carboxylase deficiency, homocysteinemia, methylmalonic aciduria and homocystinuria type cble,
MMADHC methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria 2q23.2 methylmalonic aciduria and homocystinuria type cbld, cbld, methylmalonic acidemia,
MMD monocyte to macrophage differentiation-associated 17q22 propionic acidemia methylmalonic acidemia
MMD2 monocyte to macrophage differentiation-associated 2 7p22.1 miyoshi muscular dystrophy 2
MMDK Mesomelic dysplasia, Kantaputra type 2q24-q32 mesomelic dysplasia kantaputra type
MME membrane metallo-endopeptidase 3q25.2 adenosarcoma, adenofibroma, leukemia,
MMEDF Macrocephaly with multiple epiphyseal dysplasia and distinctive facies 15q26.1 multiple epiphyseal dysplasia macrocephaly with multiple epiphyseal dysplasia and distinctive facies
MMEL1 membrane metallo-endopeptidase-like 1 1p36.32 primary biliary cirrhosis
MMP1 matrix metallopeptidase 1 (interstitial collagenase) 11q22.2 colorectal cancer, recessive dystrophic epidermolysis bullosa, pulpitis,
MMP10 matrix metallopeptidase 10 (stromelysin 2) 11q22.2 bladder transitional cell carcinoma, transitional cell carcinoma, arthritis,
MMP11 matrix metallopeptidase 11 (stromelysin 3) 22q11.23 colorectal cancer, arthritis, cutaneous fibrous histiocytoma,
MMP12 matrix metallopeptidase 12 (macrophage elastase) 11q22.2 hepatocellular carcinoma, moyamoya disease, coronary artery disease,
MMP13 matrix metallopeptidase 13 (collagenase 3) 11q22.2 diverticulitis, arthritis, osteoarthritis,
MMP14 matrix metallopeptidase 14 (membrane-inserted) 14q11.2 arthritis, ovarian cancer, laryngeal carcinoma,
MMP15 matrix metallopeptidase 15 (membrane-inserted) 16q21 arthritis encephalomyelitis
MMP16 matrix metallopeptidase 16 (membrane-inserted) 8q21.3 arthritis osteochondrosis
MMP17 matrix metallopeptidase 17 (membrane-inserted) 12q24.33 arthritis
MMP19 matrix metallopeptidase 19 12q13.2 arthritis, keloids, relapsing-remitting multiple sclerosis,
MMP2 matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) 16q12.2 colorectal cancer, breast cancer, endometriosis,
MMP20 matrix metallopeptidase 20 11q22.2 "amelogenesis imperfecta, type ia5", amelogenesis imperfecta, arthritis,
MMP21 matrix metallopeptidase 21 10q26.13 asthma encephalomyelitis
MMP23A matrix metallopeptidase 23A (pseudogene) 1p36.33 encephalomyelitis
MMP23B matrix metallopeptidase 23B 1p36.33 transient hypogammaglobulinemia, arthritis, choanal atresia
MMP24 matrix metallopeptidase 24 (membrane-inserted) 20q11.22 arthritis idiopathic pulmonary fibrosis
MMP25 matrix metallopeptidase 25 16p13.3 arthritis, dental fluorosis encephalomyelitis
MMP26 matrix metallopeptidase 26 11p15.4 endometrial carcinoma, arthritis encephalomyelitis
MMP27 matrix metallopeptidase 27 11q22.2 arthritis encephalomyelitis
MMP28 matrix metallopeptidase 28 17q12 asthma encephalomyelitis
MMP3 matrix metallopeptidase 3 (stromelysin 1, progelatinase) 11q22.2 recessive dystrophic epidermolysis bullosa, rheumatoid arthritis, takayasus arteritis,
MMP7 matrix metallopeptidase 7 (matrilysin, uterine) 11q22.2 pancreatic cancer, colon cancer, adenomyosis,
MMP8 matrix metallopeptidase 8 (neutrophil collagenase) 11q22.2 pulmonary emphysema, rosacea, abdominal aortic aneurysm,
MMP9 matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) 20q13.12 colorectal cancer, coronary artery disease, prostate cancer,
MMRFCGU Microcephaly, mental retardation, and distinctive facies, with cardiac and genitourinary malformations 16p13.3 "microcephaly, mental retardation, and distinctive facies, with cardiac and genitourinary malformations"
MMRN1 multimerin 1 4q22.1 quebec platelet disorder
MMS Malignant mesothelioma, susceptibility to 9p malignant mesothelioma
MMVP1 myxomatous mitral valve prolapse 1 16p12.1-p11.2 "mitral valve prolapse, myxomatous 1"
MMVP2 myxomatous mitral valve prolapse 2 11p15.4 "mitral valve prolapse, myxomatous 2"
MMVP3 Mitral valve prolapse, myxomatous 3 13q31.3-q32.1 "mitral valve prolapse, myxomatous 3"
MN1 meningioma (disrupted in balanced translocation) 1 22q12.1 acute myeloid leukemia meningioma
MND1 meiotic nuclear divisions 1 homolog (S. cerevisiae) 4q31.3 developmental coordination disorder
MNDA myeloid cell nuclear differentiation antigen 1q23.1 myelodysplastic syndromes
MNDEC Microtia with nasolacrimal duct imperforation and eye coloboma 4p16-p15 microtia microtia eye coloboma and imperforation of the nasolacrimal duct
MNG1 multinodular goitre 1 14q pleuropulmonary blastoma, "rhabdomyosarcoma, embryonal, 2" "goiter, multinodular 1, with or without sertoli-leydig cell tumors"
MNG2 multinodular goiter 2 Xp22 "goiter, multinodular, 2"
MNG3 Multinodular goiter-3 3q26.1-q26.3 "goiter, multinodular, 3"
MNRI meningioma, radiation-induced 1p11 meningioma radiation induced meningioma
MNT MAX network transcriptional repressor 17p13.3 tetanus neonatorum
MNX1 motor neuron and pancreas homeobox 1 7q36.3 imperforate anus, sacrococcygeal teratoma, teratoma,
MOAP1 modulator of apoptosis 1 14q32.12 pigmented villonodular synovitis villonodular synovitis
MOB4 MOB family member 4, phocein 2q33.1 cavernous malformation cerebral cavernous malformation
MOBP myelin-associated oligodendrocyte basic protein 3p22.1 schizophrenia
MOCOS molybdenum cofactor sulfurase 18q12.2 xanthinuria type 2
MOCS1 molybdenum cofactor synthesis 1 6p21.2 hyperekplexia, encephalomalacia, molybdenum cofactor deficiency,
MOCS2 molybdenum cofactor synthesis 2 5q11.2 molybdenum cofactor deficiency molybdenum cofactor deficiency b
MOCS3 molybdenum cofactor synthesis 3 20q13.13 methylmalonic aciduria and homocystinuria type cble, methylmalonic aciduria and homocystinuria type cblg, methylmalonic aciduria and homocystinuria type cblc,
MOG myelin oligodendrocyte glycoprotein 6p22.1 schizophrenia, hypersensitivity reaction type ii disease, multiple sclerosis,
MOGS mannosyl-oligosaccharide glucosidase 2p13.1 diamond-blackfan anemia 1 congenital disorder of glycosylation type 2b
MOK MOK protein kinase 14q32.31 renal cell carcinoma
MON1A MON1 secretory trafficking family member A 3p21.31 syringomyelia
MORF4 mortality factor 4 4q34.1 ataxia with oculomotor apraxia type 2
MORF4L2 mortality factor 4 like 2 Xq22.2 cervix uteri carcinoma in situ
MORN4 MORN repeat containing 4 10q24.2 learning disability
MOV10 Mov10, Moloney leukemia virus 10, homolog (mouse) 1p13.2 leukemia
MPC1 mitochondrial pyruvate carrier 1 6q27 citrullinemia mitochondrial pyruvate carrier deficiency
MPD3 Myopathy, distal 3 8p22-q11 "myopathy, distal 3"
MPDU1 mannose-P-dolichol utilization defect 1 17p13.1 congenital disorder of glycosylation congenital disorder of glycosylation type 1f
MPDZ multiple PDZ domain protein 9p23 hydrocephalus, "hydrocephalus, nonsyndromic, autosomal recessive 2" congenital communicating hydrocephalus
MPFD myopathy with fiber type disproportion 10p11.2 or 17q25 amyotrophic lateral sclerosis 20
MPG N-methylpurine-DNA glycosylase 16p13.3 familial colorectal cancer
MPI mannose phosphate isomerase 15q24.1 leishmaniasis, cutaneous leishmaniasis, protein-losing enteropathy
MPL myeloproliferative leukemia virus oncogene 1p34.2 myeloproliferative disorder, myelofibrosis, thrombocytosis,
MPLKIP M-phase specific PLK1 interacting protein 7p14.1 breast and colorectal cancer, photosensitive trichothiodystrophy, nonphotosensitive trichothiodystrophy
MPO myeloperoxidase 17q22 polyarteritis nodosa, extrahepatic cholestasis, noma,
MPP1 membrane protein, palmitoylated 1, 55kDa Xq28 burkitts lymphoma, malaria, idiopathic pulmonary fibrosis
MPP2 membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) 17q21.31 danon disease vacuolar myopathy
MPP4 membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) 2q33.1 amyotrophic lateral sclerosis lateral sclerosis
MPRIP myosin phosphatase Rho interacting protein 17p11.2 gangliocytoma
MPST mercaptopyruvate sulfurtransferase 22q12.3 microtia encephalopathy due to beta-mercaptolactate-cysteine disulfiduria
MPV17 MpV17 mitochondrial inner membrane protein 2p23.3 nephrotic syndrome, glomerulosclerosis, mitochondrial dna depletion syndrome,
MPVQTL4 Mean platelet volume QTL4 6p21.3-p21.2 mean platelet volume qtl4
MPVQTL5 Mean platelet volume QTL5 6q23.3 mean platelet volume qtl5
MPVQTL6 Mean platelet volume QTL6 7q22.3 mean platelet volume qtl6
MPZ myelin protein zero 1q23.3 charcot-marie-tooth neuropathy type 4, spinal cord injury, charcot-marie-tooth neuropathy type 2,
MR1 major histocompatibility complex, class I-related 1q25.3 hemochromatosis, microscopic colitis, klebsiella
MRAP melanocortin 2 receptor accessory protein 21q22.11 glucocorticoid deficiency 2, addisons disease, iritis,
MRAP2 melanocortin 2 receptor accessory protein 2 6q14.2 familial glucocorticoid deficiency obesity bmiq18
MRC1 mannose receptor, C type 1 10p12.33 gauchers disease klebsiella
MRC2 mannose receptor, C type 2 17q23.2 breast cancer
MRE11A MRE11 meiotic recombination 11 homolog A (S. cerevisiae) 11q21 colorectal cancer, ataxia telangiectasia, apraxia,
MRGBP MRG/MORF4L binding protein 20q13.33 colon cancer
MRGPRE MAS-related GPR, member E 11p15.4 intestinal schistosomiasis
MRGPRF MAS-related GPR, member F 11q13.3 intestinal schistosomiasis
MRI1 methylthioribose-1-phosphate isomerase 1 19p13.2 cavernous hemangioma visual agnosia
MRO maestro 18q21.2 melorheostosis osteopoikilosis
MROS Melkersson-Rosenthal syndrome 9p11 melkersson-rosenthal syndrome
MRPL11P2 mitochondrial ribosomal protein L11 pseudogene 2 5q31.3 crohns disease
MRPL28 mitochondrial ribosomal protein L28 16p13.3 melanoma, hepatitis b malaria
MRPL3 mitochondrial ribosomal protein L3 3q22.1 mitochondrial cardiomyopathy combined oxidative phosphorylation deficiency 9
MRPL40 mitochondrial ribosomal protein L40 22q11.21 digeorge syndrome velocardiofacial syndrome
MRPL43 mitochondrial ribosomal protein L43 10q24.31 chronic progressive external ophthalmoplegia
MRPL44 mitochondrial ribosomal protein L44 2q36.1 combined oxidative phosphorylation deficiency 16
MRPL49 mitochondrial ribosomal protein L49 11q13.1 glossopharyngeal neuralgia
MRPS11 mitochondrial ribosomal protein S11 15q25.3 cervical cancer
MRPS16 mitochondrial ribosomal protein S16 10q22.2 subcortical band heterotopia combined oxidative phosphorylation deficiency 2
MRPS22 mitochondrial ribosomal protein S22 3q23 blepharophimosis combined oxidative phosphorylation deficiency 5
MRPS22P1 mitochondrial ribosomal protein S22 pseudogene 1 Xq21.31 hiv-1
MRPS26 mitochondrial ribosomal protein S26 20p13 breast cancer
MRPS30 mitochondrial ribosomal protein S30 5p12 breast cancer susceptibility
MRPS35P1 mitochondrial ribosomal protein S35 pseudogene 1 3p25.3 alzheimers disease
MRPS35P3 mitochondrial ribosomal protein S35 pseudogene 3 10q21.1 crohns disease
MRPS36P2 mitochondrial ribosomal protein S36 pseudogene 2 4q35.2 major depressive disorder
MRPS7 mitochondrial ribosomal protein S7 17q25.1 dubin-johnson syndrome campylobacteriosis
MRS2 MRS2 magnesium transporter 6p22.3 hyperphosphatasia with mental retardation syndrome hyperphosphatasia with mental retardation syndrome 2
MRSD mental retardation-skeletal dysplasia Xq27-q28 mental retardation-skeletal dysplasia
MRSS Mental retardation, X-linked, with short stature Xq24 "mental retardation, x-linked, with short stature"
MRST Mental retardation, severe, with spasticity and tapetoretinal 15q24 spasticity "mental retardation, severe, with spasticity and tapetoretinal degeneration"
MRT10 mental retardation, non-syndromic, autosomal recessive, 10 16p12-q12 "mental retardation, autosomal recessive 10/20"
MRT16 Mental retardation, autosomal recessive 16 9p23-p13.3 "mental retardation, autosomal recessive 16"
MRT17 mental retardation, non-syndromic, autosomal recessive, 17 4q26-q28 intellectual disability hyperphosphatasia with mental retardation syndrome 3
MRT18 mental retardation, non-syndromic, autosomal recessive, 18 6q12-q15 "mental retardation, autosomal recessive 18"
MRT19 mental retardation, non-syndromic, autosomal recessive, 19 18p11.3 intellectual disability "mental retardation, autosomal recessive 19"
MRT20 mental retardation, non-syndromic, autosomal recessive, 20 16p12-q12 intellectual disability "mental retardation, autosomal recessive 10/20"
MRT22 mental retardation, non-syndromic, autosomal recessive, 22 8p22 intellectual disability
MRT23 mental retardation, non-syndromic, autosomal recessive, 23 11p13-q14.1 "mental retardation, autosomal recessive 23"
MRT24 mental retardation, non-syndromic, autosomal recessive, 24 6p12 "mental retardation, autosomal recessive 24"
MRT25 mental retardation, non-syndromic, autosomal recessive, 25 12q13.11-q15 "mental retardation, autosomal recessive 25"
MRT26 mental retardation, non-syndromic, autosomal recessive, 26 14q11-q12 "mental retardation, autosomal recessive, 9/26"
MRT27 mental retardation, non-syndromic, autosomal recessive, 27 15q23-q26 "mental retardation, autosomal recessive 27"
MRT28 mental retardation, non-syndromic, autosomal recessive, 28 6q26-q27 "mental retardation, autosomal recessive 28"
MRT29 Mental retardation, autosomal recessive 29 4q27-q28.2 "mental retardation, autosomal recessive 29"
MRT30 Mental retardation, autosomal recessive 30 6q12-q15 "mental retardation, autosomal recessive 30"
MRT31 Mental retardation, autosomal recessive 31 4q12-q13.1 "mental retardation, autosomal recessive 31"
MRT32 Mental retardation, autosomal recessive 32 14q32.13-q32.2 "mental retardation, autosomal recessive 32"
MRT33 Mental retardation, autosomal recessive 33 17p13.2-p13.1 "mental retardation, autosomal recessive 33"
MRT35 Mental retardation, autosomal recessive 35 17q21.31-q22 "mental retardation, autosomal recessive 35"
MRT5 mental retardation, non-syndromic, autosomal recessive, 5 5p15-p14 "mental retardation, autosomal recessive 5"
MRT9 mental retardation, non-syndromic, autosomal recessive, 9 14q11.2-q12 "mental retardation, autosomal recessive, 9/26"
MRVI1 murine retrovirus integration site 1 homolog 11p15.3 myeloid leukemia
MRX17 mental retardation, X-linked 17 Xp11.22 "mental retardation, x-linked 17/31, microduplication" 17-beta-hydroxysteroid dehydrogenase x deficiency
MRX2 mental retardation, X-linked 2 (non-dysmorphic) Xp22.3-p22.2 fragile xe syndrome
MRX23 mental retardation, X-linked 23 Xq23-q24 "mental retardation, x-linked 23"
MRX26 mental retardation, X-linked 26 Xp11.3-q21.33 renpenning syndrome
MRX3 mental retardation, X-linked 3 Xq28 "mental retardation, x-linked 3"
MRX31 mental retardation, X-linked 31 Xp11.22 "mental retardation, x-linked 17/31, microduplication" 17-beta-hydroxysteroid dehydrogenase x deficiency
MRX42 mental retardation, X-linked 42 X "mental retardation, x-linked 42"
MRX49 mental retardation, X-linked 49 Xp22.3-p22.2 "mental retardation, x-linked 49"
MRX50 mental retardation, X-linked 50 Xp11.3-p11.21 "mental retardation, x-linked 50"
MRX53 mental retardation, X-linked 53 Xq22.2-q24 "mental retardation, x-linked 53"
MRX92 Mental retardation, X-linked 92 Xp11.3 "mental retardation, x-linked 92"
MRXS11 mental retardation, X-linked, syndromic 11 Xq26-q27 "mental retardation, x-linked syndromic, shashi type"
MRXS17 Mental retardation, X-linked, syndromic 17 Xp21.1-p11.23 "mental retardation, x-linked, syndromic 17"
MRXS5 mental retardation, X-linked, syndromic 5 Xq25-q27 dandy-walker malformation with mental retardation basal ganglia disease and seizures
MRXSA Armfield X-linked mental retardation syndrome Xq28 "mental retardation syndrome, x-linked, armfield type"
MRXSAB Abidi X-linked mental retardation syndrome Xq13.2 "mental retardation, x-linked syndromic, abidi type" abidi x-linked mental retardation syndrome
MRXSCS Mental retardation, X-linked, syndromic, Chudley-Schwartz type Xq21.33-q23 "mental retardation, x-linked, syndromic, chudley-schwartz type"
MRXSL Lubs X-linked mental retardation syndrome angelman syndrome, rett syndrome, "autism susceptibility, x-linked 3",
MS multiple sclerosis reserved alzheimers disease, multiple sclerosis, adult acute lymphocytic leukemia,
MS2 Multiple sclerosis, susceptibility to, 2 10p15.1 multiple sclerosis multiple sclerosis 2
MS3 Multiple sclerosis, susceptibility to, 3 5p13.2 multiple sclerosis multiple sclerosis 3
MS4 Multiple sclerosis, susceptiblity to, 4 1p36 multiple sclerosis multiple sclerosis 4
MS4A1 membrane-spanning 4-domains, subfamily A, member 1 11q12.2 b-cell chronic lymphocytic leukemia, chronic lymphocytic leukemia, peripheral t-cell lymphoma,
MS4A12 membrane-spanning 4-domains, subfamily A, member 12 11q12.2 colon cancer
MS4A2 membrane-spanning 4-domains, subfamily A, member 2 11q12.1 asthma, atopy, wegeners granulomatosis,
MSBP1 minisatellite binding protein 1 reserved type 2 diabetes mellitus, ovarian disease, insulin resistance,
MSBP2 minisatellite binding protein 2, 77kDa reserved alzheimers disease
MSC musculin 8q13.3 follicular lymphoma
MSD microcephaly with spastic diplegia (Paine syndrome) X spastic diplegia paine syndrome
MSH2 mutS homolog 2 2p21 colorectal cancer, colon cancer, familial adenomatous polyposis,
MSH3 mutS homolog 3 5q14.1 "endometrial carcinoma, somatic"
MSH5 mutS homolog 5 6p21.33 common variable immunodeficiency premature ovarian failure
MSH6 mutS homolog 6 2p16.3 colorectal cancer, breast cancer, colon cancer,
MSI1 musashi RNA-binding protein 1 12q24.31 malignant glioma
MSL2 male-specific lethal 2 homolog (Drosophila) 3q22.3 aicardi syndrome focal dermal hypoplasia
MSL3 male-specific lethal 3 homolog (Drosophila) Xp22.2 aicardi syndrome focal dermal hypoplasia
MSLN mesothelin 16p13.3 pancreatic cancer, ovarian cancer, thoracic cancer,
MSLNL mesothelin-like 16p13.3 patellofemoral pain syndrome hemarthrosis
MSMB microseminoprotein, beta- 10q11.23 prostate cancer, prostate adenocarcinoma, familial prostate cancer,
MSMP microseminoprotein, prostate associated 9p13.3 prostate cancer
MSN moesin Xq12 measles
MSR1 macrophage scavenger receptor 1 8p22 prostate cancer, atherosclerosis, barrett esophagus/esophageal adenocarcinoma ,
MSRA methionine sulfoxide reductase A 8p23.1 intestinal obstruction, occult macular dystrophy mycobacterium abscessus
MSRB3 methionine sulfoxide reductase B3 12q14.3 "deafness, autosomal recessive 76", lipoma of colon, coach syndrome
MSSE multiple self-healing squamous epithelioma 9q22.32 "loeys-dietz syndrome, type 1" "multiple self-healing squamous epithelioma, susceptiblity to"
MST1 macrophage stimulating 1 (hepatocyte growth factor-like) 3p21.31 pancreatic cancer, primary sclerosing cholangitis, merkel cell carcinoma,
MST1R macrophage stimulating 1 receptor (c-met-related tyrosine kinase) 3p21.31 pancreatic cancer renal oncocytoma
MSTN myostatin 2q32.2 inclusion body myositis, duchenne muscular dystrophy, peyronies disease,
MSX1 msh homeobox 1 4p16.2 "tooth agenesis, selective, 1, with or without orofacial cleft", cleft lip, wolf-hirschhorn syndrome,
MSX2 msh homeobox 2 5q35.2 saethre-chotzen syndrome, crouzon syndrome, craniosynostosis,
MT-ATP6 mitochondrially encoded ATP synthase 6 MT leber hereditary optic neuropathy, dementia, renal tubular acidosis,
MT-ATP8 mitochondrially encoded ATP synthase 8 MT kearns-sayre syndrome, periodic paralysis with later-onset distal motor neuropathy, "mitochondrial complex v deficiency, mitochondrial 2"
MT-CO1 mitochondrially encoded cytochrome c oxidase I MT "colorectal cancer, somatic", colorectal cancer, colon cancer,
MT-CO2 mitochondrially encoded cytochrome c oxidase II MT phaeochromocytoma, tongue cancer, kearns-sayre syndrome,
MT-CO3 mitochondrially encoded cytochrome c oxidase III MT leber hereditary optic neuropathy, papillary thyroid carcinoma, optic neuritis,
MT-CYB mitochondrially encoded cytochrome b MT septo-optic dysplasia, leber hereditary optic neuropathy, malaria,
MT-ND1 mitochondrially encoded NADH dehydrogenase 1 MT type 2 diabetes mellitus, parkinsons disease, alzheimers disease,
MT-ND2 mitochondrially encoded NADH dehydrogenase 2 MT breast disease, age related macular degeneration, alzheimers disease,
MT-ND3 mitochondrially encoded NADH dehydrogenase 3 MT leber hereditary optic neuropathy, renal oncocytoma, denys-drash syndrome,
MT-ND4 mitochondrially encoded NADH dehydrogenase 4 MT acute myeloid leukemia, leber hereditary optic neuropathy, "deafness, mitochondrial, modifier of",
MT-ND4L mitochondrially encoded NADH dehydrogenase 4L MT leber hereditary optic neuropathy mitochondrial disorders
MT-ND5 mitochondrially encoded NADH dehydrogenase 5 MT parkinsons disease, leber hereditary optic neuropathy, kearns-sayre syndrome,
MT-ND6 mitochondrially encoded NADH dehydrogenase 6 MT leber hereditary optic neuropathy, neuritis, kearns-sayre syndrome,
MT-RNR1 mitochondrially encoded 12S RNA MT type 2 diabetes mellitus, "deafness, mitochondrial, modifier of", "nonsyndromic hearing loss and deafness, mitochondrial",
MT-RNR2 mitochondrially encoded 16S RNA MT type 2 diabetes mellitus, alzheimers disease chronic progressive external ophthalmoplegia
MT-TA mitochondrially encoded tRNA alanine MT multiple myeloma, chronic progressive external ophthalmoplegia mitochondrial disorders
MT-TC mitochondrially encoded tRNA cysteine MT mitochondrial disorders
MT-TD mitochondrially encoded tRNA aspartic acid MT mitochondrial disorders
MT-TE mitochondrially encoded tRNA glutamic acid MT type 2 diabetes mellitus, "melas, mt-th-related", maternally inherited diabetes and deafness,
MT-TF mitochondrially encoded tRNA phenylalanine MT melas syndrome, mitochondrial disorders, merrf syndrome
MT-TH mitochondrially encoded tRNA histidine MT "melas, mt-th-related", dgke-related atypical hemolytic-uremic syndrome, melas syndrome,
MT-TI mitochondrially encoded tRNA isoleucine MT chronic progressive external ophthalmoplegia
MT-TK mitochondrially encoded tRNA lysine MT chronic progressive external ophthalmoplegia, leigh disease, mitochondrial dna-associated leigh syndrome and narp,
MT-TL1 mitochondrially encoded tRNA leucine 1 (UUA/G) MT type 2 diabetes mellitus, kearns-sayre syndrome, leigh disease,
MT-TL2 mitochondrially encoded tRNA leucine 2 (CUN) MT alzheimers disease, chronic progressive external ophthalmoplegia, mitochondrial disorders,
MT-TM mitochondrially encoded tRNA methionine MT mitochondrial disorders
MT-TN mitochondrially encoded tRNA asparagine MT maternally-inherited progressive external ophthalmoplegia
MT-TP mitochondrially encoded tRNA proline MT merrf syndrome
MT-TQ mitochondrially encoded tRNA glutamine MT melas syndrome, mitochondrial disorders, merrf syndrome
MT-TR mitochondrially encoded tRNA arginine MT mitochondrial disorders
MT-TS1 mitochondrially encoded tRNA serine 1 (UCN) MT "deafness, mitochondrial, modifier of", "nonsyndromic hearing loss and deafness, mitochondrial", dgke-related atypical hemolytic-uremic syndrome,
MT-TS2 mitochondrially encoded tRNA serine 2 (AGU/C) MT melas syndrome, mitochondrial disorders, merrf syndrome,
MT-TT mitochondrially encoded tRNA threonine MT mitochondrial disorders, lethal infantile mitochondrial myopathy infantile myopathy and lactic acidosis
MT-TV mitochondrially encoded tRNA valine MT leigh disease, mitochondrial dna-associated leigh syndrome and narp mitochondrial disorders
MT-TW mitochondrially encoded tRNA tryptophan MT leigh disease, melas syndrome, mitochondrial dna-associated leigh syndrome and narp,
MT-TY mitochondrially encoded tRNA tyrosine MT mitochondrial disorders
MT1A metallothionein 1A 16q12.2 pancreatic cancer, keloids cerebral lymphoma
MT1E metallothionein 1E 16q12.2 type 2 diabetes mellitus
MT1G metallothionein 1G 16q13 hepatocellular carcinoma, papillary thyroid carcinoma, esophageal squamous cell carcinoma
MT2A metallothionein 2A 16q12.2 cerebral lymphoma
MT3 metallothionein 3 16q12.2 amyotrophic lateral sclerosis pancreatic serous cystadenoma
MTA1 metastasis associated 1 14q32.33 adenocarcinoma tonsil cancer
MTA3 metastasis associated 1 family, member 3 2p21 gastroesophageal junction adenocarcinoma
MTAP methylthioadenosine phosphorylase 9p21.3 46xy sex reversal 6, thrombocytopenia 2 diaphyseal medullary stenosis with malignant fibrous histiocytoma
MTBS1 mycobacterium tuberculosis, susceptibility to infection by, 1 2q35 "mycobacterium tuberculosis, susceptibility to infection by" tuberculosis
MTBS2 Mycobacterium tuberculosis, susceptibility to, 2 8q12-q13 tuberculosis mycobacterium tuberculosis 2
MTBS3 Mycobacterium tuberculosis, susceptibility to, 3 19q13.31-q33 tuberculosis mycobacterium tuberculosis 3
MTBSX Mycobacterium tuberculosis, susceptibility to infection by Xq "mycobacterium tuberculosis, susceptibility to infection by", tuberculosis "mycobacerium tuberculosis, susceptibility, x-linked"
MTCO1P2 MT-CO1 pseudogene 2 14q12 ankylosing spondylitis
MTCO2P1 MT-CO2 pseudogene 1 20q13.33 fatty liver disease
MTCP1 mature T-cell proliferation 1 Xq28 t-cell prolymphocytic leukemia, african tick-bite fever queensland tick typhus
MTERF mitochondrial transcription termination factor 7q21.2 melas syndrome
MTF1 metal-regulatory transcription factor 1 1p34.3 enamel erosion dentine erosion
MTFMT mitochondrial methionyl-tRNA formyltransferase 15q22.31 leigh disease, mitochondrial complex i deficiency combined oxidative phosphorylation deficiency 15
MTHFD1 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase 14q23.3 neural tube defects, spina bifida, cervical spina bifida cystica,
MTHFR methylenetetrahydrofolate reductase (NAD(P)H) 1p36.22 intestinal atresia, vascular disease, antithrombin iii deficiency,
MTHFSD methenyltetrahydrofolate synthetase domain containing 16q24.1 vacterl association
MTM1 myotubularin 1 Xq28 charcot-marie-tooth neuropathy type 4, centronuclear myopathy, myopathy,
MTMR1 myotubularin related protein 1 Xq28 myotonic dystrophy type 2
MTMR12 myotubularin related protein 12 5p13.3 cri-du-chat syndrome
MTMR14 myotubularin related protein 14 3p25.3 centronuclear myopathy "centronuclear myopathy, autosomal, modifier of"
MTMR2 myotubularin related protein 2 11q21 charcot-marie-tooth neuropathy type 4, charcot-marie-tooth disease type 4, centronuclear myopathy,
MTMR4 myotubularin related protein 4 17q22 mulibrey nanism
MTMR9 myotubularin related protein 9 8p23.1 keratolytic winter erythema, generalized epilepsy with febrile seizures plus febrile seizures
MTNR1A melatonin receptor 1A 4q35.2 sleep disorder
MTNR1B melatonin receptor 1B 11q14.3 "diabetes mellitus, type 2, susceptiblity to", sleep disorder gestational diabetes
MTO1 mitochondrial tRNA translation optimization 1 6q13 hepatocellular fibrolamellar carcinoma combined oxidative phosphorylation deficiency 10
MTOR mechanistic target of rapamycin (serine/threonine kinase) 1p36.22 breast cancer, hemimegalencephaly, tuberous sclerosis complex,
MTPAP mitochondrial poly(A) polymerase 10p11.23 "ataxia, spastic, 4"
MTR 5-methyltetrahydrofolate-homocysteine methyltransferase 1q43 coronary artery disease, neural tube defects, megaloblastic anemia,
MTRF1L mitochondrial translational release factor 1-like 6q25.2 leigh disease
MTRNR2L10 MT-RNR2-like 10 Xp11.21 alzheimers disease
MTRNR2L11 MT-RNR2-like 11 (pseudogene) 1q43 alzheimers disease
MTRNR2L12 MT-RNR2-like 12 3q11.2 alzheimers disease
MTRNR2L13 MT-RNR2-like 13 4q26 alzheimers disease
MTRNR2L2 MT-RNR2-like 2 5q14.1 alzheimers disease
MTRNR2L3 MT-RNR2-like 3 20q13.31 alzheimers disease
MTRNR2L4 MT-RNR2-like 4 16p13.3 alzheimers disease
MTRNR2L5 MT-RNR2-like 5 10q21.1 alzheimers disease
MTRNR2L6 MT-RNR2-like 6 7q34 alzheimers disease
MTRNR2L7 MT-RNR2-like 7 10p11.21 alzheimers disease
MTRNR2L8 MT-RNR2-like 8 11p15.4 alzheimers disease
MTRNR2L9 MT-RNR2-like 9 (pseudogene) 6q11.1 alzheimers disease
MTRR 5-methyltetrahydrofolate-homocysteine methyltransferase reductase 5p15.31 coronary artery disease, neural tube defects, gonorrhea,
MTTP microsomal triglyceride transfer protein 4q23 steatorrhea, 3-hydroxyacyl-coa dehydrogenase deficiency, sitosterolemia,
MTUS1 microtubule associated tumor suppressor 1 8p22 hepatocellular carcinoma, "hepatocellular carcinoma, somatic", "hepatoblastoma, somatic"
MTX1 metaxin 1 1q22 gauchers disease
MUC1 mucin 1, cell surface associated 1q22 adenocarcinoma, thymic epithelial neoplasm, pericardial effusion,
MUC13 mucin 13, cell surface associated 3q21.2 colon cancer
MUC15 mucin 15, cell surface associated 11p14.2 papillary thyroid carcinoma
MUC16 mucin 16, cell surface associated 19p13.2 adenocarcinoma, pericardial effusion, endometriosis,
MUC17 mucin 17, cell surface associated 7q22.1 cholangiocarcinoma biliary papillomatosis
MUC2 mucin 2, oligomeric mucus/gel-forming 11p15.5 bladder carcinoma, adenocarcinoma, barretts esophagus,
MUC3A mucin 3A, cell surface associated 7q22.1 renal clear cell carcinoma cap polyposis
MUC3B mucin 3B, cell surface associated 7q22 colon cancer, cystic fibrosis ulcerative colitis
MUC4 mucin 4, cell surface associated 3q29 adenocarcinoma, pancreatic cancer, cholangiocarcinoma
MUC5AC mucin 5AC, oligomeric mucus/gel-forming 11p15.5 adenocarcinoma, pancreatic cancer, cystic fibrosis,
MUC5B mucin 5B, oligomeric mucus/gel-forming 11p15.5 pulmonary fibrosis, pseudomyxoma peritonei, idiopathic pulmonary fibrosis,
MUC6 mucin 6, oligomeric mucus/gel-forming 11p15.5 duodenal ulcer, epstein-barr virus-associated gastric carcinoma, pseudomyxoma peritonei,
MUC7 mucin 7, secreted 4q13.3 asthma, oral candidiasis, hfe-associated hereditary hemochromatosis,
MUCL1 mucin-like 1 12q13.2 breast cancer
MUHH2 Hypotrichosis, hereditary, Marie Unna type, 2 1p21.1-q21.3 hypotrichosis 5
MUM1 melanoma associated antigen (mutated) 1 19p13.3 melanoma, primary mediastinal large b-cell lymphoma nodular lymphocyte predominant hodgkin lymphoma
MUM1L1 melanoma associated antigen (mutated) 1-like 1 Xq22.3 melanoma
MURC muscle-related coiled-coil protein 9q31.1 familial dilated cardiomyopathy
MUSK muscle, skeletal, receptor tyrosine kinase 9q31.3 myasthenia gravis, "myasthenic syndrome, congenital, with pre- and postsynaptic defects", congenital myasthenic syndrome associated with acetylcholine receptor deficiency,
MUSTN1 musculoskeletal, embryonic nuclear protein 1 3p21.1 enophthalmos
MUSTQTL1 Muscle strength quantitative trait locus 1 14q24.3 muscle strength quantitative trait locus 1
MUT methylmalonyl CoA mutase 6p12.3 propionic acidemia, cblf, methylmalonic acidemia,
MUTYH mutY homolog 1p34.1 bladder cancer susceptibility, colorectal cancer, stomach cancer,
MVB12B multivesicular body subunit 12B 9q33.3 hiv-1
MVD mevalonate (diphospho) decarboxylase 16q24.3 waterhouse-friderichsen syndrome
MVK mevalonate kinase 12q24.11 relapsing fever, rhizomelic chondrodysplasia punctata, intestinal obstruction,
MVP major vault protein 16p11.2 acute myeloid leukemia, frontal lobe epilepsy, "mitral valve prolapse, myxomatous 1"
MX1 myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) 21q22.3 stomatitis, multiple sclerosis, hepatitis b,
MX2 myxovirus (influenza virus) resistance 2 (mouse) 21q22.3 croup influenza
MXD1 MAX dimerization protein 1 2p13.3 acute leukemia
MXI1 MAX interactor 1, dimerization protein 10q25.2 prostate cancer, familial prostate cancer, neurofibrosarcoma,
MYAS1 Myasthenia gravis with thymus hyperplasia 6p21.3 myasthenia gravis with thymus hyperplasia
MYB v-myb avian myeloblastosis viral oncogene homolog 6q23.3 precursor t-cell acute lymphoblastic leukemia, malignant histiocytosis, histiocytosis,
MYBBP1A MYB binding protein (P160) 1a 17p13.2 mn1 brain glioma
MYBL1 v-myb avian myeloblastosis viral oncogene homolog-like 1 8q13.1 burkitts lymphoma
MYBL2 v-myb avian myeloblastosis viral oncogene homolog-like 2 20q13.12 neuroblastoma cerebellar degeneration
MYBPC1 myosin binding protein C, slow type 12q23.2 congenital contractures, distal arthrogryposis, lethal congenital contracture syndrome 4 ,
MYBPC2 myosin binding protein C, fast type 19q13.33 hypertrophic cardiomyopathy distal arthrogryposis
MYBPC3 myosin binding protein C, cardiac 11p11.2 diastolic heart failure, familial hypertrophic cardiomyopathy, hypertrophic cardiomyopathy,
MYBPH myosin binding protein H 1q32.1 measles
MYC v-myc avian myelocytomatosis viral oncogene homolog 8q24.21 adenocarcinoma, juvenile nasopharyngeal angiofibroma, breast cancer,
MYCL v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog 1p34.2 non-small cell lung carcinoma, lung cancer, lip cancer,
MYCN v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog 2p24.3 intestinal atresia, embryonal cancer, neuroblastoma,
MYCNOS MYCN opposite strand 2p24.3 neuroblastoma
MYD88 myeloid differentiation primary response 88 3p22.2 lymphocytic choriomeningitis, macroglobulinemia, lymphoplasmacytic lymphoma,
MYEOV myeloma overexpressed 11q13.3 myeloma, breast cancer susceptibility multiple myeloma
MYEOV2 myeloma overexpressed 2 2q37.3 myeloma
MYF5 myogenic factor 5 12q21.31 cerebro-costo-mandibular syndrome
MYF6 myogenic factor 6 (herculin) 12q21.31 centronuclear myopathy, becker muscular dystrophy centronuclear myopathy 3
MYH11 myosin, heavy chain 11, smooth muscle 16p13.11 acute myeloid leukemia, geleophysic dysplasia, polymorphous low-grade adenocarcinoma,
MYH14 myosin, heavy chain 14, non-muscle 19q13.33 "deafness, autosomal dominant 4b", "peripheral neuropathy, myopathy, hoarseness, and hearing loss", "deafness, autosomal dominant 4a"
MYH2 myosin, heavy chain 2, skeletal muscle, adult 17p13.1 myopathy, bone fracture, disorders of intracellular cobalamin metabolism,
MYH3 myosin, heavy chain 3, skeletal muscle, embryonic 17p13.1 congenital contractures, distal muscular dystrophy, pleomorphic rhabdomyosarcoma,
MYH6 myosin, heavy chain 6, cardiac muscle, alpha 14q11.2 patent foramen ovale, sick sinus syndrome, familial hypertrophic cardiomyopathy,
MYH7 myosin, heavy chain 7, cardiac muscle, beta 14q11.2 congenital fiber-type disproportion, myopathy, chagas disease,
MYH7B myosin, heavy chain 7B, cardiac muscle, beta 20q11.22 "left ventricular noncompaction 1, with or without congenital heart defects"
MYH8 myosin, heavy chain 8, skeletal muscle, perinatal 17p13.1 distal muscular dystrophy, neurilemmoma, carney complex,
MYH9 myosin, heavy chain 9, non-muscle 22q12.3 bernard-soulier syndrome, "nonsyndromic hearing loss and deafness, mitochondrial", nonsyndromic hearing loss and deafness,
MYL12B myosin, light chain 12B, regulatory 18p11.31 double outlet right ventricle
MYL2 myosin, light chain 2, regulatory, cardiac, slow 12q24.11 congenital fiber-type disproportion, hypertrophic cardiomyopathy, restrictive cardiomyopathy,
MYL3 myosin, light chain 3, alkali; ventricular, skeletal, slow 3p21.31 myocardial infarction, familial hypertrophic cardiomyopathy, hypertrophic cardiomyopathy,
MYL4 myosin, light chain 4, alkali; atrial, embryonic 17q21.32 myocardial infarction, herpes gestationis aortic valve disease
MYL8P myosin, light chain 8, pseudogene 6p21.32 systemic lupus erythematosus
MYLK myosin light chain kinase 3q21.1 giardiasis, aortic aneurysm, "aortic aneurysm, familial thoracic 4",
MYLK2 myosin light chain kinase 2 20q11.21 familial hypertrophic cardiomyopathy, caveolinopathies, "cardiomyopathy, familial hypertrophic, 1"
MYMY1 moyamoya disease 1 3p26-p24.2 moyamoya disease
MYMY3 moyamoya disease 3 8q23 moyamoya disease
MYMY4 Moyamoya disease 4 Xq28 moyamoya disease moyamoya disease 4
MYO15A myosin XVA 17p11.2 "deafness, autosomal recessive 76", mitochondrial complex v deficiency, "mitochondrial complex v deficiency, mitochondrial 1",
MYO18A myosin XVIIIA 17q11.2 8p11 myeloproliferative syndrome
MYO18B myosin XVIIIB 22q12.1 lung cancer
MYO1A myosin IA 12q13.3 "deafness, autosomal dominant 4b", dfna48 nonsyndromic hearing loss and deafness "deafness, autosomal dominant 48"
MYO1B myosin IB 2q32.3 amebiasis
MYO1C myosin IC 17p13.3 "deafness, autosomal dominant 4b" "glomerulosclerosis, focal segmental, 6"
MYO1E myosin IE 15q22.2 familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis, glomerulosclerosis, focal segmental glomerulosclerosis
MYO3A myosin IIIA 10p12.1 "deafness, autosomal recessive 76", "deafness, autosomal recessive 30" dfnb30 nonsyndromic hearing loss and deafness
MYO5A myosin VA (heavy chain 12, myoxin) 15q21.2 griscelli syndrome, piebaldism, neuroectodermal melanolysosomal disease,
MYO5B myosin VB 18q21.1 diarrhea, microvillus inclusion disease diarrhea with microvillus atrophy 2
MYO6 myosin VI 6q14.1 "deafness, autosomal recessive 76", "deafness, autosomal dominant 4b", dfnb37 nonsyndromic hearing loss and deafness,
MYO7A myosin VIIA 11q13.5 alzheimers disease, "deafness, autosomal recessive 76", dfnb1,
MYO9B myosin IXB 19p13.11 celiac disease, refractory celiac disease, ulcerative colitis
MYOC myocilin, trabecular meshwork inducible glucocorticoid response 1q24.3 steroid-induced glaucoma, "glaucoma 3, primary congenital, d", primary congenital glaucoma,
MYOCD myocardin 17p12 retroperitoneal leiomyosarcoma
MYOD1 myogenic differentiation 1 11p15.1 embryonal sarcoma, botryoid rhabdomyosarcoma, undifferentiated embryonal sarcoma of the liver,
MYOF myoferlin 10q23.33 dysferlinopathy miyoshi myopathy
MYOG myogenin (myogenic factor 4) 1q32.1 embryonal sarcoma, botryoid rhabdomyosarcoma, undifferentiated embryonal sarcoma of the liver,
MYOM1 myomesin 1 18p11.31 myopia-2
MYOT myotilin 5q31.2 neuromuscular disease, limb-girdle muscular dystrophy, treacher collins syndrome,
MYOZ2 myozenin 2 4q26 "cardiomyopathy, familial hypertrophic, 16" myoz2-related familial hypertrophic cardiomyopathy
MYP1 myopia 1 (X-linked) Xq28 myopia, bornholm eye disease myopia-1
MYP10 myopia 10 8p23 myopia myopia 10
MYP11 myopia 11 (high grade, autosomal dominant) 4q22-q27 myopia 11
MYP12 myopia 12 (high grade, autosomal dominant) 2q37.1 myopia myopia 12
MYP13 myopia 13 Xq23-q25 myopia myopia 13
MYP14 myopia 14 1p36 myopia 14
MYP15 myopia 15 10q21.1 myopia 15
MYP16 myopia 16 5p15.33-p15.2 myopia 16
MYP17 myopia 17 7p15 myopia 17
MYP18 myopia 18 (high grade, autosomal recessive) 14q22.1-q24.2 myopia 18
MYP19 Myopia 19, autosomal dominant 5p15.1-p13.3 myopia myopia 19
MYP2 myopia 2 (high grade, autosomal dominant) 18p11.31 myopia-2 myopia
MYP20 Myopia 20, autosomal dominant 13q12.12 "myopia 20, autosomal dominant"
MYP3 myopia 3 (high grade, autosomal dominant) 12q21-q23 myopia-3
MYP4 myopia 4 (high grade, autosomal dominant) 7q36 myopia 17
MYP5 myopia 5 (high grade, autosomal dominant) 17q21-q22 myopia 5
MYP6 myopia 6 22q12 "cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1" myopia 6
MYP7 myopia 7 11p13 myopia 7
MYP8 myopia 8 3q26 myopia 8
MYP9 myopia 9 4q12 myopia 9
MYPN myopalladin 10q21.3 "cardiomyopathy, dilated, 1w", "cardiomyopathy, dilated, 1kk", "cardiomyopaty, familial restrictive 4",
MYT1 myelin transcription factor 1 20q13.33 dysembryoplastic neuroepithelial tumor, periventricular leukomalacia leukomalacia
MZF1 myeloid zinc finger 1 19q13.43 transitional cell carcinoma
NAA10 N(alpha)-acetyltransferase 10, NatA catalytic subunit Xq28 lenz microphthalmia syndrome, oculofaciocardiodental syndrome, "microphthalmia, syndrome 1"
NAA15 N(alpha)-acetyltransferase 15, NatA auxiliary subunit 4q31.1 retinopathy of prematurity
NAA20 N(alpha)-acetyltransferase 20, NatB catalytic subunit 20p11.23 eastern equine encephalitis
NAA30 N(alpha)-acetyltransferase 30, NatC catalytic subunit 14q22.3 eastern equine encephalitis
NAB1 NGFI-A binding protein 1 (EGR1 binding protein 1) 2q32.2 charcot-marie-tooth disease type 3 charcot-marie-tooth disease type 1
NAB2 NGFI-A binding protein 2 (EGR1 binding protein 2) 12q13.3 solitary fibrous tumor
NABP1 nucleic acid binding protein 1 2q32.3 acute promyelocytic leukemia
NACA nascent polypeptide-associated complex alpha subunit 12q13.3 atopic dermatitis, dermatitis lethal midline granuloma
NACA3P NACA family member 3 pseudogene 4q32.3 babesiosis
NACC1 nucleus accumbens associated 1, BEN and BTB (POZ) domain containing 19p13.2 hyperargininemia
NAFLD1 Fatty liver disease 1, susceptiblity to 22q13 fatty liver disease, liver disease "fatty liver disease, nonalcoholic 1"
NAFLD2 Fatty liver disease, nonalcoholic, susceptibility to, 2 11q23 fatty liver disease, liver disease "fatty liver disease, nonalcoholic 2"
NAGA N-acetylgalactosaminidase, alpha- 22q13.2 fabry disease, angiokeratoma, fucosidosis,
NAGLU N-acetylglucosaminidase, alpha 17q21.2 renal agenesis, nephrotic syndrome, mucopolysaccharidosis iii,
NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 16p13.3 speech disorder
NAGS N-acetylglutamate synthase 17q21.31 urea cycle disorder, carbamoyl phosphate synthetase i deficiency disease, propionic acidemia
NAIP NLR family, apoptosis inhibitory protein 5q13.2 amyotrophic lateral sclerosis, muscular atrophy, neuromuscular disease,
NALCN sodium leak channel, non-selective 13q33.1 neuroaxonal dystrophy, "epileptic encephalopathy, early infantile, 4" "neuroaxonal neurodegeneration, infantile, with facial dysmophism"
NAMA non-protein coding RNA, associated with MAP kinase pathway and growth arrest 9q22.33 papillary thyroid carcinoma
NAMPT nicotinamide phosphoribosyltransferase 7q22.3 coronary artery disease, type 2 diabetes mellitus, insulin resistance,
NANOG Nanog homeobox 12p13.31 sacrococcygeal teratoma, ovarian germ cell tumor ovarian serous cystadenocarcinoma
NANOGP8 Nanog homeobox pseudogene 8 15q14 breast adenocarcinoma
NANOS1 nanos homolog 1 (Drosophila) 10q26.11 atherosclerosis spermatogenic failure 12
NANOS2 nanos homolog 2 (Drosophila) 19q13.32 spermatocytoma
NANS N-acetylneuraminic acid synthase 9q22.33 alexithymia hard palate cancer
NAP1L4 nucleosome assembly protein 1-like 4 11p15.4 breast cancer, beckwith-wiedemann syndrome wilms tumor
NAPA N-ethylmaleimide-sensitive factor attachment protein, alpha 19q13.33 periventricular heterotopia
NAPB N-ethylmaleimide-sensitive factor attachment protein, beta 20p11.21 ovarian cancer, hereditary neuralgic amyotrophy "leukemia, acute myeloid, therapy-related"
NAPRT1 nicotinate phosphoribosyltransferase domain containing 1 8q24.3 multiple carboxylase deficiency, pellagra, methylmalonic aciduria and homocystinuria type cble,
NAPSA napsin A aspartic peptidase 19q13.33 sarcomatoid mesothelioma, lung adenocarcinoma lung squamous cell carcinoma
NARFL nuclear prelamin A recognition factor-like 16p13.3 pertussis
NARG2 NMDA receptor regulated 2 15q22.2 breast cancer
NARS2 asparaginyl-tRNA synthetase 2, mitochondrial (putative) 11q14.1 inclusion conjunctivitis
NAT1 N-acetyltransferase 1 (arylamine N-acetyltransferase) 8p22 neural tube defects, non-hodgkin lymphoma, orthostatic intolerance ,
NAT2 N-acetyltransferase 2 (arylamine N-acetyltransferase) 8p22 parkinsons disease, breast cancer, lung cancer,
NAT6 N-acetyltransferase 6 (GCN5-related) 3p21.31 lung cancer lung cancer susceptibility
NAT8L N-acetyltransferase 8-like (GCN5-related, putative) 4p16.3 n-acetylaspartate deficiency
NAV2 neuron navigator 2 11p15.1 neuroblastoma neuroblastoma 1
NAV3 neuron navigator 3 12q21.2 subcutaneous panniculitis-like t-cell lymphoma
NBAS neuroblastoma amplified sequence 2p24.3 neuroblastoma, short stature, pelger-huet anomaly,
NBEA neurobeachin 13q13.3 myeloma, multiple myeloma chediak-higashi syndrome
NBEAL1 neurobeachin-like 1 2q33.2 amyotrophic lateral sclerosis, lateral sclerosis ovary serous adenocarcinoma
NBEAL2 neurobeachin-like 2 3p21.31 gray platelet syndrome
NBEAP1 neurobeachin pseudogene 1 15q11.2 "lymphoma, diffuse large cell"
NBL1 neuroblastoma 1, DAN family BMP antagonist 1p36.13 neuroblastoma, meningioma neuroblastoma 1
NBLST4 Neuroblastoma, susceptibility to, 4 6p22 neuroblastoma, "neuroblastoma, susceptibility" neuroblastoma 4
NBLST5 Neuroblastoma, susceptibility to, 5 2q35 neuroblastoma, neuroblastoma 5 "neuroblastoma, susceptibility"
NBLST6 Neuroblastoma, susceptibility to, 6 1q21.1 neuroblastoma, "neuroblastoma, susceptibility" neuroblastoma 6
NBN nibrin 8q21.3 breast cancer susceptibility, breast cancer, male breast cancer,
NBPF1 neuroblastoma breakpoint family, member 1 1p36.13 schizophrenia, neuroblastoma congenital heart disease
NBPF10 neuroblastoma breakpoint family, member 10 1q21.1 schizophrenia neuroblastoma
NBPF11 neuroblastoma breakpoint family, member 11 1q21.1 neuroblastoma
NBPF12 neuroblastoma breakpoint family, member 12 1q21.1 schizophrenia neuroblastoma
NBPF13P neuroblastoma breakpoint family, member 13, pseudogene 1q21.1 schizophrenia neuroblastoma
NBPF14 neuroblastoma breakpoint family, member 14 1q21.2 schizophrenia neuroblastoma
NBPF15 neuroblastoma breakpoint family, member 15 1q21.2 schizophrenia neuroblastoma
NBPF17P neuroblastoma breakpoint family, member 17, pseudogene 1q21.2 neuroblastoma
NBPF18P neuroblastoma breakpoint family, member 18, pseudogene 1q21.3 schizophrenia, neuroblastoma congenital heart disease
NBPF19 neuroblastoma breakpoint family, member 19 1q21 neuroblastoma
NBPF20 neuroblastoma breakpoint family, member 20 1q21.2 schizophrenia neuroblastoma
NBPF21P neuroblastoma breakpoint family, member 21, pseudogene 3p22.2 schizophrenia, neuroblastoma congenital heart disease
NBPF22P neuroblastoma breakpoint family, member 22, pseudogene 5q14.3 schizophrenia neuroblastoma
NBPF23P neuroblastoma breakpoint family, member 23, pseudogene 1q21.2 schizophrenia, neuroblastoma congenital heart disease
NBPF25P neuroblastoma breakpoint family, member 25, pseudogene 1q21.1 schizophrenia, neuroblastoma congenital heart disease
NBPF26 neuroblastoma breakpoint family, member 26 1q21.1 neuroblastoma
NBPF2P neuroblastoma breakpoint family, member 2, pseudogene 1p36.12 schizophrenia, neuroblastoma congenital heart disease
NBPF3 neuroblastoma breakpoint family, member 3 1p36.12 schizophrenia neuroblastoma
NBPF4 neuroblastoma breakpoint family, member 4 1p13.3 schizophrenia neuroblastoma
NBPF5P neuroblastoma breakpoint family, member 5, pseudogene 1p13.3 neuroblastoma
NBPF6 neuroblastoma breakpoint family, member 6 1p13.3 schizophrenia neuroblastoma
NBPF7 neuroblastoma breakpoint family, member 7 1p12 schizophrenia neuroblastoma
NBPF8 neuroblastoma breakpoint family, member 8 1q21.1 schizophrenia, neuroblastoma genital herpes
NBPF9 neuroblastoma breakpoint family, member 9 1q21.1 schizophrenia, neuroblastoma congenital heart disease
NBR1 neighbor of BRCA1 gene 1 17q21.31 ovarian cancer
NCAM1 neural cell adhesion molecule 1 11q23.2 monoclonal gammopathy of uncertain significance, myeloma, centronuclear myopathy,
NCAPG non-SMC condensin I complex, subunit G 4p15.31 croup
NCBP1 nuclear cap binding protein subunit 1, 80kDa 9q22.33 asthenopia
NCDN neurochondrin 1p34.3 osteochondrosis
NCF1 neutrophil cytosolic factor 1 7q11.23 chronic granulomatous disease, idiopathic pulmonary fibrosis, "chronic granulomatous disease, autosomal, due to deficiency of cyba",
NCF2 neutrophil cytosolic factor 2 1q25.3 chronic granulomatous disease, endocardial fibroelastosis, chronic granulomatous disease due to deficiency of ncf-2 ,
NCF4 neutrophil cytosolic factor 4, 40kDa 22q12.3 common variable immune deficiency, chronic granulomatous disease, "chronic granulomatous disease, autosomal, due to deficiency of cyba"
NCK1 NCK adaptor protein 1 3q22.3 wiskott-aldrich syndrome
NCK2 NCK adaptor protein 2 2q12.2 craniofrontonasal syndrome low tension glaucoma
NCKAP1 NCK-associated protein 1 2q32.1 nance-horan syndrome
NCKAP1L NCK-associated protein 1-like 12q13.13 hypochromic anemia
NCKAP5 NCK-associated protein 5 2q21.2 hypersomnia
NCKIPSD NCK interacting protein with SH3 domain 3p21.31 wiskott-aldrich syndrome
NCL nucleolin 2q37.1 parainfluenza virus type 3
NCOA1 nuclear receptor coactivator 1 2p23.3 trachea leiomyoma goldenhar syndrome
NCOA2 nuclear receptor coactivator 2 8q13.3 prostate cancer, partial androgen insensitivity syndrome, mesenchymal chondrosarcoma
NCOA3 nuclear receptor coactivator 3 20q13.12 breast cancer
NCOA4 nuclear receptor coactivator 4 10q11.23 follicular thyroid carcinoma papillary thyroid carcinoma
NCOA6 nuclear receptor coactivator 6 20q11.22 breast cancer
NCOR2 nuclear receptor corepressor 2 12q24.31 thyroid hormone resistance syndrome cortisol resistance
NCR3 natural cytotoxicity triggering receptor 3 6p21.33 malaria, proliferative vitreoretinopathy, cytomegalovirus infection,
NCSTN nicastrin 1q23.2 alzheimers disease, acne, hidradenitis suppurativa,
NDC80 NDC80 kinetochore complex component 18p11.32 retinoblastoma
NDE1 nudE neurodevelopment protein 1 16p13.11 hydranencephaly, lissencephaly, wernicke encephalopathy,
NDEL1 nudE neurodevelopment protein 1-like 1 17p13.1 iridocyclitis
NDFIP1 Nedd4 family interacting protein 1 5q31.3 breast cancer
NDFIP2 Nedd4 family interacting protein 2 13q31.1 hypochromic anemia
NDIC Nail dysplasia, isolated congenital 17p13 "nail dysplasia, isolated congenital"
NDN necdin, melanoma antigen (MAGE) family member 15q11.2 angelman syndrome, autism spectrum disorder, prader-willi syndrome,
NDNC9 Nail disorder, nonsyndromic congenital, 9 17q25.1-q25.3 "nail disorder, nonsyndromic congenital, 9"
NDNL2 necdin-like 2 15q13.1 hepatocellular carcinoma
NDOR1 NADPH dependent diflavin oxidoreductase 1 9q34.3 colorectal adenocarcinoma
NDP Norrie disease (pseudoglioma) Xp11.3 klippel-trenaunay syndrome, coats disease, telangiectasis,
NDRG1 N-myc downstream regulated 1 8q24.22 charcot-marie-tooth neuropathy type 4, charcot-marie-tooth disease type 4, charcot-marie-tooth neuropathy type 4d,
NDRG3 NDRG family member 3 20q11.23 motor peripheral neuropathy
NDRG4 NDRG family member 4 16q21 motor peripheral neuropathy
NDST1 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 5q33.1 treacher collins syndrome
NDST3 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 4q26 mast cell neoplasm
NDUFA1 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa Xq24 leber hereditary optic neuropathy, "fanconi anemia, complementation group a", leigh disease
NDUFA10 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa 2q37.3 leigh syndrome with leukodystrophy, leigh disease mitochondrial dna deletion syndromes
NDUFA11 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa 19p13.3 mitochondrial complex i deficiency
NDUFA12 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 12q22 mitochondrial dna deletion syndromes, mitochondrial dna-associated leigh syndrome and narp, leigh syndrome due to mitochondrial complex i deficiency,
NDUFA13 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 19p13.11 follicular thyroid carcinoma, thyroid hurthle cell carcinoma kidney cancer
NDUFA2 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa 5q31.3 leigh syndrome with leukodystrophy, leigh disease, mitochondrial complex i deficiency ,
NDUFA4 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa 7p21.3 dandy-walker syndrome cytochrome-c oxidase deficiency disease
NDUFA6 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa 22q13.2 21-hydroxylase deficiency
NDUFA8 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa 9q33.2 leigh disease mitochondrial complex i deficiency
NDUFA9 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa 12p13.32 mitochondrial complex i deficiency , mitochondrial dna deletion syndromes leigh syndrome due to mitochondrial complex i deficiency
NDUFAB1 NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa 16p12.2 hcl-v
NDUFAF1 NADH dehydrogenase (ubiquinone) complex I, assembly factor 1 15q15.1 mitochondrial complex i deficiency fatal infantile hypertrophic cardiomyopathy due to mitochondrial complex i deficiency
NDUFAF2 NADH dehydrogenase (ubiquinone) complex I, assembly factor 2 5q12.1 leigh disease, mitochondrial complex i deficiency mitochondrial dna deletion syndromes
NDUFAF3 NADH dehydrogenase (ubiquinone) complex I, assembly factor 3 3p21.31 mitochondrial complex i deficiency
NDUFAF4 NADH dehydrogenase (ubiquinone) complex I, assembly factor 4 6q16.1 mitochondrial complex i deficiency
NDUFAF5 NADH dehydrogenase (ubiquinone) complex I, assembly factor 5 20p12.1 leigh disease, mitochondrial complex i deficiency , leigh syndrome due to mitochondrial complex i deficiency,
NDUFAF6 NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 8q22.1 leigh syndrome with leukodystrophy, leigh disease, mitochondrial complex i deficiency ,
NDUFB3 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa 2q33.1 leigh disease mitochondrial complex i deficiency
NDUFB6 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa 9p21.1 mitochondrial complex i deficiency
NDUFB8 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa 10q24.31 myofascial pain syndrome, epicondylitis spondylosis
NDUFB9 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa 8q24.13 mitochondrial complex i deficiency
NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 11q14.1 lung cancer papillary thyroid carcinoma
NDUFS1 NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) 2q33.3 leigh syndrome with leukodystrophy, leigh disease, mitochondrial complex i deficiency
NDUFS2 NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) 1q23.3 mitochondrial complex i deficiency tricuspid valve prolapse
NDUFS3 NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase) 11p11.2 leigh syndrome with leukodystrophy, tungiasis, leigh disease,
NDUFS4 NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) 5q11.2 parkinsons disease, schizophrenia, leber hereditary optic neuropathy,
NDUFS5 NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) 1p34.3 atrophic gastritis
NDUFS6 NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) 5p15.33 leigh disease mitochondrial complex i deficiency
NDUFS7 NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) 19p13.3 leigh syndrome with leukodystrophy, leigh disease, mitochondrial complex i deficiency ,
NDUFS8 NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) 11q13.2 leigh syndrome with leukodystrophy, leigh disease, mitochondrial complex i deficiency ,
NDUFV1 NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa 11q13.2 leigh syndrome with leukodystrophy, leigh disease, mitochondrial complex i deficiency ,
NDUFV2 NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa 18p11.22 schizophrenia, bipolar disorder, hypertrophic cardiomyopathy
NDUFV3 NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa 21q22.3 autosomal recessive nonsyndromic deafness
NEB nebulin 2q23.3 myopathy, dystrophinopathies, scabies,
NEBL nebulette 10p12.31 endocardial fibroelastosis ebstein anomaly
NECAP1 NECAP endocytosis associated 1 12p13.31 "epileptic encephalopathy, early infantile, 21"
NEDD4 neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase 15q21.3 keloid formation pseudohypoaldosteronism type 1
NEDD4L neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase 18q21.31 essential hypertension, hypertension liddle syndrome
NEDD8 neural precursor cell expressed, developmentally down-regulated 8 14q12 glomuvenous malformation
NEDE nephropathy, progressive, with deafness 11q24 "nephropathy, progressive, with deafness"
NEFH neurofilament, heavy polypeptide 22q12.2 amyotrophic lateral sclerosis, lateral sclerosis, leber hereditary optic neuropathy,
NEFL neurofilament, light polypeptide 8p21.2 amyotrophic lateral sclerosis, schizophrenia, charcot-marie-tooth neuropathy type 2,
NEFM neurofilament, medium polypeptide 8p21.2 charcot-marie-tooth disease type 2, wallerian degeneration toxic encephalopathy
NEGR1-IT1 NEGR1 intronic transcript 1 (non-protein coding) 1p31.1 systemic lupus erythematosus
NEIL1 nei endonuclease VIII-like 1 (E. coli) 15q24.2 familial colorectal cancer, primary sclerosing cholangitis, steroid-resistant nephrotic syndrome
NEK1 NIMA-related kinase 1 4q33 asphyxiating thoracic dystrophy, sensenbrenner syndrome, polycystic kidney disease,
NEK2 NIMA-related kinase 2 1q32.3 leber congenital amaurosis, van der woude syndrome, plexiform neurofibroma,
NEK3 NIMA-related kinase 3 13q14.3 muscle glycogenosis, phosphorylase kinase deficiency, muscle phosphorylase kinase deficiency
NEK4 NIMA-related kinase 4 3p21.1 coffin-lowry syndrome
NEK8 nimA-related kinase 8 17q11.2 renal-hepatic-pancreatic dysplasia, renal-hepatic-pancreatic dysplasia 1 , kidney disease,
NELFA negative elongation factor complex member A 4p16.3 wolf-hirschhorn syndrome
NELL1 NEL-like 1 (chicken) 11p15.1 craniosynostosis gnathodiaphyseal dysplasia
NEMF nuclear export mediator factor 14q21.3 colon cancer
NENF neudesin neurotrophic factor 1q32.3 spinal cord injury
NES nestin 1q23.1 osteochondroma, pilocytic astrocytoma, amyotrophic lateral sclerosis,
NET1 neuroepithelial cell transforming 1 10p15.1 orthostatic intolerance skin squamous cell carcinoma
NEU1 sialidase 1 (lysosomal sialidase) 6p21.33 bernard-soulier syndrome, gangliosidosis gm1, chagas disease,
NEU2 sialidase 2 (cytosolic sialidase) 2q37.1 stomach cancer, lysinuric protein intolerance, galactosialidosis
NEU3 sialidase 3 (membrane sialidase) 11q13.4 galactosialidosis
NEU4 sialidase 4 2q37.3 galactosialidosis
NEUROD1 neuronal differentiation 1 2q31.3 type 2 diabetes mellitus, diabetes mellitus, "diabetes mellitus, noninsulin-dependent",
NEUROD2 neuronal differentiation 2 17q12 alcohol dependence
NEUROG1 neurogenin 1 5q31.1 moebius syndrome medulloblastoma
NEUROG3 neurogenin 3 10q22.1 diarrhea, "obesity, hyperphagia, and developmental delay" congenital malabsorptive diarrhea 4
NEXN nexilin (F actin binding protein) 1p31.1 chorea-acanthocytosis, neuroacanthocytosis, "cardiomyopathy, dilated, 1w",
NF1 neurofibromin 1 17q11.2 cherubism, colorectal cancer, learning disability,
NF1L1P neurofibromatosis type 1 pseudogene neurofibromatosis
NF2 neurofibromin 2 (merlin) 22q12.2 colorectal cancer, secretory meningioma, malaria,
NFASC neurofascin 1q32.1 hyperkalemic periodic paralysis
NFAT5 nuclear factor of activated T-cells 5, tonicity-responsive 16q22.1 cherubism
NFATC1 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 18q23 cherubism enchondroma
NFATC2 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 20q13.2 enchondroma
NFE2L3 nuclear factor, erythroid 2-like 3 7p15.2 fibrosarcoma
NFIB nuclear factor I/B 9p22.3 polymorphous low-grade adenocarcinoma lipoma of colon
NFIC nuclear factor I/C (CCAAT-binding transcription factor) 19p13.3 common wart
NFIL3 nuclear factor, interleukin 3 regulated 9q22.31 autism spectrum disorder
NFIX nuclear factor I/X (CCAAT-binding transcription factor) 19p13.2 sotos syndrome, common wart, sotos syndrome 2 ,
NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 4q24 limb-girdle muscular dystrophy type 2h, hepatitis d, aneurysmal bone cysts
NFKB2 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) 10q24.32 b-cell lymphomas, common variable immune deficiency, "immunodeficiency, common variable, 9",
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 14q13.2 gliosarcoma, giant cell glioblastoma, autosomal dominant disease,
NFKBIL1 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 6p21.33 chronic thromboembolic pulmonary hypertension, rheumatoid arthritis, juvenile rheumatoid arthritis,
NFS1 NFS1 cysteine desulfurase 20q11.22 combined oxidative phosphorylation deficiency 19
NFU1 NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae) 2p13.3 genital herpes, multiple mitochondrial dysfunctions syndrome 1 , lafora disease
NFXL1 nuclear transcription factor, X-box binding-like 1 4p12 colon cancer
NFYAP1 nuclear transcription factor Y, alpha pseudogene 1 13q21.31 pulmonary function
NGF nerve growth factor (beta polypeptide) 1p13.2 lesch-nyhan syndrome, neuroblastoma, neuropathy,
NGFR nerve growth factor receptor 17q21.33 amyotrophic lateral sclerosis, noma, hirschsprungs disease,
NGLY1 N-glycanase 1 3p24.2 "congenital disorder of glycosylation, type iv" alacrimia-choreoathetosis-liver dysfunction syndrome
NGRN neugrin, neurite outgrowth associated 15q26.1 neuroblastoma
NHEG1 neuroblastoma highly expressed 1 6q23.3 neuroblastoma
NHEJ1 nonhomologous end-joining factor 1 2q35 severe combined immunodeficiency, dna ligase iv deficiency, polymicrogyria with seizures
NHLH2 nescient helix loop helix 2 1p13.1 egg allergy
NHLRC1 NHL repeat containing E3 ubiquitin protein ligase 1 6p22.3 neuroleptic malignant syndrome, congenital generalized lipodystrophy, myoclonus,
NHP2 NHP2 ribonucleoprotein 5q35.3 aplastic anemia, "dyskeratosis congenita, autosomal recessive 4", dyskeratosis congenita,
NHS Nance-Horan syndrome (congenital cataracts and dental anomalies) Xp22.13 decubitus ulcer, "cataract 4, multiple types", nance-horan syndrome,
NHSL1 NHS-like 1 6q24.1 nance-horan syndrome
NICN1 nicolin 1 3p21.31 glycine encephalopathy
NID1 nidogen 1 1q42.3 goodpasture syndrome
NIDDM1 non-insulin-dependent diabetes mellitus (common, type 2) 1 2q "diabetes mellitus, noninsulin-dependent 1"
NIDDM2 non-insulin-dependent diabetes mellitus (common, type 2) 2 12q24.2 "diabetes mellitus, noninsulin-dependent, 2"
NIDDM3 Noninsulin-dependent diabetes mellitus 3 20q12-q13.1 diabetes mellitus "diabetes mellitus, noninsulin-dependent"
NIDDM4 Diabetes mellitus, noninsulin-dependent 5q34-q35.2 diabetes mellitus "diabetes mellitus, noninsulin-dependent"
NIF3L1 NIF3 NGG1 interacting factor 3-like 1 (S. cerevisiae) 2q33.1 amyotrophic lateral sclerosis lateral sclerosis
NIN ninein (GSK3B interacting protein) 14q22.1 chediak-higashi syndrome, seckel syndrome 7 , diabetic cataract
NINJ1 ninjurin 1 9q22.31 spinal cord injury acrocallosal syndrome
NINJ2 ninjurin 2 12p13.33 acrocallosal syndrome
NIPA1 non imprinted in Prader-Willi/Angelman syndrome 1 15q11.2 angelman syndrome, autosomal recessive congenital ichthyosis, microdeletion 15q11.2,
NIPA2 non imprinted in Prader-Willi/Angelman syndrome 2 15q11.2 angelman syndrome, prader-willi syndrome, autosomal recessive congenital ichthyosis
NIPA2P1 non imprinted in Prader-Willi/Angelman syndrome 2 pseudogene 1 7q21.13 angelman syndrome
NIPA2P2 non imprinted in Prader-Willi/Angelman syndrome 2 pseudogene 2 3p12.3 angelman syndrome
NIPA2P3 non imprinted in Prader-Willi/Angelman syndrome 2 pseudogene 3 21q21.1 angelman syndrome
NIPA2P4 non imprinted in Prader-Willi/Angelman syndrome 2 pseudogene 4 8q21.13 angelman syndrome
NIPA2P5 non imprinted in Prader-Willi/Angelman syndrome 2 pseudogene 5 13q31.1 angelman syndrome
NIPAL1 NIPA-like domain containing 1 4p12 angelman syndrome
NIPAL2 NIPA-like domain containing 2 8q22.2 autosomal recessive congenital ichthyosis
NIPAL4 NIPA-like domain containing 4 5q33.3 angelman syndrome, autosomal recessive congenital ichthyosis, "ichthyosis, congenital, autosomal recessive 6",
NIPBL Nipped-B homolog (Drosophila) 5p13.2 nipbl-related cornelia de lange syndrome, limb reduction defect, cornelia de lange syndrome 1 ,
NIPSNAP1 nipsnap homolog 1 (C. elegans) 22q12.2 phenylketonuria
NISCH nischarin 3p21.1 rosacea, essential hypertension morphine dependence
NKAIN2 Na+/K+ transporting ATPase interacting 2 6q22.31 genital herpes
NKCD Natural killer cell deficiency, familial isolated natural killer cell and glucocorticoid deficiency with dna repair defect
NKX2-1 NK2 homeobox 1 14q13.3 papillary adenocarcinoma, hemangioma, non-small cell lung carcinoma,
NKX2-2 NK2 homeobox 2 20p11.22 gastrointestinal neuroendocrine tumor neuroendocrine tumor
NKX2-3 NK2 homeobox 3 10q24.2 dental caries, crohns disease ulcerative colitis
NKX2-5 NK2 homeobox 5 5q35.1 patent foramen ovale, "heart block, progressive, type ia", "hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia",
NKX2-6 NK2 homeobox 6 8p21.2 velocardiofacial syndrome, conotruncal heart malformations, persistent truncus arteriosus,
NKX3-1 NK3 homeobox 1 8p21.2 prostate cancer, familial prostate cancer chromosome 8p deletion
NKX3-2 NK3 homeobox 2 4p15.33 skeletal dysplasias, osteosarcoma, metaphyseal dysplasia
NLGN3 neuroligin 3 Xq13.1 atypical autism, autism spectrum disorder, asperger syndrome,
NLGN4X neuroligin 4, X-linked Xp22.31 pervasive developmental disorder, x-linked ichthyosis, atypical autism,
NLRC4 NLR family, CARD domain containing 4 2p22.3 legionnaires disease
NLRC5 NLR family, CARD domain containing 5 16q13 legionnaires disease
NLRP1 NLR family, pyrin domain containing 1 17p13.2 vitiligo, systemic lupus erythematosus, toxoplasmosis,
NLRP11 NLR family, pyrin domain containing 11 19q13.43 necrotizing fasciitis
NLRP12 NLR family, pyrin domain containing 12 19q13.42 familial cold autoinflammatory syndrome, familial cold autoinflammatory syndrome 2 x-linked congenital stationary night blindness
NLRP3 NLR family, pyrin domain containing 3 1q44 wells syndrome, urticaria, exanthem,
NLRP5 NLR family, pyrin domain containing 5 19q13.43 autoimmune polyendocrine syndrome type 1
NLRP7 NLR family, pyrin domain containing 7 19q13.42 partial hydatidiform mole, gestational trophoblastic neoplasm, trophoblastic neoplasm,
NM neutrophil migration 7q22-qter inclusion body myositis, sialuria "neutrophil chemotactic repsonse, abnormal"
NMB neuromedin B 15q25.3 lung cancer, gastrinoma, late-infantile neuronal ceroid lipofuscinosis
NME1 NME/NM23 nucleoside diphosphate kinase 1 17q21.33 hepatocellular carcinoma, adenocarcinoma, papillary adenocarcinoma,
NME2 NME/NM23 nucleoside diphosphate kinase 2 17q21.33 acute myeloid leukemia
NME4 NME/NM23 nucleoside diphosphate kinase 4 16p13.3 cystic fibrosis fatal infantile lactic acidosis
NME8 NME/NM23 family member 8 7p14.1 "ciliary dyskinesia, primary, 19", "ciliary dyskinesia, primary, 6", primary ciliary dyskinesia 6: nme8-related primary ciliary dyskinesia
NMLFS Nablus mask-like facial syndrome 8q22.1 nablus mask-like facial syndrome
NMNAT1 nicotinamide nucleotide adenylyltransferase 1 1p36.22 leber congenital amaurosis, leber congenital amaurosis 17, wallerian degeneration,
NMS neuromedin S 2q11.2 acral lentiginous melanoma, nodular malignant melanoma vulvar melanoma
NMSR Neuropathy, hereditary motor and sensory, Russe type 10q23.2 "neuropathy, hereditary motor and sensory, russe type" "neuropathy, motor and sensory, russe type"
NMTC1 Nonmedullary thyroid carcinoma 1 2q21 "thyroid carcinoma, nonmedullary, 1"
NMUR1 neuromedin U receptor 1 2q37.1 hypertension
NMUR2 neuromedin U receptor 2 5q33.1 hypertension
NNMT nicotinamide N-methyltransferase 11q23.2 parkinsons disease, thyroid cancer, kidney cancer
NNO1 nanophthalmos 1 11p13 nanophthalmos-1
NNO3 nanophthalmos 3 2q11-q14 nanophthalmos 3
NNT nicotinamide nucleotide transhydrogenase 5p12 familial glucocorticoid deficiency, "glucocorticoid deficiency, due to acth unresponsiveness" glucocorticoid deficiency 4
NOB1 NIN1/RPN12 binding protein 1 homolog (S. cerevisiae) 16q22.1 adenocarcinoma
NOBOX NOBOX oogenesis homeobox 7q35 premature ovarian failure 5 , premature ovarian failure ovarian cyst
NOD1 nucleotide-binding oligomerization domain containing 1 7p14.3 blau syndrome
NOD2 nucleotide-binding oligomerization domain containing 2 16q12.1 colorectal cancer, guttate psoriasis, sarcoidosis,
NODAL nodal growth differentiation factor 10q22.1 septopreoptic holoprosencephaly, midline interhemispheric variant of holoprosencephaly, lobar holoprosencephaly,
NOG noggin 17q22 multiple synostosis syndrome 1, multiple synostoses syndrome, prostate cancer,
NOL3 nucleolar protein 3 (apoptosis repressor with CARD domain) 16q22.1 "myoclonus, familial cortical", pain agnosia, agnosia
NOLC1 nucleolar and coiled-body phosphoprotein 1 10q24.32 hepatitis c, hepatitis c virus hepatitis
NONO non-POU domain containing, octamer-binding Xq13.1 renal cell carcinoma, papillary renal cell carcinoma "renal cell carcinoma, papillary, 1"
NONOP2 non-POU domain containing, octamer-binding pseudogene 2 2p16.1 psoriatic arthritis
NOP10 NOP10 ribonucleoprotein 15q14 aplastic anemia, "dyskeratosis congenita, autosomal recessive 4", "dyskeratosis congenita, autosomal recessive 1",
NOP16 NOP16 nucleolar protein 5q35.2 breast cancer
NOP56 NOP56 ribonucleoprotein 20p13 spinocerebellar ataxia 36
NOS1 nitric oxide synthase 1 (neuronal) 12q24.22 amyotrophic lateral sclerosis, schizophrenia, hirschsprungs disease,
NOS1AP nitric oxide synthase 1 (neuronal) adaptor protein 1q23.3 long qt syndrome 1
NOS2 nitric oxide synthase 2, inducible 17q11.2 ischemia, krabbe disease, retinal vasculitis,
NOS3 nitric oxide synthase 3 (endothelial cell) 7q36.1 pre-eclampsia, diabetic macular edema, coronary artery disease,
NOTCH1 notch 1 9q34.3 bladder transitional cell carcinoma, transitional cell carcinoma, breast cancer,
NOTCH2 notch 2 1p11.2 splenic marginal zone lymphoma, nodular regenerative hyperplasia, alagille syndrome,
NOTCH2NL notch 2 N-terminal like 1q21.1 hajdu-cheney syndrome
NOTCH3 notch 3 19p13.12 pseudobulbar palsy, varicose veins, migraine,
NOTCH4 notch 4 6p21.32 schizophrenia, pseudobulbar palsy, klippel-trenaunay syndrome
NOTO notochord homeobox 2p13.2 diphyllobothriasis central sleep apnea
NOV nephroblastoma overexpressed 8q24.12 alveolar rhabdomyosarcoma nephroblastoma
NOVA1 neuro-oncological ventral antigen 1 14q12 breast cancer, lung cancer paraneoplastic neurologic disorders
NOVA2 neuro-oncological ventral antigen 2 19q13.32 paraneoplastic neurologic disorders
NOXA1 NADPH oxidase activator 1 9q34.3 colon cancer
NPAP1 nuclear pore associated protein 1 15q11.2 prader-willi syndrome
NPAS2 neuronal PAS domain protein 2 2q11.2 seasonal affective disorder
NPAS3 neuronal PAS domain protein 3 14q13.1 learning disability, schizophrenia esotropia
NPAT nuclear protein, ataxia-telangiectasia locus 11q22.3 ataxia telangiectasia ataxia
NPB neuropeptide B 17q25.3 colorectal adenocarcinoma
NPC1 Niemann-Pick disease, type C1 18q11.2 sandhoff disease, mucolipidosis ii, niemann-pick disease,
NPC1L1 NPC1-like 1 7p13 niemann-pick disease picks disease
NPC2 Niemann-Pick disease, type C2 14q24.3 niemann-pick disease, picks disease, "niemann-pick disease type c, juvenile neurologic onset",
NPCA1 Nasopharyngeal carcinoma 1 4p15.1-q12 nasopharyngeal carcinoma 1
NPCA2 Nasopharyngeal carcinoma, susceptibility to, 2 6p21.3 nasopharyngeal carcinoma 2
NPFF neuropeptide FF-amide peptide precursor 12q13.13 withdrawal disorder, opioid abuse opiate dependence
NPHP1 nephronophthisis 1 (juvenile) 2q13 joubert syndrome and related disorders, "bardet-biedl syndrome, modifier of", senior-loken syndrome,
NPHP3 nephronophthisis 3 (adolescent) 3q22.1 nephronophthisis, senior-loken syndrome 1, renal-hepatic-pancreatic dysplasia,
NPHP3-ACAD11 NPHP3-ACAD11 readthrough (NMD candidate) 3q22.1 nephronophthisis 3
NPHP4 nephronophthisis 4 1p36.31 senior-loken syndrome, end stage renal failure, senior-loken syndrome 4 ,
NPHS1 nephrosis 1, congenital, Finnish type (nephrin) 19q13.12 nephrotic syndrome, familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis, glomerulosclerosis,
NPHS2 nephrosis 2, idiopathic, steroid-resistant (podocin) 1q25.2 nephrotic syndrome, familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis, glomerulosclerosis,
NPM1 nucleophosmin (nucleolar phosphoprotein B23, numatrin) 5q35.1 reticulosarcoma, acute myeloid leukemia, shwachman-diamond syndrome,
NPPA natriuretic peptide A 1p36.22 collagen disease, primary pulmonary hypertension, myocardial infarction,
NPPB natriuretic peptide B 1p36.22 polyhydramnios, chronic thromboembolic pulmonary hypertension, pulmonary embolism,
NPPC natriuretic peptide C 2q37.1 achondroplasia, skeletal dysplasias, colon adenocarcinoma,
NPR1 natriuretic peptide receptor 1 1q21.3 colon adenocarcinoma, breast adenocarcinoma, essential hypertension,
NPR2 natriuretic peptide receptor 2 9p13.3 osteochondrodysplasia, essential hypertension, renovascular hypertension,
NPR3 natriuretic peptide receptor 3 5p13.3 hypertension "hypertension, salt-resistant"
NPRL3 nitrogen permease regulator-like 3 (S. cerevisiae) 16p13.3 secondary hypertrophic osteoarthropathy myoblastoma
NPSR1 neuropeptide S receptor 1 7p14.3 asthma asthma 2
NPSR1-AS1 NPSR1 antisense RNA 1 7p14.3 asthma
NPTN neuroplastin 15q24.1 allergic bronchopulmonary aspergillosis
NPTX1 neuronal pentraxin I 17q25.3 prostate cancer wallerian degeneration
NPTX2 neuronal pentraxin II 7q22.1 parkinsons disease, pearson syndrome, autism spectrum disorder,
NPVF neuropeptide VF precursor 7p15.3 cystoid macular dystrophy
NPW neuropeptide W 16p13.3 colorectal adenocarcinoma
NPY neuropeptide Y 7p15.3 schizophrenia, neuroblastoma, essential hypertension,
NPY1R neuropeptide Y receptor Y1 4q32.2 angina pectoris, proliferative vitreoretinopathy, morbid obesity
NPY5R neuropeptide Y receptor Y5 4q32.2 obesity papillon-lefevre disease
NQO1 NAD(P)H dehydrogenase, quinone 1 16q22.1 colon adenocarcinoma, colon cancer, breast adenocarcinoma,
NQO2 NAD(P)H dehydrogenase, quinone 2 6p25.2 breast cancer susceptibility, schizophrenia, hepatoblastoma,
NR0B1 nuclear receptor subfamily 0, group B, member 1 Xp21.2 developmental disabilities, lipoid adrenal hyperplasia, gestational trophoblastic neoplasm,
NR0B2 nuclear receptor subfamily 0, group B, member 2 1p36.11 dosage-sensitive sex reversal, hepatopulmonary syndrome, obesity
NR1H2 nuclear receptor subfamily 1, group H, member 2 19q13.33 seborrheic keratosis, breast cancer, androgen insensitivity syndrome,
NR1H3 nuclear receptor subfamily 1, group H, member 3 11p11.2 atherosclerosis, acth-secreting pituitary adenoma myxoid liposarcoma
NR1H4 nuclear receptor subfamily 1, group H, member 4 12q23.1 cholestasis, intrahepatic cholestasis, fragile x syndrome,
NR1I2 nuclear receptor subfamily 1, group I, member 2 3q13.33 cholangitis, biliary tract disease acute porphyria
NR1I3 nuclear receptor subfamily 1, group I, member 3 1q23.3 humoral hypercalcemia of malignancy, hyperparathyroidism, hypercalcemia,
NR2C2AP nuclear receptor 2C2-associated protein 19p13.11 non-small cell lung carcinoma
NR2E1 nuclear receptor subfamily 2, group E, member 1 6q21 lymphoid leukemia
NR2E3 nuclear receptor subfamily 2, group E, member 3 15q23 leber congenital amaurosis, esotropia, accommodative esotropia,
NR2F1 nuclear receptor subfamily 2, group F, member 1 5q15 bladder transitional cell carcinoma, transitional cell carcinoma, ovarian epithelial cancer
NR2F2 nuclear receptor subfamily 2, group F, member 2 15q26.2 endometriosis, partial atrioventricular canal, ring chromosome 15,
NR2F6 nuclear receptor subfamily 2, group F, member 6 19p13.11 chronic purulent otitis media
NR3C1 nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) 5q31.3 breast cancer, dosage-sensitive sex reversal, in situ carcinoma,
NR3C2 nuclear receptor subfamily 3, group C, member 2 4q31.23 nephrosclerosis, hypertension, anuria,
NR4A1 nuclear receptor subfamily 4, group A, member 1 12q13.13 impetigo staphyloenterotoxemia
NR4A2 nuclear receptor subfamily 4, group A, member 2 2q24.1 parkinsons disease, schizophrenia, rheumatoid arthritis,
NR4A3 nuclear receptor subfamily 4, group A, member 3 9q22.33 chondrosarcoma extraskeletal myxoid chondrosarcoma
NR5A1 nuclear receptor subfamily 5, group A, member 1 9q33.3 partial androgen insensitivity syndrome, cryptorchidism, endometriosis,
NR5A2 nuclear receptor subfamily 5, group A, member 2 1q32.1 hepatitis b dental caries
NRARP NOTCH-regulated ankyrin repeat protein 9q34.3 inflammatory breast carcinoma
NRAS neuroblastoma RAS viral (v-ras) oncogene homolog 1p13.2 "epidermal nevus, somatic", "colorectal cancer, somatic", colorectal cancer,
NRBP2 nuclear receptor binding protein 2 8q24.3 medulloblastoma
NRCLP2 Narcolepsy, HLA-associated 4p13-q21 narcolepsy narcolepsy 2
NRCLP3 Narcolepsy 3 21q11.2 narcolepsy narcolepsy 3
NRCLP4 Narcolepsy 4 22q13 narcolepsy narcolepsy 4
NRCLP5 Narcolepsy 5 14q11.2 narcolepsy narcolepsy 5
NRCLP6 Narcolepsy 6 19p13.2 narcolepsy narcolepsy 6
NRF1 nuclear respiratory factor 1 7q32.2 skin carcinoma in situ
NRG1 neuregulin 1 8p12 breast cancer, schizophrenia, bipolar disorder,
NRG3 neuregulin 3 10q23.1 schizophrenia schizoaffective disorder
NRGN neurogranin (protein kinase C substrate, RC3) 11q24.2 schizophrenia, hypothyroidism, paraneoplastic cerebellar degeneration,
NRIP1 nuclear receptor interacting protein 1 21q21.1 granuloma inguinale
NRIP3 nuclear receptor interacting protein 3 11p15.4 sarcoma
NRK Nik related kinase Xq22.3 hypermobility syndrome
NRL neural retina leucine zipper 14q11.2 leber congenital amaurosis, retinal disease, retinitis pigmentosa,
NRN1 neuritin 1 6p25.1 astrocytoma
NRP1 neuropilin 1 10p11.22 multiple endocrine neoplasia type 2a, acute hemorrhagic leukoencephalitis, retinal vascular disease
NRP2 neuropilin 2 2q33.3 infantile epileptic encephalopathy wallerian degeneration
NRTN neurturin 19p13.3 parkinsons disease, hirschsprungs disease, keratoconjunctivitis sicca,
NRXN1 neurexin 1 2p16.3 schizophrenia, pitt-hopkins-like syndrome 2 , schizophrenia 17,
NRXN2 neurexin 2 11q13.1 pancreatic gastrinoma spinal cancer
NRXN3 neurexin 3 14q24.3 alcohol dependence autism spectrum disorder
NS2 Noonan syndrome 2 noonan syndrome 2
NSA2 NSA2 ribosome biogenesis homolog (S. cerevisiae) 5q13.3 leukemia, diabetic nephropathy hairy cell leukemia
NSD1 nuclear receptor binding SET domain protein 1 5q35.2 acute myeloid leukemia, beckwith-wiedemann syndrome, sotos syndrome,
NSDHL NAD(P) dependent steroid dehydrogenase-like Xq28 verruciform xanthoma of skin, chikungunya, child syndrome,
NSF N-ethylmaleimide-sensitive factor 17q21.31 botulism neuronal intranuclear inclusion disease
NSMAF neutral sphingomyelinase (N-SMase) activation associated factor 8q12.1 8p11 myeloproliferative syndrome
NSMF NMDA receptor synaptonuclear signaling and neuronal migration factor 9q34.3 hypogonadotropic hypogonadism 8 with or without anosmia, hypogonadotropic hypogonadism 17 with or without anosmia, cardiac rupture
NSUN2 NOP2/Sun RNA methyltransferase family, member 2 5p15.31 "mental retardation, autosomal recessive 43", dirofilariasis, "mental retardation, autosomal recessive 5"
NSUN5 NOP2/Sun domain family, member 5 7q11.23 williams-beuren syndrome, supravalvular aortic stenosis intracranial embolism
NSUN5P1 NOP2/Sun domain family, member 5 pseudogene 1 7q11.23 williams-beuren syndrome
NSUN5P2 NOP2/Sun domain family, member 5 pseudogene 2 7q11.23 williams-beuren syndrome
NSX N syndrome (mental retardation, malformations, chromosome breakage) Xp22.3-p21.1 n syndrome
NT5C 5', 3'-nucleotidase, cytosolic 17q25.1 acute myeloid leukemia, scabies norwegian scabies
NT5C1B 5'-nucleotidase, cytosolic IB 2p24.2 infertility
NT5C2 5'-nucleotidase, cytosolic II 10q24.33 sphenoid sinusitis, cellulitis, orbital cellulitis
NT5C3A 5'-nucleotidase, cytosolic IIIA 7p14.3 "anemia, hemolytic, due to umph1 deficiency"
NT5E 5'-nucleotidase, ecto (CD73) 6q14.3 intestinal tuberculosis calcification of joints and arteries
NT5M 5',3'-nucleotidase, mitochondrial 17p11.2 dentin sensitivity
NTAN1 N-terminal asparagine amidase 16p13.11 secondary progressive multiple sclerosis
NTF3 neurotrophin 3 12p13.31 schizophrenia, dry eye syndrome, charcot-marie-tooth disease type 1,
NTF4 neurotrophin 4 19q13.33 proliferative vitreoretinopathy, eating disorder, tuberous sclerosis complex,
NTHL1 nth endonuclease III-like 1 (E. coli) 16p13.3 primary sclerosing cholangitis, mitochondrial disorders sclerosing cholangitis
NTM neurotrimin 11q25 juvenile pilocytic astrocytoma
NTN3 netrin 3 16p13.3 "polycystic kidney disease, type 1", mantle cell lymphoma "tuberous sclerosis, type 2"
NTNG1 netrin G1 1p13.3 "epileptic encephalopathy, early infantile, 2" atypical rett syndrome
NTRK1 neurotrophic tyrosine kinase, receptor, type 1 1q23.1 relapsing fever, neuroblastoma, chagas disease,
NTRK2 neurotrophic tyrosine kinase, receptor, type 2 9q21.33 pilocytic astrocytoma, neuroblastoma, obesity
NTRK3 neurotrophic tyrosine kinase, receptor, type 3 15q25.3 medulloblastoma, mesoblastic nephroma, congenital mesoblastic nephroma,
NTS neurotensin 12q21.31 schizophrenia, pancreatic cancer, zollinger-ellison syndrome,
NTSR1 neurotensin receptor 1 (high affinity) 20q13.33 hyperglycemia
NUAK1 NUAK family, SNF1-like kinase, 1 12q23.3 omphalocele
NUB1 negative regulator of ubiquitin-like proteins 1 7q36.1 leber congenital amaurosis, dementia multiple system atrophy
NUBPL nucleotide binding protein-like 14q12 mitochondrial complex i deficiency
NUCB2 nucleobindin 2 11p15.1 seizure disorder
NUDT1 nudix (nucleoside diphosphate linked moiety X)-type motif 1 7p22.3 parkinsons disease, familial adenomatous polyposis, primary sclerosing cholangitis,
NUDT2 nudix (nucleoside diphosphate linked moiety X)-type motif 2 9p13.3 cartilage-hair hypoplasia
NUDT6 nudix (nucleoside diphosphate linked moiety X)-type motif 6 4q28.1 bladder carcinoma, moyamoya disease, gastric ulcer,
NUFIP1 nuclear fragile X mental retardation protein interacting protein 1 13q14.12 mental retardation
NUMA1 nuclear mitotic apparatus protein 1 11q13.4 acute promyelocytic leukemia "leukemia, acute promyelocytic, numa/rara type"
NUMB numb homolog (Drosophila) 14q24.3 tactile agnosia lip disease
NUP107 nucleoporin 107kDa 12q15 mesenchymal chondrosarcoma
NUP155 nucleoporin 155kDa 5p13.2 "atrial fibrillation, familial, 9" atrial fibrillation 15
NUP214 nucleoporin 214kDa 9q34.13 acute myeloid leukemia, myeloid leukemia acute t cell leukemia
NUP50P3 nucleoporin 50 pseudogene 3 5p14.3 pulmonary function
NUP62 nucleoporin 62kDa 19q13.33 striatonigral degeneration, parotid gland cancer striatonigral degeneration infantile
NUP98 nucleoporin 98kDa 11p15.4 breast cancer, acute myeloid leukemia, wilms tumor,
NUS1P2 nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae) pseudogene 2 13q12.12 cannabis dependence
NXF1 nuclear RNA export factor 1 11q12.3 branchiootorenal syndrome genital herpes
NXF3 nuclear RNA export factor 3 Xq22.1 pelizaeus-merzbacher disease
NXF5 nuclear RNA export factor 5 Xq22.1 progressive bulbar palsy
NXN nucleoredoxin 17p13.3 polycystic liver disease vulvitis
NXNL1 nucleoredoxin-like 1 19p13.11 leber congenital amaurosis
NXPH4 neurexophilin 4 12q13.3 otitis externa
NYS2 nystagmus 2, congenital autosomal dominant 6p12 congenital nystagmus, "nystagmus 2, congenital, autosomal dominant" spasmus nutans
NYS3 nystagmus 3, congenital autosomal dominant 7p11 congenital nystagmus "nystagmus 3, congenital, autosomal dominant"
NYS4 nystagmus 4, congenital autosomal dominant 13q31-q33 "nystagmus 4, congenital, autosomal dominant"
NYS5 Nystagmus 5, infantile periodic alternating "nystagmus 5, congenital, x-linked"
NYS7 Nystagmus 7, congenital 1q31-q32.2 "nystagmus 7, congenital, autosomal dominant"
NYX nyctalopin Xp11.4 astigmatism, retinal disease, "night blindness, congenital stationary , 1d, autosomal recessive",
OA1 Osteoarthritis QTL 1 "congenital nystagmus 6, x-linked" "ocular albinism, type i, nettleship-falls type"
OA12 Osteoarthritis QTL 12 osteoarthritis
OA14 Osteoarthritis QTL 14 osteoarthritis
OA15 Osteoarthritis QTL 15 osteoarthritis
OA17 Osteoarthritis QTL 17 osteoarthritis
OA18 Osteoarthritis QTL 18 osteoarthritis
OA19 Osteoarthritis QTL 19 osteoarthritis
OA2 Osteoarthritis QTL 2 "night blindness, congenital stationary , 2a, x-linked", aland island eye disease "cone-rod dystropy, x-linked, 3"
OA20 Osteoarthritis QTL 20 osteoarthritis
OA21 Osteoarthritis QTL 21 osteoarthritis
OA22 Osteoarthritis QTL 22 osteoarthritis
OA23 Osteoarthritis QTL 23 osteoarthritis
OA25 Osteoarthritis QTL 25 osteoarthritis
OA29 Osteoarthritis QTL 29 osteoarthritis
OA30 Osteoarthritis QTL 29 osteoarthritis
OA6 Osteoarthritis QTL 6 osteoarthritis
OAS1 2'-5'-oligoadenylate synthetase 1, 40/46kDa 12q24.13 type 1 diabetes mellitus, tick-borne encephalitis, west nile virus,
OAS2 2'-5'-oligoadenylate synthetase 2, 69/71kDa 12q24.13 tick-borne encephalitis, eczema herpeticum west nile encephalitis
OAS3 2'-5'-oligoadenylate synthetase 3, 100kDa 12q24.13 tick-borne encephalitis, chikungunya west nile encephalitis
OASD ocular albinism and sensorineural deafness Xp22.3 albinism ocular late onset sensorineural deafness
OASL 2'-5'-oligoadenylate synthetase-like 12q24.31 west nile encephalitis
OAT ornithine aminotransferase 10q26.13 orotic aciduria, cystinuria, gyrate atrophy,
OAZ3 ornithine decarboxylase antizyme 3 1q21.3 infertility
OBFC1 oligonucleotide/oligosaccharide-binding fold containing 1 10q24.33 idiopathic pulmonary fibrosis
OBSL1 obscurin-like 1 2q35 hydrocele, 3-m syndrome, dubowitz syndrome,
OCA2 oculocutaneous albinism II 15q13.1 angelman syndrome, familial melanoma, prader-willi syndrome,
OCA5 oculocutaneous albinism 5 (autosomal recessive) 4q24 "albinism, oculocutaneous, type v"
OCIAD2 OCIA domain containing 2 4p11 ovarian mucinous neoplasm
OCLM oculomedin 1q31.1 glaucoma
OCLN occludin 5q13.2 brain glioma, torch syndrome, pseudo-torch syndrome
OCM oncomodulin 7p22.1 benign paroxysmal positional nystagmus
OCM2 oncomodulin 2 7q21.3 benign paroxysmal positional nystagmus menieres disease
OCR1 ovarian cancer-related protein 1 1q32.1 ovarian cancer
OCRL oculocerebrorenal syndrome of Lowe Xq25 collecting duct carcinoma, oculocerebrorenal syndrome, dents disease
OCTN3 organic cation transporter 3 5q31 crohns disease ulcerative colitis
ODAM odontogenic, ameloblast asssociated 4q13.3 ossifying fibroma calcifying epithelial odontogenic tumor
ODC1 ornithine decarboxylase 1 2p25.1 gastric ulcer, colon adenocarcinoma, colon cancer,
ODF1 outer dense fiber of sperm tails 1 8q22.3 infertility
ODF4 outer dense fiber of sperm tails 4 17p13.1 chronic myeloid leukemia
ODPF Osseous dysplasia, digital, with facial pigmentary defects and multiple frenula terminal osseous dysplasia
ODS1 Opioid dependence, susceptibility to, 1 idiopathic generalized epilepsy, opiate dependence opioid dependence 1
OED Oregon eye disease Xp21.3 duchenne muscular dystrophy aland island eye disease
OFC1 orofacial cleft 1 6p24 orofacial cleft-1, otofaciocervical syndrome, "branchiootorenal syndrome 1, with or without cataracts",
OFC12 Orofacial cleft 12 8q24.31 orofacial cleft 12
OFC13 Orofacial cleft 13 1p33 orofacial cleft 13
OFC2 orofacial cleft 2 2p14-p13 orofacial cleft-2 otofaciocervical syndrome 2
OFC3 orofacial cleft 3 19q13 orofacial cleft-3
OFC4 Orofacial cleft 4 4q21-q31 orofacial cleft 4
OFC9 Orofacial cleft 9 13q33.1-q34 orofacial cleft 9
OFCC1 orofacial cleft 1 candidate 1 6p24.3 orofacial cleft, chronic tic disorder tic disorder
OFD1 oral-facial-digital syndrome 1 Xp22.2 developmental disabilities, leber congenital amaurosis, joubert syndrome and related disorders,
OFD1P10Y OFD1 pseudogene 10, Y-linked Yq11.223 angelman syndrome
OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 7p13 primary biliary cirrhosis, wernicke-korsakoff syndrome, wernicke encephalopathy
OGFR opioid growth factor receptor 20q13.33 squamous cell carcinoma of the head and neck pancreatic cancer
OGG1 8-oxoguanine DNA glycosylase 3p25.3 bladder cancer susceptibility, lung cancer, familial adenomatous polyposis,
OGN osteoglycin 9q22.31 vaginal cancer
OGS2 Opitz G syndrome, type II 22q11.2 "opitz gbbb syndrome, type ii"
OHDS Orthostatic hypotensive disorder of Streeten 18q orthostatic hypotensive disorder of streeten
OIT3 oncoprotein induced transcript 3 10q22.1 familial juvenile hyperuricaemic nephropathy
OLAH oleoyl-ACP hydrolase 10p13 rheumatoid arthritis arthritis
OLFM1 olfactomedin 1 9q34.3 neuroblastoma
OLIG1 oligodendrocyte transcription factor 1 21q22.11 astrocytoma
OLIG2 oligodendrocyte lineage transcription factor 2 21q22.11 pilocytic astrocytoma, lymphoblastic leukemia, astrocytoma,
OLR1 oxidized low density lipoprotein (lectin-like) receptor 1 12p13.2 coronary stenosis, myocardial infarction, coronary artery disease,
OMD osteomodulin 9q22.31 aneurysmal bone cysts blepharospasm
OMG oligodendrocyte myelin glycoprotein 17q11.2 learning disability, autistic disorder, neurofibromatosis
OMP olfactory marker protein 11q13.5 cholera, cystic fibrosis, sepsis,
OMS otitis media, susceptibility to 10q26.3;19q13.42 otitis media
ONECUT1 one cut homeobox 1 15q21.3 intestinal atresia hemophilia b
ONECUT2 one cut homeobox 2 18q21.31 hemophilia b
ONECUT3 one cut homeobox 3 19p13.3 loiasis, pulmonary venoocclusive disease dracunculiasis
OPA1 optic atrophy 1 (autosomal dominant) 3q29 primary angle-closure glaucoma, dominant optic atrophy, opa3-related 3-methylglutaconic aciduria,
OPA2 optic atrophy 2 (obscure) Xp11.4-p11.2 early-onset x-linked optic atrophy, "optic atrophy 2, x-linked" optic atrophy 2
OPA3 optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) 19q13.32 leigh-like syndrome, dominant optic atrophy, optic atrophy 3 with cataract ,
OPA4 optic atrophy 4 (autosomal dominant) 18q12.2 dominant optic atrophy optic atrophy-4
OPA5 optic atrophy 5 (autosomal dominant) 22q12.1-q13.1 dominant optic atrophy optic atrophy 5
OPA6 optic atrophy 6 (autosomal recessive) 8q21.13-q22.1 optic atrophy 6
OPA8 optic atrophy 8 (autosomal dominant) 16q22 dominant optic atrophy
OPALIN oligodendrocytic myelin paranodal and inner loop protein 10q24.1 fucosidosis
OPCML opioid binding protein/cell adhesion molecule-like 11q25 ovarian cancer, acute urate nephropathy, "ovarian cancer, somatic"
OPHLC Omphalocele due to duplication of 1p31.3 1p31.3 omphalocele due to duplication of 1p31.3
OPHN1 oligophrenin 1 Xq12 mental retardation, cerebellar hypoplasia, mental retardation x-linked with cerebellar hypoplasia and distinctive facial appearance
OPLAH 5-oxoprolinase (ATP-hydrolysing) 8q24.3 metabolic acidosis, glutathione synthetase deficiency 5-oxoprolinase deficiency
OPN1LW opsin 1 (cone pigments), long-wave-sensitive Xq28 alpha 1-antitrypsin deficiency, cone-rod dystrophy 2, blue cone monochromatism,
OPN1MW opsin 1 (cone pigments), medium-wave-sensitive Xq28 cone-rod dystrophy 2, blue-mono-cone-monochromatic type colorblindness, blue cone monochromatism,
OPN1MW2 opsin 1 (cone pigments), medium-wave-sensitive 2 Xq28 blue cone monochromacy thyroid hormone resistance syndrome
OPN1SW opsin 1 (cone pigments), short-wave-sensitive 7q32.1 retinal disease, blindness, color blindness
OPN3 opsin 3 1q43 enamel erosion mitral valve insufficiency
OPN4 opsin 4 10q23.2 seasonal affective disorder
OPRD1 opioid receptor, delta 1 1p35.3 neuroblastoma, myocardial stunning, morphine dependence,
OPRK1 opioid receptor, kappa 1 8q11.23 hypertrophic scars, agoraphobia, uremic pruritus,
OPRL1 opiate receptor-like 1 20q13.33 pain agnosia, agnosia drug dependence
OPRM1 opioid receptor, mu 1 6q25.2 withdrawal disorder, somatoform disorder, complex partial epilepsy,
OPTC opticin 1q32.1 skeletal dysplasias, posterior column ataxia vitreous detachment
OPTN optineurin 10p13 amyotrophic lateral sclerosis, neuropathy, pagets disease of bone,
OR10A2 olfactory receptor, family 10, subfamily A, member 2 11p15.4 vasomotor rhinitis
OR10J3 olfactory receptor, family 10, subfamily J, member 3 1q23.2 childhood leukemia
OR10K2 olfactory receptor, family 10, subfamily K, member 2 1q23.1 peroneal neuropathy
OR10R2 olfactory receptor, family 10, subfamily R, member 2 1q23.1 tinea unguium verrucous papilloma
OR10X1 olfactory receptor, family 10, subfamily X, member 1 (gene/pseudogene) 1q23.1 nevoid basal cell carcinoma syndrome basal cell carcinoma
OR12D3 olfactory receptor, family 12, subfamily D, member 3 6p22.1 breast and colorectal cancer
OR13F1 olfactory receptor, family 13, subfamily F, member 1 9q31.1 paratyphoid fever
OR13G1 olfactory receptor, family 13, subfamily G, member 1 1q44 familial hypercholesterolemia
OR2B6 olfactory receptor, family 2, subfamily B, member 6 6p22.1 murray valley encephalitis
OR2T12 olfactory receptor, family 2, subfamily T, member 12 1q44 moyamoya disease
OR2T33 olfactory receptor, family 2, subfamily T, member 33 1q44 placenta accreta
OR4C12 olfactory receptor, family 4, subfamily C, member 12 11p11.12 pineoblastoma medulloblastoma
OR4D2 olfactory receptor, family 4, subfamily D, member 2 17q22 pertussis essential hypertension
OR51A1P olfactory receptor, family 51, subfamily A, member 1 pseudogene 11p15.4 hereditary persistence of fetal hemoglobin
OR51E2 olfactory receptor, family 51, subfamily E, member 2 11p15.4 prostate cancer
OR52I1 olfactory receptor, family 52, subfamily I, member 1 11p15.4 type 2 diabetes mellitus
OR5H2 olfactory receptor, family 5, subfamily H, member 2 3q11.2 drug-induced liver injury due to flucloxacillin
OR5H8P olfactory receptor, family 5, subfamily H, member 8 pseudogene 3q11.2 drug-induced liver injury due to flucloxacillin
OR5K2 olfactory receptor, family 5, subfamily K, member 2 3q11.2 intestinal perforation placenta praevia
OR6B2 olfactory receptor, family 6, subfamily B, member 2 2q37.3 ophthalmia neonatorum
OR6R2P olfactory receptor, family 6, subfamily R, member 2 pseudogene 8p21.3 alzheimers disease
OR7E106P olfactory receptor, family 7, subfamily E, member 106 pseudogene 14q22.1 alzheimers disease
ORAI1 ORAI calcium release-activated calcium modulator 1 12q24.31 "myopathy, tubular aggregate, 1", immunodeficiency 9 "myopathy, tubular aggregate, 2"
ORAOV1 oral cancer overexpressed 1 11q13.3 breast cancer susceptibility, oral squamous cell carcinoma, oral cancer
ORAOV1P1 oral cancer overexpressed 1 pseudogene 1 4q35.1 oral cancer
ORC1 origin recognition complex, subunit 1 1p32.3 malaria, meier-gorlin syndrome 1 meier-gorlin syndrome
ORC4 origin recognition complex, subunit 4 2q23.1 meier-gorlin syndrome 1, meier-gorlin syndrome meier-gorlin syndrome 2
ORC6 origin recognition complex, subunit 6 16q11.2 coronary aneurysm, meier-gorlin syndrome 1, meier-gorlin syndrome
ORM1 orosomucoid 1 9q32 chronic myeloid leukemia pediatric multiple sclerosis
ORMDL3 ORM1-like 3 (S. cerevisiae) 17q12 primary biliary cirrhosis hfe-associated hereditary hemochromatosis
OS9 osteosarcoma amplified 9, endoplasmic reticulum lectin 12q13.3 hypoxia osteosarcoma
OSBP2 oxysterol binding protein 2 22q12.2 opisthorchiasis
OSBPL5 oxysterol binding protein-like 5 11p15.4 adult syndrome
OSBPL7 oxysterol binding protein-like 7 17q21.32 opisthorchiasis
OSBPL9P2 oxysterol binding protein-like 9 pseudogene 2 11q14.3 hiv-1
OSCAR osteoclast associated, immunoglobulin-like receptor 19q13.42 decubitus ulcer
OSCP1 organic solute carrier partner 1 1p34.3 nasopharynx carcinoma
OSGEP O-sialoglycoprotein endopeptidase 14q11.2 hereditary elliptocytosis, pasteurellosis shipyard eye
OSM oncostatin M 22q12.2 kaposis sarcoma, cerebral meningioma, sialadenitis
OSMR oncostatin M receptor 5p13.1 amyloidosis, primary cutaneous amyloidosis "amyloidosis, primary localized cutaneous, 1"
OSR2 odd-skipped related transciption factor 2 8q22.2 "blepharophimosis, ptosis, and epicanthus inversus syndrome"
OSTM1 osteopetrosis associated transmembrane protein 1 6q21 osteopetrosis, osteopetrosis autosomal recessive 5 ostm1-related autosomal recessive osteopetrosis
OSTN osteocrin 3q28 acromesomelic dysplasia
OTC ornithine carbamoyltransferase Xp11.4 hyperargininemia, lysinuric protein intolerance, duchenne muscular dystrophy,
OTDD Otodental dysplasia chromsome deletion syndrome 11q13 otodental dysplasia chromsome deletion syndrome otodental dysplasia
OTOA otoancorin 16p12.2 "deafness, autosomal recessive 76", empty sella syndrome, dfnb22 nonsyndromic hearing loss and deafness,
OTOF otoferlin 2p23.3 "deafness, autosomal recessive 76", "auditory neuropathy, autosomal recessive, 1", "deafness, autosomal recessive 9",
OTOG otogelin 11p15.1 "deafness, autosomal recessive 76", nonsyndromic deafness, autosomal recessive nonsyndromic deafness
OTOGL otogelin-like 12q21.31 "deafness, autosomal recessive 76" "deafness, autosomal recessive 84b"
OTOP1 otopetrin 1 4p16.3 benign paroxysmal positional nystagmus
OTOR otoraplin 20p12.1 melanoma
OTOS otospiralin 2q37.3 vestibular disease
OTP orthopedia homeobox 5q14.1 skull base meningioma meningioma
OTSC1 otosclerosis 1 15q25-q26 otosclerosis 1
OTSC10 otosclerosis 10 1q41-q44 otosclerosis 10
OTSC2 otosclerosis 2 7q34-q36 otosclerosis 2
OTSC3 otosclerosis 3 6p22.3-p21.2 otosclerosis 3
OTSC4 otosclerosis 4 16q21-q23.2 otosclerosis 4
OTSC5 otosclerosis 5 3q22.1-q24 otosclerosis 5
OTSC7 otosclerosis 7 6q13-q16.1 otosclerosis 7
OTSC8 otosclerosis 8 9p13.1-9q21.11 otosclerosis 8
OTUD4 OTU deubiquitinase 4 4q31.21 hiv-1 hypogonadotropism
OTX1 orthodenticle homeobox 1 2p15 non-hodgkin lymphoma autism spectrum disorder
OTX2 orthodenticle homeobox 2 14q22.3 septo-optic dysplasia, medulloblastoma, dysgnathia complex,
OVAAL ovarian adenocarcinoma amplified long non-coding RNA 1q25.3 adenocarcinoma
OVCA2 ovarian tumor suppressor candidate 2 17p13.3 ovarian cancer intrahepatic cholangiocarcinoma
OVCAS1 Ovarian cancer, epithelial, susceptibility to 3p25-p22 ovarian cancer
OVOL2 ovo-like zinc finger 2 20p11.23 corneal edema
OXA1L oxidase (cytochrome c) assembly 1-like 14q11.2 hyperthyroxinemia, dental caries, protein-losing enteropathy
OXCT1 3-oxoacid CoA transferase 1 5p13.1 scot deficiency
OXSM 3-oxoacyl-ACP synthase, mitochondrial 3p24.2 phaeohyphomycosis
OXT oxytocin/neurophysin I prepropeptide 20p13 polyhydramnios, gestational trophoblastic tumor, oligohydramnios,
OXTR oxytocin receptor 3p25.3 adenomyosis, atypical autism, leiomyoma
P2RX1 purinergic receptor P2X, ligand-gated ion channel, 1 17p13.2 bleeding disorder due to p2rx1 defect
P2RX2 purinergic receptor P2X, ligand-gated ion channel, 2 12q24.33 "deafness, autosomal dominant 4b", pheochromocytoma, neurogenic bladder
P2RX3 purinergic receptor P2X, ligand-gated ion channel, 3 11q12.1 burning mouth syndrome
P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 12q24.31 chronic pain
P2RX5 purinergic receptor P2X, ligand-gated ion channel, 5 17p13.2 nephropathic cystinosis, cystinosis, chronic myeloid leukemia,
P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 12q24.31 tuberculosis extrapulmonary tuberculosis
P2RY11 purinergic receptor P2Y, G-protein coupled, 11 19p13.2 narcolepsy 1 narcolepsy
P2RY12 purinergic receptor P2Y, G-protein coupled, 12 3q25.1 angina pectoris, coronary thrombosis, coronary artery disease,
P2RY14 purinergic receptor P2Y, G-protein coupled, 14 3q25.1 usher syndrome type 3
P2RY8 purinergic receptor P2Y, G-protein coupled, 8 Xp22.33 follicular lymphoma
P4HB prolyl 4-hydroxylase, beta polypeptide 17q25.3 malaria
P4HTM prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum) 3p21.31 hypoxia
PAAF1 proteasomal ATPase-associated factor 1 11q13.4 splenic abscess bladder leiomyoma
PABPC1 poly(A) binding protein, cytoplasmic 1 8q22.3 rift valley fever
PABPC1P2 poly(A) binding protein, cytoplasmic 1 pseudogene 2 2q22.3 oculopharyngeal muscular dystrophy
PABPN1 poly(A) binding protein, nuclear 1 14q11.2 exophthalmos, neuromuscular disease, dysphagia,
PACRG PARK2 co-regulated 6q26 parkinsons disease, leprosy parkinson disease 1
PACS1 phosphofurin acidic cluster sorting protein 1 11q13.1 hiv-1 "mental retardation, autosomal dominant 17"
PADI2 peptidyl arginine deiminase, type II 1p36.13 alzheimers disease multiple sclerosis
PADI4 peptidyl arginine deiminase, type IV 1p36.13 rheumatoid arthritis palindromic rheumatism
PAEP progestagen-associated endometrial protein 9q34.3 biphasic synovial sarcoma, uterine fibroid, endometrial adenocarcinoma,
PAF1 Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae) 19q13.2 vulvitis, peroxisome biogenesis disorder 5a peroxisome biogenesis disorder 5b
PAFAH1B1 platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) 17p13.3 schizophrenia, periventricular nodular heterotopia, lissencephaly,
PAFC Preauricular fistulae, congenital 8q11.1-q13.3 "preauricular fistulae, congenital"
PAGE4 P antigen family, member 4 (prostate associated) Xp11.23 germ cell tumors, prostate cancer, stomach cancer,
PAGE5 P antigen family, member 5 (prostate associated) Xp11.21 hepatocellular fibrolamellar carcinoma
PAH phenylalanine hydroxylase 12q23.2 dihydropteridine reductase deficiency, tetrahydrobiopterin deficiency, phenylketonuria,
PAK3 p21 protein (Cdc42/Rac)-activated kinase 3 Xq23 "mental retardation, x-linked 17/31, microduplication", mental retardation, "mental retardation, x-linked",
PAK4 p21 protein (Cdc42/Rac)-activated kinase 4 19q13.2 breast adenoma
PAK6 p21 protein (Cdc42/Rac)-activated kinase 6 15q15.1 prostate cancer la crosse encephalitis
PALB2 partner and localizer of BRCA2 16p12.2 breast cancer susceptibility, breast cancer, male breast cancer,
PALLD palladin, cytoskeletal associated protein 4q32.3 myocardial infarction, dysplastic nevus syndrome, pancreatic cancer,
PAM16 presequence translocase-associated motor 16 homolog (S. cerevisiae) 16p13.3 acth-secreting pituitary adenoma "autosomal recessive spondylometaphyseal dysplasia, m??garban?? type"
PAND1 Panic disorder 1 13q22-q32 panic disorder syndrome 1
PAND2 panic disorder 2 9q31 panic disorder 2
PAND3 panic disorder 3 4q31-q34 panic disorder 3
PANDAR promoter of CDKN1A antisense DNA damage activated RNA 6p21.2 pandas
PANK1 pantothenate kinase 1 10q23.31 neuroaxonal dystrophy pantothenate kinase-associated neurodegeneration
PANK2 pantothenate kinase 2 20p13 neuroacanthocytosis, movement disease, neuroaxonal dystrophy,
PAOD1 Peripheral arterial occlusive disease 1 1p31 peripheral arterial occlusive disease 1
PAPA2 postaxial polydactyly, type A2 13q21-q32 postaxial polydactyly type a "postaxial polydactyly, type a2"
PAPA3 Polydactyly, postaxial, type A3 19p13.2-p13.1 postaxial polydactyly type a "polydactyly, postaxial, type a3"
PAPA4 Polydactyly, postaxial, type A4 7q22 postaxial polydactyly type a "polydactyly, postaxial, type a4"
PAPA5 Polydactyly, postaxial, type A5 13q13.3-q21 "polydactyly, postaxial, type a5"
PAPLN papilin, proteoglycan-like sulfated glycoprotein 14q24.2 weill-marchesani syndrome
PAPPA pregnancy-associated plasma protein A, pappalysin 1 9q33.1 triploidy, edwards syndrome, limb-girdle muscular dystrophy type 2h,
PAPSS1 3'-phosphoadenosine 5'-phosphosulfate synthase 1 4q25 spondyloepimetaphyseal dysplasia
PAPSS2 3'-phosphoadenosine 5'-phosphosulfate synthase 2 10q23.2 brachyolmia, iritis, spondyloepimetaphyseal dysplasia,
PAQR8 progestin and adipoQ receptor family member VIII 6p12.2 epilepsy with generalized tonic-clonic seizures
PARD3B par-3 family cell polarity regulator beta 2q33.3 amyotrophic lateral sclerosis lateral sclerosis
PARG poly (ADP-ribose) glycohydrolase 10q11.23 spinal cord injury
PARK10 Parkinson disease 10 (susceptibility) 1p parkinsons disease parkinson disease 10
PARK11 Parkinson disease 11 (autosomal recessive, early onset) 2q36-q37 parkinsons disease parkinson disease 11
PARK12 Parkinson disease 12 (susceptibility) Xq21-q25 parkinsons disease parkinson disease 12
PARK16 Parkinson disease 16 (susceptibility) 1q32 parkinsons disease, alzheimers disease parkinson disease 16
PARK2 parkin RBR E3 ubiquitin protein ligase 6q26 thanatophoric dysplasia, parkinsons disease, hypersomnia,
PARK3 Parkinson disease 3 (autosomal dominant, Lewy body) 2p13 parkinsons disease parkinson disease type 3
PARK4 Parkinson disease (autosomal dominant, Lewy body) 4 4p15 parkinsons disease, lewy body dementia, parkinson disease 1
PARK7 parkinson protein 7 1p36.23 amyotrophic lateral sclerosis, parkinsons disease, amyotrophic lateral sclerosis-parkinsonism/dementia complex,
PARM1 prostate androgen-regulated mucin-like protein 1 4q13.3 epispadias
PARP1 poly (ADP-ribose) polymerase 1 1q42.12 colorectal cancer, breast cancer, brain injury,
PARP10 poly (ADP-ribose) polymerase family, member 10 8q24.3 diphtheria
PARP15 poly (ADP-ribose) polymerase family, member 15 3q21.1 urethral intrinsic sphincter deficiency
PARP16 poly (ADP-ribose) polymerase family, member 16 15q22.31 diphtheria
PARP2 poly (ADP-ribose) polymerase 2 14q11.2 diphtheria
PARP3 poly (ADP-ribose) polymerase family, member 3 3p21.2 diphtheria
PARP4 poly (ADP-ribose) polymerase family, member 4 13q12.12 cardia cancer
PARP6 poly (ADP-ribose) polymerase family, member 6 15q23 diphtheria
PART1 prostate androgen-regulated transcript 1 (non-protein coding) 5q12.1 adenocarcinoma prostate adenocarcinoma
PARVA parvin, alpha 11p15.3 theileriasis, adiaspiromycosis breast giant fibroadenoma
PARVB parvin, beta 22q13.31 coronary restenosis
PASD1 PAS domain containing 1 Xq28 diffuse large b-cell lymphoma small intestine cancer
PASK PAS domain containing serine/threonine kinase 2q37.3 glanders
PATE1 prostate and testis expressed 1 11q24.2 intracranial abscess
PATZ1 POZ (BTB) and AT hook containing zinc finger 1 22q12.2 sarcoma
PAURT1 Preauricular tag, isolated, autosomal dominant, 1 14q11.2-q12 "preauricular tag, isolated, autosomal dominant, 1"
PAWR PRKC, apoptosis, WT1, regulator 12q21.2 amyotrophic lateral sclerosis
PAX1 paired box 1 20p11.22 otofaciocervical syndrome 2, otofaciocervical syndrome, klippel-feil syndrome
PAX2 paired box 2 10q24.31 renal agenesis, anophthalmia/microphthalmia, multicystic dysplastic kidney,
PAX3 paired box 3 2q36.1 septo-optic dysplasia, alveolar rhabdomyosarcoma, neural tube defects,
PAX4 paired box 4 7q32.1 type 2 diabetes mellitus, insulinoma, monogenic diabetes,
PAX5 paired box 5 9p13.2 histiocytic sarcoma, acute lymphocytic leukemia, lymphoplasmacytic lymphoma,
PAX6 paired box 6 11p13 intestinal atresia, schizophrenia, anophthalmia/microphthalmia,
PAX7 paired box 7 1p36.13 alveolar rhabdomyosarcoma, rhabdomyosarcoma, pleomorphic rhabdomyosarcoma,
PAX8 paired box 8 2q13 thymic epithelial neoplasm, sarcomatoid renal cell carcinoma, pendred syndrome,
PAX9 paired box 9 14q13.3 "tooth agenesis, selective, 1, with or without orofacial cleft", cleft lip, tooth agenesis,
PAXIP1 PAX interacting (with transcription-activation domain) protein 1 7q36.2 breast cancer alzheimers disease
PBC2 Biliary cirrhosis, primary, 2 6p21.3 "biliary cirrhosis, primary, 2"
PBC3 Biliary cirrhosis, primary, 3 1p31.2 "biliary cirrhosis, primary, 3"
PBC4 Biliary cirrhosis, primary, 4 7q32 "biliary cirrhosis, primary, 4"
PBC5 Biliary cirrhosis, primary, 5 17q12 "biliary cirrhosis, primary, 5"
PBCA Pancreatic beta cell, agenesis of "diabetes mellitus, insulin-dependent, neonatal"
PBCRA1 progressive bifocal chorioretinal atrophy 1 6q14-q16.2 progressive bifocal chorioretinal atrophy north carolina macular dystrophy
PBK PDZ binding kinase 8p21.1 corneal edema plexiform neurofibroma
PBOV1 prostate and breast cancer overexpressed 1 6q23.3 breast cancer
PBRM1 polybromo 1 3p21.1 keratomalacia, renal cell carcinoma clear cell renal cell carcinoma
PBX1 pre-B-cell leukemia homeobox 1 1q23.3 lymphoblastic leukemia, shwachman-diamond syndrome, leukemia,
PBX2 pre-B-cell leukemia homeobox 2 6p21.32 t-cell leukemia
PBX4 pre-B-cell leukemia homeobox 4 19p13.11 leukemia
PC pyruvate carboxylase 11q13.2 reye syndrome, short-chain acyl-coa dehydrogenase deficiency, hyperlysinemia,
PCA3 prostate cancer associated 3 (non-protein coding) 9q21.2 prostate cancer prostate cancer 3
PCAP predisposing for prostate cancer 1q42.2-q43 prostate cancer
PCAT1 prostate cancer associated transcript 1 (non-protein coding) 8q24.21 prostate cancer
PCAT14 prostate cancer associated transcript 14 (non-protein coding) 22q11.23 prostate cancer
PCAT18 prostate cancer associated transcript 18 (non-protein coding) 18q11.2 prostate cancer
PCAT19 prostate cancer associated transcript 19 (non-protein coding) 19q13.2 prostate cancer
PCAT2 prostate cancer associated transcript 2 (non-protein coding) 8q24.21 prostate cancer
PCAT4 prostate cancer associated transcript 4 (non-protein coding) 4q21.21 prostate cancer
PCAT5 prostate cancer associated transcript 5 (non-protein coding) 10p11.21 prostate cancer
PCAT6 prostate cancer associated transcript 6 (non-protein coding) 1q32.1 prostate cancer
PCAT7 prostate cancer associated transcript 7 (non-protein coding) 9q22.32 prostate cancer
PCBD1 pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha 10q22.1 vitiligo, tetrahydrobiopterin deficiency, mild hyperphenylalaninemia,
PCBP1 poly(rC) binding protein 1 2p13.3 hepatitis
PCBP2 poly(rC) binding protein 2 12q13.13 hepatitis myotonic dystrophy type 2
PCCA propionyl CoA carboxylase, alpha polypeptide 13q32.3 propionic acidemia, biotin deficiency, methylmalonic acidemia,
PCCB propionyl CoA carboxylase, beta polypeptide 3q22.3 propionic acidemia, the organic acidemias: an, organic acidemia,
PCDH10 protocadherin 10 4q28.3 dravet syndrome
PCDH11Y protocadherin 11 Y-linked Yp11.2 prostate cancer
PCDH15 protocadherin-related 15 10q21.1 "deafness, autosomal recessive 76", dfnb1, "usher syndrome, type 1d/f digenic",
PCDH19 protocadherin 19 Xq22.1 mental retardation, infantile epileptic encephalopathy, ohtahara syndrome,
PCDHA3 protocadherin alpha 3 5q31.3 restless legs syndrome
PCDHGA10 protocadherin gamma subfamily A, 10 5q31.3 pineoblastoma
PCED1A PC-esterase domain containing 1A 20p13 sarcoma
PCGEM1 PCGEM1, prostate-specific transcript (non-protein coding) 2q32.3 prostate cancer
PCGF2 polycomb group ring finger 2 17q12 acute promyelocytic leukemia
PCK1 phosphoenolpyruvate carboxykinase 1 (soluble) 20q13.31 type 2 diabetes mellitus "phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency"
PCK2 phosphoenolpyruvate carboxykinase 2 (mitochondrial) 14q11.2 insulin resistance, short-chain acyl-coa dehydrogenase deficiency, hyperglycemia,
PCLO piccolo presynaptic cytomatrix protein 7q21.11 bipolar disorder major depressive disorder
PCM1 pericentriolar material 1 8p22 follicular thyroid carcinoma, papillary thyroid carcinoma, chronic myeloid leukemia,
PCMT1 protein-L-isoaspartate (D-aspartate) O-methyltransferase 6q25.1 spina bifida premature ovarian failure
PCMTD1 protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 8q11.23 primary angle-closure glaucoma
PCNA proliferating cell nuclear antigen 20p12.3 hepatocellular carcinoma, maxillary sinus squamous cell carcinoma, juvenile nasopharyngeal angiofibroma,
PCNT pericentrin 21q22.3 dwarfism, seckel syndrome, seckel syndrome type 8
PCNXL4 pecanex-like 4 (Drosophila) 14q23.1 hepatitis c, hepatitis c virus hepatitis
PCOLCE procollagen C-endopeptidase enhancer 7q22.1 oculopharyngeal muscular dystrophy bone fracture
PCOS1 polycystic ovary syndrome 1 19p13.2 polycystic ovary syndrome polycystic ovary syndrome 1
PCP2 Purkinje cell protein 2 19p13.2 pycnodysostosis
PCSK1 proprotein convertase subtilisin/kexin type 1 5q15 acth deficiency, obesity, adrenocorticotropic hormone deficiency ,
PCSK1N proprotein convertase subtilisin/kexin type 1 inhibitor Xp11.23 obesity
PCSK2 proprotein convertase subtilisin/kexin type 2 20p12.1 myocardial infarction
PCSK5 proprotein convertase subtilisin/kexin type 5 9q21.13 hiv-1, influenza, pachyonychia congenita
PCSK6 proprotein convertase subtilisin/kexin type 6 15q26.3 influenza
PCSK9 proprotein convertase subtilisin/kexin type 9 1p32.3 familial hypercholesterolemia, hypercholesterolemia, familial hyperlipidemia,
PCTP phosphatidylcholine transfer protein 17q22 cannabis dependence
PCYT1A phosphate cytidylyltransferase 1, choline, alpha 3q29 spondylometaphyseal dysplasia with cone-rod dystrophy
PCYT1B phosphate cytidylyltransferase 1, choline, beta Xp22.11 periventricular nodular heterotopia
PDA1 Patent ductus arteriosus, susceptibility to 12q24 patent ductus arteriosus
PDB4 Paget disease of bone 4 5q31 pagets disease of bone
PDB5 Paget disease of bone 5 2q36 pagets disease of bone
PDB6 Paget disease of bone 6 10p13 pagets disease of bone
PDC phosducin 1q31.1 familial paroxysmal nonkinesigenic dyskinesia, prostate cancer 1 usher syndrome type ii
PDCD1 programmed cell death 1 2q37.3 systemic lupus erythematosus, lupus erythematosus, takayasus arteritis,
PDCD10 programmed cell death 10 3q26.1 klippel-trenaunay syndrome, coats disease, cerebral cavernous malformations-1 ,
PDCD11 programmed cell death 11 10q24.33 epididymo-orchitis orchitis
PDCD1LG2 programmed cell death 1 ligand 2 9p24.1 cysticercosis
PDCD4 programmed cell death 4 (neoplastic transformation inhibitor) 10q25.2 colorectal cancer
PDCOS Podoconiosis, susceptibility to 6p21.3 podoconiosis
PDDC1 Parkinson disease 7 domain containing 1 11p15.5 parkinsons disease
PDE11A phosphodiesterase 11A 2q31.2 acth-independent macronodular adrenal hyperplasia, primary pigmented nodular adrenocortical disease, retinitis pigmentosa 42 ,
PDE12 phosphodiesterase 12 3p14.3 pharyngitis
PDE4A phosphodiesterase 4A, cAMP-specific 19p13.2 rubinstein-taybi syndrome
PDE4B phosphodiesterase 4B, cAMP-specific 1p31.3 schizophrenia
PDE4D phosphodiesterase 4D, cAMP-specific 5q12.1 "acrodysostosis 2, with or without hormone resistance", "acrodysostosis 1, with or without hormone resistance" acrodysostosis
PDE4DIP phosphodiesterase 4D interacting protein 1q21.1 myeloproliferative disorder, thrombophlebitis eosinophilia
PDE5A phosphodiesterase 5A, cGMP-specific 4q26 anterior ischemic optic neuropathy, priapism, premature ejaculation,
PDE6A phosphodiesterase 6A, cGMP-specific, rod, alpha 5q32 leber congenital amaurosis, cystoid macular edema, pde6a-related retinitis pigmentosa
PDE6B phosphodiesterase 6B, cGMP-specific, rod, beta 4p16.3 leber congenital amaurosis, "night blindness, congenital stationary , 1d, autosomal recessive", blindness,
PDE6C phosphodiesterase 6C, cGMP-specific, cone, alpha prime 10q23.33 cone dystrophy, achromatopsia, achromatopsia 2,
PDE6D phosphodiesterase 6D, cGMP-specific, rod, delta 2q37.1 joubert syndrome 22, latent syphilis, primary syphilis
PDE6G phosphodiesterase 6G, cGMP-specific, rod, gamma 17q25.3 leber congenital amaurosis, idiopathic pulmonary fibrosis, familial retinoblastoma,
PDE6H phosphodiesterase 6H, cGMP-specific, cone, gamma 12p12.3 cone dystrophy, color blindness, urethral syndrome,
PDE7A phosphodiesterase 7A 8q13.1 low compliance bladder
PDE8A phosphodiesterase 8A 15q25.3 granulomatous amebic encephalitis
PDE8B phosphodiesterase 8B 5q13.3 hyperthyroxinemia, primary pigmented nodular adrenocortical disease, "striatal degeneration, autosomal dominant",
PDGFA platelet-derived growth factor alpha polypeptide 7p22.3 pilocytic astrocytoma, wrinkles, diffuse mesangial sclerosis
PDGFB platelet-derived growth factor beta polypeptide 22q13.1 kaposis sarcoma, meningioma, "basal ganglia cancification, idiopathic, 1",
PDGFD platelet derived growth factor D 11q22.3 mesangial proliferative glomerulonephritis
PDGFRA platelet-derived growth factor receptor, alpha polypeptide 4q12 mesenchymal cell neoplasm, juvenile myelomonocytic leukemia, neural tube defects,
PDGFRB platelet-derived growth factor receptor, beta polypeptide 5q32 myeloproliferative disorder, gliosarcoma, pilocytic astrocytoma,
PDGFRL platelet-derived growth factor receptor-like 8p22 "colorectal cancer, somatic", colorectal cancer, prostate cancer,
PDHA1 pyruvate dehydrogenase (lipoamide) alpha 1 Xp22.12 pyruvate decarboxylase deficiency, coffin-lowry syndrome, retinoschisis,
PDHB pyruvate dehydrogenase (lipoamide) beta 3p14.3 "tumoral calcinosis, hyperphosphatemic", pyruvate decarboxylase deficiency pyruvate dehydrogenase e1-beta deficiency
PDHX pyruvate dehydrogenase complex, component X 11p13 primary biliary cirrhosis, pyruvate decarboxylase deficiency, liver disease,
PDK3 pyruvate dehydrogenase kinase, isozyme 3 Xp22.11 "charcot-marie-tooth disease, x-linked dominant, 6"
PDLIM1 PDZ and LIM domain 1 10q24.1 dental enamel hypoplasia, supravalvular aortic stenosis, hyperacusis
PDLIM2 PDZ and LIM domain 2 (mystique) 8p21.3 breast cancer, t-cell leukemia adult t-cell leukemia
PDLIM3 PDZ and LIM domain 3 4q35.1 malignant histiocytosis, myotonic dystrophy, osteitis fibrosa
PDLIM4 PDZ and LIM domain 4 5q31.1 osteoporosis multiple personality disorder
PDLIM5 PDZ and LIM domain 5 4q22.3 nail-patella syndrome barth syndrome
PDLIM7 PDZ and LIM domain 7 (enigma) 5q35.3 pleural empyema nasopharynx carcinoma
PDON2 Periodontitis, localized aggressive 1q25 periodontitis "periodontitis, aggressive, 2"
PDP1 pyruvate dehyrogenase phosphatase catalytic subunit 1 8q22.1 primary biliary cirrhosis, ovarian disease, cystic fibrosis,
PDPN podoplanin 1p36.21 kaposis sarcoma, central nervous system germ cell tumor, malignant mesothelioma,
PDR pigment disorder, reticulate Xp22-p21 "pigment disorder, reticulate" x-linked reticulate pigmentary disorder with systemic manifestations
PDSS1 prenyl (decaprenyl) diphosphate synthase, subunit 1 10p12.1 prosopagnosia, "coenzyme q10 deficiency, primary, 2", pdss1-related coenzyme q10 deficiency
PDSS2 prenyl (decaprenyl) diphosphate synthase, subunit 2 6q21 "coenzyme q10 deficiency, primary, 3", pdss2-related coenzyme q10 deficiency "coenzyme q10 deficiency, primary, 1"
PDX1 pancreatic and duodenal homeobox 1 13q12.2 type 2 diabetes mellitus, pancreatic cancer, diabetes mellitus,
PDXP pyridoxal (pyridoxine, vitamin B6) phosphatase 22q13.1 laurence-moon syndrome
PDYN prodynorphin 20p13 parkinsons disease, alcohol dependence, schizophrenia,
PDZD11 PDZ domain containing 11 Xq13.1 pleomorphic adenoma carcinoma
PDZD2 PDZ domain containing 2 5p13.3 prostate cancer
PDZD3 PDZ domain containing 3 11q23.3 cystic fibrosis secretory diarrhea
PDZD7 PDZ domain containing 7 10q24.31 retinal disease, urethral stricture, usher syndrome type ii,
PDZD8 PDZ domain containing 8 10q26.11 sarcoma
PDZK1 PDZ domain containing 1 1q21.1 myeloma multiple myeloma
PDZK1IP1 PDZK1 interacting protein 1 1p33 tricuspid valve insufficiency, malignant pleural mesothelioma, endolymphatic hydrops
PEA15 phosphoprotein enriched in astrocytes 15 1q23.2 type 2 diabetes mellitus insulin resistance
PECAM1 platelet/endothelial cell adhesion molecule 1 17q23.3 radiation proctitis, cavernous hemangioma, kaposis sarcoma,
PEE1 preeclampsia/eclampsia 1 2p13 pre-eclampsia, eclampsia preeclampsia/eclampsia 1
PEE2 Preeclampsia/eclampsia 2 2p25 eclampsia preeclampsia/eclampsia 2
PEE3 Preeclampsia/eclampsia 3 9p13 eclampsia preeclampsia/eclampsia 3
PEF1 penta-EF-hand domain containing 1 1p35.2 intermediate charcot-marie-tooth neuropathy
PEG10 paternally expressed 10 7q21.3 hepatocellular carcinoma multiple personality disorder
PEG3 paternally expressed 3 19q13.43 embryonal sarcoma undifferentiated embryonal sarcoma of the liver
PEMT phosphatidylethanolamine N-methyltransferase 17p11.2 whiplash
PENK proenkephalin 8q12.1 squamous cell carcinoma of the head and neck, pancreatic cancer, pain agnosia,
PEPD peptidase D 19q13.11 prolidase deficiency, legg-calve-perthes disease bacterial vaginosis
PER1 period circadian clock 1 17p13.1 advanced sleep phase syndrome delayed sleep phase syndrome
PER2 period circadian clock 2 2q37.3 q fever, sleep disorder, advanced sleep phase syndrome,
PER3 period circadian clock 3 1p36.23 seasonal affective disorder, advanced sleep phase syndrome delayed sleep phase syndrome
PES1 pescadillo ribosomal biogenesis factor 1 22q12.2 breast cancer
PET100 PET100 homolog (S. cerevisiae) 19p13.2 cytochrome-c oxidase deficiency disease intrahepatic cholangiocarcinoma
PEX1 peroxisomal biogenesis factor 1 7q21.2 mulibrey nanism , infantile refsum disease, refsum disease,
PEX10 peroxisomal biogenesis factor 10 1p36.32 infantile refsum disease, neonatal adrenoleukodystrophy, adrenoleukodystrophy,
PEX11B peroxisomal biogenesis factor 11 beta 1q21.1 hawkinsinuria , arrhythmogenic right ventricular dysplasia 5 , peroxisome biogenesis disorder 2b
PEX12 peroxisomal biogenesis factor 12 17q12 rhizomelic chondrodysplasia punctata, infantile refsum disease, pontocerebellar hypoplasia,
PEX13 peroxisomal biogenesis factor 13 2p16.1 rhizomelic chondrodysplasia punctata, infantile refsum disease, epidermodysplasia verruciformis,
PEX14 peroxisomal biogenesis factor 14 1p36.22 hawkinsinuria , peroxisome biogenesis disorder 2b, zellweger spectrum,
PEX16 peroxisomal biogenesis factor 16 11p11.2 hawkinsinuria , peroxisome biogenesis disorder 2b, zellweger spectrum,
PEX19 peroxisomal biogenesis factor 19 1q23.2 intermittent claudication, lens subluxation, hawkinsinuria ,
PEX2 peroxisomal biogenesis factor 2 8q21.11 neuronal migration disorders, beta-ketothiolase deficiency, ketothiolase deficiency,
PEX26 peroxisomal biogenesis factor 26 22q11.21 rhizomelic chondrodysplasia punctata, infantile refsum disease, refsum disease,
PEX3 peroxisomal biogenesis factor 3 6q24.2 rhizomelic chondrodysplasia punctata, infantile refsum disease, hawkinsinuria ,
PEX5 peroxisomal biogenesis factor 5 12p13.31 mulibrey nanism , rhizomelic chondrodysplasia punctata, primary hyperoxaluria,
PEX6 peroxisomal biogenesis factor 6 6p21.1 beta-ketothiolase deficiency, ketothiolase deficiency, infantile refsum disease,
PEX7 peroxisomal biogenesis factor 7 6q23.3 chondrodysplasia, mulibrey nanism , rhizomelic chondrodysplasia punctata,
PF4 platelet factor 4 4q13.3 learning disability, myocardial infarction, sneddon syndrome,
PFAS phosphoribosylformylglycinamidine synthase 17p13.1 fetal alcohol syndrome, alcohol-related neurodevelopmental disorder partial fetal alcohol syndrome
PFBI Plasmodium falciparum blood infection levels 5q31-q33 "malaria, intensity of infection"
PFFE1 Plasmodium falciparum fever episodes QTL1 10p15 plasmodium falciparum fever episodes qtl1
PFKL phosphofructokinase, liver 21q22.3 autoimmune polyendocrine syndrome type 1 hemolytic anemia due to phosphofructokinase deficiency
PFKM phosphofructokinase, muscle 12q13.11 hyperuricemia, tularemia, phosphoglycerate kinase deficiency
PFN1 profilin 1 17p13.2 amyotrophic lateral sclerosis, huntingtons disease, miller-dieker syndrome,
PFN2 profilin 2 3q25.1 developmental coordination disorder
PFN3 profilin 3 5q35.3 shigellosis
PFN4 profilin family, member 4 2p23.3 shigellosis coccidiosis
PGA5 pepsinogen 5, group I (pepsinogen A) 11q12.2 stomach cancer
PGAM1 phosphoglycerate mutase 1 (brain) 10q24.1 corticobasal degeneration phosphoglycerate mutase deficiency
PGAM2 phosphoglycerate mutase 2 (muscle) 7p13 multidrug-resistant tuberculosis, hereditary neuropathy with liability to pressure palsies phosphoglycerate mutase deficiency
PGAM5P1 phosphoglycerate mutase family member 5 pseudogene 1 5q21.3 alzheimers disease
PGAP1 post-GPI attachment to proteins 1 2q33.1 autosomal recessive spastic paraplegia type 67 "mental retardation, autosomal recessive 42"
PGAP2 post-GPI attachment to proteins 2 11p15.4 hyperphosphatasia with mental retardation syndrome 1, hyperphosphatasia with mental retardation syndrome 3 hyperphosphatasia with mental retardation syndrome
PGAP3 post-GPI attachment to proteins 3 17q12 hyperphosphatasia with mental retardation syndrome 4 hyperphosphatasia with mental retardation syndrome 1
PGBD3 piggyBac transposable element derived 3 10q11.23 breast and colorectal cancer
PGC progastricsin (pepsinogen C) 6p21.1 stomach cancer gastritis
PGD phosphogluconate dehydrogenase 1p36.22 leishmaniasis, cutaneous leishmaniasis, trypanosomiasis
PGF placental growth factor 14q24.3 pre-eclampsia, myocardial infarction, epithelioid hemangioendothelioma,
PGK1 phosphoglycerate kinase 1 Xq21.1 hemolytic anemia, menkes disease phosphoglycerate kinase deficiency
PGLYRP2 peptidoglycan recognition protein 2 19p13.12 bacterial meningitis
PGLYRP3 peptidoglycan recognition protein 3 1q21.3 high pressure neurological syndrome
PGM1 phosphoglucomutase 1 1p31.3 glycogen storage disease, fetal macrosomia, myeloid sarcoma,
PGM3 phosphoglucomutase 3 6q14.2 diabetic nephropathy immunodeficiency 23
PGP phosphoglycolate phosphatase 16p13.3 acute myeloid leukemia
PGR progesterone receptor 11q22.1 adenocarcinoma, juvenile nasopharyngeal angiofibroma, endometrial carcinoma,
PGRMC1 progesterone receptor membrane component 1 Xq24 placental choriocarcinoma, parotitis, spondylolisthesis,
PHA2A Pseudohypoaldosteronism type II (gene A) 1q31-q42 pseudohypoaldosteronism type ii, hypertension "pseudohypoaldosteronism, type iia"
PHB prohibitin 17q21.33 breast cancer ovarian cancer
PHB2 prohibitin 2 12p13.31 enthesopathy, urethritis dysentery
PHC1 polyhomeotic homolog 1 (Drosophila) 12p13.31 primary autosomal recessive microcephalies and seckel syndrome spectrum disorders, primary autosomal recessive microcephaly type 1 primary autosomal recessive microcephaly type 11
PHC3 polyhomeotic homolog 3 (Drosophila) 3q26.2 acute chest syndrome
PHEX phosphate regulating endopeptidase homolog, X-linked Xp22.11 epidermal nevus, enthesopathy, oncogenic osteomalacia,
PHF1 PHD finger protein 1 6p21.32 ossifying fibromyxoid tumor
PHF11 PHD finger protein 11 13q14.2 asthma
PHF13 PHD finger protein 13 1p36.31 ovarian cancer
PHF14 PHD finger protein 14 7p21.3 dandy-walker syndrome
PHF20 PHD finger protein 20 20q11.22 hepatocellular carcinoma, medulloblastoma large cell medulloblastoma
PHF21A PHD finger protein 21A 11p11.2 potocki-shaffer syndrome
PHF23 PHD finger protein 23 17p13.1 acute myeloid leukemia
PHF6 PHD finger protein 6 Xq26.2 borjeson-forssman-lehmann syndrome, obesity hypogonadism
PHF8 PHD finger protein 8 Xp11.22 "x-linked intellectual disability, siderius type"
PHGDH phosphoglycerate dehydrogenase 1p12 west syndrome, cerebral folate deficiency, malaria,
PHIP pleckstrin homology domain interacting protein 6q14.1 legg-calve-perthes disease
PHKA1 phosphorylase kinase, alpha 1 (muscle) Xq13.2 muscle glycogenosis, phosphorylase kinase deficiency, phka1-related phosphorylase kinase deficiency
PHKA1P1 phosphorylase kinase, alpha 1 pseudogene 1 1p22.2 muscle glycogenosis
PHKA2 phosphorylase kinase, alpha 2 (liver) Xp22.13 glycogen storage disease, muscle glycogenosis, phosphorylase kinase deficiency,
PHKB phosphorylase kinase, beta 16q12.1 colorectal cancer, muscle glycogenosis, phosphorylase kinase deficiency,
PHKG1 phosphorylase kinase, gamma 1 (muscle) 7p11.2 muscle glycogenosis phosphorylase kinase deficiency
PHKG1P1 phosphorylase kinase, gamma 1 pseudogene 1 7q11.21 muscle glycogenosis
PHKG1P2 phosphorylase kinase, gamma 1 pseudogene 2 7q11.21 muscle glycogenosis
PHKG1P3 phosphorylase kinase, gamma 1 pseudogene 3 11p11.12 muscle glycogenosis
PHKG2 phosphorylase kinase, gamma 2 (testis) 16p11.2 glycogen storage disease, phosphorylase kinase deficiency, cirrhosis due to liver phosphorylase kinase deficiency,
PHLDA1 pleckstrin homology-like domain, family A, member 1 12q21.2 morpheaform basal cell carcinoma
PHLDA2 pleckstrin homology-like domain, family A, member 2 11p15.4 breast cancer, gestational trophoblastic neoplasm, trophoblastic neoplasm,
PHLDA3 pleckstrin homology-like domain, family A, member 3 1q32.1 testicular germ cell tumor
PHLPP1 PH domain and leucine rich repeat protein phosphatase 1 18q21.33 obesity
PHOBS Phobia, specific specific phobia
PHOX2A paired-like homeobox 2a 11q13.4 congenital central hypoventilation syndrome, central hypoventilation syndrome, exotropia,
PHOX2B paired-like homeobox 2b 4p13 learning disability, autonomic dysfunction, hirschsprungs disease,
PHYH phytanoyl-CoA 2-hydroxylase 10p13 rhizomelic chondrodysplasia punctata, rhizomelic chondrodysplasia punctata type 2, infantile refsum disease,
PHYKPL 5-phosphohydroxy-L-lysine phospho-lyase 5q35.3 phosphohydroxylysinuria
PI15 peptidase inhibitor 15 8q21.11 neuroblastoma
PI3 peptidase inhibitor 3, skin-derived 20q13.12 cystic fibrosis, hepatopulmonary syndrome, sinusitis,
PI4K2B phosphatidylinositol 4-kinase type 2 beta 4p15.2 endogenous depression
PIAS2 protein inhibitor of activated STAT, 2 18q21.1 tinea capitis
PIAS4 protein inhibitor of activated STAT, 4 19p13.3 limb-girdle muscular dystrophy type 2h
PICALM phosphatidylinositol binding clathrin assembly protein 11q14.2 acute myeloid leukemia, lymphoblastic leukemia, leukemia,
PICK1 protein interacting with PRKCA 1 22q13.1 schizophrenia, nervous system disease, central nervous system disease
PIEZO1 piezo-type mechanosensitive ion channel component 1 16q24.3 dehydrated hereditary stomatocytosis dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema
PIEZO2 piezo-type mechanosensitive ion channel component 2 18p11.21 pseudohypoaldosteronism type ii, distal arthrogryposis type 5 marden-walker syndrome
PIGA phosphatidylinositol glycan anchor biosynthesis, class A Xp22.2 "epileptic encephalopathy, early infantile, 5", aplastic anemia, hemoglobinuria,
PIGB phosphatidylinositol glycan anchor biosynthesis, class B 15q21.3 griscelli syndrome
PIGC phosphatidylinositol glycan anchor biosynthesis, class C 1q24.3 lassa fever
PIGL phosphatidylinositol glycan anchor biosynthesis, class L 17p11.2 babesiosis, zunich neuroectodermal syndrome "coloboma, congenital heart disease, ichthyosiform dermatosis, mental retardation, and ear anomalies syndrome"
PIGM phosphatidylinositol glycan anchor biosynthesis, class M 1q23.2 glycosylphosphatidylinositol deficiency
PIGN phosphatidylinositol glycan anchor biosynthesis, class N 18q21.33 hypotonia multiple congenital anomalies-hypotonia-seizures syndrome 1
PIGO phosphatidylinositol glycan anchor biosynthesis, class O 9p13.3 malaria, hyperphosphatasia with mental retardation syndrome 1, hyperphosphatasia with mental retardation syndrome
PIGP phosphatidylinositol glycan anchor biosynthesis, class P 21q22.13 down syndrome
PIGQ phosphatidylinositol glycan anchor biosynthesis, class Q 16p13.3 "epileptic encephalopathy, early infantile, 17"
PIGR polymeric immunoglobulin receptor 1q32.1 hepatocellular carcinoma protein-energy malnutrition
PIGT phosphatidylinositol glycan anchor biosynthesis, class T 20q13.12 paroxysmal nocturnal hemoglobinuria, multiple congenital anomalies-hypotonia-seizures syndrome 3 paroxysmal nocturnal hemoglobinuria 2
PIGV phosphatidylinositol glycan anchor biosynthesis, class V 1p36.11 glycosylphosphatidylinositol deficiency, hyperphosphatasia with mental retardation syndrome 1, hyperphosphatasia with mental retardation syndrome
PIGW phosphatidylinositol glycan anchor biosynthesis, class W 17q12 babesiosis hyperphosphatasia with mental retardation syndrome 1
PIGY phosphatidylinositol glycan anchor biosynthesis, class Y 4q22.1 pthirus pubis infestation sarcocystosis
PIH pregnancy-induced hypertension (pre-eclampsia, eclampsia, toxemia of pregnancy included) pre-eclampsia, hypertension eclampsia
PIH1D3 PIH1 domain containing 3 Xq22.3 sarcoma
PIH2 pregnancy-induced hypertension syndrome-related protein 8q13.3 hypertension
PIK3AP1 phosphoinositide-3-kinase adaptor protein 1 10q24.1 pigmentary retinopathy
PIK3C2A phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha 11p15.1 scleromyxedema, pericardial effusion, myocardial infarction,
PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 3q26.32 hepatocellular carcinoma, "epidermal nevus, somatic", dermatosis papulosa nigra,
PIK3CD phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 1p36.22 pasli disease
PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma 7q22.3 meningioma
PIK3R1 phosphoinositide-3-kinase, regulatory subunit 1 (alpha) 5q13.1 insulin resistance, leopard syndrome, agammaglobulinemia 3 ,
PIK3R2 phosphoinositide-3-kinase, regulatory subunit 2 (beta) 19p13.11 megalencephaly, hydrocephalus "megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic"
PIK3R5 phosphoinositide-3-kinase, regulatory subunit 5 17p13.1 apraxia, doid:4019, spinocerebellar ataxia autosomal recessive 1
PIKFYVE phosphoinositide kinase, FYVE finger containing 2q34 transient neonatal diabetes mellitus corneal fleck dystrophy
PIM1 pim-1 oncogene 6p21.2 prostate cancer, lung cancer, marginal zone b-cell lymphoma,
PIM2 pim-2 oncogene Xp11.23 colorectal adenocarcinoma mantle cell lymphoma
PIM3 pim-3 oncogene 22q13.33 cannabis dependence
PIN1 peptidylprolyl cis/trans isomerase, NIMA-interacting 1 19p13.2 alzheimers disease adenoid cystic carcinoma
PIN4 protein (peptidylprolyl cis/trans isomerase) NIMA-interacting, 4 (parvulin) Xq13.1 myelophthisic anemia
PINK1 PTEN induced putative kinase 1 1p36.12 parkinsons disease, parkinson disease 1, alpha-methylacyl-coa racemase deficiency ,
PINX1 PIN2/TERF1 interacting, telomerase inhibitor 1 8p23.1 hepatocellular carcinoma telangiectasis
PIP prolactin-induced protein 7q34 breast cancer, microglandular adenosis, sweat gland carcinoma,
PIP4K2A phosphatidylinositol-5-phosphate 4-kinase, type II, alpha 10p12.2 "leukemia, acute lymphoblastic 3"
PIP5K1C phosphatidylinositol-4-phosphate 5-kinase, type I, gamma 19p13.3 congenital contractures lethal congenital contractural syndrome 3
PIPOX pipecolic acid oxidase 17q11.2 rhizomelic chondrodysplasia punctata
PITPNA phosphatidylinositol transfer protein, alpha 17p13.3 partial central choroid dystrophy
PITPNM1 phosphatidylinositol transfer protein, membrane-associated 1 11q13.2 retinal degeneration
PITPNM3 PITPNM family member 3 17p13.2 retinal degeneration, cone-rod dystrophy 2, cone-rod dystrophy
PITX1 paired-like homeodomain 1 5q31.1 diarrhea, exophthalmos, isolated acth deficiency,
PITX2 paired-like homeodomain 2 4q25 anophthalmia/microphthalmia, axenfeld-rieger syndrome, "atrial fibrillation, familial, 9",
PITX3 paired-like homeodomain 3 10q24.32 parkinsons disease, anophthalmia/microphthalmia, corticobasal degeneration,
PJA1 praja ring finger 1, E3 ubiquitin protein ligase Xq13.1 craniofrontonasal syndrome
PKD1 polycystic kidney disease 1 (autosomal dominant) 16p13.3 polycystic liver disease, congenital hepatic fibrosis, autosomal dominant disease,
PKD1L1 polycystic kidney disease 1 like 1 7p12.3 kidney disease, polycystic kidney disease diaphanospondylodysostosis
PKD1L2 polycystic kidney disease 1-like 2 16q23.2 kidney disease polycystic kidney disease
PKD1L3 polycystic kidney disease 1-like 3 16q22.2 kidney disease
PKD1P1 polycystic kidney disease 1 (autosomal dominant) pseudogene 1 16p13.11 kidney disease
PKD1P2 polycystic kidney disease 1 (autosomal dominant) pseudogene 2 16p13.11 kidney disease
PKD1P3 polycystic kidney disease 1 (autosomal dominant) pseudogene 3 16p13.11 kidney disease
PKD1P4 polycystic kidney disease 1 (autosomal dominant) pseudogene 4 16p13.12 kidney disease
PKD1P5 polycystic kidney disease 1 (autosomal dominant) pseudogene 5 16p12.3 kidney disease
PKD1P6 polycystic kidney disease 1 (autosomal dominant) pseudogene 6 16p13.11 polycystic liver disease kidney disease
PKD2 polycystic kidney disease 2 (autosomal dominant) 4q22.1 polycystic liver disease, liver disease, autosomal dominant disease,
PKD2L1 polycystic kidney disease 2-like 1 10q24.31 leishmaniasis, mucocutaneous leishmaniasis, kidney disease
PKD2L2 polycystic kidney disease 2-like 2 5q31.2 kidney disease polycystic kidney disease
PKD3 polycystic kidney disease 3 (autosomal dominant) 2p kidney disease "polycystic kidney disease, type 2"
PKDREJ polycystin (PKD) family receptor for egg jelly 22q13.31 kidney disease polycystic kidney disease
PKDTS polycystic kidney disease, infantile severe, with tuberous sclerosis 16p13.3 tuberous sclerosis, kidney disease "polycystic kidneys, severe infantile with tuberous sclerosis"
PKHD1 polycystic kidney and hepatic disease 1 (autosomal recessive) 6p12.2 polycystic liver disease, polycystic kidney and hepatic disease, congenital hepatic fibrosis,
PKHD1L1 polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1 8q23.1 polycystic kidney and hepatic disease
PKIB protein kinase (cAMP-dependent, catalytic) inhibitor beta 6q22.31 prostate cancer
PKLR pyruvate kinase, liver and RBC 1q22 gauchers disease, hemolytic anemia, endomyocardial fibrosis,
PKM pyruvate kinase, muscle 15q23 pyruvate kinase deficiency
PKP1 plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) 1q32.1 hypohidrotic ectodermal dysplasia, ectodermal dysplasia, ectodermal dysplasia skin fragility syndrome,
PKP2 plakophilin 2 12p11.21 "familial isolated arrhythmogenic ventricular dysplasia, biventricular form", "familial isolated arrhythmogenic ventricular dysplasia, right dominant form", "familial isolated arrhythmogenic ventricular dysplasia, left dominant form",
PLA2G10 phospholipase A2, group X 16p13.12 acute chest syndrome meconium aspiration syndrome
PLA2G16 phospholipase A2, group XVI 11q12.3 neutral lipid storage disease, lipid storage disease leptin deficiency
PLA2G1B phospholipase A2, group IB (pancreas) 12q24.31 blepharitis, "distal hereditary motor neuropathy, type ii", acinar cell carcinoma
PLA2G2A phospholipase A2, group IIA (platelets, synovial fluid) 1p36.13 colorectal cancer, ischemia, krabbe disease,
PLA2G2D phospholipase A2, group IID 1p36.12 surfactant dysfunction hemopneumothorax
PLA2G4A phospholipase A2, group IVA (cytosolic, calcium-dependent) 1q31.1 colorectal cancer, krabbe disease, small bowel adenocarcinoma
PLA2G5 phospholipase A2, group V 1p36.13 fundus albipunctatus , color blindness, red color blindness
PLA2G6 phospholipase A2, group VI (cytosolic, calcium-independent) 22q13.1 parkinsons disease, krabbe disease, blepharitis,
PLA2G7 phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) 6p12.3 bronchopulmonary dysplasia, asthma, coronary artery disease,
PLAA phospholipase A2-activating protein 9p21.2 malaria
PLAG1 pleiomorphic adenoma gene 1 8q12.1 adenoma, atypical lipomatous tumor, angiomatosis,
PLAGL1 pleiomorphic adenoma gene-like 1 6q24.2 intestinal atresia, diabetes mellitus, adenoma,
PLAGL2 pleiomorphic adenoma gene-like 2 20q11.21 adenoma
PLAT plasminogen activator, tissue 8p11.21 dysfibrinogenemia, pulmonary embolism, coronary thrombosis,
PLAU plasminogen activator, urokinase 10q22.2 prostate cancer, breast cancer, pancreatic cancer,
PLAUR plasminogen activator, urokinase receptor 19q13.31 pancreatic cancer, colon cancer, malaria,
PLB1 phospholipase B1 2p23.2 invasive aspergillosis
PLCB1 phospholipase C, beta 1 (phosphoinositide-specific) 20p12.3 "epileptic encephalopathy, early infantile, 5" "epileptic encephalopathy, early infantile, 12"
PLCB2 phospholipase C, beta 2 15q15.1 platelet plc beta-2 deficiency prostate leiomyosarcoma
PLCB3 phospholipase C, beta 3 (phosphatidylinositol-specific) 11q13.1 wermer syndrome
PLCB4 phospholipase C, beta 4 20p12.3 struma ovarii, auriculocondylar syndrome 2 auriculocondylar syndrome 1
PLCD1 phospholipase C, delta 1 3p22.2 acute salpingitis, salpingitis, nail disease
PLCE1 phospholipase C, epsilon 1 10q23.33 familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis, nephrotic syndrome, familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,
PLCG1 phospholipase C, gamma 1 20q12 mycobacterium kansasii
PLCG2 phospholipase C, gamma 2 (phosphatidylinositol-specific) 16q23.3 birt-hogg-dube syndrome, familial cold autoinflammatory syndrome, familial cold autoinflammatory syndrome 3
PLD1 phospholipase D1, phosphatidylcholine-specific 3q26.31 coffin-lowry syndrome kidney sarcoma
PLD2 phospholipase D2 17p13.2 colorectal cancer
PLD3 phospholipase D family, member 3 19q13.2 alzheimers disease "alzheimer disease 19, late onset"
PLEC plectin 8q24.3 alexander disease, epidermolysis bullosa simplex, epidermolysis bullosa,
PLEK pleckstrin 2p14 aarskog-scott syndrome scott syndrome
PLEK2 pleckstrin 2 14q23.3 clonorchiasis pyosalpinx
PLEKHA1 pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 10q26.13 age related macular degeneration kuhnt-junius degeneration
PLEKHA7 pleckstrin homology domain containing, family A member 7 11p15.1 primary angle-closure glaucoma
PLEKHA8 pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8 7p14.3 breast cancer
PLEKHB2 pleckstrin homology domain containing, family B (evectins) member 2 2q21.1 exudative vitreoretinopathy
PLEKHG4 pleckstrin homology domain containing, family G (with RhoGef domain) member 4 16q22.1 ataxia, dentatorubral-pallidoluysian atrophy, spinocerebellar ataxia
PLEKHG5 pleckstrin homology domain containing, family G (with RhoGef domain) member 5 1p36.31 muscular atrophy, spinal muscular atrophy, "spinal muscular atrophy, distal, autosomal recessive, 4",
PLEKHM1 pleckstrin homology domain containing, family M (with RUN domain) member 1 17q21.31 osteopetrosis, plekhm1-related autosomal recessive osteopetrosis osteopetrosis autosomal recessive 6
PLF Pulmonary function 6q21-q22 pulmonary function
PLG plasminogen 6q26 corneal neovascularization, thrombophilia, malaria,
PLIN1 perilipin 1 15q26.1 placental choriocarcinoma, insulin resistance, obesity,
PLIN2 perilipin 2 9p22.1 acrodermatitis enteropathica, acrodermatitis, enteropathica,
PLIN3 perilipin 3 19p13.3 sebaceous adenoma
PLK1 polo-like kinase 1 16p12.2 tetraploidy
PLLP plasmolipin 16q13 pelizaeus-merzbacher disease
PLN phospholamban 6q22.31 septic shock, familial hypertrophic cardiomyopathy, congestive heart failure,
PLOD1 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 1p36.22 alzheimers disease, congenital contractures, ehlers-danlos syndrome,
PLOD2 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 3q24 systemic scleroderma, fructosuria bruck syndrome 2
PLOD3 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 7q22.1 ullrich congenital muscular dystrophy lysyl hydroxylase 3 deficiency
PLP1 proteolipid protein 1 Xq22.2 quadriplegia, spastic quadriplegia, autoimmune encephalitis,
PLRG1 pleiotropic regulator 1 4q31.3 poikiloderma with neutropenia
PLS3 plastin 3 Xq23 cutaneous t cell lymphoma "bone mineral density qtl18, osteoporosis"
PLSA1 Primary lateral sclerosis, adult, 1 4p16 "primary lateral sclerosis, adult, 1"
PLSCR1 phospholipid scramblase 1 3q24 scott syndrome
PLTP phospholipid transfer protein 20q13.12 hypoalphalipoproteinemia, tangier disease hyperalphalipoproteinemia
PLXNA1 plexin A1 3q21.3 hereditary congenital facial paresis
PLXNA2 plexin A2 1q32.2 generalized anxiety disorder
PLXNC1 plexin C1 12q22 polycystic kidney and hepatic disease
PLXND1 plexin D1 3q22.1 double outlet right ventricle, ischemic retinopathy mobius syndrome
PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1 18q21.32 alveolar rhabdomyosarcoma, squamous cell carcinoma of the head and neck, t-cell leukemia,
PMCH pro-melanin-concentrating hormone 12q23.2 pheochromocytoma keratosis follicularis
PMEL premelanosome protein 12q13.2 melanoma, juvenile xanthogranuloma halo nevi
PML promyelocytic leukemia 15q24.1 leukemia, acute promyelocytic leukemia, neuronal intranuclear inclusion disease
PMM1 phosphomannomutase 1 22q13.2 congenital disorder of glycosylation type 1a
PMM2 phosphomannomutase 2 16p13.2 cardiac rupture congenital disorder of glycosylation type 1a
PMP2 peripheral myelin protein 2 8q21.13 microsporidiosis polyradiculoneuropathy
PMP22 peripheral myelin protein 22 17p12 neuropathy, hereditary ataxia, pelizaeus-merzbacher disease,
PMS1 PMS1 postmeiotic segregation increased 1 (S. cerevisiae) 2q32.2 colorectal cancer, colon cancer, rhabdomyosarcoma,
PMS2 PMS2 postmeiotic segregation increased 2 (S. cerevisiae) 7p22.1 colorectal cancer, colon cancer, familial hyperaldosteronism,
PMVK phosphomevalonate kinase 1q21.3 rhizomelic chondrodysplasia punctata dacryoadenitis
PNKD paroxysmal nonkinesigenic dyskinesia 2q35 paroxysmal dyskinesia, hepatitis c, hepatitis c virus,
PNKD2 paroxysmal nonkinesigenic dyskinesia 2 2q31 paroxysmal nonkinesigenic dyskinesia 2
PNKP polynucleotide kinase 3'-phosphatase 19q13.33 "epileptic encephalopathy, early infantile, 17", ohtahara syndrome, microcephaly,
PNLIP pancreatic lipase 10q25.3 steatorrhea, pancreatitis, exocrine pancreatic insufficiency,
PNLIPRP1 pancreatic lipase-related protein 1 10q25.3 choledocholithiasis
PNMA2 paraneoplastic Ma antigen 2 8p21.2 akinetic mutism, mutism, neuroendocrine tumor
PNMT phenylethanolamine N-methyltransferase 17q12 parkinsons disease, essential hypertension, heavy chain disease,
PNOC prepronociceptin 8p21.1 schizophrenia, postpartum depression pain disorder
PNP purine nucleoside phosphorylase 14q11.2 lesch-nyhan syndrome, malaria, adenosine deaminase deficiency,
PNPLA1 patatin-like phospholipase domain containing 1 6p21.31 autosomal recessive congenital ichthyosis, "ichthyosis, congenital, autosomal recessive 2", "ichthyosis, congenital, autosomal recessive 10"
PNPLA2 patatin-like phospholipase domain containing 2 11p15.5 systemic primary carnitine deficiency disease, neutral lipid storage disease, lipid storage disease
PNPLA3 patatin-like phospholipase domain containing 3 22q13.31 fatty liver disease, obesity, liver disease
PNPLA6 patatin-like phospholipase domain containing 6 19p13.2 neuropathy, cerebellar ataxia and hypogonadotropic hypogonadism, spastic paraplegia 39,
PNPLA8 patatin-like phospholipase domain containing 8 7q31.1 weaver syndrome
PNPO pyridoxamine 5'-phosphate oxidase 17q21.32 ariboflavinosis, pyridoxal 5-phosphate-dependent epilepsy pyridoxamine 5-phosphate oxidase deficiency
PNPT1 polyribonucleotide nucleotidyltransferase 1 2p16.1 "deafness, autosomal recessive 76", nonsyndromic deafness, autosomal recessive nonsyndromic deafness,
POC1A POC1 centriolar protein A 3p21.2 hypotrichosis, short stature "short stature, onychodysplasia, facial dysmorphism, and hypotrichosis"
PODXL podocalyxin-like 7q32.3 sick sinus syndrome
PODXL2 podocalyxin-like 2 3q21.3 facial paralysis
POF1B premature ovarian failure, 1B Xq21.2 premature ovarian failure, amenorrhea premature ovarian failure 2b
POFUT1 protein O-fucosyltransferase 1 20q11.21 spondylocostal dysostosis, degos disease, dowling-degos disease 2
POGLUT1 protein O-glucosyltransferase 1 3q13.33 myelodysplastic syndromes, degos disease, dowling-degos disease 2,
POLA1 polymerase (DNA directed), alpha 1, catalytic subunit Xp22.11 netherton syndrome n syndrome
POLB polymerase (DNA directed), beta 8p11.21 werner syndrome
POLD1 polymerase (DNA directed), delta 1, catalytic subunit 19q13.33 colorectal cancer, "mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome" colorectal cancer 10
POLE polymerase (DNA directed), epsilon, catalytic subunit 12q24.33 colorectal cancer, short stature, fils syndrome
POLG polymerase (DNA directed), gamma 15q26.1 ophthalmoplegia, cerebral folate deficiency, neuropathy,
POLG2 polymerase (DNA directed), gamma 2, accessory subunit 17q23.3 ophthalmoplegia, autosomal dominant progressive external ophthalmoplegia, chronic progressive external ophthalmoplegia,
POLH polymerase (DNA directed), eta 6p21.1 xeroderma pigmentosum, polh-related xeroderma pigmentosum "xeroderma pigmentosum, variant type"
POLI polymerase (DNA directed) iota 18q21.2 tracheitis
POLK polymerase (DNA directed) kappa 5q13.3 cholinergic urticaria brain compression
POLL polymerase (DNA directed), lambda 10q24.32 patent foramen ovale
POLM polymerase (DNA directed), mu 7p13 burkitts lymphoma lung adenoma
POLR1A polymerase (RNA) I polypeptide A, 194kDa 2p11.2 kidney hypertrophy
POLR1C polymerase (RNA) I polypeptide C, 30kDa 6p21.1 connective tissue disease, treacher collins syndrome, mixed connective tissue disease,
POLR1D polymerase (RNA) I polypeptide D, 16kDa 13q12.2 treacher collins syndrome, treacher collins syndrome 3, polr1d-related treacher collins syndrome
POLR2A polymerase (RNA) II (DNA directed) polypeptide A, 220kDa 17p13.1 la crosse encephalitis
POLR2B polymerase (RNA) II (DNA directed) polypeptide B, 140kDa 4q12 mycetoma eumycotic mycetoma
POLR2E polymerase (RNA) II (DNA directed) polypeptide E, 25kDa 19p13.3 hepatitis
POLR2I polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa 19q13.12 hiv-1 photosensitive trichothiodystrophy
POLR2J polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa 7q22.1 hiv-1
POLR2K polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa 8q22.2 hiv-1
POLR2L polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa 11p15.5 malaria
POLR3A polymerase (RNA) III (DNA directed) polypeptide A, 155kDa 10q22.3 pol iii-related leukodystrophies
POLR3B polymerase (RNA) III (DNA directed) polypeptide B 12q23.3 leukodystrophy, histoplasmosis pol iii-related leukodystrophies
POLR3K polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa 16p13.3 rheumatic disease herpes simplex
POLRMT polymerase (RNA) mitochondrial (DNA directed) 19p13.3 autosomal dominant progressive external ophthalmoplegia essential thrombocythemia
POMC proopiomelanocortin 2p23.3 antley-bixler syndrome, cytochrome p450 oxidoreductase deficiency, west syndrome,
POMGNT1 protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) 1p34.1 "muscular dystrophy-dystroglycanopathy , type a, 7", "muscular dystrophy-dystroglycanopathy , type a, 14", muscular dystrophy-dystroglycanopathy,
POMGNT2 protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) 3p22.1 osteochondroma, colorectal cancer, familial tumoral calcinosis,
POMK protein-O-mannose kinase 8p11.21 "muscular dystrophy-dystroglycanopathy , type a, 7", muscular dystrophy-dystroglycanopathy, walker-warburg syndrome
POMP proteasome maturation protein 13q12.3 prostate carcinoma in situ, peptic ulcer perforation keratosis linearis with ichthyosis congenita and sclerosing keratoderma
POMT1 protein-O-mannosyltransferase 1 9q34.13 "muscular dystrophy-dystroglycanopathy , type a, 7", "muscular dystrophy-dystroglycanopathy , type a, 14", muscular dystrophy-dystroglycanopathy,
POMT2 protein-O-mannosyltransferase 2 14q24.3 vitelliform macular dystrophy, "muscular dystrophy-dystroglycanopathy , type a, 7", "muscular dystrophy-dystroglycanopathy , type a, 14",
PON1 paraoxonase 1 7q21.3 myocardial infarction, coronary artery disease, amyotrophic lateral sclerosis,
PON2 paraoxonase 2 7q21.3 vascular disease, coronary artery disease, amyotrophic lateral sclerosis,
PON3 paraoxonase 3 7q21.3 amyotrophic lateral sclerosis, atherosclerosis peripheral artery disease
POP1 processing of precursor 1, ribonuclease P/MRP subunit (S. cerevisiae) 8q22.2 anauxetic dysplasia
POP5 processing of precursor 5, ribonuclease P/MRP subunit (S. cerevisiae) 12q24.31 cartilage-hair hypoplasia
POR P450 (cytochrome) oxidoreductase 7q11.23 antley-bixler syndrome, cytochrome p450 oxidoreductase deficiency, amenorrhea,
PORCN porcupine homolog (Drosophila) Xp11.23 non-small cell lung carcinoma, klinefelters syndrome, focal dermal hypoplasia
POROK2 Porokeratosis, palmar, plantar, and disseminated 1 12q24.1-q24.2 porokeratosis "porokeratosis 2, palmar, plantar, and disseminated"
POROK4 disseminated superficial actinic porokeratosis 2 15q25.1-q26.1 porokeratosis "porokeratosis 4, disseminated superficial actinic"
POROK5 Porokeratosis, disseminated superficial actinic, 3 1p31.3-p31.1 porokeratosis "porokeratosis 5, disseminated superficial actinic"
POROK6 Porokeratosis, disseminated superficial actinic, 4 18p11.3 porokeratosis porokeratosis 6
POROK7 Porokeratosis 7, disseminated superficial actinic 16q24.1-q24.3 porokeratosis porokeratosis 7
POSTN periostin, osteoblast specific factor 13q13.3 hypertensive nephropathy
POT1 protection of telomeres 1 7q31.33 b-cell chronic lymphocytic leukemia, "melanoma, malignant, somatic" "melanoma, cutaneous malignant 10"
POU1F1 POU class 1 homeobox 1 3p11.2 dwarfism, septo-optic dysplasia, borjeson-forssman-lehmann syndrome,
POU2AF1 POU class 2 associating factor 1 11q23.1 primary biliary cirrhosis, primary mediastinal large b-cell lymphoma nodular lymphocyte predominant hodgkin lymphoma
POU2F1 POU class 2 homeobox 1 1q24.1 hereditary persistence of fetal hemoglobin
POU2F2 POU class 2 homeobox 2 19q13.2 nodular lymphocyte predominant hodgkin lymphoma
POU2F3 POU class 2 homeobox 3 11q23.3 cervical cancer coronary thrombosis
POU3F1 POU class 3 homeobox 1 1p34.3 schizophrenia
POU3F4 POU class 3 homeobox 4 Xq21.1 alcohol dependence, choroideremia, nonsyndromic deafness,
POU4F1 POU class 4 homeobox 1 13q31.1 cervical cancer
POU4F2 POU class 4 homeobox 2 4q31.22 neuroblastoma, herpes simplex differentiating neuroblastoma
POU4F3 POU class 4 homeobox 3 5q32 vitelliform macular dystrophy, "deafness, autosomal dominant 4b", merkel cell carcinoma,
POU5F1 POU class 5 homeobox 1 6p21.33 seborrheic keratosis, malignant germ cell tumor, sacrococcygeal teratoma,
POU6F2 POU class 6 homeobox 2 7p14.1 wilms tumor, "wilms tumor, type 1" wilms tumor susceptibility-5
PPA1 pyrophosphatase (inorganic) 1 10q22.1 pseudogout
PPAN peter pan homolog (Drosophila) 19p13.2 middle cerebral artery infarction
PPARA peroxisome proliferator-activated receptor alpha 22q13.31 insulin resistance, hypertensive heart disease, obesity,
PPARD peroxisome proliferator-activated receptor delta 6p21.31 colorectal cancer, obesity, diabetic cataract
PPARG peroxisome proliferator-activated receptor gamma 3p25.2 gliosarcoma, giant cell glioblastoma, carotid intimal medial thickness,
PPARGC1A peroxisome proliferator-activated receptor gamma, coactivator 1 alpha 4p15.2 amyotrophic lateral sclerosis, breast cancer, obesity,
PPARGC1B peroxisome proliferator-activated receptor gamma, coactivator 1 beta 5q32 type 2 diabetes mellitus, obesity "obesity, variation in"
PPAT phosphoribosyl pyrophosphate amidotransferase 4q12 lesch-nyhan syndrome, malignant glioma phosphoribosylpyrophosphate synthetase superactivity
PPBP pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) 4q13.3 vascular disease, myocardial infarction, coronary artery disease,
PPBPP1 pro-platelet basic protein pseudogene 1 4q13.3 atopic dermatitis
PPCS phosphopantothenoylcysteine synthetase 1p34.2 methylmalonic aciduria and homocystinuria type cble, methylmalonic aciduria and homocystinuria type cblg, methylmalonic aciduria and homocystinuria type cblc,
PPEF1 protein phosphatase, EF-hand calcium binding domain 1 Xp22.13 retinoschisis x-linked juvenile retinoschisis
PPEF2 protein phosphatase, EF-hand calcium binding domain 2 4q21.1 retinal degeneration
PPFIBP1 PTPRF interacting protein, binding protein 1 (liprin beta 1) 12p11.23 ollier disease
PPH2 primary pulmonary hypertension 2 2q31-q32 hypertension "pulmonary hypertension, primary, 2"
PPIA peptidylprolyl isomerase A (cyclophilin A) 7p13 in situ carcinoma
PPIAL4E peptidylprolyl isomerase A (cyclophilin A)-like 4E 1q21.2 tongue squamous cell carcinoma
PPIAP15 peptidylprolyl isomerase A (cyclophilin A) pseudogene 15 3q13.13 hiv-1
PPIB peptidylprolyl isomerase B (cyclophilin B) 15q22.31 "osteogenesis imperfecta, type ii", osteogenesis imperfecta, osteogenesis imperfecta type iii,
PPIC peptidylprolyl isomerase C (cyclophilin C) 5q23.2 acute promyelocytic leukemia
PPID peptidylprolyl isomerase D 4q32.1 mitochondrial disorders
PPIF peptidylprolyl isomerase F 10q22.3 ullrich congenital muscular dystrophy bethlem myopathy
PPIG peptidylprolyl isomerase G (cyclophilin G) 2q31.1 myocardial infarction, liver disease, venous insufficiency
PPIL1 peptidylprolyl isomerase (cyclophilin)-like 1 6p21.2 hiv-1
PPIL2 peptidylprolyl isomerase (cyclophilin)-like 2 22q11.21 hiv-1
PPIL4 peptidylprolyl isomerase (cyclophilin)-like 4 6q25.1 breast cancer hiv-1
PPKB palmoplantar keratoderma, Bothnia type 12q11-q13 "diffuse palmoplantar keratoderma, bothnian type" "palmoplantar keratoderma, bothnia type"
PPKP1B Keratoderma, palmoplantar, punctate type IB 8q24.13-q24.21 "keratoderma, palmoplantar, punctate type ib"
PPL periplakin 16p13.3 follicular dendritic cell sarcoma, dendritic cell sarcoma, paraneoplastic pemphigus
PPM1B protein phosphatase, Mg2+/Mn2+ dependent, 1B 2p21 cystinuria 2p21 microdeletion syndrome
PPM1D protein phosphatase, Mg2+/Mn2+ dependent, 1D 17q23.2 breast cancer ovarian cancer
PPM1E protein phosphatase, Mg2+/Mn2+ dependent, 1E 17q22 mulibrey nanism
PPM1K protein phosphatase, Mg2+/Mn2+ dependent, 1K 4q22.1 maple syrup urine disease, maple syrup urine disease type 2 "maple syrup urine disease, mild variant"
PPME1 protein phosphatase methylesterase 1 11q13.4 malignant glioma unverricht-lundborg syndrome
PPOX protoporphyrinogen oxidase 1q23.3 erythropoietic protoporphyria, acute intermittent porphyria, acute porphyria,
PPP1CA protein phosphatase 1, catalytic subunit, alpha isozyme 11q13.2 hiv-1
PPP1CB protein phosphatase 1, catalytic subunit, beta isozyme 2p23.2 hiv-1 cardiac conduction defect
PPP1R11 protein phosphatase 1, regulatory (inhibitor) subunit 11 6p22.1 hemochromatosis
PPP1R12A protein phosphatase 1, regulatory subunit 12A 12q21.31 moebius syndrome
PPP1R13L protein phosphatase 1, regulatory subunit 13 like 19q13.32 lung cancer
PPP1R14A protein phosphatase 1, regulatory (inhibitor) subunit 14A 19q13.2 cutaneous anthrax, dracunculiasis tularemia
PPP1R14C protein phosphatase 1, regulatory (inhibitor) subunit 14C 6q25.1 breast cancer
PPP1R15A protein phosphatase 1, regulatory subunit 15A 19q13.33 herpes simplex
PPP1R16A protein phosphatase 1, regulatory subunit 16A 8q24.3 papillary thyroid carcinoma
PPP1R17 protein phosphatase 1, regulatory subunit 17 7p14.3 hypercholesterolemia
PPP1R1B protein phosphatase 1, regulatory (inhibitor) subunit 1B 17q12 schizophrenia
PPP1R3A protein phosphatase 1, regulatory subunit 3A 7q31.1 colorectal cancer, type 2 diabetes mellitus, insulin resistance,
PPP1R3F protein phosphatase 1, regulatory subunit 3F Xp11.23 autism spectrum disorder
PPP1R9B protein phosphatase 1, regulatory subunit 9B 17q21.33 schizophrenia limbic encephalitis
PPP2R1B protein phosphatase 2, regulatory subunit A, beta 11q23.1 lung cancer
PPP2R2B protein phosphatase 2, regulatory subunit B, beta 5q32 ataxia, spinocerebellar ataxia type 12, spinocerebellar ataxia,
PPP2R3B protein phosphatase 2, regulatory subunit B'', beta Xp22.33 cavernous malformation cerebral cavernous malformation
PPP2R3C protein phosphatase 2, regulatory subunit B'', gamma 14q13.2 rhabdomyosarcoma
PPP2R4 protein phosphatase 2A activator, regulatory subunit 4 9q34.11 hypersomnia chromosome 5q deletion
PPP2R5B protein phosphatase 2, regulatory subunit B', beta 11q13.1 wermer syndrome, pancreatic gastrinoma cavernous malformation
PPP3CC protein phosphatase 3, catalytic subunit, gamma isozyme 8p21.3 schizophrenia
PPP3R1 protein phosphatase 3, regulatory subunit B, alpha 2p14 calcaneonavicular coalition
PPP5C protein phosphatase 5, catalytic subunit 19q13.32 breast cancer
PPP6R1 protein phosphatase 6, regulatory subunit 1 19q13.42 denture stomatitis
PPR1 Photoparoxysmal response 1 6p21.1 photoparoxysmal response 1
PPR2 Photoparoxysmal response 2 13q31.3 photoparoxysmal response 2
PPR3 photoparoxysmal response 3 7q32 photoparoxysmal response 3
PPRC1 peroxisome proliferator-activated receptor gamma, coactivator-related 1 10q24.32 oxyphilic adenoma
PPT1 palmitoyl-protein thioesterase 1 1p34.2 neuronal ceroid-lipofuscinoses, late-infantile neuronal ceroid lipofuscinosis, neuronal ceroid lipofuscinosis,
PPY pancreatic polypeptide 17q21.31 cholera, anorexia nervosa, wermer syndrome,
PQBP1 polyglutamine binding protein 1 Xp11.23 non-specific x-linked mental retardation, mental retardation, periventricular heterotopia,
PRAC1 prostate cancer susceptibility candidate 1 17q21.32 prostate cancer
PRAC2 prostate cancer susceptibility candidate 2 17q21.32 prostate cancer
PRAM1 PML-RARA regulated adaptor molecule 1 19p13.2 acute promyelocytic leukemia
PRAME preferentially expressed antigen in melanoma 22q11.22 soft tissue sarcoma, acute myeloid leukemia, melanoma,
PRAP1 proline-rich acidic protein 1 10q26.3 hypohidrotic ectodermal dysplasia autism spectrum disorder
PRB1 proline-rich protein BstNI subfamily 1 12p13.2 spinal cord injury
PRBNS Pierre Robin syndrome 17q24.3-q25.1 isolated pierre robin sequence
PRCC papillary renal cell carcinoma (translocation-associated) 1q23.1 renal cell carcinoma, oxyphilic adenoma, papillary renal cell carcinoma,
PRCD progressive rod-cone degeneration 17q25.1 leber congenital amaurosis, retinal degeneration, membranous glomerulonephritis,
PRCP prolylcarboxypeptidase (angiotensinase C) 11q14.1 essential hypertension, hypertension c1 inhibitor deficiency
PRD primary retinal dysplasia Xp11.3 norrie disease
PRDM1 PR domain containing 1, with ZNF domain 6q21 myeloma, b-cell lymphomas, plasmacytoma
PRDM13 PR domain containing 13 6q16.2 medulloblastoma
PRDM14 PR domain containing 14 8q13.3 breast cancer
PRDM16 PR domain containing 16 1p36.32 acute myeloid leukemia, myeloid leukemia, "cardiomyopathy, dilated, 1w",
PRDM2 PR domain containing 2, with ZNF domain 1p36.21 retinoblastoma
PRDM5 PR domain containing 5 4q27 type vi ehlers-danlos syndrome brittle cornea syndrome 2
PRDM8 PR domain containing 8 4q21.21 early-onset lafora body disease
PRDX2 peroxiredoxin 2 19p13.2 in situ carcinoma fuchs endothelial dystrophy
PRDX3 peroxiredoxin 3 10q26.11 fuchs endothelial dystrophy
PRDX4 peroxiredoxin 4 Xp22.11 cystic echinococcosis
PRDX5 peroxiredoxin 5 11q13.1 malaria, corticobasal degeneration fuchs endothelial dystrophy
PRDX6 peroxiredoxin 6 1q25.1 fuchs endothelial dystrophy gnathomiasis
PREB prolactin regulatory element binding 2p23.3 testicular leukemia
PRED1 putative gene, protein kinase C ETA type (EC 2.7.1.) like legius syndrome
PREP prolyl endopeptidase 6q21 post-traumatic stress disorder, trypanosomiasis amnestic disorder
PREPL prolyl endopeptidase-like 2p21 cystinuria, 2p21 microdeletion syndrome, atypical hypotonia - cystinuria syndrome,
PRF1 perforin 1 (pore forming protein) 10q22.1 hypersensitivity reaction type ii disease, cardiac rupture, aplastic anemia,
PRG1 p53-responsive gene 1 19q13.2 b-cell lymphomas diffuse large b-cell lymphoma
PRG2 proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) 11q12.1 atopy, esophagitis, ocular cicatricial pemphigoid,
PRG4 proteoglycan 4 1q31.1 arthropathy, pericarditis, myxoid liposarcoma
PRICKLE1 prickle homolog 1 (Drosophila) 12q12 prickle1-related progressive myoclonus epilepsy with ataxia, myoclonus, myoclonus epilepsy,
PRICKLE2 prickle homolog 2 (Drosophila) 3p14.1 progressive myoclonic epilepsy 5
PRIMPOL primase and polymerase (DNA-directed) 4q35.1 "myopia 22, autosomal dominant"
PRINS psoriasis associated non-protein coding RNA induced by stress 10p12.1 psoriasis
PRKAA1 protein kinase, AMP-activated, alpha 1 catalytic subunit 5p13.1 wolff-parkinson-white syndrome
PRKAA2 protein kinase, AMP-activated, alpha 2 catalytic subunit 1p32.2 ischemia, aromatase deficiency, phosphorylase kinase deficiency,
PRKAB1 protein kinase, AMP-activated, beta 1 non-catalytic subunit 12q24.23 krabbe disease
PRKAB2 protein kinase, AMP-activated, beta 2 non-catalytic subunit 1q21.1 atrioventricular septal defect
PRKACA protein kinase, cAMP-dependent, catalytic, alpha 19p13.12 primary pigmented nodular adrenocortical disease, "cushing syndrome, acth-independent adrenal, somatic" hepatocellular fibrolamellar carcinoma
PRKACB protein kinase, cAMP-dependent, catalytic, beta 1p31.1 primary pigmented nodular adrenocortical disease
PRKACG protein kinase, cAMP-dependent, catalytic, gamma 9q21.11 primary pigmented nodular adrenocortical disease
PRKAG2 protein kinase, AMP-activated, gamma 2 non-catalytic subunit 7q36.1 phosphorylase kinase deficiency, danon disease, wolff-parkinson-white syndrome,
PRKAG3 protein kinase, AMP-activated, gamma 3 non-catalytic subunit 2q35 wolff-parkinson-white syndrome
PRKAR1A protein kinase, cAMP-dependent, regulatory, type I, alpha 17q24.2 mccune albright syndrome, hyperparathyroidism, pituitary adenoma,
PRKAR1B protein kinase, cAMP-dependent, regulatory, type I, beta 7p22.3 familial atrial fibrillation
PRKCA protein kinase C, alpha 17q24.2 "pituitary tumor, invasive"
PRKCB protein kinase C, beta 16p12.2 diabetic macular edema
PRKCD protein kinase C, delta 3p21.1 common variable immune deficiency, "immunodeficiency, common variable, 9", acth-secreting pituitary adenoma,
PRKCE protein kinase C, epsilon 2p21 ischemia rift valley fever
PRKCG protein kinase C, gamma 19q13.42 spinocerebellar ataxia type 14 spinocerebellar ataxia type14
PRKCH protein kinase C, eta 14q23.1 "stroke, ischemic"
PRKCQ protein kinase C, theta 10p14 gastrointestinal stromal tumor
PRKCSH protein kinase C substrate 80K-H 19p13.2 polycystic liver disease, liver disease, hemiplegic migraine
PRKCZ protein kinase C, zeta 1p36.33 parainfluenza virus type 3
PRKDC protein kinase, DNA-activated, catalytic polypeptide 8q11.21 severe combined immunodeficiency due to dna-pkcs deficiency artemis deficiency
PRKG1 protein kinase, cGMP-dependent, type I 10q11.23 hemangioma, intraductal papilloma, erdheim-chester disease,
PRKRA protein kinase, interferon-inducible double stranded RNA dependent activator 2q31.2 microtia, dystonia dystonia 16
PRL prolactin 6p22.3 breast fibroadenoma, mccune albright syndrome, exophthalmos,
PRLHR prolactin releasing hormone receptor 10q26.11 uterine fibroid
PRLR prolactin receptor 5p13.2 lobular neoplasia, breast fibroadenoma, hyperprolactinemia,
PRMT6 protein arginine methyltransferase 6 1p13.3 wolff-parkinson-white syndrome
PRNCR1 prostate cancer associated non-coding RNA 1 8q24.21 prostate cancer
PRND prion protein 2 (dublet) 20p13 variant creutzfeldt-jakob disease, prion disease, creutzfeldt-jakob disease,
PRNP prion protein 20p13 huntingtons disease, akinetic mutism, mutism,
PRNT prion protein (testis specific) 20p13 rift valley fever dengue disease
PROC protein C (inactivator of coagulation factors Va and VIIIa) 2q14.3 thrombophilia, venous thromboembolism, protein c deficiency,
PROCR protein C receptor, endothelial 20q11.22 myocardial infarction, sepsis, venous thromboembolism,
PRODH proline dehydrogenase (oxidase) 1 22q11.21 velocardiofacial syndrome, schizophrenia, primary hyperoxaluria,
PRODH2 proline dehydrogenase (oxidase) 2 19q13.12 schizophrenia, hyperprolinemia schizophrenia 4
PROK1 prokineticin 1 1p13.3 hypoxia, ectopic pregnancy osteonecrosis
PROK2 prokineticin 2 3p13 hypogonadotropic hypogonadism 8 with or without anosmia, hypogonadotropic hypogonadism 17 with or without anosmia, kallmann syndrome,
PROKR1 prokineticin receptor 1 2p13.3 ectopic pregnancy
PROKR2 prokineticin receptor 2 20p12.3 hypogonadotropic hypogonadism 8 with or without anosmia, hypogonadotropic hypogonadism 17 with or without anosmia, kallmann syndrome,
PROM1 prominin 1 4p15.32 leber congenital amaurosis, malignant germ cell tumor, macular dystrophy,
PROP1 PROP paired-like homeobox 1 5q35.3 septo-optic dysplasia, borjeson-forssman-lehmann syndrome, pituitary tumors,
PROS1 protein S (alpha) 3q11.1 colorectal cancer, antithrombin iii deficiency, prostate cancer,
PROSP protein S pseudogene (beta) 3p11.1 alveoli adenoma
PROX1 prospero homeobox 1 1q32.3 breast cancer, kaposiform hemangioendothelioma, inflammatory breast carcinoma,
PROZ protein Z, vitamin K-dependent plasma glycoprotein 13q34 cerebral sinovenous thrombosis
PRPF18 pre-mRNA processing factor 18 10p13 palmoplantar keratosis pityriasis rubra pilaris
PRPF19 pre-mRNA processing factor 19 11q12.2 poikiloderma with neutropenia
PRPF3 pre-mRNA processing factor 3 1q21.2 leber congenital amaurosis, retinitis, retinitis pigmentosa,
PRPF31 pre-mRNA processing factor 31 19q13.42 breast cancer, leber congenital amaurosis, retinitis pigmentosa,
PRPF4 pre-mRNA processing factor 4 9q32 leber congenital amaurosis ovarian cancer
PRPF6 pre-mRNA processing factor 6 20q13.33 leber congenital amaurosis, retinitis pigmentosa 60 prpf6-related retinitis pigmentosa
PRPF8 pre-mRNA processing factor 8 17p13.3 leber congenital amaurosis, retinitis pigmentosa, ascending cholangitis,
PRPH peripherin 12q13.12 amyotrophic lateral sclerosis, lateral sclerosis, vitelliform macular dystrophy,
PRPH2 peripherin 2 (retinal degeneration, slow) 6p21.1 amyotrophic lateral sclerosis, leber congenital amaurosis, vitelliform macular dystrophy,
PRPS1 phosphoribosyl pyrophosphate synthetase 1 Xq22.3 lesch-nyhan syndrome, nonsyndromic hearing loss and deafness, hemophilia b,
PRPS2 phosphoribosyl pyrophosphate synthetase 2 Xp22.2 lesch-nyhan syndrome purine nucleoside phosphorylase deficiency
PRR4 proline rich 4 (lacrimal) 12p13.2 ectodermal dysplasia-syndactyly syndrome 1
PRRC2A proline-rich coiled-coil 2A 6p21.33 rheumatoid arthritis coronary artery aneurysm
PRRG4 proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) 11p13 wagr syndrome
PRRT2 proline-rich transmembrane protein 2 16p11.2 paroxysmal dyskinesia, familial paroxysmal kinesigenic dyskinesia, glut1 deficiency syndrome 2 ,
PRRX1 paired related homeobox 1 1q24.2 agnathia-otocephaly complex acute myelomonocytic leukemia
PRS Prieto X-linked mental retardation syndrome Xp21-p11 prieto x-linked mental retardation syndrome
PRSM2 protease, metallo, 2 reserved hiv-1
PRSS1 protease, serine, 1 (trypsin 1) 7q34 pancreatic cancer, steatorrhea, tropical calcific pancreatitis,
PRSS12 protease, serine, 12 (neurotrypsin, motopsin) 4q26 "mental retardation, autosomal recessive 43"
PRSS2 protease, serine, 2 (trypsin 2) 7q34 primary hyperparathyroidism, acute pancreatitis, tropical calcific pancreatitis,
PRSS21 protease, serine, 21 (testisin) 16p13.3 germ cell tumors, testicular cancer dracunculiasis
PRSS52P protease, serine, 52, pseudogene 8p23.1 alzheimers disease
PRSS56 protease, serine, 56 2q37.1 "microphthalmia, isolated 2", primary angle-closure glaucoma, refractive error,
PRSS8 protease, serine, 8 16p11.2 bladder transitional cell carcinoma, transitional cell carcinoma, cystic fibrosis,
PRTFDC1 phosphoribosyl transferase domain containing 1 10p12.1 lesch-nyhan syndrome
PRTN3 proteinase 3 19p13.3 polyarteritis nodosa, vasculitis, alpha 1-antitrypsin deficiency,
PRX periaxin 19q13.2 charcot-marie-tooth neuropathy type 4, charcot-marie-tooth disease type 4, neuropathy,
PRY PTPN13-like, Y-linked Yq11.223 y chromosome infertility
PRY2 PTPN13-like, Y-linked 2 Yq11.223 y chromosome infertility
PSAP prosaposin 10q22.1 learning disability, "metachromatic leukodystrophy, juvenile form", "metachromatic leukodystrophy, late infantile form",
PSAT1 phosphoserine aminotransferase 1 9q21.2 prostate cancer, schizotypal personality disorder, schizophrenia,
PSC Cholangitis, primary sclerosing 3p21 primary sclerosing cholangitis
PSCA prostate stem cell antigen 8q24.3 bladder cancer susceptibility, bladder carcinoma, prostate cancer,
PSD pleckstrin and Sec7 domain containing 10q24.32 retinal artery occlusion branch retinal artery occlusion
PSD3 pleckstrin and Sec7 domain containing 3 8p22 hepatocellular carcinoma
PSEN1 presenilin 1 14q24.2 frontotemporal lobar degeneration with ubiquitin-positive inclusions, "dementia, familial, nonspecific", semantic dementia,
PSEN2 presenilin 2 1q42.13 breast cancer, alzheimers disease, familial idiopathic basal ganglia calcification,
PSENEN presenilin enhancer gamma secretase subunit 19q13.12 alzheimers disease, pain agnosia, agnosia,
PSG1 pregnancy specific beta-1-glycoprotein 1 19q13.2 gestational trophoblastic neoplasm, trophoblastic neoplasm factor vii deficiency
PSG2 pregnancy specific beta-1-glycoprotein 2 19q13.31 colorectal cancer, pericardial effusion, breast cancer,
PSG9 pregnancy specific beta-1-glycoprotein 9 19q13.31 gestational trophoblastic neoplasm trophoblastic neoplasm
PSHK2 Pseudohyperkalemia, familial, 2, due to red cell leak 2q35-q36 "pseudohyperkalemia, familial, 2, due to red cell leak"
PSIP1 PC4 and SFRS1 interacting protein 1 9p22.3 dysembryoplastic neuroepithelial tumor
PSMA6 proteasome (prosome, macropain) subunit, alpha type, 6 14q13.2 myocardial infarcation
PSMA7 proteasome (prosome, macropain) subunit, alpha type, 7 20q13.33 hypoxia, hepatitis b, hepatitis c,
PSMB4 proteasome (prosome, macropain) subunit, beta type, 4 1q21.3 neurotic disorder
PSMB8 proteasome (prosome, macropain) subunit, beta type, 8 6p21.32 cardiac sarcoidosis, brucellosis, wagr syndrome,
PSMB9 proteasome (prosome, macropain) subunit, beta type, 9 6p21.32 brucellosis, epstein-barr virus-associated gastric carcinoma, renal oncocytoma,
PSMC1 proteasome (prosome, macropain) 26S subunit, ATPase, 1 14q32.11 hepatitis b, hepatitis, borna disease
PSMC3IP PSMC3 interacting protein 17q21.2 gonadal dysgenesis, ovarian dysgenesis 1 ovarian dysgenesis 3
PSMC4 proteasome (prosome, macropain) 26S subunit, ATPase, 4 19q13.2 hemimegalencephaly, indolent systemic mastocytosis, timothy syndrome,
PSMC5 proteasome (prosome, macropain) 26S subunit, ATPase, 5 17q23.3 mulibrey nanism indolent systemic mastocytosis
PSMD10 proteasome (prosome, macropain) 26S subunit, non-ATPase, 10 Xq22.3 hepatocellular carcinoma
PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 11p15.5 spondylolisthesis
PSMD14 proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 2q24.2 hereditary renal cell carcinoma
PSMD6 proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 3p14.1 breast cancer
PSMD7 proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 16q23.1 hereditary renal cell carcinoma
PSMD9 proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 12q24.31 hypertensive retinopathy
PSMG1 proteasome (prosome, macropain) assembly chaperone 1 21q22.2 papillary thyroid carcinoma down syndrome
PSMG2 proteasome (prosome, macropain) assembly chaperone 2 18p11.21 hepatocellular carcinoma
PSMG3 proteasome (prosome, macropain) assembly chaperone 3 7p22.3 autoimmune thrombocytopenic purpura
PSMNSW Parasomnia, sleepwalking type 20q12-q13.12 "parasomnia, sleepwalking type"
PSNP2 supranuclear palsy, progressive, 2 1q31.1 "supranuclear palsy, progressive, 2"
PSNP3 Supranuclear palsy, progressive, 3 11p12-p11 "supranuclear palsy, progressive, 3"
PSORS10 psoriasis susceptibility 10 18p11.23 psoriasis psoriasis susceptibility 10
PSORS11 Psoriasis susceptibility 11 5q31.1-q33.1 psoriasis psoriasis susceptibility 11
PSORS1C1 psoriasis susceptibility 1 candidate 1 6p21.33 psoriasis, psoriasis susceptibility 1, toxic epidermal necrolysis
PSORS1C2 psoriasis susceptibility 1 candidate 2 6p21.33 psoriasis psoriasis susceptibility 1
PSORS1C3 psoriasis susceptibility 1 candidate 3 (non-protein coding) 6p21.33 psoriasis psoriasis susceptibility 1
PSORS2 psoriasis susceptibility 2 17q psoriasis, psoriatic arthritis, pityriasis rubra pilaris
PSORS3 psoriasis susceptibility 3 4q psoriasis psoriasis susceptibility 3
PSORS4 psoriasis susceptibility 4 1q21 psoriasis, psoriatic arthritis psoriasis susceptibility 4
PSORS5 psoriasis susceptibility 5 3q21 psoriasis, psoriatic arthritis psoriasis susceptibility 5
PSORS6 psoriasis susceptibility 6 19p13 psoriasis susceptibility 6
PSORS7 psoriasis susceptibility 7 1p psoriasis psoriasis susceptibility 7
PSORS8 psoriasis susceptibility 8 16q psoriasis psoriasis susceptibility 8
PSORS9 psoriasis susceptibility 9 4q31-q34 psoraisis susceptibility 9
PSPC1 paraspeckle component 1 13q12.11 western equine encephalitis
PSPH phosphoserine phosphatase 7p11.2 serine deficiency, williams syndrome, lead poisoning,
PSPN persephin 19p13.3 parkinsons disease hirschsprungs disease
PSS Potocki-Shaffer syndrome 11p11.2 hypotrichosis 2, peeling skin syndrome potocki-shaffer syndrome
PSTPIP1 proline-serine-threonine phosphatase interacting protein 1 15q24.3 wiskott-aldrich syndrome, acne, psoriatic juvenile idiopathic arthritis,
PSTPIP2 proline-serine-threonine phosphatase interacting protein 2 18q21.1 sapho syndrome mast-cell leukemia
PTAFR platelet-activating factor receptor 1p35.3 lymphoid leukemia
PTBP1 polypyrimidine tract binding protein 1 19p13.3 human t-cell leukemia virus type 2
PTBP2 polypyrimidine tract binding protein 2 1p21.3 cancer-associated retinopathy
PTCH1 patched 1 9q22.32 septopreoptic holoprosencephaly, midline interhemispheric variant of holoprosencephaly, lobar holoprosencephaly,
PTCH2 patched 2 1p34.1 medulloblastoma, nevoid basal cell carcinoma syndrome, basal cell carcinoma,
PTCHD1 patched domain containing 1 Xp22.11 learning disability, "mental retardation, x-linked 17/31, microduplication" intellectual disability
PTCPRN Papillary thyroid carcinoma with papillary renal neoplasia 1q21 papillary thyroid carcinoma "thyroid carcinoma, papillary, with papillary renal neoplasia"
PTCSC1 papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding) 8q24 papillary thyroid carcinoma
PTCSC3 papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding) 14q13.3 papillary thyroid carcinoma
PTDSS1 phosphatidylserine synthase 1 8q22.1 lenz majewski hyperostotic dwarfism
PTEN phosphatase and tensin homolog 10q23.31 gliosarcoma, giant cell glioblastoma, epidermal nevus,
PTENP1 phosphatase and tensin homolog pseudogene 1 (functional) 9p13.3 cowden disease
PTER phosphotriesterase related 10p13 cri-du-chat syndrome patau syndrome
PTF1A pancreas specific transcription factor, 1a 10p12.2 cerebellar agenesis, pancreatic agenesis "diabetes mellitus, permanent neonatal, with cerebellar agenesis"
PTGDR prostaglandin D2 receptor (DP) 14q22.1 asthma asthma 1
PTGDR2 prostaglandin D2 receptor 2 11q12.2 asthma, folliculitis eosinophilic pustular folliculitis
PTGDS prostaglandin D2 synthase 21kDa (brain) 9q34.3 sandhoff disease, complete androgen insensitivity syndrome, breast cyst,
PTGER2 prostaglandin E receptor 2 (subtype EP2), 53kDa 14q22.1 asthma, gastric ulcer, amyotrophic lateral sclerosis,
PTGER3 prostaglandin E receptor 3 (subtype EP3) 1p31.1 corneal disease conjunctivochalasis
PTGER4 prostaglandin E receptor 4 (subtype EP4) 5p13.1 osteoporosis, benign mesothelioma lymphocytic colitis
PTGES2 prostaglandin E synthase 2 9q34.11 patent ductus arteriosus
PTGFR prostaglandin F receptor (FP) 1p31.1 menieres disease endometrial adenocarcinoma
PTGIS prostaglandin I2 (prostacyclin) synthase 20q13.13 myocardial infarction, essential hypertension atherosclerosis
PTGS1 prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) 9q33.2 gastric ulcer, urticaria, ureteral obstruction,
PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 1q31.1 adenocarcinoma, coronary thrombosis, barretts esophagus,
PTH parathyroid hormone 11p15.2 oncogenic osteomalacia, hyperphosphatemia, hypophosphatemia,
PTH1R parathyroid hormone 1 receptor 3p21.31 thanatophoric dysplasia, oncogenic osteomalacia, osteomalacia,
PTH2R parathyroid hormone 2 receptor 2q34 jansens metaphyseal chondrodysplasia
PTHLH parathyroid hormone-like hormone 12p11.22 osteochondroma, bronchopulmonary dysplasia, prostate cancer,
PTK2 protein tyrosine kinase 2 8q24.3 breast cancer, gastroesophageal junction adenocarcinoma, askins tumor
PTK6 protein tyrosine kinase 6 20q13.33 recurrent corneal erosion
PTK7 protein tyrosine kinase 7 6p21.1 agoraphobia, social phobia panic disorder
PTLAH patella aplasia-hypoplasia 17q absent patella
PTLS Potocki-Lupski syndrome 17p11.2 potocki-lupski syndrome
PTMA prothymosin, alpha 2q37.1 hepatitis b
PTMAP6 prothymosin, alpha pseudogene 6 20q13.31 major depressive disorder
PTN pleiotrophin 7q33 meningioma tetraploidy
PTOS1 ptosis, congenital 1 (autosomal dominant) 1p34.1-p32 "ptosis, congenital" "ptosis, hereditary congenital, 1"
PTOS2 Ptosis, hereditary congenital 2 Xq24-q27.1 "ptosis, hereditary congenital 2"
PTPLA protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A 10p12.33 congenital fiber-type disproportion
PTPMT1 protein tyrosine phosphatase, mitochondrial 1 11p11.2 stomach cancer cogans syndrome
PTPN1 protein tyrosine phosphatase, non-receptor type 1 20q13.13 insulin resistance, obesity, leopard syndrome,
PTPN11 protein tyrosine phosphatase, non-receptor type 11 12q24.13 cherubism, acute myeloid leukemia, noma,
PTPN12 protein tyrosine phosphatase, non-receptor type 12 7q11.23 colon cancer "colon cancer, somatic"
PTPN14 protein tyrosine phosphatase, non-receptor type 14 1q41 choanal atresia, lymphedema choanal atresia and lymphedema
PTPN2 protein tyrosine phosphatase, non-receptor type 2 18p11.21 oligoarticular juvenile arthritis polyarticular onset juvenile idiopathic arthritis
PTPN22 protein tyrosine phosphatase, non-receptor type 22 (lymphoid) 1p13.2 vitiligo, graves disease, systemic lupus erythematosus,
PTPN3 protein tyrosine phosphatase, non-receptor type 3 9q31.3 scott syndrome, cholangiocarcinoma, bannayan-riley-ruvalcaba syndrome
PTPN6 protein tyrosine phosphatase, non-receptor type 6 12p13.31 polycythemia, polycythemia vera cd45 deficiency
PTPRA protein tyrosine phosphatase, receptor type, A 20p13 estrogen-receptor negative breast cancer
PTPRB protein tyrosine phosphatase, receptor type, B 12q15 hyperkalemic periodic paralysis
PTPRC protein tyrosine phosphatase, receptor type, C 1q31.3 lymphoepithelioma-like carcinoma, histiocytic sarcoma, mucinous cystadenocarcinoma,
PTPRCAP protein tyrosine phosphatase, receptor type, C-associated protein 11q13.2 autoimmune hepatitis
PTPRD protein tyrosine phosphatase, receptor type, D 9p23 familial melanoma
PTPRE protein tyrosine phosphatase, receptor type, E 10q26.2 ascending colon cancer
PTPRF protein tyrosine phosphatase, receptor type, F 1p34.2 insulin resistance ureterocele
PTPRG protein tyrosine phosphatase, receptor type, G 3p14.2 renal cell carcinoma
PTPRH protein tyrosine phosphatase, receptor type, H 19q13.42 stomach cancer
PTPRJ protein tyrosine phosphatase, receptor type, J 11p11.2 colorectal cancer, colon cancer, pendred syndrome,
PTPRN protein tyrosine phosphatase, receptor type, N 2q35 diabetes mellitus, type 1 diabetes mellitus maternally inherited diabetes and deafness
PTPRN2 protein tyrosine phosphatase, receptor type, N polypeptide 2 7q36.3 diabetes mellitus spondylolysis
PTPRO protein tyrosine phosphatase, receptor type, O 12p12.3 familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation, nephrotic syndrome, familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,
PTPRQ protein tyrosine phosphatase, receptor type, Q 12q21.31 mesangial proliferative glomerulonephritis, "deafness, autosomal recessive 76", proliferative glomerulonephritis,
PTPRR protein tyrosine phosphatase, receptor type, R 12q15 colorectal cancer
PTPRS protein tyrosine phosphatase, receptor type, S 19p13.3 pituitary hypoplasia, chordoid glioma, pineal gland cancer
PTPRZ1 protein tyrosine phosphatase, receptor-type, Z polypeptide 1 7q31.32 h. pylori infection hyperkalemic periodic paralysis
PTRF polymerase I and transcript release factor 17q21.2 congenital generalized lipodystrophy, lipodystrophy, lung cancer susceptibility 2
PTS 6-pyruvoyltetrahydropterin synthase 11q23.1 colorectal cancer, dihydropteridine reductase deficiency, tetrahydrobiopterin deficiency,
PTTG1 pituitary tumor-transforming 1 5q33.3 thyroid cancer thymic hyperplasia
PTX3 pentraxin 3, long 3q25.32 myocardial infarction, rheumatic disease, acute myocardial infarction,
PUF60 poly-U binding splicing factor 60KDa 8q24.3 verheij syndrome
PUJO pelviureteric junction obstruction 6p "multicystic renal dysplasia, bilateral"
PUM1 pumilio RNA-binding family member 1 1p35.2 intermediate charcot-marie-tooth neuropathy
PURA purine-rich element binding protein A 5q31.2 relapsing fever, urethral intrinsic sphincter deficiency, tick-borne relapsing fever
PURB purine-rich element binding protein B 7p13 relapsing fever tick-borne relapsing fever
PUS1 pseudouridylate synthase 1 12q24.33 periventricular heterotopia, myopathy, pearson syndrome,
PVALB parvalbumin 22q12.3 amyotrophic lateral sclerosis, schizophrenia, west syndrome,
PVNH3 Periventricular nodular heterotopia 3 5p15.1 periventricular nodular heterotopia periventricular nodular heterotopia 3
PVNH5 Periventricular nodular heterotopia 5 5q14.3-q15 periventricular nodular heterotopia periventricular nodular heterotopia 5
PVOP1 Pelvic organ prolapse, susceptibility to, 1 1q31 pelvic organ prolapse 1
PVOP2 Pelvic organ prolapse, susceptibility to, 2 9q21 pelvic organ prolapse 2
PVR poliovirus receptor 19q13.31 paralytic poliomyelitis, poliomyelitis malignant glioma
PVRL1 poliovirus receptor-related 1 (herpesvirus entry mediator C) 11q23.3 septo-optic dysplasia, cleft lip, cleft palate,
PVRL2 poliovirus receptor-related 2 (herpesvirus entry mediator B) 19q13.32 multiple sclerosis herpes simplex
PVRL4 poliovirus receptor-related 4 1q23.3 syndactyly ectodermal dysplasia-syndactyly syndrome 1
PWAR4 Prader Willi/Angelman region RNA 4 15q11.2 major depressive disorder
PWAR5 Prader Willi/Angelman region RNA 5 15q11.2 angelman syndrome autism spectrum disorder
PWARSN Prader Willi/Angelman region RNA, SNRPN neighbor 15q11.2 angelman syndrome
PWP1 PWP1 homolog (S. cerevisiae) 12q23.3 cardiac tamponade
PWRN1 Prader-Willi region non-protein coding RNA 1 15q11.2 prader-willi syndrome
PXDN peroxidasin homolog (Drosophila) 2p25.3 congenital cataract microcornea with corneal opacity
PXK PX domain containing serine/threonine kinase 3p14.3 systemic lupus erythematosus sle susceptibility
PXMP4 peroxisomal membrane protein 4, 24kDa 20q11.22 prostate adenocarcinoma
PYCARD PYD and CARD domain containing 16p11.2 cryopyrin-associated periodic syndrome
PYCR1 pyrroline-5-carboxylate reductase 1 17q25.3 gyrate atrophy, de barsy syndrome, pycr1-related cutis laxa,
PYCR2 pyrroline-5-carboxylate reductase family, member 2 1q42.12 gyrate atrophy
PYCRL pyrroline-5-carboxylate reductase-like 8q24.3 gyrate atrophy
PYGL phosphorylase, glycogen, liver 14q22.1 glycogen storage disease, hypoglycemia glycogen storage disease vi
PYGM phosphorylase, glycogen, muscle 11q13.1 insulin resistance, vitelliform macular dystrophy, glycogen storage disease,
PYGO1 pygopus family PHD finger 1 15q21.3 acute diarrhea
PYGO2 pygopus family PHD finger 2 1q21.3 oligospermia
PYHIN1 pyrin and HIN domain family, member 1 1q23.1 breast cancer
PYY peptide YY 17q21.31 serotonin syndrome, anorexia nervosa, prader-willi syndrome,
PZP pregnancy-zone protein 12p13.31 oophoritis
QARS glutaminyl-tRNA synthetase 3p21.31 diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome "microcephaly, progressive, seizures, and cerebral and cerebellar atrophy"
QDPR quinoid dihydropteridine reductase 4p15.32 vitiligo, neuroblastoma, hypokalemic periodic paralysis,
QKI QKI, KH domain containing, RNA binding 6q26 schizophrenia 6q terminal deletion syndrome
QPRT quinolinate phosphoribosyltransferase 16p11.2 seizure disorder, follicular thyroid carcinoma pellagra
QRSL1 glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1 6q21 lymphogranuloma venereum
QSOX2 quiescin Q6 sulfhydryl oxidase 2 9q34.3 neuroblastoma
RA1 Rheumatoid arthritis QTL 01 rheumatoid arthritis
RA10 Rheumatoid arthritis QTL 10 rheumatoid arthritis
RA11 Rheumatoid arthritis QTL 11 rheumatoid arthritis
RA12 Rheumatoid arthritis QTL 12 rheumatoid arthritis
RA13 Rheumatoid arthritis QTL 13 rheumatoid arthritis
RA14 Rheumatoid arthritis QTL 14 rheumatoid arthritis
RA15 Rheumatoid arthritis QTL 15 rheumatoid arthritis
RA16 Rheumatoid arthritis QTL 16 rheumatoid arthritis
RA17 Rheumatoid arthritis QTL 17 rheumatoid arthritis
RA18 Rheumatoid arthritis QTL 18 rheumatoid arthritis
RA19 Rheumatoid arthritis QTL 19 rheumatoid arthritis
RA2 Rheumatoid arthritis QTL 01 rheumatoid arthritis
RA20 Rheumatoid arthritis QTL 20 rheumatoid arthritis
RA21 Rheumatoid arthritis QTL 21 rheumatoid arthritis
RA22 Rheumatoid arthritis QTL 22 rheumatoid arthritis
RA23 Rheumatoid arthritis QTL 23 rheumatoid arthritis
RA24 Rheumatoid arthritis QTL 24 rheumatoid arthritis
RA25 Rheumatoid arthritis QTL 25 rheumatoid arthritis
RA26 Rheumatoid arthritis QTL 26 rheumatoid arthritis
RA27 Rheumatoid arthritis QTL 27 rheumatoid arthritis
RA28 Rheumatoid arthritis QTL 28 rheumatoid arthritis
RA29 Rheumatoid arthritis QTL 29 rheumatoid arthritis
RA3 Rheumatoid arthritis QTL 02 rheumatoid arthritis
RA30 Rheumatoid arthritis QTL 30 rheumatoid arthritis
RA31 Rheumatoid arthritis QTL 31 rheumatoid arthritis
RA4 Rheumatoid arthritis QTL 04 rheumatoid arthritis
RA5 Rheumatoid arthritis QTL 01 rheumatoid arthritis
RA6 Rheumatoid arthritis QTL 06 rheumatoid arthritis
RA7 Rheumatoid arthritis QTL 07 rheumatoid arthritis
RA8 Rheumatoid arthritis QTL 08 rheumatoid arthritis
RA9 Rheumatoid arthritis QTL 09 rheumatoid arthritis
RAB11A RAB11A, member RAS oncogene family 15q22.31 charcot-marie-tooth disease type 4 esophagus squamous cell carcinoma
RAB11FIP1 RAB11 family interacting protein 1 (class I) 8p11.23 griscelli syndrome
RAB11FIP3 RAB11 family interacting protein 3 (class II) 16p13.3 medulloblastoma
RAB11FIP5 RAB11 family interacting protein 5 (class I) 2p13.2 atypical autism
RAB15 RAB15, member RAS oncogene family 14q23.3 neuroblastoma, lung cancer lung cancer susceptibility
RAB18 RAB18, member RAS oncogene family 10p12.1 medulloblastoma, hormone producing pituitary cancer, large cell medulloblastoma,
RAB1A RAB1A, member RAS oncogene family 2p14 choroideremia, legionnaires disease rectum adenocarcinoma
RAB1B RAB1B, member RAS oncogene family 11q13.2 platelet storage pool deficiency
RAB23 RAB23, member RAS oncogene family 6p11.2 beare-stevenson cutis gyrata syndrome, dextrocardia, carpenter syndrome
RAB27A RAB27A, member RAS oncogene family 15q21.3 choroideremia, griscelli syndrome, chediak-higashi syndrome,
RAB27B RAB27B, member RAS oncogene family 18q21.2 platelet storage pool deficiency, griscelli syndrome birt-hogg-dube syndrome
RAB28 RAB28, member RAS oncogene family 4p15.33 cone-rod dystrophy 2, "ectodermal dysplasia 4, hair/nail type" cone-rod dystrophy 18
RAB2A RAB2A, member RAS oncogene family 8q12.1 vaginal cancer duane retraction syndrome
RAB33B RAB33B, member RAS oncogene family 4q31.1 spondyloepimetaphyseal dysplasia, smith-mccort dysplasia 2 smith mccort dysplasia
RAB36 RAB36, member RAS oncogene family 22q11.22 rhabdoid cancer
RAB39B RAB39B, member RAS oncogene family Xq28 "mental retardation, x-linked 17/31, microduplication" mental retardation
RAB3A RAB3A, member RAS oncogene family 19p13.11 choroideremia
RAB3GAP1 RAB3 GTPase activating protein subunit 1 (catalytic) 2q21.3 spastic diplegia, epidermolytic hyperkeratosis, warburg micro syndrome 1,
RAB3GAP2 RAB3 GTPase activating protein subunit 2 (non-catalytic) 1q41 ichthyosis vulgaris, warburg micro syndrome 1, warburg micro syndrome,
RAB3IL1 RAB3A interacting protein (rabin3)-like 1 11q12.2 necrotizing fasciitis
RAB40AL RAB40A, member RAS oncogene family-like Xq22.1 duchenne muscular dystrophy "mental retardation, x-linked, syndromic, martin-probst type"
RAB5A RAB5A, member RAS oncogene family 3p24.3 choroideremia, venezuelan equine encephalitis borna disease
RAB6A RAB6A, member RAS oncogene family 11q13.4 choroideremia proximal spinal muscular atrophy
RAB7A RAB7A, member RAS oncogene family 3q21.3 choroideremia, charcot-marie-tooth neuropathy type 2, venezuelan equine encephalitis,
RAB7B RAB7B, member RAS oncogene family 1q32 acute promyelocytic leukemia
RAB8A RAB8A, member RAS oncogene family 19p13.12 sphingolipidosis
RAB9A RAB9A, member RAS oncogene family Xp22.2 vaccinia
RAB9B RAB9B, member RAS oncogene family Xq22.2 pelizaeus-merzbacher disease
RABEP2 rabaptin, RAB GTPase binding effector protein 2 16p11.2 pertussis
RABGGTA Rab geranylgeranyltransferase, alpha subunit 14q12 choroideremia
RABGGTB Rab geranylgeranyltransferase, beta subunit 1p31.1 choroideremia
RABL6 RAB, member RAS oncogene family-like 6 9q34.3 breast cancer
RAC2 ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) 22q13.1 neutrophil immunodeficiency syndrome
RAD17P1 RAD17 homolog (S. pombe) pseudogene 1 7p21.1 seminoma
RAD17P2 RAD17 homolog (S. pombe) pseudogene 2 13q14.2 seminoma
RAD21 RAD21 homolog (S. pombe) 8q24.11 cornelia de lange syndrome 1 , cornelia de lange syndrome, roberts syndrome,
RAD23A RAD23 homolog A (S. cerevisiae) 19p13.2 "xeroderma pigmentosum, group c"
RAD23B RAD23 homolog B (S. cerevisiae) 9q31.2 "xeroderma pigmentosum, group c", xeroderma pigmentosum mutagen sensitivity
RAD50 RAD50 homolog (S. cerevisiae) 5q31.1 breast cancer, ataxia telangiectasia, "breast-ovarian cancer, familial, 2",
RAD51 RAD51 recombinase 15q15.1 breast cancer susceptibility, breast cancer, male breast cancer,
RAD51C RAD51 paralog C 17q22 mulibrey nanism , ovarian cancer, "fanconi anemia, complementation group c",
RAD51D RAD51 paralog D 17q12 ovarian cancer, acral lentiginous melanoma, "breast-ovarian cancer, familial, 2",
RAD52 RAD52 homolog (S. cerevisiae) 12p13.33 familial chronic lymphocytic leukemia acoustic neuroma
RAD54B RAD54 homolog B (S. cerevisiae) 8q22.1 colon cancer, "colon cancer, somatic" "lymphoma, non-hodgkin, somatic"
RAD54L RAD54-like (S. cerevisiae) 1p34.1 werner syndrome, ovarian cancer, familial chronic lymphocytic leukemia,
RAET1E retinoic acid early transcript 1E 6q25.1 cerebral angioma
RAF1 v-raf-1 murine leukemia viral oncogene homolog 1 3p25.2 pilocytic astrocytoma, encephalitis, leopard syndrome,
RAG1 recombination activating gene 1 11p12 lymphoblastic lymphoma, lymphopenia, severe combined immunodeficiency,
RAG2 recombination activating gene 2 11p12 infectious mononucleosis, severe combined immunodeficiency, omenn syndrome,
RAI1 retinoic acid induced 1 17p11.2 smith magenis syndrome 17p11.2 microduplication syndrome
RAI2 retinoic acid induced 2 Xp22.13 nance-horan syndrome
RAMP2 receptor (G protein-coupled) activity modifying protein 2 17q21.31 pheochromocytoma acute closed-angle glaucoma
RAN RAN, member RAS oncogene family 12q24.33 muscular atrophy chronic myelomonocytic leukemia
RANBP2 RAN binding protein 2 2q12.3 cardiofaciocutaneous syndrome, cardiofaciocutaneous syndrome 2 , familial acute necrotizing encephalopathy,
RAP1A RAP1A, member of RAS oncogene family 1p13.2 leukocyte adhesion deficiency, tuberous sclerosis, lung adenoma
RAP1GDS1 RAP1, GTP-GDP dissociation stimulator 1 4q23 "lymphocytic leukemia, acute t-cell"
RAP2A RAP2A, member of RAS oncogene family 13q32.1 kuhnt-junius degeneration
RAP2B RAP2B, member of RAS oncogene family 3q25.2 platelet storage pool deficiency
RAPH1 Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 2q33.2 amyotrophic lateral sclerosis lateral sclerosis
RAPSN receptor-associated protein of the synapse 11p11.2 myasthenia gravis, "myasthenic syndrome, congenital, with pre- and postsynaptic defects", rapsn-related congenital myasthenic syndrome,
RARA retinoic acid receptor, alpha 17q21.2 acanthoma, juvenile myelomonocytic leukemia, neuroblastoma,
RARB retinoic acid receptor, beta 3p24.2 matthew-wood syndrome, hepatocellular carcinoma, colorectal cancer,
RARRES1 retinoic acid receptor responder (tazarotene induced) 1 3q25.32 prostate cancer
RARRES2 retinoic acid receptor responder (tazarotene induced) 2 7q36.1 vascular disease, type 2 diabetes mellitus, acute promyelocytic leukemia,
RARRES3 retinoic acid receptor responder (tazarotene induced) 3 11q12.3 colorectal adenocarcinoma
RARS2 arginyl-tRNA synthetase 2, mitochondrial 6q15 pontocerebellar hypoplasia, "woolly hair, autosomal dominant", "pontocerebellar hypoplasia, type 1b"
RASA1 RAS p21 protein activator (GTPase activating protein) 1 5q14.3 arteriovenous malformation, klippel-trenaunay syndrome, neurofibromatosis,
RASA2 RAS p21 protein activator 2 3q23 neurofibromatosis kuru
RASD1 RAS, dexamethasone-induced 1 17p11.2 myeloma multiple myeloma
RASGRP1 RAS guanyl releasing protein 1 (calcium and DAG-regulated) 15q14 systemic lupus erythematosus leukocyte adhesion deficiency
RASGRP2 RAS guanyl releasing protein 2 (calcium and DAG-regulated) 11q13.1 leukocyte adhesion deficiency, "leukocyte adhesion deficiency, type iii" "bleeding disorder, platelet-type, 18"
RASSF1 Ras association (RalGDS/AF-6) domain family member 1 3p21.31 papilloma, male germ cell tumor, breast cancer,
RASSF6 Ras association (RalGDS/AF-6) domain family member 6 4q13.3 bronchiolitis
RAX retina and anterior neural fold homeobox 18q21.32 "microphthalmia, isolated 2", anophthalmia/microphthalmia, microphthalmia,
RAX2 retina and anterior neural fold homeobox 2 19p13.3 age related macular degeneration, cone-rod dystrophy 2, cone-rod dystrophy,
RB1 retinoblastoma 1 13q14.2 "bladder cancer, somatic", gliomatosis cerebri, retinoblastoma,
RB1CC1 RB1-inducible coiled-coil 1 8q11.23 retinoblastoma, ovarian cancer "breast cancer, somatic"
RBAK RB-associated KRAB zinc finger 7p22.1 familial hyperaldosteronism
RBBP4 retinoblastoma binding protein 4 1p35.1 retinoblastoma intermediate charcot-marie-tooth neuropathy
RBBP5 retinoblastoma binding protein 5 1q32.1 retinoblastoma
RBBP6 retinoblastoma binding protein 6 16p12.1 retinoblastoma
RBBP7 retinoblastoma binding protein 7 Xp22.2 retinoblastoma
RBBP8 retinoblastoma binding protein 8 18q11.2 retinoblastoma, primary autosomal recessive microcephalies and seckel syndrome spectrum disorders, jawad syndrome ,
RBBP9 retinoblastoma binding protein 9 20p11.23 retinoblastoma
RBCK1 RanBP-type and C3HC4-type zinc finger containing 1 20p13 hepatitis b, hepatitis, polyglucosan body myopathy,
RBFOX1 RNA binding protein, fox-1 homolog (C. elegans) 1 16p13.3 dengue shock syndrome
RBFOX2 RNA binding protein, fox-1 homolog (C. elegans) 2 22q12.3 kaposis sarcoma
RBFOX3 RNA binding protein, fox-1 homolog (C. elegans) 3 17q25.3 central neurocytoma pediatric ependymoma
RBL1 retinoblastoma-like 1 20q11.23 retinoblastoma, bilateral retinoblastoma unilateral retinoblastoma
RBL2 retinoblastoma-like 2 16q12.2 retinoblastoma, bilateral retinoblastoma unilateral retinoblastoma
RBM10 RNA binding motif protein 10 Xp11.23 tarp syndrome lymphogranuloma venereum
RBM12 RNA binding motif protein 12 20q11.22 gas gangrene
RBM14 RNA binding motif protein 14 11q13.2 lipogranulomatosis farber lipogranulomatosis
RBM15 RNA binding motif protein 15 1p13.3 megakaryocytic leukemia
RBM20 RNA binding motif protein 20 10q25.2 "cardiomyopathy, dilated, 1dd", rbm20-related dilated cardiomyopathy, familial dilated cardiomyopathy,
RBM28 RNA binding motif protein 28 7q32.1 alopecia "alopecia, neurologic defects, and endocrinopathy syndrome"
RBM39 RNA binding motif protein 39 20q11.22 hepatocellular carcinoma
RBM4 RNA binding motif protein 4 11q13.2 lipogranulomatosis farber lipogranulomatosis
RBM41 RNA binding motif protein 41 Xq22.3 ebstein anomaly
RBM5 RNA binding motif protein 5 3p21.31 lung cancer
RBM6 RNA binding motif protein 6 3p21.31 lung cancer
RBM8A RNA binding motif protein 8A 1q21.1 thrombocytopenia-absent radius syndrome, developmental coordination disorder thrombocytopenia
RBM8B RNA binding motif protein 8B pseudogene 14q23.1 thrombocytopenia-absent radius syndrome
RBMS1 RNA binding motif, single stranded interacting protein 1 2q24.2 cervical cancer
RBMS3 RNA binding motif, single stranded interacting protein 3 3p24.1 osteonecrosis of the jaw
RBMXL2 RNA binding motif protein, X-linked-like 2 11p15.4 male infertility infertility
RBMXP1 RNA binding motif protein, X-linked pseudogene 1 6p12.3 oral squamous cell carcinoma
RBMY1A1 RNA binding motif protein, Y-linked, family 1, member A1 Yq11.223 y chromosome infertility, "spermatogenic failure, y-linked, 2" azoospermia
RBMY1D RNA binding motif protein, Y-linked, family 1, member D Yq11.223 azoospermia
RBMY1E RNA binding motif protein, Y-linked, family 1, member E Yq11.223 azoospermia
RBP1 retinol binding protein 1, cellular 3q23 acute promyelocytic leukemia
RBP3 retinol binding protein 3, interstitial 10q11.22 retinitis pigmentosa 66, leber congenital amaurosis, retinoblastoma,
RBP4 retinol binding protein 4, plasma 10q23.33 bronchopulmonary dysplasia, matthew-wood syndrome, type 2 diabetes mellitus,
RBPJ recombination signal binding protein for immunoglobulin kappa J region 4p15.2 adams-oliver syndrome 1 , oliver syndrome, candida glabrata,
RBX1 ring-box 1, E3 ubiquitin protein ligase 22q13.2 transitional cell carcinoma, mulibrey nanism , invasive bladder transitional cell carcinoma,
RCA1 renal carcinoma associated 1 3p14.2 kidney cancer
RCAN1 regulator of calcineurin 1 21q22.12 alzheimers disease, down syndrome mixed malaria
RCAN2 regulator of calcineurin 2 6p12.3 down syndrome
RCAN3 RCAN family member 3 1p36.11 down syndrome
RCBTB1 regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1 13q14.2 alcohol dependence, b-cell chronic lymphocytic leukemia, leukemia
RCD1 retinal cone dystrophy 1 6q25-q26 retinal cone dystrophy 1
RCE1 Ras converting CAAX endopeptidase 1 11q13.2 mandibuloacral dysplasia, follicular mucinosis phaeohyphomycosis
RCHTS Roifman-Chitayat syndrome 15q11-q21.1 roifman-chitayat syndrome
RCM2 cardiomyopathy, familial restrictive, 2 10q23.3 restrictive cardiomyopathy "cardiomyopathy, familial restrictive, 2"
RCN1 reticulocalbin 1, EF-hand calcium binding domain 11p13 prostate cancer nephrogenic systemic fibrosis
RCN2 reticulocalbin 2, EF-hand calcium binding domain 15q24.3 anogenital venereal wart
RCN3 reticulocalbin 3, EF-hand calcium binding domain 19q13.33 ollier disease
RCVRN recoverin 17p13.1 lung cancer, autoimmune retinopathy cancer-associated retinopathy
RD3 retinal degeneration 3 1q32.3 leber congenital amaurosis, leber congenital amaurosis 17, rd3-related leber congenital amaurosis,
RDH10 retinol dehydrogenase 10 (all-trans) 8q21.11 fundus albipunctatus
RDH11 retinol dehydrogenase 11 (all-trans/9-cis/11-cis) 14q24.1 epiglottitis
RDH12 retinol dehydrogenase 12 (all-trans/9-cis/11-cis) 14q24.1 leber congenital amaurosis, leber congenital amaurosis 17, rdh12-related leber congenital amaurosis
RDH5 retinol dehydrogenase 5 (11-cis/9-cis) 12q13.2 rdh5-related fundus albipunctatus, fundus albipunctatus , refractive error
RDH8 retinol dehydrogenase 8 (all-trans) 19p13.2 leber congenital amaurosis
RDPA refsum disease, adult, with increased pipecolicacidemia 10pter-p11.2 "refsum disease, adult, with increased pipecolicacidemia"
RDX radixin 11q22.3 west syndrome, "deafness, autosomal recessive 76", "deafness, autosomal recessive 24"
RDXP2 radixin pseudogene 2 Xp21.3 west syndrome
RECK reversion-inducing-cysteine-rich protein with kazal motifs 9p13.3 bernard-soulier syndrome, malaria, lactose intolerance,
RECQL RecQ helicase-like 12p12.1 rothmund-thomson syndrome, "xeroderma pigmentosum, group c", rapadilino syndrome
RECQL4 RecQ protein-like 4 8q24.3 radioulnar synostosis, parkinsons disease, imperforate anus,
RECQL5 RecQ protein-like 5 17q25.1 rothmund-thomson syndrome, rapadilino syndrome baller-gerold syndrome
REEP1 receptor accessory protein 1 2p11.2 distal hereditary motor neuropathy type v, "neuropathy, distal hereditary motor, type va", distal hereditary motor neuropathy,
REEP2 receptor accessory protein 2 5q31.2 "spastic paraplegia 72, autosomal dominant" "spastic paraplegia 72, autosomal recessive"
REG1A regenerating islet-derived 1 alpha 2p12 tropical calcific pancreatitis, hereditary pancreatitis, pancreatitis,
REG3A regenerating islet-derived 3 alpha 2p12 hepatocellular carcinoma, pancreatic cancer, cystic fibrosis
REG3G regenerating islet-derived 3 gamma 2p12 pancreatitis
REG4 regenerating islet-derived family, member 4 1p12 pseudomyxoma peritonei
REL v-rel avian reticuloendotheliosis viral oncogene homolog 2p16.1 primary mediastinal large b-cell lymphoma, hypersplenism, hodgkins lymphoma
RELA v-rel avian reticuloendotheliosis viral oncogene homolog A 11q13.1 hypersplenism ependymoma
RELN reelin 7q22.1 schizophrenia, periventricular nodular heterotopia, lissencephaly with cerebellar hypoplasia,
REN renin 1q32.1 polyarteritis nodosa, diabetic macular edema, ovarian disease,
RENBP renin binding protein Xq28 essential hypertension toxocariasis
RENS2 Renpenning syndrome 2 Xq12-q21.31 renpenning syndrome
RERE arginine-glutamic acid dipeptide (RE) repeats 1p36.23 normal pressure hydrocephalus
RERG RAS-like, estrogen-regulated, growth inhibitor 12p12.3 pituitary carcinoma
RET ret proto-oncogene 10q11.21 hyperparathyroidism, renal agenesis, hirschsprungs disease,
RETN resistin 19p13.2 myocardial infarction, coronary artery disease, type 2 diabetes mellitus,
RETNLB resistin like beta 3q13.13 insulin resistance
REXO1L1P REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1, pseudogene 8q21.2 hepatitis d
RFC1 replication factor C (activator 1) 1, 145kDa 4p14 pediatric osteosarcoma homocysteine plasma level
RFC2 replication factor C (activator 1) 2, 40kDa 7q11.23 williams-beuren syndrome, williams syndrome tsh producing pituitary tumor
RFH1 Renal failure, progressive, with hypertension 1q21 hypertension nephropathy-hypertension
RFK riboflavin kinase 9q21.13 riboflavin deficiency
RFMN Roifman syndrome roifman syndrome
RFT1 RFT1 homolog (S. cerevisiae) 3p21.1 congenital disorder of glycosylation
RFX1 regulatory factor X, 1 (influences HLA class II expression) 19p13.12 mhc class ii deficiency, hepatitis b hepatitis
RFX3 regulatory factor X, 3 (influences HLA class II expression) 9p24.2 pineoblastoma chordoid glioma
RFX5 regulatory factor X, 5 (influences HLA class II expression) 1q21.3 mhc class ii deficiency, malaria, plasmodium falciparum malaria,
RFX6 regulatory factor X, 6 6q22.1 intestinal atresia, carasil, "pancreatic hypoplasia, intestinal atresia, and gallbladder aplasia or hypoplasia, with or without tracheoesophageal fistula",
RFXANK regulatory factor X-associated ankyrin-containing protein 19p13.11 mhc class ii deficiency, bare lymphocyte syndrome, "mhc class ii deficiency, complementation group b",
RFXAP regulatory factor X-associated protein 13q13.3 mhc class ii deficiency, bare lymphocyte syndrome, "bare lymphocyte syndrome, type ii, complementation group c"
RGL2 ral guanine nucleotide dissociation stimulator-like 2 6p21.32 familial tumoral calcinosis normophosphatemic familial tumoral calcinosis
RGMB repulsive guidance molecule family member b 5q15 dermatomycosis chronic monocytic leukemia
RGN regucalcin Xp11.23 scurvy
RGPD1 RANBP2-like and GRIP domain containing 1 2p11.2 pseudosarcomatous fibromatosis
RGR retinal G protein coupled receptor 10q23.1 leber congenital amaurosis, retinitis pigmentosa, rgr-related retinitis pigmentosa,
RGS10 regulator of G-protein signaling 10 10q26.11 schizophrenia
RGS11 regulator of G-protein signaling 11 16p13.3 hereditary night blindness
RGS13 regulator of G-protein signaling 13 1q31.2 mantle cell lymphoma
RGS16 regulator of G-protein signaling 16 1q25.3 chordoid glioma
RGS19 regulator of G-protein signaling 19 20q13.33 colon cancer
RGS2 regulator of G-protein signaling 2, 24kDa 1q31.2 generalized anxiety disorder, syncope axenfeld-rieger syndrome type 2
RGS3 regulator of G-protein signaling 3 9q32 sick building syndrome
RGS4 regulator of G-protein signaling 4 1q23.3 schizophrenia
RGS5 regulator of G-protein signaling 5 1q23.3 hypoxia benign paroxysmal positional nystagmus
RGS6 regulator of G-protein signaling 6 14q24.2 sick sinus syndrome
RGS9 regulator of G-protein signaling 9 17q24.1 bradyopsia
RGS9BP regulator of G protein signaling 9 binding protein 19q13.11 bradyopsia
RHAG Rh-associated glycoprotein 6p12.3 juvenile myoclonic epilepsy, hemolytic anemia, "anemia, hemolytic, rh-null, regulator type",
RHBDF1 rhomboid 5 homolog 1 (Drosophila) 16p13.3 fgfr-related craniosynostosis syndromes
RHBDF2 rhomboid 5 homolog 2 (Drosophila) 17q25.1 palmoplantar keratosis, esophageal cancer tylosis with esophageal cancer
RHCE Rh blood group, CcEe antigens 1p36.11 kernicterus, "rh-null disease, amorph type", "anemia, hemolytic, rh-null, regulator type"
RHD Rh blood group, D antigen 1p36.11 malaria, hereditary elliptocytosis, hereditary spherocytosis,
RHDNS1 Renal hypodysplasia, nonsyndromic, 1 1p33-p32 "renal hypodysplasia, nonsyndromic, 1"
RHEB Ras homolog enriched in brain 7q36.1 tuberous sclerosis
RHO rhodopsin 3q22.1 leber congenital amaurosis, xerophthalmia, keratomalacia,
RHOBTB2 Rho-related BTB domain containing 2 8p21.3 breast cancer
RHOC ras homolog family member C 1p13.2 hepatocellular carcinoma, breast cancer non-small cell lung carcinoma
RHOD ras homolog family member D 11q13.2 pancreatic cancer, fibrosarcoma, tuberous sclerosis
RHOF ras homolog family member F (in filopodia) 12q24.31 malaria
RHOG ras homolog family member G 11p15.4 shigellosis
RHOH ras homolog family member H 4p14 appendicitis, thyroid lymphoma, marginal zone b-cell lymphoma,
RHOU ras homolog family member U 1q42.13 denture stomatitis
RHOXF1 Rhox homeobox family, member 1 Xq24 endometrial adenocarcinoma
RICTOR RPTOR independent companion of MTOR, complex 2 5p13.1 foramen magnum meningioma
RIEG2 Rieger syndrome 2 13q14 axenfeld-rieger syndrome type 2
RIF1 RAP1 interacting factor homolog (yeast) 2q23.3 candida glabrata
RILP Rab interacting lysosomal protein 17p13.3 prickle1-related progressive myoclonus epilepsy with ataxia
RIMBP2 RIMS binding protein 2 12q24.33 cd40 ligand deficiency
RIMS1 regulating synaptic membrane exocytosis 1 6q13 benign concentric annular macular dystrophy, cone-rod dystrophy 2, cone-rod dystrophy 7 ,
RIMS2 regulating synaptic membrane exocytosis 2 8q22.3 lung cancer
RIN1 Ras and Rab interactor 1 11q13.2 acute promyelocytic leukemia
RIN2 Ras and Rab interactor 2 20p11.23 cutis laxa, alopecia "macrocephaly, alopecia, cutis laxa, and scoliosis"
RING1 ring finger protein 1 6p21.32 embryonal cancer, adenoiditis occult macular dystrophy
RIPK4 receptor-interacting serine-threonine kinase 4 21q22.3 severe nonproliferative diabetic retinopathy, "popliteal pterygium syndrome 2, lethal type", popliteal pterygium syndrome lethal type,
RIPPLY3 ripply transcriptional repressor 3 21q22.13 down syndrome
RIT1 Ras-like without CAAX 1 1q22 pheochromocytoma, noonan syndrome 8 noonan syndrome 1
RJBS Rajab syndrome 2q36.2 rajab syndrome
RLBP1 retinaldehyde binding protein 1 15q26.1 leber congenital amaurosis, age related macular degeneration, retinitis,
RLN1 relaxin 1 9p24.1 preterm premature rupture of the membranes
RLN2 relaxin 2 9p24.1 anterior cruciate ligament tears
RLN3 relaxin 3 19p13.12 tick infestation
RLS1 Restless legs syndrome, susceptibility to 12q12-q21 "restless legs syndrome, susceptibility to, 1"
RLS2 Restless legs syndrome 2 14q13-q21 "restless legs syndrome, susceptibility to, 2"
RLS3 Restless legs syndrome 3 9p24-p22 "restless legs syndrome, susceptibility to, 3"
RLS4 Restless legs syndrome 4 2q33 "restless legs syndrome, susceptibility to, 4"
RLS5 Restless legs syndrome, susceptibility to, 5 20p13 "restless legs syndrome, susceptibility to, 5"
RLS6 Restless legs syndrome, susceptibility to, 6 6p21 "restless legs syndrome, susceptibility to, 6"
RLS7 Restless legs syndrome 7 2p14-p13 restless legs syndrome 7
RLS8 Restless legs syndrome, susceptibility to, 8 5q31 restless legs syndrome 8
RMD1 rippling muscle disease 1 1q41 rippling muscle disease "rippling muscle disease, 1"
RMND1 required for meiotic nuclear division 1 homolog (S. cerevisiae) 6q25.1 ebstein anomaly combined oxidative phosphorylation deficiency 11
RMND5A required for meiotic nuclear division 5 homolog A (S. cerevisiae) 2p11.2 meningoencephalocele
RMRP RNA component of mitochondrial RNA processing endoribonuclease 9p13.3 skeletal dysplasias, developmental disabilities, non-hodgkin lymphoma,
RN7SL1 RNA, 7SL, cytoplasmic 1 14q21.3 hiv-1
RNANC Retinal nonattachment, nonsyndromic congenital 10q21 "retinal nonattachment, nonsyndromic congenital"
RNASE1 ribonuclease, RNase A family, 1 (pancreatic) 14q11.2 gyrate atrophy osteogenesis imperfecta type iii
RNASE10 ribonuclease, RNase A family, 10 (non-active) 14q11.2 orchitis
RNASE3 ribonuclease, RNase A family, 3 14q11.2 bronchopulmonary dysplasia, asthma, urinary schistosomiasis,
RNASEH1 ribonuclease H1 2p25.3 cartilage-hair hypoplasia mitochondrial disorders
RNASEH2A ribonuclease H2, subunit A 19p13.2 aicardi-goutieres syndrome, aicardi-goutieres syndrome 7, cartilage-hair hypoplasia
RNASEH2B ribonuclease H2, subunit B 13q14.3 aicardi-goutieres syndrome, aicardi-goutieres syndrome 7 aicardi-goutieres syndrome type 2
RNASEH2C ribonuclease H2, subunit C 11q13.1 aicardi-goutieres syndrome, aicardi-goutieres syndrome 7, ipex syndrome
RNASEL ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) 1q25.3 prostate cancer, chronic fatigue syndrome, familial prostate cancer,
RNASET2 ribonuclease T2 6q27 congenital cytomegalovirus, megalencephaly, alcohol-related neurodevelopmental disorder
RND1 Rho family GTPase 1 12q13.12 alcoholic psychosis mood disorder
RND2 Rho family GTPase 2 17q21.31 ovarian cancer
RNF130 ring finger protein 130 5q35.3 gestational trophoblastic neoplasm trophoblastic neoplasm
RNF135 ring finger protein 135 17q11.2 sotos syndrome, neurofibromatosis, iris hypoplasia,
RNF139 ring finger protein 139 8q24.13 thyroid cancer, renal cell carcinoma, kidney cancer,
RNF14 ring finger protein 14 5q31.3 prostate cancer
RNF146 ring finger protein 146 6q22.33 cherubism
RNF168 ring finger protein 168, E3 ubiquitin protein ligase 3q29 riddle syndrome
RNF170 ring finger protein 170 8p11.21 ataxia "ataxia, sensory, 1, autosomal dominant"
RNF186 ring finger protein 186 1p36.13 ulcerative colitis
RNF19A ring finger protein 19A, RBR E3 ubiquitin protein ligase 8q22.2 amyotrophic lateral sclerosis lateral sclerosis
RNF2 ring finger protein 2 1q25.3 embryonal cancer
RNF212 ring finger protein 212 4p16.3 recombination rate qtl 1
RNF213 ring finger protein 213 17q25.3 moyamoya disease, anaplastic large cell lymphoma inflammatory myofibroblastic tumor
RNF216 ring finger protein 216 7p22.1 hypogonadotropism cerebellar ataxia and hypogonadotropic hypogonadism
RNF40 ring finger protein 40, E3 ubiquitin protein ligase 16p11.2 retinoblastoma
RNF43 ring finger protein 43 17q22 colon cancer
RNF6 ring finger protein (C3H2C3 type) 6 13q12.13 esophageal squamous cell carcinoma "esophageal cancer, somatic"
RNF7 ring finger protein 7 3q23 glomuvenous malformation
RNF8 ring finger protein 8, E3 ubiquitin protein ligase 6p21.2 morgagni cataract
RNMT RNA (guanine-7-) methyltransferase 18p11.21 bowen-conradi syndrome dubowitz syndrome
RNPC3 RNA-binding region (RNP1, RRM) containing 3 1p21.1 rheumatic disease, measles, connective tissue disease,
RNPS1 RNA binding protein S1, serine-rich domain 16p13.3 "polycystic kidney disease, type 1", acinar cell carcinoma "tuberous sclerosis, type 2"
RNR1 RNA, ribosomal cluster 1 13p12 "nonsyndromic hearing loss and deafness, mitochondrial", nonsyndromic hearing loss and deafness, congenital cytomegalovirus,
RNR2 RNA, ribosomal cluster 2 14p12 cyclic vomiting syndrome
RNU2-4P RNA, U2 small nuclear 4, pseudogene 17q21.31 multiple myeloma
RNU4ATAC RNA, U4atac small nuclear (U12-dependent splicing) 2q14.2 dwarfism microcephalic osteodysplastic primordial dwarfism type 1
RNU5A-1 RNA, U5A small nuclear 1 15q22.31 poikiloderma with neutropenia
RNU6-1 RNA, U6 small nuclear 1 15q23 poikiloderma with neutropenia
RNY1 RNA, Ro-associated Y1 7q36.1 rheumatic disease, sjogrens syndrome systemic lupus erythematosus
ROBO1 roundabout, axon guidance receptor, homolog 1 (Drosophila) 3p12.2 articulation disorder
ROBO2 roundabout, axon guidance receptor, homolog 2 (Drosophila) 3p12.3 factor v deficiency, vesicoureteral reflux, thrombophilia due to activated protein c resistance
ROBO3 roundabout, axon guidance receptor, homolog 3 (Drosophila) 11q24.2 gilles de la tourette syndrome, amblyopia, horizontal gaze palsy with progressive scoliosis
ROCK1 Rho-associated, coiled-coil containing protein kinase 1 18q11.1 "sry-negative 46,xx testicular disorder of sex development" "46,xx testicular disorder of sex development"
ROGDI rogdi homolog (Drosophila) 16p13.3 focal epilepsy kohlschutter tonz syndrome
ROM1 retinal outer segment membrane protein 1 11q12.3 leber congenital amaurosis, rheumatic disease, retinal disease,
ROR2 receptor tyrosine kinase-like orphan receptor 2 9q22.31 robinow syndrome, brachydactyly type b, brachydactyly,
RORA RAR-related orphan receptor A 15q22.2 hypoalphalipoproteinemia
RORC RAR-related orphan receptor C 1q21.3 color blindness red color blindness
RP1 retinitis pigmentosa 1 (autosomal dominant) 8q12.1 leber congenital amaurosis, retinitis, retinitis pigmentosa,
RP1-234P15.4 uncharacterized LOC100506804 6q14.1 breast cancer
RP11-1084I9.1 uncharacterized LOC100128714 15q12 schizophrenia insulin resistance
RP11-115J16.1 uncharacterized LOC157273 8p23.1 coronary artery disease, insulin resistance, artery disease
RP11-125P18.1 uncharacterized LOC100270679 20p11.22 alopecia
RP11-140I24.1 uncharacterized LOC100506172 16q22.3 breast cancer
RP11-146N18.1 uncharacterized LOC284294 18q22.1 neutropenia
RP11-205M3.3 uncharacterized LOC100506085 4q33 myopia
RP11-264C15.2 uncharacterized LOC100128505 9q33.1 pulmonary function
RP11-267C16.1 uncharacterized LOC100287225 18q21.2 obesity
RP11-276H19.1 uncharacterized LOC100506834 9q21.33 insulin resistance
RP11-305P22.9 uncharacterized LOC63930 20q13.33 prostate cancer
RP11-307C12.11 uncharacterized LOC100505666 1q22 prostate cancer
RP11-318M2.2 uncharacterized LOC100499183 8q22.3 parkinsons disease
RP11-40F8.2 uncharacterized LOC100873065 Xp22.11 prostate cancer, intellectual disability autism spectrum disorder
RP11-473M20.14 uncharacterized LOC100507458 16p13.3 atherosclerosis
RP11-486A14.2 uncharacterized LOC643339 12q22 fatty liver disease liver disease
RP11-514D23.1 uncharacterized LOC146513 16q24.1 obesity
RP11-622A1.2 hCG1813624 4q13.3 prostate cancer
RP11-638L3.1 uncharacterized LOC643542 18q22.1 attention deficit hyperactivity disorder major depressive disorder
RP11-696N14.1 uncharacterized LOC100507053 4q23 obesity, esophageal squamous cell carcinoma atherosclerosis
RP11-76E12.1 uncharacterized LOC100129345 14q32.2 neutropenia
RP11-945C19.1 uncharacterized LOC645355 18p11.31 obesity
RP11-96H19.1 uncharacterized LOC100288798 12q13.11 hepatocellular carcinoma
RP11-973H7.4 uncharacterized LOC100996324 18p11.21 leukemia
RP13-143G15.3 uncharacterized LOC644135 6q23.3 alzheimers disease
RP13-60M5.2 uncharacterized LOC286238 9q22.1 obesity
RP1L1 retinitis pigmentosa 1-like 1 8p23.1 macular dystrophy occult macular dystrophy
RP2 retinitis pigmentosa 2 (X-linked recessive) Xp11.23 retinitis pigmentosa 2, leber congenital amaurosis, leber hereditary optic neuropathy,
RP22 retinitis pigmentosa 22 (autosomal recessive) 16p12.3-p12.1 retinitis pigmentosa 22
RP23 retinitis pigmentosa 23 (X-linked recessive) Xp22 joubert syndrome 10 , oral-facial-digital syndrome type i , "simpson-golabi-behmel syndrome, type 2"
RP24 retinitis pigmentosa 24 (X-linked recessive) Xq26-q27 retinitis pigmentosa 24
RP29 retinitis pigmentosa 29 (autosomal recessive) 4q32-q34 retinitis pigmentosa 29
RP3-395M20.9 uncharacterized LOC100996583 1p36.32 inflammatory bowel disease ulcerative colitis
RP32 retinitis pigmentosa 32 (autosomal recessive) 1p21.2-p13.3 retinitis pigmentosa 32
RP34 retinitis pigmentosa 34 (X-linked recessive) Xq28 retinitis pigmentosa 34
RP35 retinitis pigmentosa 35 (autosomal dominant) reserved retinitis pigmentosa 35 cone-rod dystrophy 10
RP5-1043L13.1 uncharacterized LOC284757 20q13.33 kidney disease
RP5-1086L22.1 uncharacterized LOC154449 6q27 obesity
RP5-896L10.1 uncharacterized LOC100129620 1p21.3 obesity, neutropenia myopia
RP6 retinitis pigmentosa 6 (X-linked recessive) Xp21.3-p21.2 "retinitis pigmentosa, x-linked recessive, 6" retinitis pigmentosa 6
RP63 retinitis pigmentosa 63 (autosomal dominant) 6q23 retinitis pigmentosa 63
RP9 retinitis pigmentosa 9 (autosomal dominant) 7p14.3 leber congenital amaurosis, retinitis, retinitis pigmentosa,
RP9P retinitis pigmentosa 9 pseudogene 7p14.3 retinitis pigmentosa 9
RPA1 replication protein A1, 70kDa 17p13.3 werner syndrome xeroderma pigmentosum
RPA2 replication protein A2, 32kDa 1p35.3 ataxia telangiectasia, familial melanoma, xeroderma pigmentosum
RPA4 replication protein A4, 30kDa Xq21.33 lung cancer, lung cancer susceptibility babesiosis
RPE65 retinal pigment epithelium-specific protein 65kDa 1p31.2 leber congenital amaurosis, choroideremia, leber congenital amaurosis 17,
RPGR retinitis pigmentosa GTPase regulator Xp11.4 retinitis pigmentosa 2, leber congenital amaurosis, "ciliary dyskinesia, primary, 19",
RPGRIP1 retinitis pigmentosa GTPase regulator interacting protein 1 14q11.2 leber congenital amaurosis, leber congenital amaurosis 17, retinitis,
RPGRIP1L RPGRIP1-like 16q12.2 joubert syndrome and related disorders, gender identity disorder, l-2-hydroxyglutaric aciduria,
RPIA ribose 5-phosphate isomerase A 2p11.2 necrotizing sialometaplasia ribose 5-phosphate isomerase deficiency
RPL10 ribosomal protein L10 Xq28 autism spectrum disorder, wilms tumor, hypoadrenalism
RPL11 ribosomal protein L11 1p36.11 diamond-blackfan anemia 1, rpl11-related diamond-blackfan anemia, diamond-blackfan anemia 7
RPL12P7 ribosomal protein L12 pseudogene 7 14q24.1 crohns disease
RPL13 ribosomal protein L13 16q24.3 skin atrophy
RPL13AP14 ribosomal protein L13a pseudogene 14 5q14.3 ankylosing spondylitis
RPL13AP15 ribosomal protein L13a pseudogene 15 6q22.31 hiv-1
RPL13AP21 ribosomal protein L13a pseudogene 21 12q12 alzheimers disease
RPL13P6 ribosomal protein L13 pseudogene 6 14q32.32 primary biliary cirrhosis
RPL15 ribosomal protein L15 3p24.2 diamond-blackfan anemia 12 diamond-blackfan anemia 1
RPL15P15 ribosomal protein L15 pseudogene 15 11q23.3 hiv-1
RPL17P46 ribosomal protein L17 pseudogene 46 18q21.2 alzheimers disease
RPL18A ribosomal protein L18a 19p13.11 hepatitis c, hepatitis c virus hepatitis
RPL21 ribosomal protein L21 13q12.2 hypotrichosis simplex, hypotrichosis 12 hypotrichosis 11
RPL21P105 ribosomal protein L21 pseudogene 105 12q24.22 alzheimers disease
RPL21P111 ribosomal protein L21 pseudogene 111 13q31.1 conduct disorder
RPL21P119 ribosomal protein L21 pseudogene 119 16p13.2 hiv-1
RPL21P126 ribosomal protein L21 pseudogene 126 18q21.2 hiv-1
RPL21P33 ribosomal protein L21 pseudogene 33 2p16.1 psoriatic arthritis
RPL21P50 ribosomal protein L21 pseudogene 50 4q28.1 pulmonary function
RPL21P75 ribosomal protein L21 pseudogene 75 7p21.1 hiv-1
RPL21P93 ribosomal protein L21 pseudogene 93 10p12.1 cannabis dependence
RPL21P94 ribosomal protein L21 pseudogene 94 11p15.4 pulmonary function
RPL22 ribosomal protein L22 1p36.31 acute myeloid leukemia, lymphoepithelioma-like carcinoma myeloid leukemia
RPL23A ribosomal protein L23a 17q11.2 pure red-cell aplasia
RPL23AP39 ribosomal protein L23a pseudogene 39 3p26.3 alzheimers disease
RPL23P11 ribosomal protein L23 pseudogene 11 10p11.22 major depressive disorder
RPL24P5 ribosomal protein L24 pseudogene 5 1q31.3 primary biliary cirrhosis
RPL26 ribosomal protein L26 17p13.1 diamond-blackfan anemia 1, diamond-blackfan anemia 11 rpl26-related diamond-blackfan anemia
RPL28 ribosomal protein L28 19q13.42 esophagus squamous cell carcinoma
RPL28P3 ribosomal protein L28 pseudogene 3 5q23.2 hiv-1
RPL29P8 ribosomal protein L29 pseudogene 8 2q31.1 fatty liver disease
RPL3 ribosomal protein L3 22q13.1 hiv-1
RPL30P13 ribosomal protein L30 pseudogene 13 12q12 crohns disease
RPL31 ribosomal protein L31 2q11.2 chancroid
RPL31P13 ribosomal protein L31 pseudogene 13 1q32.3 alzheimers disease
RPL31P54 ribosomal protein L31 pseudogene 54 13q22.3 pulmonary function
RPL34 ribosomal protein L34 4q25 mhc class i deficiency
RPL34P11 ribosomal protein L34 pseudogene 11 3p24.1 alzheimers disease
RPL35 ribosomal protein L35 9q33.3 pure red-cell aplasia
RPL35A ribosomal protein L35a 3q29 diamond-blackfan anemia 1, diamond-blackfan anemia, diamond-blackfan anemia 5
RPL35P3 ribosomal protein L35 pseudogene 3 6q21 crohns disease ulcerative colitis
RPL39 ribosomal protein L39 Xq24 pure red-cell aplasia
RPL39P10 ribosomal protein L39 pseudogene 10 1q43 hiv-1
RPL39P28 ribosomal protein L39 pseudogene 28 12q15 ulcerative colitis
RPL3L ribosomal protein L3-like 16p13.3 "polycystic kidney disease, type 1" "tuberous sclerosis, type 2"
RPL3P2 ribosomal protein L3 pseudogene 2 6p21.33 hiv-1
RPL4 ribosomal protein L4 15q22.31 cat-scratch disease
RPL41P5 ribosomal protein L41 pseudogene 5 12q22 fatty liver disease
RPL4P5 ribosomal protein L4 pseudogene 5 9p24.1 hiv-1
RPL5 ribosomal protein L5 1p22.1 diffuse astrocytoma, diamond-blackfan anemia 1, diamond-blackfan anemia,
RPL6 ribosomal protein L6 12q24.13 t-cell leukemia, phimosis human t-cell leukemia virus type 1
RPL6P8 ribosomal protein L6 pseudogene 8 3q25.33 primary biliary cirrhosis
RPL7 ribosomal protein L7 8q21.11 systemic lupus erythematosus, lupus erythematosus esophagus squamous cell carcinoma
RPL7AP53 ribosomal protein L7a pseudogene 53 10p11.22 pulmonary function
RPL7AP9 ribosomal protein L7a pseudogene 9 12q21.2 systemic lupus erythematosus
RPL7P32 ribosomal protein L7 pseudogene 32 7q31.1 esophagus squamous cell carcinoma
RPL8P1 ribosomal protein L8 pseudogene 1 6p22.1 systemic lupus erythematosus
RPL9P19 ribosomal protein L9 pseudogene 19 7p21.3 alzheimers disease
RPLP0P3 ribosomal protein, large, P0 pseudogene 3 14q13.2 multiple myeloma
RPLP1 ribosomal protein, large, P1 15q23 pandas
RPLP1P9 ribosomal protein, large, P1 pseudogene 9 8p21.2 pulmonary function
RPLP2 ribosomal protein, large, P2 11p15.5 cysticercosis
RPP25 ribonuclease P/MRP 25kDa subunit 15q24.2 autism spectrum disorder cartilage-hair hypoplasia
RPP30 ribonuclease P/MRP 30kDa subunit 10q23.31 microphthalmia with linear skin defects syndrome
RPRM reprimo, TP53 dependent G2 arrest mediator candidate 2q23.3 pancreatic ductal adenocarcinoma gastric adenocarcinoma
RPS10 ribosomal protein S10 6p21.31 diamond-blackfan anemia 1, diamond-blackfan anemia 9 rps10-related diamond-blackfan anemia
RPS12P16 ribosomal protein S12 pseudogene 16 10p11.21 crohns disease
RPS14 ribosomal protein S14 5q33.1 chromosome 5q deletion, "macrocytic anemia, refractory, due to 5q deletion, somatic" macrocytic anemia
RPS14P1 ribosomal protein S14 pseudogene 1 1q32.1 crohns disease ulcerative colitis
RPS15 ribosomal protein S15 19p13.3 insulinoma
RPS15AP14 ribosomal protein S15a pseudogene 14 2q31.1 major depressive disorder
RPS17 ribosomal protein S17 15q25.2 reactive arthritis, hepatitis e, diamond-blackfan anemia 1,
RPS18 ribosomal protein S18 6p21.32 bowen-conradi syndrome
RPS18P12 ribosomal protein S18 pseudogene 12 17p12 bowen-conradi syndrome
RPS19 ribosomal protein S19 19q13.2 microtia, transient erythroblastopenia of childhood, cartilage-hair hypoplasia,
RPS19P6 ribosomal protein S19 pseudogene 6 9q21.31 alzheimers disease
RPS23 ribosomal protein S23 5q14.2 pasteurellosis
RPS24 ribosomal protein S24 10q22.3 diamond-blackfan anemia 1, diamond-blackfan anemia, rps24-related diamond-blackfan anemia
RPS25 ribosomal protein S25 11q23.3 pandas
RPS26 ribosomal protein S26 12q13.2 klippel-feil syndrome, diamond-blackfan anemia 1, diamond-blackfan anemia,
RPS26P28 ribosomal protein S26 pseudogene 28 5p15.1 alzheimers disease
RPS26P6 ribosomal protein S26 pseudogene 6 8q22.3 klippel-feil syndrome
RPS27A ribosomal protein S27a 2p16.1 amyotrophic lateral sclerosis, parkinsons disease, frontotemporal lobar degeneration with ubiquitin-positive inclusions,
RPS27AP12 ribosomal protein S27a pseudogene 12 7q36.3 multiple myeloma
RPS27AP16 ribosomal protein S27a pseudogene 16 16q21 multiple myeloma
RPS27P18 ribosomal protein S27 pseudogene 18 10q26.13 fatty liver disease
RPS28 ribosomal protein S28 19p13.2 pasteurellosis
RPS29 ribosomal protein S29 14q21.3 diamond-blackfan anemia 1
RPS2P34 ribosomal protein S2 pseudogene 34 9q21.32 ulcerative colitis
RPS2P6 ribosomal protein S2 pseudogene 6 18q22.2 systemic lupus erythematosus
RPS3 ribosomal protein S3 11q13.4 mycetoma eumycotic mycetoma
RPS3AP42 ribosomal protein S3a pseudogene 42 11q14.3 gestational diabetes
RPS3AP51 ribosomal protein S3a pseudogene 51 22q12.2 crohns disease
RPS3AP9 ribosomal protein S3a pseudogene 9 1q31.1 systemic lupus erythematosus
RPS4XP13 ribosomal protein S4X pseudogene 13 11q12.1 childhood leukemia
RPS4Y2 ribosomal protein S4, Y-linked 2 Yq11.223 y chromosome infertility
RPS5P5 ribosomal protein S5 pseudogene 5 8q21.13 atopic dermatitis
RPS6 ribosomal protein S6 9p22.1 hemimegalencephaly tuberous sclerosis
RPS6KA1 ribosomal protein S6 kinase, 90kDa, polypeptide 1 1p36.11 tuberous sclerosis coffin-lowry syndrome
RPS6KA2 ribosomal protein S6 kinase, 90kDa, polypeptide 2 6q27 coffin-lowry syndrome
RPS6KA3 ribosomal protein S6 kinase, 90kDa, polypeptide 3 Xp22.12 "mental retardation, x-linked 17/31, microduplication", partington syndrome , estrogen resistance,
RPS6KA5 ribosomal protein S6 kinase, 90kDa, polypeptide 5 14q32.11 coffin-lowry syndrome
RPS6KA6 ribosomal protein S6 kinase, 90kDa, polypeptide 6 Xq21.1 choroideremia, coffin-lowry syndrome x-linked nonsyndromic deafness
RPS6KB1 ribosomal protein S6 kinase, 70kDa, polypeptide 1 17q23.1 tuberous sclerosis complex tuberous sclerosis
RPS6KB2 ribosomal protein S6 kinase, 70kDa, polypeptide 2 11q13.2 landau-kleffner syndrome, coffin-lowry syndrome kleine-levin syndrome
RPS7 ribosomal protein S7 2p25.3 frontal lobe epilepsy, diamond-blackfan anemia 1, diamond-blackfan anemia,
RPS9P3 ribosomal protein S9 pseudogene 3 5q21.1 fatty liver disease
RPSA ribosomal protein SA 3p22.1 lung cancer, venezuelan equine encephalitis "asplenia, isolated congenital"
RPSAP11 ribosomal protein SA pseudogene 11 3p22.3 alcohol dependence
RPSAP38 ribosomal protein SA pseudogene 38 5p13.1 systemic lupus erythematosus
RPSAP47 ribosomal protein SA pseudogene 47 8q21.13 hiv-1
RPTOR regulatory associated protein of MTOR, complex 1 17q25.3 lens subluxation
RPY Retinitis pigmentosa, Y-linked "retinitis pigmentosa, y-linked"
RRAD Ras-related associated with diabetes 16q22.1 insulin resistance
RRAGB Ras-related GTP binding B Xp11.21 clonorchiasis, paragonimiasis taeniasis
RRAS2 related RAS viral (r-ras) oncogene homolog 2 11p15.2 teratocarcinoma, ovarian cancer acute urate nephropathy
RRBP1 ribosome binding protein 1 20p12.1 anuria
RRDX Radial ray deficiency Xq24-q25 radial ray deficiency
RREB1 ras responsive element binding protein 1 6p24.3 substance-induced psychosis vulvar melanoma
RRM1 ribonucleotide reductase M1 11p15.4 breast cancer, pancreatic cancer, beckwith-wiedemann syndrome
RRM2 ribonucleotide reductase M2 2p25.1 pancreatic cancer pancreas adenocarcinoma
RRM2B ribonucleotide reductase M2 B (TP53 inducible) 8q22.3 ophthalmoplegia, mitochondrial dna depletion syndrome, autosomal dominant progressive external ophthalmoplegia,
RRNAD1 ribosomal RNA adenine dimethylase domain containing 1 1q23.1 periodontal disease
RRP8 ribosomal RNA processing 8, methyltransferase, homolog (yeast) 11p15.4 bowen-conradi syndrome
RS1 retinoschisin 1 Xp22.13 retinoschisis, retinal detachment x-linked juvenile retinoschisis
RSCIS Radiation sensitivity/chromosome instability syndrome, autosomal dominant 14q11.2 "radiation sensitivity/chromosome instability syndrome, autosomal dominant"
RSF1 remodeling and spacing factor 1 11q14.1 hepatocellular carcinoma, hepatitis b hepatitis
RSPH1 radial spoke head 1 homolog (Chlamydomonas) 21q22.3 "ciliary dyskinesia, primary, 19", myotonia "ciliary dyskinesia, primary, 24"
RSPH4A radial spoke head 4 homolog A (Chlamydomonas) 6q22.1 "ciliary dyskinesia, primary, 19", myotonia, primary ciliary dyskinesia11: rsph4a-related primary ciliary dyskinesia
RSPH9 radial spoke head 9 homolog (Chlamydomonas) 6p21.1 "ciliary dyskinesia, primary, 19", dextrocardia, primary ciliary dyskinesia,
RSPO1 R-spondin 1 1p34.3 hermaphroditism, palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal palmoplantar hyperkeratosis and true hermaphroditism
RSPO4 R-spondin 4 20p13 nail-patella syndrome, nail disease anonychia congenita
RSRC1 arginine/serine-rich coiled-coil 1 3q25.32 schizophrenia
RSS Russell Silver syndrome 17q25 silver-russell syndrome
RTDR1 rhabdoid tumor deletion region gene 1 22q11.22 rhabdoid cancer
RTEL1 regulator of telomere elongation helicase 1 20q13.33 dental caries, "dyskeratosis congenita, autosomal recessive 4", dyskeratosis congenita,
RTEL1-TNFRSF6B RTEL1-TNFRSF6B readthrough (NMD candidate) 20q13.33 ulcerative colitis
RTKN rhotekin 2p13.1 hereditary neuralgic amyotrophy
RTL1 retrotransposon-like 1 14q32.2 "maternal uniparental disomy, chromosome 14" "uniparental disomy, paternal, chromosome 14"
RTN2 reticulon 2 19q13.32 paraplegia, "spastic paraplegia 12, autosomal dominant" spastic paraplegia 12
RTN4 reticulon 4 2p16.1 amyotrophic lateral sclerosis schizophrenia
RTN4IP1 reticulon 4 interacting protein 1 6q21 spinal cord injury
RTN4R reticulon 4 receptor 22q11.21 schizophrenia
RTTN rotatin 18q22.2 polymicrogyria, hereditary myopathy with early respiratory failure polymicrogyria with seizures
RUNX1 runt-related transcription factor 1 21q22.12 8p11 myeloproliferative syndrome, acute myeloid leukemia, lymphoblastic leukemia,
RUNX1T1 runt-related transcription factor 1; translocated to, 1 (cyclin D-related) 8q21.3 acute myeloid leukemia, leukemia, myeloid leukemia,
RUNX2 runt-related transcription factor 2 6p21.1 saethre-chotzen syndrome, acute myeloid leukemia, aortic valve disease,
RUNX3 runt-related transcription factor 3 1p36.11 acute myeloid leukemia, leukemia, esophagus squamous cell carcinoma,
RWDD2B RWD domain containing 2B 21q21.3 monosomy 21
RWS Ragweed sensitivity 6p21.3 ragweed sensitivity
RXFP1 relaxin/insulin-like family peptide receptor 1 4q32.1 endometriosis placenta accreta
RXFP2 relaxin/insulin-like family peptide receptor 2 13q13.1 cryptorchidism anorchia
RXFP3 relaxin/insulin-like family peptide receptor 3 5p13.2 schizotypal personality disorder
RXRA retinoid X receptor, alpha 9q34.2 recessive dystrophic epidermolysis bullosa x-linked adrenal hypoplasia congenita
RXRB retinoid X receptor, beta 6p21.32 x-linked adrenal hypoplasia congenita
RXRG retinoid X receptor, gamma 1q23.3 lung cancer, functioning pituitary adenoma non-functioning pituitary adenoma
RYR1 ryanodine receptor 1 (skeletal) 19q13.2 central core myopathy, neuroleptic malignant syndrome, benign samaritan congenital myopathy,
RYR2 ryanodine receptor 2 (cardiac) 1q43 central core myopathy, catecholaminergic polymorphic ventricular tachycardia, "familial isolated arrhythmogenic ventricular dysplasia, biventricular form",
RYR3 ryanodine receptor 3 15q14 central core myopathy neuroleptic malignant syndrome
S100A1 S100 calcium binding protein A1 1q21.3 sarcomatoid renal cell carcinoma, rosai-dorfman disease, microglandular adenosis,
S100A10 S100 calcium binding protein A10 1q21.3 borna disease
S100A12 S100 calcium binding protein A12 1q21.3 rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis
S100A14 S100 calcium binding protein A14 1q21.3 breast cancer small intestine adenocarcinoma
S100A2 S100 calcium binding protein A2 1q21.3 breast cancer, pancreatic cancer, non-small cell lung carcinoma,
S100A3 S100 calcium binding protein A3 1q21.3 anaplastic astrocytoma pilomatrixoma
S100A4 S100 calcium binding protein A4 1q21.3 adenocarcinoma, breast cancer, pancreatic cancer,
S100A5 S100 calcium binding protein A5 1q21.3 anaplastic astrocytoma meningioma
S100A6 S100 calcium binding protein A6 1q21.3 amyotrophic lateral sclerosis, endometrial carcinoma, pancreatic cancer,
S100A7 S100 calcium binding protein A7 1q21.3 trachoma, breast cancer, psoriasis,
S100A8 S100 calcium binding protein A8 1q21.3 cystic fibrosis, cardiac sarcoidosis, relapsing polychondritis,
S100A9 S100 calcium binding protein A9 1q21.3 cystic fibrosis, rheumatoid arthritis, cardiac sarcoidosis
S100B S100 calcium binding protein B 21q22.3 giant cell glioblastoma, papilloma, epulis,
S100G S100 calcium binding protein G Xp22.2 duodenum cancer
S100P S100 calcium binding protein P 4p16.1 prostate cancer, non-small cell lung carcinoma parachordoma
S100PBP S100P binding protein 1p35.1 adenocarcinoma pancreatic ductal adenocarcinoma
S1PR1 sphingosine-1-phosphate receptor 1 1p21.2 follicular thyroid carcinoma
S1PR3 sphingosine-1-phosphate receptor 3 9q22.1 follicular thyroid carcinoma
SAA1 serum amyloid A1 11p15.1 amyloidosis, myocardial infarction, rheumatoid arthritis,
SAA2 serum amyloid A2 11p15.1 pertussis, septic shock, "amyloidosis, secondary"
SAA4 serum amyloid A4, constitutive 11p15.1 recessive dystrophic epidermolysis bullosa, myocardial infarction, coronary artery disease,
SACS sacsin molecular chaperone 13q12.12 prostate cancer, spasticity, muscular atrophy,
SAE1 SUMO1 activating enzyme subunit 1 19q13.32 color blindness adult dermatomyositis
SAFB scaffold attachment factor B 19p13.3 cysticercosis
SAG S-antigen; retina and pineal gland (arrestin) 2q37.1 leber congenital amaurosis, retinal vasculitis, pineoblastoma,
SAGE1 sarcoma antigen 1 Xq26.3 papillary renal cell carcinoma, retroperitoneal fibrosis ductal carcinoma in situ
SALL1 spalt-like transcription factor 1 16q12.1 developmental disabilities, renal agenesis, imperforate anus,
SALL3 spalt-like transcription factor 3 18q23 18q deletion syndrome
SALL4 spalt-like transcription factor 4 20q13.2 germ cell tumors, wolf-hirschhorn syndrome, extragonadal germ cell tumor,
SAMD14 sterile alpha motif domain containing 14 17q21.33 lung adenoma
SAMD9 sterile alpha motif domain containing 9 7q21.2 calcinosis, familial tumoral calcinosis, normophosphatemic familial tumoral calcinosis
SAMHD1 SAM domain and HD domain 1 20q11.23 chilblain lupus , aicardi-goutieres syndrome, aicardi-goutieres syndrome 7,
SAP18 Sin3A-associated protein, 18kDa 13q12.11 pallister-hall syndrome
SAR1A secretion associated, Ras related GTPase 1A 10q22.1 platelet storage pool deficiency
SAR1B secretion associated, Ras related GTPase 1B 5q31.1 legionellosis chylomicron retention disease
SARDH sarcosine dehydrogenase 9q34.2 bladder carcinoma in situ, sarcosinemia dimethylglycine dehydrogenase deficiency
SARM1 sterile alpha and TIR motif containing 1 17q11.2 retinoschisis wallerian degeneration
SARNP SAP domain containing ribonucleoprotein 12q13.2 hepatocellular carcinoma
SARS2 seryl-tRNA synthetase 2, mitochondrial 19q13.2 hyperuricemia "hyperuricemia, pulmonary hypertension, renal failure, and alkalosis"
SART1 squamous cell carcinoma antigen recognized by T cells 11q13.1 atopy
SART3 squamous cell carcinoma antigen recognized by T cells 3 12q23.3 hiv-1, porokeratosis, "porokeratosis 3, disseminated superficial actinic"
SAT1 spermidine/spermine N1-acetyltransferase 1 Xp22.11 keratosis, keratosis follicularis, "keratosis follicularis spinulosa decalvans, x-linked",
SAT2 spermidine/spermine N1-acetyltransferase family member 2 17p13.1 lung cancer lung cancer susceptibility
SATB2 SATB homeobox 2 2q33.1 cleft palate, 2q33.1 microdeletion syndrome glass syndrome
SBDS Shwachman-Bodian-Diamond syndrome 7q11.21 shwachman-diamond syndrome, aplastic anemia, exocrine pancreatic insufficiency,
SBDSP1 Shwachman-Bodian-Diamond syndrome pseudogene 1 7q11.23 shwachman-diamond syndrome
SBF1 SET binding factor 1 22q13.33 charcot-marie-tooth neuropathy type 4, charcot-marie-tooth disease type 4, centronuclear myopathy,
SBF2 SET binding factor 2 11p15.4 charcot-marie-tooth neuropathy type 4, charcot-marie-tooth disease type 4, centronuclear myopathy,
SBK1 SH3 domain binding kinase 1 16p11.2 esophagus squamous cell carcinoma
SBSN suprabasin 19q13.12 adenoid cystic carcinoma
SC5D sterol-C5-desaturase 11q23.3 lathosterolosis
SCA18 spinocerebellar ataxia 18 (sensory with neurogenic muscular atrophy) 7q22-q32 spinocerebellar ataxia 18
SCA19 spinocerebellar ataxia 19 1p21-q21 spinocerebellar ataxia 19
SCA20 spinocerebellar ataxia 20 11p11.2-q13.3 spinocerebellar ataxia type 20
SCA21 spinocerebellar ataxia 21 7p21.3-p15.1 spinocerebellar ataxia 21
SCA22 spinocerebellar ataxia 22 1p21-q23 spinocerebellar ataxia 19
SCA25 spinocerebellar ataxia 25 2p21-p15 spinocerebellar ataxia 25
SCA26 spinocerebellar ataxia 26 19p13.3 spinocerebellar ataxia 26
SCA30 spinocerebellar ataxia 30 4q34.3-q35.1 spinocerebellar ataxia 30
SCA31 spinocerebellar ataxia 31 16q22 spinocerebellar ataxia 31
SCA32 spinocerebellar ataxia 32 7q32-q33 spinocerebellar ataxia 32
SCA34 spinocerebellar ataxia 34 6q12.3-q16.2 spinocerebellar ataxia 34
SCA37 spinocerebellar ataxia 37 1p32 spinocerebellar ataxia type 37
SCA9 spinocerebellar ataxia 9 reserved spinocerebellar ataxia 9
SCAF4 SR-related CTD-associated factor 4 21q22.11 wells syndrome
SCAMP2 secretory carrier membrane protein 2 15q24.1 bartter disease
SCAPER S-phase cyclin A-associated protein in the ER 15q24.3 composite lymphoma
SCAR12 Spinocerebellar ataxia, autosomal recessive 12 16q21-q23 "spinocrebellar ataxia, autosomal recessive 12", "esophageal squamous cell carcinoma, somatic" "spinocerebellar ataxia, autosomal recessive 12"
SCAR2 spinocerebellar ataxia, autosomal recessive 2 9q34.3 cerebelloparenchymal disorder 3
SCAR3 spinocerebellar ataxia, autosomal recessive 3 6p23-p21 spinocerebellar ataxia autosomal recessive 3
SCAR6 spinocerebellar ataxia, autosomal recessive 6 20q11-q13 spinocerebellar ataxia autosomal recessive 6
SCAR7 spinocerebellar ataxia, autosomal recessive 7 11p15 late-infantile neuronal ceroid lipofuscinosis, ceroid lipofuscinosis neuronal 2 "spinocerebellar ataxia, autosomal recessive 7"
SCARA3 scavenger receptor class A, member 3 8p21.1 triple-a syndrome
SCARA5 scavenger receptor class A, member 5 (putative) 8p21.1 placenta accreta placenta praevia
SCARB1 scavenger receptor class B, member 1 12q24.31 hepatitis c, hepatitis c virus, hepatitis,
SCARB2 scavenger receptor class B, member 2 4q21.1 gauchers disease, mouth disease, myoclonus,
SCARF2 scavenger receptor class F, member 2 22q11.21 histidinemia marden walker like syndrome
SCARNA22 small Cajal body-specific RNA 22 4p16.3 multiple myeloma
SCARNA5 small Cajal body-specific RNA 5 2q37.1 crohns disease
SCASI spinocerebellar ataxia with saccadic intrusions 1p36 ataxia spinocerebellar ataxia autosomal recessive 4
SCAX5 Spinocerebellar ataxia, X-linked 5 Xq25-q27.1 "spinocerebellar ataxia, x-linked 5"
SCCPDH saccharopine dehydrogenase (putative) 1q44 hyperlysinemia cystinuria
SCD stearoyl-CoA desaturase (delta-9-desaturase) 10q24.31 obesity systemic primary carnitine deficiency disease
SCD5 stearoyl-CoA desaturase 5 4q21.22 obesity spondylocostal dysostosis
SCG2 secretogranin II 2q36.1 cholera, collagenous colitis, insulinoma,
SCG3 secretogranin III 15q21.2 "limb-girdle muscular dystrophy, type 2c"
SCGB1A1 secretoglobin, family 1A, member 1 (uteroglobin) 11q12.3 bronchopulmonary dysplasia, asthma, vitelliform macular dystrophy,
SCGB1C1 secretoglobin, family 1C, member 1 11p15.5 common cold
SCGB1D1 secretoglobin, family 1D, member 1 11q12.3 prostate cancer, intracranial hypotension patellofemoral pain syndrome
SCGB1D2 secretoglobin, family 1D, member 2 11q12.3 prostate cancer
SCGB1D4 secretoglobin, family 1D, member 4 11q12.3 common cold
SCGB2A1 secretoglobin, family 2A, member 1 11q12.3 ovarian cancer
SCGB2A2 secretoglobin, family 2A, member 2 11q12.3 breast cancer
SCGB3A1 secretoglobin, family 3A, member 1 5q35.3 breast cancer, lung cancer, sporadic breast cancer
SCGB3A2 secretoglobin, family 3A, member 2 5q32 asthma interstitial lung disease
SCHIP1 schwannomin interacting protein 1 3q25.33 papillary renal cell carcinoma
SCHLAP1 SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding) 2q31.3 prostate cancer prostate cancer 1
SCKL3 Seckel syndrome 3 14q23 seckel syndrome 3
SCLC1 small cell cancer of the lung 3p23-p21 lung small cell carcinoma
SCLL Chromosome 8p11 myeloproliferative syndrome 8p11 8p11 myeloproliferative syndrome chromosome 8p11 myeloproliferative syndrome
SCN10A sodium channel, voltage-gated, type X, alpha subunit 3p22.2 trigeminal neuralgia, hereditary sensory neuropathy, erythromelalgia,
SCN11A sodium channel, voltage-gated, type XI, alpha subunit 3p22.2 hereditary sensory neuropathy, erythromelalgia, "episodic pain syndrome, familial, 3",
SCN1A sodium channel, voltage-gated, type I, alpha subunit 2q24.3 infantile epileptic encephalopathy, seizure disorder, "epileptic encephalopathy, early infantile, 12",
SCN1B sodium channel, voltage-gated, type I, beta subunit 19q13.12 idiopathic generalized epilepsy, seizure disorder, "heart block, progressive, type ia",
SCN2A sodium channel, voltage-gated, type II, alpha subunit 2q24.3 "epileptic encephalopathy, early infantile, 5", "epileptic encephalopathy, early infantile, 17", ohtahara syndrome,
SCN2B sodium channel, voltage-gated, type II, beta subunit 11q23.3 weill-marchesani-like syndrome, "atrial fibrillation, familial, 9", rasmussen encephalitis
SCN3A sodium channel, voltage-gated, type III, alpha subunit 2q24.3 trigeminal neuralgia, pain disorder, dravet syndrome,
SCN3B sodium channel, voltage-gated, type III, beta subunit 11q24.1 brugada syndrome 1, "atrial fibrillation, familial, 9", brugada syndrome
SCN4A sodium channel, voltage-gated, type IV, alpha subunit 17q23.3 malignant hyperthermia susceptibility, malignant hyperthermia, hypokalemic periodic paralysis,
SCN4B sodium channel, voltage-gated, type IV, beta subunit 11q23.3 "atrial fibrillation, familial, 9", familial atrial fibrillation, long qt syndrome 1,
SCN5A sodium channel, voltage-gated, type V, alpha subunit 3p22.2 cardiac conduction defect, "heart block, progressive, type ia", right bundle branch block,
SCN7A sodium channel, voltage-gated, type VII, alpha subunit 2q24.3 hypokalemic periodic paralysis, hypokalemic periodic paralysis type 2, cardiac conduction defect,
SCN8A sodium channel, voltage gated, type VIII, alpha subunit 12q13.13 infantile epileptic encephalopathy, pulpitis, generalized epilepsy with febrile seizures plus,
SCN9A sodium channel, voltage-gated, type IX, alpha subunit 2q24.3 seizure disorder, burning mouth syndrome, trigeminal neuralgia,
SCNN1A sodium channel, non-voltage-gated 1 alpha subunit 12p13.31 pseudohypoaldosteronism type ii, bronchiectasis, liddle syndrome,
SCNN1B sodium channel, non-voltage-gated 1, beta subunit 16p12.2 cystic fibrosis, bronchiectasis, liddle syndrome,
SCNN1G sodium channel, non-voltage-gated 1, gamma subunit 16p12.2 miliaria rubra, miliaria, bronchiectasis,
SCO1 SCO1 cytochrome c oxidase assembly protein 17p13.1 leigh disease, cytochrome-c oxidase deficiency disease, cardioencephalomyopathy,
SCO2 SCO2 cytochrome c oxidase assembly protein 22q13.33 leigh disease, cytochrome-c oxidase deficiency disease, mitochondrial disorders,
SCP2 sterol carrier protein 2 1p32.3 lipoid adrenal hyperplasia, yellow fever, rhizomelic chondrodysplasia punctata,
SCP2D1 SCP2 sterol-binding domain containing 1 20p11.23 d-bifunctional protein deficiency
SCPEP1 serine carboxypeptidase 1 17q22 retinal perforation
SCRIB scribbled planar cell polarity protein 8q24.3 neural tube defects, spina bifida, tick-borne encephalitis,
SCRN3 secernin 3 2q31.1 acrodysostosis
SCRT1 scratch family zinc finger 1 8q24.3 skull base meningioma, meningioma, cerebellar astrocytoma,
SCT secretin 11p15.5 papillary adenocarcinoma, developmental disabilities, pervasive developmental disorder,
SCTR secretin receptor 2q14.2 pancreatic cancer
SCXA scleraxis homolog A (mouse) 8q24.3 eosinophilia-myalgia syndrome
SCXB scleraxis homolog B (mouse) 8q24.3 eosinophilia-myalgia syndrome
SCZD1 schizophrenia disorder 1 5q11.2-q13.3 schizophrenia
SCZD10 schizophrenia disorder 10 (periodic catatonia) 15q15 schizophrenia schizophrenia 10
SCZD11 Schizophrenia susceptibility locus, chromosome 10q-related 10q22.3 schizophrenia
SCZD12 schizophrenia 12 1p schizophrenia schizophrenia 12
SCZD13 schizophrenia 13 15q13 schizophrenia schizophrenia 13
SCZD14 schizophrenia, susceptibility to, 14 2q32.1 schizophrenia schizophrenia 14
SCZD2 schizophrenia disorder 2 11q14-q21 schizophrenia
SCZD3 schizophrenia disorder 3 6p24-p22 schizophrenia
SCZD4 schizophrenia disorder 4 22q11-q13 schizophrenia, hyperprolinemia schizophrenia 4
SCZD5 schizophrenia disorder 5 6q13-q26 schizophrenia
SCZD6 schizophrenia disorder 6 8p21 schizophrenia
SCZD7 schizophrenia disorder 7 13q32 schizophrenia
SCZD8 schizophrenia disorder 8 18p schizophrenia
SDC1 syndecan 1 2p24.1 monoclonal gammopathy of uncertain significance, hiv-1, breast carcinoma in situ,
SDC2 syndecan 2 8q22.1 hiv-1
SDC3 syndecan 3 1p35.2 obesity "obesity, association with"
SDCBP syndecan binding protein (syntenin) 8q12.1 melanoma asthenopia
SDCCAG3 serologically defined colon cancer antigen 3 9q34.3 colon cancer
SDCCAG3P1 serologically defined colon cancer antigen 3 pseudogene 1 18q21.32 colon cancer
SDCCAG3P2 serologically defined colon cancer antigen 3 pseudogene 2 1q25.1 colon cancer
SDCCAG8 serologically defined colon cancer antigen 8 1q43 colon cancer, "bardet-biedl syndrome, modifier of", senior-loken syndrome,
SDHA succinate dehydrogenase complex, subunit A, flavoprotein (Fp) 5p15.33 leigh syndrome with leukodystrophy, pheochromocytoma, chondroma,
SDHAF1 succinate dehydrogenase complex assembly factor 1 19q13.12 leigh disease, mitochondrial complex ii deficiency "mitochondrial respiratory chain complex ii deficiency, sdhaf1-related"
SDHAF2 succinate dehydrogenase complex assembly factor 2 11q12.2 pheochromocytoma, phaeochromocytoma, glomus tumor,
SDHB succinate dehydrogenase complex, subunit B, iron sulfur (Ip) 1p36.13 chronic progressive external ophthalmoplegia, pheochromocytoma, neurofibromatosis,
SDHC succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa 1q23.3 pheochromocytoma, chondroma, phaeochromocytoma,
SDHD succinate dehydrogenase complex, subunit D, integral membrane protein 11q23.1 cerebellopontine angle tumor, pheochromocytoma, neurofibromatosis,
SDS serine dehydratase 12q24.13 shwachman-diamond syndrome
SEC11B SEC11 homolog B, pseudogene (S. cerevisiae) 8q11.23 dengue shock syndrome
SEC14L1 SEC14-like 1 (S. cerevisiae) 17q25.2 nonepidermolytic palmoplantar keratoderma brachial plexus neuropathy
SEC23A Sec23 homolog A (S. cerevisiae) 14q21.1 craniolenticulosutural dysplasia
SEC23B Sec23 homolog B (S. cerevisiae) 20p11.23 congenital dyserythropoietic anemia, siderosis congenital dyserythropoietic anemia type 2
SEC23IP SEC23 interacting protein 10q26.11 nodular malignant melanoma
SEC24D SEC24 family member D 4q26 liddle syndrome
SEC31A SEC31 homolog A (S. cerevisiae) 4q21.22 alk-positive large b-cell lymphoma ectodermal dysplasia-syndactyly syndrome 1
SEC61A1 Sec61 alpha 1 subunit (S. cerevisiae) 3q21.3 polycystic liver disease
SEC63 SEC63 homolog (S. cerevisiae) 6q21 polycystic liver disease liver disease
SECISBP2 SECIS binding protein 2 9q22.2 "thyroid hormone metabolism, abnormal" sepn1-related myopathy
SECTM1 secreted and transmembrane 1 17q25.3 amblyopia
SEH1L SEH1-like (S. cerevisiae) 18p11.21 nail disease
SELE selectin E 1q24.2 vascular disease, coronary artery disease, type 2 diabetes mellitus,
SELK selenoprotein K 3p21.1 staphyloenterotoxemia
SELL selectin L 1q24.2 bronchopulmonary dysplasia, cryptococcosis, sepsis,
SELM selenoprotein M 22q12.2 staphyloenterotoxemia
SELO selenoprotein O 22q13.33 familial hypercholesterolemia staphyloenterotoxemia
SELP selectin P (granule membrane protein 140kDa, antigen CD62) 1q24.2 pre-eclampsia, vascular disease, intermittent claudication,
SELPLG selectin P ligand 12q24.11 pustulosis palmaris et plantaris, primary effusion lymphoma, cerebrovascular disease,
SELV selenoprotein V 19q13.2 staphyloenterotoxemia
SEMA3A sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A 7q21.11 hypogonadotropic hypogonadism 8 with or without anosmia, schizophrenia, wallerian degeneration,
SEMA3B sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B 3p21.31 phencyclidine abuse
SEMA3C sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C 7q21.11 allan-herndon-dudley syndrome
SEMA3E sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E 7q21.11 charge syndrome ischemic retinopathy
SEMA3F sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F 3p21.31 wallerian degeneration brachial plexus lesion
SEMA4A sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A 1q22 leber congenital amaurosis, cone-rod dystrophy 2, cone-rod dystrophy,
SEMA4F sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F 2p13.1 prostate cancer breast cancer
SEMA5A sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A 5p15.31 cri-du-chat syndrome
SEMA7A semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) 15q24.1 exotropia
SEN2 senescence (cellular)-related 2 1q42-q44 pontocerebellar hypoplasia, pontocerebellar hypoplasia type 2b pontocerebellar hypoplasia type 2
SEN3 senescence (cellular)-related 3 X pontocerebellar hypoplasia pontocerebellar hypoplasia type 2c
SENP6 SUMO1/sentrin specific peptidase 6 6q14.1 sarcocystosis
SENP7 SUMO1/sentrin specific peptidase 7 3q12.3 malaria
SEPHS1 selenophosphate synthetase 1 10p13 schizophrenia
SEPN1 selenoprotein N, 1 1p36.11 multiminicore disease , congenital fiber-type disproportion, rigid spine syndrome,
SEPSECS Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase 4p15.2 autoimmune hepatitis, primary biliary cirrhosis, acute liver failure,
SEPT1 septin 1 16p11.2 breast cancer acute myeloid leukemia
SEPT11 septin 11 4q21.1 chronic neutrophilic leukemia hereditary neuralgic amyotrophy
SEPT12 septin 12 16p13.3 spermatogenic failure, spermatogenic failure 10 sertoli cell-only syndrome
SEPT14 septin 14 7p11.2 gliosarcoma giant cell glioblastoma
SEPT3 septin 3 22q13.2 teratocarcinoma
SEPT4 septin 4 17q22 hereditary neuralgic amyotrophy
SEPT5 septin 5 22q11.21 acute myeloid leukemia myeloid leukemia
SEPT6 septin 6 Xq24 acute myeloid leukemia myeloid leukemia
SEPT9 septin 9 17q25.2 cri-du-chat syndrome, neuritis, ovarian cancer,
SERAC1 serine active site containing 1 6q25.3 leigh-like syndrome megdel syndrome
SERF1A small EDRK-rich factor 1A (telomeric) 5q13.2 muscular atrophy
SERPINA1 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 14q32.13 pulmonary emphysema, blastoma, diverticulitis,
SERPINA10 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 14q32.13 venous thromboembolism venous thrombosis
SERPINA12 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 14q32.13 insulin resistance obesity
SERPINA2 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 2 (gene/pseudogene) 14q32.13 alpha 1-antitrypsin deficiency, wegeners granulomatosis bacteriuria
SERPINA3 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 14q32.13 parkinsons disease, alzheimers disease, malignant histiocytosis,
SERPINA6 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 14q32.13 endometriosis, hyperthyroidism, anoxia,
SERPINA7 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 Xq22.3 hepatocellular carcinoma, breast cyst, hyperthyroidism,
SERPINB1 serpin peptidase inhibitor, clade B (ovalbumin), member 1 6p25.2 alpha 1-antitrypsin deficiency, thromboangiitis obliterans "pulmonary disease, chronic obstructive"
SERPINB2 serpin peptidase inhibitor, clade B (ovalbumin), member 2 18q21.33 bladder carcinoma, male breast cancer, ovarian cancer,
SERPINB3 serpin peptidase inhibitor, clade B (ovalbumin), member 3 18q21.33 hepatocellular carcinoma, cervical cancer, liver disease,
SERPINB4 serpin peptidase inhibitor, clade B (ovalbumin), member 4 18q21.33 cervical cancer, burns, idiopathic pulmonary fibrosis,
SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 18q21.33 bladder carcinoma, prostate cancer, breast cancer,
SERPINB6 serpin peptidase inhibitor, clade B (ovalbumin), member 6 6p25.2 "deafness, autosomal recessive 76", sensorineural hearing loss "deafness, autosomal recessive 91"
SERPINB7 serpin peptidase inhibitor, clade B (ovalbumin), member 7 18q21.33 palmoplantar keratosis, iga glomerulonephritis, "palmoplantar keratoderma, nagashima type"
SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 1q25.1 pre-eclampsia, dysfibrinogenemia, antithrombin iii deficiency,
SERPIND1 serpin peptidase inhibitor, clade D (heparin cofactor), member 1 22q11.21 dysfibrinogenemia, antithrombin iii deficiency, thrombophilia
SERPINE1 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 7q22.1 pre-eclampsia, carotid intimal medial thickness, vascular disease,
SERPINE2 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 2q36.1 amyotrophic lateral sclerosis
SERPINF1 serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 17p13.3 corneal neovascularization, diabetic macular edema, diabetic retinopathy,
SERPINF2 serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 17p13.3 pulmonary embolism, angina pectoris, thrombocytosis,
SERPING1 serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 11q12.1 "complement component 4, partial deficiency of", capillary leak syndrome, angioedema,
SERPINH1 serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) 11q13.5 nonspecific interstitial pneumonia, usual interstitial pneumonia, oligohydramnios,
SERPINI1 serpin peptidase inhibitor, clade I (neuroserpin), member 1 3q26.1 dementia, myoclonus familial encephalopathy with neuroserpin inclusion bodies
SESN3 sestrin 3 11q21 insulin resistance obesity
SETBP1 SET binding protein 1 18q12.3 acute myeloid leukemia, juvenile myelomonocytic leukemia, myelodysplastic syndromes,
SETD1A SET domain containing 1A 16p11.2 hemometra
SETD2 SET domain containing 2 3p21.31 ischemia, ankylosis, endolymphatic sac tumor
SETD5 SET domain containing 5 3p25.3 intellectual disability-facial dysmorphism syndrome due to setd5 haploinsufficiency "mental retardation, autosomal dominant 23"
SETDB1 SET domain, bifurcated 1 1q21.3 huntingtons disease
SETDB2 SET domain, bifurcated 2 13q14.2 leukemia chronic lymphocytic leukemia
SETP2 SET pseudogene 2 14q22.1 alzheimers disease
SETX senataxin 9q34.13 amyotrophic lateral sclerosis, lateral sclerosis, ataxia,
SEZ6L2 seizure related 6 homolog (mouse)-like 2 16p11.2 seizure disorder lung cancer
SF Stoltzfus blood group 4q28-q31 "hyperpigmentation, familial progressive, 2"
SF1 splicing factor 1 11q13.1 46xy sex reversal 3, familial isolated pituitary adenoma, adrenocortical insufficiency,
SF3B1 splicing factor 3b, subunit 1, 155kDa 2q33.1 "myelodysplastic syndrome, somatic"
SF3B4 splicing factor 3b, subunit 4, 49kDa 1q21.2 frontometaphyseal dysplasia nager acrofacial dysostosis
SFMBT1 Scm-like with four mbt domains 1 3p21.1 acute poststreptococcal glomerulonephritis normal pressure hydrocephalus
SFN stratifin 1p36.11 bladder squamous cell carcinoma limbal stem cell deficiency
SFPQ splicing factor proline/glutamine-rich 1p34.3 papillary renal cell carcinoma "renal cell carcinoma, papillary, 1"
SFRP2 secreted frizzled-related protein 2 4q31.3 colorectal cancer
SFRP4 secreted frizzled-related protein 4 7p14.1 oncogenic osteomalacia "hypophosphatemic rickets, autosomal dominant"
SFTPA1 surfactant protein A1 10q22.3 hemangioma, sclerosing hemangioma, pulmonary fibrosis,
SFTPA2 surfactant protein A2 10q22.3 pulmonary tuberculosis, pulmonary fibrosis, idiopathic pulmonary fibrosis,
SFTPB surfactant protein B 2p11.2 bronchopulmonary dysplasia, hemangioma, sclerosing hemangioma,
SFTPC surfactant protein C 8p21.3 nonspecific interstitial pneumonia, usual interstitial pneumonia, adult respiratory distress syndrome,
SFTPD surfactant protein D 10q22.3 vascular disease, collagen disease, pulmonary emphysema,
SFXN1 sideroflexin 1 5q35.2 aceruloplasminemia
SFXN4 sideroflexin 4 10q26.11 breast cancer, macrocytic anemia combined oxidative phosphorylation deficiency 18
SGCA sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) 17q21.33 limb-girdle muscular dystrophy, embryonal rhabdomyosarcoma, walker-warburg syndrome,
SGCB sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) 4q12 neuromuscular disease, limb-girdle muscular dystrophy, hepatic encephalopathy,
SGCD sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) 5q33.2 "cardiomyopathy, dilated, 1w", dilated cardiomyopathy, sarcoglycanopathies,
SGCE sarcoglycan, epsilon 7q21.3 dystonia, gilles de la tourette syndrome, obsessive-compulsive disorder,
SGCEP sarcoglycan, epsilon, pseudogene 2q22.3 pulmonary function
SGCG sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) 13q12.12 limb-girdle muscular dystrophy, sarcoglycanopathies, muscular dystrophy
SGCZ sarcoglycan, zeta 8p22 generalized epilepsy with febrile seizures plus
SGK1 serum/glucocorticoid regulated kinase 1 6q23.2 diabetic nephropathy hypertension
SGOL1 shugoshin-like 1 (S. pombe) 3p24.3 breast cancer
SGSH N-sulfoglucosamine sulfohydrolase 17q25.3 mucopolysaccharidosis, mucopolysaccharidosis iii, lysosomal storage disease,
SGTA small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha 19p13.3 hidradenoma, hidrocystoma, clear cell hidradenoma
SH2B1 SH2B adaptor protein 1 16p11.2 myeloproliferative disorder, obesity, severe early-onset obesity-insulin resistance syndrome due to sh2b1 deficiency,
SH2B3 SH2B adaptor protein 3 12q24.12 myeloproliferative disorder, myelofibrosis, celiac disease,
SH2D1A SH2 domain containing 1A Xq25 infectious mononucleosis, vaginitis, burkitts lymphoma,
SH2D2A SH2 domain containing 2A 1q23.1 juvenile rheumatoid arthritis, polyradiculoneuropathy chronic inflammatory demyelinating polyradiculoneuropathy
SH2D3A SH2 domain containing 3A 19p13.3 venezuelan equine encephalitis
SH2D3C SH2 domain containing 3C 9q34.11 eastern equine encephalitis venezuelan equine encephalitis
SH2D4B SH2 domain containing 4B 10q23.1 lymphocytic vasculitis
SH3BP2 SH3-domain binding protein 2 4p16.3 cherubism giant cell reparative granuloma
SH3BP5 SH3-domain binding protein 5 (BTK-associated) 3p25.1 bursitis
SH3BP5-AS1 SH3BP5 antisense RNA 1 3p25.1 alcohol dependence
SH3GL1 SH3-domain GRB2-like 1 19p13.3 acute myeloid leukemia, leukemia, lymphoid leukemia
SH3KBP1 SH3-domain kinase binding protein 1 Xp22.12 mast-cell leukemia
SH3PXD2B SH3 and PX domains 2B 5q35.1 charcot-marie-tooth neuropathy type 2e/1f , frank ter haar syndrome "dermato-cardio-skeletal syndrome, borrone type"
SH3RF1 SH3 domain containing ring finger 1 4q33 benign paroxysmal positional nystagmus
SH3TC2 SH3 domain and tetratricopeptide repeats 2 5q32 charcot-marie-tooth neuropathy type 4, charcot-marie-tooth disease type 4, charcot-marie-tooth disease,
SHANK2 SH3 and multiple ankyrin repeat domains 2 11q13.4 autism spectrum disorder, secretory diarrhea autism susceptibility 17
SHANK3 SH3 and multiple ankyrin repeat domains 3 22q13.33 schizophrenia, autism spectrum disorder, ring chromosome 22,
SHB Src homology 2 domain containing adaptor protein B 9p13.2 methemoglobinemia sulfhemoglobinemia
SHBG sex hormone-binding globulin 17p13.1 type 2 diabetes mellitus, breast cancer, androgen insensitivity syndrome,
SHC1 SHC (Src homology 2 domain containing) transforming protein 1 1q21.3 prostate cancer multiple endocrine neoplasia type 2a
SHC4 SHC (Src homology 2 domain containing) family, member 4 15q21.1 urethral stricture
SHD Src homology 2 domain containing transforming protein D 19p13.3 sandhoff disease tay-sachs disease
SHE Src homology 2 domain containing E 1q21.3 strongyloidiasis
SHFL1 Split-hand/foot malformation with long bone deficiency 1 1q42.2-q43 split-hand/foot malformation with long bone deficiency 1
SHFLD2 Split-hand/foot malformation with long deficiency 2 6q14.1 split-hand/foot malformation with long bone deficiency 2
SHFLD3 Split-hand/foot malformation with long bone deficiency 3 17p13.3-p13.1 split-hand/foot malformation with long bone deficiency 3
SHFM1 split hand/foot malformation (ectrodactyly) type 1 7q21.3 split foot, split hand, male breast cancer,
SHFM1P1 split hand/foot malformation (ectrodactyly) type 1 pseudogene 1 5q14.1 split foot split hand
SHFM2 split hand/foot malformation (ectrodactyly) type 2 Xq26 split hand split hand/foot malformation 2
SHFM3 Split-hand/foot malformation 3 10q24 split hand, "split-hand/foot malformation 3, gene duplication syndrome" split-hand/foot malformation 3
SHFM5 split hand/foot malformation (ectrodactyly) type 5 2q31 split hand split-hand/foot malformation 5
SHH sonic hedgehog 7q36.3 matthew-wood syndrome, nonspecific interstitial pneumonia, septopreoptic holoprosencephaly,
SHKBP1 SH3KBP1 binding protein 1 19q13.2 korean hemorrhagic fever
SHMT1 serine hydroxymethyltransferase 1 (soluble) 17p11.2 autonomic dysfunction, neural tube defects, non-hodgkin lymphoma,
SHMT2 serine hydroxymethyltransferase 2 (mitochondrial) 12q13.3 pyridoxine deficiency
SHOC2 soc-2 suppressor of clear homolog (C. elegans) 10q25.2 leopard syndrome noonan-like syndrome with loose anagen hair
SHOX short stature homeobox Xp22.33 hypochondroplasia, dwarfism, klinefelters syndrome,
SHOX2 short stature homeobox 2 3q25.32 hard palate cancer
SHPK sedoheptulokinase 17p13.2 nephropathic cystinosis
SHROOM3 shroom family member 3 4q21.1 heterotaxy
SHROOM4 shroom family member 4 Xp11.22 stocco dos santos syndrome
SI sucrase-isomaltase (alpha-glucosidase) 3q26.1 intestinal atresia, microvillus inclusion disease, congenital sucrase-isomaltase deficiency with starch and lactose intolerance,
SIAE sialic acid acetylesterase 11q24.2 autoimmune disease 6
SIAH1 siah E3 ubiquitin protein ligase 1 16q12.1 hypoxia
SIAH2 siah E3 ubiquitin protein ligase 2 3q25.1 hypoxia
SIGLEC10 sialic acid binding Ig-like lectin 10 19q13.41 mucocele of salivary gland
SIGLEC5 sialic acid binding Ig-like lectin 5 19q13.41 obesity
SIGLEC6 sialic acid binding Ig-like lectin 6 19q13.41 obesity
SIGLEC7 sialic acid binding Ig-like lectin 7 19q13.41 hiv-1, pheochromocytoma, miller fisher syndrome
SIGMAR1 sigma non-opioid intracellular receptor 1 9p13.3 amyotrophic lateral sclerosis, lateral sclerosis, blue cone monochromacy ,
SIKE1 suppressor of IKBKE 1 1p13.2 cavernous malformation cerebral cavernous malformation
SIL1 SIL1 nucleotide exchange factor 5q31.2 sjogrens syndrome, agoraphobia, dysphagia
SIM1 single-minded family bHLH transcription factor 1 6q16.3 morbid obesity, obesity, down syndrome,
SIM2 single-minded family bHLH transcription factor 2 21q22.13 down syndrome
SIPA1 signal-induced proliferation-associated 1 11q13.1 juvenile myelomonocytic leukemia sporadic breast cancer
SIPA1L1 signal-induced proliferation-associated 1 like 1 14q24.2 papilloma
SIRPA signal-regulatory protein alpha 20p13 vertebrobasilar insufficiency
SIRPB1 signal-regulatory protein beta 1 20p13 composite lymphoma
SIRT1 sirtuin 1 10q21.3 aortic valve disease "xeroderma pigmentosum, group d"
SIRT3 sirtuin 3 11p15.5 uterine fibroid
SIX1 SIX homeobox 1 14q23.1 branchiootorenal syndrome, "deafness, autosomal dominant 4b", mitral valve insufficiency,
SIX2 SIX homeobox 2 2p21 microtia
SIX3 SIX homeobox 3 2p21 moyamoya disease, septopreoptic holoprosencephaly, midline interhemispheric variant of holoprosencephaly,
SIX5 SIX homeobox 5 19q13.32 branchiootorenal syndrome, myotonic dystrophy, congenital myotonic dystrophy,
SIX6 SIX homeobox 6 14q23.1 anophthalmia/microphthalmia, microphthalmia, branchiootorenal syndrome,
SKA1 spindle and kinetochore associated complex subunit 1 18q21.1 acute poststreptococcal glomerulonephritis
SKA2 spindle and kinetochore associated complex subunit 2 17q22 acute poststreptococcal glomerulonephritis impetigo
SKA3 spindle and kinetochore associated complex subunit 3 13q12.11 acute poststreptococcal glomerulonephritis
SKAP2 src kinase associated phosphoprotein 2 7p15.2 oral candidiasis, candida glabrata, vulvovaginal candidiasis
SKCG-1 sporadic kidney cancer gene 1 11q22.3 kidney cancer
SKI v-ski avian sarcoma viral oncogene homolog 1p36.33 sarcoma, anophthalmia/microphthalmia, opisthorchiasis,
SKIV2L superkiller viralicidic activity 2-like (S. cerevisiae) 6p21.33 syndromic diarrhea, trichohepatoenteric syndrome 2 trichohepatoenteric syndrome 1
SKP1 S-phase kinase-associated protein 1 5q31.1 coffin-lowry syndrome, retinoschisis, glomuvenous malformation,
SLA Src-like-adaptor 8q24.22 pontocerebellar hypoplasia type 2d
SLA2 Src-like-adaptor 2 20q11.23 blastomycosis
SLAMF1 signaling lymphocytic activation molecule family member 1 1q23.3 measles
SLAMF6 SLAM family member 6 1q23.2 griscelli syndrome leukocyte adhesion deficiency
SLBP stem-loop binding protein 4p16.3 wolf-hirschhorn syndrome
SLC10A1 solute carrier family 10 (sodium/bile acid cotransporter), member 1 14q24.2 primary biliary cirrhosis, hepatoblastoma, biliary atresia
SLC10A2 solute carrier family 10 (sodium/bile acid cotransporter), member 2 13q33.1 familial colorectal cancer, biliary atresia, "bile acid malabsorption, primary",
SLC11A1 solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 2q35 q fever, rheumatoid arthritis, malaria,
SLC11A2 solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 12q13.12 microcytic anemia, hypochromic microcytic anemia with iron overload, hypochromic microcytic anemia,
SLC12A1 solute carrier family 12 (sodium/potassium/chloride transporter), member 1 15q21.1 polyhydramnios, gitelman syndrome, hypokalemia,
SLC12A2 solute carrier family 12 (sodium/potassium/chloride transporter), member 2 5q23.3 hypothalamic hamartomas, arachnoid cysts bartter disease
SLC12A3 solute carrier family 12 (sodium/chloride transporter), member 3 16q13 hypokalemic periodic paralysis, pseudohypoaldosteronism type ii, pendred syndrome,
SLC12A5 solute carrier family 12 (potassium/chloride transporter), member 5 20q13.12 gitelman syndrome hypothalamic hamartomas
SLC12A6 solute carrier family 12 (potassium/chloride transporter), member 6 15q14 neuropathy, hereditary motor and sensory neuropathy with agenesis of the corpus callosum, peripheral neuropathy
SLC12A8 solute carrier family 12, member 8 3q21.2 psoriasis gitelman syndrome
SLC12A9 solute carrier family 12, member 9 7q22.1 gitelman syndrome
SLC13A1 solute carrier family 13 (sodium/sulfate symporter), member 1 7q31.32 primary hyperoxaluria
SLC13A2 solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 17q11.2 metabolic acidosis
SLC13A3 solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 20q13.12 axenfeld-rieger syndrome
SLC14A1 solute carrier family 14 (urea transporter), member 1 (Kidd blood group) 18q12.3 bladder cancer susceptibility
SLC15A4 solute carrier family 15 (oligopeptide transporter), member 4 12q24.33 cri-du-chat syndrome
SLC16A1 solute carrier family 16 (monocarboxylate transporter), member 1 1p13.2 alveolar soft part sarcoma, erythrocyte lactate transporter defect exercise-induced hyperinsulinemic hypoglycemia
SLC16A10 solute carrier family 16 (aromatic amino acid transporter), member 10 6q21 allan-herndon-dudley syndrome
SLC16A12 solute carrier family 16, member 12 10q23.31 "cataract, juvenile, with microcornea and glucosuria"
SLC16A2 solute carrier family 16, member 2 (thyroid hormone transporter) Xq13.2 paroxysmal dyskinesia, x-linked disease, allan-herndon-dudley syndrome,
SLC16A6 solute carrier family 16, member 6 17q24.2 breast cancer
SLC16A7 solute carrier family 16 (monocarboxylate transporter), member 7 12q14.1 colorectal cancer
SLC17A1 solute carrier family 17 (organic anion transporter), member 1 6p22.2 cardiovascular disease risk factor
SLC17A2 solute carrier family 17, member 2 6p22.2 "hypophosphatemic nephrolithiasis/osteoporosis, 1" fanconi renotubular syndrome 2
SLC17A3 solute carrier family 17 (organic anion transporter), member 3 6p22.2 gout gout susceptibility 4
SLC17A5 solute carrier family 17 (acidic sugar transporter), member 5 6q13 pre-eclampsia, primary biliary cirrhosis, subcutaneous panniculitis-like t-cell lymphoma,
SLC17A6 solute carrier family 17 (vesicular glutamate transporter), member 6 11p14.3 schizophrenia, gnathodiaphyseal dysplasia tendinosis
SLC17A7 solute carrier family 17 (vesicular glutamate transporter), member 7 19q13.33 schizophrenia
SLC17A8 solute carrier family 17 (vesicular glutamate transporter), member 8 12q23.1 dfna25 nonsyndromic hearing loss and deafness, "deafness, autosomal dominant 25", central retinal artery occlusion,
SLC18A2 solute carrier family 18 (vesicular monoamine transporter), member 2 10q25.3 parkinsons disease, brain dopamine-serotonin vesicular transport disease, cocaine dependence,
SLC18A3 solute carrier family 18 (vesicular acetylcholine transporter), member 3 10q11.23 amyotrophic lateral sclerosis, alzheimers disease, tendinosis,
SLC19A1 solute carrier family 19 (folate transporter), member 1 21q22.3 choriocarcinoma, neural tube defects, basal ganglia disease,
SLC19A2 solute carrier family 19 (thiamine transporter), member 2 1q24.2 diabetes mellitus, aspartylglucosaminuria, basal ganglia disease,
SLC19A3 solute carrier family 19 (thiamine transporter), member 3 2q36.3 basal ganglia disease, biotin-responsive basal ganglia disease, biotin deficiency,
SLC1A1 solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 9p24.2 ischemia, schizophrenia, traumatic brain injury,
SLC1A2 solute carrier family 1 (glial high affinity glutamate transporter), member 2 11p13 amyotrophic lateral sclerosis, ischemia, schizophrenia,
SLC1A3 solute carrier family 1 (glial high affinity glutamate transporter), member 3 5p13.2 amyotrophic lateral sclerosis, ischemia, schizophrenia,
SLC1A4 solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 2p14 schizophrenia, cystinuria hartnup disease
SLC1A5 solute carrier family 1 (neutral amino acid transporter), member 5 19q13.32 cystinuria, hartnup disease pellagra
SLC1A6 solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 19p13.12 ischemia, schizophrenia, traumatic brain injury,
SLC1A7 solute carrier family 1 (glutamate transporter), member 7 1p32.3 ischemia, schizophrenia, traumatic brain injury
SLC20A1 solute carrier family 20 (phosphate transporter), member 1 2q13 leukemia, isolated growth hormone deficiency aortic valve disease
SLC20A2 solute carrier family 20 (phosphate transporter), member 2 8p11.21 arterial calcification of infancy, leukemia, familial idiopathic basal ganglia calcification,
SLC22A1 solute carrier family 22 (organic cation transporter), member 1 6q25.3 chronic myeloid leukemia
SLC22A11 solute carrier family 22 (organic anion/urate transporter), member 11 11q13.1 cardiovascular disease risk factor
SLC22A12 solute carrier family 22 (organic anion/urate transporter), member 12 11q13.1 renal hypouricemia, renal hypouricemia 1, gout
SLC22A18 solute carrier family 22, member 18 11p15.4 breast cancer, non-small cell lung carcinoma, beckwith-wiedemann syndrome,
SLC22A18AS solute carrier family 22 (organic cation transporter), member 18 antisense 11p15.4 beckwith-wiedemann syndrome
SLC22A2 solute carrier family 22 (organic cation transporter), member 2 6q25.3 choriocarcinoma
SLC22A4 solute carrier family 22 (organic cation/zwitterion transporter), member 4 5q31.1 rheumatoid arthritis
SLC22A5 solute carrier family 22 (organic cation/carnitine transporter), member 5 5q31.1 glycogen storage disease iiib , crohns disease, hypoglycemia,
SLC22A6 solute carrier family 22 (organic anion transporter), member 6 11q12.3 bipolar i disorder
SLC22A7 solute carrier family 22 (organic anion transporter), member 7 6p21.1 citrullinemia citrin deficiency
SLC24A1 solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 15q22.31 "night blindness, congenital stationary , 1d, autosomal recessive", blindness, "congenital stationary night blindness, type 1d"
SLC24A2 solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 9p22.1 brain injury
SLC24A4 solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 14q32.12 "amelogenesis imperfecta, type ia5" "amelogenesis imperfecta, type iii"
SLC24A5 solute carrier family 24 (sodium/potassium/calcium exchanger), member 5 15q21.1 "albinism, oculocutaneous, type vi", oculocutaneous albinism, patent ductus arteriosus
SLC25A1 solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 22q11.21 velocardiofacial syndrome, combined d-2- and l-2-hydroxyglutaric aciduria , l-2-hydroxyglutaric aciduria,
SLC25A12 solute carrier family 25 (aspartate/glutamate carrier), member 12 2q31.1 global cerebral hypomyelination
SLC25A13 solute carrier family 25 (aspartate/glutamate carrier), member 13 7q21.3 citrullinemia, citrin deficiency, adult-onset citrullinemia type ii,
SLC25A14 solute carrier family 25 (mitochondrial carrier, brain), member 14 Xq26.1 congenital nystagmus
SLC25A15 solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 13q14.11 urea cycle disorder, ornithine translocase deficiency gyrate atrophy
SLC25A16 solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16 10q21.3 graves disease, sphenoid sinusitis, subclavian artery aneurysm
SLC25A17 solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17 22q13.2 adrenomyeloneuropathy, rhizomelic chondrodysplasia punctata, peroxisomal disease
SLC25A18 solute carrier family 25 (glutamate carrier), member 18 22q11.21 cat eye syndrome
SLC25A19 solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 17q25.1 amish lethal microcephaly, thiamine metabolism dysfunction syndrome 4, detrusor sphincter dyssynergia,
SLC25A2 solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2 5q31.3 urea cycle disorder ornithine translocase deficiency
SLC25A20 solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 3p21.31 sudden infant death syndrome, fatty acid oxidation disorders, carnitine-acylcarnitine translocase deficiency,
SLC25A22 solute carrier family 25 (mitochondrial carrier: glutamate), member 22 11p15.5 "epileptic encephalopathy, early infantile, 17", infantile epileptic encephalopathy, ohtahara syndrome,
SLC25A28 solute carrier family 25 (mitochondrial iron transporter), member 28 10q24.2 hypochromic anemia
SLC25A29 solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 14q32.2 ornithine translocase deficiency
SLC25A3 solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 12q23.1 mitochondrial phosphate carrier deficiency
SLC25A37 solute carrier family 25 (mitochondrial iron transporter), member 37 8p21.2 erythropoietic protoporphyria
SLC25A38 solute carrier family 25, member 38 3p22.1 pearson syndrome, aspartylglucosaminuria, pyridoxine-refractory autosomal recessive sideroblastic anemia
SLC25A4 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 4q35.1 ophthalmoplegia, cataract and cardiomyopathy, "progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 2",
SLC25A43 solute carrier family 25, member 43 Xq24 pagets disease of bone
SLC25A47 solute carrier family 25, member 47 14q32.2 hepatocellular carcinoma
SLC25A6 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 Xp22.33 autosomal dominant progressive external ophthalmoplegia
SLC26A1 solute carrier family 26 (anion exchanger), member 1 4p16.3 primary hyperoxaluria, renal tubular acidosis, mucopolysaccharidoses,
SLC26A10 solute carrier family 26, member 10 12q13.3 primary hyperoxaluria
SLC26A2 solute carrier family 26 (anion exchanger), member 2 5q32 achondrogenesis type ia, achondrogenesis, osteochondrodysplasia,
SLC26A3 solute carrier family 26 (anion exchanger), member 3 7q31.1 polyhydramnios, diarrhea, pendred syndrome,
SLC26A4 solute carrier family 26 (anion exchanger), member 4 7q22.3 "deafness, autosomal recessive 76", follicular thyroid carcinoma, pendred syndrome,
SLC26A5 solute carrier family 26 (anion exchanger), member 5 7q22.1 achondrogenesis, "deafness, autosomal recessive 76", pendred syndrome,
SLC26A6 solute carrier family 26 (anion exchanger), member 6 3p21.31 primary hyperparathyroidism, primary hyperoxaluria acute urate nephropathy
SLC26A8 solute carrier family 26 (anion exchanger), member 8 6p21.31 spermatogenic failure 3 spermatogenic failure
SLC26A9 solute carrier family 26 (anion exchanger), member 9 1q32.1 ileus meconium ileus
SLC27A1 solute carrier family 27 (fatty acid transporter), member 1 19p13.11 insulin resistance, ichthyosis prematurity syndrome wrinkles
SLC27A4 solute carrier family 27 (fatty acid transporter), member 4 9q34.11 insulin resistance, ichthyosis prematurity syndrome, wrinkles,
SLC29A1 solute carrier family 29 (equilibrative nucleoside transporter), member 1 6p21.1 colorectal cancer, pancreatic cancer pancreas adenocarcinoma
SLC29A2 solute carrier family 29 (equilibrative nucleoside transporter), member 2 11q13.2 b-cell chronic lymphocytic leukemia hyperglycemia
SLC29A3 solute carrier family 29 (equilibrative nucleoside transporter), member 3 10q22.1 familial sinus histiocytosis with massive lymphadenopathy, hypertrichosis, histiocytosis-lymphadenopathy plus syndrome ,
SLC29A4 solute carrier family 29 (equilibrative nucleoside transporter), member 4 7p22.1 desmoplastic small round cell tumor
SLC2A1 solute carrier family 2 (facilitated glucose transporter), member 1 1p34.2 thymic epithelial neoplasm, paroxysmal dyskinesia, spasticity,
SLC2A10 solute carrier family 2 (facilitated glucose transporter), member 10 20q13.12 arterial tortuosity syndrome loeys-dietz syndrome
SLC2A2 solute carrier family 2 (facilitated glucose transporter), member 2 3q26.2 diabetes mellitus, "diabetes mellitus, noninsulin-dependent", fanconi syndrome,
SLC2A3 solute carrier family 2 (facilitated glucose transporter), member 3 12p13.31 huntingtons disease fetal macrosomia
SLC2A4 solute carrier family 2 (facilitated glucose transporter), member 4 17p13.1 type 2 diabetes mellitus, insulin resistance, diabetes mellitus,
SLC2A4RG SLC2A4 regulator 20q13.33 huntingtons disease
SLC2A6 solute carrier family 2 (facilitated glucose transporter), member 6 9q34.2 testis seminoma
SLC2A9 solute carrier family 2 (facilitated glucose transporter), member 9 4p16.1 renal hypouricemia 2, "uric acid concentration, serum, qtl 2" renal hypouricemia
SLC30A10 solute carrier family 30, member 10 1q41 hypermanganesemia with dystonia polycythemia and cirrhosis, "dystonia/parkinsonism, hypermanganesemia, polycythemia, and chronic liver disease", polycythemia
SLC30A2 solute carrier family 30 (zinc transporter), member 2 1p36.11 "zinc deficiency, transient neonatal"
SLC30A4 solute carrier family 30 (zinc transporter), member 4 15q21.1 acrodermatitis enteropathica, acrodermatitis, enteropathica
SLC30A5 solute carrier family 30 (zinc transporter), member 5 5q13.1 acrodermatitis enteropathica, acrodermatitis enteropathica
SLC30A8 solute carrier family 30 (zinc transporter), member 8 8q24.11 diabetes mellitus "diabetes mellitus, noninsulin-dependent"
SLC31A1 solute carrier family 31 (copper transporter), member 1 9q32 wilson disease ethylmalonic encephalopathy
SLC33A1 solute carrier family 33 (acetyl-CoA transporter), member 1 3q25.31 amyotrophic lateral sclerosis, "congenital cataracts, hearing loss, and neurodegeneration", spastic paraplegia 42
SLC34A1 solute carrier family 34 (type II sodium/phosphate contransporter), member 1 5q35.3 hyperphosphatemia, hypophosphatemia, hereditary hypophosphatemic rickets,
SLC34A2 solute carrier family 34 (type II sodium/phosphate contransporter), member 2 4p15.2 testicular microlithiasis pulmonary alveolar microlithiasis
SLC34A3 solute carrier family 34 (type II sodium/phosphate contransporter), member 3 9q34.3 hypophosphatemia, hereditary hypophosphatemic rickets, hypophosphatemic rickets with hypercalciuria,
SLC35A1 solute carrier family 35 (CMP-sialic acid transporter), member A1 6q15 "congenital disorder of glycosylation, type iif" sialuria
SLC35A2 solute carrier family 35 (UDP-galactose transporter), member A2 Xp11.23 kernicterus, urogenital tuberculosis, hepatitis d,
SLC35A3 solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 1p21.2 "arthrogryposis, mental retardation, and seizures"
SLC35B2 solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B2 6p21.1 pulmonary valve stenosis dextrocardia
SLC35C1 solute carrier family 35 (GDP-fucose transporter), member C1 11p11.2 leukocyte adhesion deficiency, congenital disorder of glycosylation type 2c congenital disorder of glycosylation
SLC35C2 solute carrier family 35 (GDP-fucose transporter), member C2 20q13.12 ovarian cancer
SLC35D1 solute carrier family 35 (UDP-GlcA/UDP-GalNAc transporter), member D1 1p31.3 schneckenbecken dysplasia
SLC35D3 solute carrier family 35, member D3 6q23.3 chediak-higashi syndrome
SLC35F5 solute carrier family 35, member F5 2q14.1 hepatitis c hepatitis c virus
SLC35F6 solute carrier family 35, member F6 2p23.3 pancreatic ductal adenocarcinoma
SLC35G3 solute carrier family 35, member G3 17q12 keratolytic winter erythema
SLC35G5 solute carrier family 35, member G5 8p23.1 keratolytic winter erythema
SLC35G6 solute carrier family 35, member G6 17p13.1 sporadic breast cancer
SLC36A1 solute carrier family 36 (proton/amino acid symporter), member 1 5q33.1 hartnup disease, allan-herndon-dudley syndrome iminoglycinuria
SLC36A2 solute carrier family 36 (proton/amino acid symporter), member 2 5q33.1 iminoglycinuria, hyperglycinuria "iminoglycinuria, digenic"
SLC37A1 solute carrier family 37 (glucose-6-phosphate transporter), member 1 21q22.3 hereditary folate malabsorption
SLC37A4 solute carrier family 37 (glucose-6-phosphate transporter), member 4 11q23.3 glycogen storage disease, juvenile hereditary hemochromatosis, glycogen storage disease i,
SLC38A2 solute carrier family 38, member 2 12q13.11 adult syndrome
SLC38A4 solute carrier family 38, member 4 12q13.11 tricuspid valve insufficiency
SLC38A8 solute carrier family 38, member 8 16q23.3 "foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis" foveal hypoplasia
SLC39A1 solute carrier family 39 (zinc transporter), member 1 1q21.3 prostate cancer, breast cancer, acrodermatitis enteropathica,
SLC39A13 solute carrier family 39 (zinc transporter), member 13 11p11.2 tricuspid valve insufficiency "spondylocheirodysplasia, ehlers-danlos syndrome-like"
SLC39A2 solute carrier family 39 (zinc transporter), member 2 14q11.2 lung cancer, artery disease lung cancer susceptibility
SLC39A4 solute carrier family 39 (zinc transporter), member 4 8q24.3 mitochondrial complex iii deficiency, acrodermatitis enteropathica, acrodermatitis
SLC39A5 solute carrier family 39 (zinc transporter), member 5 12q13.3 acrodermatitis enteropathica, acrodermatitis enteropathica
SLC3A1 solute carrier family 3 (amino acid transporter heavy chain), member 1 2p21 lysinuric protein intolerance, cystinuria, 2p21 microdeletion syndrome,
SLC3A2 solute carrier family 3 (amino acid transporter heavy chain), member 2 11q12.3 lysinuric protein intolerance, cystinuria, halo nevi
SLC40A1 solute carrier family 40 (iron-regulated transporter), member 1 2q32.2 hemochromatosis, hemochromatosis type 4, slc40a1-related hereditary hemochromatosis,
SLC43A1 solute carrier family 43 (amino acid system L transporter), member 1 11q12.1 prostate cancer encephalomalacia
SLC44A3 solute carrier family 44, member 3 1p21.3 cystinuria
SLC45A1 solute carrier family 45, member 1 1p36.23 neuroblastoma neuroblastoma 5
SLC45A2 solute carrier family 45, member 2 5p13.2 melanoma, oculocutaneous albinism, albinism,
SLC45A3 solute carrier family 45, member 3 1q32.1 prostate cancer, bladder adenocarcinoma, ovarian mucinous adenocarcinoma
SLC46A1 solute carrier family 46 (folate transporter), member 1 17q11.2 folic acid deficiency anemia, hereditary folate malabsorption, basal ganglia disease
SLC4A1 solute carrier family 4 (anion exchanger), member 1 (Diego blood group) 17q21.31 malaria, pendred syndrome, oral candidiasis,
SLC4A10 solute carrier family 4, sodium bicarbonate transporter, member 10 2q24.2 complex partial epilepsy
SLC4A11 solute carrier family 4, sodium borate transporter, member 11 20p13 corneal dystrophy fuchs endothelial 1, corneal endothelial dystrophy and perceptive deafness , "corneal dystrophy, fuchs endothelial, 4",
SLC4A1AP solute carrier family 4 (anion exchanger), member 1, adaptor protein 2p23.3 lung cancer
SLC4A2 solute carrier family 4 (anion exchanger), member 2 7q36.1 primary biliary cirrhosis hereditary elliptocytosis
SLC4A3 solute carrier family 4 (anion exchanger), member 3 2q35 thymoma epithelial malignant thymoma
SLC4A4 solute carrier family 4 (sodium bicarbonate cotransporter), member 4 4q13.3 cystic fibrosis, renal tubular acidosis, transvestism,
SLC4A5 solute carrier family 4 (sodium bicarbonate cotransporter), member 5 2p13.1 proximal renal tubular acidosis with ocular abnormalities alstrom syndrome
SLC4A7 solute carrier family 4, sodium bicarbonate cotransporter, member 7 3p24.1 breast cancer susceptibility
SLC51B solute carrier family 51, beta subunit 15q22.31 extrahepatic cholestasis
SLC52A1 solute carrier family 52 (riboflavin transporter), member 1 17p13.2 "pituitary hormone deficiency, combined, 6" riboflavin deficiency
SLC52A2 solute carrier family 52 (riboflavin transporter), member 2 8q24.3 hypotonia, brown-vialetto-van laere syndrome 2 , brown-vialetto-van laere syndrome
SLC52A3 solute carrier family 52 (riboflavin transporter), member 3 20p13 malaria, brown-vialetto-van laere syndrome, brown-vialetto-van laere syndrome 1,
SLC5A1 solute carrier family 5 (sodium/glucose cotransporter), member 1 22q12.3 hartnup disease, glucose-galactose malabsorption renal glycosuria
SLC5A2 solute carrier family 5 (sodium/glucose cotransporter), member 2 16p11.2 type 2 diabetes mellitus, aminoaciduria, renal glycosuria,
SLC5A5 solute carrier family 5 (sodium/iodide cotransporter), member 5 19p13.11 follicular thyroid carcinoma, rapsn-related congenital myasthenic syndrome, neonatal hypothyroidism,
SLC5A6 solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 2p23.3 basal ganglia disease, biotin-responsive basal ganglia disease, urinary tract obstruction
SLC5A7 solute carrier family 5 (sodium/choline cotransporter), member 7 2q12.3 "neuronopathy, distal hereditary motor, type viia"
SLC6A1 solute carrier family 6 (neurotransmitter transporter), member 1 3p25.3 schizophrenia female stress incontinence
SLC6A11 solute carrier family 6 (neurotransmitter transporter), member 11 3p25.3 schizophrenia, pulmonary valve insufficiency meconium aspiration syndrome
SLC6A12 solute carrier family 6 (neurotransmitter transporter), member 12 12p13.33 schizophrenia
SLC6A13 solute carrier family 6 (neurotransmitter transporter), member 13 12p13.33 schizophrenia
SLC6A14 solute carrier family 6 (amino acid transporter), member 14 Xq23 autism spectrum disorder, obesity, ileus,
SLC6A18 solute carrier family 6 (neutral amino acid transporter), member 18 5p15.33 iminoglycinuria, hyperglycinuria "iminoglycinuria, digenic"
SLC6A19 solute carrier family 6 (neutral amino acid transporter), member 19 5p15.33 placental choriocarcinoma, aminoaciduria, hartnup disease,
SLC6A2 solute carrier family 6 (neurotransmitter transporter), member 2 16q12.2 mitral valve prolapse, anorexia nervosa, substance abuse,
SLC6A20 solute carrier family 6 (proline IMINO transporter), member 20 3p21.31 hartnup disease, iminoglycinuria, hyperglycinuria ,
SLC6A3 solute carrier family 6 (neurotransmitter transporter), member 3 5p15.33 lesch-nyhan syndrome, parkinsons disease, metachromatic leukodystrophy ,
SLC6A4 solute carrier family 6 (neurotransmitter transporter), member 4 17q11.2 primary pulmonary hypertension, coronary thrombosis, metachromatic leukodystrophy ,
SLC6A5 solute carrier family 6 (neurotransmitter transporter), member 5 11p15.1 hyperekplexia, gnathodiaphyseal dysplasia, hyperekplexia 3 ,
SLC6A6 solute carrier family 6 (neurotransmitter transporter), member 6 3p25.1 myofascial pain syndrome
SLC6A8 solute carrier family 6 (neurotransmitter transporter), member 8 Xq28 ornithine translocase deficiency, creatine deficiency syndromes, creatine transporter deficiency,
SLC6A9 solute carrier family 6 (neurotransmitter transporter, glycine), member 9 1p34.1 schizophrenia
SLC7A10 solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 19q13.11 cystinuria
SLC7A11 solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 4q28.3 kaposis sarcoma, cystinuria dyscalculia
SLC7A14 solute carrier family 7, member 14 3q26.2 leber congenital amaurosis, cystinuria retinitis pigmentosa 68
SLC7A2 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 8p22 lysinuric protein intolerance
SLC7A3 solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 Xq13.1 allan-herndon-dudley syndrome
SLC7A4 solute carrier family 7, member 4 22q11.21 b-cell chronic lymphocytic leukemia chronic lymphocytic leukemia
SLC7A5 solute carrier family 7 (amino acid transporter light chain, L system), member 5 16q24.2 bladder carcinoma lysinuric protein intolerance
SLC7A5P2 solute carrier family 7 (amino acid transporter light chain, L system), member 5 pseudogene 2 16p12.2 histidinemia
SLC7A6 solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 16q22.1 lysinuric protein intolerance
SLC7A7 solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 14q11.2 lysinuric protein intolerance, cystinuria fanconi syndrome
SLC7A8 solute carrier family 7 (amino acid transporter light chain, L system), member 8 14q11.2 lysinuric protein intolerance cystinuria
SLC7A9 solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 19q13.11 cystinuria aminoaciduria
SLC8A1 solute carrier family 8 (sodium/calcium exchanger), member 1 2p22.1 aromatase deficiency
SLC9A1 solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 1p36.11 essential hypertension myocardial stunning
SLC9A3 solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 5p15.33 meconium ileus
SLC9A3R1 solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 17q25.1 breast cancer, osteoporosis, cystic fibrosis,
SLC9A3R2 solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 16p13.3 cystic fibrosis, myocardial stunning secretory diarrhea
SLC9A5 solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 16q22.1 familial paroxysmal kinesigenic dyskinesia
SLC9A6 solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 Xq26.3 slc9a6-related syndromic mental retardation christianson syndrome
SLC9A9 solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9 3q24 ornithine carbamoyltransferase deficiency, attention deficit hyperactivity disorder autism susceptibility 16
SLCO1A2 solute carrier organic anion transporter family, member 1A2 12p12.1 aneurysmal bone cysts
SLCO1B1 solute carrier organic anion transporter family, member 1B1 12p12.2 "hyperbilirubinemia, rotor type, digenic" rotor syndrome
SLCO1B3 solute carrier organic anion transporter family, member 1B3 12p12.2 "hyperbilirubinemia, rotor type, digenic" rotor syndrome
SLCO1C1 solute carrier organic anion transporter family, member 1C1 12p12.2 hyperthyroidism
SLCO2A1 solute carrier organic anion transporter family, member 2A1 3q22.2 secondary hypertrophic osteoarthropathy, "hypertrophic osteoarthropathy, primary, autosomal recessive 2", primary hypertrophic osteoarthropathy
SLCO3A1 solute carrier organic anion transporter family, member 3A1 15q26.1 aneurysmal bone cysts
SLCO4A1 solute carrier organic anion transporter family, member 4A1 20q13.33 aneurysmal bone cysts mucinous cystadenocarcinoma
SLCO4C1 solute carrier organic anion transporter family, member 4C1 5q21.1 eastern equine encephalitis
SLCO5A1 solute carrier organic anion transporter family, member 5A1 8q13.3 mesomelia-synostoses syndrome mesomelia
SLEB1 systemic lupus erythematosus susceptibility 1 1q41-q42 systemic lupus erythematosus, lupus erythematosus, legionaire disease,
SLEB12 Systemic lupus erythematosus, susceptibility to, 12 8p23.1 systemic lupus erythematosus, lupus erythematosus systemic lupus erythematosus 12
SLEB13 Systemic lupus erythematosus, susceptibility to, 13 6q23 systemic lupus erythematosus, lupus erythematosus systemic lupus erythematosus 13
SLEB14 Systemic lupus erythematosus, susceptiblity to, 14 1q21-q23 systemic lupus erythematosus, lupus erythematosus systemic lupus erythematosus 14
SLEB15 Systemic lupus erthematosus, susceptibility to, 15 Xq28 systemic lupus erthematosus 15
SLEB3 systemic lupus erythematosus susceptibility 3 4p16-p15.2 systemic lupus erythematosus, lupus erythematosus systemic lupus erythematosus 3
SLEB4 systemic lupus erythematosus, susceptibility to, 4 12q24 systemic lupus erythematosus, lupus erythematosus systemic lupus erythematosus 4
SLEB5 Systemic lupus erythematosus, susceptibility to, 5 13q32 systemic lupus erythematosus, lupus erythematosus systemic lupus erythematosus 5
SLEB7 Systemic lupus erythematosus, susceptibility to, 7 20p12 systemic lupus erythematosus, lupus erythematosus systemic lupus erythematosus 7
SLEB8 Systemic lupus erythematosus, susceptibility to, 8 20q13 systemic lupus erythematosus systemic lupus erythematosus 8
SLED1 proteoglycan 3 pseudogene 4q35.1 systemic lupus erythematosus
SLEH1 systemic lupus erythematosus with hemolytic anemia 1 11q14 systemic lupus erythematosus, lupus erythematosus systemic lupus erythematosus with hemolytic anemia
SLEN1 systemic lupus erythematosus with nephritis 1 10q22.3 systemic lupus erythematosus, lupus erythematosus systemic lupus erythematosus with nephritis 1
SLEN2 systemic lupus erythematosus with nephritis 2 2q34-q35 systemic lupus erythematosus, nephritis, lupus erythematosus
SLEN3 systemic lupus erythematosus with nephritis 3 11p15.5 systemic lupus erythematosus, lupus erythematosus systemic lupus erythematosus with nephritis 3
SLI1 Specific language impairment QTL, 1 16q "specific language impairment qtl, 1"
SLI2 Specific language impairment QTL, 2 19q "specific language impairment qtl, 2"
SLI3 Specific language impairment QTL, 3 13q21 "specific language impairment qtl, 3"
SLI4 Specific language impairment 4 7q35-q36 specific language impairment 4
SLITRK1 SLIT and NTRK-like family, member 1 13q31.1 trichotillomania , kleptomania, body dysmorphic disorder,
SLITRK2 SLIT and NTRK-like family, member 2 Xq27.3 autism spectrum disorder
SLITRK6 SLIT and NTRK-like family, member 6 13q31.1 "deafness, autosomal recessive 76", auditory neuropathy, deafness and myopia
SLPI secretory leukocyte peptidase inhibitor 20q13.12 osteoporosis, cystic fibrosis, oral candidiasis,
SLSN3 Senior-Loken syndrome 3 3q22 senior-loken syndrome 3 senior-loken syndrome
SLURP1 secreted LY6/PLAUR domain containing 1 8q24.3 hydranencephaly, meleda disease , palmoplantar keratosis
SLX4 SLX4 structure-specific endonuclease subunit 16p13.3 slx4-related fanconi anemia, "fanconi anemia, complementation group p", "fanconi anemia, complementation group c"
SM1 Schistosoma mansoni, susceptibility/resistance to 5q31-q33 "schistosoma mansoni infection, susceptibility/"
SM2 Hepatic fibrosis susceptibility due to Schistosoma mansoni infection 6q22-q23 hepatic fibrosis susceptibility due to schistosoma mansoni infection
SMA4 glucuronidase, beta pseudogene 5q13.2 adult spinal muscular atrophy, spinal muscular atrophy 1, juvenile spinal muscular atrophy
SMAD1 SMAD family member 1 4q31.21 melorheostosis, sc phocomelia syndrome, phocomelia,
SMAD2 SMAD family member 2 18q21.1 colorectal cancer, melorheostosis, nephrogenic systemic fibrosis,
SMAD3 SMAD family member 3 15q22.33 colorectal cancer, anisakiasis, loeys-dietz syndrome,
SMAD4 SMAD family member 4 18q21.2 colorectal cancer, prostate cancer, pancreatic cancer,
SMAD6 SMAD family member 6 15q22.31 aortic valve disease aortic valve disease 2
SMAD7 SMAD family member 7 18q21.1 colorectal cancer, pernicious anemia, localized scleroderma
SMAD9 SMAD family member 9 13q13.3 acinar cell carcinoma, heritable pulmonary arterial hypertension, smad9-related heritable pulmonary arterial hypertension
SMAJ Spinal muscular atrophy, Jokela type 22q11.2-q13.2 "spinal muscular atrophy, jokela type"
SMAL spinal muscular atrophy, congenital nonprogressive, of lower limbs muscular atrophy, charcot-marie-tooth disease type 2c, distal congenital nonprogressive spinal muscular atrophy,
SMAP2 small ArfGAP2 1p34.2 "dentin dysplasia, type i, with microdontia and misshapen teeth"
SMAR Spinal muscular atrophy, chronic distal, autosomal recessive 11q13 "spinal muscular atrophy, chronic distal, autosomal recessive"
SMARCA1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 Xq25 alpha thalassemia
SMARCA2 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 9p24.3 nicolaides baraitser syndrome alpha thalassemia
SMARCA4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 19p13.2 coffin-siris syndrome, alpha thalassemia, bacteremia,
SMARCA5 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 4q31.21 extraskeletal ewing sarcoma
SMARCAD1 SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 4q22.3 adermatoglyphia
SMARCAL1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1 2q35 t cell deficiency schimke immunoosseous dysplasia
SMARCB1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 22q11.23 coffin-siris syndrome, hiv-1, meningioma,
SMARCD1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 12q13.12 triple-a syndrome
SMARCD2 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 17q23.3 triple-a syndrome
SMARCE1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 17q21.2 coffin-siris syndrome, meningioma, spinal meningioma,
SMC1A structural maintenance of chromosomes 1A Xp11.22 cornelia de lange syndrome 1 , cornelia de lange syndrome, sc phocomelia syndrome,
SMC2 structural maintenance of chromosomes 2 9q31.1 smith-mccort dysplasia 2
SMC3 structural maintenance of chromosomes 3 10q25.2 cornelia de lange syndrome 1 , cornelia de lange syndrome, sc phocomelia syndrome,
SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 18p11.32 facioscapulohumeral muscular dystrophy, "fascioscapulohumeral muscular dystrophy 2, digenic" facioscapulohumeral muscular dystrophy 2
SMCP sperm mitochondria-associated cysteine-rich protein 1q21.3 hard palate cancer
SMCR8 Smith-Magenis syndrome chromosome region, candidate 8 17p11.2 smith magenis syndrome
SMG1 SMG1 phosphatidylinositol 3-kinase-related kinase 16p12.3 ullrich congenital muscular dystrophy
SMG7 SMG7 nonsense mediated mRNA decay factor 1q25.3 breast cancer
SMG8 SMG8 nonsense mediated mRNA decay factor 17q22 breast cancer
SMN1 survival of motor neuron 1, telomeric 5q13.2 amyotrophic lateral sclerosis, muscular atrophy, progressive muscular atrophy,
SMN2 survival of motor neuron 2, centromeric 5q13.2 amyotrophic lateral sclerosis, muscular atrophy, progressive muscular atrophy,
SMNDC1 survival motor neuron domain containing 1 10q25.2 muscular atrophy proximal spinal muscular atrophy
SMO smoothened, frizzled class receptor 7q32.1 pancreatic cancer, basal cell carcinoma "basal cell carcinoma, somatic"
SMOC1 SPARC related modular calcium binding 1 14q24.2 microphthalmia anophthalmos with limb anomalies
SMOC2 SPARC related modular calcium binding 2 6q27 ischemia, dentin dysplasia, pulmonary function
SMPD1 sphingomyelin phosphodiesterase 1, acid lysosomal 11p15.4 mucolipidosis ii, mucolipidosis, beckwith-wiedemann syndrome,
SMPD2 sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase) 6q21 lipid storage disease
SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 16q22.1 dentinogenesis imperfecta
SMPX small muscle protein, X-linked Xp22.12 prurigo nodularis, "deafness, x-linked 6", "deafness, x-linked 1",
SMS spermine synthase Xp22.11 mental retardation, smith magenis syndrome snyder-robinson syndrome
SMUG1 single-strand-selective monofunctional uracil-DNA glycosylase 1 12q13.13 familial colorectal cancer
SMYD1 SET and MYND domain containing 1 2p11.2 axenfeld-rieger syndrome hypoplastic left heart syndrome
SNAI2 snail family zinc finger 2 8q11.21 hepatocellular carcinoma, gliosarcoma, pancreatic cancer,
SNAP23 synaptosomal-associated protein, 23kDa 15q15.1 congenital dyserythropoietic anemia type i botulism
SNAP25 synaptosomal-associated protein, 25kDa 20p12.2 attention deficit hyperactivity disorder, antisocial personality disorder botulism
SNAP29 synaptosomal-associated protein, 29kDa 22q11.21 "cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome"
SNAPIN SNAP-associated protein 1q21.3 platelet storage pool deficiency tricuspid valve stenosis
SNAX1 sensory ataxia 1 (autosomal dominant) 8p12-q12.1 posterior column ataxia "ataxia, sensory, 1, autosomal dominant"
SNCA synuclein, alpha (non A4 component of amyloid precursor) 4q22.1 amyotrophic lateral sclerosis, parkinsons disease, neuroblastoma,
SNCAIP synuclein, alpha interacting protein 5q23.2 parkinsons disease lrrk2-related parkinson disease
SNCB synuclein, beta 5q35.2 parkinsons disease, alzheimers disease, lewy body dementia,
SNCG synuclein, gamma (breast cancer-specific protein 1) 10q23.2 parkinsons disease, breast cancer, follicular dendritic cell sarcoma
SNHG12 small nucleolar RNA host gene 12 (non-protein coding) 1p35.3 mast cell neoplasm
SNHG16 small nucleolar RNA host gene 16 (non-protein coding) 17q25.1 neuroblastoma
SNIP1 Smad nuclear interacting protein 1 1p34.3 tongue squamous cell carcinoma "psychomotor retardation, epilepsy, and craniofacial dysmorphism"
SNN stannin 16p13.13 cavernous hemangioma
SNORA33 small nucleolar RNA, H/ACA box 33 6q23.2 diabetic nephropathy
SNORA34 small nucleolar RNA, H/ACA box 34 12q13.11 multiple myeloma
SNORA54 small nucleolar RNA, H/ACA box 54 11p15.4 alcohol dependence
SNORA57 small nucleolar RNA, H/ACA box 57 11q12.3 multiple myeloma
SNORA71D small nucleolar RNA, H/ACA box 71D 20q11.23 multiple myeloma
SNORD10 small nucleolar RNA, C/D box 10 17p13.1 multiple myeloma
SNORD109A small nucleolar RNA, C/D box 109A 15q11.2 prader-willi syndrome
SNORD109B small nucleolar RNA, C/D box 109B 15q11.2 prader-willi syndrome
SNORD113-6 small nucleolar RNA, C/D box 113-6 14q32.31 angelman syndrome
SNORD113@ small nucleolar RNA, C/D box 113 cluster 14q32.31 angelman syndrome
SNORD114-10 small nucleolar RNA, C/D box 114-10 14q32.31 angelman syndrome
SNORD114-11 small nucleolar RNA, C/D box 114-11 14q32.31 angelman syndrome
SNORD114-12 small nucleolar RNA, C/D box 114-12 14q32.31 angelman syndrome
SNORD114-14 small nucleolar RNA, C/D box 114-14 14q32.31 angelman syndrome
SNORD114-15 small nucleolar RNA, C/D box 114-15 14q32.31 angelman syndrome
SNORD114-8 small nucleolar RNA, C/D box 114-8 14q32 angelman syndrome
SNORD114@ small nucleolar RNA, C/D box 114 cluster 14q32.31 angelman syndrome
SNORD115-1 small nucleolar RNA, C/D box 115-1 15q11.2 angelman syndrome
SNORD115@ small nucleolar RNA, C/D box 115 cluster 15q11.2 prader-willi syndrome, prader-willi syndrome due to paternal deletion of 15q11q13 type 1 prader-willi syndrome due to imprinting mutation
SNORD116-18 small nucleolar RNA, C/D box 116-18 15q11.2 multiple myeloma
SNORD116-22 small nucleolar RNA, C/D box 116-22 15q11.2 multiple myeloma
SNORD116-24 small nucleolar RNA, C/D box 116-24 15q11.2 multiple myeloma
SNORD116-29 small nucleolar RNA, C/D box 116-29 15q11.2 multiple myeloma
SNORD116@ small nucleolar RNA, C/D box 116 cluster 15q11.2 prader-willi syndrome, prader-willi syndrome due to paternal deletion of 15q11q13 type 1, prader-willi syndrome due to imprinting mutation
SNORD19 small nucleolar RNA, C/D box 19 3p21.1 multiple myeloma
SNORD1C small nucleolar RNA, C/D box 1C 17q25.1 multiple myeloma
SNORD22 small nucleolar RNA, C/D box 22 11q12.3 b-cell lymphomas
SNORD3C small nucleolar RNA, C/D box 3C 17p11.2 multiple myeloma
SNORD48 small nucleolar RNA, C/D box 48 6p21.33 hiv-1
SNORD50A small nucleolar RNA, C/D box 50A 6q14.3 multiple myeloma b-cell lymphomas
SNORD50B small nucleolar RNA, C/D box 50B 6q14.3 multiple myeloma b-cell lymphomas
SNORD64 small nucleolar RNA, C/D box 64 15q11.2 prader-willi syndrome
SNORD88C small nucleolar RNA, C/D box 88C 19q13.33 multiple myeloma
SNORD95 small nucleolar RNA, C/D box 95 5q35.3 multiple myeloma
SNPH syntaphilin 20p13 normal pressure hydrocephalus
SNRNP200 small nuclear ribonucleoprotein 200kDa (U5) 2q11.2 leber congenital amaurosis, retinitis, retinitis pigmentosa,
SNRNP40 small nuclear ribonucleoprotein 40kDa (U5) 1p35.2 intermediate charcot-marie-tooth neuropathy
SNRPA1 small nuclear ribonucleoprotein polypeptide A' 15q26.3 pasteurellosis
SNRPB small nuclear ribonucleoprotein polypeptides B and B1 20p13 systemic lupus erythematosus
SNRPB2 small nuclear ribonucleoprotein polypeptide B 20p12.1 systemic lupus erythematosus
SNRPD1 small nuclear ribonucleoprotein D1 polypeptide 16kDa 18q11.2 phimosis neurotic disorder
SNRPE small nuclear ribonucleoprotein polypeptide E 1q32.1 hypotrichosis simplex hypotrichosis 11
SNRPN small nuclear ribonucleoprotein polypeptide N 15q11.2 angelman syndrome, autism spectrum disorder, prader-willi syndrome,
SNTA1 syntrophin, alpha 1 20q11.21 sudden infant death syndrome, long qt syndrome 1, long qt syndrome 12
SNTB1 syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1) 8q24.12 duchenne muscular dystrophy
SNTB2 syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) 16q22.1 duchenne muscular dystrophy
SNTG1 syntrophin, gamma 1 8q11.21 scrub typhus
SNTG2 syntrophin, gamma 2 2p25.3 duchenne muscular dystrophy
SNURF SNRPN upstream reading frame 15q11.2 angelman syndrome, prader-willi syndrome albrights hereditary osteodystrophy
SNW1 SNW domain containing 1 14q24.3 oculopharyngeal muscular dystrophy
SNX10 sorting nexin 10 7p15.2 "osteopetrosis, autosomal recessive 8" osteopetrosis autosomal recessive 1
SNX13 sorting nexin 13 7p21.1 acrocephalosyndactylia
SNX15 sorting nexin 15 11q13.1 mitochondrial disorders
SNX16 sorting nexin 16 8q21.13 low tension glaucoma
SNX3 sorting nexin 3 6q21 short rib-polydactyly syndrome microphthalmia syndromic 8
SNX5 sorting nexin 5 20p11.23 papillary thyroid carcinoma "fanconi anemia, complementation group a"
SNX7 sorting nexin 7 1p21.3 hiatus hernia
SNX9 sorting nexin 9 6q25.3 wiskott-aldrich syndrome
SOAT1 sterol O-acyltransferase 1 1q25.2 atherosclerosis, gallbladder disease, hypercholesterolemia
SOBP sine oculis binding protein homolog (Drosophila) 6q21 intellectual disability, postcholecystectomy syndrome, biliary dyskinesia
SOCS1 suppressor of cytokine signaling 1 16p13.13 hepatocellular carcinoma silent pituitary adenoma
SOCS2 suppressor of cytokine signaling 2 12q22 chronic myeloid leukemia primary polycythemia
SOCS3 suppressor of cytokine signaling 3 17q25.3 insulin resistance, obesity, polycythemia,
SOD1 superoxide dismutase 1, soluble 21q22.11 pre-eclampsia, septo-optic dysplasia, amyotrophic lateral sclerosis,
SOD2 superoxide dismutase 2, mitochondrial 6q25.3 diabetic macular edema, amyotrophic lateral sclerosis, barretts esophagus,
SOD3 superoxide dismutase 3, extracellular 4p15.2 usual interstitial pneumonia, coronary stenosis, myocardial infarction,
SOHLH1 spermatogenesis and oogenesis specific basic helix-loop-helix 1 9q34.3 azoospermia
SON SON DNA binding protein 21q22.11 hepatitis b hepatitis
SORBS1 sorbin and SH3 domain containing 1 10q24.1 insulin resistance
SORD sorbitol dehydrogenase 15q21.1 fascioliasis, drug-induced hepatitis, diabetic cataract,
SORL1 sortilin-related receptor, L(DLR class) A repeats containing 11q24.1 alzheimers disease, alzheimer disease type 2 "alzheimer disease, pathogenesis, association with"
SORT1 sortilin 1 1p13.3 cerebral artery occlusion
SOS1 son of sevenless homolog 1 (Drosophila) 2p22.1 pulmonary valve stenosis, leopard syndrome, cardiofaciocutaneous syndrome,
SOST sclerostin 17q21.31 type 2 diabetes mellitus, primary hyperparathyroidism, osteoporosis,
SOX10 SRY (sex determining region Y)-box 10 22q13.1 hypogonadotropic hypogonadism 8 with or without anosmia, pilocytic astrocytoma, schizophrenia,
SOX11 SRY (sex determining region Y)-box 11 2p25.2 coffin-siris syndrome, mantle cell lymphoma, malignant glioma
SOX14 SRY (sex determining region Y)-box 14 3q22.3 papillon-lefevre disease, "blepharophimosis, ptosis, and epicanthus inversus syndrome" mobius syndrome
SOX17 SRY (sex determining region Y)-box 17 8q11.23 vesicoureteral reflux, vesicoureteral reflux 2 , nephronophthisis 16
SOX18 SRY (sex determining region Y)-box 18 20q13.33 klippel-trenaunay syndrome, hypotrichosis, telangiectasis,
SOX2 SRY (sex determining region Y)-box 2 3q26.33 matthew-wood syndrome, septo-optic dysplasia, teratoma,
SOX3 SRY (sex determining region Y)-box 3 Xq27.1 septo-optic dysplasia, borjeson-forssman-lehmann syndrome, mental retardation,
SOX5 SRY (sex determining region Y)-box 5 12p12.1 developmental and speech delay due to sox5 deficiency 12p12.1 microdeletion syndrome
SOX7 SRY (sex determining region Y)-box 7 8p23.1 barretts adenocarcinoma
SOX8 SRY (sex determining region Y)-box 8 16p13.3 myoblastoma campomelic dysplasia
SOX9 SRY (sex determining region Y)-box 9 17q24.3 mixed gonadal dysgenesis, frasier syndrome, mesenchymal chondrosarcoma,
SP1 Sp1 transcription factor 12q13.13 erythropoietic protoporphyria, dengue disease, hailey-hailey disease,
SP100 SP100 nuclear antigen 2q37.1 primary biliary cirrhosis
SP110 SP110 nuclear body protein 2q37.1 pulmonary tuberculosis, tuberculosis, lymph node tuberculosis
SP2 Sp2 transcription factor 17q21.32 brain cancer
SP7 Sp7 transcription factor 12q13.13 osteochondrodysplasia, ankylosis, osteogenesis imperfecta type 4,
SP8 Sp8 transcription factor 7p21.1 bipolar i disorder skin papilloma
SPA17 sperm autoantigenic protein 17 11q24.2 myeloma ovarian cancer
SPACA1 sperm acrosome associated 1 6q15 infertility
SPAG1 sperm associated antigen 1 8q22.2 "ciliary dyskinesia, primary, 19", myofascial pain syndrome, infertility
SPAG11A sperm associated antigen 11A 8p23.1 choroid plexus carcinoma
SPAG11B sperm associated antigen 11B 8p23.1 choroid plexus carcinoma
SPAG5 sperm associated antigen 5 17q11.2 tendinitis patellar tendinitis
SPAG6 sperm associated antigen 6 10p12.2 infertility
SPAG8 sperm associated antigen 8 9p13.3 infertility
SPAG9 sperm associated antigen 9 17q21.33 lung cancer dengue disease
SPAM1 sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding) 7q31.32 mucopolysaccharidosis ix
SPANXA2 SPANX family, member A2 Xq27.2 intrahepatic cholangiocarcinoma
SPARC secreted protein, acidic, cysteine-rich (osteonectin) 5q33.1 gray platelet syndrome, clear cell chondrosarcoma, osteofibrous dysplasia,
SPAST spastin 2p22.3 arachnoid cysts, paraplegia, hereditary spastic paraplegia
SPATA16 spermatogenesis associated 16 3q26.31 spermatogenic failure, globozoospermia spermatogenic failure 6
SPATA18 spermatogenesis associated 18 4q12 limb-girdle muscular dystrophy type 2e
SPATA7 spermatogenesis associated 7 14q31.3 leber congenital amaurosis, mixed gonadal dysgenesis, leber congenital amaurosis 17,
SPAX3 Ataxia, spastic, 3, autosomal recessive "spastic ataxia 3, autosomal recessive"
SPD3 Synpolydactyly 3 14q11.2-q12 synpolydactyly 3
SPDA2 Spondyloarthropathy, susceptibility to, 2 9q31-q34 spondyloarthropathy 2
SPDA3 Spondylarthropathy, susceptibility to, 3 2q36.1-q36.3 spondylarthropathy spondyloarthropathy 3
SPDEF SAM pointed domain containing ETS transcription factor 6p21.31 prostate cancer
SPDL1 spindle apparatus coiled-coil protein 1 5q35.1 rhabdomyosarcoma
SPDYE1 speedy/RINGO cell cycle regulator family member E1 7p13 williams-beuren syndrome
SPECC1 sperm antigen with calponin homology and coiled-coil domains 1 17p11.2 juvenile myelomonocytic leukemia
SPECC1L sperm antigen with calponin homology and coiled-coil domains 1-like 22q11.23 commissural facial cleft "facial clefting, oblique, 1"
SPEG SPEG complex locus 2q35 necrotizing fasciitis, fasciitis pharyngitis
SPEN spen family transcriptional repressor 1p36.21 megakaryocytic leukemia, microcystic adenoma pancreatic cystadenoma
SPG11 spastic paraplegia 11 (autosomal recessive) 15q21.1 amyotrophic lateral sclerosis, paraplegia, hereditary spastic paraplegia,
SPG14 spastic paraplegia 14 (autosomal recessive) 3q27-q28 spastic paraplegia 14 "spastic paraplegia 14, autosomal recessive"
SPG16 spastic paraplegia 16 (complicated, X-linked recessive) Xq11.2 spastic paraplegia 16, "spastic paraplegia 16, x-linked, complicated" x-linked spastic paraplegia type 16
SPG18 spastic paraplegia 18 (autosomal dominant) reserved "spastic paraplegia 18, autosomal recessive" spastic paraplegia 18
SPG19 spastic paraplegia 19 (autosomal dominant) 9q "spastic paraplegia 19, autosomal dominant" spastic paraplegia 19
SPG20 spastic paraplegia 20 (Troyer syndrome) 13q13.3 hepatitis c, hepatitis c virus, hepatitis,
SPG21 spastic paraplegia 21 (autosomal recessive, Mast syndrome) 15q22.31 paraplegia mast syndrome
SPG23 spastic paraplegia 23 (autosomal recessive) 1q24-q32 spastic paraplegia 23
SPG24 spastic paraplegia 24 (autosomal recessive) 13q14 spastic paraplegia 24 "spastic paraplegia 24, autosomal recessive"
SPG25 spastic paraplegia 25 (autosomal recessive, with disc herniation) 6q23-q24.1 "spastic paraplegia 25, autosomal recessive" spastic paraplegia 25
SPG27 spastic paraplegia 27 (autosomal recessive) 10q22.1-q24.1 "spastic paraplegia 27, autosomal recessive"
SPG29 spastic paraplegia 29 (autosomal dominant) 1p31.1-p21.1 spastic paraplegia 29 "spastic paraplegia 29, autosomal dominant"
SPG32 spastic paraplegia 32 (autosomal recessive) 14q12-q21 "spastic paraplegia 32, autosomal recessive"
SPG34 spastic paraplegia 34 (autosomal dominant) Xq24-q25 "spastic paraplegia 34, x-linked"
SPG36 spastic paraplegia 36 (autosomal dominant) 12q23-q24 "spastic paraplegia 36, autosomal dominant"
SPG37 spastic paraplegia 37 (autosomal dominant) 8p21.2-q13.3 "spastic paraplegia 37, autosomal dominant"
SPG38 spastic paraplegia 38 (autosomal dominant, Silver syndrome) 4p16-p15 "spastic paraplegia 38, autosomal dominant"
SPG41 spastic paraplegia 41 (autosomal dominant) 11p14.1-p11.2 "spastic paraplegia 41, autosomal dominant"
SPG43 spastic paraplegia 43 (autosomal recessive) mitochondrial membrane protein-associated neurodegeneration "spastic paraplegia 43, autosomal recessive"
SPG45 spastic paraplegia 45 (autosomal recessive) 10q24.3-q25.1 spastic paraplegia 45 "spastic paraplegia 45, autosomal recessive"
SPG46 spastic paraplegia 46 (autosomal recessive) 9p21.1-q21.11 "spastic paraplegia 46, autosomal recessive"
SPG56 spastic paraplegia 56 (autosomal dominant) reserved "spastic paraplegia 56, autosomal recessive"
SPG5B spastic paraplegia 5B (autosomal recessive) reserved spastic paraplegia 5b
SPG7 spastic paraplegia 7 (pure and complicated autosomal recessive) 16q24.3 spasticity, hereditary ataxia, loeys-dietz syndrome,
SPG9 spastic paraplegia 9 (autosomal dominant) 10q23.3-q24.2 spastic paraplegia 9 "spastic paraplegia 9, autosomal dominant"
SPGF2 Spermatogenic failure spermatogenic failure 2
SPGFX2 Spermatogenic failure, X-linked, 2 "spermatogenic failure, x-linked, 2"
SPHK1 sphingosine kinase 1 17q25.1 hereditary neuralgic amyotrophy
SPHK2 sphingosine kinase 2 19q13.33 breast cancer
SPI1 spleen focus forming virus (SFFV) proviral integration oncogene 11p11.2 primary effusion lymphoma
SPIB Spi-B transcription factor (Spi-1/PU.1 related) 19q13.33 primary biliary cirrhosis blastic plasmacytoid dendritic cell
SPIC Spi-C transcription factor (Spi-1/PU.1 related) 12q23.2 wolman disease lipomatosis
SPIN1 spindlin 1 9q22.1 ovarian cancer
SPIN4 spindlin family, member 4 Xq11.1 cysticercosis
SPINK1 serine peptidase inhibitor, Kazal type 1 5q32 prostate cancer, primary hyperparathyroidism, pancreatic cancer,
SPINK13 serine peptidase inhibitor, Kazal type 13 (putative) 5q32 hepatitis b hepatitis
SPINK5 serine peptidase inhibitor, Kazal type 5 5q32 atopy, netherton syndrome, ectropion
SPINK6 serine peptidase inhibitor, Kazal type 6 5q32 dyshidrosis
SPINK7 serine peptidase inhibitor, Kazal type 7 (putative) 5q32 esophageal cancer
SPINK9 serine peptidase inhibitor, Kazal type 9 5q32 fatty liver disease dyshidrosis
SPINT2 serine peptidase inhibitor, Kunitz type, 2 19q13.2 diarrhea, alpha 1-antitrypsin deficiency, c1 inhibitor deficiency,
SPN sialophorin 16p11.2 b-cell chronic lymphocytic leukemia, wiskott-aldrich syndrome, myelodysplastic syndromes,
SPOAN spastic paraplegia, optic atrophy, and neuropathy "spastic paraplegia, optic atrophy, and neuropathy"
SPOCK3 sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 4q32.3 t-cell leukemia adult t-cell leukemia
SPOP speckle-type POZ protein 17q21.33 mulibrey nanism
SPP1 secreted phosphoprotein 1 4q22.1 hepatocellular carcinoma, calcinosis, hyperphosphatemia,
SPPL2C signal peptide peptidase like 2C 17q21.31 progressive supranuclear palsy
SPR sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase) 2p13.2 parkinsons disease, dihydropteridine reductase deficiency, tetrahydrobiopterin deficiency,
SPRED1 sprouty-related, EVH1 domain containing 1 15q14 hypersomnia, neurofibromatosis, legius syndrome,
SPRED2 sprouty-related, EVH1 domain containing 2 2p14 legius syndrome
SPRED3 sprouty-related, EVH1 domain containing 3 19q13.2 legius syndrome
SPRN shadow of prion protein homolog (zebrafish) 10q26.3 variant creutzfeldt-jakob disease
SPRNP1 shadow of prion protein homolog (zebrafish) pseudogene 1 10q26.3 alzheimers disease
SPRR1B small proline-rich protein 1B 1q21.3 epidermolytic hyperkeratosis
SPRR2A small proline-rich protein 2A 1q21.3 esophageal squamous cell carcinoma
SPRR2B small proline-rich protein 2B 1q21.3 oral squamous cell carcinoma
SPRR2G small proline-rich protein 2G 1q21.3 cystitis
SPRR3 small proline-rich protein 3 1q21.3 esophagitis eosinophilic esophagitis
SPRY1 sprouty homolog 1, antagonist of FGF signaling (Drosophila) 4q28.1 legius syndrome
SPRY2 sprouty homolog 2 (Drosophila) 13q31.1 thanatophoric dysplasia legius syndrome
SPRY3 sprouty homolog 3 (Drosophila) Xq28 legius syndrome
SPRY4 sprouty homolog 4 (Drosophila) 5q31.3 "male germ cell tumor, somatic", hypogonadotropic hypogonadism 8 with or without anosmia, hypogonadotropic hypogonadism 17 with or without anosmia,
SPRYD7 SPRY domain containing 7 13q14.2 b-cell chronic lymphocytic leukemia chronic lymphocytic leukemia
SPTA1 spectrin, alpha, erythrocytic 1 (elliptocytosis 2) 1q23.1 hereditary elliptocytosis, "spherocytosis, hereditary, type 5", hereditary spherocytosis,
SPTAN1 spectrin, alpha, non-erythrocytic 1 9q34.11 quadriplegia, spastic quadriplegia, west syndrome,
SPTB spectrin, beta, erythrocytic 14q23.3 hereditary elliptocytosis, "spherocytosis, hereditary, type 5", hereditary spherocytosis,
SPTBN2 spectrin, beta, non-erythrocytic 2 11q13.2 ataxia, infantile onset spinocerebellar ataxia, spinocerebellar ataxia,
SPTBN5 spectrin, beta, non-erythrocytic 5 15q15.1 usher syndrome type i macular holes
SPTLC1 serine palmitoyltransferase, long chain base subunit 1 9q22.31 neuropathy, tabes dorsalis, hereditary sensory neuropathy type 1,
SPTLC2 serine palmitoyltransferase, long chain base subunit 2 14q24.3 neuropathy, hereditary sensory neuropathy, "neuropathy, hereditary sensory and autonomic, type ia"
SQLE squalene epoxidase 8q24.13 tinea pedis, candida glabrata, tinea capitis,
SQRDL sulfide quinone reductase-like (yeast) 15q21.1 ethylmalonic encephalopathy
SQSTM1 sequestosome 1 5q35.3 amyotrophic lateral sclerosis, nephropathic cystinosis, cystinosis,
SQTL1 Smoking as a quantitative trait locus 1 10q22 smoking as a quantitative trait locus 1
SQTL2 Smoking as a quantitative trait locus 2 22q12 smoking as a quantitative trait locus 2
SRA1 steroid receptor RNA activator 1 5q31.3 breast cancer, mn1, campomelic dysplasia
SRC v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog 20q11.23 cherubism, sarcoma, breast cancer,
SRCAP Snf2-related CREBBP activator protein 16p11.2 short stature, thin basement membrane nephropathy, eaf,
SRCIN1 SRC kinase signaling inhibitor 1 17q12 elephantiasis, fascioliasis, cystoisosporiasis,
SRD5A1 steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) 5p15.31 laryngitis, prostate cancer, hermaphroditism,
SRD5A2 steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) 2p23.1 prostate cancer, hypospadias, androgen insensitivity syndrome,
SRD5A3 steroid 5 alpha-reductase 3 4q12 transsexualism, torch syndrome, pseudo-torch syndrome,
SREBF1 sterol regulatory element binding transcription factor 1 17p11.2 insulin resistance
SREBF2 sterol regulatory element binding transcription factor 2 22q13.2 avascular necrosis of the femoral head
SRF serum response factor (c-fos serum response element-binding transcription factor) 6p21.1 syringomyelia, rheumatoid arthritis, rheumatoid vasculitis,
SRGAP2 SLIT-ROBO Rho GTPase activating protein 2 1q32.1 infantile epileptic encephalopathy atrioventricular septal defect
SRGAP3 SLIT-ROBO Rho GTPase activating protein 3 3p25.3 pilocytic astrocytoma
SRGN serglycin 10q22.1 diffuse cutaneous mastocytosis cutaneous mastocytosis
SRM spermidine synthase 1p36.22 chagas disease, malaria, sleeping sickness
SRMS src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites 20q13.33 metanephric adenoma
SRP54 signal recognition particle 54kDa 14q13.2 polyclonal hypergammaglobulinemia
SRP68P1 signal recognition particle 68kDa pseudogene 1 17p11.2 smith magenis syndrome
SRP72 signal recognition particle 72kDa 4q12 iritis, bone marrow failure syndrome 1 , "bone marrow failure, familial"
SRP9 signal recognition particle 9kDa 1q42.12 sost-related sclerosing bone dysplasia
SRPX sushi-repeat containing protein, X-linked Xp11.4 neuroendocrine tumor pulmonary neuroendocrine tumor
SRPX2 sushi-repeat containing protein, X-linked 2 Xq22.1 pseudobulbar palsy, oligohydramnios, benign epilepsy with centrotemporal spikes,
SRR serine racemase 17p13.3 schizophrenia, serine deficiency, rabies
SRRD SRR1 domain containing 22q12.1 hepatocellular carcinoma hemochromatosis
SRRM4 serine/arginine repetitive matrix 4 12q24.23 medulloblastoma
SRSF1 serine/arginine-rich splicing factor 1 17q22 afibrinogenemia cble
SRSF2 serine/arginine-rich splicing factor 2 17q25.1 holt-oram syndrome papillary renal carcinoma
SRSF5 serine/arginine-rich splicing factor 5 14q24.1 pyruvate decarboxylase deficiency
SRSF7 serine/arginine-rich splicing factor 7 2p22.1 allergic bronchopulmonary aspergillosis
SRXN1 sulfiredoxin 1 20p13 idiopathic pulmonary fibrosis
SRXX2 46XX sex reversal 2 17q24.3-q25.1 46xx sex reversal 2
SRXX3 46XX sex reversal 3 Xq26.3 46xx sex reversal 3
SRY sex determining region Y Yp11.31 prostatic hypertrophy, hypospadias, hermaphroditism,
SS18 synovial sarcoma translocation, chromosome 18 18q11.2 sarcoma, biphasic synovial sarcoma, synovial sarcoma,
SS18L1 synovial sarcoma translocation gene on chromosome 18-like 1 20q13.33 synovial sarcoma
SS18L2 synovial sarcoma translocation gene on chromosome 18-like 2 3p22.1 synovial sarcoma
SS18L2P1 synovial sarcoma translocation gene on chromosome 18-like 2 pseudogene 1 10p11.21 synovial sarcoma
SS18L2P2 synovial sarcoma translocation gene on chromosome 18-like 2 pseudogene 2 18q21.2 synovial sarcoma
SS3 Sarcoidosis, susceptibility to, 3 10q22.3 sarcoidosis sarcoidosis 3
SSB Sjogren syndrome antigen B (autoantigen La) 2q31.1 sjogrens syndrome, systemic lupus erythematosus, lupus erythematosus,
SSBP1 single-stranded DNA binding protein 1, mitochondrial 7q34 herpes simplex
SSBP3 single stranded DNA binding protein 3 1p32.3 thyroid lymphoma
SSH1 slingshot protein phosphatase 1 12q24.11 porokeratosis
SSNA1 Sjogren syndrome nuclear autoantigen 1 9q34.3 sjogrens syndrome paralytic squint
SSPN sarcospan 12p12.1 adrenal carcinoma, sarcoglycanopathies fukuyama congenital muscular dystrophy
SSR4 signal sequence receptor, delta Xq28 terminal osseous dysplasia ssr4-cdg
SSSCA1 Sjogren syndrome/scleroderma autoantigen 1 11q13.1 sjogrens syndrome scleroderma
SST somatostatin 3q27.3 diabetic macular edema, pancreatic cancer, pituitary adenoma,
SSTR1 somatostatin receptor 1 14q21.1 prostate cancer, oncogenic osteomalacia, pancreatic cancer,
SSTR2 somatostatin receptor 2 17q25.1 oncogenic osteomalacia, pancreatic cancer, neuroblastoma,
SSTR3 somatostatin receptor 3 22q13.1 oncogenic osteomalacia, pituitary adenoma vipoma
SSTR4 somatostatin receptor 4 20p11.21 pheochromocytoma
SSTR5 somatostatin receptor 5 16p13.3 oncogenic osteomalacia, osteomalacia, pancreatic cancer,
SSX1 synovial sarcoma, X breakpoint 1 Xp11.23 sarcoma, synovial sarcoma, mesenchymal chondrosarcoma,
SSX2 synovial sarcoma, X breakpoint 2 Xp11.22 sarcoma, testicular cancer, seminoma,
SSX2B synovial sarcoma, X breakpoint 2B Xp11.22 sarcoma, mesoblastic nephroma, congenital mesoblastic nephroma,
SSX2IP synovial sarcoma, X breakpoint 2 interacting protein 1p22.3 sarcoma, synovial sarcoma constrictive pericarditis
SSX3 synovial sarcoma, X breakpoint 3 Xp11.23 sarcoma synovial sarcoma
SSX4 synovial sarcoma, X breakpoint 4 Xp11.23 sarcoma synovial sarcoma
SSX4B synovial sarcoma, X breakpoint 4B Xp11.23 sarcoma synovial sarcoma
SSX5 synovial sarcoma, X breakpoint 5 Xp11.23 sarcoma synovial sarcoma
SSX6 synovial sarcoma, X breakpoint 6 (pseudogene) Xp11.23 sarcoma synovial sarcoma
SSX7 synovial sarcoma, X breakpoint 7 Xp11.22 sarcoma synovial sarcoma
SSX8 synovial sarcoma, X breakpoint 8 Xp11.22 synovial sarcoma
SSX9 synovial sarcoma, X breakpoint 9 Xp11.23 sarcoma synovial sarcoma
SSXP4 SSX family pseudogene 4 Xp11.22 synovial sarcoma
ST11 suppression of tumorigenicity 11 (pancreas) 3p25 pancreatic endocrine tumors
ST13P3 suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 3 12q23.3 multiple myeloma
ST13P4 suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 4 13q14.2 b-cell chronic lymphocytic leukemia chronic lymphocytic leukemia
ST13P5 suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 5 11p15.1 multiple myeloma
ST13P6 suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 6 8q24.22 multiple myeloma
ST13P7 suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 7 7q33 multiple myeloma
ST14 suppression of tumorigenicity 14 (colon carcinoma) 11q24.3 "ichthyosis, congenital, autosomal recessive 11" "ichthyosis, follicular"
ST18 suppression of tumorigenicity 18, zinc finger 8q11.23 primary angle-closure glaucoma
ST20 suppressor of tumorigenicity 20 15q25.1 cervical cancer
ST3 suppression of tumorigenicity 3 11q13-q23 cervical cancer
ST3GAL3 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 1p34.1 mental retardation, west syndrome, "epileptic encephalopathy, early infantile, 5",
ST3GAL5 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 2p11.2 cortical blindness, epilepsy syndrome, amish infantile epilepsy syndrome
ST3GAL6 ST3 beta-galactoside alpha-2,3-sialyltransferase 6 3q12.1 sialuria inflammatory breast carcinoma
ST6GAL1 ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 3q27.3 drug-induced liver injury due to flucloxacillin
ST6GAL2 ST6 beta-galactosamide alpha-2,6-sialyltranferase 2 2q12.3 alpha 1-antitrypsin deficiency
ST6GALNAC2 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 17q25.1 iga glomerulonephritis
ST7 suppression of tumorigenicity 7 7q31.2 atypical autism mandibular cancer
STAB1 stabilin 1 3p21.1 juvenile xanthogranuloma rosai-dorfman disease
STAB2 stabilin 2 12q23.3 pasteurellosis, la crosse encephalitis, louping ill,
STAC3 SH3 and cysteine rich domain 3 12q13.3 native american myopathy
STAG2 stromal antigen 2 Xq25 legg-calve-perthes disease, laryngotracheitis tracheitis
STAG3 stromal antigen 3 7q22.1 premature ovarian failure 8
STAMBP STAM binding protein 2p13.1 microcephaly-capillary malformation syndrome
STAR steroidogenic acute regulatory protein 8p11.23 lipoid adrenal hyperplasia, ovarian disease, dosage-sensitive sex reversal,
STARD10 StAR-related lipid transfer (START) domain containing 10 11q13.4 colon cancer hereditary myopathy with early respiratory failure
STARD7 StAR-related lipid transfer (START) domain containing 7 2q11.2 gestational trophoblastic tumor, gestational trophoblastic neoplasm trophoblastic neoplasm
STARD8 StAR-related lipid transfer (START) domain containing 8 Xq13.1 craniofrontonasal syndrome
STAT1 signal transducer and activator of transcription 1, 91kDa 2q32.2 thanatophoric dysplasia, colorectal cancer, "candidiasis, familial, 2, autosomal recessive",
STAT2 signal transducer and activator of transcription 2, 113kDa 12q13.3 skin squamous cell carcinoma, venezuelan equine encephalitis mumps
STAT3 signal transducer and activator of transcription 3 (acute-phase response factor) 17q21.2 breast cancer, pancreatic cancer, primary cutaneous anaplastic large cell lymphoma,
STAT4 signal transducer and activator of transcription 4 2q32.3 systemic lupus erythematosus, rheumatoid arthritis, lupus erythematosus,
STAT5A signal transducer and activator of transcription 5A 17q21.2 myeloma, breast cancer, chronic myeloid leukemia,
STAT5B signal transducer and activator of transcription 5B 17q21.2 breast cancer, acute promyelocytic leukemia, primary cutaneous anaplastic large cell lymphoma,
STAT6 signal transducer and activator of transcription 6, interleukin-4 induced 12q13.3 urinary schistosomiasis, schistosomiasis, primary mediastinal large b-cell lymphoma,
STATH statherin 4q13.3 atypical autism denture stomatitis
STBMS1 Strabismus, susceptibility to, 1 7p22.1 strabismus 1
STC1 stanniocalcin 1 8p21.2 pheochromocytoma fibrosarcoma
STEAP2 STEAP family member 2, metalloreductase 7q21.13 prostate cancer
STEAP3 STEAP family member 3, metalloreductase 2q14.2 hypochromic anemia hypochromic microcytic anemia with iron overload 2
STEAP4 STEAP family member 4 7q21.12 prostate cancer insulin resistance
STH saitohin 17q21.31 parkinsons disease, alzheimers disease, progressive supranuclear palsy,
STHAG5 tooth agenesis, selective, 5 10q "tooth agenesis, selective, 5"
STIL SCL/TAL1 interrupting locus 1p33 precursor t-cell acute lymphoblastic leukemia, primary autosomal recessive microcephalies and seckel syndrome spectrum disorders, primary autosomal recessive microcephaly type 1,
STIM1 stromal interaction molecule 1 11p15.4 kaposis sarcoma, breast cancer, beckwith-wiedemann syndrome,
STK10 serine/threonine kinase 10 5q35.1 "spermatocytic seminoma, somatic", "testicular tumor, somatic", "male germ cell tumor, somatic",
STK11 serine/threonine kinase 11 19p13.3 "spermatocytic seminoma, somatic", "testicular tumor, somatic", "male germ cell tumor, somatic",
STK11IP serine/threonine kinase 11 interacting protein 2q35 bannayan-riley-ruvalcaba syndrome ruvalcaba syndrome
STK16 serine/threonine kinase 16 2q35 cryptococcosis diffuse mesangial sclerosis
STK19 serine/threonine kinase 19 6p21.33 21-hydroxylase deficiency
STK25 serine/threonine kinase 25 2q37.3 anoxia pseudopseudohypoparathyroidism
STK32B serine/threonine kinase 32B 4p16.2 ellis-van creveld syndrome
STK39 serine threonine kinase 39 2q24.3 glanders
STK4 serine/threonine kinase 4 20q13.12 encephalocele, occipital encephalocele "t-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations"
STMN1 stathmin 1 1p36.11 leukemia, agoraphobia, anaplastic oligodendroglioma,
STMN2 stathmin 2 8q21.13 variant creutzfeldt-jakob disease
STMN4 stathmin-like 4 8p21.2 exfoliation syndrome
STOM stomatin 9q33.2 malaria, dehydrated hereditary stomatocytosis, obsessive-compulsive personality disorder
STOML2 stomatin (EPB72)-like 2 9p13.3 acromesomelic dysplasia
STOML3 stomatin (EPB72)-like 3 13q13.3 mesenchymal cell neoplasm
STOX1 storkhead box 1 10q21.3 pre-eclampsia, eclampsia, dysgraphia
STRA13 stimulated by retinoic acid 13 17q25.3 fanconis anemia
STRA6 stimulated by retinoic acid 6 15q24.1 matthew-wood syndrome, anophthalmia/microphthalmia, microphthalmia,
STRADA STE20-related kinase adaptor alpha 17q23.3 polyhydramnios, breast cancer, megalencephaly
STRADB STE20-related kinase adaptor beta 2q33.1 amyotrophic lateral sclerosis lateral sclerosis
STRC stereocilin 15q15.3 "deafness, autosomal recessive 76", male infertility, sensorineural hearing loss,
STS steroid sulfatase (microsomal), isozyme S Xp22.31 renal agenesis, periventricular nodular heterotopia, cryptorchidism,
STT3A STT3A, subunit of the oligosaccharyltransferase complex (catalytic) 11q24.2 "congenital disorder of glycosylation, type iw"
STT3B STT3B, subunit of the oligosaccharyltransferase complex (catalytic) 3p23 "congenital disorder of glycosylation, type ix"
STUB1 STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase 16p13.3 colon cancer, "spinocerebellar ataxia, autosomal recessive 16" cerebellar ataxia and hypogonadotropic hypogonadism
STUT3 Stuttering, familial persistent, 3 3q13.2-q13.33 "stuttering, familial persistent, 3"
STUT4 Stuttering, familial persistent, 4 16q12.1-q23.1 "stuttering, familial persistent, 4"
STX11 syntaxin 11 6q24.2 chediak-higashi syndrome, chronic granulomatous disease, hemophagocytic lymphohistiocytosis,
STX12 syntaxin 12 1p35.3 platelet storage pool deficiency
STX16 syntaxin 16 20q13.32 cardiovascular disease risk factor, albrights hereditary osteodystrophy, pseudohypoparathyroidism type 1b
STX1A syntaxin 1A (brain) 7q11.23 cystic fibrosis, williams syndrome cerebral arteritis
STX2 syntaxin 2 12q24.33 type 1 von willebrand disease
STX3 syntaxin 3 11q12.1 microvillus inclusion disease
STX5 syntaxin 5 11q12.3 endometriosis
STX8 syntaxin 8 17p13.1 visual epilepsy
STXBP1 syntaxin binding protein 1 9q34.11 west syndrome, "epileptic encephalopathy, early infantile, 17", hydranencephaly,
STXBP2 syntaxin binding protein 2 19p13.2 hemophagocytic lymphohistiocytosis, "coenzyme q10 deficiency, primary, 6", "hemophagocytic lymphohistiocytosis, familial",
STXBP5 syntaxin binding protein 5 (tomosyn) 6q24.3 type 1 von willebrand disease
STYK1 serine/threonine/tyrosine kinase 1 12p13.2 chronic inflammatory demyelinating polyneuritis
SUB1 SUB1 homolog (S. cerevisiae) 5p13.3 tinea unguium
SUCLA2 succinate-CoA ligase, ADP-forming, beta subunit 13q14.2 mitochondrial dna depletion syndrome, x-linked sideroblastic anemia, methylmalonic acidemia,
SUCLA2P1 succinate-CoA ligase, ADP-forming, beta subunit pseudogene 1 6p21.33 systemic lupus erythematosus
SUCLG1 succinate-CoA ligase, alpha subunit 2p11.2 tay-sachs disease, pearson syndrome, mitochondrial dna depletion syndrome,
SUCLG2 succinate-CoA ligase, GDP-forming, beta subunit 3p14.1 pharyngitis
SUCNR1 succinate receptor 1 3q25.1 renovascular hypertension, hypertension atherosclerosis
SUFU suppressor of fused homolog (Drosophila) 10q24.32 medulloblastoma, meningioma, "medulloblastoma, desmoplastic",
SUGCT succinylCoA:glutarate-CoA transferase 7p14.1 pustulosis palmaris et plantaris glutaric acidemia type 3
SULF1 sulfatase 1 8q13.2 mesomelia-synostoses syndrome mesomelia
SULT1A1 sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 16p11.2 breast cancer susceptibility, breast cancer male breast cancer
SULT1A3 sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 16p11.2 angina pectoris, myocardial infarction, malaria,
SULT1E1 sulfotransferase family 1E, estrogen-preferring, member 1 4q13.3 endometrial carcinoma, endometrial adenocarcinoma endometrial stromal sarcoma
SULT2A1 sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 19q13.33 x-linked ichthyosis polycystic ovary syndrome
SULT2B1 sulfotransferase family, cytosolic, 2B, member 1 19q13.33 variegate porphyria
SULT4A1 sulfotransferase family 4A, member 1 22q13.31 schizotypal personality disorder schizophrenia
SUMF1 sulfatase modifying factor 1 3p26.1 metachromatic leukodystrophy , mucosulfatidosis, mucolipidosis ii
SUMF2 sulfatase modifying factor 2 7p11.2 campylobacteriosis, impetigo listeriosis
SUMO1 small ubiquitin-like modifier 1 2q33.1 orofacial cleft, familial partial lipodystrophy, cortisol resistance,
SUMO4 small ubiquitin-like modifier 4 6q25.1 type 2 diabetes mellitus, diabetes mellitus "diabetes mellitus, insulin-dependent, 5"
SUN2 Sad1 and UNC84 domain containing 2 22q13.1 primary biliary cirrhosis, chronic fatigue syndrome, reynolds syndrome
SUOX sulfite oxidase 12q13.2 primary biliary cirrhosis, encephalomalacia, glycine encephalopathy,
SUPT7L suppressor of Ty 7 (S. cerevisiae)-like 2p23.3 adenocarcinoma
SURF1 surfeit 1 9q34.2 leigh syndrome with leukodystrophy, hypertrichosis, leigh disease,
SUV39H1 suppressor of variegation 3-9 homolog 1 (Drosophila) Xp11.23 idiopathic pulmonary fibrosis
SUZ12 SUZ12 polycomb repressive complex 2 subunit 17q11.2 endometrial stromal tumor
SV2A synaptic vesicle glycoprotein 2A 1q21.2 gastrointestinal stromal tumor
SV2B synaptic vesicle glycoprotein 2B 15q26.1 prostate small cell carcinoma
SV2C synaptic vesicle glycoprotein 2C 5q13.3 botulism
SVEP1 sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 9q31.3 breast cancer
SWAP70 SWAP switching B-cell complex 70kDa subunit 11p15.4 x-linked hyper igm syndrome nodular lymphocyte predominant hodgkin lymphoma
SXI2 X inactivation, familial skewed, 2 Xq25-q26 "x inactivation, familial skewed, 2"
SYCP3 synaptonemal complex protein 3 12q23.2 pregnancy loss, gemistocytic astrocytoma, azoospermia,
SYK spleen tyrosine kinase 9q22.2 cherubism mycobacterium abscessus
SYN1 synapsin I Xp11.23 rett syndrome "epilepsy, x-linked, with variable learning disabilities and behavior disorders"
SYN2 synapsin II 3p25.2 schizophrenia bipolar disorder
SYN3 synapsin III 22q12.3 schizophrenia vulvitis
SYNC syncoilin, intermediate filament protein 1p35.1 intermediate charcot-marie-tooth neuropathy
SYNE1 spectrin repeat containing, nuclear envelope 1 6q25.2 ataxia, cerebellar ataxia, emery-dreifuss muscular dystrophy,
SYNE2 spectrin repeat containing, nuclear envelope 2 14q23.2 emery-dreifuss muscular dystrophy, syne2-related emery-dreifuss muscular dystrophy, "emery-dreifuss muscular dystrophy 5, autosomal dominant"
SYNE4 spectrin repeat containing, nuclear envelope family member 4 19q13.12 "deafness, autosomal recessive 76"
SYNGAP1 synaptic Ras GTPase activating protein 1 6p21.32 "mental retardation, autosomal dominant 10"
SYNJ1 synaptojanin 1 21q22.11 "parkinson disease 20, early-onset" "parkinson disease 19, juvenile-onset"
SYNM synemin, intermediate filament protein 15q26.3 sclerosing hemangioma, pleomorphic xanthoastrocytoma, mesenchymal chondrosarcoma,
SYNPO synaptopodin 5q33.1 focal segmental glomerulosclerosis, membranous glomerulonephritis, pauci-immune glomerulonephritis
SYNSTH Synesthesia 2q24.1 synesthesia
SYP synaptophysin Xp11.23 giant cell glioblastoma, pilocytic astrocytoma, amyotrophic lateral sclerosis,
SYT11 synaptotagmin XI 1q22 parkinsons disease autosomal recessive juvenile parkinson disease
SYT14 synaptotagmin XIV 1q32.2 "spinocerebellar ataxia, autosomal recessive 11"
SYT2 synaptotagmin II 1q32.1 botulism
SYT4 synaptotagmin IV 18q12.3 pheochromocytoma
SYT7 synaptotagmin VII 11q12.2 prostate cancer
SYTL2 synaptotagmin-like 2 11q14.1 breast cancer
SZT2 seizure threshold 2 homolog (mouse) 1p34.2 "epileptic encephalopathy, early infantile, 18"
T T, brachyury homolog (mouse) 6q27 neural tube defects, spina bifida, autoimmune hemolytic anemia,
TAAR6 trace amine associated receptor 6 6q23.2 schizophrenia mood disorder
TAB2 TGF-beta activated kinase 1/MAP3K7 binding protein 2 6q25.1 hypohidrotic ectodermal dysplasia, "congenital heart defects, nonsyndromic, 2" hypohidrosis
TAC1 tachykinin, precursor 1 7q21.3 serotonin syndrome, burning mouth syndrome, cryptosporidiosis,
TAC3 tachykinin 3 12q13.3 pre-eclampsia, hypogonadotropic hypogonadism 17 with or without anosmia, hypertension,
TAC4 tachykinin 4 (hemokinin) 17q21.33 shipyard eye
TACC1 transforming, acidic coiled-coil containing protein 1 8p11.22 gliosarcoma, giant cell glioblastoma breast cancer
TACC3 transforming, acidic coiled-coil containing protein 3 4p16.3 bladder cancer susceptibility, gliosarcoma giant cell glioblastoma
TACO1 translational activator of mitochondrially encoded cytochrome c oxidase I 17q23.3 denys-drash syndrome, leigh disease, cytochrome-c oxidase deficiency disease
TACR1 tachykinin receptor 1 2p12 social phobia causalgia
TACR3 tachykinin receptor 3 4q24 hypogonadotropic hypogonadism 8 with or without anosmia, hypogonadotropic hypogonadism 17 with or without anosmia, cowden disease,
TACSTD2 tumor-associated calcium signal transducer 2 1p32.1 pancreatic cancer, cysticercosis, corneal dystrophy,
TADA1 transcriptional adaptor 1 1q24.1 tuberculous empyema
TADA3 transcriptional adaptor 3 3p25.3 epicondylitis staphyloenterotoxemia
TAF1 TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa Xq13.1 dystonia, spinocerebellar ataxia type 17, x-linked dystonia-parkinsonism
TAF15 TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa 17q12 amyotrophic lateral sclerosis, acute leukemia, chondrosarcoma,
TAF2 TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa 8q24.12 "mental retardation, autosomal recessive 40"
TAF4B TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa 18q11.2 spermatogenic failure 13
TAF7 TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa 5q31.3 gestational choriocarcinoma
TAGAP T-cell activation RhoGTPase activating protein 6q25.3 agnosia, celiac disease, multiple sclerosis,
TAGLN2 transgelin 2 1q23.2 neural tube defects
TAL1 T-cell acute lymphocytic leukemia 1 1p33 lymphoblastic leukemia, leukemia, precursor t-cell acute lymphoblastic leukemia,
TAL2 T-cell acute lymphocytic leukemia 2 9q31.2 lymphoblastic leukemia, leukemia, acute lymphocytic leukemia,
TALDO1 transaldolase 1 11p15.5 multiple sclerosis, bartter disease, transaldolase deficiency,
TALDO1P1 transaldolase 1 pseudogene 1 1p32.3 transaldolase deficiency
TAM Myeloproliferative syndrome, transient (transient abnormal 21q11.2 "leukemia, transient, of down syndrome"
TAP1 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) 6p21.32 celiac disease, diabetes mellitus, cardiac sarcoidosis,
TAP2 transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) 6p21.32 celiac disease, diabetes mellitus, cardiac sarcoidosis,
TAPBP TAP binding protein (tapasin) 6p21.32 maxillary sinus squamous cell carcinoma, spondylitis, mhc class i deficiency
TAPVR1 total anomalous pulmonary venous return 1 4p13-q11 scimitar syndrome
TARBP1 TAR (HIV-1) RNA binding protein 1 1q42.2 hiv-1 acquired immunodeficiency syndrome
TARBP2 TAR (HIV-1) RNA binding protein 2 12q13.13 hiv-1, blastoma, acquired immunodeficiency syndrome,
TARBP2P TAR (HIV-1) RNA binding protein 2 pseudogene 8q22.3 hiv-1
TARDBP TAR DNA binding protein 1p36.22 amyotrophic lateral sclerosis, dysplastic nevus syndrome, hiv-1,
TARM1 T cell-interacting, activating receptor on myeloid cells 1 19q13.42 exanthema subitum
TARS threonyl-tRNA synthetase 5p13.3 antisynthetase syndrome
TAS1R1 taste receptor, type 1, member 1 1p36.31 bile duct carcinoma
TAS1R2 taste receptor, type 1, member 2 1p36.13 bile duct carcinoma
TAS1R3 taste receptor, type 1, member 3 1p36.33 bile duct carcinoma
TAS2R1 taste receptor, type 2, member 1 5p15.31 hypersomnia
TAS2R13 taste receptor, type 2, member 13 12p13.2 breast and colorectal cancer
TAS2R16 taste receptor, type 2, member 16 7q31.32 alcohol dependence nicotine dependence
TAS2R38 taste receptor, type 2, member 38 7q34 dental caries nicotine dependence
TAS2R64P taste receptor, type 2, member 64, pseudogene 12p13.2 ductal carcinoma in situ
TAT tyrosine aminotransferase 16q22.2 kaposis sarcoma, disseminated intravascular coagulation, hiv-1,
TAX1BP1 Tax1 (human T-cell leukemia virus type I) binding protein 1 7p15.2 t-cell leukemia
TAX1BP3 Tax1 (human T-cell leukemia virus type I) binding protein 3 17p13.2 nephropathic cystinosis
TAZ tafazzin Xq28 endocardial fibroelastosis, familial dilated cardiomyopathy, "cardiomyopathy, dilated, 1w",
TBC1D20 TBC1 domain family, member 20 20p13 hepatitis c, hepatitis c virus, hepatitis,
TBC1D24 TBC1 domain family, member 24 16p13.3 familial infantile myoclonic epilepsy, "deafness, autosomal recessive 76", "deafness, autosomal dominant 4b",
TBC1D25 TBC1 domain family, member 25 Xp11.23 mood disorder
TBC1D3 TBC1 domain family, member 3 17q12 prostate cancer
TBC1D3B TBC1 domain family, member 3B 17q12 prostate cancer
TBC1D3F TBC1 domain family, member 3F 17q12 prostate cancer
TBC1D3H TBC1 domain family, member 3H 17q12 intrahepatic cholangiocarcinoma
TBC1D7 TBC1 domain family, member 7 6p24.1 tuberous sclerosis, megalencephaly, "megalencephaly, autosomal recessive"
TBC1D9 TBC1 domain family, member 9 (with GRAM domain) 4q31.21 osteochondrosis
TBCC tubulin folding cofactor C 6p21.1 retinitis pigmentosa 2, quadriplegia spastic quadriplegia
TBCD tubulin folding cofactor D 17q25.3 retinitis pigmentosa 2, lattice corneal dystrophy corneal granular dystrophy
TBCE tubulin folding cofactor E 1q42.3 retinitis pigmentosa 2, caffey disease, hypoparathyroidism,
TBK1 TANK-binding kinase 1 12q14.2 herpes simplex encephalitis 1, herpes simplex encephalitis, herpes simplex
TBKBP1 TBK1 binding protein 1 17q21.32 low tension glaucoma
TBL1X transducin (beta)-like 1X-linked Xp22.31 albinism ocular albinism
TBL2 transducin (beta)-like 2 7q11.23 williams-beuren syndrome supravalvular aortic stenosis
TBP TATA box binding protein 6q27 parkinsons disease, ataxia, malaria,
TBPL1 TBP-like 1 6q23.2 sleeping sickness, infertility degenerative disc disease
TBR1 T-box, brain, 1 2q24.2 sleeping sickness
TBRG1 transforming growth factor beta regulator 1 11q24.2 weill-marchesani syndrome tracheal stenosis
TBX1 T-box 1 22q11.21 pervasive developmental disorder, digeorge syndrome, velocardiofacial syndrome,
TBX10 T-box 10 11q13.2 cleft lip cleft palate
TBX15 T-box 15 1p12 cavernous malformations of cns and retina , cousin syndrome acromegaloid facial appearance syndrome
TBX19 T-box 19 1q24.2 isolated acth deficiency, acth deficiency, acth-secreting pituitary adenoma,
TBX2 T-box 2 17q23.2 adrenocortical carcinoma, ulnar-mammary syndrome, polyploidy,
TBX20 T-box 20 7p14.2 patent foramen ovale, acute stress disorder, atrial septal defect 4
TBX21 T-box 21 17q21.32 asthma, hypersensitivity reaction type ii disease, aplastic anemia,
TBX22 T-box 22 Xq21.1 cleft lip, cleft palate, cleft palate x-linked,
TBX3 T-box 3 12q24.21 mayer-rokitansky-kuster-hauser syndrome, holt-oram syndrome, ulnar-mammary syndrome
TBX4 T-box 4 17q23.2 radioulnar synostosis, clubfoot, tracheal stenosis,
TBX5 T-box 5 12q24.21 atrioventricular septal defect, atrioventricular block, mayer-rokitansky-kuster-hauser syndrome,
TBX6 T-box 6 16p11.2 spondylocostal dysostosis, klippel-feil syndrome, classic mayer-rokitansky-k??ster-hauser syndrome,
TBXA2R thromboxane A2 receptor 19p13.3 atopy, essential hypertension, gilles de la tourette syndrome,
TBXAS1 thromboxane A synthase 1 (platelet) 7q34 thromboxane synthase deficiency ghosal hematodiaphyseal syndrome
TCAP titin-cap 17q12 neuromuscular disease, limb-girdle muscular dystrophy, familial hypertrophic cardiomyopathy,
TCEAL7 transcription elongation factor A (SII)-like 7 Xq22.1 gastric adenocarcinoma
TCEB2 transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) 16p13.3 renal clear cell carcinoma kidney cancer
TCEB3B transcription elongation factor B polypeptide 3B (elongin A2) 18q21.1 breast and colorectal cancer
TCEB3C transcription elongation factor B polypeptide 3C (elongin A3) 18q21.1 tinea capitis
TCEB3CL transcription elongation factor B polypeptide 3C-like 18q21.1 tinea capitis
TCERG1 transcription elongation regulator 1 5q32 huntingtons disease
TCF12 transcription factor 12 15q21.3 craniosynostosis 3, "craniosynostosis, type 1", craniosynostosis,
TCF19 transcription factor 19 6p21.33 tetraploidy
TCF20 transcription factor 20 (AR1) 22q13.2 pseudosarcomatous fibromatosis
TCF21 transcription factor 21 6q23.2 clear cell renal cell carcinoma
TCF3 transcription factor 3 19p13.3 lymphoblastic leukemia, acute leukemia, acute lymphocytic leukemia,
TCF4 transcription factor 4 18q21.2 type 2 diabetes mellitus, corneal dystrophy fuchs endothelial 1, primary sclerosing cholangitis,
TCF7L2 transcription factor 7-like 2 (T-cell specific, HMG-box) 10q25.2 colorectal cancer, type 2 diabetes mellitus, prostate cancer,
TCHH trichohyalin 1q21.3 pilomatrixoma, epidermolytic hyperkeratosis monilethrix
TCIRG1 T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 11q13.2 hepatoerythropoietic porphyria, osteopetrosis, osteopetrosis autosomal recessive 1,
TCL1A T-cell leukemia/lymphoma 1A 14q32.13 b-cell chronic lymphocytic leukemia, leukemia, malignant germ cell tumor,
TCL1B T-cell leukemia/lymphoma 1B 14q32.13 t-cell leukemia "leukemia/lymphoma, t-cell"
TCL4 T-cell leukemia/lymphoma 4 2q34 "leukemia/lymphoma, t-cell"
TCL6 T-cell leukemia/lymphoma 6 (non-protein coding) 14q32.13 t-cell leukemia
TCN1 transcobalamin I (vitamin B12 binding protein, R binder family) 11q12.1 oral cancer, pernicious anemia vitamin b12 deficiency
TCN2 transcobalamin II 22q12.2 colon adenocarcinoma, neural tube defects, malaria,
TCO Thyroid carcinoma, nonmedullary, with cell oxyphilia 19p13.2 "thyroid carcinoma, nonmedullary, with cell oxyphilia"
TCOF1 Treacher Collins-Franceschetti syndrome 1 5q32 microtia, treacher collins syndrome, choanal atresia,
TCPT thrombocytopenia, Paris-Trousseau type 11q23 paris-trousseau thrombocytopenia
TCTA T-cell leukemia translocation altered 3p21.31 leukemia t-cell leukemia
TCTE1 t-complex-associated-testis-expressed 1 6p21.1 meningocele cleidocranial dysplasia
TCTE3 t-complex-associated-testis-expressed 3 6q27 congenital diaphragmatic hernia
TCTN1 tectonic family member 1 12q24.11 joubert syndrome 21, joubert syndrome and related disorders tctn1-related joubert syndrome
TCTN2 tectonic family member 2 12q24.31 joubert syndrome 21, joubert syndrome and related disorders, meckel syndrome 1,
TCTN3 tectonic family member 3 10q24.1 joubert syndrome and related disorders, orofaciodigital syndrome, joubert syndrome 22,
TDG thymine-DNA glycosylase 12q23.3 "xeroderma pigmentosum, group c" toxic diffuse goiter
TDGF1 teratocarcinoma-derived growth factor 1 3p21.31 septopreoptic holoprosencephaly, midline interhemispheric variant of holoprosencephaly, lobar holoprosencephaly,
TDGF1P3 teratocarcinoma-derived growth factor 1 pseudogene 3 Xq23 germ cell tumors, bladder carcinoma, endometrial carcinoma,
TDGF1P5 teratocarcinoma-derived growth factor 1 pseudogene 5 8q11.23 teratocarcinoma
TDGF1P6 teratocarcinoma-derived growth factor 1 pseudogene 6 3q22.3 teratocarcinoma
TDGF1P7 teratocarcinoma-derived growth factor 1 pseudogene 7 19q13.2 teratocarcinoma
TDH L-threonine dehydrogenase (pseudogene) 8p23.1 keratolytic winter erythema acalculous cholecystitis
TDO2 tryptophan 2,3-dioxygenase 4q32.1 pervasive developmental disorder, schizophrenia, pellagra,
TDP1 tyrosyl-DNA phosphodiesterase 1 14q32.11 neuropathy, ataxia, hereditary ataxia,
TDP2 tyrosyl-DNA phosphodiesterase 2 6p22.3 autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to tud deficiency
TDRD6 tudor domain containing 6 6p12.3 autoimmune polyendocrine syndrome type 1
TDRD7 tudor domain containing 7 9q22.33 cataract 36, glaucoma "cataract, autosomal recessive congenital 4"
TEAD1 TEA domain family member 1 (SV40 transcriptional enhancer factor) 11p15.3 sveinsson choreoretinal atrophy
TEAD4 TEA domain family member 4 12p13.33 cardiac conduction defect
TEC tec protein tyrosine kinase 4p11 behcets disease, transient erythroblastopenia of childhood b cell deficiency
TECPR2 tectonin beta-propeller repeat containing 2 14q32.31 "spastic paraplegia 49, autosomal recessive"
TECR trans-2,3-enoyl-CoA reductase 19p13.12 "mental retardation, autosomal recessive 43", tinea pedis, alazami syndr
TECTA tectorin alpha 11q23.3 "deafness, autosomal recessive 76", "deafness, autosomal dominant 4b", pierson syndrome,
TECTB tectorin beta 10q25.2 enlarged vestibular aqueduct
TEF thyrotrophic embryonic factor 22q13.2 imperforate anus, tracheal stenosis vacterl association
TEK TEK tyrosine kinase, endothelial 9p21.2 colorectal cancer, cavernous hemangioma, hemangioma,
TEKT4 tektin 4 2q11.1 breast and colorectal cancer
TENM3 teneurin transmembrane protein 3 4q34.3 matthew-wood syndrome
TERC telomerase RNA component 3q26.2 cervical cancer, endometrial carcinoma, barretts esophagus,
TERF1 telomeric repeat binding factor (NIMA-interacting) 1 8q21.11 townes-brocks syndrome
TERT telomerase reverse transcriptase 5p15.33 hepatocellular carcinoma, coronary artery disease, acute myeloid leukemia,
TES testis derived transcript (3 LIM domains) 7q31.2 toxocariasis
TESC tescalcin 12q24.22 spindle cell hemangioma
TET1 tet methylcytosine dioxygenase 1 10q21.3 leukemia
TET18P Tetrasomy 18p 18p chromosome 18p tetrasomy
TET2 tet methylcytosine dioxygenase 2 4q24 acute myeloid leukemia, polycythemia vera, blastic plasmacytoid dendritic cell,
TEX101 testis expressed 101 19q13.31 scleroderma
TEX28 testis expressed 28 Xq28 blue cone monochromacy , color blindness, achromatopsia
TEX28P2 testis expressed 28 pseudogene 2 Xq28 blue cone monochromacy , color blindness achromatopsia
TF transferrin 3q22.1 radiation proctitis, nephrotic syndrome, oligospermia,
TFAM transcription factor A, mitochondrial 10q21.1 extrahepatic cholestasis autosomal dominant progressive external ophthalmoplegia
TFAP2A transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) 6p24.3 medulloblastoma, hereditary hemorrhagic telangiectasia, childhood medulloblastoma,
TFAP2B transcription factor AP-2 beta (activating enhancer binding protein 2 beta) 6p12.3 patent ductus arteriosus, skeletal muscle neoplasm, exencephaly
TFAP2C transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) 20q13.31 endometrial carcinoma exencephaly
TFB1M transcription factor B1, mitochondrial 6q25.3 dgke-related atypical hemolytic-uremic syndrome
TFB2M transcription factor B2, mitochondrial 1q44 hepatitis c, hepatitis c virus hepatitis
TFDP3 transcription factor Dp family, member 3 Xq26.2 hepatocellular carcinoma
TFE3 transcription factor binding to IGHM enhancer 3 Xp11.23 alveolar soft part sarcoma, x-linked sideroblastic anemia, mesoblastic nephroma,
TFEB transcription factor EB 6p21.1 pycnodysostosis "renal cell carcinoma, papillary, 1"
TFF1 trefoil factor 1 21q22.3 gastric ulcer, breast cancer, pancreatic cancer,
TFF2 trefoil factor 2 21q22.3 autosomal recessive nonsyndromic deafness burns
TFF3 trefoil factor 3 (intestinal) 21q22.3 prostate cancer, colon cancer, autosomal recessive nonsyndromic deafness,
TFG TRK-fused gene 3q12.2 follicular thyroid carcinoma, chondrosarcoma, myxoid chondrosarcoma,
TFPI tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) 2q32.1 crescentic glomerulonephritis
TFPI2 tissue factor pathway inhibitor 2 7q21.3 amelanotic melanoma fibrosarcoma
TFPT TCF3 (E2A) fusion partner (in childhood Leukemia) 19q13.42 neuroblastoma childhood leukemia
TFR2 transferrin receptor 2 7q22.1 hemochromatosis, porphyria cutanea tarda, "hemochromatosis, type 3",
TFRC transferrin receptor 3q29 gliosarcoma, beta thalassemia, malaria,
TG thyroglobulin 8q24.22 graves disease, thyrotoxicosis, nodular goiter,
TGCT1 testicular germ cell tumor susceptibility 1 Xq27 germ cell tumors testicular germ cell tumor
TGFA transforming growth factor, alpha 2p13.3 embryonal cancer, cavernous hemangioma, "tooth agenesis, selective, 1, with or without orofacial cleft",
TGFB1 transforming growth factor, beta 1 19q13.2 laryngitis, burn scar, recessive dystrophic epidermolysis bullosa,
TGFB1I1 transforming growth factor beta 1 induced transcript 1 16p11.2 mesangial proliferative glomerulonephritis prostate cancer
TGFB2 transforming growth factor, beta 2 1q41 osteochondroma, seborrheic keratosis, diabetic retinopathy,
TGFB3 transforming growth factor, beta 3 14q24.3 juvenile nasopharyngeal angiofibroma, cleft lip, cleft palate,
TGFBI transforming growth factor, beta-induced, 68kDa 5q31.1 corneal dystrophy, variant creutzfeldt-jakob disease, corneal dystrophy thiel behnke type,
TGFBR1 transforming growth factor, beta receptor 1 9q22.33 colorectal cancer, breast cancer, transient hypogammaglobulinemia,
TGFBR2 transforming growth factor, beta receptor II (70/80kDa) 3p24.1 colorectal cancer, breast cancer, gallbladder cancer,
TGFBR3 transforming growth factor, beta receptor III 1p22.1 priapism familial cerebral saccular aneurysm
TGIF1 TGFB-induced factor homeobox 1 18p11.31 moyamoya disease, prostate cancer, septopreoptic holoprosencephaly,
TGM1 transglutaminase 1 14q12 renal agenesis, x-linked ichthyosis, autosomal recessive congenital ichthyosis,
TGM2 transglutaminase 2 20q11.23 celiac disease, chorea-acanthocytosis, huntingtons disease,
TGM4 transglutaminase 4 3p21.31 prostate cancer lip cancer
TGM5 transglutaminase 5 15q15.2 congenital dyserythropoietic anemia type i, congenital dyserythropoietic anemia, peeling skin syndrome
TGM6 transglutaminase 6 20p13 ataxia, spinocerebellar ataxia, inherited acute myeloid leukemia,
TGS1 trimethylguanosine synthase 1 8q12.1 hepatocellular carcinoma
TH tyrosine hydroxylase 11p15.5 parkinsons disease, schizophrenia, neuroblastoma,
THADA thyroid adenoma associated 2p21 adenoma thyroid adenoma
THAP1 THAP domain containing, apoptosis associated protein 1 8p11.21 aicardi-goutieres syndrome, dystonia, torsion dystonia,
THAP10 THAP domain containing 10 15q23 breast cancer
THAS thoracoabdominal syndrome X thoracoabdominal syndrome
THBD thrombomodulin 20p11.21 dysfibrinogenemia, peripheral vascular disease, diabetic macular edema,
THBS1 thrombospondin 1 15q14 diabetic retinopathy, pilocytic astrocytoma, acute chest syndrome,
THBS2 thrombospondin 2 6q27 posterior uveal melanoma, hydrolethalus syndrome, hydrolethalus syndrome 1
THBS4 thrombospondin 4 5q14.1 coronary artery disease, hypertrophic scars, mesoblastic nephroma
THCYTX Thrombocytosis, familial X-linked "thrombocythemia, x-linked"
THEM5 thioesterase superfamily member 5 1q21.3 glossitis median rhomboid glossitis
THEMIS2 thymocyte selection associated family member 2 1p35.3 endometrial adenocarcinoma
THM thymoma reserved thymoma absence of tibia
THOC5 THO complex 5 22q12.2 meningioma
THOC6 THO complex 6 homolog (Drosophila) 16p13.3 beaulieu-boycott-innes syndrome
THPO thrombopoietin 3q27.1 myelofibrosis, bernard-soulier syndrome, thrombocytosis,
THRA thyroid hormone receptor, alpha 17q21.1 hyperthyroxinemia, follicular thyroid carcinoma "hypothyroidism, congenital, nongoitrous, 6"
THRAP3P1 thyroid hormone receptor associated protein 3 pseudogene 1 3p23 hiv-1
THRB thyroid hormone receptor, beta 3p24.2 generalized resistance to thyroid hormone, goiter, thyroid hormone resistance syndrome,
THRSP thyroid hormone responsive 11q14.1 euthyroid sick syndrome
THSD7A thrombospondin, type I, domain containing 7A 7p21.3 osteoporosis
THTPA thiamine triphosphatase 14q11.2 wernicke-korsakoff syndrome
THY1 Thy-1 cell surface antigen 11q23.3 mesangial proliferative glomerulonephritis, central retinal artery occlusion retinal artery occlusion
TIA1 TIA1 cytotoxic granule-associated RNA binding protein 2p13.3 reticulosarcoma, peripheral t-cell lymphoma, panniculitis,
TIAM1 T-cell lymphoma invasion and metastasis 1 21q22.11 colorectal cancer, quadriplegia spastic quadriplegia
TICAM1 toll-like receptor adaptor molecule 1 19p13.3 herpes simplex encephalitis 1, herpes simplex encephalitis, encephalitis,
TICAM2 toll-like receptor adaptor molecule 2 5q22.3 vaccinia
TIGD2 tigger transposable element derived 2 4q22.1 intrahepatic cholangiocarcinoma
TIMD4 T-cell immunoglobulin and mucin domain containing 4 5q33.3 malaria histiocytic sarcoma
TIMELESS timeless circadian clock 12q13.3 prostate cancer, breast cancer, lung cancer,
TIMM13 translocase of inner mitochondrial membrane 13 homolog (yeast) 19p13.3 appendiceal neoplasm, cortical blindness deafness dystonia syndrome
TIMM17A translocase of inner mitochondrial membrane 17 homolog A (yeast) 1q32.1 barth syndrome
TIMM23 translocase of inner mitochondrial membrane 23 homolog (yeast) 10q11.23 deafness dystonia syndrome
TIMM8A translocase of inner mitochondrial membrane 8 homolog A (yeast) Xq22.1 x-linked disease, dystonia, focal dystonia,
TIMMDC1 translocase of inner mitochondrial membrane domain containing 1 3q13.33 primary biliary cirrhosis
TIMP1 TIMP metallopeptidase inhibitor 1 Xp11.23 retinitis pigmentosa 2, endodermal sinus tumor, pulpitis,
TIMP2 TIMP metallopeptidase inhibitor 2 17q25.3 moyamoya disease, rheumatic heart disease, varicose veins,
TIMP3 TIMP metallopeptidase inhibitor 3 22q12.3 colorectal cancer, diabetic retinopathy, pilocytic astrocytoma,
TIMP4 TIMP metallopeptidase inhibitor 4 3p25.2 idiopathic pulmonary fibrosis
TINAG tubulointerstitial nephritis antigen 6p12.1 nephritis
TINAGL1 tubulointerstitial nephritis antigen-like 1 1p35.2 nephritis
TINF2 TERF1 (TRF1)-interacting nuclear factor 2 14q12 aplastic anemia, "dyskeratosis congenita, autosomal recessive 4", dyskeratosis congenita,
TIPARP TCDD-inducible poly(ADP-ribose) polymerase 3q25.31 diphtheria
TIRAP toll-interleukin 1 receptor (TIR) domain containing adaptor protein 11q24.2 malaria, tuberculosis, bacteremia,
TJP1 tight junction protein 1 15q13.1 malaria
TJP2 tight junction protein 2 9q21.11 ataxia, friedreich ataxia, "deafness, autosomal dominant 4b",
TK1 thymidine kinase 1, soluble 17q25.3 thanatophoric dysplasia, hypochondroplasia, colorectal cancer
TK2 thymidine kinase 2, mitochondrial 16q21 mitochondrial dna depletion syndrome, iminoglycinuria, "mitochondrial dna depletion syndrome, myopathic form",
TKCR torticollis, keloids, cryptorchidism and renal dysplasia Xq28 goeminne tkcr syndrome keloids
TKT transketolase 3p21.1 thanatophoric dysplasia, gliosarcoma, colorectal cancer,
TKTL1 transketolase-like 1 Xq28 hypochondroplasia, nasopharyngitis wernicke-korsakoff syndrome
TKTL2 transketolase-like 2 4q32.2 nasopharyngitis
TLE1 transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) 9q21.32 acute myeloid leukemia west syndrome
TLE2 transducin-like enhancer of split 2 19p13.3 spindle cell sarcoma
TLL1 tolloid-like 1 4q32.3 patent foramen ovale, mandibuloacral dysplasia, heart septal defect,
TLR1 toll-like receptor 1 4p14 malt lymphoma, leprosy, pulmonary tuberculosis,
TLR10 toll-like receptor 10 4p14 menieres disease melioidosis
TLR12P toll-like receptor 12, pseudogene 1p35.1 cytomegalovirus infection
TLR2 toll-like receptor 2 4q31.3 colorectal cancer, burning mouth syndrome, malaria,
TLR3 toll-like receptor 3 4q35.1 herpes simplex encephalitis 1, herpes simplex encephalitis, encephalitis,
TLR4 toll-like receptor 4 9q33.1 colorectal cancer, malaria, "systemic lupus erythematosus, association with",
TLR5 toll-like receptor 5 1q41 systemic lupus erythematosus, lupus erythematosus, legionaire disease,
TLR6 toll-like receptor 6 4p14 asthma, invasive aspergillosis, pelvic inflammatory disease
TLR7 toll-like receptor 7 Xp22.2 congenital heart block anogenital venereal wart
TLR8 toll-like receptor 8 Xp22.2 hemorrhagic fever crimean-congo hemorrhagic fever
TLR9 toll-like receptor 9 3p21.2 malaria, "systemic lupus erythematosus, association with", hemorrhagic fever,
TLX1 T-cell leukemia homeobox 1 10q24.31 split foot, split hand, leukemia,
TLX2 T-cell leukemia homeobox 2 2p13.1 t-cell leukemia megacolon
TLX3 T-cell leukemia homeobox 3 5q35.1 precursor t-cell acute lymphoblastic leukemia, t-cell leukemia, congenital central hypoventilation syndrome
TM4SF20 transmembrane 4 L six family member 20 2q36.3 autism spectrum disorder specific language impairment 5
TMBIM4 transmembrane BAX inhibitor motif containing 4 12q14.3 lymphocytic choriomeningitis, alpha 1-antitrypsin deficiency, lassa fever,
TMC1 transmembrane channel-like 1 9q21.13 "deafness, autosomal recessive 76", "deafness, autosomal dominant 4b", megacolon,
TMC3 transmembrane channel-like 3 15q25.1 epidermodysplasia verruciformis
TMC4 transmembrane channel-like 4 19q13.42 gas gangrene
TMC6 transmembrane channel-like 6 17q25.3 epidermodysplasia verruciformis, pityriasis versicolor reticular dysgenesis
TMC8 transmembrane channel-like 8 17q25.3 epidermodysplasia verruciformis, pityriasis versicolor reticular dysgenesis
TMCO1 transmembrane and coiled-coil domains 1 1q24.1 cystic nephroma, glaucoma, open-angle glaucoma
TMEFF1 transmembrane protein with EGF-like and two follistatin-like domains 1 9q31.1 brain cancer
TMEM100 transmembrane protein 100 17q22 autism spectrum disorder
TMEM114 transmembrane protein 114 16p13.2 microphthalmia with cataract 2
TMEM126A transmembrane protein 126A 11q14.1 auditory neuropathy, staphyloenterotoxemia, optic atrophy
TMEM127 transmembrane protein 127 2q11.2 pheochromocytoma, renal clear cell carcinoma, corneal staphyloma,
TMEM131 transmembrane protein 131 2q11.2 campylobacteriosis
TMEM132E transmembrane protein 132E 17q12 glycogen storage disease xv
TMEM138 transmembrane protein 138 11q12.2 joubert syndrome and related disorders, joubert syndrome 2, joubert syndrome,
TMEM139 transmembrane protein 139 7q34 intrahepatic cholangiocarcinoma
TMEM158 transmembrane protein 158 (gene/pseudogene) 3p21.31 brain injury ductal carcinoma in situ
TMEM165 transmembrane protein 165 4q12 camurati-engelmann disease, frey syndrome "congenital disorder of glycosylation, type iik"
TMEM173 transmembrane protein 173 5q31.2 neurogenic bladder, japanese encephalitis ureterocele
TMEM176A transmembrane protein 176A 7q36.1 hepatocellular carcinoma
TMEM182 transmembrane protein 182 2q12.1 low tension glaucoma
TMEM185A transmembrane protein 185A Xq28 pervasive developmental disorder, atypical autism fraxf syndrome
TMEM2 transmembrane protein 2 9q21.13 benign familial infantile epilepsy
TMEM207 transmembrane protein 207 3q28 signet ring cell adenocarcinoma
TMEM216 transmembrane protein 216 11q12.2 joubert syndrome and related disorders, doid:4019, joubert syndrome 22,
TMEM231 transmembrane protein 231 16q23.1 joubert syndrome and related disorders, doid:4019, meckel syndrome 1,
TMEM237 transmembrane protein 237 2q33.1 amyotrophic lateral sclerosis, joubert syndrome 21, joubert syndrome and related disorders,
TMEM256 transmembrane protein 256 17p13.1 intrahepatic cholangiocarcinoma
TMEM27 transmembrane protein 27 Xp22.2 hartnup disease
TMEM30B transmembrane protein 30B 14q23.1 malignant peritoneal mesothelioma
TMEM38B transmembrane protein 38B 9q31.2 osteogenesis imperfecta type 4 "osteogenesis imperfecta, type xiv"
TMEM43 transmembrane protein 43 3p25.1 "familial isolated arrhythmogenic ventricular dysplasia, biventricular form", "familial isolated arrhythmogenic ventricular dysplasia, right dominant form", "familial isolated arrhythmogenic ventricular dysplasia, left dominant form",
TMEM5 transmembrane protein 5 12q14.2 lissencephaly, blastoma, pleuropulmonary blastoma,
TMEM50A transmembrane protein 50A 1p36.11 cervical cancer
TMEM54 transmembrane protein 54 1p35.1 hard palate cancer
TMEM62 transmembrane protein 62 15q15.2 congenital dyserythropoietic anemia type i
TMEM67 transmembrane protein 67 8q22.1 joubert syndrome 21, joubert syndrome and related disorders, "bardet-biedl syndrome 14, modifier of",
TMEM70 transmembrane protein 70 8q21.11 mitochondrial complex v deficiency "mitochondrial complex v deficiency, nuclear type 2"
TMEM87A transmembrane protein 87A 15q15.1 congenital dyserythropoietic anemia type i
TMEM88 transmembrane protein 88 17p13.1 lung adenocarcinoma
TMEM8B transmembrane protein 8B 9p13.3 nasopharynx carcinoma
TMEM9 transmembrane protein 9 1q32.1 exfoliation syndrome
TMIE transmembrane inner ear 3p21.31 "deafness, autosomal recessive 76", deafness and hereditary hearing loss, "deafness, autosomal recessive 6"
TMLHE trimethyllysine hydroxylase, epsilon Xq28 epsilon-trimethyllysine hydroxylase deficiency
TMOD2 tropomodulin 2 (neuronal) 15q21.2 amyotrophic lateral sclerosis
TMOD4 tropomodulin 4 (muscle) 1q21.3 osteosarcoma
TMPO thymopoietin 12q23.1 lymphocytic choriomeningitis, oral candidiasis, alopecia,
TMPRSS11A transmembrane protease, serine 11A 4q13.2 esophageal cancer, iron-refractory iron deficiency anemia, deficiency anemia,
TMPRSS11D transmembrane protease, serine 11D 4q13.2 brain stem glioma
TMPRSS15 transmembrane protease, serine 15 21q21.1 diarrhea, steatorrhea, hereditary pancreatitis,
TMPRSS2 transmembrane protease, serine 2 21q22.3 prostate cancer
TMPRSS3 transmembrane protease, serine 3 21q22.3 "deafness, autosomal recessive 76", "deafness, autosomal recessive 8/10" dfnb 8/10 nonsyndromic hearing loss and deafness
TMPRSS4 transmembrane protease, serine 4 11q23.3 autosomal recessive cerebral atrophy
TMPRSS6 transmembrane protease, serine 6 22q12.3 iron-refractory iron deficiency anemia, deficiency anemia iron deficiency anemia
TMSB10 thymosin beta 10 2p11.2 chronic graft versus host disease
TMSB15A thymosin beta 15a Xq22.1 neuroblastoma
TMTC1 transmembrane and tetratricopeptide repeat containing 1 12p11.22 spinal cord disease, radiculopathy diffuse idiopathic skeletal hyperostosis
TNAP TRAFs and NIK-associated protein ankylosing spondylitis
TNC tenascin C 9q33.1 usual interstitial pneumonia, pilocytic astrocytoma, astrocytoma,
TNDM diabetes mellitus, transient neonatal diabetes mellitus transient neonatal diabetes mellitus
TNF tumor necrosis factor 6p21.33 asthma, monoclonal gammopathy of uncertain significance, carotid intimal medial thickness,
TNFAIP1 tumor necrosis factor, alpha-induced protein 1 (endothelial) 17q11.2 malaria
TNFAIP2 tumor necrosis factor, alpha-induced protein 2 14q32.32 acute promyelocytic leukemia primary mediastinal large b-cell lymphoma
TNFAIP3 tumor necrosis factor, alpha-induced protein 3 6q23.3 hodgkins lymphoma
TNFAIP6 tumor necrosis factor, alpha-induced protein 6 2q23.3 chronic active epstein-barr virus infection, rheumatoid arthritis, arthritis
TNFRSF10A tumor necrosis factor receptor superfamily, member 10a 8p21.3 colon cancer, lung cancer post-transplant lymphoproliferative disease
TNFRSF10B tumor necrosis factor receptor superfamily, member 10b 8p21.3 amyotrophic lateral sclerosis, squamous cell carcinoma of the head and neck, pancreatic cancer
TNFRSF10C tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain 8p21.3 pancreatic cancer
TNFRSF11A tumor necrosis factor receptor superfamily, member 11a, NFKB activator 18q21.33 humoral hypercalcemia of malignancy, osteoporosis, pagets disease of bone,
TNFRSF11B tumor necrosis factor receptor superfamily, member 11b 8q24.12 myeloma, pericardial effusion, coronary artery disease,
TNFRSF12A tumor necrosis factor receptor superfamily, member 12A 16p13.3 glioblastoma multiforme
TNFRSF13B tumor necrosis factor receptor superfamily, member 13B 17p11.2 common variable immune deficiency, "immunodeficiency, common variable, 9", common variable immunodeficiency,
TNFRSF13C tumor necrosis factor receptor superfamily, member 13C 22q13.2 rheumatic disease, primary biliary cirrhosis, systemic lupus erythematosus,
TNFRSF14 tumor necrosis factor receptor superfamily, member 14 1p36.32 herpes simplex, follicular lymphoma subacute sclerosing panencephalitis
TNFRSF17 tumor necrosis factor receptor superfamily, member 17 16p13.13 myeloma, primary biliary cirrhosis, multiple myeloma
TNFRSF18 tumor necrosis factor receptor superfamily, member 18 1p36.33 diverticulitis wegeners granulomatosis
TNFRSF19 tumor necrosis factor receptor superfamily, member 19 13q12.12 hypohidrotic ectodermal dysplasia
TNFRSF1A tumor necrosis factor receptor superfamily, member 1A 12p13.31 wells syndrome, relapsing fever, systemic lupus erythematosus,
TNFRSF1B tumor necrosis factor receptor superfamily, member 1B 1p36.22 schizophrenia, rheumatoid arthritis, malaria,
TNFRSF25 tumor necrosis factor receptor superfamily, member 25 1p36.31 type 1 diabetes mellitus
TNFRSF4 tumor necrosis factor receptor superfamily, member 4 1p36.33 graves disease, myasthenia gravis, thymoma,
TNFRSF6B tumor necrosis factor receptor superfamily, member 6b, decoy 20q13.33 hepatocellular carcinoma, autoimmune hepatitis, pancreatic cancer,
TNFRSF8 tumor necrosis factor receptor superfamily, member 8 1p36.22 reticulosarcoma, lymphoepithelioma-like carcinoma, malaria,
TNFRSF9 tumor necrosis factor receptor superfamily, member 9 1p36.23 follicular dendritic cell tumor
TNFSF10 tumor necrosis factor (ligand) superfamily, member 10 3q26.31 hepatocellular carcinoma, pericardial effusion, prostate cancer,
TNFSF11 tumor necrosis factor (ligand) superfamily, member 11 13q14.11 cherubism, myeloma, prostate cancer,
TNFSF12 tumor necrosis factor (ligand) superfamily, member 12 17p13.1 septic shock, klippel-trenaunay syndrome, type 1 diabetes mellitus,
TNFSF12-TNFSF13 TNFSF12-TNFSF13 readthrough 17p13.1 rheumatic disease
TNFSF13 tumor necrosis factor (ligand) superfamily, member 13 17p13.1 b-cell chronic lymphocytic leukemia, glioblastoma multiforme brain glioblastoma multiforme
TNFSF13B tumor necrosis factor (ligand) superfamily, member 13b 13q33.3 myasthenia gravis, systemic lupus erythematosus, chronic lymphocytic leukemia,
TNFSF15 tumor necrosis factor (ligand) superfamily, member 15 9q32 primary biliary cirrhosis irritable bowel syndrome
TNFSF18 tumor necrosis factor (ligand) superfamily, member 18 1q25.1 lumbar disc herniation
TNFSF4 tumor necrosis factor (ligand) superfamily, member 4 1q25.1 myocardial infarction, stromal keratitis, takayasus arteritis,
TNFSF8 tumor necrosis factor (ligand) superfamily, member 8 9q32 takayasus arteritis, hodgkins lymphoma spastic diplegia
TNFSF9 tumor necrosis factor (ligand) superfamily, member 9 19p13.3 primary biliary cirrhosis wegeners granulomatosis
TNIP1 TNFAIP3 interacting protein 1 5q33.1 hiv-1, systemic lupus erythematosus, rheumatoid arthritis,
TNK2 tyrosine kinase, non-receptor, 2 3q29 infantile-onset mesial temporal lobe epilepsy with severe cognitive regression
TNKS tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 8p23.1 cherubism, diphtheria cerebral atherosclerosis
TNKS2 tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 10q23.32 cherubism
TNMD tenomodulin Xq22.1 obesity mitral valve insufficiency
TNN tenascin N 1q25.1 dysplastic nevus syndrome
TNNC1 troponin C type 1 (slow) 3p21.1 familial hypertrophic cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy,
TNNI1 troponin I type 1 (skeletal, slow) 1q32.1 atrophy of testis
TNNI2 troponin I type 2 (skeletal, fast) 11p15.5 fissured tongue, distal arthrogryposis, arthrogryposis multiplex congenita distal type 1,
TNNI3 troponin I type 3 (cardiac) 19q13.42 myocardial infarction, myocardial stunning, familial hypertrophic cardiomyopathy,
TNNI3K TNNI3 interacting kinase 1p31.1 restrictive cardiomyopathy
TNNT1 troponin T type 1 (skeletal, slow) 19q13.42 myopathy, restrictive cardiomyopathy, leukorrhea,
TNNT2 troponin T type 2 (cardiac) 1q32.1 myocardial infarction, myocardial stunning, familial hypertrophic cardiomyopathy,
TNNT3 troponin T type 3 (skeletal, fast) 11p15.5 congenital contractures, fissured tongue, distal arthrogryposis,
TNPO1 transportin 1 5q13.2 retinitis pigmentosa 2 legionnaires disease
TNPO3 transportin 3 7q32.1 primary biliary cirrhosis, hiv-1 limb-girdle muscular dystrophy type 1f
TNR tenascin R 1q25.1 osteochondritis dissecans familial osteochondritis dissecans
TNS1 tensin 1 2q35 bannayan-riley-ruvalcaba syndrome, ruvalcaba syndrome cowden disease
TNS4 tensin 4 17q21.2 kidney cancer
TNXA tenascin XA (pseudogene) 6p21.33 scott syndrome, juvenile rheumatoid arthritis, burns
TNXB tenascin XB 6p21.33 hypermobility syndrome, ehlers-danlos syndrome, "ehlers-danlos syndrome, hypermobility type",
TOC tylosis with oesophageal cancer tylosis with esophageal cancer
TOMM40 translocase of outer mitochondrial membrane 40 homolog (yeast) 19q13.32 charcot-marie-tooth neuropathy type 2, alzheimers disease, barth syndrome,
TOMM5 translocase of outer mitochondrial membrane 5 homolog (yeast) 9p13.2 bronchiolitis, bronchiolitis obliterans organizing pneumonia cryptogenic organizing pneumonia
TOP1 topoisomerase (DNA) I 20q12 colorectal cancer, pericardial effusion, colon cancer,
TOP2A topoisomerase (DNA) II alpha 170kDa 17q21.2 breast cancer, neuroblastoma, "dna topoisomerase ii inhibition of, by amsacrine"
TOP3A topoisomerase (DNA) III alpha 17p11.2 "fanconi anemia, complementation group m"
TOP3B topoisomerase (DNA) III beta 22q11.22 breast cancer
TOPORS topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase 9p21.1 leber congenital amaurosis, retinitis, retinitis pigmentosa,
TOR1A torsin family 1, member A (torsin A) 9q34.11 acanthocytosis, chorea-acanthocytosis, dystonia,
TOR1B torsin family 1, member B (torsin B) 9q34.11 torsion dystonia focal dystonia
TOR2A torsin family 2, member A 9q34.11 torsion dystonia atherosclerosis
TOR3A torsin family 3, member A 1q25.2 torsion dystonia
TOX3 TOX high mobility group box family member 3 16q12.1 breast cancer susceptibility, breast cancer male breast cancer
TP53 tumor protein p53 17p13.1 hepatocellular carcinoma, gliosarcoma, giant cell glioblastoma,
TP53AIP1 tumor protein p53 regulated apoptosis inducing protein 1 11q24.3 brain cancer oral leukoplakia
TP53I3 tumor protein p53 inducible protein 3 2p23.3 squamous cell carcinoma of the head and neck
TP53INP2 tumor protein p53 inducible nuclear protein 2 20q11.22 obesity
TP53RK TP53 regulating kinase 20q13.12 shipyard eye
TP63 tumor protein p63 3q28 seborrheic keratosis, papilloma, keratosis,
TP73 tumor protein p73 1p36.32 neuroblastoma, astrocytoma, epstein-barr virus-associated gastric carcinoma,
TPBG trophoblast glycoprotein 6q14.1 malignant pleural mesothelioma vaccinia
TPD52L2 tumor protein D52-like 2 20q13.33 breast cancer lymphoblastic leukemia
TPH1 tryptophan hydroxylase 1 11p15.1 schizophrenia, west syndrome, infantile epileptic encephalopathy,
TPH2 tryptophan hydroxylase 2 12q21.1 schizophrenia, endogenous depression, bipolar disorder,
TPI1 triosephosphate isomerase 1 12p13.31 malaria, giardiasis, molybdenum cofactor deficiency,
TPK1 thiamin pyrophosphokinase 1 7q35 beriberi, wernicke-korsakoff syndrome thiamine metabolism dysfunction syndrome 5
TPM1 tropomyosin 1 (alpha) 15q22.2 familial hypertrophic cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy,
TPM2 tropomyosin 2 (beta) 9p13.3 congenital fiber-type disproportion, myopathy, childhood-onset nemaline myopathy,
TPM3 tropomyosin 3 1q21.3 reticulosarcoma, "myopathy, congenital, with fiber-type disproportion 1", congenital fiber-type disproportion,
TPM4 tropomyosin 4 19p13.12 inflammatory myofibroblastic tumor
TPMT thiopurine S-methyltransferase 6p22.3 autoimmune hepatitis, leukopenia, invasive aspergillosis,
TPO thyroid peroxidase 2p25.3 graves disease, hyperthyroidism, nodular goiter,
TPP1 tripeptidyl peptidase I 11p15.4 argininosuccinic aciduria, neuronal ceroid-lipofuscinoses, late-infantile neuronal ceroid lipofuscinosis,
TPPP tubulin polymerization promoting protein 5p15.33 lewy body dementia
TPPP3 tubulin polymerization-promoting protein family member 3 16q22.1 schizophrenia, myelomeningocele, huntingtons disease,
TPR translocated promoter region, nuclear basket protein 1q31.1 8p11 myeloproliferative syndrome, follicular thyroid carcinoma, pediatric ependymoma
TPRN taperin 9q34.3 "deafness, autosomal recessive 76", dfnb79 nonsyndromic hearing loss and deafness "deafness, autosomal recessive 79"
TPSAB1 tryptase alpha/beta 1 16p13.3 asthma, abdominal aortic aneurysm, cutaneous mastocytosis,
TPSB2 tryptase beta 2 (gene/pseudogene) 16p13.3 asthma
TPSD1 tryptase delta 1 16p13.3 asthma
TPSG1 tryptase gamma 1 16p13.3 asthma
TPST1 tyrosylprotein sulfotransferase 1 7q11.21 shwachman-diamond syndrome
TPT1 tumor protein, translationally-controlled 1 13q14.13 mycetoma
TPX2 TPX2, microtubule-associated 20q11.21 hepatocellular carcinoma colorectal cancer
TRA T cell receptor alpha locus 14q11.2 precursor t-cell acute lymphoblastic leukemia, "immunodeficiency 7, tcr-alpha/beta deficient", feltys syndrome,
TRAC T cell receptor alpha constant 14q11.2 "immunodeficiency 7, tcr-alpha/beta deficient" hypersensitivity reaction type ii disease
TRADD TNFRSF1A-associated via death domain 16q22.1 north american indian childhood cirrhosis
TRAF2 TNF receptor-associated factor 2 9q34.3 factor 2 deficiency
TRAF3 TNF receptor-associated factor 3 14q32.32 herpes simplex encephalitis 1, herpes simplex encephalitis 3, herpes simplex encephalitis,
TRAF3IP2 TRAF3 interacting protein 2 6q21 "candidiasis, familial, 8", psoriasis susceptibility 13 "candidiasis, familial, 2, autosomal recessive"
TRAF4 TNF receptor-associated factor 4 17q11.2 mulibrey nanism
TRAF5 TNF receptor-associated factor 5 1q32.2 mulibrey nanism
TRAF6 TNF receptor-associated factor 6, E3 ubiquitin protein ligase 11p12 "ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant" hypohidrotic ectodermal dysplasia
TRAF7 TNF receptor-associated factor 7, E3 ubiquitin protein ligase 16p13.3 secretory meningioma
TRAK1 trafficking protein, kinesin binding 1 3p22.1 hypertonia
TRAK2 trafficking protein, kinesin binding 2 2q33.1 amyotrophic lateral sclerosis lateral sclerosis
TRAM1L1 translocation associated membrane protein 1-like 1 4q26 alcohol dependence
TRAM2 translocation associated membrane protein 2 6p12.2 polycystic kidney and hepatic disease
TRAP triiodothyronine receptor auxiliary protein cataract 36
TRAP1 TNF receptor-associated protein 1 16p13.3 hereditary multiple exostoses
TRAPPC1 trafficking protein particle complex 1 17p13.1 myeloma multiple myeloma
TRAPPC11 trafficking protein particle complex 11 4q35.1 intellectual disability-hyperkinetic movement-truncal ataxia syndrome, calpainopathy intellectual disability
TRAPPC2 trafficking protein particle complex 2 Xp22.2 x-linked spondyloepiphyseal dysplasia tarda, osteochondrodysplasia leber hereditary optic neuropathy
TRAPPC2P1 trafficking protein particle complex 2 pseudogene 1 19q13.43 x-linked spondyloepiphyseal dysplasia tarda
TRAPPC9 trafficking protein particle complex 9 8q24.3 intellectual disability - obesity - brain malformations - facial dysmorphism "mental retardation, autosomal recessive 43"
TRB T cell receptor beta locus 7q34 precursor t-cell acute lymphoblastic leukemia, guttate psoriasis, eosinophilic fasciitis,
TRBJ2-5 T cell receptor beta joining 2-5 7q34 diverticulitis
TRBV6-2 T cell receptor beta variable 6-2 (gene/pseudogene) 7q34 peripheral t-cell lymphoma
TRD T cell receptor delta locus 14q11.2 acute myeloid leukemia, lymphoblastic leukemia, subcutaneous panniculitis-like t-cell lymphoma,
TRDN triadin 6q22.31 catecholaminergic polymorphic ventricular tachycardia, "ventricular tachycardia, catecholaminergic polymorphic, 2", "ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness",
TREH trehalase (brush-border membrane glycoprotein) 11q23.3 intestinal atresia, oligohydramnios, trehalase deficiency ,
TREM1 triggering receptor expressed on myeloid cells 1 6p21.1 acute cholangitis, suppurative cholangitis, septic shock
TREM2 triggering receptor expressed on myeloid cells 2 6p21.1 amyotrophic lateral sclerosis, polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, trem2-related polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy,
TREML1 triggering receptor expressed on myeloid cells-like 1 6p21.1 gray platelet syndrome
TRERF1 transcriptional regulating factor 1 6p21.1 breast cancer, estrogen resistance swayback
TRESMCR TRE oncogene, Smith Magenis syndrome chromosome region 17p11.2 smith magenis syndrome
TREX1 three prime repair exonuclease 1 3p21.31 systemic lupus erythematosus, encephalitis, chilblain lupus ,
TRG T cell receptor gamma locus 7p14 rheumatic disease, angioimmunoblastic lymphadenopathy with dysproteinemia, cytophagic histiocytic panniculitis,
TRH thyrotropin-releasing hormone 3q22.1 exophthalmos, thyrotropin-releasing hormone deficiency , central hypothyroidism and testicular enlargement,
TRHDE thyrotropin-releasing hormone degrading enzyme 12q21.1 good syndrome
TRHR thyrotropin-releasing hormone receptor 8q23.1 prolactinoma, resistance to thyrotropin-releasing hormone syndrome, "thyrotropin-releasing hormone resistance, generalized",
TRIB1 tribbles pseudokinase 1 8q24.13 megakaryocytic leukemia familial hypercholesterolemia
TRIB3 tribbles pseudokinase 3 20p13 anoxia insulin resistance
TRICY1 trichilemmal cyst 1 3p24.1-p22.1 trichilemmal cyst 1
TRIM11 tripartite motif containing 11 1q42.13 congenital central hypoventilation syndrome central hypoventilation syndrome
TRIM13 tripartite motif containing 13 13q14.2 b-cell chronic lymphocytic leukemia, leukemia chronic lymphocytic leukemia
TRIM2 tripartite motif containing 2 4q31.3 "charcot-marie-tooth disease, type 2r"
TRIM21 tripartite motif containing 21 11p15.4 rheumatic disease, sjogrens syndrome, congenital heart block,
TRIM22 tripartite motif containing 22 11p15.4 hiv-1, mhc class ii deficiency, congenital erythropoietic porphyria
TRIM23 tripartite motif containing 23 5q12.3 cholera
TRIM24 tripartite motif containing 24 7q33 8p11 myeloproliferative syndrome, intestinal disaccharidase deficiency, cerebellar agenesis,
TRIM25 tripartite motif containing 25 17q22 breast cancer
TRIM26 tripartite motif containing 26 6p22.1 endodermal sinus tumor seizure disorder
TRIM27 tripartite motif containing 27 6p22.1 follicular thyroid carcinoma
TRIM29 tripartite motif containing 29 11q23.3 ataxia telangiectasia ataxia
TRIM31 tripartite motif containing 31 6p22.1 lymphocytic choriomeningitis
TRIM32 tripartite motif containing 32 9q33.1 hiv-1, "bardet-biedl syndrome 1, modifier of", bardet-biedl syndrome 15,
TRIM33 tripartite motif containing 33 1p13.2 follicular thyroid carcinoma papillary thyroid carcinoma
TRIM37 tripartite motif containing 37 17q22 mulibrey nanism ovarian fibrothecoma
TRIM38 tripartite motif containing 38 6p22.2 acute promyelocytic leukemia
TRIM39 tripartite motif containing 39 6p22.1 dissociative disorder
TRIM4 tripartite motif containing 4 7q22.1 dermatophytosis
TRIM47 tripartite motif containing 47 17q25.1 astrocytoma
TRIM54 tripartite motif containing 54 2p23.3 cardiac rupture
TRIM62 tripartite motif containing 62 1p35.1 ring chromosome 1
TRIM63 tripartite motif containing 63, E3 ubiquitin protein ligase 1p36.11 myopathy of critical illness alveolar soft part sarcoma
TRIM68 tripartite motif containing 68 11p15.4 prostate cancer
TRIM74 tripartite motif containing 74 7q11.23 williams-beuren syndrome
TRIOBP TRIO and F-actin binding protein 22q13.1 "deafness, autosomal recessive 28", dfnb28 nonsyndromic hearing loss and deafness, "deafness, autosomal recessive 76",
TRIP11 thyroid hormone receptor interactor 11 14q32.12 mucopolysaccharidosis iii, achondrogenesis type ia achondrogenesis
TRIP12 thyroid hormone receptor interactor 12 2q36.3 chronic dacryocystitis dacryocystitis
TRIP13 thyroid hormone receptor interactor 13 5p15.33 lung cancer
TRIP4Q32.1Q32.2 Chromosome 4q32.1-q32.2 triplication syndrome 4q32.1-q32.2 chromosome 4q32.1-q32.2 triplication syndrome
TRIT1 tRNA isopentenyltransferase 1 1p34.2 tinea pedis
TRMT10A tRNA methyltransferase 10 homolog A (S. cerevisiae) 4q23 primary microcephaly-mild intellectual disability-young-onset diabetes syndrome
TRMT12 tRNA methyltransferase 12 homolog (S. cerevisiae) 8q24.13 noma
TRMU tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase 22q13.31 "liver failure, transient infantile", "deafness, mitochondrial, modifier of", liver failure acute infantile,
TRNAA46P transfer RNA alanine 46 (anticodon UGC) pseudogene 6p22.1 systemic lupus erythematosus
TRNAL43P transfer RNA leucine 43 (anticodon AAG) pseudogene 5q35.3 hiv-1
TRNAQ33P transfer RNA glutamine 33 (anticodon UUG) pseudogene 5q14.1 alzheimers disease
TRNT1 tRNA nucleotidyl transferase, CCA-adding, 1 3p26.2 "liver failure, transient infantile" "deafness, mitochondrial, modifier of"
TRO trophinin Xp11.21 endometrial carcinoma, teratocarcinoma, juvenile rheumatoid arthritis
TROAP trophinin associated protein 12q13.12 teratocarcinoma ectopic pregnancy
TROVE2 TROVE domain family, member 2 1q31.2 sjogrens syndrome congenital heart block
TRPA1 transient receptor potential cation channel, subfamily A, member 1 8q13.3 dentin sensitivity, somatoform disorder, "episodic pain syndrome, familial",
TRPC3 transient receptor potential cation channel, subfamily C, member 3 4q27 malignant hypertension
TRPC4AP transient receptor potential cation channel, subfamily C, member 4 associated protein 20q11.22 plantar fasciitis, epididymo-orchitis, elephantiasis,
TRPC5 transient receptor potential cation channel, subfamily C, member 5 Xq23 pseudohypoaldosteronism type ii
TRPC6 transient receptor potential cation channel, subfamily C, member 6 11q22.1 familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis, malignant hypertension, diencephalic neoplasm,
TRPM1 transient receptor potential cation channel, subfamily M, member 1 15q13.3 "congenital stationary night blindness, type 1c", "night blindness, congenital stationary , 1c, autosomal recessive", "night blindness, congenital stationary , 1d, autosomal recessive"
TRPM3 transient receptor potential cation channel, subfamily M, member 3 9q21.13 dentin sensitivity
TRPM4 transient receptor potential cation channel, subfamily M, member 4 19q13.33 "heart block, progressive, type ia", progressive familial heart block type 1b, right bundle branch block
TRPM5 transient receptor potential cation channel, subfamily M, member 5 11p15.5 beckwith-wiedemann syndrome
TRPM6 transient receptor potential cation channel, subfamily M, member 6 9q21.13 "hypomagnesemia 1, intestinal" hypomagnesemia with secondary hypocalcemia
TRPM7 transient receptor potential cation channel, subfamily M, member 7 15q21.2 amyotrophic lateral sclerosis, lateral sclerosis, hypomagnesemia with secondary hypocalcemia,
TRPM8 transient receptor potential cation channel, subfamily M, member 8 2q37.1 dentin sensitivity
TRPS1 trichorhinophalangeal syndrome I 8q23.3 metatropic dysplasia , brachyolmia, spondylometaphyseal dysplasia kozlowski type,
TRPV1 transient receptor potential cation channel, subfamily V, member 1 17p13.2 dentin sensitivity, pulpitis, burning mouth syndrome,
TRPV2 transient receptor potential cation channel, subfamily V, member 2 17p11.2 dentin sensitivity
TRPV3 transient receptor potential cation channel, subfamily V, member 3 17p13.2 dentin sensitivity, "palmoplantar keratoderma, mutilating, with periorificial keratotic plaques" olmsted syndrome
TRPV4 transient receptor potential cation channel, subfamily V, member 4 12q24.11 rheumatic myocarditis, charcot-marie-tooth neuropathy type 2, charcot-marie-tooth disease type 2c,
TRPV5 transient receptor potential cation channel, subfamily V, member 5 7q34 hypervitaminosis d, pseudohypoaldosteronism type ii aromatase deficiency
TRPV6 transient receptor potential cation channel, subfamily V, member 6 7q34 prostate cancer, hypervitaminosis d, pseudohypoaldosteronism type ii,
TRRAP transformation/transcription domain-associated protein 7q22.1 glioblastoma multiforme dosage-sensitive sex reversal
TS13 Temperature sensitivity complementation, ts13 stomach cancer
TSC1 tuberous sclerosis 1 9q34.13 learning disability, pilocytic astrocytoma, astrocytoma,
TSC2 tuberous sclerosis 2 16p13.3 hemimegalencephaly, tuberous sclerosis complex, lymphangiomatosis,
TSC22D1 TSC22 domain family, member 1 13q14.11 diabetic nephropathy lung adenoma
TSEN15 TSEN15 tRNA splicing endonuclease subunit 1q25.3 bartter disease
TSEN2 TSEN2 tRNA splicing endonuclease subunit 3p25.2 pontocerebellar hypoplasia, tsen2-related pontocerebellar hypoplasia, pontocerebellar hypoplasia type 2b ,
TSEN34 TSEN34 tRNA splicing endonuclease subunit 19q13.42 pontocerebellar hypoplasia, pontocerebellar hypoplasia type 2a, pontocerebellar hypoplasia type 2,
TSEN54 TSEN54 tRNA splicing endonuclease subunit 17q25.1 pontocerebellar hypoplasia, "pontocerebellar hypoplasia, type 1b", pontocerebellar hypoplasia type 1,
TSFM Ts translation elongation factor, mitochondrial 12q14.1 combined oxidative phosphorylation deficiency 3
TSG101 tumor susceptibility 101 11p15.1 breast cancer, ovarian cancer "breast cancer, somatic"
TSG11 Tumor suppressor gene on chromosome 11 11q23 non-small cell lung carcinoma
TSGA10 testis specific, 10 2q11.2 gemistocytic astrocytoma, autoimmune polyendocrine syndrome type 1 parapsoriasis
TSHB thyroid stimulating hormone, beta 1p13.2 hyperthyroidism, pituitary tumors, meningioma,
TSHR thyroid stimulating hormone receptor 14q31.1 graves disease, exophthalmos, thyrotoxicosis,
TSHZ1 teashirt zinc finger homeobox 1 18q22.3 colon cancer congenital aural atresia
TSHZ2 teashirt zinc finger homeobox 2 20q13.2 colon cancer ovarian cancer
TSKS testis-specific serine kinase substrate 19q13.33 testicular cancer
TSLP thymic stromal lymphopoietin 5q22.1 asthma, membranoproliferative glomerulonephritis, atopy,
TSN translin 2q14.3 botulism
TSNAX translin-associated factor X 1q42.2 schizophrenia
TSNAX-DISC1 TSNAX-DISC1 readthrough (NMD candidate) 1q42.2 schizophrenia
TSPAN12 tetraspanin 12 7q31.31 coats disease, exudative vitreoretinopathy, "familial exudative vitreoretinopathy, autosomal dominant",
TSPAN2 tetraspanin 2 1p13.2 clonorchiasis
TSPAN31 tetraspanin 31 12q14.1 sarcoma, osteosarcoma, chondroma
TSPAN32 tetraspanin 32 11p15.5 beckwith-wiedemann syndrome, malaria, wilms tumor,
TSPAN4 tetraspanin 4 11p15.5 congenital hypomyelination neuropathy
TSPAN6 tetraspanin 6 Xq22.1 trichomoniasis
TSPAN7 tetraspanin 7 Xp11.4 "mental retardation, x-linked 17/31, microduplication", mental retardation, lymphoblastic leukemia,
TSPEAR thrombospondin-type laminin G domain and EAR repeats 21q22.3 "deafness, autosomal recessive 76" "deafness, autosomal recessive 98"
TSPO translocator protein (18kDa) 22q13.2 amyotrophic lateral sclerosis, schizophrenia, lipoid adrenal hyperplasia,
TSPO2 translocator protein 2 6p21.1 lung cancer lung cancer susceptibility
TSPY1 testis specific protein, Y-linked 1 Yp11.2 germ cell tumors, prostate cancer, gonadoblastoma,
TSPYL1 TSPY-like 1 6q22.1 sudden infant death syndrome, brain cancer sudden infant death with dysgenesis of the testes syndrome
TSR1 TSR1, 20S rRNA accumulation, homolog (S. cerevisiae) 17p13.3 sick building syndrome
TSR2 TSR2, 20S rRNA accumulation, homolog (S. cerevisiae) Xp11.22 blepharospasm
TSSC1 tumor suppressing subtransferable candidate 1 2p25.3 breast cancer wilms tumor
TSSC4 tumor suppressing subtransferable candidate 4 11p15.5 breast cancer, beckwith-wiedemann syndrome, wilms tumor,
TSSK2 testis-specific serine kinase 2 22q11.21 digeorge syndrome
TSSK4 testis-specific serine kinase 4 14q12 spondylolisthesis, spinal stenosis spondylosis
TSSK6 testis-specific serine kinase 6 19p13.11 oligospermia
TST1 Tuberculin skin test reactivity, absence of 11p14 papillary thyroid carcinoma
TSTA3 tissue specific transplantation antigen P35B 8q24.3 leukocyte adhesion deficiency mast cell neoplasm
TTBK2 tau tubulin kinase 2 15q15.2 congenital dyserythropoietic anemia type i, ataxia, spinocerebellar ataxia type 11,
TTC19 tetratricopeptide repeat domain 19 17p12 "mitochondrial complex iii deficiency, nuclear type 6", mitochondrial complex iii deficiency, "mitochondrial complex iii deficiency, nuclear type 2"
TTC21B tetratricopeptide repeat domain 21B 2q24.3 asphyxiating thoracic dystrophy, joubert syndrome and related disorders, "bardet-biedl syndrome 1, modifier of",
TTC23 tetratricopeptide repeat domain 23 15q26.3 cervical cancer
TTC37 tetratricopeptide repeat domain 37 5q15 early onset absence epilepsy trichohepatoenteric syndrome 1
TTC7A tetratricopeptide repeat domain 7A 2p21 intestinal atresia, multiple intestinal atresia, "immunodeficiency, common variable, 11"
TTC8 tetratricopeptide repeat domain 8 14q31.3 leber congenital amaurosis, bardet-biedl syndrome 8, bardet-biedl syndrome,
TTC9 tetratricopeptide repeat domain 9 14q24.2 breast cancer
TTF1 transcription termination factor, RNA polymerase I 9q34.13 pulmonary blastoma, blastoma, small cell carcinoma,
TTF2 transcription termination factor, RNA polymerase II 1p13.1 somatoform disorder, insulin resistance, chronic venous leg ulcers,
TTI2 TELO2 interacting protein 2 8p12 temtamy preaxial brachydactyly syndrome "mental retardation, autosomal recessive 39"
TTLL5 tubulin tyrosine ligase-like family, member 5 14q24.3 cone-rod dystrophy 19
TTN titin 2q31.2 centronuclear myopathy, myasthenia gravis, "familial isolated arrhythmogenic ventricular dysplasia, biventricular form",
TTPA tocopherol (alpha) transfer protein 8q12.3 ataxia, friedreich ataxia, hereditary ataxia,
TTR transthyretin 18q12.1 hereditary amyloidosis, amyloidosis, hyperthyroxinemia,
TUB tubby bipartite transcription factor 11p15.4 leber congenital amaurosis obesity
TUBA1A tubulin, alpha 1a 12q13.12 lissencephaly, "distal hereditary motor neuropathy, type ii", treacher collins syndrome,
TUBA1B tubulin, alpha 1b 12q13.12 "distal hereditary motor neuropathy, type ii" pachygyria
TUBA1C tubulin, alpha 1c 12q13.12 "distal hereditary motor neuropathy, type ii" osteoblastoma
TUBA3C tubulin, alpha 3c 13q12.11 dfnb1 kabuki syndrome
TUBA8 tubulin, alpha 8 22q11.21 cytochrome p450 oxidoreductase deficiency, bipolar i disorder, optic nerve hypoplasia
TUBAP tubulin, alpha pseudogene 21q21.2 major depressive disorder
TUBAP2 tubulin, alpha pseudogene 2 11q14.3 multiple myeloma
TUBB tubulin, beta class I 6p21.33 "distal hereditary motor neuropathy, type ii", pleomorphic xanthoastrocytoma, polyneuropathy,
TUBB1 tubulin, beta 1 class VI 20q13.32 "macrothrombocytopenia, autosomal dominant, tubb1-related"
TUBB2A tubulin, beta 2A class IIa 6p25.2 "cortical dysplasia, complex, with other brain malformations 5"
TUBB2B tubulin, beta 2B class IIb 6p25.2 congenital fibrosis of the extraocular muscles 2, polymicrogyria, pachygyria,
TUBB3 tubulin, beta 3 class III 16q24.3 congenital fibrosis of the extraocular muscles 2, congenital fibrosis of the extraocular muscles, ovarian carcinosarcoma,
TUBB4A tubulin, beta 4A class IVa 19p13.3 leukodystrophy, dystonia, torsion dystonia,
TUBB6 tubulin, beta 6 class V 18p11.21 nail disease
TUBB8 tubulin, beta 8 class VIII 10p15.3 brain cancer
TUBE1 tubulin, epsilon 1 6q21 intestinal obstruction, tracheitis frontal sinusitis
TUBG1 tubulin, gamma 1 17q21.2 anaplastic astrocytoma, "cortical dysplasia, complex, with other brain malformations" "cortical dysplasia, complex, with other brain malformations 4"
TUBGCP6 tubulin, gamma complex associated protein 6 22q13.33 antley-bixler syndrome microcephaly and chorioretinopathy with or without mental retardation
TUFM Tu translation elongation factor, mitochondrial 16p11.2 lactic acidosis combined oxidative phosphorylation deficiency 4
TUKLS Tukel syndrome 21q22 tukel syndrome
TULP1 tubby like protein 1 6p21.31 leber congenital amaurosis, leber congenital amaurosis 17, retinitis pigmentosa,
TULP4 tubby like protein 4 6q25.3 sensenbrenner syndrome
TUSC1 tumor suppressor candidate 1 9p21.2 lung cancer, cutaneous malignant melanoma drug-induced liver injury due to flucloxacillin
TUSC2 tumor suppressor candidate 2 3p21.31 lung cancer
TUSC3 tumor suppressor candidate 3 8p22 prostate cancer "mental retardation, autosomal recessive 43"
TWF1 twinfilin actin-binding protein 1 12q12 sleeping sickness
TWF2 twinfilin actin-binding protein 2 3p21.2 monkeypox
TWIST1 twist family bHLH transcription factor 1 7p21.1 hepatocellular carcinoma, muenke syndrome, gliosarcoma,
TWIST2 twist family bHLH transcription factor 2 2q37.3 saethre-chotzen syndrome, progeria, "focal facial dermal dysplasia 3, setleis type"
TWISTNB TWIST neighbor 7p21.1 acrocephalosyndactylia
TXK TXK tyrosine kinase 4p12 behcets disease
TXLNG taxilin gamma Xp22.2 antisocial personality disorder scarlet fever
TXN thioredoxin 9q31.3 skin squamous cell carcinoma, acute myocarditis, myocarditis,
TXN2 thioredoxin 2 22q12.3 ocular hypertension urethra cancer
TXNDC2 thioredoxin domain containing 2 (spermatozoa) 18p11.22 malignant pleural mesothelioma
TXNDC5 thioredoxin domain containing 5 (endoplasmic reticulum) 6p24.3 hypoxia
TXNDC9 thioredoxin domain containing 9 2q11.2 pellagra, akinetic mutism mutism
TXNIP thioredoxin interacting protein 1q21.1 hyperglycemia
TXNL1 thioredoxin-like 1 18q21.31 thymus adenocarcinoma
TXNRD2 thioredoxin reductase 2 22q11.21 thyrotoxicosis, generalized resistance to thyroid hormone, follicular thyroid carcinoma,
TYK2 tyrosine kinase 2 19p13.2 subacute cutaneous lupus erythematosus, polycythemia vera, oligoarticular juvenile arthritis,
TYMP thymidine phosphorylase 22q13.33 colorectal cancer, breast cancer, pancreatic cancer,
TYMS thymidylate synthetase 18p11.32 colorectal cancer, breast cancer, pancreatic cancer,
TYR tyrosinase 11q14.3 vitiligo, juvenile xanthogranuloma, oculocutaneous albinism,
TYRL tyrosinase-like (pseudogene) 11p11.12 oculocutaneous albinism type 1
TYROBP TYRO protein tyrosine kinase binding protein 19q13.12 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy tyrobp-related polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy
TYRP1 tyrosinase-related protein 1 9p23 vitiligo, melanoma, sympathetic ophthalmia,
TYS sclerotylosis 4q28-q31 sclerotylosis
TYW3 tRNA-yW synthesizing protein 3 homolog (S. cerevisiae) 1p31.1 noma
UACA uveal autoantigen with coiled-coil domains and ankyrin repeats 15q23 panuveitis
UAP1 UDP-N-acteylglucosamine pyrophosphorylase 1 1q23.3 hepadnavirus infection
UBA1 ubiquitin-like modifier activating enzyme 1 Xp11.23 spinal muscular atrophy, wallerian degeneration, "spinal muscular atrophy, x-linked 2, infantile"
UBA2 ubiquitin-like modifier activating enzyme 2 19q13.11 adult dermatomyositis
UBA52 ubiquitin A-52 residue ribosomal protein fusion product 1 19p13.11 apocrine adenoma
UBA52P1 ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 1 7p15.2 alzheimers disease
UBA7 ubiquitin-like modifier activating enzyme 7 3p21.31 acute promyelocytic leukemia progeria
UBAC2 UBA domain containing 2 13q32.3 behcets disease
UBAP1 ubiquitin associated protein 1 9p13.3 intermediate coronary syndrome neurocirculatory asthenia
UBASH3B ubiquitin associated and SH3 domain containing B 11q24.1 cat-scratch disease
UBB ubiquitin B 17p11.2 mulibrey nanism , down syndrome "cleft palate, isolated"
UBC ubiquitin C 12q24.31 cherubism, mulibrey nanism , congenital central hypoventilation syndrome,
UBD ubiquitin D 6p22.1 nephrosclerosis severe acute respiratory syndrome
UBE2A ubiquitin-conjugating enzyme E2A Xq24 "mental retardation, x-linked, syndromic, nascimento type"
UBE2B ubiquitin-conjugating enzyme E2B 5q31.1 male infertility
UBE2D1 ubiquitin-conjugating enzyme E2D 1 10q21.1 hypoxia hemochromatosis
UBE2G1 ubiquitin-conjugating enzyme E2G 1 17p13.2 cri-du-chat syndrome
UBE2G2 ubiquitin-conjugating enzyme E2G 2 21q22.3 cri-du-chat syndrome
UBE2I ubiquitin-conjugating enzyme E2I 16p13.3 cortisol resistance
UBE2L1 ubiquitin-conjugating enzyme E2L 1 (pseudogene) 14q22.3 alzheimers disease
UBE2L3 ubiquitin-conjugating enzyme E2L 3 22q11.21 keloid formation
UBE2L6 ubiquitin-conjugating enzyme E2L 6 11q12.1 diverticulitis
UBE3A ubiquitin protein ligase E3A 15q11.2 papilloma, angelman syndrome, rett syndrome,
UBE3B ubiquitin protein ligase E3B 12q24.11 intellectual disability, kaufman oculocerebrofacial syndrome, blepharophimosis-ptosis-intellectual disability syndrome
UBE4A ubiquitination factor E4A 11q23.3 ovarian serous cystadenocarcinoma
UBE4B ubiquitination factor E4B 1p36.22 neuroblastoma, wallerian degeneration neuroblastoma 1
UBIAD1 UbiA prenyltransferase domain containing 1 1p36.22 landau-kleffner syndrome, menieres disease corneal dystrophy crystalline of schnyder
UBL5 ubiquitin-like 5 19p13.2 autism spectrum disorder obesity
UBOX5 U-box domain containing 5 20p13 neurohypophyseal diabetes insipidus
UBQLN1 ubiquilin 1 9q21.32 brown-vialetto-van laere syndrome
UBQLN1P1 ubiquilin 1 pseudogene 1 6p22.1 systemic lupus erythematosus
UBQLN2 ubiquilin 2 Xp11.21 amyotrophic lateral sclerosis, dementia, brown-vialetto-van laere syndrome,
UBQLN4P1 ubiquilin 4 pseudogene 1 3q24 hiv-1
UBR1 ubiquitin protein ligase E3 component n-recognin 1 15q15.2 imperforate anus, congenital dyserythropoietic anemia type i, exocrine pancreatic insufficiency,
UBR2 ubiquitin protein ligase E3 component n-recognin 2 6p21.1 johanson-blizzard syndrome rapadilino syndrome
UBR4 ubiquitin protein ligase E3 component n-recognin 4 1p36.13 retinoblastoma
UBR5 ubiquitin protein ligase E3 component n-recognin 5 8q22.3 acneiform dermatitis
UBXN11 UBX domain protein 11 1p36.11 osteoporosis choanal atresia
UCA1 urothelial cancer associated 1 (non-protein coding) 19p13.12 retinitis pigmentosa 48
UCHL1 ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) 4p13 parkinsons disease, parkinson disease 1, large cell carcinoma,
UCHL5 ubiquitin carboxyl-terminal hydrolase L5 1q31.2 cannabis dependence
UCK2 uridine-cytidine kinase 2 1q24.1 human monocytic ehrlichiosis
UCN urocortin 2p23.3 endometrial carcinoma, anorexia nervosa, pheochromocytoma
UCN2 urocortin 2 3p21.31 alcohol dependence
UCN3 urocortin 3 10p15.1 pheochromocytoma
UCP1 uncoupling protein 1 (mitochondrial, proton carrier) 4q31.1 insulin resistance, morbid obesity, obesity,
UCP2 uncoupling protein 2 (mitochondrial, proton carrier) 11q13.4 neural tube defects, obesity, familial hyperinsulinism ,
UCP3 uncoupling protein 3 (mitochondrial, proton carrier) 11q13.4 amyotrophic lateral sclerosis, type 2 diabetes mellitus, insulin resistance,
UFD1L ubiquitin fusion degradation 1 like (yeast) 22q11.21 digeorge syndrome, velocardiofacial syndrome tetralogy of fallot
UGCG UDP-glucose ceramide glucosyltransferase 9q31.3 sandhoff disease
UGDH UDP-glucose 6-dehydrogenase 4p14 hypoxia
UGT1A UDP glucuronosyltransferase 1 family, polypeptide A complex locus 2q37 colon cancer, crigler-najjar syndrome, urogenital tuberculosis,
UGT1A1 UDP glucuronosyltransferase 1 family, polypeptide A1 2q37.1 beta thalassemia, dubin-johnson syndrome, crigler-najjar syndrome,
UGT1A10 UDP glucuronosyltransferase 1 family, polypeptide A10 2q37.1 kernicterus, bilirubin metabolic disorder sickle cell anemia
UGT1A11P UDP glucuronosyltransferase 1 family, polypeptide A11 pseudogene 2q37.1 hiv-1
UGT1A12P UDP glucuronosyltransferase 1 family, polypeptide A12 pseudogene 2q37.1 hiv-1
UGT1A3 UDP glucuronosyltransferase 1 family, polypeptide A3 2q37.1 bilirubin metabolic disorder, drug-induced hepatitis sickle cell anemia
UGT1A4 UDP glucuronosyltransferase 1 family, polypeptide A4 2q37.1 crigler-najjar syndrome, kernicterus, bilirubin metabolic disorder,
UGT1A5 UDP glucuronosyltransferase 1 family, polypeptide A5 2q37.1 kernicterus, bilirubin metabolic disorder sickle cell anemia
UGT1A6 UDP glucuronosyltransferase 1 family, polypeptide A6 2q37.1 colon adenocarcinoma, crigler-najjar syndrome, kernicterus,
UGT1A7 UDP glucuronosyltransferase 1 family, polypeptide A7 2q37.1 hepatocellular carcinoma, pancreatic cancer, kernicterus,
UGT1A8 UDP glucuronosyltransferase 1 family, polypeptide A8 2q37.1 kernicterus
UGT1A9 UDP glucuronosyltransferase 1 family, polypeptide A9 2q37.1 colorectal cancer, crigler-najjar syndrome, kernicterus,
UGT2A1 UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus 4q13.3 gilbert syndrome
UGT2A3 UDP glucuronosyltransferase 2 family, polypeptide A3 4q13.2 gilbert syndrome
UGT2B10 UDP glucuronosyltransferase 2 family, polypeptide B10 4q13.2 gilbert syndrome
UGT2B11 UDP glucuronosyltransferase 2 family, polypeptide B11 4q13.2 gilbert syndrome
UGT2B15 UDP glucuronosyltransferase 2 family, polypeptide B15 4q13.2 prostate cancer, familial prostate cancer gilbert syndrome
UGT2B17 UDP glucuronosyltransferase 2 family, polypeptide B17 4q13.2 prostate cancer, osteoporosis, acute graft versus host disease
UGT2B28 UDP glucuronosyltransferase 2 family, polypeptide B28 4q13.2 gilbert syndrome
UGT2B4 UDP glucuronosyltransferase 2 family, polypeptide B4 4q13.2 gilbert syndrome
UGT2B7 UDP glucuronosyltransferase 2 family, polypeptide B7 4q13.2 hepatocellular adenoma
UGT3A1 UDP glycosyltransferase 3 family, polypeptide A1 5p13.2 gilbert syndrome
UGT3A2 UDP glycosyltransferase 3 family, polypeptide A2 5p13.2 gilbert syndrome
UGT8 UDP glycosyltransferase 8 4q26 metachromatic leukodystrophy picks disease
UHMK1 U2AF homology motif (UHM) kinase 1 1q23.3 schizophrenia
UHRF2 ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase 9p24.1 aminoacylase 1 deficiency
ULBP2 UL16 binding protein 2 6q25.1 b-cell chronic lymphocytic leukemia
ULK3 unc-51 like kinase 3 15q24.1 chronic myeloid leukemia
UMOD uromodulin 16p12.3 vesicoureteral reflux, gout, hyperuricemia,
UMPS uridine monophosphate synthetase 3q21.2 malaria orotic aciduria
UNC119 unc-119 homolog (C. elegans) 17q11.2 retinitis pigmentosa, cone-rod dystrophy 2, partial central choroid dystrophy,
UNC13A unc-13 homolog A (C. elegans) 19p13.11 amyotrophic lateral sclerosis
UNC13B unc-13 homolog B (C. elegans) 9p13.3 hyperglycemia
UNC13C unc-13 homolog C (C. elegans) 15q21.3 infantile epileptic encephalopathy
UNC13D unc-13 homolog D (C. elegans) 17q25.1 griscelli syndrome, chediak-higashi syndrome, macrophage activation syndrome,
UNC45B unc-45 homolog B (C. elegans) 17q12 "cataract 4, multiple types"
UNC93B1 unc-93 homolog B1 (C. elegans) 11q13.2 herpes simplex encephalitis 1, herpes simplex encephalitis, encephalitis,
UNG uracil-DNA glycosylase 12q24.11 colorectal cancer, colon adenocarcinoma, rubella,
UPB1 ureidopropionase, beta 22q11.23 ornithine carbamoyltransferase deficiency, propionic acidemia beta-ureidopropionase deficiency
UPF1 UPF1 regulator of nonsense transcripts homolog (yeast) 19p13.11 ullrich congenital muscular dystrophy
UPF3B UPF3 regulator of nonsense transcripts homolog B (yeast) Xq24 "mental retardation, x-linked 17/31, microduplication", schizophrenia, "mental retardation, x-linked"
UPK1A uroplakin 1A 19q13.12 transitional cell carcinoma ovarian brenner tumor
UPK1B uroplakin 1B 3q13.32 ovarian brenner tumor
UPK2 uroplakin 2 11q23.3 bladder carcinoma, bladder squamous cell carcinoma, bladder carcinoma in situ
UPK3A uroplakin 3A 22q13.31 bladder carcinoma, renal agenesis, vesicoureteral reflux,
UPP2 uridine phosphorylase 2 2q24.1 timothy syndrome
UQCC1 ubiquinol-cytochrome c reductase complex assembly factor 1 20q11.22 osteoarthritis
UQCC2 ubiquinol-cytochrome c reductase complex assembly factor 2 6p21.31 breast cancer, "mitochondrial complex iii deficiency, nuclear type 7" "mitochondrial complex iii deficiency, nuclear type 6"
UQCRB ubiquinol-cytochrome c reductase binding protein 8q22.1 hypoxia, "mitochondrial complex iii deficiency, nuclear type 6", "mitochondrial complex iii deficiency, nuclear type 3",
UQCRC2 ubiquinol-cytochrome c reductase core protein II 16p12.2 "mitochondrial complex iii deficiency, nuclear type 6", mitochondrial complex iii deficiency "mitochondrial complex v deficiency, nuclear type 3"
UQCRHL ubiquinol-cytochrome c reductase hinge protein-like 1p36.21 fatty liver disease
UQCRQ ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa 5q31.1 "mitochondrial complex iii deficiency, nuclear type 6", mitochondrial complex iii deficiency, "mitochondrial complex iii deficiency, nuclear type 4"
URB2 URB2 ribosome biogenesis 2 homolog (S. cerevisiae) 1q42.13 buruli ulcer disease
URGCP upregulator of cell proliferation 7p13 hepatocellular carcinoma, hepatitis b hepatitis
URI1 URI1, prefoldin-like chaperone 19q12 hepatocellular carcinoma ovarian cancer
UROC1 urocanate hydratase 1 3q21.3 urocanase deficiency
UROD uroporphyrinogen decarboxylase 1p34.1 congenital erythropoietic porphyria, viral hepatitis, hypertrichosis,
UROS uroporphyrinogen III synthase 10q26.2 congenital erythropoietic porphyria, dubin-johnson syndrome, erythropoietic protoporphyria,
USB1 U6 snRNA biogenesis 1 16q21 "dyskeratosis congenita, autosomal recessive 4", rothmund-thomson syndrome poikiloderma with neutropenia
USF1 upstream transcription factor 1 1q23.3 familial hypertriglyceridemia, familial hyperlipidemia, familial combined hyperlipidemia
USH1A Usher syndrome 1A (autosomal recessive, severe) 14q32 usher syndrome type i "usher syndrome, type 1b"
USH1C Usher syndrome 1C (autosomal recessive, severe) 11p15.1 "deafness, autosomal recessive 76", "usher syndrome, type 1d", usher syndrome type 1g,
USH1E Usher syndrome 1E (autosomal recessive, severe) 21q21 usher syndrome type 1g, usher syndrome type i "usher syndrome, type 1e"
USH1G Usher syndrome 1G (autosomal recessive) 17q25.1 retinal disease, usher syndrome type 1g, usher syndrome type i,
USH1H Usher syndrome 1H (autosomal recessive) 15q22-q23 usher syndrome type 1g, usher syndrome type i usher syndrome type 1h
USH1K Usher syndrome 1K (autosomal recessive) 10p11.21-q21.1 usher syndrome type 1g "usher syndrome, type ik"
USH2A Usher syndrome 2A (autosomal recessive, mild) 1q41 leber congenital amaurosis, usher syndrome type ii, "retinal disease in usher syndrome type iia, modifier of",
USH3B Usher syndrome 3B reserved usher syndrome type 3b
USHBP1 Usher syndrome 1C binding protein 1 19p13.11 colon cancer
USP14 ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) 18p11.32 ovarian serous cystadenocarcinoma
USP15 ubiquitin specific peptidase 15 12q14.1 spinocerebellar ataxia type 3
USP18 ubiquitin specific peptidase 18 22q11.21 acute promyelocytic leukemia
USP2 ubiquitin specific peptidase 2 11q23.3 ovarian serous cystadenocarcinoma
USP20 ubiquitin specific peptidase 20 9q34.11 hypoxia
USP26 ubiquitin specific peptidase 26 Xq26.2 male infertility, infertility sertoli cell-only syndrome
USP39 ubiquitin specific peptidase 39 2p11.2 generalized anxiety disorder agoraphobia
USP4 ubiquitin specific peptidase 4 (proto-oncogene) 3p21.31 oculopharyngeal muscular dystrophy
USP53 ubiquitin specific peptidase 53 4q26 hypertrichosis
USP6 ubiquitin specific peptidase 6 (Tre-2 oncogene) 17p13.2 cherubism, aneurysmal bone cysts, myositis ossificans
USP8 ubiquitin specific peptidase 8 15q21.2 autosomal recessive spastic paraplegia type 59
USP9X ubiquitin specific peptidase 9, X-linked Xp11.4 "mental retardation, x-linked 17/31, microduplication", turner syndrome "mental retardation, x-linked 99"
USP9Y ubiquitin specific peptidase 9, Y-linked Yq11.21 klinefelters syndrome, spermatogenic failure, y chromosome infertility
UST uronyl-2-sulfotransferase 6q25.1 female stress incontinence liver inflammatory pseudotumor
UTF1 undifferentiated embryonic cell transcription factor 1 10q26.3 germ cell tumors testicular germ cell tumor
UTP14A UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast) Xq26.1 colon cancer
UTP15 UTP15, U3 small nucleolar ribonucleoprotein, homolog (S. cerevisiae) 5q13.2 exostosis
UTP3 UTP3, small subunit (SSU) processome component, homolog (S. cerevisiae) 4q13.3 choledocholithiasis
UTP6 UTP6, small subunit (SSU) processome component, homolog (yeast) 17q11.2 hepatocellular carcinoma
UTRN utrophin 6q24.2 dystrophinopathies annular pancreas
UTS2 urotensin 2 1p36.23 myocardial infarction, coronary artery disease, type 2 diabetes mellitus,
UTS2R urotensin 2 receptor 17q25.3 type 2 diabetes mellitus pheochromocytoma
UVM1 Melanoma, uveal, susceptibility to, 1 3q24-q26 "melanoma, uveal 1"
UVM2 Melanoma, uveal, susceptibility to, 2 3p25.2-p25.1 "melanoma, uveal 2"
UVRAG UV radiation resistance associated 11q13.5 colon cancer, senior-loken syndrome, "xeroderma pigmentosum, group c",
UVSSA UV-stimulated scaffold protein A 4p16.3 multiple chemical sensitivity, uv-sensitive syndrome 1 uv-sensitive syndrome 3
VAC14 Vac14 homolog (S. cerevisiae) 16q22.2 t-cell leukemia
VAMAS6 Vitiligo 6p21.3 vitiligo-associated multiple autoimmune disease susceptiblity 6
VAMP1 vesicle-associated membrane protein 1 (synaptobrevin 1) 12p13.31 "spastic ataxia 1, autosomal dominant"
VAMP2 vesicle-associated membrane protein 2 (synaptobrevin 2) 17p13.1 tetanus botulism
VAMP3 vesicle-associated membrane protein 3 1p36.23 tetanus
VAMP4 vesicle-associated membrane protein 4 1q24.3 human granulocytic anaplasmosis
VAMP7 vesicle-associated membrane protein 7 Xq28 tetanus
VANGL1 VANGL planar cell polarity protein 1 1p13.1 strabismus, neural tube defects, spina bifida,
VANGL2 VANGL planar cell polarity protein 2 1q23.2 strabismus, neural tube defects, spina bifida,
VAPA VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa 18p11.22 edwards syndrome botulism
VAPB VAMP (vesicle-associated membrane protein)-associated protein B and C 20q13.32 amyotrophic lateral sclerosis, spinal muscular atrophy, amyotrophic lateral sclerosis type 8,
VARS valyl-tRNA synthetase 6p21.33 scotoma
VASH1 vasohibin 1 14q24.3 pre-eclampsia female breast carcinoma
VASP vasodilator-stimulated phosphoprotein 19q13.32 shigellosis
VAV1 vav 1 guanine nucleotide exchange factor 19p13.3 cherubism hiv-1
VAV2 vav 2 guanine nucleotide exchange factor 9q34.2 primary angle-closure glaucoma
VAV3 vav 3 guanine nucleotide exchange factor 1p13.3 primary angle-closure glaucoma
VAX1 ventral anterior homeobox 1 10q25.3 corpus callosum agenesis, orofacial cleft, anophthalmia/microphthalmia
VAX2 ventral anterior homeobox 2 2p13.3 corpus callosum agenesis
VBP1 von Hippel-Lindau binding protein 1 Xq28 neuroblastoma
VCAM1 vascular cell adhesion molecule 1 1p21.2 pre-eclampsia, vascular disease, diabetic retinopathy,
VCAN versican 5q14.2 odontogenic myxoma, wagner syndrome vcan-related vitreoretinopathy
VCL vinculin 10q22.2 shigellosis, malaria, hailey-hailey disease,
VCP valosin containing protein 9p13.3 amyotrophic lateral sclerosis, frontotemporal lobar degeneration with ubiquitin-positive inclusions, "dementia, familial, nonspecific",
VCX variable charge, X-linked Xp22.31 x-linked ichthyosis lung adenocarcinoma
VCX2 variable charge, X-linked 2 Xp22.31 x-linked ichthyosis
VCX3A variable charge, X-linked 3A Xp22.31 x-linked ichthyosis
VCX3B variable charge, X-linked 3B Xp22.31 x-linked ichthyosis
VCY variable charge, Y-linked Yq11.221 x-linked ichthyosis y chromosome infertility
VCY1B variable charge, Y-linked 1B Yq11.221 x-linked ichthyosis
VDAC1 voltage-dependent anion channel 1 5q31.1 cystic fibrosis gonorrhea
VDI vesicular stomatitis virus defective interfering particle suppression 16 stomatitis
VDR vitamin D (1,25- dihydroxyvitamin D3) receptor 12q13.11 colorectal cancer, prostate cancer, rickets,
VEGFA vascular endothelial growth factor A 6p21.1 pre-eclampsia, adenocarcinoma, vascular disease,
VEGFB vascular endothelial growth factor B 11q13.1 cleidocranial dysplasia intracranial arteriovenous malformation
VEGFC vascular endothelial growth factor C 4q34.3 cervical cancer, breast cancer, papillary thyroid carcinoma,
VENTX VENT homeobox 10q26.3 acute myeloid leukemia
VGF VGF nerve growth factor inducible 7q22.1 pheochromocytoma, pulmonary large cell neuroendocrine carcinoma vaccinia
VHL von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase 3p25.3 hypoxia, keratomalacia, acute mountain sickness,
VHLL von Hippel-Lindau tumor suppressor-like 1q22 hypoxia kidney cancer
VIL1 villin 1 2q35 "cholestasis, progressive canalicular"
VIM vimentin 10p13 giant cell glioblastoma, epulis, pericardial effusion,
VIP vasoactive intestinal peptide 6q25.2 cholera, hirschsprungs disease, cystic fibrosis,
VIPAS39 VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog 14q24.3 cholestasis, "vipas39-related arthrogryposis, renal dysfunction, and cholestasis syndrome", "arthrogryposis, renal dysfunction, and cholestasis 2",
VIPR1 vasoactive intestinal peptide receptor 1 3p22.1 idiopathic achalasia
VKORC1 vitamin K epoxide reductase complex, subunit 1 16p11.2 venous thromboembolism, hemorrhagic disease, vitamin k deficiency hemorrhagic disease,
VKORC1L1 vitamin K epoxide reductase complex, subunit 1-like 1 7q11.21 warfarin resistance
VLDLR very low density lipoprotein receptor 9p24.2 tay-sachs disease, age related macular degeneration, cerebellar hypoplasia,
VMA21 VMA21 vacuolar H+-ATPase homolog (S. cerevisiae) Xq28 myopathy, hypertensive encephalopathy, x-linked myopathy with excessive autophagy,
VMD1 vitelliform macular dystrophy, atypical 8q24.3 vitelliform macular dystrophy
VN2R20P vomeronasal 2 receptor 20 pseudogene 21q21.2 fatty liver disease
VPRBP Vpr (HIV-1) binding protein 3p21.2 hiv-1
VPREB1 pre-B lymphocyte 1 22q11.22 common variable immunodeficiency conidiobolomycosis
VPS11 vacuolar protein sorting 11 homolog (S. cerevisiae) 11q23.3 acute intermittent porphyria chronic apical periodontitis
VPS13A vacuolar protein sorting 13 homolog A (S. cerevisiae) 9q21.2 acanthocytosis, chorea-acanthocytosis, neuroacanthocytosis,
VPS13B vacuolar protein sorting 13 homolog B (yeast) 8q22.2 cohen syndrome
VPS13C vacuolar protein sorting 13 homolog C (S. cerevisiae) 15q22.2 chorea-acanthocytosis
VPS13D vacuolar protein sorting 13 homolog D (S. cerevisiae) 1p36.22 chorea-acanthocytosis
VPS18 vacuolar protein sorting 18 homolog (S. cerevisiae) 15q15.1 arc syndrome
VPS33A vacuolar protein sorting 33 homolog A (S. cerevisiae) 12q24.31 arc syndrome
VPS33B vacuolar protein sorting 33 homolog B (yeast) 15q26.1 cholestasis, ivic syndrome , arc syndrome,
VPS35 vacuolar protein sorting 35 homolog (S. cerevisiae) 16q11.2 parkinsons disease, parkinson disease 1, eales disease,
VPS37A vacuolar protein sorting 37 homolog A (S. cerevisiae) 8p22 hepatocellular carcinoma "spastic paraplegia 53, autosomal recessive"
VPS37D vacuolar protein sorting 37 homolog D (S. cerevisiae) 7q11.23 williams-beuren syndrome sall4-related disorders
VPS39 vacuolar protein sorting 39 homolog (S. cerevisiae) 15q15.1 arc syndrome
VPS45 vacuolar protein sorting 45 homolog (S. cerevisiae) 1q21.2 neutropenia "neutropenia, severe congenital, 5, autosomal recessive"
VPS53 vacuolar protein sorting 53 homolog (S. cerevisiae) 17p13.3 "pontocerebellar hypoplasia, type 2e"
VPS54 vacuolar protein sorting 54 homolog (S. cerevisiae) 2p14 hepatocellular carcinoma
VRK1 vaccinia related kinase 1 14q32.2 vaccinia, pontocerebellar hypoplasia, werdnig-hoffmann disease,
VRK2 vaccinia related kinase 2 2p16.1 schizophrenia, vaccinia benign familial infantile epilepsy
VRK3 vaccinia related kinase 3 19q13.33 vaccinia
VRNI vitreoretinopathy, neovascular inflammatory 11q13 "vitreoretinopathy, neovascular inflammatory"
VSPA Visuospatial/perceptual abilities Xp22.33 turner syndrome-associated neurocognitive phenotype
VSX1 visual system homeobox 1 20p11.21 astigmatism, corneal dystrophy, corneal edema,
VSX2 visual system homeobox 2 14q24.3 matthew-wood syndrome, "microphthalmia, isolated 2", anophthalmia/microphthalmia,
VTI1A vesicle transport through interaction with t-SNAREs 1A 10q25.2 multiple mitochondrial dysfunctions syndrome 3
VTN vitronectin 17q11.2 diabetic retinopathy, age related macular degeneration, proliferative vitreoretinopathy,
VUR Vesicoureteral reflux 1p13 vesicoureteral reflux
VUR4 Vesicoureteral reflux 4 5q14.2 vesicoureteral reflux 4
VUR5 Vesicoureteral reflux 5 13q33.2 vesicoureteral reflux 5
VUR6 Vesicoureteral reflux 6 18q12.3 vesicoureteral reflux 6
VUR7 Vesicoureteral reflux 7 12p11-q13 vesicoureteral reflux 7
VWA2 von Willebrand factor A domain containing 2 10q25.3 colon cancer
VWA5A von Willebrand factor A domain containing 5A 11q24.2 breast cancer
VWF von Willebrand factor 12p13.31 afibrinogenemia, intermittent claudication, bernard-soulier syndrome,
VWSM Van der Woude syndrome modifier 17p11.2-p11.2 van der woude syndrome
WAGRO WAGRO syndrome 11p13-p12 wagro syndrome
WAPAL wings apart-like homolog (Drosophila) 10q23.2 mu chain disease
WARS tryptophanyl-tRNA synthetase 14q32.2 trachoma, gonorrhea, yaws
WAS Wiskott-Aldrich syndrome Xp11.23 wiskott-aldrich syndrome, primary immunodeficiency disease, neutropenia,
WASF1 WAS protein family, member 1 6q21 wiskott-aldrich syndrome
WASF2 WAS protein family, member 2 1p36.11 wiskott-aldrich syndrome
WASF3 WAS protein family, member 3 13q12.13 wiskott-aldrich syndrome ganglioneuroblastoma
WASF4P WAS protein family, member 4, pseudogene Xp11.23 wiskott-aldrich syndrome
WASF5P WAS protein family, member 5, pseudogene 6p21.33 wiskott-aldrich syndrome, hiv-1 psoriatic arthritis
WASL Wiskott-Aldrich syndrome-like 7q31.32 wiskott-aldrich syndrome
WBP1L WW domain binding protein 1-like 10q24.32 acute leukemia
WBS2 Williams-Beuren syndrome type 2 4q33-q35.1 williams-beuren syndrome
WBSCR16 Williams-Beuren syndrome chromosome region 16 7q11.23 williams-beuren syndrome hypertensive retinopathy
WBSCR17 Williams-Beuren syndrome chromosome region 17 7q11.22 williams-beuren syndrome
WBSCR2 Williams-Beuren syndrome chromosome region 2 7q11.23 williams-beuren syndrome
WBSCR22 Williams Beuren syndrome chromosome region 22 7q11.23 williams-beuren syndrome supravalvular aortic stenosis
WBSCR27 Williams Beuren syndrome chromosome region 27 7q11.23 williams-beuren syndrome
WBSCR28 Williams-Beuren syndrome chromosome region 28 7q11.23 williams-beuren syndrome
WDFY3 WD repeat and FYVE domain containing 3 4q21.23 chediak-higashi syndrome
WDHD1 WD repeat and HMG-box DNA binding protein 1 14q22.2 trench fever
WDM Welander distal myopathy 2p13 "welander distal myopathy, swedish type"
WDPCP WD repeat containing planar cell polarity effector 2p15 bardet-biedl syndrome 15, bardet-biedl syndrome, "bardet-biedl syndrome, modifier of",
WDR11 WD repeat domain 11 10q26.12 hypogonadotropic hypogonadism 8 with or without anosmia, hypogonadotropic hypogonadism 17 with or without anosmia, infantile onset spinocerebellar ataxia,
WDR19 WD repeat domain 19 4p14 asphyxiating thoracic dystrophy, ellis-van creveld syndrome, senior-loken syndrome,
WDR20 WD repeat domain 20 14q32.31 mitral valve insufficiency enamel caries
WDR34 WD repeat domain 34 9q34.11 asphyxiating thoracic dystrophy, short-rib thoracic dysplasia 11 with or without polydactyly short-rib thoracic dysplasia 2 with or without polydactyly
WDR35 WD repeat domain 35 2p24.1 asphyxiating thoracic dystrophy, ellis-van creveld syndrome, sensenbrenner syndrome,
WDR36 WD repeat domain 36 5q22.1 primary congenital glaucoma, glaucoma, primary open angle glaucoma,
WDR4 WD repeat domain 4 21q22.3 nonsyndromic deafness
WDR45 WD repeat domain 45 Xp11.23 neurodegeneration with brain iron accululation 5, alcohol-related neurodevelopmental disorder, beta-propeller protein-associated neurodegeneration
WDR48 WD repeat domain 48 3p22.2 autosomal recessive spastic paraplegia type 60
WDR60 WD repeat domain 60 7q36.3 polydactyly, short rib-polydactyly syndrome, short-rib thoracic dysplasia 11 with or without polydactyly,
WDR62 WD repeat domain 62 19q13.12 priapism, microcephaly, primary autosomal recessive microcephalies and seckel syndrome spectrum disorders,
WDR65 WD repeat domain 65 1p34.2 van der woude syndrome van der woude syndrome 2
WDR72 WD repeat domain 72 15q21.3 brachyolmia, "amelogenesis imperfecta, type ia5", amelogenesis imperfecta,
WDR81 WD repeat domain 81 17p13.3 cerebellar ataxia, cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, dysequilibrium syndrome
WDR83 WD repeat domain 83 19p13.2 hypoxia
WEE1 WEE1 G2 checkpoint kinase 11p15.4 suppurative lymphadenitis
WEE2 WEE1 homolog 2 (S. pombe) 7q34 western equine encephalitis
WFDC1 WAP four-disulfide core domain 1 16q24.1 wilms tumor
WFDC2 WAP four-disulfide core domain 2 20q13.12 ovarian cancer
WFS1 Wolfram syndrome 1 (wolframin) 4p16.1 diabetes mellitus, "deafness, autosomal dominant 4b", insulinoma,
WG Wegener granulomatosis 6p21.3 wegeners granulomatosis
WHCR Wolf-Hirschhorn syndrome chromosome region 4p16 wolf-hirschhorn syndrome seizure disorder
WHSC1 Wolf-Hirschhorn syndrome candidate 1 4p16.3 myeloma, wolf-hirschhorn syndrome multiple myeloma
WHSC1L1 Wolf-Hirschhorn syndrome candidate 1-like 1 8p11.23 wolf-hirschhorn syndrome acute myeloid leukemia
WHSC1L2P Wolf-Hirschhorn syndrome candidate 1-like 2, pseudogene 17q21.31 wolf-hirschhorn syndrome
WIBG within bgcn homolog (Drosophila) 12q13.2 cavernous hemangioma mucoepidermoid carcinoma
WIPF1 WAS/WASL interacting protein family, member 1 2q31.1 wiskott-aldrich syndrome, x-linked thrombocytopenia wiskott-aldrich syndrome 2
WIPF2 WAS/WASL interacting protein family, member 2 17q21.1 peripheral retinal degeneration laryngeal tuberculosis
WIPI1 WD repeat domain, phosphoinositide interacting 1 17q24.2 alcohol-related neurodevelopmental disorder
WISP1 WNT1 inducible signaling pathway protein 1 8q24.22 hemimegalencephaly
WISP3 WNT1 inducible signaling pathway protein 3 6q21 breast cancer, arthropathy, nephroblastoma
WLS wntless Wnt ligand secretion mediator 1p31.3 focal dermal hypoplasia
WM1 Macroglobulinemia, Waldenstrom, susceptibility to, 1 6p21.3 "macroglobulinemia, waldenstrom 1"
WM2 Macroglobulinemia, Waldenstrom, susceptibility to, 2 4q "macroglobulinemia, waldenstrom 2"
WNK1 WNK lysine deficient protein kinase 1 12p13.33 neuropathy, pseudohypoaldosteronism type ii, gitelman syndrome,
WNK2 WNK lysine deficient protein kinase 2 9q22.31 colon cancer
WNK4 WNK lysine deficient protein kinase 4 17q21.31 pseudohypoaldosteronism type ii, essential hypertension, metabolic acidosis,
WNT1 wingless-type MMTV integration site family, member 1 12q13.12 hepatocellular carcinoma, osteoporosis, cerebellar hypoplasia,
WNT10A wingless-type MMTV integration site family, member 10A 2q35 colorectal cancer, "tooth agenesis, selective, 1, with or without orofacial cleft", tooth agenesis,
WNT10B wingless-type MMTV integration site family, member 10B 12q13.12 breast cancer, split-hand/foot malformation 6 skeletal muscle regeneration
WNT11 wingless-type MMTV integration site family, member 11 11q13.5 mass syndrome
WNT16 wingless-type MMTV integration site family, member 16 7q31.31 coffin-siris syndrome osteoporotic fracture
WNT3 wingless-type MMTV integration site family, member 3 17q21.32 tetra-amelia syndrome
WNT3A wingless-type MMTV integration site family, member 3A 1q42.13 hypotrichosis simplex "osteoporosis, early-onset autosomal dominant"
WNT4 wingless-type MMTV integration site family, member 4 1p36.12 hermaphroditism, dosage-sensitive sex reversal, eaf,
WNT5A wingless-type MMTV integration site family, member 5A 3p14.3 breast cancer, robinow syndrome, zimmermann-laband syndrome,
WNT6 wingless-type MMTV integration site family, member 6 2q35 cervical cancer colorectal cancer
WNT7A wingless-type MMTV integration site family, member 7A 3p25.1 talipes equinovarus, phocomelia, nail-patella syndrome,
WNT8A wingless-type MMTV integration site family, member 8A 5q31.2 germ cell tumors
WNT9B wingless-type MMTV integration site family, member 9B 17q21.32 teratocarcinoma mayer-rokitansky-kuster-hauser syndrome
WRAP53 WD repeat containing, antisense to TP53 17p13.1 "dyskeratosis congenita, autosomal recessive 4", dyskeratosis congenita, "dyskeratosis congenita, autosomal recessive 3"
WRB tryptophan rich basic protein 21q22.2 down syndrome congenital heart disease
WRN Werner syndrome, RecQ helicase-like 8p12 colorectal cancer, werner syndrome, rothmund-thomson syndrome,
WRNIP1 Werner helicase interacting protein 1 6p25.2 mitral valve insufficiency posterior myocardial infarction
WS2B Waardenburg syndrome, type 2B 1p21-p13.3 waardenburg syndrome type 2 waardenburg syndrome type 2b
WS2C Waardenburg syndrome, type IIC 8p23 waardenburg syndrome type iic
WSN Waisman syndrome Xq27.3-qter waisman parkinsonism-mental retardation syndrome "parkinsonism, early onset with mental retardation"
WT1 Wilms tumor 1 11p13 acute myeloid leukemia, familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis, nephrotic syndrome,
WT1-AS WT1 antisense RNA 11p13 acute myeloid leukemia, focal segmental glomerulosclerosis wilms tumor
WT2 Wilms tumor 2 11p15.5 beckwith-wiedemann syndrome, wilms tumor, wilms tumor 2
WT3 Wilms tumor-3 16q wilms tumor "wilms tumor, type 3"
WT4 Wilms tumor-4 17q12-q21 "wilms tumor, type 4"
WTAP Wilms tumor 1 associated protein 6q25.3 wilms tumor
WTRS Wittwer syndrome Xp22.3 wittwer syndrome
WWOX WW domain containing oxidoreductase 16q23.1 esophageal squamous cell carcinoma, 46xy sex reversal 3, "spinocrebellar ataxia, autosomal recessive 12"
WWP2 WW domain containing E3 ubiquitin protein ligase 2 16q22.1 campomelic dysplasia
WWTR1 WW domain containing transcription regulator 1 3q25.1 epithelioid hemangioendothelioma barth syndrome
XAGE1A X antigen family, member 1A Xp11.22 non-small cell lung carcinoma, rhabdomyosarcoma lung adenocarcinoma
XAGE1B X antigen family, member 1B Xp11.22 non-small cell lung carcinoma, rhabdomyosarcoma lung adenocarcinoma
XAGE1C X antigen family, member 1C Xp11.22 non-small cell lung carcinoma, rhabdomyosarcoma lung adenocarcinoma
XAGE1D X antigen family, member 1D Xp11.22 prostate cancer, non-small cell lung carcinoma, testicular cancer,
XAGE1E X antigen family, member 1E Xp11.22 non-small cell lung carcinoma, rhabdomyosarcoma lung adenocarcinoma
XAGE2 X antigen family, member 2 Xp11.22 germ cell tumors, breast cancer, hydrocele
XAGE2B X antigen family, member 2B Xp11.22 hydrocele
XBP1 X-box binding protein 1 22q12.1 cavernous hemangioma, amyotrophic lateral sclerosis, schizophrenia,
XCE X chromosome controlling element Xq13 "x-inactivation, familial skewed", "arthrogryposis, distal, type 5d" triple x syndrome
XCL1 chemokine (C motif) ligand 1 1q24.2 wegeners granulomatosis renal tuberculosis
XDH xanthine dehydrogenase 2p23.1 colorectal cancer, lesch-nyhan syndrome, ischemia,
XECD Corneal dystrophy, endothelial, X-linked Xq25 "corneal dystrophy, endothelial, x-linked"
XG Xg blood group Xp22.33 x-linked ichthyosis color blindness
XIAP X-linked inhibitor of apoptosis Xq25 pleomorphic adenoma, cowpox, chronic neutrophilic leukemia,
XIC X chromosome inactivation center Xq12-q13 "x-inactivation, familial skewed"
XIRP2 xin actin-binding repeat containing 2 2q24.3 osteochondrosis
XIST X inactive specific transcript (non-protein coding) Xq13.2 "x-inactivation, familial skewed"
XK X-linked Kx blood group (McLeod syndrome) Xp21.1 calpainopathy, acanthocytosis, chorea-acanthocytosis,
XKR6 XK, Kell blood group complex subunit-related family, member 6 8p23.1 hydrocele keratolytic winter erythema
XKRY XK, Kell blood group complex subunit-related, Y-linked Yq11.222 y chromosome infertility
XPA xeroderma pigmentosum, complementation group A 9q22.33 lung cancer, photosensitive trichothiodystrophy, nevoid basal cell carcinoma syndrome,
XPC xeroderma pigmentosum, complementation group C 3p25.1 lung cancer, photosensitive trichothiodystrophy, li-fraumeni syndrome,
XPNPEP1 X-prolyl aminopeptidase (aminopeptidase P) 1, soluble 10q25.1 mature cataract
XPNPEP2 X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound Xq26.1 angioedema angioedema induced by ace inhibitors
XPNPEP3 X-prolyl aminopeptidase (aminopeptidase P) 3, putative 22q13.2 nephronophthisis, late-onset autosomal recessive medullary cystic kidney disease, steatocystoma multiplex
XPO4 exportin 4 13q12.11 pinguecula
XPO5 exportin 5 6p21.1 blastoma pleuropulmonary blastoma
XRCC1 X-ray repair complementing defective repair in Chinese hamster cells 1 19q13.31 bladder cancer susceptibility, colorectal cancer, microtia,
XRCC2 X-ray repair complementing defective repair in Chinese hamster cells 2 7q36.1 soft tissue sarcoma, breast cancer susceptibility, breast disease,
XRCC3 X-ray repair complementing defective repair in Chinese hamster cells 3 14q32.33 breast cancer susceptibility, breast cancer, squamous cell carcinoma of the head and neck,
XRCC4 X-ray repair complementing defective repair in Chinese hamster cells 4 5q14.2 microtia "xeroderma pigmentosum, group d"
XRCC5 X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) 2q35 tinea capitis
XRCC6 X-ray repair complementing defective repair in Chinese hamster cells 6 22q13.2 systemic lupus erythematosus
XRCC6P2 X-ray repair complementing defective repair in Chinese hamster cells 6 pseudogene 2 Xq28 multiple myeloma
XRN1 5'-3' exoribonuclease 1 3q23 osteosarcoma
XYLT1 xylosyltransferase I 16p12.3 eastern equine encephalitis, "pseudoxanthoma elasticum, modifier of severity of", desbuquois dysplasia 2,
XYLT2 xylosyltransferase II 17q21.33 eastern equine encephalitis, scleroderma "pseudoxanthoma elasticum, modifier of severity of"
YAP1 Yes-associated protein 1 11q22.1 epithelioid hemangioendothelioma, coloboma, japanese spotted fever
YARS tyrosyl-tRNA synthetase 1p35.1 intermediate charcot-marie-tooth neuropathy, primary cutaneous amyloidosis, bamforth-lazarus syndrome ,
YARS2 tyrosyl-tRNA synthetase 2, mitochondrial 12p11.21 sideroblastic anemia, lactic acidosis, "myopathy, lactic acidosis, and sideroblastic anemia 2"
YES1 v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 18p11.32 sarcoma megaesophagus
YIPF4 Yip1 domain family, member 4 2p22.3 skin sarcoidosis
YME1L1 YME1-like 1 ATPase 10p12.1 pulmonary valve insufficiency
YOD1 YOD1 deubiquitinase 1q32.2 hiv-1
YPEL1 yippee-like 1 (Drosophila) 22q11.21 digeorge syndrome
YPEL3 yippee-like 3 (Drosophila) 16p11.2 estrogen-receptor positive breast cancer
YRDC yrdC N(6)-threonylcarbamoyltransferase domain containing 1p34.3 ischemia
YTHDF1 YTH domain family, member 1 20q13.33 dermatomyositis
YTHDF2 YTH domain family, member 2 1p35.3 acute myeloid leukemia myeloid leukemia
YWHAE tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon 17p13.3 periventricular heterotopia, lung cancer, miller-dieker syndrome,
YWHAH tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta 22q12.3 schizophrenia, bipolar disorder early-onset schizophrenia
YWHAQ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta 2p25.1 amyotrophic lateral sclerosis
YY1 YY1 transcription factor 14q32.2 hailey-hailey disease cervical intraepithelial neoplasia
YY1AP1 YY1 associated protein 1 1q22 hepatocellular carcinoma
YY2 YY2 transcription factor Xp22.12 breast and colorectal cancer genital herpes
ZACN zinc activated ligand-gated ion channel 17q25.1 idiopathic generalized epilepsy transient neonatal diabetes mellitus
ZAK sterile alpha motif and leucine zipper containing kinase AZK 2q31.1 cervical cancer
ZAN zonadhesin (gene/pseudogene) 7q22.1 diffuse panbronchiolitis
ZAP70 zeta-chain (TCR) associated protein kinase 70kDa 2q11.2 juvenile nasopharyngeal angiofibroma, b-cell chronic lymphocytic leukemia, chronic lymphocytic leukemia,
ZAR1 zygote arrest 1 4p11 western equine encephalitis
ZASP ZO-2 associated speckle protein "myopathy, myofibrillar, 4", "left ventricular noncompaction 3, with or without dilated cardiomyopathy" "cardiomyopathy, dilated 1c"
ZBTB1 zinc finger and BTB domain containing 1 14q23.3 t cell deficiency
ZBTB16 zinc finger and BTB domain containing 16 11q23.2 leukemia, acute promyelocytic leukemia, mednik syndrome ,
ZBTB18 zinc finger and BTB domain containing 18 1q44 barth syndrome "mental retardation, autosomal dominant 22"
ZBTB20 zinc finger and BTB domain containing 20 3q13.31 juvenile pilocytic astrocytoma
ZBTB24 zinc finger and BTB domain containing 24 6q21 immunodeficiency-centromeric instability-facial anomalies syndrome-2
ZBTB32 zinc finger and BTB domain containing 32 19q13.12 fanconis anemia primary syphilis
ZBTB38 zinc finger and BTB domain containing 38 3q23 kuru
ZBTB7A zinc finger and BTB domain containing 7A 19p13.3 hiv-1
ZC3H12D zinc finger CCCH-type containing 12D 6q25.1 salla disease , patellofemoral pain syndrome, decubitus ulcer
ZC3H13 zinc finger CCCH-type containing 13 13q14.13 imperforate anus esotropia
ZC3H14 zinc finger CCCH-type containing 14 14q31.3 "mental retardation, autosomal recessive 43"
ZC3HAV1 zinc finger CCCH-type, antiviral 1 7q34 diphtheria
ZC4H2 zinc finger, C4H2 domain containing Xq11.2 hepatocellular carcinoma wieacker-wolf syndrome
ZCCHC12 zinc finger, CCHC domain containing 12 Xq24 papillary thyroid carcinoma
ZCRB1 zinc finger CCHC-type and RNA binding motif 1 12q12 morphine dependence
ZD1 Zygodactyly 1 3p21.31 zygodactyly 1
ZDHHC15 zinc finger, DHHC-type containing 15 Xq13.3 dihydropyrimidinase deficiency
ZDHHC20P2 zinc finger, DHHC-type containing 20 pseudogene 2 6p21.33 hiv-1
ZDHHC8 zinc finger, DHHC-type containing 8 22q11.21 schizophrenia
ZDHHC9 zinc finger, DHHC-type containing 9 Xq26.1 lujan syndrome "mental retardation, x-linked, syndromic, raymond type"
ZEB1 zinc finger E-box binding homeobox 1 10p11.22 corneal dystrophy fuchs endothelial 1, corneal dystrophy, posterior polymorphous corneal dystrophy,
ZEB2 zinc finger E-box binding homeobox 2 2q22.3 hirschsprungs disease, mowat-wilson syndrome, mowat-wilson syndrome due to monosomy 2q22
ZFAT zinc finger and AT hook domain containing 8q24.22 croup
ZFHX3 zinc finger homeobox 3 16q22.3 prostate cancer
ZFHX4 zinc finger homeobox 4 8q21.11 pineoblastoma, chordoid glioma "ptosis, congenital"
ZFP42 ZFP42 zinc finger protein 4q35.2 male germ cell tumor chromophobe adenocarcinoma
ZFP57 ZFP57 zinc finger protein 6p22.1 diabetes mellitus, frasier syndrome, silver-russell syndrome,
ZFP90 ZFP90 zinc finger protein 16q22.1 opa3-related 3-methylglutaconic aciduria "spastic paraplegia, optic atrophy, and neuropathy"
ZFPM1 zinc finger protein, FOG family member 1 16q24.2 x-linked thrombocytopenia dyserythropoietic anemia and thrombocytopenia
ZFPM2 zinc finger protein, FOG family member 2 8q23.1 tetralogy of fallot , tetrology of fallot, double outlet right ventricle,
ZFR zinc finger RNA binding protein 5p13.3 cri-du-chat syndrome autosomal recessive spastic paraplegia type 71
ZFX zinc finger protein, X-linked Xp22.11 x-linked disease retinoschisis
ZFY zinc finger protein, Y-linked Yp11.31 hermaphroditism, prostate adenocarcinoma, campomelic dysplasia
ZFYVE26 zinc finger, FYVE domain containing 26 14q24.1 spastic paraplegia 15
ZFYVE27 zinc finger, FYVE domain containing 27 10q24.2 hereditary spastic paraplegia, carotid artery thrombosis, spastic paraplegia 33
ZG16B zymogen granule protein 16B 16p13.3 adenocarcinoma pancreatic ductal adenocarcinoma
ZIC1 Zic family member 1 3q24 neural tube defects, medulloblastoma, spina bifida,
ZIC2 Zic family member 2 13q32.3 moyamoya disease, septopreoptic holoprosencephaly, midline interhemispheric variant of holoprosencephaly,
ZIC3 Zic family member 3 Xq26.3 neural tube defects, heterotaxy, congenital heart disease,
ZIC4 Zic family member 4 3q24 paraneoplastic neurologic disorders, heterotaxy, visceral heterotaxy,
ZIC5 Zic family member 5 13q32.3 heterotaxy visceral heterotaxy
ZKSCAN5 zinc finger with KRAB and SCAN domains 5 7q22.1 pharyngitis
ZLS Zimmerman-Laband Syndrome 3p21.2 elephantiasis, zimmermann-laband syndrome laband syndrome
ZMIZ1 zinc finger, MIZ-type containing 1 10q22.3 lymphoblastic leukemia
ZMIZ2 zinc finger, MIZ-type containing 2 7p13 blepharitis
ZMPSTE24 zinc metallopeptidase STE24 1p34.2 mandibuloacral dysplasia, progeria, "lethal restrictive dermopathy, zmpste24-related",
ZMYM2 zinc finger, MYM-type 2 13q12.11 myeloproliferative disorder 8p11 myeloproliferative syndrome
ZMYM6 zinc finger, MYM-type 6 1p34.3 non-specific x-linked mental retardation
ZMYND10 zinc finger, MYND-type containing 10 3p21.31 "ciliary dyskinesia, primary, 19", choroid plexus papilloma, nasopharynx carcinoma,
ZMYND15 zinc finger, MYND-type containing 15 17p13.2 spermatogenic failure 13 spermatogenic failure 14
ZNF106 zinc finger protein 106 15q15.1 congenital dyserythropoietic anemia type i
ZNF124 zinc finger protein 124 1q44 dandy-walker complex
ZNF133 zinc finger protein 133 20p11.23 osteoblastoma
ZNF135 zinc finger protein 135 19q13.43 renal pelvis carcinoma ureteral benign neoplasm
ZNF141 zinc finger protein 141 4p16.3 postaxial polydactyly type a, "postaxial polydactyly type a, bilateral" "polydactyly, postaxial, type a6"
ZNF143 zinc finger protein 143 11p15.4 roberts syndrome
ZNF17 zinc finger protein 17 19q13.43 croup parainfluenza virus type 3
ZNF185 zinc finger protein 185 (LIM domain) Xq28 intussusception
ZNF213 zinc finger protein 213 16p13.3 patent ductus arteriosus
ZNF217 zinc finger protein 217 20q13.2 ovarian serous cystadenocarcinoma ovarian cystadenocarcinoma
ZNF230 zinc finger protein 230 19q13.31 lung cancer lung cancer susceptibility
ZNF25 zinc finger protein 25 10p11.1 sipple syndrome
ZNF280D zinc finger protein 280D 15q21.3 doid:4019 articulation disorder
ZNF296 zinc finger protein 296 19q13.32 acute myeloid leukemia
ZNF32 zinc finger protein 32 10q11.21 viral encephalitis
ZNF334 zinc finger protein 334 20q13.12 rheumatoid arthritis
ZNF335 zinc finger protein 335 20q13.12 primary syphilis "microcephaly 10, primary, autosomal recessive"
ZNF33A zinc finger protein 33A 10p11.1 sipple syndrome
ZNF347 zinc finger protein 347 19q13.42 chikungunya
ZNF350 zinc finger protein 350 19q13.41 breast cancer, neuroma acoustic neuroma
ZNF354C zinc finger protein 354C 5q35.3 ischemia
ZNF365 zinc finger protein 365 10q21.2 nephrolithiasis, acute urate nephropathy, narcolepsy 1
ZNF384 zinc finger protein 384 12p13.31 acute leukemia
ZNF395 zinc finger protein 395 8p21.1 huntingtons disease
ZNF408 zinc finger protein 408 11p11.2 exudative vitreoretinopathy
ZNF41 zinc finger protein 41 Xp11.23 "mental retardation, x-linked 17/31, microduplication", eye disease aland island eye disease
ZNF423 zinc finger protein 423 16q12.1 nephronophthisis, joubert syndrome 19 , nephronophthisis 14
ZNF444 zinc finger protein 444 19q13.43 epithelial-myoepithelial carcinoma
ZNF467 zinc finger protein 467 7q36.1 idiopathic pulmonary fibrosis
ZNF469 zinc finger protein 469 16q24.2 brittle cornea syndrome 1 type vi ehlers-danlos syndrome
ZNF513 zinc finger protein 513 2p23.3 leber congenital amaurosis, retinitis pigmentosa 58 znf513-related retinitis pigmentosa
ZNF519 zinc finger protein 519 18p11.21 nail disease
ZNF577 zinc finger protein 577 19q13.41 hemorrhagic thrombocythemia
ZNF592 zinc finger protein 592 15q25.3 ataxia, spinocerebellar ataxia autosomal recessive 5 spinocerebellar ataxia
ZNF644 zinc finger protein 644 1p22.2 myopia "myopia 21, autosomal dominant"
ZNF674 zinc finger protein 674 Xp11.23 "mental retardation, x-linked 17/31, microduplication", xp11.3 deletion syndrome znf674-related x-linked mental retardation
ZNF699 zinc finger protein 699 19p13.2 alcohol dependence hangover
ZNF711 zinc finger protein 711 Xq21.1 "mental retardation, x-linked 17/31, microduplication", allan-herndon-dudley syndrome, znf711-related x-linked mental retardation
ZNF74 zinc finger protein 74 22q11.21 tetralogy of fallot atrioventricular septal defect
ZNF750 zinc finger protein 750 17q25.3 dermatitis seborrhea-like dermatitis with psoriasiform elements
ZNF764 zinc finger protein 764 16p11.2 thyroid hormone resistance syndrome 16p11.2 microdeletion
ZNF77 zinc finger protein 77 19p13.3 epididymitis, bladder diverticulum tuberculous epididymitis
ZNF778 zinc finger protein 778 16q24.3 16q24.3 microdeletion syndrome kbg syndrome
ZNF783 zinc finger family member 783 7q36.1 acrodysostosis
ZNF79 zinc finger protein 79 9q33.3 prostate carcinoma in situ
ZNF80 zinc finger protein 80 3q13.31 endogenous depression
ZNF804A zinc finger protein 804A 2q32.1 schizotypal personality disorder
ZNF81 zinc finger protein 81 Xp11.23 "mental retardation, x-linked 17/31, microduplication", mental retardation, "mental retardation, x-linked",
ZNF83 zinc finger protein 83 19q13.41 croup
ZNF85 zinc finger protein 85 19p12 anteroseptal myocardial infarction
ZNF92 zinc finger protein 92 7q11.21 myocardial stunning
ZNHIT6 zinc finger, HIT-type containing 6 1p22.3 breast cancer
ZNRD1 zinc ribbon domain containing 1 6p22.1 gastric adenocarcinoma
ZP1 zona pellucida glycoprotein 1 (sperm receptor) 11q12.2 oophoritis, female infertility due to zona pellucida defect oocyte maturation defect
ZP2 zona pellucida glycoprotein 2 (sperm receptor) 16p12.2 oophoritis acheiropody
ZP3 zona pellucida glycoprotein 3 (sperm receptor) 7q11.23 oophoritis
ZP4 zona pellucida glycoprotein 4 1q43 oophoritis
ZPBP2 zona pellucida binding protein 2 17q12 primary biliary cirrhosis
ZRANB3 zinc finger, RAN-binding domain containing 3 2q21.3 speech disorder
ZSCAN16 zinc finger and SCAN domain containing 16 6p22.1 breast and colorectal cancer
ZSCAN20 zinc finger and SCAN domain containing 20 1p35.1 intermediate charcot-marie-tooth neuropathy
ZSCAN29 zinc finger and SCAN domain containing 29 15q15.3 congenital dyserythropoietic anemia type i congenital dyserythropoietic anemia
ZSCAN32 zinc finger and SCAN domain containing 32 16p13.3 cervical cancer
ZW10 zw10 kinetochore protein 11q23.2 roberts syndrome
ZWINT ZW10 interacting kinetochore protein 10q21.1 roberts syndrome
ZXDC ZXD family zinc finger C 3q21.3 rectum adenocarcinoma
ZYX zyxin 7q34 tetraploidy
